Citrus Sinensis ID: 021053
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 318 | 2.2.26 [Sep-21-2011] | |||||||
| P42158 | 450 | Casein kinase I isoform d | no | no | 0.883 | 0.624 | 0.758 | 1e-132 | |
| Q5BP74 | 415 | Casein kinase I isoform d | N/A | no | 0.883 | 0.677 | 0.708 | 1e-121 | |
| Q5ZLL1 | 416 | Casein kinase I isoform e | yes | no | 0.883 | 0.675 | 0.711 | 1e-121 | |
| Q6P647 | 415 | Casein kinase I isoform d | no | no | 0.883 | 0.677 | 0.708 | 1e-121 | |
| Q7T2E3 | 403 | Casein kinase I isoform d | yes | no | 0.883 | 0.697 | 0.711 | 1e-121 | |
| Q9JMK2 | 416 | Casein kinase I isoform e | yes | no | 0.883 | 0.675 | 0.708 | 1e-121 | |
| Q6P3K7 | 409 | Casein kinase I isoform d | no | no | 0.883 | 0.687 | 0.708 | 1e-121 | |
| P48730 | 415 | Casein kinase I isoform d | yes | no | 0.883 | 0.677 | 0.704 | 1e-121 | |
| P35508 | 415 | Casein kinase I isoform d | yes | no | 0.883 | 0.677 | 0.704 | 1e-121 | |
| Q06486 | 415 | Casein kinase I isoform d | no | no | 0.883 | 0.677 | 0.704 | 1e-121 |
| >sp|P42158|KC1D_ARATH Casein kinase I isoform delta-like OS=Arabidopsis thaliana GN=At4g26100 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 470 bits (1209), Expect = e-132, Method: Compositional matrix adjust.
Identities = 213/281 (75%), Positives = 254/281 (90%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G K++LGRKIGSGSFGEI+L +++ TNE +A+K+EN TKHPQLLYE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+G+PN+KW+GV+G+ NVLV+DLLGPSLEDLF +C RK SLK+VLMLADQMI R+E+ H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ FLHRD+KPDNFLMGLGR+ANQVYIIDFGLAKKYRD TT++HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGY+L+YFL+GSLPWQGLKA TKKQKY++I EKKVST IE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
C+ +P+EFASYFHYC+SL FD +PDY +LKR+F DLF REG
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. It can phosphorylate a large number of proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q5BP74|KC1D_XENLA Casein kinase I isoform delta OS=Xenopus laevis GN=csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 436 bits (1120), Expect = e-121, Method: Compositional matrix adjust.
Identities = 199/281 (70%), Positives = 245/281 (87%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + +E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAASEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Isoform 1 can phosphorylate a large number of proteins. Isoform 2 has no kinase activity. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5ZLL1|KC1E_CHICK Casein kinase I isoform epsilon OS=Gallus gallus GN=CSNK1E PE=2 SV=2 | Back alignment and function description |
|---|
Score = 435 bits (1118), Expect = e-121, Method: Compositional matrix adjust.
Identities = 200/281 (71%), Positives = 246/281 (87%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G KY+LGRKIGSGSFG+I+L +++ T E VA+K+E TKHPQL E+K YK++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIATGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP+IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CK +P+EF++Y ++C+SL FD +PDY +L++LF +LF R+G
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P647|KC1D_XENTR Casein kinase I isoform delta OS=Xenopus tropicalis GN=csnk1d PE=2 SV=1 | Back alignment and function description |
|---|
Score = 434 bits (1116), Expect = e-121, Method: Compositional matrix adjust.
Identities = 199/281 (70%), Positives = 244/281 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAAEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Xenopus tropicalis (taxid: 8364) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T2E3|KC1DA_DANRE Casein kinase I isoform delta-A OS=Danio rerio GN=csnk1da PE=2 SV=1 | Back alignment and function description |
|---|
Score = 434 bits (1116), Expect = e-121, Method: Compositional matrix adjust.
Identities = 200/281 (71%), Positives = 245/281 (87%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + T E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDITTGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9JMK2|KC1E_MOUSE Casein kinase I isoform epsilon OS=Mus musculus GN=Csnk1e PE=1 SV=2 | Back alignment and function description |
|---|
Score = 434 bits (1116), Expect = e-121, Method: Compositional matrix adjust.
Identities = 199/281 (70%), Positives = 246/281 (87%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G KY+LGRKIGSGSFG+I+L +++ + E VA+K+E TKHPQL E+K YK++Q
Sbjct: 1 MELRVGNKYRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP+IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPSIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CK +P+EF++Y ++C+SL FD +PDY +L++LF +LF R+G
Sbjct: 241 CKGYPSEFSTYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Can phosphorylate a large number of proteins. Participates in Wnt signaling. Phosphorylates DVL1. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2. Retains PER1 in the cytoplasm. Inhibits cytokine-induced granuloytic differentiation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P3K7|KC1DB_DANRE Casein kinase I isoform delta-B OS=Danio rerio GN=csnk1db PE=2 SV=1 | Back alignment and function description |
|---|
Score = 433 bits (1114), Expect = e-121, Method: Compositional matrix adjust.
Identities = 199/281 (70%), Positives = 244/281 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDISVGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP IKW G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIKWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating per1 and per2, which may lead to their degradation. Participates in wnt signaling. Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P48730|KC1D_HUMAN Casein kinase I isoform delta OS=Homo sapiens GN=CSNK1D PE=1 SV=2 | Back alignment and function description |
|---|
Score = 433 bits (1114), Expect = e-121, Method: Compositional matrix adjust.
Identities = 198/281 (70%), Positives = 244/281 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|P35508|KC1D_BOVIN Casein kinase I isoform delta OS=Bos taurus GN=CSNK1D PE=2 SV=2 | Back alignment and function description |
|---|
Score = 433 bits (1114), Expect = e-121, Method: Compositional matrix adjust.
Identities = 198/281 (70%), Positives = 244/281 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
| >sp|Q06486|KC1D_RAT Casein kinase I isoform delta OS=Rattus norvegicus GN=Csnk1d PE=1 SV=2 | Back alignment and function description |
|---|
Score = 433 bits (1114), Expect = e-121, Method: Compositional matrix adjust.
Identities = 198/281 (70%), Positives = 244/281 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
Essential serine/threonine-protein kinase that regulates diverse cellular growth and survival processes including Wnt signaling, DNA repair and circadian rhythms. It can phosphorylate a large number of proteins. Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Phosphorylates connexin-43/GJA1, MAP1A, SNAPIN, MAPT/TAU, TOP2A, DCK, HIF1A, EIF6, p53/TP53, DVL2, DVL3, ESR1, AIB1/NCOA3, DNMT1, PKD2, YAP1, PER1 and PER2. Central component of the circadian clock. May act as a negative regulator of circadian rhythmicity by phosphorylating PER1 and PER2, leading to retain PER1 in the cytoplasm. YAP1 phosphorylation promotes its SCF(beta-TRCP) E3 ubiquitin ligase-mediated ubiquitination and subsequent degradation. DNMT1 phosphorylation reduces its DNA-binding activity. Phosphorylation of ESR1 and AIB1/NCOA3 stimulates their activity and coactivation. Phosphorylation of DVL2 and DVL3 regulates WNT3A signaling pathway that controls neurite outgrowth. EIF6 phosphorylation promotes its nuclear export. Triggers down-regulation of dopamine receptors in the forebrain. Activates DCK in vitro by phosphorylation. TOP2A phosphorylation favors DNA cleavable complex formation. May regulate the formation of the mitotic spindle apparatus in extravillous trophoblast. Modulates connexin-43/GJA1 gap junction assembly by phosphorylation. Probably involved in lymphocyte physiology. Regulates fast synaptic transmission mediated by glutamate. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 6 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 318 | ||||||
| 359484562 | 433 | PREDICTED: casein kinase I isoform delta | 0.883 | 0.648 | 0.911 | 1e-153 | |
| 356523722 | 430 | PREDICTED: casein kinase I isoform delta | 0.883 | 0.653 | 0.914 | 1e-153 | |
| 356513159 | 430 | PREDICTED: casein kinase I isoform delta | 0.883 | 0.653 | 0.914 | 1e-153 | |
| 356531301 | 426 | PREDICTED: casein kinase I isoform delta | 0.883 | 0.659 | 0.914 | 1e-152 | |
| 388495184 | 431 | unknown [Lotus japonicus] | 0.883 | 0.651 | 0.907 | 1e-151 | |
| 356495220 | 662 | PREDICTED: casein kinase I isoform delta | 0.883 | 0.424 | 0.907 | 1e-151 | |
| 224142173 | 424 | predicted protein [Populus trichocarpa] | 0.883 | 0.662 | 0.914 | 1e-151 | |
| 449530861 | 433 | PREDICTED: casein kinase I isoform delta | 0.880 | 0.646 | 0.907 | 1e-150 | |
| 357520927 | 430 | Casein kinase I isoform delta-like prote | 0.952 | 0.704 | 0.832 | 1e-149 | |
| 357500563 | 424 | Casein kinase I isoform delta-like prote | 0.883 | 0.662 | 0.889 | 1e-149 |
| >gi|359484562|ref|XP_002284044.2| PREDICTED: casein kinase I isoform delta-like [Vitis vinifera] gi|297738784|emb|CBI28029.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 546 bits (1407), Expect = e-153, Method: Compositional matrix adjust.
Identities = 256/281 (91%), Positives = 269/281 (95%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G KYKLGRKIGSGSFGEI+LA+HVDT EIVAVKIENS TKHPQLLYEAK+Y +LQ
Sbjct: 1 MERIVGGKYKLGRKIGSGSFGEIYLATHVDTFEIVAVKIENSKTKHPQLLYEAKLYNLLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP I+W G+DG+DN+LVLDLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEYVH
Sbjct: 61 GGSGIPGIRWSGIDGDDNILVLDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REG
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFTREG 281
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356523722|ref|XP_003530484.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 546 bits (1406), Expect = e-153, Method: Compositional matrix adjust.
Identities = 257/281 (91%), Positives = 270/281 (96%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIVGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIPNIKW G+DGEDNVLV+DLLGPSLEDLFVYC RKFSLKTVL+LADQMI RIEYVH
Sbjct: 61 GGSGIPNIKWSGIDGEDNVLVIDLLGPSLEDLFVYCGRKFSLKTVLLLADQMITRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC+KK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICQKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REG
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFAREG 281
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356513159|ref|XP_003525281.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 545 bits (1405), Expect = e-153, Method: Compositional matrix adjust.
Identities = 257/281 (91%), Positives = 270/281 (96%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIVGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIPNIKW G+DGEDNVLV+DLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEYVH
Sbjct: 61 GGSGIPNIKWSGIDGEDNVLVIDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC+KK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICQKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+R+G
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFARDG 281
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356531301|ref|XP_003534216.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 543 bits (1398), Expect = e-152, Method: Compositional matrix adjust.
Identities = 257/281 (91%), Positives = 268/281 (95%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERIIG KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIEN TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIIGAKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENGKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP+IKW GVDGEDNVLV+DLLGPSLEDLFVYC RKFSLK+VLMLADQM+ RIEYVH
Sbjct: 61 GGSGIPSIKWCGVDGEDNVLVMDLLGPSLEDLFVYCGRKFSLKSVLMLADQMMTRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ LKAATKKQKYDKICEKKVSTPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQNLKAATKKQKYDKICEKKVSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REG
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFTREG 281
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388495184|gb|AFK35658.1| unknown [Lotus japonicus] | Back alignment and taxonomy information |
|---|
Score = 541 bits (1395), Expect = e-151, Method: Compositional matrix adjust.
Identities = 255/281 (90%), Positives = 267/281 (95%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G KYKLGRKIGSGSFGEI+LA+H+DT EIVAVKIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIVGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP +W GVDGEDNVLVLDLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEY H
Sbjct: 61 GGSGIPGTRWSGVDGEDNVLVLDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYAH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD +TNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSSTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC+KK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICQKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REG
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFAREG 281
|
Source: Lotus japonicus Species: Lotus japonicus Genus: Lotus Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495220|ref|XP_003516477.1| PREDICTED: casein kinase I isoform delta-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1390), Expect = e-151, Method: Compositional matrix adjust.
Identities = 255/281 (90%), Positives = 267/281 (95%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERII KYKLGRKIGSGSFGEI+LA+++DT EIVAVKIEN TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIICAKYKLGRKIGSGSFGEIYLATNIDTFEIVAVKIENGKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIPNIKW GVDGEDNVLV+DLLGPSLEDLFVYC RKFSLK+VLMLADQM+ RIEYVH
Sbjct: 61 GGSGIPNIKWCGVDGEDNVLVMDLLGPSLEDLFVYCGRKFSLKSVLMLADQMMTRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD +TNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDSSTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ LKAATKKQKYDKICEKKVSTPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQNLKAATKKQKYDKICEKKVSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REG
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFAREG 281
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224142173|ref|XP_002324433.1| predicted protein [Populus trichocarpa] gi|222865867|gb|EEF02998.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 539 bits (1388), Expect = e-151, Method: Compositional matrix adjust.
Identities = 257/281 (91%), Positives = 266/281 (94%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERIIG KYKLGRKIGSGSFGEI+LA+H+DT EIVA+KIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIIGGKYKLGRKIGSGSFGEIYLATHIDTFEIVAIKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP+IKW GVDGEDN LVLDLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEYVH
Sbjct: 61 GGSGIPSIKWSGVDGEDNALVLDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDATTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CKSHP EFASY HYC SLTFDQRPDYGFLKRLF DLFS G
Sbjct: 241 CKSHPVEFASYMHYCHSLTFDQRPDYGFLKRLFRDLFSHGG 281
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449530861|ref|XP_004172410.1| PREDICTED: casein kinase I isoform delta-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1386), Expect = e-150, Method: Compositional matrix adjust.
Identities = 254/280 (90%), Positives = 267/280 (95%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MER+IG KYKLGRKIGSGSFGEI+LA+H++T EIVAVKIEN+ TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERVIGGKYKLGRKIGSGSFGEIYLATHIETFEIVAVKIENNKTKHPQLLYEAKLYSILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP KW G+DGE+NVLVLDLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEYVH
Sbjct: 61 GGSGIPATKWSGIDGEENVLVLDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRDATTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKLSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+RE
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFARE 280
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357520927|ref|XP_003630752.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355524774|gb|AET05228.1| Casein kinase I isoform delta-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 533 bits (1373), Expect = e-149, Method: Compositional matrix adjust.
Identities = 253/304 (83%), Positives = 275/304 (90%), Gaps = 1/304 (0%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERI+G YKLGRKIGSGSFGEI+LA+H+DT EIVAVKIENS TKHPQLLYEAK+Y ILQ
Sbjct: 1 MERIVGGSYKLGRKIGSGSFGEIYLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP +KW+G+D EDNVL +DLLGPSLEDLFVYC RKFSLKTVLMLADQMI RIEYVH
Sbjct: 61 GGSGIPGLKWFGIDREDNVLAIDLLGPSLEDLFVYCGRKFSLKTVLMLADQMITRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+G+LHRDIKPDNFLMGLGRKANQVYIIDFGLAK+YR+ TTNRHIPYRENK+LTGTARYA
Sbjct: 121 SKGYLHRDIKPDNFLMGLGRKANQVYIIDFGLAKRYRESTTNRHIPYRENKSLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL+AATKKQKY+KIC+KKVSTPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLRAATKKQKYEKICQKKVSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMSYCSLHSITFQ 300
CKSHP EFASYFHYC SLTFDQRPDYGFLKRLF DLF+REG F+ + L Q
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLKRLFRDLFAREGH-EFDFVFDWTILKYQQSQ 299
Query: 301 TNII 304
N++
Sbjct: 300 KNLV 303
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357500563|ref|XP_003620570.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|357500745|ref|XP_003620661.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355495585|gb|AES76788.1| Casein kinase I isoform delta-like protein [Medicago truncatula] gi|355495676|gb|AES76879.1| Casein kinase I isoform delta-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 533 bits (1372), Expect = e-149, Method: Compositional matrix adjust.
Identities = 250/281 (88%), Positives = 266/281 (94%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+RIIG K+KLGRKIGSGSFGEI+LA+H+DT EIVAVKIE TKHPQLLYEAK+Y ILQ
Sbjct: 1 MDRIIGDKFKLGRKIGSGSFGEIYLATHIDTFEIVAVKIETGKTKHPQLLYEAKLYNILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP+I+W GVDGEDNVLV+DLLGPSLEDLFVYC RKFSLKTVLMLADQM+ RIEYVH
Sbjct: 61 GGSGIPSIRWSGVDGEDNVLVMDLLGPSLEDLFVYCGRKFSLKTVLMLADQMMTRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+GFLHRDIKPDNFLMGLGRKAN VY+IDFGLAK+YRD TTNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGFLHRDIKPDNFLMGLGRKANLVYVIDFGLAKRYRDSTTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ LKAATKKQKYDKICEKKVSTPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQNLKAATKKQKYDKICEKKVSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CKSHP EFASYFHYC SLTFDQRPDYGFL+RLF +LF+REG
Sbjct: 241 CKSHPVEFASYFHYCHSLTFDQRPDYGFLRRLFRELFAREG 281
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 318 | ||||||
| TAIR|locus:2117778 | 415 | ckl3 "casein kinase I-like 3" | 0.883 | 0.677 | 0.882 | 2e-136 | |
| TAIR|locus:2117843 | 414 | ckl4 "casein kinase I-like 4" | 0.883 | 0.678 | 0.875 | 8.5e-136 | |
| TAIR|locus:504954933 | 435 | ckl12 "casein kinase I-like 12 | 0.883 | 0.645 | 0.772 | 6.5e-122 | |
| TAIR|locus:2167634 | 476 | ckl7 "casein kinase I-like 7" | 0.883 | 0.590 | 0.772 | 7.4e-121 | |
| UNIPROTKB|Q6K9N1 | 463 | OJ1234_B11.27 "Os02g0622100 pr | 0.911 | 0.626 | 0.742 | 1.2e-120 | |
| TAIR|locus:2120765 | 450 | CK1 "casein kinase 1" [Arabido | 0.883 | 0.624 | 0.758 | 2e-120 | |
| TAIR|locus:2024147 | 471 | ADK1 "dual specificity kinase | 0.883 | 0.596 | 0.768 | 2.5e-120 | |
| TAIR|locus:2121338 | 479 | CKL6 "casein kinase I-like 6" | 0.883 | 0.586 | 0.772 | 4.1e-120 | |
| UNIPROTKB|Q70YQ4 | 463 | Q70YQ4 "Putative casein kinase | 0.911 | 0.626 | 0.738 | 1.1e-119 | |
| TAIR|locus:2030170 | 465 | CKL2 "casein kinase 1-like pro | 0.880 | 0.602 | 0.765 | 1.1e-119 |
| TAIR|locus:2117778 ckl3 "casein kinase I-like 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1336 (475.4 bits), Expect = 2.0e-136, P = 2.0e-136
Identities = 248/281 (88%), Positives = 264/281 (93%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERIIG KYKLGRKIG GSFGEIFLA+HVDT EIVAVKIENS TKHPQLLYEAK+Y+IL+
Sbjct: 1 MERIIGGKYKLGRKIGGGSFGEIFLATHVDTFEIVAVKIENSKTKHPQLLYEAKLYRILE 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP IKW+GVDG +N LV+DLLGPSLEDLFVYC RKFS KTVLMLADQM+ RIE+VH
Sbjct: 61 GGSGIPRIKWFGVDGTENALVMDLLGPSLEDLFVYCGRKFSPKTVLMLADQMLTRIEFVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+G+LHRDIKPDNFLMGLGRKANQVY+IDFGLAK+YRD TNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGYLHRDIKPDNFLMGLGRKANQVYLIDFGLAKRYRDANTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA KKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAVDKKQKYDKICEKKISTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CK+HP EFASYFHYC +LTFDQRPDYGFLKRLF DLFSREG
Sbjct: 241 CKNHPVEFASYFHYCHTLTFDQRPDYGFLKRLFRDLFSREG 281
|
|
| TAIR|locus:2117843 ckl4 "casein kinase I-like 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1330 (473.2 bits), Expect = 8.5e-136, P = 8.5e-136
Identities = 246/281 (87%), Positives = 262/281 (93%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
MERIIG KYKLGRKIG GSFGEIFLA+H+DT EIVAVKIENS TKHPQLLYEAK+Y+ L+
Sbjct: 1 MERIIGGKYKLGRKIGGGSFGEIFLATHIDTFEIVAVKIENSKTKHPQLLYEAKLYRTLE 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP I+W+GVDG +N LV+DLLGPSLEDLFVYC RKFS KTVLMLADQM+ RIEYVH
Sbjct: 61 GGSGIPRIRWFGVDGTENALVMDLLGPSLEDLFVYCGRKFSPKTVLMLADQMLTRIEYVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+G+LHRDIKPDNFLMGLGRKANQVY+IDFGLAK+YRD TNRHIPYRENKNLTGTARYA
Sbjct: 121 SKGYLHRDIKPDNFLMGLGRKANQVYLIDFGLAKRYRDANTNRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
SCNTHLGIEQ RRDDLESLGYVLLYFLRGSLPWQGLKA KKQKYDKICEKK+STPIEVL
Sbjct: 181 SCNTHLGIEQGRRDDLESLGYVLLYFLRGSLPWQGLKAVDKKQKYDKICEKKISTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CKSHP EFASYFHYC +LTFDQRPDYGFLKRLF DLFSREG
Sbjct: 241 CKSHPVEFASYFHYCHTLTFDQRPDYGFLKRLFRDLFSREG 281
|
|
| TAIR|locus:504954933 ckl12 "casein kinase I-like 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1199 (427.1 bits), Expect = 6.5e-122, P = 6.5e-122
Identities = 217/281 (77%), Positives = 254/281 (90%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G KY+LGRKIGSGSFGEI+L +H+ TNE VA+K+EN TKHPQLLYE+K+Y+ILQ
Sbjct: 1 MEPRVGNKYRLGRKIGSGSFGEIYLGTHIQTNEEVAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+G+PNIKW+GV+G+ N LV+DLLGPSLEDLF +C RK SLK+VLMLADQMI R+EY H
Sbjct: 61 GGTGVPNIKWFGVEGDYNTLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEYFH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ FLHRD+KPDNFLMGLGR+ANQV+IIDFGLAKKYRD TT++HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVHIIDFGLAKKYRDNTTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGY+L+YFL+GSLPWQGLKA TKKQKY++I EKKVST IE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIESL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
C+ +P+EFASYFHYC+SL FD +PDYG+LKR+F DLF REG
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYGYLKRIFRDLFIREG 281
|
|
| TAIR|locus:2167634 ckl7 "casein kinase I-like 7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1189 (423.6 bits), Expect = 7.4e-121, P = 7.4e-121
Identities = 217/281 (77%), Positives = 252/281 (89%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+ +IG K+KLG+KIGSGSFGE++L +V T E VAVK+EN TKHPQL YE+K+Y +LQ
Sbjct: 1 MDLVIGGKFKLGKKIGSGSFGELYLGVNVQTGEEVAVKLENVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIPNIKW+GV+G+ +V+V+DLLGPSLEDLF YC RK +LKTVLMLADQ++ R+E++H
Sbjct: 61 GGSGIPNIKWFGVEGDYSVMVIDLLGPSLEDLFNYCNRKLTLKTVLMLADQLLNRVEFMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+RGFLHRDIKPDNFLMGLGRKANQVYIIDFGL KKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLG+EQSRRDDLESLGYVL+YFL+GSLPWQGLKA TKKQKYD+I EKKVSTPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CK+ P+EF SYFHYC+SL FD +PDY +LKRLF DLF REG
Sbjct: 241 CKNQPSEFVSYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281
|
|
| UNIPROTKB|Q6K9N1 OJ1234_B11.27 "Os02g0622100 protein" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1187 (422.9 bits), Expect = 1.2e-120, P = 1.2e-120
Identities = 216/291 (74%), Positives = 258/291 (88%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +IG K+KLGRKIGSGSFGE++L ++ ++E VA+K+E+ ++HPQL YE+K+Y +LQ
Sbjct: 1 MEHVIGGKFKLGRKIGSGSFGELYLGVNIQSSEEVAIKLESVKSRHPQLHYESKLYMLLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+GIP++KW+GV+GE NV+V+DLLGPSLEDLF YC RKFSLKTVLMLADQMI R+EY+H
Sbjct: 61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+RGFLHRDIKPDNFLMGLGRKA+QVY+ID+GLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKASQVYVIDYGLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLG+EQSRRDDLESLGYVL+YFLRGSLPWQGLKA TKKQKYDKI EKK+ TP+EVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMSY 291
CKS+P EF SYFHYC+SL F+ +PDY +LKRLF DLF REG L +I +
Sbjct: 241 CKSYPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG-YQLDYIFDW 290
|
|
| TAIR|locus:2120765 CK1 "casein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1185 (422.2 bits), Expect = 2.0e-120, P = 2.0e-120
Identities = 213/281 (75%), Positives = 254/281 (90%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G K++LGRKIGSGSFGEI+L +++ TNE +A+K+EN TKHPQLLYE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIHTNEELAIKLENVKTKHPQLLYESKLYRILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+G+PN+KW+GV+G+ NVLV+DLLGPSLEDLF +C RK SLK+VLMLADQMI R+E+ H
Sbjct: 61 GGTGVPNVKWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKSVLMLADQMINRVEFFH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ FLHRD+KPDNFLMGLGR+ANQVYIIDFGLAKKYRD TT++HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDLKPDNFLMGLGRRANQVYIIDFGLAKKYRDSTTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGY+L+YFL+GSLPWQGLKA TKKQKY++I EKKVST IE L
Sbjct: 181 SMNTHLGIEQSRRDDLESLGYILMYFLKGSLPWQGLKAGTKKQKYERISEKKVSTSIEAL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
C+ +P+EFASYFHYC+SL FD +PDY +LKR+F DLF REG
Sbjct: 241 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRIFRDLFIREG 281
|
|
| TAIR|locus:2024147 ADK1 "dual specificity kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1184 (421.8 bits), Expect = 2.5e-120, P = 2.5e-120
Identities = 216/281 (76%), Positives = 251/281 (89%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+ +IG K+KLGRKIGSGSFGE++L +V T E VAVK+E+ TKHPQL YE+K+Y +LQ
Sbjct: 1 MDLVIGGKFKLGRKIGSGSFGELYLGINVQTGEEVAVKLESVKTKHPQLHYESKLYMLLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+G+PN+KWYGV+G+ NV+V+DLLGPSLEDLF YC RK SLKTVLMLADQ+I R+E++H
Sbjct: 61 GGTGVPNLKWYGVEGDYNVMVIDLLGPSLEDLFNYCNRKLSLKTVLMLADQLINRVEFMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+RGFLHRDIKPDNFLMGLGRKANQVYIIDFGL KKYRD T+RHIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLGKKYRDLQTHRHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLG+EQSRRDDLE+LGYVL+YFL+GSLPWQGLKA TKKQKYD+I EKKV+TPIEVL
Sbjct: 181 SVNTHLGVEQSRRDDLEALGYVLMYFLKGSLPWQGLKAGTKKQKYDRISEKKVATPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CK+ P+EF SYF YC+SL FD +PDY +LKRLF DLF REG
Sbjct: 241 CKNQPSEFVSYFRYCRSLRFDDKPDYSYLKRLFRDLFIREG 281
|
|
| TAIR|locus:2121338 CKL6 "casein kinase I-like 6" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1182 (421.1 bits), Expect = 4.1e-120, P = 4.1e-120
Identities = 217/281 (77%), Positives = 248/281 (88%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+ +IG K+KLGRKIG GSFGE+FLA + T E AVK+E + TKHPQL YE+K+Y +LQ
Sbjct: 5 MDNVIGGKFKLGRKIGGGSFGELFLAVSLQTGEEAAVKLEPAKTKHPQLHYESKIYMLLQ 64
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GGSGIP++KW+GV G+ N +V+DLLGPSLEDLF YC R+ +LK VLMLADQ+I+R+EY+H
Sbjct: 65 GGSGIPSLKWFGVQGDYNAMVIDLLGPSLEDLFNYCNRRLTLKAVLMLADQLISRVEYMH 124
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD T+RHIPYRENKNLTGTARYA
Sbjct: 125 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDLQTHRHIPYRENKNLTGTARYA 184
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLG+EQSRRDDLESLGYVL+YFLRGSLPWQGLKA TKKQKYD+I EKKVSTPIEVL
Sbjct: 185 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDRISEKKVSTPIEVL 244
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CKS+P EF SYF YC+SL F+ +PDY +LKRLF DLF REG
Sbjct: 245 CKSYPPEFVSYFQYCRSLRFEDKPDYSYLKRLFRDLFIREG 285
|
|
| UNIPROTKB|Q70YQ4 Q70YQ4 "Putative casein kinase I" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1178 (419.7 bits), Expect = 1.1e-119, P = 1.1e-119
Identities = 215/291 (73%), Positives = 257/291 (88%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +IG K+KLGRKIGSGSFGE++L ++ ++E VA+K+E+ ++HPQL YE+K+Y +LQ
Sbjct: 1 MEHVIGGKFKLGRKIGSGSFGELYLGVNIQSSEEVAIKLESVKSRHPQLHYESKLYMLLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+GIP++KW+GV+GE NV+V+DLLGPSLEDLF YC RKFSLKTVLMLADQMI R+EY+H
Sbjct: 61 GGTGIPHLKWFGVEGEYNVMVIDLLGPSLEDLFNYCNRKFSLKTVLMLADQMINRVEYMH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+RGFLHRDIKPDNFLMGLGRKA+QVY+ID+ LAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 TRGFLHRDIKPDNFLMGLGRKASQVYVIDYVLAKKYRDLQTHKHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLG+EQSRRDDLESLGYVL+YFLRGSLPWQGLKA TKKQKYDKI EKK+ TP+EVL
Sbjct: 181 SVNTHLGVEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYDKISEKKMLTPVEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMSY 291
CKS+P EF SYFHYC+SL F+ +PDY +LKRLF DLF REG L +I +
Sbjct: 241 CKSYPTEFISYFHYCRSLRFEDKPDYSYLKRLFRDLFIREG-YQLDYIFDW 290
|
|
| TAIR|locus:2030170 CKL2 "casein kinase 1-like protein 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1178 (419.7 bits), Expect = 1.1e-119, P = 1.1e-119
Identities = 215/281 (76%), Positives = 251/281 (89%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G K++LGRKIG GSFGEI+L +++ TNE VA+K+EN TKHPQLLYE+K+YK+LQ
Sbjct: 1 MEPRVGNKFRLGRKIGGGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKLYKVLQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+G+PN+KWYGV+G+ NVLV+DLLGPSLEDLF +C RK SLKTVLMLADQMI RIE+VH
Sbjct: 61 GGTGVPNVKWYGVEGDYNVLVIDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRIEFVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+ FLHRDIKPDNFLMGLGR+ANQVY+IDFGLAKKYRD + ++HIPYRENKNLTGTARYA
Sbjct: 121 QKSFLHRDIKPDNFLMGLGRRANQVYVIDFGLAKKYRD-SNHQHIPYRENKNLTGTARYA 179
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLG+VL+YFL+GSLPWQGLKA KKQKY+KI EKKVST IE L
Sbjct: 180 SMNTHLGIEQSRRDDLESLGFVLMYFLKGSLPWQGLKAGNKKQKYEKISEKKVSTSIEAL 239
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
C+ +P+EFASYFHYC+SL FD +PDY +LKRLF DLF REG
Sbjct: 240 CRGYPSEFASYFHYCRSLRFDDKPDYAYLKRLFRDLFIREG 280
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8BK63 | KC1A_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.7101 | 0.8679 | 0.8189 | no | no |
| Q556Y4 | KC1_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.6512 | 0.8836 | 0.6596 | yes | no |
| P67827 | KC1A_BOVIN | 2, ., 7, ., 1, 1, ., 1 | 0.7101 | 0.8679 | 0.8492 | no | no |
| P67829 | KC1A_SHEEP | 2, ., 7, ., 1, 1, ., 1 | 0.7101 | 0.8679 | 0.8492 | N/A | no |
| P67828 | KC1A_RABIT | 2, ., 7, ., 1, 1, ., 1 | 0.7101 | 0.8679 | 0.8492 | no | no |
| P97633 | KC1A_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.7101 | 0.8679 | 0.8492 | no | no |
| P48730 | KC1D_HUMAN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7046 | 0.8836 | 0.6771 | yes | no |
| Q6QNM1 | KC1_TOXGO | 2, ., 7, ., 1, 1, ., 1 | 0.7117 | 0.8836 | 0.8672 | N/A | no |
| P35508 | KC1D_BOVIN | 2, ., 7, ., 1, 1, ., 2, 6 | 0.7046 | 0.8836 | 0.6771 | yes | no |
| P67962 | KC1A_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.7101 | 0.8679 | 0.8189 | no | no |
| P67963 | KC1A_XENLA | 2, ., 7, ., 1, 1, ., 1 | 0.7101 | 0.8679 | 0.8189 | N/A | no |
| Q7T2E3 | KC1DA_DANRE | 2, ., 7, ., 1, 1, ., 1 | 0.7117 | 0.8836 | 0.6972 | yes | no |
| P42168 | KC1A_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.6897 | 0.8616 | 0.8035 | yes | no |
| Q7RBX5 | KC1_PLAYO | 2, ., 7, ., 1, 1, ., 1 | 0.6725 | 0.8836 | 0.8699 | N/A | no |
| Q5RC72 | KC1D_PONAB | 2, ., 7, ., 1, 1, ., 2, 6 | 0.6975 | 0.8836 | 0.6771 | yes | no |
| P40235 | HHP1_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.7028 | 0.8679 | 0.7561 | yes | no |
| O15726 | KC1_PLAF4 | 2, ., 7, ., 1, 1, ., 1 | 0.6619 | 0.8836 | 0.8672 | N/A | no |
| O76324 | DCO_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.6868 | 0.8836 | 0.6386 | yes | no |
| Q8IHZ9 | KC1_PLAF7 | 2, ., 7, ., 1, 1, ., 1 | 0.6725 | 0.8836 | 0.8699 | yes | no |
| P48729 | KC1A_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.7101 | 0.8679 | 0.8189 | no | no |
| Q5ZLL1 | KC1E_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.7117 | 0.8836 | 0.6754 | yes | no |
| Q6QNL9 | KC1_EIMTE | 2, ., 7, ., 1, 1, ., 1 | 0.6790 | 0.9276 | 0.8805 | N/A | no |
| Q5BP74 | KC1D_XENLA | 2, ., 7, ., 1, 1, ., 1 | 0.7081 | 0.8836 | 0.6771 | N/A | no |
| Q9JMK2 | KC1E_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.7081 | 0.8836 | 0.6754 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 318 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-47 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-35 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-33 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-30 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-24 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-22 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-21 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-19 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-18 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-18 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-16 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-16 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-15 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-15 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-15 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-15 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-14 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-14 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-14 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-13 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-13 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-13 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-13 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-11 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-11 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-11 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-11 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-10 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-10 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-10 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-09 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-09 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-09 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-09 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-09 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-08 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-08 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-08 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-08 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 7e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-07 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-07 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-07 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-07 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-07 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-07 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-07 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-07 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 5e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-07 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-07 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-07 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 8e-07 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-06 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-06 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-06 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-06 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-06 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-06 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-06 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-06 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-06 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-06 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-06 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-06 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-06 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-06 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 5e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-06 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-06 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-06 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-06 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-05 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-05 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-05 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-05 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-05 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-05 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-05 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-05 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-05 | |
| COG2112 | 201 | COG2112, COG2112, Predicted Ser/Thr protein kinase | 5e-05 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-05 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 7e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-05 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-04 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-04 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 2e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-04 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-04 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-04 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 3e-04 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 6e-04 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 6e-04 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-04 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-04 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 7e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-04 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.001 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.001 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.001 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 0.001 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.001 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.001 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 0.002 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.002 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 0.002 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.002 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.002 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 0.002 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.003 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 0.003 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 0.003 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 0.004 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.004 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.004 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 0.004 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 5e-47
Identities = 77/266 (28%), Positives = 110/266 (41%), Gaps = 27/266 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
Y+L RK+GSGSFG ++ A H T +IVAVKI K E ++ + L
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSH--- 57
Query: 65 IPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYV 119
PNI + + + LV++ DLF Y R S +A Q++ +EY+
Sbjct: 58 -PNIVRLIDAFEDKDHLYLVMEYCEGG--DLFDYLSRGGPLSEDEAKKIALQILRGLEYL 114
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
HS G +HRD+KP+N L+ + V I DFGLAKK GT Y
Sbjct: 115 HSNGIIHRDLKPENILLD---ENGVVKIADFGLAKK-------LLKSSSSLTTFVGTPWY 164
Query: 180 ASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
+ L G + D+ SLG +L L G P+ G + Q +I +
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEP 224
Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRP 264
S E C + +RP
Sbjct: 225 KWS-SGSEEAKDLIKKCLNKDPSKRP 249
|
Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 5e-35
Identities = 77/241 (31%), Positives = 121/241 (50%), Gaps = 17/241 (7%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
Y++ RK+G GSFGE++LA ++VA+K+ E+ + + L E ++ L
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 63 SGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYV 119
I + + D LV++ + G SLEDL R S L + Q+++ +EY+
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
HS+G +HRDIKP+N L L R V +IDFGLAK DP + IP + ++ GT Y
Sbjct: 118 HSKGIIHRDIKPENIL--LDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSV-GTPGY 174
Query: 180 ASCNTHLGIEQ---SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
+ LG+ S D+ SLG L L G P++G K ++ + KI + +
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234
Query: 237 I 237
+
Sbjct: 235 L 235
|
Length = 384 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 3e-33
Identities = 68/200 (34%), Positives = 98/200 (49%), Gaps = 21/200 (10%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI-KW 70
+G G FG ++LA T + VA+KI E+S + +LL E ++ K L PNI K
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH----PNIVKL 56
Query: 71 YGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
YGV D LV++ G SL+DL K S +L + Q++ +EY+HS G +HR
Sbjct: 57 YGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
D+KP+N L L +V + DFGL+K K + GT Y + LG
Sbjct: 117 DLKPENIL--LDSDNGKVKLADFGLSKLLTSDK-------SLLKTIVGTPAYMAPEVLLG 167
Query: 188 I-EQSRRDDLESLGYVLLYF 206
S + D+ SLG +L
Sbjct: 168 KGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 2e-30
Identities = 73/246 (29%), Positives = 115/246 (46%), Gaps = 27/246 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y++ K+G GSFG+++LA T ++VA+K+ + ++L E K+ K L+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKH---- 56
Query: 66 PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
PNI + Y V D + LV++ G L DL R + S Q+++ +EY+HS
Sbjct: 57 PNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHS 115
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+G +HRD+KP+N L+ + V + DFGLA++ GT Y +
Sbjct: 116 KGIVHRDLKPENILLD---EDGHVKLADFGLARQLDPGEK--------LTTFVGTPEYMA 164
Query: 182 CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
LG + D+ SLG V+LY L G P+ G + + KI + K P
Sbjct: 165 PEVLLGKGYGKAVDIWSLG-VILYELLTGKPPFPG--DDQLLELFKKIGKPKPPFPPPEW 221
Query: 241 CKSHPA 246
S A
Sbjct: 222 DISPEA 227
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 3e-24
Identities = 68/221 (30%), Positives = 112/221 (50%), Gaps = 24/221 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTK-HPQLLYEAKVYKILQGGS 63
+++ G KIG G+FG+++ A ++DT E++AVK I+++ K ++ E KV ++L+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-- 58
Query: 64 GIPNI-KWYGVDGEDN-VLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PN+ K+YGV+ V + G +LE+L + R + + Q++ + Y+
Sbjct: 59 --PNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYL 115
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN-KNLTGTAR 178
HS G +HRDIKP N + + + DFG A K ++ TT E ++L GT
Sbjct: 116 HSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTT----TMGEEVQSLAGTPA 168
Query: 179 YASCNTHLGIEQS---RRDDLESLGYVLLYFLRGSLPWQGL 216
Y + G + R D+ SLG V+L G PW L
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 3e-23
Identities = 56/216 (25%), Positives = 89/216 (41%), Gaps = 31/216 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGS 63
+YK+ +IG G+ G +F A +T E VA+K Q L E K + Q
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH-- 58
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P + K V G VLV++ + L ++ R V ++ + Y+H
Sbjct: 59 --PYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP------YRENKNLT 174
+ G +HRD+KP N L+ + I DFGLA+ + + + YR + L
Sbjct: 117 ANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 210
G +Y G+ DL ++G + L GS
Sbjct: 174 GARKYDP-----GV------DLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 5e-22
Identities = 67/233 (28%), Positives = 101/233 (43%), Gaps = 37/233 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKILQ 60
+K G+ IG GSF + LA +TN+ A+KI E K + E +V L
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK---KVKYVKIEKEVLTRLN 59
Query: 61 GGSGIPNIKWYGV--DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
G GI IK Y D E+N+ VL+ G L+ ++ K A +++
Sbjct: 60 GHPGI--IKLYYTFQD-EENLYFVLEYAPNGELLQ--YIRKYGSLDEKCTRFYAAEILLA 114
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-------------TN 162
+EY+HS+G +HRD+KP+N L+ K + I DFG AK + +
Sbjct: 115 LEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
R + GTA Y S + DL +LG ++ L G P++G
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-21
Identities = 85/304 (27%), Positives = 141/304 (46%), Gaps = 53/304 (17%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL 59
I G ++K+ + IG G FG ++ H N+ VA KIEN ++ ++ E VY +
Sbjct: 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVA-KIEN--LENETIVMETLVYNNI 65
Query: 60 QGGSGIPNIKWYGVDGEDNV--------------------LVLDLLGPSLEDLF--VYCR 97
I W + D++ ++L+ L + +++F + C+
Sbjct: 66 YDIDKIAL--WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCK 123
Query: 98 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
K +K ++ M+ +EY+H G H DIKP+N +M G N+ YIID+G+A +
Sbjct: 124 NKKLIKNIMK---DMLTTLEYIHEHGISHGDIKPEN-IMVDGN--NRGYIIDYGIASHF- 176
Query: 158 DPTTNRHIPY-RENKNL-TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
+HI Y +E K+L GT YA + H G +RR DLESLGY +L + LPW+G
Sbjct: 177 -IIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKG 235
Query: 216 LKA------ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269
A K ++ E K+ K+ + L+++++PDY L
Sbjct: 236 FGHNGNLIHAAKCDFIKRLHEGKIKI------KNANKFIYDFIECVTKLSYEEKPDYDAL 289
Query: 270 KRLF 273
++F
Sbjct: 290 IKIF 293
|
Length = 294 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (223), Expect = 7e-21
Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 29/219 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAKVYKILQGGS 63
++ G +G GSFG ++LA DT E++AVK +S + L E ++ LQ
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-- 58
Query: 64 GIPNI-KWYGVDGEDNVLVLDLL-----GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
PNI ++YG + ++ L++ G SL L + K + Q++ +
Sbjct: 59 --PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSL-LKKFGKLPEPVIRKYTRQILEGLA 115
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
Y+HS G +HRDIK N L+ V + DFG AK+ D T ++ GT
Sbjct: 116 YLHSNGIVHRDIKGANILVDSDG---VVKLADFGCAKRLGDIETG-----EGTGSVRGTP 167
Query: 178 RYAS---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ + G E R D+ SLG ++ G PW
Sbjct: 168 YWMAPEVIR---GEEYGRAADIWSLGCTVIEMATGKPPW 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 85.3 bits (212), Expect = 4e-19
Identities = 51/173 (29%), Positives = 80/173 (46%), Gaps = 33/173 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTK---HPQLLYEAKVYKILQ 60
+Y+ G+K+G G++ ++ A +T IVA+K E K + L E K+ + L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 61 GGSGIPNI----KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD----- 110
PNI +G N+ LV + + LE + + K VL AD
Sbjct: 61 H----PNIIGLLDVFGHK--SNINLVFEFMETDLEKVI---KDK---SIVLTPADIKSYM 108
Query: 111 QMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
M R +EY+HS LHRD+KP+N L+ + + DFGLA+ + P
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIA---SDGVLKLADFGLARSFGSPNRK 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 1e-18
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
+++ KIG G FGE++ A H T + VA+K+ S K +++ E ++ K +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH---- 56
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
PNI K+YG + ++ +V++ G SL+DL + + + + +++ +EY+HS
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHS 116
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
G +HRDIK N L+ +V +IDFGL+ + D + + GT + +
Sbjct: 117 NGIIHRDIKAANILL--TSDG-EVKLIDFGLSAQLSDT--------KARNTMVGTPYWMA 165
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
G + D+ SLG + G P
Sbjct: 166 PEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 7e-18
Identities = 66/253 (26%), Positives = 109/253 (43%), Gaps = 39/253 (15%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSG--IPNIKW 70
+G GSFG++ L DT ++ A+K+ K ++ + IL + I + +
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 71 YGVDGEDNVLVLDLL--GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLH 126
E LVL+ G +LF + + +FS + A +++ +EY+HS G ++
Sbjct: 61 AFQTEEKLYLVLEYAPGG----ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIY 116
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTTNRHIPYRENKNLTGTARYASCNT 184
RD+KP+N L L + + + DFGLAK+ TN GT Y +
Sbjct: 117 RDLKPENIL--LDADGH-IKLTDFGLAKELSSEGSRTN---------TFCGTPEYLAPEV 164
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP-------- 236
LG + D SLG +L L G P+ A +K+ Y+KI + + P
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGKPPFY---AEDRKEIYEKILKDPLRFPEFLSPEAR 221
Query: 237 --IEVLCKSHPAE 247
I L + P +
Sbjct: 222 DLISGLLQKDPTK 234
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 2e-16
Identities = 54/175 (30%), Positives = 83/175 (47%), Gaps = 24/175 (13%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQLLY-EAKVYKILQGG 62
LG+K+G G+FGE++ VAVK E++ + + EA++ + L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
PN+ K GV + E +V++ + G L R K SL +L A Q IAR +E
Sbjct: 61 ---PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQ-IARGME 116
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYR 168
Y+ S+ F+HRD+ N L+G + V I DFGL++ D +P R
Sbjct: 117 YLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDDDYYRKRGGKLPIR 168
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 77/271 (28%), Positives = 115/271 (42%), Gaps = 61/271 (22%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAK------- 54
+Y + R IG G GE++LA + VA+K EN + L EAK
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENP-LLKKRFLREAKIAADLIH 61
Query: 55 -----VYKILQGGSGI----PNIKWYGVDG-EDNVLVLDLLGPSLEDLFVYCRRKFSLKT 104
VY I G + P I+ Y + +V + L L + K S+
Sbjct: 62 PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAE-------KTSVGA 114
Query: 105 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK---------- 154
L + ++ A IEYVHS+G LHRD+KPDN L+GL +V I+D+G A
Sbjct: 115 FLSIFHKICATIEYVHSKGVLHRDLKPDNILLGL---FGEVVILDWGAAIFKKLEEEDLL 171
Query: 155 --KYRDPTTNRH---IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 209
+ IP + + GT Y + LG+ S D+ +LG +L L
Sbjct: 172 DIDVDERNICYSSMTIPGK----IVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL 227
Query: 210 SLPWQGLKAATKKQKYDKICEK-KVSTPIEV 239
S P+ +++K KI + + +PIEV
Sbjct: 228 SFPY-------RRKKGRKISYRDVILSPIEV 251
|
Length = 932 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 8e-16
Identities = 46/153 (30%), Positives = 79/153 (51%), Gaps = 7/153 (4%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
YK+ +++G G+FG ++LA + +T E+VA+K + + K L+ + PNI
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 69 -KWYGVDGEDNVL--VLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
K V E++ L V + + +L L + FS + + Q++ + ++H GF
Sbjct: 61 VKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGF 120
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
HRD+KP+N L+ V I DFGLA++ R
Sbjct: 121 FHRDLKPENLLV---SGPEVVKIADFGLAREIR 150
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 2e-15
Identities = 53/157 (33%), Positives = 77/157 (49%), Gaps = 20/157 (12%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
+LG+K+G G+FGE++ T VAVK G + L EA + K L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH- 60
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
PNI + GV GE +V + + G L D K +LK +L +A Q IA+ +E
Sbjct: 61 ---PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQ-IAKGME 116
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ S+ F+HRD+ N L + V I DFGL++
Sbjct: 117 YLESKNFVHRDLAARNCL--VTEN-LVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (180), Expect = 7e-15
Identities = 47/161 (29%), Positives = 72/161 (44%), Gaps = 20/161 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGSG 64
Y+ K+G G++G ++ A T EIVA+K ++N P L E + K L+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH--- 57
Query: 65 IPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEY 118
PNI K V + LV + DL Y S + + Q++ + Y
Sbjct: 58 -PNIVKLLDVIHTERKLYLVFEYCD---MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAY 113
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
HS LHRD+KP N L+ + + + DFGLA+ + P
Sbjct: 114 CHSHRILHRDLKPQNILIN---RDGVLKLADFGLARAFGIP 151
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 8e-15
Identities = 56/176 (31%), Positives = 84/176 (47%), Gaps = 25/176 (14%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQLLY-EAKVYKILQGG 62
LG+K+G G+FGE++ VAVK E++ + + EA++ + L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH- 60
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKF-SLKTVLMLADQMIAR-I 116
PNI K GV + E ++V++ + G L D R K SL +L A Q IAR +
Sbjct: 61 ---PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQ-IARGM 116
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYR 168
EY+ S+ F+HRD+ N L+G V I DFGL++ D +P R
Sbjct: 117 EYLESKNFIHRDLAARNCLVGEN---LVVKISDFGLSRDLYDDDYYKVKGGKLPIR 169
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 9e-15
Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK---ILQGGSG- 64
++L R IG G+FG++ + DT ++ A+K N K + V ILQ +
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQELNHP 60
Query: 65 -IPNIKWYGV-DGEDNVLVLDLLGPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVH 120
+ N+ WY D E+ LV+DLL DL + + KFS + V +++ +EY+H
Sbjct: 61 FLVNL-WYSFQDEENMYLVVDLLLGG--DLRYHLSQKVKFSEEQVKFWICEIVLALEYLH 117
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT-GTARY 179
S+G +HRDIKPDN L+ + V+I DF +A + T GT Y
Sbjct: 118 SKGIIHRDIKPDNILLD---EQGHVHITDFNIA---------TKVTPDTLTTSTSGTPGY 165
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
+ S D SLG LRG P++G
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 1e-14
Identities = 48/158 (30%), Positives = 70/158 (44%), Gaps = 14/158 (8%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAKVYKILQGGSG 64
Y+ KIG G++G ++ A T EIVA+K S L E K+ K L
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH--- 57
Query: 65 IPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
PNI K V D LV + + L L +R + Q++ + + HS
Sbjct: 58 -PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
G LHRD+KP+N L+ + + DFGLA+ + P
Sbjct: 117 HGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSP 151
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 2e-14
Identities = 49/161 (30%), Positives = 74/161 (45%), Gaps = 20/161 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKH-PQLLYEAKVYKILQGGS 63
KY++ ++IG GSFG+++L ++ +K + N K L E K+ K L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH-- 58
Query: 64 GIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLF---VYCRRKFSLKTVLMLADQMIARI 116
PNI K+Y E L V++ G L + F + +L Q+ +
Sbjct: 59 --PNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 117 EYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKY 156
+Y+HSR LHRDIKP N FL V + DFG++K
Sbjct: 117 KYLHSRKILHRDIKPQNIFLT----SNGLVKLGDFGISKVL 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-14
Identities = 66/247 (26%), Positives = 108/247 (43%), Gaps = 52/247 (21%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL--------QGGSG 64
+ I G+FG ++LA T + A+K+ K ++ + +V + QG S
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKV----LKKSDMIAKNQVTNVKAERAIMMIQGES- 56
Query: 65 IPNIK--WYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR----- 115
P + +Y +D + LV++ L G L +KT+ L + +
Sbjct: 57 -PYVAKLYYSFQSKDYLYLVMEYLNGGDCASL---------IKTLGGLPEDWAKQYIAEV 106
Query: 116 ---IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
+E +H RG +HRDIKP+N L+ + + + DFGL++ ENK
Sbjct: 107 VLGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRN-----------GLENKK 152
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
GT Y + T LG+ + D SLG V+ FL G P+ A T +D I ++
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH---AETPDAVFDNILSRR 209
Query: 233 VSTPIEV 239
++ P EV
Sbjct: 210 INWPEEV 216
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 30/206 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGS 63
K+ + +IG G++G+++ A DT E+VA V+++N P + E K+ + L +
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRN 67
Query: 64 GIPNIKWYGVDGEDNV----------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
I N+K D +D + LV + + L L FS + Q++
Sbjct: 68 -IVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLL 126
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY----RDPTTNRHIP--Y 167
+ Y H + FLHRDIK N L+ Q+ + DFGLA+ Y P TN+ I Y
Sbjct: 127 EGLNYCHKKNFLHRDIKCSNILLN---NKGQIKLADFGLARLYNSEESRPYTNKVITLWY 183
Query: 168 RENKNLTGTARYA------SCNTHLG 187
R + L G RY SC LG
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILG 209
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 9e-14
Identities = 66/237 (27%), Positives = 111/237 (46%), Gaps = 36/237 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGSG 64
Y+ +IG G++G+++ A + T E+VA+K +EN P + E K+ + L+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR---- 56
Query: 65 IPNI-KWYGV---DGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PNI + + G+ ++ +V + + L L KF+ + Q++ ++Y+
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY----RDPTTNRHIP--YRENKNL 173
HS G LHRDIK N L + + + DFGLA+ Y TNR I YR + L
Sbjct: 117 HSNGILHRDIKGSNIL--INNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 174 TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
G RY + D+ S+G +L G +QG +T+ ++ +KI E
Sbjct: 174 LGATRYGP-----EV------DMWSVGCILAELFLGKPIFQG---STELEQLEKIFE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-13
Identities = 71/246 (28%), Positives = 110/246 (44%), Gaps = 30/246 (12%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLYEAKVYK-ILQGGSGIPNIK-WY 71
I G++G +FLA T +I A+K+ + + + + IL +K +Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 72 GVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQM----IARI----EYVHS 121
G+ N+ LV++ L G L L L+ V L + + IA I EY+HS
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASL---------LENVGSLDEDVARIYIAEIVLALEYLHS 111
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKNLTGTARYA 180
G +HRD+KPDN L+ + + DFGL+K N + +E+K + GT Y
Sbjct: 112 NGIIHRDLKPDNILID---SNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYI 168
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
+ LG S+ D SLG +L FL G P+ G T ++ + I K+ E +
Sbjct: 169 APEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG---ETPEEIFQNILNGKIE-WPEDV 224
Query: 241 CKSHPA 246
S A
Sbjct: 225 EVSDEA 230
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-13
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 44/226 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHP----QLLYEAKVYKILQ 60
+++ G +GSGSFG ++ ++D + AVK + + G QL E + LQ
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 61 GGSGIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRKF-SLKTVL--MLADQMI 113
PNI ++ G + E++ L L+L+ G SL L +K+ S + + Q++
Sbjct: 61 H----PNIVQYLGTEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQIL 112
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+EY+H R +HRDIK N L+ V + DFG+AK+ + + K+
Sbjct: 113 LGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQV--------VEFSFAKSF 161
Query: 174 TGTARY------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
G+ + A + D+ SLG +L G PW
Sbjct: 162 KGSPYWMAPEVIAQQGGY-----GLAADIWSLGCTVLEMATGKPPW 202
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 3e-13
Identities = 72/291 (24%), Positives = 122/291 (41%), Gaps = 65/291 (22%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP--------QLLYEAKVYKILQ 60
++ + +G+GSFG + L H + + A+KI + K +L E ++ + ++
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILS---KAKIVKLKQVEHVLNEKRILQSIR 59
Query: 61 GGSGIPNI-KWYGVDGEDNVL--VLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIAR 115
P + YG +D+ L V++ + +LF + R+ +F A Q++
Sbjct: 60 H----PFLVNLYGSFQDDSNLYLVMEYVPGG--ELFSHLRKSGRFPEPVARFYAAQVVLA 113
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
+EY+HS ++RD+KP+N L+ + I DFG AK+ + T L G
Sbjct: 114 LEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGRT----------YTLCG 160
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVS 234
T Y + L + D +LG +L+Y L G P+ Q Y+KI E KV
Sbjct: 161 TPEYLAPEIILSKGYGKAVDWWALG-ILIYEMLAGYPPF---FDDNPIQIYEKILEGKV- 215
Query: 235 TPIEVLCKSHPAEFASYFHY-CQSLTFDQRPDYGFLKRLF-HDLFSREGSL 283
F S+F + L ++ L DL R G+L
Sbjct: 216 ------------RFPSFFSPDAKDL----------IRNLLQVDLTKRLGNL 244
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 6e-13
Identities = 76/282 (26%), Positives = 120/282 (42%), Gaps = 45/282 (15%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IE---NSGTKHPQLLY--------EAK 54
K+ G IG G++G ++LA +V T E++AVK +E +H E +
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 55 VYKILQGGSGIPNIKWY-GVDGEDNVLVLDL---LGPSLEDLFVYCRR--KFSLKTVLML 108
K L NI Y G + + L + L G S+ R +F + V
Sbjct: 61 TLKDLDH----LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL---RTYGRFEEQLVRFF 113
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+Q++ + Y+HS+G LHRD+K DN L+ I DFG++KK D N
Sbjct: 114 TEQVLEGLAYLHSKGILHRDLKADNLLVDA---DGICKISDFGISKKSDDIYDN-----D 165
Query: 169 ENKNLTGT----ARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK 224
+N ++ G+ A + G S + D+ SLG V+L G PW +A
Sbjct: 166 QNMSMQGSVFWMAPEVIHSYSQGY--SAKVDIWSLGCVVLEMFAGRRPWSDEEAI---AA 220
Query: 225 YDKICEKKVSTPI--EVLCKSHPAEFASYFHYCQSLTFDQRP 264
K+ K+ + PI +V P + + C ++ D RP
Sbjct: 221 MFKLGNKRSAPPIPPDVSMNLSPVA-LDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 7e-13
Identities = 46/160 (28%), Positives = 76/160 (47%), Gaps = 30/160 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY-EAKVYKILQGGSGIP 66
YK KIG G+ GE++ A+ T + VA+K ++ +L+ E + K + P
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH----P 75
Query: 67 NI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI------ 116
NI +Y + G++ +V++ + G SL D+ + + + IA +
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVR--------MNEPQIAYVCREVLQ 127
Query: 117 --EYVHSRGFLHRDIKPDNFLMGL-GRKANQVYIIDFGLA 153
EY+HS+ +HRDIK DN L+ G V + DFG A
Sbjct: 128 GLEYLHSQNVIHRDIKSDNILLSKDGS----VKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 62/224 (27%), Positives = 93/224 (41%), Gaps = 23/224 (10%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNI-K 69
+G GS G ++ H T +I A+K + QLL E K + S P + K
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKT--LRSCES--PYVVK 63
Query: 70 WYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFL 125
YG + +VL+ + G SL DL K + +A Q++ ++Y+H+ R +
Sbjct: 64 CYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHII 122
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185
HRDIKP N L+ +V I DFG++K + + GT Y S
Sbjct: 123 HRDIKPSNLLIN---SKGEVKIADFGISKVLENTLDQCN-------TFVGTVTYMSPERI 172
Query: 186 LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229
G S D+ SLG LL G P+ + + IC
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC 216
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-12
Identities = 51/180 (28%), Positives = 77/180 (42%), Gaps = 25/180 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y+L IG G+ ++ A + NE VA+K E T +L E +
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH---- 58
Query: 66 PNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRK-----FSLKTVLMLADQMIARI 116
PN+ K+Y + L V+ L G SL D+ + + TVL +++ +
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL---KEVLKGL 115
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
EY+HS G +HRDIK N L+G + V I DFG++ D + K GT
Sbjct: 116 EYLHSNGQIHRDIKAGNILLG---EDGSVKIADFGVSASLADGGDRTR---KVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 7e-12
Identities = 50/170 (29%), Positives = 80/170 (47%), Gaps = 26/170 (15%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTK---HPQLLYEAKVYKILQGGS 63
Y+LG IG G+FG ++ +++T + VA+K I K ++ E + K L+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-- 58
Query: 64 GIPNI-KWYGVDGEDNVL--VLDL-LGPSLEDLFVYCRRKF-----SLKTVLMLADQMIA 114
PNI K+ G + L +L+ SL + +KF SL V + Q++
Sbjct: 59 --PNIVKYIGSIETSDSLYIILEYAENGSLRQII----KKFGPFPESLVAVYVY--QVLQ 110
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+ Y+H +G +HRDIK N L K V + DFG+A K D + +
Sbjct: 111 GLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKDDA 157
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 49/185 (26%), Positives = 77/185 (41%), Gaps = 19/185 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTK---HPQLLYEAKVYKILQGGSG 64
Y++ K+G G+FGE++ A + T +VA+K I K L E K+ K L+ +
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69
Query: 65 IPNIKWYGVDGEDNV-------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
+P I + + +V + L L K + + Q++ I
Sbjct: 70 VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN 129
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
Y+H LHRDIK N L+ + I DFGLA+ Y P P + GT
Sbjct: 130 YLHENHILHRDIKAANILID---NQGILKIADFGLARPYDGP-----PPNPKGGGGGGTR 181
Query: 178 RYASC 182
+Y +
Sbjct: 182 KYTNL 186
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 73/278 (26%), Positives = 125/278 (44%), Gaps = 38/278 (13%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
KL RK+G+G FGE+++ + T + VAVK GT P+ L EA++ K L+
Sbjct: 9 KLERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH----DKL 63
Query: 68 IKWYGV--DGEDNVLVLDLLGP-SLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVH 120
++ Y V + E +V + + SL D + + +K L ++ +A Q+ + Y+
Sbjct: 64 VQLYAVCSEEEPIYIVTEYMSKGSLLD---FLKSGEGKKLRLPQLVDMAAQIAEGMAYLE 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARY 179
SR ++HRD+ N L+G I DFGLA+ D + + K + TA
Sbjct: 121 SRNYIHRDLAARNILVGEN---LVCKIADFGLARLIED---DEYTAREGAKFPIKWTAPE 174
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
A+ I + D+ S G +LL G +P+ G+ T ++ +++ E+ P
Sbjct: 175 AANYGRFTI----KSDVWSFG-ILLTEIVTYGRVPYPGM---TNREVLEQV-ERGYRMPR 225
Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275
C P E C ++RP + +L+ D
Sbjct: 226 PPNC---PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 44/175 (25%), Positives = 71/175 (40%), Gaps = 30/175 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAKVYKILQGGS 63
KY++ +G G++G + + T EIVA+K E+ L E KV + L+
Sbjct: 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRH-- 59
Query: 64 GIPNI-----------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQM 112
NI + Y LV + + +L +L V Q+
Sbjct: 60 --ENIVNLKEAFRRKGRLY--------LVFEYVERTLLELLEASPGGLPPDAVRSYIWQL 109
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
+ I Y HS +HRDIKP+N L+ ++ + + DFG A+ R + Y
Sbjct: 110 LQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDY 161
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 2e-11
Identities = 71/245 (28%), Positives = 103/245 (42%), Gaps = 53/245 (21%)
Query: 13 RKIGSGSFGEIFLA---SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSGIP 66
+K+G G+FGE++ VAVK + L EA+V K L G P
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL----GHP 56
Query: 67 NI-KWYGV--DGEDNVLVL------DLLG---PSLEDLFVYCRRKFSLKTVLMLADQMIA 114
N+ + GV + E LVL DLL S + SLK +L A Q IA
Sbjct: 57 NVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ-IA 115
Query: 115 R-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP-----TTNRHIPYR 168
+ +EY+ S+ F+HRD+ N L+G + V I DFGL++ D T +P R
Sbjct: 116 KGMEYLASKKFVHRDLAARNCLVG---EDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR 172
Query: 169 ----ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKK 222
E + + + +S D+ S G VLL+ F G+ P+ GL
Sbjct: 173 WMAPE------SLKDGIFTS-----KS---DVWSFG-VLLWEIFTLGATPYPGLSNEEVL 217
Query: 223 QKYDK 227
+ K
Sbjct: 218 EYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 2e-11
Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 10/155 (6%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGSGIPNIK 69
+I G++G ++ A T EIVA +K+E P L E + LQ + I +K
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPN-IVTVK 70
Query: 70 WYGV-DGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
V D + +V++ + L+ L ++ F V L Q+++ + ++H LHR
Sbjct: 71 EVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHR 130
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
D+K N L+ + I DFGLA++Y P
Sbjct: 131 DLKTSNLLL---NNRGILKICDFGLAREYGSPLKP 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 49/151 (32%), Positives = 79/151 (52%), Gaps = 14/151 (9%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
+L RK+G+G FGE++ +T VAVK GT P+ L EA++ K L+ P
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQIMKKLRH----PKL 63
Query: 68 IKWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I+ Y V E +V +L+ G LE L R L ++ +A Q+ + + Y+ ++
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
++HRD+ N L+G + N + DFGLA+
Sbjct: 124 YIHRDLAARNVLVG---ENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-11
Identities = 72/269 (26%), Positives = 110/269 (40%), Gaps = 61/269 (22%)
Query: 12 GRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
+IGSG+ G ++ H T + A+K+ + T Q+ E + IL+ + PN+
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIE---ILRDVNH-PNV 134
Query: 69 ----KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ +GE VL+ + G SLE + + + +A Q+++ I Y+H R
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIAYLHRRHI 189
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAK---KYRDPTTNRHIPYRENKNLTGTARYAS 181
+HRDIKP N L+ + V I DFG+++ + DP + GT Y S
Sbjct: 190 VHRDIKPSNLLINSAK---NVKIADFGVSRILAQTMDPCNSS----------VGTIAYMS 236
Query: 182 ---CNTHLGIEQSRRD----DLESLGYVLLYFLRGSLP--------WQGLKAATKKQKYD 226
NT L D D+ SLG +L F G P W L A
Sbjct: 237 PERINTDL--NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA------- 287
Query: 227 KICEKKVSTPIEVLCKSHPAEFASYFHYC 255
IC +S P E + EF + C
Sbjct: 288 -IC---MSQPPEAPATASR-EFRHFISCC 311
|
Length = 353 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 50/167 (29%), Positives = 81/167 (48%), Gaps = 30/167 (17%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-GTKHPQLLYEAKVYKILQGGSG 64
++L IG G++G+++ A H T ++VA+KI + + ++ E Y IL+ S
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEE---YNILRKYSN 61
Query: 65 IPNI-KWYGV-------DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
PNI +YG +D + LV++L G S+ DL K K L ++ IA
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV-----KGLRKKGKRLKEEWIA 116
Query: 115 RI--------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
I Y+H +HRDIK N L+ K +V ++DFG++
Sbjct: 117 YILRETLRGLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-11
Identities = 74/275 (26%), Positives = 119/275 (43%), Gaps = 28/275 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQ-LLYEAKVYKILQGGS 63
+++ +KIG G F E++ A+ + + VA+K E K Q + E + K L +
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSL---KTVLMLADQMIARIEYV 119
I + + D E N+ VL+L L + Y +++ L +TV Q+ + +E++
Sbjct: 64 VIKYLDSFIEDNELNI-VLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 120 HSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
HSR +HRDIKP N F+ G V + D GL + + TT H +L GT
Sbjct: 123 HSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVGTPY 171
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
Y S + + D+ SLG +L P+ G K +C+K
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-----DKMNLFSLCQKIEQCDYP 226
Query: 239 VLCKSHPAE-FASYFHYCQSLTFDQRPDYGFLKRL 272
L H +E C DQRPD G++ ++
Sbjct: 227 PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-11
Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 39/231 (16%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP-------QLLYEAKVYKIL 59
++ G+ +G G+FG ++L VDT +AVK P L E ++ K L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 60 QGGSGIPNI-KWYGVDGEDNVLVL---DLLGPSLEDLFVYCRRKFSLKTVLMLAD----- 110
Q I ++YG +D L + + G S++D LK L +
Sbjct: 62 QH----ERIVQYYGCLRDDETLSIFMEYMPGGSVKD---------QLKAYGALTETVTRK 108
Query: 111 ---QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
Q++ +EY+HS +HRDIK N L A V + DFG +K R T
Sbjct: 109 YTRQILEGVEYLHSNMIVHRDIKGANILRDS---AGNVKLGDFGASK--RLQTICSSGTG 163
Query: 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
K++TGT + S G R+ D+ S+G ++ L PW +A
Sbjct: 164 M--KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 6e-11
Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 30/231 (12%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIEN-------SGTKHPQLLYEAKVYKILQGGSGIPN 67
+G+G+FG + L + A+K+ +H E +V K + I
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVH--NEKRVLKEVSH-PFIIR 65
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ W D ++++ + P E LF Y R +FS T L A +++ +EY+HS+ +
Sbjct: 66 LFWTEHDQRFLYMLMEYV-PGGE-LFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIV 123
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185
+RD+KP+N L+ K + + DFG AKK RD T L GT Y +
Sbjct: 124 YRDLKPENILLD---KEGHIKLTDFGFAKKLRDRTW----------TLCGTPEYLAPEVI 170
Query: 186 LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
++ D +LG ++ L G P+ Y+KI K+ P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFFD---DNPFGIYEKILAGKLEFP 218
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 6e-11
Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 24/164 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----------IENSGTKHPQLLYEAKVYK 57
KY+ KIG G++G +F A + +T+EIVA+K + +S + LL E K
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 58 ILQGGSGIPNIKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
I ++ Y V D LV + L+ F C + V Q++
Sbjct: 61 I---------VRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKG 111
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
+ + HS LHRD+KP N L+ K ++ + DFGLA+ + P
Sbjct: 112 LAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIP 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 51/174 (29%), Positives = 77/174 (44%), Gaps = 21/174 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHP-QLLYEAKVYKILQGGS 63
KY+ KIG G+FGE+F A H T +IVA+K +EN P L E K+ ++L+ +
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHEN 72
Query: 64 GIPNI-------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
+ I Y LV + L L KF+L + + ++ +
Sbjct: 73 VVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGL 132
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-------TNR 163
Y+H LHRD+K N L+ K + + DFGLA+ + TNR
Sbjct: 133 YYIHRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 8e-11
Identities = 33/116 (28%), Positives = 47/116 (40%), Gaps = 26/116 (22%)
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD------------- 158
++ ++ VH GF+HRDIKPDN L + + + + DFGL KK
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNIL--IDADGH-IKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 159 --PTTNRHIPYRENKNLT-------GTARYASCNTHLGIEQSRRDDLESLGYVLLY 205
N + R++K GT Y + G D SLG V+LY
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLG-VILY 221
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 37/164 (22%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI-- 65
Y+L ++IGSG++G+++ A + T E+VA+K+ L ++I+Q +
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVIK--------LEPGDDFEIIQQEISMLK 55
Query: 66 ----PNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI- 116
PNI ++G + L V++ G SL+D++ R L++ IA +
Sbjct: 56 ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP--------LSELQIAYVC 107
Query: 117 -------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
Y+H G +HRDIK N L+ + V + DFG++
Sbjct: 108 RETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 62/242 (25%), Positives = 103/242 (42%), Gaps = 40/242 (16%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
+++G +G+GSFG + +A H T E A+K K ++L +V + Q S + +
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKC----LKKREILKMKQVQHVAQEKSILMEL 75
Query: 69 K-------WYGVDGEDNVLVLDLLGPSLE-----DLFVYCRR--KFSLKTVLMLADQMIA 114
E+ V L LE +LF + R+ +F +++
Sbjct: 76 SHPFIVNMMCSFQDENRVYFL------LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL 129
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
EY+HS+ ++RD+KP+N L L K + V + DFG AKK D T L
Sbjct: 130 AFEYLHSKDIIYRDLKPENLL--LDNKGH-VKVTDFGFAKKVPDRTF----------TLC 176
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234
GT Y + + D ++G +L F+ G P+ T + Y+KI ++
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFD---DTPFRIYEKILAGRLK 233
Query: 235 TP 236
P
Sbjct: 234 FP 235
|
Length = 329 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 1e-10
Identities = 48/177 (27%), Positives = 76/177 (42%), Gaps = 56/177 (31%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQL----LYEAKVYKILQGG 62
+Y+L + IGSG++G + A T VA+K I N L E K+ + L+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-FDDLIDAKRILREIKLLRHLR-- 57
Query: 63 SGIPNIKWYGVDGEDNVL-VLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD--------- 110
+N++ +LD+L P + F VY + T LM D
Sbjct: 58 -------------HENIIGLLDILRPPSPEDFNDVY------IVTELMETDLHKVIKSPQ 98
Query: 111 ------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
Q++ ++Y+HS +HRD+KP N L+ +N + I DFGLA+
Sbjct: 99 PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV----NSNCDLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-10
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 23/200 (11%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSGIPNI 68
R +G G+FGE L + + +V K N S + L E + +LQ PNI
Sbjct: 6 RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH----PNI 61
Query: 69 -KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRG 123
+Y +DN L++++ G +L D V + + F + VL Q+++ + Y+H G
Sbjct: 62 IAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG 121
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
LHRDIK N + KA + + DFG++K Y + + GT Y S
Sbjct: 122 ILHRDIKTLNIFL---TKAGLIKLGDFGISKILGS-------EYSMAETVVGTPYYMSPE 171
Query: 184 THLGIEQSRRDDLESLGYVL 203
G++ + + D+ +LG VL
Sbjct: 172 LCQGVKYNFKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 57/190 (30%), Positives = 90/190 (47%), Gaps = 25/190 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGS 63
+Y+ KIG G++G ++ A TNE +A+K +E P + E + K +Q G
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG- 61
Query: 64 GIPNI-KWYGVDGEDNVL-----VLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
NI + V + L LDL L ++ + + +KT L Q++ I
Sbjct: 62 ---NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLY---QILRGI 115
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENK 171
Y HS LHRD+KP N L + R+ N + + DFGLA+ + P T H + YR +
Sbjct: 116 AYCHSHRVLHRDLKPQNLL--IDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPE 173
Query: 172 NLTGTARYAS 181
L G+ Y++
Sbjct: 174 ILLGSRHYST 183
|
Length = 294 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 1e-10
Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 27/207 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGS 63
KY+ R +G G+FG + L ++V +K +E E +V K+L
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH-- 58
Query: 64 GIPN-IKWYGVDGEDNVLVLDLL---GPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEY 118
PN I++Y ED L++ + G +L + C T+L Q++ + +
Sbjct: 59 --PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHH 116
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--GT 176
VH++ LHRD+K N L+ + V I DFG++K I ++K T GT
Sbjct: 117 VHTKLILHRDLKTQNILL--DKHKMVVKIGDFGISK----------ILSSKSKAYTVVGT 164
Query: 177 ARYASCNTHLGIEQSRRDDLESLGYVL 203
Y S G +++ D+ +LG VL
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVL 191
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 69/276 (25%), Positives = 122/276 (44%), Gaps = 29/276 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+L K+G G FGE+++ + T VA+K GT P+ L EA+V K L+ +
Sbjct: 9 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEK---LV 64
Query: 69 KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ Y V E+ + ++ G L+ L + L ++ +A Q+ + + YV ++
Sbjct: 65 QLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYV 124
Query: 126 HRDIKPDNFLMGLGRKANQV-YIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCN 183
HRD++ N L+G N V + DFGLA+ D N + + K + TA A+
Sbjct: 125 HRDLRAANILVG----ENLVCKVADFGLARLIED---NEYTARQGAKFPIKWTAPEAALY 177
Query: 184 THLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
I + D+ S G +L +G +P+ G+ ++ D++ E+ P C
Sbjct: 178 GRFTI----KSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC- 228
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
P C ++RP + +L+ D F+
Sbjct: 229 --PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 262
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 79/307 (25%), Positives = 124/307 (40%), Gaps = 66/307 (21%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGSGI 65
KL R IG G++G ++ A + EIVA V+++N P L E + L+
Sbjct: 11 KLNR-IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRH---- 65
Query: 66 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFV---YCR-----------RKFSLKTVLMLAD 110
PNI V + +++ G L+ +F+ YC FS V L
Sbjct: 66 PNI----------VELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLML 115
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP---- 166
Q++ ++Y+H +HRD+K N L+ + I DFGLA+ Y P P
Sbjct: 116 QLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLPAKPM-TPKVVT 171
Query: 167 --YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK 224
YR + L G + D+ ++G +L L P L ++ ++
Sbjct: 172 LWYRAPELLLGCT-----------TYTTAIDMWAVGCILAELLAHK-PL--LPGKSEIEQ 217
Query: 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLL 284
D I + + TP E + P F+ T ++P Y LK F L S G L
Sbjct: 218 LDLIIQ-LLGTPNESIW---PG-FSDLPLV-GKFTLPKQP-YNNLKHKFPWL-SEAGLRL 269
Query: 285 LQFIMSY 291
L F++ Y
Sbjct: 270 LNFLLMY 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-10
Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 42/276 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
+ L RK+GSG FGE++ + VA+KI + K E + K L+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKH--- 63
Query: 67 NIKWYGV--DGEDNVLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVH 120
I + V GE ++ +L+ L + R + + +++ +A Q+ + Y+
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKG--SLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP---TTNRHIPYRENKNLTGTA 177
+ +HRD+ N L+G + DFGLA+ ++ ++++ IPY+ TA
Sbjct: 122 EQNSIHRDLAARNILVGEDLVCK---VADFGLARLIKEDVYLSSDKKIPYK------WTA 172
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEK-KVS 234
A+ + S + D+ S G +LLY F G +P+ G + YD+I ++
Sbjct: 173 PEAASHGTF----STKSDVWSFG-ILLYEMFTYGQVPYPG---MNNHEVYDQITAGYRMP 224
Query: 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270
P + C P E C + + RP + L+
Sbjct: 225 CPAK--C---PQEIYKIMLECWAAEPEDRPSFKALR 255
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 48/209 (22%), Positives = 93/209 (44%), Gaps = 24/209 (11%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
++G+G+ G + H T +I+AVK +E + Q+L E + P I
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILH----KCNSPYIV 62
Query: 69 KWYG---VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGF 124
+YG +G+ ++ + + G SL+ + + + + + +A ++ + Y+H
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRD+KP N L+ Q+ + DFG++ + + K GT+ Y +
Sbjct: 123 IHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSLA---------KTFVGTSSYMAPER 170
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
G + S + D+ SLG L+ G P+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFPY 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 5e-10
Identities = 42/165 (25%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHP---QLLYEAKVYKIL 59
+G +YK IGSG++G + A + + VA+K I ++ + L E K+ +
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF 61
Query: 60 QGGSGIPNI-------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQM 112
+ NI + G D +D +V+DL+ L + ++ + + + + Q+
Sbjct: 62 KH----DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHI-IHSDQPLTEEHIRYFLYQL 116
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ---VYIIDFGLAK 154
+ ++Y+HS +HRD+KP N L+ N+ + I DFG+A+
Sbjct: 117 LRGLKYIHSANVIHRDLKPSNLLV------NEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 5e-10
Identities = 61/222 (27%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 12 GRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLL----YEAKVYKILQ 60
G IGSGSFG ++L + + E++AVK +S + +L E + K LQ
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 61 GGSGIPNIKWY---GVDGEDNVLVLDLL-GPSLEDLF-VYCRRKFSLKTVLMLADQMIAR 115
NI Y +D + + L+ + G S+ L Y F V Q++
Sbjct: 65 H----ENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKG 118
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR----DPTTNRHIPYRENK 171
+ Y+H+RG +HRDIK N L+ + I DFG++KK TN P
Sbjct: 119 LNYLHNRGIIHRDIKGANILVD---NKGGIKISDFGISKKLEANSLSTKTNGARP----- 170
Query: 172 NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+L G+ + + +R+ D+ SLG +++ L G P+
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 9e-10
Identities = 39/144 (27%), Positives = 73/144 (50%), Gaps = 11/144 (7%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI-KWYG 72
K+G GS+G ++ A H +T ++VA+K+ +++ E + K P I K+YG
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDS----PYIVKYYG 65
Query: 73 VDGEDNVL--VLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
++ L V++ G S+ D+ + + + + + Q + +EY+HS +HRDI
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDI 125
Query: 130 KPDNFLMGLGRKANQVYIIDFGLA 153
K N L+ + Q + DFG++
Sbjct: 126 KAGNILLN---EEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 42/165 (25%), Positives = 81/165 (49%), Gaps = 37/165 (22%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEA-KVYKILQGGSGIPN 67
+++ ++G G +G++FLA DT EIVA+K LL++ +V +L +
Sbjct: 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKK-----SLLFKLNEVRHVLTERDILTT 57
Query: 68 IK--WYGVDGEDNVLVLDLLGPSLEDLFVYCRRKF----SLKTVL----MLAD------- 110
K W ++ LL +D ++Y ++ +T+L +L++
Sbjct: 58 TKSEW----------LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYM 107
Query: 111 -QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+M ++ +H G++HRD+KP+NFL+ + + + DFGL+K
Sbjct: 108 AEMFEAVDALHELGYIHRDLKPENFLID---ASGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 62/260 (23%), Positives = 97/260 (37%), Gaps = 50/260 (19%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
+G G FG + L N A+K +E +H E ++ + P
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFS--EKEILEECNH----PF 54
Query: 68 I-KWYG--VDGEDNVLVLDL-LGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHS 121
I K Y D + ++++ LG +L+ R F T ++ EY+H+
Sbjct: 55 IVKLYRTFKDKKYIYMLMEYCLG---GELWTILRDRGLFDEYTARFYIACVVLAFEYLHN 111
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--GTARY 179
RG ++RD+KP+N L+ V ++DFG AKK K T GT Y
Sbjct: 112 RGIIYRDLKPENLLLD---SNGYVKLVDFGFAKKL----------KSGQKTWTFCGTPEY 158
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKA-----------ATKKQKYDK 227
+ L D SLG +LLY L G P+ K ++
Sbjct: 159 VAPEIILNKGYDFSVDYWSLG-ILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN 217
Query: 228 ICEKKVSTPIEVLCKSHPAE 247
+K I+ L + +P E
Sbjct: 218 YIDKAAKDLIKQLLRRNPEE 237
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-09
Identities = 52/162 (32%), Positives = 75/162 (46%), Gaps = 33/162 (20%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQ----LLYEA------KV 55
+ IG G+FGE+ L VDTN + A+K + + H + +L EA K+
Sbjct: 7 KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66
Query: 56 YKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
Y Q + + Y + G D + +L LG EDL +F + L A
Sbjct: 67 YYSFQDKDNLYFVMDY-IPGGDMMSLLIRLGIFEEDL-----ARFYIAE-LTCA------ 113
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
IE VH GF+HRDIKPDN L+ + + + DFGL +R
Sbjct: 114 IESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 1e-09
Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 16/164 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSG 64
+ L IG GSFGE++ A TN++VA+K+ E + + + E + +
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR---- 57
Query: 65 IPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P I K+YG + G ++++ G S DL K + + +++ +EY+H
Sbjct: 58 SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH 115
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
G +HRDIK N L+ + V + DFG++ + + R+
Sbjct: 116 EEGKIHRDIKAANILLS---EEGDVKLADFGVSGQLTSTMSKRN 156
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 29/210 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQ-LLYEAKVYKILQGGS 63
+K+ +KIG G F ++ A + +VA+K E K Q L E + K L
Sbjct: 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH-- 61
Query: 64 GIPN-IKWYGVDGEDNVLVLDLLGPSLEDL------FVYCRRKFSLKTVLMLADQMIARI 116
PN IK+ E+N L + L DL F +R +T+ Q+ + +
Sbjct: 62 --PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
E++HS+ +HRDIKP N + A V + D GL + + TT H +L G
Sbjct: 120 EHMHSKRIMHRDIKPANVFIT----ATGVVKLGDLGLGRFFSSKTTAAH-------SLVG 168
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLY 205
T Y S + + D+ SLG LLY
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLG-CLLY 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 2e-09
Identities = 48/171 (28%), Positives = 75/171 (43%), Gaps = 37/171 (21%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGSG 64
Y+ +IG G++G ++ A ++T VA+K + S P L E + K L+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLES-FE 59
Query: 65 IPNIKWYGVDGEDNVLVLD-LLGPSLE--------------DLFVYCRR----KFSLKTV 105
PNI V +LD GP + DL Y + +T+
Sbjct: 60 HPNI----------VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETI 109
Query: 106 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
L Q++ ++++HS +HRD+KP N L+ QV I DFGLA+ Y
Sbjct: 110 KDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG---QVKIADFGLARIY 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 70/273 (25%), Positives = 124/273 (45%), Gaps = 29/273 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+L K+G G FGE+++ + T + VA+K GT P+ L EA++ K L+ +P
Sbjct: 9 RLDVKLGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVP-- 65
Query: 69 KWYGVDGEDNV-LVLDLLGP-SLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSRGFL 125
Y V E+ + +V + +G SL D K+ L ++ +A Q+ + Y+ ++
Sbjct: 66 -LYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYI 124
Query: 126 HRDIKPDNFLMGLGRKANQV-YIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCN 183
HRD++ N L+G N V I DFGLA+ D N + + K + TA A+
Sbjct: 125 HRDLRAANILVG----DNLVCKIADFGLARLIED---NEYTARQGAKFPIKWTAPEAALY 177
Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
I + D+ S G +L + +G +P+ G+ ++ +++ E+ P C
Sbjct: 178 GRFTI----KSDVWSFGILLTELVTKGRVPYPGM---VNREVLEQV-ERGYRMPCPQGC- 228
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275
P C D+RP + +++ D
Sbjct: 229 --PESLHELMKLCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 3e-09
Identities = 48/162 (29%), Positives = 78/162 (48%), Gaps = 15/162 (9%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAV-KIENSGT----KHPQLLYEAKVYKILQGGSGIPN- 67
+IG GSFG ++ A++ TNE+VAV K+ SG K ++ E K + L+ PN
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH----PNT 83
Query: 68 IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
I++ G +++ LV++ S DL ++ + + + + Y+HS +
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
HRDIK N L+ + QV + DFG A K + PY
Sbjct: 144 HRDIKAGNILL---TEPGQVKLADFGSASKSSPANSFVGTPY 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.3 bits (135), Expect = 4e-09
Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 18/210 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSG 64
KY KIG G+ G +F A V T + VA+K N K P+ ++ E V K L+ +
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINL-QKQPKKELIINEILVMKELKNPNI 78
Query: 65 IPNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRG 123
+ + + V E V++ L G SL D+ C + + V + + +E++H+
Sbjct: 79 VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAV---CRECLQALEFLHANQ 135
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
+HRDIK DN L+G+ V + DFG + + R + GT + +
Sbjct: 136 VIHRDIKSDNVLLGM---DGSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPE 185
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 73/275 (26%), Positives = 111/275 (40%), Gaps = 34/275 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQGGS 63
+++ +KIG G F E++ A+ + VA+K + E + K L
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-- 61
Query: 64 GIPN-IKWYGVDGEDNVLVLDLLGPSLEDL------FVYCRRKFSLKTVLMLADQMIARI 116
PN IK+Y EDN L + L DL F +R KTV Q+ + +
Sbjct: 62 --PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 117 EYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
E++HSR +HRDIKP N F+ G V + D GL + + TT H +L G
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRFFSSKTTAAH-------SLVG 168
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
T Y S + + D+ SLG +L P+ G K +C+K
Sbjct: 169 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-----DKMNLYSLCKKIEQC 223
Query: 236 PIEVLCKSH-PAEFASYFHYCQSLTFDQRPDYGFL 269
L H E + C + ++RPD ++
Sbjct: 224 DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 6e-09
Identities = 46/173 (26%), Positives = 76/173 (43%), Gaps = 28/173 (16%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQL--LYEAKVYKILQGGSGI 65
YK+ KIG G+F E+ A T + A+K ++ Q+ L E + + L S
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRL---SPH 57
Query: 66 PNIKWYGVDGEDNV---------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
PNI + + + LV +L+ +L +L +R K V Q++ +
Sbjct: 58 PNI----LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
+++H G HRDIKP+N L+ K + + + DFG + PY E
Sbjct: 114 DHMHRNGIFHRDIKPENILI----KDDILKLADFGSCR-----GIYSKPPYTE 157
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-09
Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 7/147 (4%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
KY KIG G+ G ++ A V T + VA+K N K ++ E V + + + +
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIV 79
Query: 66 PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ Y V E V++ L G SL D+ + + + + +E++HS +
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVI 137
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGL 152
HRDIK DN L+G+ V + DFG
Sbjct: 138 HRDIKSDNILLGMD---GSVKLTDFGF 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 68/272 (25%), Positives = 123/272 (45%), Gaps = 27/272 (9%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+L +K+G+G FGE+++ + + N VAVK GT P+ L EA++ K L+ +
Sbjct: 9 QLIKKLGNGQFGEVWMGTW-NGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDK---LV 64
Query: 69 KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ Y V E+ + ++ G L+ L R L ++ +A Q+ A + Y+ ++
Sbjct: 65 QLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYI 124
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK-NLTGTARYASCNT 184
HRD++ N L+G G I DFGLA+ D N + + K + TA A+
Sbjct: 125 HRDLRSANILVGDGLVCK---IADFGLARLIED---NEYTARQGAKFPIKWTAPEAALYG 178
Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
I + D+ S G +L + +G +P+ G+ ++ +++ E+ P C
Sbjct: 179 RFTI----KSDVWSFGILLTELVTKGRVPYPGM---NNREVLEQV-ERGYRMPCPQDC-- 228
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275
P C ++RP + +L+ D
Sbjct: 229 -PISLHELMLQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 8e-09
Identities = 44/149 (29%), Positives = 72/149 (48%), Gaps = 15/149 (10%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGSGIPN 67
R+IG GSFG ++ A V TNE+VA+K + S K ++ E K + ++ PN
Sbjct: 31 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH----PN 86
Query: 68 -IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I++ G ++ LV++ S DL ++ + + + + Y+HS
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
+HRDIK N L+ + QV + DFG A
Sbjct: 147 IHRDIKAGNILL---TEPGQVKLADFGSA 172
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 47/168 (27%), Positives = 73/168 (43%), Gaps = 12/168 (7%)
Query: 10 KLGRKIGSGSFGEIFL----ASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI 65
K R +G G FG++ L ++ T E+VAVK K IL+
Sbjct: 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE 66
Query: 66 PNIKWYGV--DGEDNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSR 122
+K+ G + L L + L L Y + K +L +L+ A Q+ + Y+HS+
Sbjct: 67 NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
++HRD+ N L+ V I DFGLAK P + + RE+
Sbjct: 127 HYIHRDLAARNVLL---DNDRLVKIGDFGLAKAV--PEGHEYYRVRED 169
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 45/165 (27%), Positives = 81/165 (49%), Gaps = 18/165 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL-------- 59
+Y+ +GSG++G + A + VAVK L++ + Y+ L
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVK--KLSRPFQSLIHARRTYRELRLLKHMKH 73
Query: 60 QGGSGIPNIKWYGVDGED---NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
+ G+ ++ E+ LV +L+G L ++ V C+ K S + V L Q++ +
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNI-VKCQ-KLSDEHVQFLIYQLLRGL 131
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
+Y+HS G +HRD+KP N + + ++ I+DFGLA++ D T
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVN---EDCELRILDFGLARQADDEMT 173
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG- 72
+IG GSFGE+F T ++VA+KI + ++ + +L K+YG
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 73 -VDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
+ G ++++ L G +L+ L +F + T+L +++ ++Y+HS +HRDI
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATML---KEILKGLDYLHSEKKIHRDI 127
Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE 189
K N L+ + V + DFG+A + D R GT + + I+
Sbjct: 128 KAANVLLS---EQGDVKLADFGVAGQLTDTQIKR-------NTFVGTPFWMAPEV---IQ 174
Query: 190 QSRRD---DLESLGYVLLYFLRGSLP 212
QS D D+ SLG + +G P
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 71/275 (25%), Positives = 114/275 (41%), Gaps = 53/275 (19%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQGGSGIPNI- 68
+IG G+FGE+F N VAVK T P L L EA++ K PNI
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVK-SCRETLPPDLKAKFLQEARILKQYSH----PNIV 56
Query: 69 KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVHSRG 123
+ GV + +V++L+ D + R + +K ++ + + A +EY+ S+
Sbjct: 57 RLIGVCTQKQPIYIVMELVQGG--DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH 114
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN-----RHIPYR----ENKNLT 174
+HRD+ N L+ + N + I DFG++++ D + IP + E N
Sbjct: 115 CIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY- 170
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKK 232
RY+S D+ S G +LL+ F G++P+ A Q+ + E+
Sbjct: 171 --GRYSS-----------ESDVWSFG-ILLWEAFSLGAVPY----ANLSNQQTREAIEQG 212
Query: 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 267
V P LC P C QRP +
Sbjct: 213 VRLPCPELC---PDAVYRLMERCWEYDPGQRPSFS 244
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 57/213 (26%), Positives = 91/213 (42%), Gaps = 37/213 (17%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV 73
KIG GSFGE+F T ++VA+KI + ++ + +L K+YG
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 74 DGEDNVL-----------VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+D L LDLL P D + + T+L +++ ++Y+HS
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGPLD-------ETQIATILR---EILKGLDYLHSE 120
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
+HRDIK N L+ + +V + DFG+A + D R+ GT + +
Sbjct: 121 KKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMAP 170
Query: 183 NTHLGIEQSRRD---DLESLGYVLLYFLRGSLP 212
I+QS D D+ SLG + +G P
Sbjct: 171 EV---IKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 9/150 (6%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIK- 69
+ +G G+FGE+ LA VDT+ + A+K + Q+ + IL +K
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 70 WYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHR 127
+Y +DN+ V+D + P + + + R + F ++ IE VH GF+HR
Sbjct: 67 YYSFQDKDNLYFVMDYI-PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHR 125
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
DIKPDN L+ L + + DFGL +R
Sbjct: 126 DIKPDNILIDLD---GHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 3e-08
Identities = 58/227 (25%), Positives = 93/227 (40%), Gaps = 49/227 (21%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT---------KHPQLLYEAKVYKILQGGSGI 65
IG G++G ++ HV T +VA+KI N T + LL + + S
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQ-------SQP 61
Query: 66 PNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLM---LADQMIARI----- 116
PNI K+YG L GP L + Y S++T++ +A++ I+ I
Sbjct: 62 PNITKYYGS---------YLKGPRLWIIMEYAEGG-SVRTLMKAGPIAEKYISVIIREVL 111
Query: 117 ---EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+Y+H G +HRDIK N L+ V + DFG+A ++ R
Sbjct: 112 VALKYIHKVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNSSKR-------STF 161
Query: 174 TGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219
GT + + G + D+ SLG + G+ P+ + A
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-08
Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
KIG GS G + +A + VAVK+ + + +LL+ E + + Q + + K Y
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 72 GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131
V E VL+ L G +L D+ R + + + + + ++ + Y+HS+G +HRDIK
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 132 DNFLMGL-GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 190
D+ L+ L GR V + DFG + ++ +P R K+L GT + +
Sbjct: 146 DSILLTLDGR----VKLSDFGFCAQ-----ISKDVPKR--KSLVGTPYWMAPEVISRTPY 194
Query: 191 SRRDDLESLGYVLLYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-08
Identities = 43/135 (31%), Positives = 62/135 (45%), Gaps = 39/135 (28%)
Query: 77 DNVL-VLDLLGPSLEDLFVYCRRKFSLKTVLMLAD---------------------QMIA 114
DNVL LD+L P D F + + T LM +D Q++
Sbjct: 59 DNVLSALDILQPPHIDPF----EEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR 114
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIP------- 166
++Y+HS G LHRDIKP N L+ +N + I DFGLA+ +P ++H+
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLV----NSNCVLKICDFGLARV-EEPDESKHMTQEVVTQY 169
Query: 167 YRENKNLTGTARYAS 181
YR + L G+ Y S
Sbjct: 170 YRAPEILMGSRHYTS 184
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-08
Identities = 73/277 (26%), Positives = 117/277 (42%), Gaps = 56/277 (20%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI-----PN 67
KIG G+FG+++ + N VAVK T L + K K LQ + PN
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVK-----TCRSTLPPDLKR-KFLQEAEILKQYDHPN 53
Query: 68 I-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEYVHS 121
I K GV + +V++L+ L + R+K ++K +L ++ A +EY+ S
Sbjct: 54 IVKLIGVCVQKQPIYIVMELV--PGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLES 111
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-----YRDPTTNRHIPYR----ENKN 172
+ +HRD+ N L+G N + I DFG++++ Y + IP + E N
Sbjct: 112 KNCIHRDLAARNCLVGEN---NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALN 168
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICE 230
RY S D+ S G +LL+ F G P+ G+ + +Q ++I E
Sbjct: 169 ---YGRYTS-----------ESDVWSYG-ILLWETFSLGDTPYPGM---SNQQTRERI-E 209
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 267
P LC P E C + + RP +
Sbjct: 210 SGYRMPAPQLC---PEEIYRLMLQCWAYDPENRPSFS 243
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-08
Identities = 42/167 (25%), Positives = 82/167 (49%), Gaps = 25/167 (14%)
Query: 9 YKLGRKIGSGSFGEIF-LASHVDTNEIVAVKIENSGTKHPQLLYEAK-----VYKILQGG 62
Y + +GSG+FG ++ + + ++A+K N +P + + + I+
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEIN--VHNPAFGKDKRERDKSIGDIVSEV 59
Query: 63 SGI------PNIKWYG---VDGEDNVLVLDLL-GPSLEDLFVYCRRK---FSLKTVLMLA 109
+ I PNI Y ++ + +V+DL+ G L + F + K F+ + + +
Sbjct: 60 TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119
Query: 110 DQMIARIEYVHSRGFL-HRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
QM+ + Y+H + HRD+ P+N ++G + ++V I DFGLAK+
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTITDFGLAKQ 163
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 7e-08
Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 25/152 (16%)
Query: 73 VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 132
V+G D +L +G L V R + +TVL L EY+H+ G +HRD+KPD
Sbjct: 83 VEGGDCATLLKNIGA----LPVDMARMYFAETVLAL--------EYLHNYGIVHRDLKPD 130
Query: 133 NFLM-GLGRKANQVYIIDFGLAK-KYRDPTTNRHIPYRE-------NKNLTGTARYASCN 183
N L+ +G + + DFGL+K TTN + + E +K + GT Y +
Sbjct: 131 NLLITSMG----HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPE 186
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
L + D ++G +L FL G +P+ G
Sbjct: 187 VILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 7e-08
Identities = 52/209 (24%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
KY KIG G+ G ++ A V T + VA++ N K ++ E V + + + +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80
Query: 66 PNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ Y V E V++ L G SL D+ C + + V + + +E++HS
Sbjct: 81 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALEFLHSNQV 137
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRDIK DN L+G+ V + DFG + + R + GT + +
Sbjct: 138 IHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPEV 187
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-08
Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 29/238 (12%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSG-----IPN 67
IG G+FG+++ DT I A+K+ + ++ + IL I
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFL 125
+K+ D LV D + S +LF + ++ +FS +++ +E++H +
Sbjct: 61 LKFSFQTDSDLYLVTDYM--SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTTNRHIPYRENKNLTGTARYASCN 183
+RD+KP+N L+ + + DFGL+K + TTN GT Y +
Sbjct: 119 YRDLKPENILLD---ATGHIALCDFGLSKANLTDNKTTN---------TFCGTTEYLAPE 166
Query: 184 THLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
L + ++ D SLG ++ G W A +Q Y I KV P VL
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCG---WSPFYAEDTQQMYRNIAFGKVRFPKNVL 221
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 7e-08
Identities = 61/246 (24%), Positives = 99/246 (40%), Gaps = 37/246 (15%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGS 63
Y++ IG GSFG + +I+ K + G + QL+ E + + L+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKH-- 58
Query: 64 GIPNI-KWYG--VDGEDNVLVLDL---LGPSLEDLFVYCRRKFSL---KTVLMLADQMIA 114
PNI ++Y +D + L + + G L L C+++ + + + Q++
Sbjct: 59 --PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 115 RIEYVHSRG-----FLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+ H+R LHRD+KP N FL N V + DFGLAK ++
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDA----NNNVKLGDFGLAKILGHDSS------- 165
Query: 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228
K GT Y S + + D+ SLG ++ S P+ A + Q KI
Sbjct: 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT---ARNQLQLASKI 222
Query: 229 CEKKVS 234
E K
Sbjct: 223 KEGKFR 228
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 9e-08
Identities = 46/145 (31%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNIK-WY 71
IG G+FGE+ L DT I A+KI + + Q+ + IL G +K +Y
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68
Query: 72 GVDGEDNV-LVLDLLGPSLEDLFVYCRRKFSL---KTVLMLADQMIARIEYVHSRGFLHR 127
+ N+ L+++ L D+ +K +L T +A+ ++A I+ +H GF+HR
Sbjct: 69 SFQDKRNLYLIMEFLPGG--DMMTLLMKKDTLSEEATQFYIAETVLA-IDAIHQLGFIHR 125
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGL 152
DIKPDN L+ V + DFGL
Sbjct: 126 DIKPDNLLLD---AKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGSGIPN 67
R+IG GSFG ++ A V +E+VA+K + S K ++ E + + L+ PN
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH----PN 76
Query: 68 -IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I++ G ++ LV++ S DL ++ + + + + Y+HS
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
+HRD+K N L+ + V + DFG A
Sbjct: 137 IHRDVKAGNILL---SEPGLVKLGDFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 1e-07
Identities = 46/162 (28%), Positives = 75/162 (46%), Gaps = 33/162 (20%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQ----LLYEA------KV 55
+ +G G+FGE+ LA VDT + A+K + + H + +L EA ++
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 56 YKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
Y Q + + Y + G D + +L +G EDL +F + ++
Sbjct: 67 YYSFQDKDNLYFVMDY-IPGGDMMSLLIRMGIFPEDL-----ARFYIA-------ELTCA 113
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
+E VH GF+HRDIKPDN L+ + + + DFGL +R
Sbjct: 114 VESVHKMGFIHRDIKPDNILID---RDGHIKLTDFGLCTGFR 152
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 1e-07
Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 33/191 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQ--LLYEAKVYKILQGGS 63
KY+ +G GS+G + H +T +IVA+K +E+ K + + E ++ K L+ +
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61
Query: 64 GIPNI-------KWYGVDGEDNVLVLDLLGPS-LEDLFVYCRRKFSLKTVLMLADQMIAR 115
+ I + Y LV + + + L+DL Y V Q++
Sbjct: 62 LVNLIEVFRRKKRLY--------LVFEFVDHTVLDDLEKYPN-GLDESRVRKYLFQILRG 112
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-------YRDPTTNRHIPYR 168
IE+ HS +HRDIKP+N L+ ++ V + DFG A+ Y D R YR
Sbjct: 113 IEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEVYTDYVATRW--YR 167
Query: 169 ENKNLTGTARY 179
+ L G +Y
Sbjct: 168 APELLVGDTKY 178
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 2e-07
Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 20/159 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
YKLG IG+GSFG ++ A +DT+E VA+K + PQ Y+ + I++ + I I
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIK---KVLQDPQ--YKNRELLIMKNLNHINII 122
Query: 69 ---KWYGVD----GEDNV---LVLDLLGPSLEDLF-VYCRRKFSLKTVL--MLADQMIAR 115
+Y + E N+ +V++ + ++ Y R +L L + + Q+
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ Y+HS+ HRD+KP N L + + + + DFG AK
Sbjct: 183 LAYIHSKFICHRDLKPQNLL--IDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 51/221 (23%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT--------KHPQLLYEAKVYK 57
++L R +G+G++G++FL V D ++ A+K+ T +H + E +V +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRT--ERQVLE 59
Query: 58 ILQGGSGIPNIKW-YGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLADQMIA 114
++ + + + + D + + L+LD + +LF +Y R F+ V + +++
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLH-LILDYVNGG--ELFTHLYQREHFTESEVRVYIAEIVL 116
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
++++H G ++RDIK +N L+ V + DFGL+K++ R +
Sbjct: 117 ALDHLHQLGIIYRDIKLENILLD---SEGHVVLTDFGLSKEFLAEEEERAYSF------C 167
Query: 175 GTARYASCNTHLGIEQSRRD--DLESLGYVLLYFLRGSLPW 213
GT Y + G D SLG + L G+ P+
Sbjct: 168 GTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.2 bits (123), Expect = 2e-07
Identities = 48/164 (29%), Positives = 68/164 (41%), Gaps = 45/164 (27%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGSGIPNI- 68
KIG G++G ++ A T EIVA+K +E P + E + K L PNI
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH----PNIV 61
Query: 69 KWYGVDGEDNVLVL-------DL-----------LGPSLEDLFVYCRRKFSLKTVLMLAD 110
+ V +N L L DL L P L ++Y
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLY--------------- 106
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Q++ I Y HS LHRD+KP N L+ + + + DFGLA+
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 50.9 bits (121), Expect = 3e-07
Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
KY KIG G+ G ++ A + T + VA+K N K ++ E V + + + +
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79
Query: 66 PNIKWYGVDGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ Y V E V++ L G SL D+ C + + V + + ++++HS
Sbjct: 80 NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV---CRECLQALDFLHSNQV 136
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRDIK DN L+G+ V + DFG + + R + GT + +
Sbjct: 137 IHRDIKSDNILLGMD---GSVKLTDFGFCAQITPEQSKR-------STMVGTPYWMAPEV 186
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ D+ SLG + + + G P+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 12/155 (7%)
Query: 13 RKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
R +G G FG++ L + +T E VAVK + + K +IL+ +
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 69 KWYGVDGEDN----VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
K+ G+ ED L+++ L SL++ + K +LK L A Q+ ++Y+ SR
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
++HRD+ N L+ +QV I DFGL K
Sbjct: 130 YVHRDLAARNVLV---ESEHQVKIGDFGLTKAIET 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 62/233 (26%), Positives = 107/233 (45%), Gaps = 29/233 (12%)
Query: 15 IGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIK-- 69
+G GSFG++FL + D ++ A+K+ T + K+ + + P I
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 70 WYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTV-LMLADQMIARIEYVHSRGFL 125
Y E + L+LD L DLF ++ F+ + V LA+ +A ++++HS G +
Sbjct: 64 HYAFQTEGKLYLILDFLRGG--DLFTRLSKEVMFTEEDVKFYLAELALA-LDHLHSLGII 120
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK--NLTGTARYASCN 183
+RD+KP+N L+ + + + DFGL+K+ D E K + GT Y +
Sbjct: 121 YRDLKPENILLD---EEGHIKLTDFGLSKESID---------HEKKAYSFCGTVEYMAPE 168
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
++ D S G ++ L GSLP+QG +K+ I + K+ P
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQG---KDRKETMTMILKAKLGMP 218
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 20/158 (12%)
Query: 10 KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
K +++G G FG++ L + +T E VAVK N + E ++ + L
Sbjct: 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH- 65
Query: 63 SGIPNI-KWYGV---DGEDNV-LVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARI 116
NI K+ GV G ++ L+++ L SL D R + +LK +L+ + Q+ +
Sbjct: 66 ---ENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+Y+ S+ ++HRD+ N L+ + V I DFGLAK
Sbjct: 123 DYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 3e-07
Identities = 70/237 (29%), Positives = 101/237 (42%), Gaps = 22/237 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEA-KVYKILQGGSGIP 66
+Y++ +KIG GSFG+I+LA +E +K E TK P EA K IL P
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIK-EIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 67 NI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEYVHS 121
NI ++ E+ L + + DL R+ FS +L Q+ ++++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 122 RGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
R LHRDIK N FL G A + DFG+A++ D GT Y
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAK---LGDFGIARQLNDSM-------ELAYTCVGTPYYL 169
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
S + + D+ SLG VL P++G Q KIC+ + PI
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEG---NNLHQLVLKICQGYFA-PI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-07
Identities = 24/146 (16%), Positives = 57/146 (39%), Gaps = 12/146 (8%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWY 71
+ + G ++L +E +KI S K E + ++L +P +
Sbjct: 4 KLLKGGLTNRVYLLG--TKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLAS 61
Query: 72 GVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
G + L+++ + G +L+++ + + + +++A++ + H D+
Sbjct: 62 GESDGWSYLLMEWIEGETLDEV-----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLH 116
Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKY 156
P N L+ + IID+ A
Sbjct: 117 PGNILV---DDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 15/152 (9%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPN- 67
KLG IG G FG++ L + + VAVK +++ T L EA V L+ PN
Sbjct: 9 KLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRH----PNL 62
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEYVHSRG 123
++ GV + N L + + L Y R + +L L A + +EY+ +
Sbjct: 63 VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
F+HRD+ N L+ + + DFGLAK+
Sbjct: 123 FVHRDLAARNVLVS---EDLVAKVSDFGLAKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-07
Identities = 39/149 (26%), Positives = 77/149 (51%), Gaps = 11/149 (7%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
KL +K+G+G FGE+++ + + + VA+K G+ P+ L EA + K LQ +
Sbjct: 9 KLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPR---LV 64
Query: 69 KWYGVDGEDNVLVLD--LLGPSLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ Y V ++ + ++ + SL D L K ++ ++ +A Q+ + ++ + ++
Sbjct: 65 RLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI 124
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
HRD++ N L+ + I DFGLA+
Sbjct: 125 HRDLRAANILVS---ETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-07
Identities = 46/157 (29%), Positives = 71/157 (45%), Gaps = 35/157 (22%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
IG G+FGE+ L DT +I A+K +++ K QL + K + + S P W
Sbjct: 9 IGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAH-VKAERDVLAESDSP---W-- 62
Query: 73 VDGEDNVLVLDLLGPSLEDLFVYCRRKF----SLKTVLMLAD------------QMIARI 116
V+ L + ++Y +F L T+L+ D + + I
Sbjct: 63 --------VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAI 114
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
E VH GF+HRDIKPDN L+ + + + DFGL+
Sbjct: 115 EAVHKLGFIHRDIKPDNILID---RGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 3e-07
Identities = 47/169 (27%), Positives = 82/169 (48%), Gaps = 22/169 (13%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLY-EAKVYKILQGGSGIPNI--- 68
KIG GS G + +A+ T VAVK + + +LL+ E + + Q PNI
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH----PNIVEM 81
Query: 69 -KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
Y V E V++ L G +L D+ + R + + + + ++ + ++H++G +HR
Sbjct: 82 YSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLHAQGVIHR 139
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
DIK D+ L+ +V + DFG + ++ +P R K+L GT
Sbjct: 140 DIKSDSILL---TSDGRVKLSDFGFCAQ-----VSKEVPRR--KSLVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 4e-07
Identities = 51/153 (33%), Positives = 81/153 (52%), Gaps = 21/153 (13%)
Query: 15 IGSGSFGEIFLASHV----DTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+G G+FG + L + +T E+VAVK +++S +H + E ++ K LQ NI
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQH----DNI 67
Query: 69 -KWYGV---DGEDNV-LVLDLLGP--SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
K+ GV G N+ LV++ L P SL D R + + +L+ A Q+ +EY+ S
Sbjct: 68 VKYKGVCYSAGRRNLRLVMEYL-PYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGS 126
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ ++HRD+ N L+ N+V I DFGL K
Sbjct: 127 KRYVHRDLATRNILV---ESENRVKIGDFGLTK 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 4e-07
Identities = 64/274 (23%), Positives = 112/274 (40%), Gaps = 38/274 (13%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY----KILQGG 62
+ ++ G+ +G G+FG ++L VDT +A K + P+ E ++L+
Sbjct: 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61
Query: 63 SGIPNIKWYGV---DGEDNVLVLD--LLGPSLED-------LFVYCRRKFSLKTVLMLAD 110
+++YG E + + + G S++D L RK++
Sbjct: 62 QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT--------R 113
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
Q++ + Y+HS +HRDIK N L A V + DFG +K+ + +
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRLQTICMSG----TGI 166
Query: 171 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
+++TGT + S G R+ D+ SLG ++ L PW +A KI
Sbjct: 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---AIFKIAT 223
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
+ + + SH +E A F C + RP
Sbjct: 224 QPTNPQL----PSHISEHARDFLGCIFVEARHRP 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 53/212 (25%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQGGSGIPN 67
+ +G GSFG++FLA TN+ A+K + E +V + + +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFL 125
+ E+ V++ L DL + + KF L A ++I ++++HS+G +
Sbjct: 61 LYCTFQTKENLFFVMEYLNGG--DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTTNRHIPYRENKNLTGTARYASCN 183
+RD+K DN L+ + I DFG+ K+ D T GT Y +
Sbjct: 119 YRDLKLDNILLD---TDGHIKIADFGMCKENMLGDAKTC---------TFCGTPDYIAPE 166
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
LG + + D S G +L L G P+ G
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-07
Identities = 70/288 (24%), Positives = 123/288 (42%), Gaps = 48/288 (16%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
+ +Y+ +GSG++G + + DT + V ++ +++ + Y+ L+
Sbjct: 15 VPERYQNLSPVGSGAYGSV--CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL--- 69
Query: 65 IPNIKWYGVDG--------------EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD 110
+ ++K V G D LV L+G L ++ V C+ K + V L
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQ-KLTDDHVQFLIY 127
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
Q++ ++Y+HS +HRD+KP N + + ++ I+DFGLA+ D T
Sbjct: 128 QILRGLKYIHSADIIHRDLKPSNLAVN---EDCELKILDFGLARHTDDEMT--------- 175
Query: 171 KNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229
T Y + L + ++ D+ S+G ++ L G + G T K+
Sbjct: 176 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG----TDHIDQLKLI 230
Query: 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277
+ V TP L K +E A +Y QSLT Q P K F ++F
Sbjct: 231 LRLVGTPGAELLKKISSESAR--NYIQSLT--QMP-----KMNFANVF 269
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 39/218 (17%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKV-------YKILQGGS 63
+IG GSFGE++ T E+VA+KI E + + + E V Y GS
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 64 GIPNIK-WYGVDGEDNVLVLDLLGPS-LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ K W ++ LDLL P LE+ ++ T+L +++ ++Y+HS
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPGPLEETYI--------ATILR---EILKGLDYLHS 119
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+HRDIK N L+ + V + DFG+A + D R+ GT + +
Sbjct: 120 ERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRN-------TFVGTPFWMA 169
Query: 182 CNTHLGIEQSRRD---DLESLGYVLLYFLRGSLPWQGL 216
I+QS D D+ SLG + +G P L
Sbjct: 170 PEV---IKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQGGSGIPN 67
R+IG GSFG ++ A V TNE+VA+K + K ++ E + + L+ PN
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH----PN 76
Query: 68 -IKWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I++ G ++ LV++ S D+ ++ + + + + Y+HS
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
+HRDIK N L+ + V + DFG A
Sbjct: 137 IHRDIKAGNILL---TEPGTVKLADFGSA 162
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 51/203 (25%), Positives = 98/203 (48%), Gaps = 16/203 (7%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
KIG GS G + +A+ T + VAVK ++ + +LL+ E + + + + Y
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 72 GVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
V E V++ L G +L D+ + R + + TV + ++ + Y+H++G +HRDIK
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCL---SVLRALSYLHNQGVIHRDIK 145
Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ 190
D+ L+ ++ + DFG + ++ +P R K+L GT + + +
Sbjct: 146 SDSILL---TSDGRIKLSDFGFCAQ-----VSKEVPKR--KSLVGTPYWMAPEVISRLPY 195
Query: 191 SRRDDLESLGYVLLYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 196 GTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 6e-07
Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 16/154 (10%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
+ G+ + + R + GS G +F +SH D + V VK + ++EA++ + L +
Sbjct: 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVK----AGWYASSVHEARLLRRLSHPA 221
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLE-DLFVYCRRK---FSLKTVLMLADQMIARIEYV 119
+ + V G LVL P DL+ Y + L V +A Q+++ I+Y+
Sbjct: 222 VLALLDVRVVGGL-TCLVL----PKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYI 276
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
H G +HRDIK +N L+ + + DFG A
Sbjct: 277 HGEGIIHRDIKTENVLVN---GPEDICLGDFGAA 307
|
Length = 461 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-07
Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 25/225 (11%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKIL 59
V ++LG+ +G G+FGE++L DT +AVK + + + L E ++ K L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 60 QGGSGIPNIKWYGV--DGED---NVLVLDLLGPSLED-LFVYCRRKFSLKTVLMLADQMI 113
+ +++YG D E+ ++ V + G S++D L Y + Q++
Sbjct: 62 RHDR---IVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQIL 116
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+ Y+HS +HRDIK N L A V + DFG +K+ + + K++
Sbjct: 117 QGVSYLHSNMIVHRDIKGANILRD---SAGNVKLGDFGASKRIQ----TICMSGTGIKSV 169
Query: 174 TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
TGT + S G R+ D+ S+ ++ L PW +A
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 6e-07
Identities = 58/217 (26%), Positives = 93/217 (42%), Gaps = 24/217 (11%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQ---LLYEAKVYKILQGGSGIPNI-- 68
IG G FGE++ DT ++ A+K ++ K Q L ++ L P I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 69 KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFL 125
Y D + +LDL+ DL + + FS + A ++I +E++H+R +
Sbjct: 62 MSYAFHTPDKLSFILDLMNGG--DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT- 184
+RD+KP N L+ + V I D GLA + ++ P+ GT Y +
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDF-----SKKKPHAS----VGTHGYMAPEVL 167
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221
G+ D SLG +L LRG P++ K K
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 7e-07
Identities = 21/50 (42%), Positives = 30/50 (60%), Gaps = 1/50 (2%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDP 159
Q++ + Y+HS LHRD+KP N +MG G + V I D GLA+ + P
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 7e-07
Identities = 51/202 (25%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGGSGIPNIKWY 71
KIG GS G + +A+ + ++VAVK ++ + +LL+ E + + Q + + Y
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 72 GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP 131
V E V++ L G +L D+ + R + LA ++ + +H++G +HRDIK
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLA--VLKALSVLHAQGVIHRDIKS 144
Query: 132 DNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQS 191
D+ L+ +V + DFG + ++ +P R K+L GT + + +
Sbjct: 145 DSILL---THDGRVKLSDFGFCAQ-----VSKEVPRR--KSLVGTPYWMAPELISRLPYG 194
Query: 192 RRDDLESLGYVLLYFLRGSLPW 213
D+ SLG +++ + G P+
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 7e-07
Identities = 48/176 (27%), Positives = 71/176 (40%), Gaps = 58/176 (32%)
Query: 8 KY-KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQGG 62
KY KL KIG GS+G +F + +T +IVA+K P + L E ++ K L+
Sbjct: 2 KYEKLS-KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH- 59
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD------------ 110
PN LV +L ++F RRK L V D
Sbjct: 60 ---PN------------LV------NLIEVF---RRKRKLHLVFEYCDHTVLNELEKNPR 95
Query: 111 ------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Q + + + H +HRD+KP+N L+ K Q+ + DFG A+
Sbjct: 96 GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 7e-07
Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 23/154 (14%)
Query: 11 LGRKIGSGSFGEIFLA---SHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIP 66
+++GSG FG + L +D VA+K+ G + EAKV L P
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKID----VAIKMIREGAMSEDDFIEEAKVMMKLSH----P 59
Query: 67 N-IKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVH 120
N ++ YGV + +V + + + L Y R K + +L + + +EY+
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYM--ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
S GF+HRD+ N L+G + N V + DFGLA+
Sbjct: 118 SNGFIHRDLAARNCLVG---EDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 8e-07
Identities = 41/163 (25%), Positives = 68/163 (41%), Gaps = 45/163 (27%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD 74
IG G+FGE+ L DT I A+K + ++L + +V V
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKK----LRKSEMLEKEQVAH---------------VR 49
Query: 75 GEDNVL-------VLDLLGPSLEDLFVYCRRKF----SLKTVLMLAD------------Q 111
E ++L V+ L ++ ++Y ++ + T+LM D +
Sbjct: 50 AERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAE 109
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
I I+ +H G++HRDIKPDN L+ + + DFGL
Sbjct: 110 TILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCT 149
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 46/159 (28%), Positives = 78/159 (49%), Gaps = 28/159 (17%)
Query: 11 LGRKIGSGSFGEIFLASHVD-TNEIVAV-----KIENSGTKHPQLLYEAKVYKILQGGSG 64
LGR IG G FG+++ ++ NE +AV K S + + L EA + +
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDH--- 66
Query: 65 IPNI-KWYGVDGEDNV-LVLDL-----LGPSLEDLFVYCRRKFSLK--TVLMLADQMIAR 115
P+I K GV E+ V +V++L L L+ K+SL ++++ + Q+
Sbjct: 67 -PHIVKLIGVITENPVWIVMELAPLGELRSYLQ------VNKYSLDLASLILYSYQLSTA 119
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ Y+ S+ F+HRDI N L+ + V + DFGL++
Sbjct: 120 LAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 67/287 (23%), Positives = 113/287 (39%), Gaps = 64/287 (22%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGIPNI-KW 70
IG G+FG + H + I+AVK + +LL + V S P I K+
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM---RSSDCPYIVKF 68
Query: 71 YGV---DGEDNVLVLDLLGPSLEDL--FVYCRRKFSLKTVLMLADQMIARIEYVHSRGF- 124
YG +G D + ++L+ SL+ +VY K ++ ++++ +I +
Sbjct: 69 YGALFREG-DCWICMELMDISLDKFYKYVYEVLK------SVIPEEILGKIAVATVKALN 121
Query: 125 --------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
+HRD+KP N L L R N + + DFG++ + D
Sbjct: 122 YLKEELKIIHRDVKPSNIL--LDRNGN-IKLCDFGISGQLVDSIAK-------------- 164
Query: 177 ARYASCNTHLG---IEQSRRD------DLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227
R A C ++ I+ S RD D+ SLG L G P+ + +D+
Sbjct: 165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQ 219
Query: 228 ICEKKVSTPIEVLCKSHPAEFA----SYFHYCQSLTFDQRPDYGFLK 270
+ + V +L S EF+ ++ + C +RP Y L
Sbjct: 220 LTQ-VVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELL 265
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 9e-07
Identities = 44/145 (30%), Positives = 72/145 (49%), Gaps = 13/145 (8%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIK-WY 71
IG G+FGE+ L DT + A+KI + Q+ + IL + +K +Y
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 72 GVDGEDNV-LVLDLLGPSLEDLFVYCRRKFSL---KTVLMLADQMIARIEYVHSRGFLHR 127
+ N+ L+++ L D+ +K +L +T +A+ ++A I+ +H GF+HR
Sbjct: 69 SFQDKLNLYLIMEFLPGG--DMMTLLMKKDTLTEEETQFYIAETVLA-IDSIHQLGFIHR 125
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGL 152
DIKPDN L+ V + DFGL
Sbjct: 126 DIKPDNLLLD---SKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 9e-07
Identities = 42/153 (27%), Positives = 76/153 (49%), Gaps = 11/153 (7%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
KL +K+G+G FGE+++A++ + + VAVK G+ + L EA V K LQ +
Sbjct: 9 KLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDK---LV 64
Query: 69 KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
K + V ++ + ++ G L+ L K L ++ + Q+ + ++ R ++
Sbjct: 65 KLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI 124
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
HRD++ N L+ + I DFGLA+ D
Sbjct: 125 HRDLRAANILVS---ASLVCKIADFGLARVIED 154
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 13 RKIGSGSFGEIFLASHVDTN-EIVAVK-IENSGT-KHPQLLYEAKVYKILQGGSGIPNIK 69
R +G+GSFG + LA++ + + VA+K E S K Q+ + KIL + +
Sbjct: 36 RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95
Query: 70 WYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHR 127
YG +++ L L L + F + RR +F A Q++ EY+ S ++R
Sbjct: 96 LYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYR 155
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
D+KP+N L+ K + + DFG AK + L GT Y + L
Sbjct: 156 DLKPENLLLD---KDGFIKMTDFGFAK----------VVDTRTYTLCGTPEYIAPEILLN 202
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPW 213
+ + D +LG + L G P+
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 55/235 (23%), Positives = 88/235 (37%), Gaps = 73/235 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-----------------IENS----GTKHPQLL--- 50
+G GSFG++ LA TNE A+K +E +HP L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 51 --YEAK-----VYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLK 103
++ K V + L GG + +I+ G +F
Sbjct: 63 CTFQTKEHLFFVMEYLNGGDLMFHIQSSG--------------------------RFDEA 96
Query: 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPTT 161
A ++I ++++H +G ++RD+K DN L+ K + I DFG+ K+ +
Sbjct: 97 RARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLD---KDGHIKIADFGMCKENMNGEGKA 153
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQG 215
+ GT Y + G + + D S G VLLY L G P+ G
Sbjct: 154 S---------TFCGTPDYIAPEILKGQKYNESVDWWSFG-VLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 46/167 (27%), Positives = 73/167 (43%), Gaps = 39/167 (23%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK---------- 57
KY++ +K+G G++G ++ A T E+VA+K K++
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALK---------------KIFDAFRNATDAQR 52
Query: 58 ------ILQGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLE-DLFVYCRRKFSLKTVLM-- 107
LQ PNI K V +N + L+ +E DL R L+ V
Sbjct: 53 TFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANI-LEDVHKRY 111
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ Q++ ++Y+HS +HRD+KP N L L V + DFGLA+
Sbjct: 112 IMYQLLKALKYIHSGNVIHRDLKPSNIL--LNSDCR-VKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 47/171 (27%), Positives = 82/171 (47%), Gaps = 18/171 (10%)
Query: 1 MERI-IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKI 58
MER I +K+KLG G +GE++ + VAVK ++ + + L EA V K
Sbjct: 3 MERTDITMKHKLG----GGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 58
Query: 59 LQGGSGIPN-IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLML--ADQMI 113
++ PN ++ GV + + + +L Y R + + V++L A Q+
Sbjct: 59 IKH----PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+ +EY+ + F+HRD+ N L+G + + V + DFGL++ T H
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAH 162
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 64/273 (23%), Positives = 117/273 (42%), Gaps = 34/273 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
+++ IG G++G++F + AVKI + + + EA+ Y IL+ S PN+
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEI-EAE-YNILKALSDHPNV 77
Query: 69 -KWYG-------VDGEDNVLVLDLL-GPSLEDL---FVYCRRKFSLKTVLMLADQMIARI 116
K+YG +G+ LVL+L G S+ DL F+ + + + + + +
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
+++H +HRD+K +N L+ V ++DFG++ + T+ R R N ++ GT
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTE---GGVKLVDFGVSAQL---TSTRL---RRNTSV-GT 187
Query: 177 ARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231
+ +C L R D+ SLG + G P L K +
Sbjct: 188 PFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP 247
Query: 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
+ P + EF + C + +++RP
Sbjct: 248 TLHQP-----ELWSNEFNDFIRKCLTKDYEKRP 275
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-06
Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 17/162 (10%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY------KILQGGSG--IP 66
+G G FGE+ + T +I A+K+ K LL + V IL + IP
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKV----MKKSVLLAQETVSFFEEERDILSISNSPWIP 64
Query: 67 NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+++ D ++ LV++ G L L +F +++ I VH G++
Sbjct: 65 QLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYV 124
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKY-RDPTTNRHIP 166
HRDIKP+N L+ + + + DFG A + + N +P
Sbjct: 125 HRDIKPENVLID---RTGHIKLADFGSAARLTANKMVNSKLP 163
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 58/229 (25%), Positives = 88/229 (38%), Gaps = 22/229 (9%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIK 69
IG GSFG++ LA AVK+ T + ++ E V + +
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 70 WYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHR 127
+ E VLD + +LF + +R+ F A ++ + I Y+HS ++R
Sbjct: 63 YSFQTAEKLYFVLDYVNGG--ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
D+KP+N L+ V + DFGL K+ +P GT Y +
Sbjct: 121 DLKPENILLD---SQGHVVLTDFGLCKEGVEPEET-------TSTFCGTPEYLAPEVLRK 170
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
R D LG VL L G P+ + Q YD I K + P
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 16/214 (7%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK----IENSGTKHPQLLYEAKVYKILQGGSG 64
+ G+++G+G+F + A V T ++AVK + N+ ++ +++ + L
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN 61
Query: 65 IPNI-KWYGVDGED---NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P+I + G ED N+ V + G S+ L + F ++ +Q++ + Y+H
Sbjct: 62 HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHL-LSKYGAFKEAVIINYTEQLLRGLSYLH 120
Query: 121 SRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
+HRD+K N L+ G++ + I DFG A + T L GT +
Sbjct: 121 ENQIIHRDVKGANLLIDSTGQR---LRIADFGAAARLAAKGTGAG---EFQGQLLGTIAF 174
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ G + R D+ S+G V++ PW
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 19/220 (8%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY----KILQGGSG 64
++LG+ +G G+FG ++L DT +AVK + P+ E ++L+
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 65 IPNIKWYGV--DGEDNVLVL---DLLGPSLED-LFVYCRRKFSLKTVLMLADQMIARIEY 118
+++YG D + L + + G S++D L Y + Q++ + Y
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSY 121
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+HS +HRDIK N L V + DFG +K+ + + K++TGT
Sbjct: 122 LHSNMIVHRDIKGANILRD---SVGNVKLGDFGASKRLQTIC----LSGTGMKSVTGTPY 174
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
+ S G R+ D+ S+G ++ L PW +A
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA 214
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 34/106 (32%), Positives = 56/106 (52%), Gaps = 13/106 (12%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI-PYRE 169
QM+ I+++HS G +HRD+KP N ++ + + I+DFGLA R TN + PY
Sbjct: 131 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLA---RTACTNFMMTPY-- 182
Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
T Y + LG+ D+ S+G ++ ++GS+ +QG
Sbjct: 183 ----VVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 59/238 (24%), Positives = 97/238 (40%), Gaps = 30/238 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIP 66
+++ + IG G+FGE+ + + +++ A+KI N K + + +L G
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN-- 60
Query: 67 NIKW-----YGVDGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
+W Y E+N+ LV+D +G L L + +M+ I+ V
Sbjct: 61 --QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV 118
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
H ++HRDIKPDN LM + + + DFG K + T ++ GT Y
Sbjct: 119 HQLHYVHRDIKPDNILMDMN---GHIRLADFGSCLKLMEDGT------VQSSVAVGTPDY 169
Query: 180 ASCNTHLGIEQSR-----RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
S +E + D SLG + L G P+ A + + Y KI K
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY---AESLVETYGKIMNHK 224
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 45/151 (29%), Positives = 66/151 (43%), Gaps = 17/151 (11%)
Query: 14 KIGSGSFGEIFLA-SHVDTNEI--VAVKIENSG--TKHPQ-LLYEAKVYKILQGGSGIPN 67
K+G GSFG + ++ VAVK S + L EA + L N
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDH----EN 57
Query: 68 -IKWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I+ YGV + +V +L LG L+ L F + T+ A Q+ + Y+ S+
Sbjct: 58 LIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
F+HRD+ N L+ K V I DFGL +
Sbjct: 118 FIHRDLAARNILLASDDK---VKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 2e-06
Identities = 51/185 (27%), Positives = 85/185 (45%), Gaps = 29/185 (15%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQL-LYEAKVYKILQGGSGIPNIK 69
KIG G++G ++ + T +IVA+K +E+ P + E + K LQ PNI
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH----PNI- 61
Query: 70 WYGVDGEDNV-------LVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIARIEYVH 120
V +D + L+ + L L+ + + L+ + Q++ I + H
Sbjct: 62 ---VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTG 175
SR LHRD+KP N L+ + + DFGLA+ + P T+ + YR + L G
Sbjct: 119 SRRVLHRDLKPQNLLID---NKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG 175
Query: 176 TARYA 180
+ RY+
Sbjct: 176 SPRYS 180
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 12/176 (6%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGIPNIKW 70
K+G G++ +F T +VA+K +E+ + E + K L+ + +
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 71 YGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130
D + LV + L L+ C S+ V + Q++ + Y H R LHRD+K
Sbjct: 73 VHTD-KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131
Query: 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTGTARYAS 181
P N L+ + ++ + DFGLA+ PT +N + YR L G++ Y++
Sbjct: 132 PQNLLIN---ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-06
Identities = 71/274 (25%), Positives = 118/274 (43%), Gaps = 51/274 (18%)
Query: 14 KIGSGSFGEIF--LASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPN 67
++GSG+FG + + + + VAVKI + P +LL EA V + L P
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN----PY 57
Query: 68 I-KWYGV-DGEDNVLVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I + G+ + E +LV++L LGP + F+ + + K + L Q+ ++Y+
Sbjct: 58 IVRMIGICEAESWMLVMELAELGPL--NKFLQKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 124 FLHRDIKPDNFLMGLGRKANQVY--IIDFGLAK------KYRDPTTNRHIPYRENKNLTG 175
F+HRD+ N L+ Q Y I DFGL+K Y T+ P +
Sbjct: 116 FVHRDLAARNVLL-----VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVK------- 163
Query: 176 TARYA-SCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKK 232
YA C + S + D+ S G VL++ F G P++G+K Q + ++
Sbjct: 164 --WYAPECMNYYKF--SSKSDVWSFG-VLMWEAFSYGQKPYKGMKGNEVTQMIES--GER 216
Query: 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266
+ P + P E C + D+RP +
Sbjct: 217 MECP-----QRCPPEMYDLMKLCWTYGVDERPGF 245
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 8/107 (7%)
Query: 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 139
LV + L L+ C S+ V + Q++ + Y H R LHRD+KP N L+
Sbjct: 80 LVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN-- 137
Query: 140 RKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTGTARYAS 181
+ ++ + DFGLA+ PT +N + YR L G+ Y++
Sbjct: 138 -EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYST 183
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 51/212 (24%), Positives = 90/212 (42%), Gaps = 28/212 (13%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNI- 68
++G G+ G + +T I A+K + Q+L E ++ K + P I
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKS----PYIV 62
Query: 69 KWYGV-----DGEDNVLVLDLLGPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEYVH 120
K+YG + + G SL+ ++ +++ K + +A+ ++ + Y+H
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
SR +HRDIKP N L+ + QV + DFG++ + + TGT+ Y
Sbjct: 123 SRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA---------GTFTGTSFYM 170
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
+ G S D+ SLG LL + P
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-06
Identities = 36/157 (22%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
R+ Y++ + IG G+FGE+ L H T ++ A+K+ E +E +
Sbjct: 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 59 LQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
+ + + D +V++ + P + + + K +++ ++
Sbjct: 99 FANSPWVVQLFYAFQDDRYLYMVMEYM-PGGDLVNLMSNYDVPEKWARFYTAEVVLALDA 157
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+HS GF+HRD+KPDN L+ K+ + + DFG K
Sbjct: 158 IHSMGFIHRDVKPDNMLLD---KSGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 40/168 (23%), Positives = 74/168 (44%), Gaps = 21/168 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
Y+ KIG G++G+++ A +T ++VA+K ++ G P L E + ++L
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIP-PTALREISLLQMLSES 60
Query: 63 SGIPNIKWYGVDGEDN-------VLVLDLLGPSLEDLFVYCRRKFS----LKTVLMLADQ 111
I ++ V+ + LV + L L+ R KT+ Q
Sbjct: 61 IYI--VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
++ + + H G +HRD+KP N L + ++ + I D GL + + P
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLL--VDKQKGLLKIADLGLGRAFSIP 164
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 49/221 (22%), Positives = 106/221 (47%), Gaps = 30/221 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT--------KHPQLLYEAKVYK 57
++L + +G+G++G++FL V D+ ++ A+K+ T +H + E +V +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRT--ERQVLE 59
Query: 58 ILQGGSGIPNIKWYGVDGEDNV-LVLDLLGPSLEDLFVYC--RRKFSLKTVLMLADQMIA 114
++ + + Y + + L+LD + +LF + R +F + V + + +++
Sbjct: 60 HIRQSPFLVTLH-YAFQTDTKLHLILDYINGG--ELFTHLSQRERFKEQEVQIYSGEIVL 116
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
+E++H G ++RDIK +N L+ V + DFGL+K++ + R +
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFGLSKEFHEDEVERAY------SFC 167
Query: 175 GTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPW 213
GT Y + + G + + D S+G ++ L G+ P+
Sbjct: 168 GTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-06
Identities = 40/151 (26%), Positives = 79/151 (52%), Gaps = 10/151 (6%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
Y+L +++GSG++G+++ A ++ T E+ AVKI L + +++ + + NI
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHC--NI 68
Query: 69 -KWYG--VDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
++G + E + ++ G SL+D++ + S + + + + + Y+HS+G
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+HRDIK N L+ V + DFG+A K
Sbjct: 128 MHRDIKGANILL---TDNGDVKLADFGVAAK 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 3e-06
Identities = 37/151 (24%), Positives = 79/151 (52%), Gaps = 10/151 (6%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
++L ++IGSG++G+++ A +V+T E+ A+K+ + + ++ I+ NI
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI--IMMKDCKHSNI 68
Query: 69 -KWYGVDGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
++G + L + + G SL+D++ + S + ++ + + + Y+HS+G
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIY-HVTGPLSESQIAYVSRETLQGLYYLHSKGK 127
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+HRDIK N L+ V + DFG++ +
Sbjct: 128 MHRDIKGANILL---TDNGHVKLADFGVSAQ 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 3e-06
Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 19/152 (12%)
Query: 13 RKIGSGSFGEIFLASHVDTN--EI-VAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIP 66
+++G G+FG + ++ + E+ VAVK E+ + L EA V L P
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH----P 56
Query: 67 NI-KWYGV-DGEDNVLVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
I + GV GE +LV++L LGP L+ ++ RR+ + + LA Q+ + Y+ S+
Sbjct: 57 CIVRLIGVCKGEPLMLVMELAPLGPLLK--YLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
F+HRD+ N L+ +Q I DFG+++
Sbjct: 115 HFVHRDLAARNVLL---VNRHQAKISDFGMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 58/252 (23%), Positives = 91/252 (36%), Gaps = 64/252 (25%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
+ +G GSFG++ LA T+E+ AVK+ ILQ +++
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDV-------------ILQDD----DVECTM 43
Query: 73 VDGEDNVLVLDLLGPSLEDLFV-------------YCR-----------RKFSLKTVLML 108
E VL L P L L Y +F
Sbjct: 44 T--EKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY 101
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHI 165
A +++ ++++H RG ++RD+K DN L+ + I DFG+ K+ T
Sbjct: 102 AAEIVLGLQFLHERGIIYRDLKLDNVLLD---SEGHIKIADFGMCKEGILGGVTT----- 153
Query: 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQK 224
GT Y + D +LG VLLY L G P++G + +
Sbjct: 154 -----STFCGTPDYIAPEILSYQPYGPAVDWWALG-VLLYEMLAGQSPFEG---DDEDEL 204
Query: 225 YDKICEKKVSTP 236
+ I E +V P
Sbjct: 205 FQSILEDEVRYP 216
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 49/178 (27%), Positives = 77/178 (43%), Gaps = 52/178 (29%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKH---PQLLYEAKVYKILQ 60
+ KY + IG G++G + A + +TNE VA+K I N+ + L E K+ + L
Sbjct: 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL- 61
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD-------- 110
D E+ + + D++ P + F VY + LM D
Sbjct: 62 -------------DHENVIAIKDIMPPPHREAFNDVY------IVYELMDTDLHQIIRSS 102
Query: 111 -------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
Q++ ++Y+HS LHRD+KP N L+ AN + I DFGLA+
Sbjct: 103 QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 4e-06
Identities = 44/151 (29%), Positives = 69/151 (45%), Gaps = 9/151 (5%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGS 63
+Y + +G G+FG + A T + VA+K P + E K+ K L+ +
Sbjct: 11 RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHEN 70
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I + ED V +LLG L L R + + Q++ ++YVHS G
Sbjct: 71 IISLSDIFISPLEDIYFVTELLGTDLHRLLT--SRPLEKQFIQYFLYQILRGLKYVHSAG 128
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+HRD+KP N L+ + + I DFGLA+
Sbjct: 129 VVHRDLKPSNILIN---ENCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 56/227 (24%), Positives = 91/227 (40%), Gaps = 28/227 (12%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW---- 70
IG GSFG++ LA H + AVK+ K L + + + + + + N+K
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQ---KKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 71 ---YGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGF 124
+ D + VLD + +LF + +R+ F A ++ + + Y+HS
Sbjct: 60 GLHFSFQTADKLYFVLDYINGG--ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNI 117
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
++RD+KP+N L+ + + DFGL K+ + GT Y +
Sbjct: 118 VYRDLKPENILLD---SQGHIVLTDFGLCKENIEHNGT-------TSTFCGTPEYLAPEV 167
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231
R D LG VL L G P+ A + YD I K
Sbjct: 168 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNILNK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 45/165 (27%), Positives = 79/165 (47%), Gaps = 23/165 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHP-QLLYEAKVYKILQGGS 63
+Y+ +IG G++G ++ A + VA V+++ + P + E + K L+
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFD 60
Query: 64 GIPNI-KWYGV------DGEDNV-LVLDLLGPSLEDLFVYCRR----KFSLKTVLMLADQ 111
PNI + V D E V LV + + +DL Y + +T+ L Q
Sbjct: 61 H-PNIVRLMDVCATSRTDRETKVTLVFEHVD---QDLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
+ ++++H+ +HRD+KP+N L+ G QV + DFGLA+ Y
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-06
Identities = 47/198 (23%), Positives = 86/198 (43%), Gaps = 24/198 (12%)
Query: 1 MERIIGVKYK-LGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQL---- 49
M I +Y G +G G++G++ A T +IVA+K I N TK QL
Sbjct: 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMC 61
Query: 50 ------LYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLK 103
L E K+ ++ + + + Y V+G+ LV+D++ L+ + + + +
Sbjct: 62 GIHFTTLRELKIMNEIKHENIMGLVDVY-VEGDFINLVMDIMASDLKKVV-DRKIRLTES 119
Query: 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163
V + Q++ + +H F+HRD+ P N + I DFGLA++Y P +
Sbjct: 120 QVKCILLQILNGLNVLHKWYFMHRDLSPANIFIN---SKGICKIADFGLARRYGYPPYSD 176
Query: 164 HIPYRENKNLTGTARYAS 181
+++ + S
Sbjct: 177 --TLSKDETMQRREEMTS 192
|
Length = 335 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 5e-06
Identities = 57/262 (21%), Positives = 108/262 (41%), Gaps = 27/262 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
+Y + R +G GSFG L HV++++ A+K E K + +++ +L PN
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMK-EIRLPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 68 IKWY--GVDGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
I + + + ++ +V++ G ++ + + + F T+L QM ++++H +
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
LHRDIK N + + +V + DFG A+ P GT Y
Sbjct: 120 RVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGAYAC-------TYVGTPYYVPP 169
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
+ + + D+ SLG +L P+Q A + K K+C+ P+
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQ---ANSWKNLILKVCQGSYK-PL----- 220
Query: 243 SHPAEFASYFHYCQSLTFDQRP 264
P+ ++ F + P
Sbjct: 221 --PSHYSYELRSLIKQMFKRNP 240
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-06
Identities = 30/112 (26%), Positives = 54/112 (48%), Gaps = 19/112 (16%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT---TNRHIP- 166
Q++ + Y+H R LHRD+KP N L+ ++ + DFGLA+ P+ +N +
Sbjct: 111 QLLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVPSHTYSNEVVTL 167
Query: 167 -YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217
YR L G+ Y++C D+ +G + + ++G + G+K
Sbjct: 168 WYRPPDVLLGSTEYSTCL-----------DMWGVGCIFVEMIQGVAAFPGMK 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 52/169 (30%), Positives = 74/169 (43%), Gaps = 29/169 (17%)
Query: 11 LGRKIGSGSFGEIF--LASHVDTNEI---VAVKI---ENSGTKHPQLLYEAKVYKILQGG 62
L R +G G+FGE++ L D + + VAVK S L EA ++
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEA----LIMSK 65
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLL-GPSLEDLFVYCR----RKFSL--KTVLMLADQM 112
NI + GV E ++L+L+ G L+ R R SL K +L A +
Sbjct: 66 FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125
Query: 113 IARIEYVHSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFGLAKK-YR 157
+Y+ F+HRDI N L+ G GR A I DFG+A+ YR
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAK---IADFGMARDIYR 171
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 6e-06
Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 45/233 (19%)
Query: 11 LGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQLL------YEAKVYKIL 59
L R++G G+FG++FLA S +VAVK K P L EA++ L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVK----ALKDPTLAARKDFQREAELLTNL 64
Query: 60 QGGSGIPNIKWYGV--DGEDNVLVLDLL------------GPSLEDLF----VYCRRKFS 101
Q +K+YGV DG+ ++V + + GP L + +
Sbjct: 65 QHEH---IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
L +L +A Q+ + + Y+ S+ F+HRD+ N L+G V I DFG++ RD +
Sbjct: 122 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL---LVKIGDFGMS---RDVYS 175
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPW 213
+ YR + R+ + + + + D+ S G +L F G PW
Sbjct: 176 TDY--YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 7e-06
Identities = 50/221 (22%), Positives = 101/221 (45%), Gaps = 30/221 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-SGTKHPQLLYEAKVYKILQGGSGIPN 67
++L +G+G++G+++ HV T ++ A+K+ + +G + ++ E + K I
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 68 IKWYGV------DGEDNV--LVLDLLGP-SLEDLFVYCRRKFSLKT--VLMLADQMIARI 116
+YG G D+ LV++ G S+ DL + + +LK + + +++ +
Sbjct: 68 --YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL-IKNTKGNTLKEEWIAYICREILRGL 124
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
++H +HRDIK N L+ + +V ++DFG++ + D T R GT
Sbjct: 125 SHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQL-DRTVGRR------NTFIGT 174
Query: 177 ARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
+ +C+ + + DL SLG + G+ P
Sbjct: 175 PYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 24/219 (10%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQ---LLYEAKVYKILQGGSGIPNI-- 68
IG G FGE++ DT ++ A+K ++ K Q L ++ L P I
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 69 KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFL 125
Y D + +LDL+ DL + + FS K + A ++I +E++H+R +
Sbjct: 62 MTYAFHTPDKLCFILDLMNGG--DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT- 184
+RD+KP N L+ + V I D GLA + + + GT Y +
Sbjct: 120 YRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMAPEVL 167
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223
G D SLG +L LRG P++ K K +
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 7e-06
Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 40/171 (23%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQ 60
+G +Y+ IG G++G + A+H T VA+K + S +H L E K+ + +
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIK-KISPFEHQTFCQRTLREIKILRRFK 61
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGP-SLEDL----FVYCRRKFSLKTVL---MLAD-- 110
E+ + +LD++ P S E V + L ++ L++
Sbjct: 62 H--------------ENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDH 107
Query: 111 ------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
Q++ ++Y+HS LHRD+KP N L+ N + I DFGLA+
Sbjct: 108 IQYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTNCDLKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 9e-06
Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 18/202 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
K+++ +G G++G + H +T EIVA+K EN K L E K+ + L+
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTL-RELKMLRTLKQE 60
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+ + + + G+ LV + + ++ +L + V Q+I I + H
Sbjct: 61 NIVELKEAFRRRGK-LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 123 GFLHRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+HRDIKP+N L+ N V + DFG A+ + + + Y T Y S
Sbjct: 120 DIVHRDIKPENLLI----SHNDVLKLCDFGFARNLSEGSNANYTEY------VATRWYRS 169
Query: 182 CNTHLGIEQSRRDDLESLGYVL 203
LG + D+ S+G +L
Sbjct: 170 PELLLGAPYGKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 1e-05
Identities = 66/278 (23%), Positives = 109/278 (39%), Gaps = 81/278 (29%)
Query: 13 RKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT---------------------KHP- 47
+ +G G +G++F V DT +I A+K+ T KHP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 48 --QLLY----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK-- 99
L+Y K+Y IL+ SG GE LF++ R+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSG----------GE---------------LFMHLEREGI 96
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
F T ++ +E++H +G ++RD+KP+N L+ V + DFGL K+
Sbjct: 97 FMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLD---AQGHVKLTDFGLCKESIHE 153
Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219
T H GT Y + + + D SLG ++ L G+ P+ A
Sbjct: 154 GTVTH-------TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT---AE 203
Query: 220 TKKQKYDKICEKKVSTP----------IEVLCKSHPAE 247
+K+ DKI + K++ P ++ L K +P+
Sbjct: 204 NRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSS 241
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 61/229 (26%), Positives = 93/229 (40%), Gaps = 32/229 (13%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW---- 70
IG GSFG++ LA H + AVK+ K E K + + + + N+K
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQK--KAILKKKEQK-HIMAERNVLLKNVKHPFLV 59
Query: 71 ---YGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGF 124
Y D + VLD + +LF + +R+ F A ++ + + Y+HS
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGG--ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNI 117
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP--TTNRHIPYRENKNLTGTARYASC 182
++RD+KP+N L+ V + DFGL K+ + TT+ GT Y +
Sbjct: 118 IYRDLKPENILLD---SQGHVVLTDFGLCKEGIEHSKTTS---------TFCGTPEYLAP 165
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231
R D LG VL L G P+ A + YD I K
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMYDNILNK 211
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 1e-05
Identities = 39/159 (24%), Positives = 74/159 (46%), Gaps = 18/159 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
+Y+ +++GSG++G + S +D V I+ L+ + Y+ L+ + +
Sbjct: 16 RYRDLKQVGSGAYGTV--CSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKH 73
Query: 68 IKWYGV-----------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
G+ D LV+ +G L L + K S + L QM+ +
Sbjct: 74 ENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGL 131
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+Y+H+ G +HRD+KP N + + ++ I+DFGLA++
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ 167
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 1e-05
Identities = 51/220 (23%), Positives = 90/220 (40%), Gaps = 51/220 (23%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
++G+G+ G +F SH + I+A K I N + Q+L+E I
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 65
Query: 65 IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ +YG DGE ++ + + G SL+ + LK + +Q++ ++
Sbjct: 66 ---VGFYGAFYSDGEISICMEHMDGGSLDQV---------LKKAGRIPEQILGKVSIAVI 113
Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
+G +HRD+KP N L+ ++ + DFG++ + D N +
Sbjct: 114 KGLTYLREKHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMAN---------S 161
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
GT Y S G S + D+ S+G L+ G P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 1e-05
Identities = 44/155 (28%), Positives = 67/155 (43%), Gaps = 14/155 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
KY +KIG GSFG+ L + + +K N P+ E++ + PN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 68 IKWYGVDGEDN---VLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEYVH 120
I Y E+N +V+D DL+ + F +L Q+ +++VH
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGG--DLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 121 SRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAK 154
R LHRDIK N FL K + + DFG+A+
Sbjct: 119 DRKILHRDIKSQNIFLT----KDGTIKLGDFGIAR 149
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 47/171 (27%), Positives = 77/171 (45%), Gaps = 44/171 (25%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGS 63
+YK+ IG GS+G + A T E VA+K N +H ++L E K+ ++L+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRH-- 58
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPS----LEDLFVYCRRKFS-LKTVLMLAD-------- 110
P+I V + ++ P +D++V S L V+ D
Sbjct: 59 --PDI----------VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQ 106
Query: 111 ----QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN---QVYIIDFGLAK 154
Q++ ++Y+H+ HRD+KP N L AN ++ I DFGLA+
Sbjct: 107 FFLYQLLRALKYIHTANVFHRDLKPKNIL------ANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 44/169 (26%), Positives = 71/169 (42%), Gaps = 35/169 (20%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSG 64
+K K+G G++ ++ + T EIVA+K + GT + E + K L+
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAI-REISLMKELKH--- 57
Query: 65 IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYC-------------RRKFSLKTVLMLAD 110
NI + + V +N L+L +F Y R TV
Sbjct: 58 -ENIVRLHDVIHTENKLML---------VFEYMDKDLKKYMDTHGVRGALDPNTVKSFTY 107
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
Q++ I + H LHRD+KP N L+ K ++ + DFGLA+ + P
Sbjct: 108 QLLKGIAFCHENRVLHRDLKPQNLLIN---KRGELKLADFGLARAFGIP 153
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 21/56 (37%), Positives = 33/56 (58%), Gaps = 3/56 (5%)
Query: 99 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
S V L QM+ ++Y+HS G +HRD+KP N + + ++ I+DFGLA+
Sbjct: 113 PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVN---EDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 46/179 (25%), Positives = 78/179 (43%), Gaps = 56/179 (31%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLY-EAKVYKILQ 60
+Y+ +GSG++G++ A T VA+K ++ H + Y E ++ K +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS--AIHAKRTYRELRLLKHMD 72
Query: 61 GGSGIPNIKWYGVDGEDNVL-VLDLLGP--SLEDLFVYCRRKFSLKTVLMLAD------- 110
+NV+ +LD+ P SLED + L T LM AD
Sbjct: 73 ---------------HENVIGLLDVFTPASSLEDF-----QDVYLVTHLMGADLNNIVKC 112
Query: 111 -------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKK 155
Q++ ++Y+HS G +HRD+KP N + + ++ I+DFGLA+
Sbjct: 113 QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSN----IAVNEDCELKILDFGLARH 167
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 57/238 (23%), Positives = 100/238 (42%), Gaps = 36/238 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEA-KVYKILQGGSGIPN 67
+K+ +K+G GS+G ++ + N+ A+K + G+ + +A +IL + PN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH-PN 60
Query: 68 IKWYG---VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI-------- 116
I Y +DG N L + + DL ++ + ++ +Q I RI
Sbjct: 61 IISYKEAFLDG--NKLCIVMEYAPFGDLSKAISKRKKKRK--LIPEQEIWRIFIQLLRGL 116
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYII-DFGLAKKYRDPTTNRHIPYRENKNLTG 175
+ +H + LHRD+K N L AN + I D G++K + I G
Sbjct: 117 QALHEQKILHRDLKSANIL----LVANDLVKIGDLGISKVLKKNMAKTQI---------G 163
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG-----LKAATKKQKYDKI 228
T Y + G S + D+ SLG +L + P++ L+ ++ KY I
Sbjct: 164 TPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI 221
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 12/154 (7%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
KL +K+G+G FGE+++ + ++ + VAVK GT Q L EA + K LQ +
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNNSTK-VAVKTLKPGTMSVQAFLEEANLMKTLQHDK---LV 64
Query: 69 KWYGV-DGEDNVLVLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ Y V E+ + ++ G L+ L K L ++ + Q+ + Y+ + +
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY 124
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+HRD++ N L+ ++ I DFGLA+ D
Sbjct: 125 IHRDLRAANVLVS---ESLMCKIADFGLARVIED 155
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 51/214 (23%), Positives = 90/214 (42%), Gaps = 31/214 (14%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLL---------YEAKVYKILQGGSGI 65
+G GSFG++ LA E AVK K +L E +V + +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVK----ALKKDVVLIDDDVECTMVEKRVLALAWENPFL 58
Query: 66 PNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRG 123
++ E V++ L DL + + K F L A +++ ++++HS+G
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGG--DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--GTARYAS 181
++RD+K DN ++ + + I DFG+ K+ + +N+ T GT Y +
Sbjct: 117 IIYRDLKLDNVMLD---RDGHIKIADFGMCKEN---------VFGDNRASTFCGTPDYIA 164
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
G++ + D S G +L L G P+ G
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-05
Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 29/209 (13%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
IG GSFG++ DT I A+K + S H L E V + +P
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHT--LAERTVLAQVNCPFIVP- 57
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFL 125
+K+ E LVL + +LF + +R +F L +++ +E +H +
Sbjct: 58 LKFSFQSPEKLYLVLAFINGG--ELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAK--KYRDPTTNRHIPYRENKNLTGTARYASCN 183
+RD+KP+N L+ + + DFGL K D TN GT Y +
Sbjct: 116 YRDLKPENILLDY---QGHIALCDFGLCKLNMKDDDKTN---------TFCGTPEYLAPE 163
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLP 212
LG ++ D +LG VLLY + LP
Sbjct: 164 LLLGHGYTKAVDWWTLG-VLLYEMLTGLP 191
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 47/242 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVK-IENSGTKH--PQLLYEAKVYK 57
+ LG+ +G G FG++ +A + ++ VAVK +++ T L+ E ++ K
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK 72
Query: 58 ILQGGSGIPNIKW-------------YGVDGEDNVLVLDLLGPSLEDLFVYCR---RKFS 101
++ I N+ Y G + P ++ F C+ + +
Sbjct: 73 MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KY 156
K ++ A Q+ +EY+ S+ +HRD+ N L+ + N + I DFGLA+ Y
Sbjct: 133 FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV---TEDNVMKIADFGLARDVHNIDY 189
Query: 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQ 214
TTN +P K + A + TH + D+ S G VLL+ F G P+
Sbjct: 190 YKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLLWEIFTLGGSPYP 238
Query: 215 GL 216
G+
Sbjct: 239 GI 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 32/154 (20%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKV------YKILQGGSGIPNI 68
IG G+FGE+ + +T ++ A+KI N ++L A+ +L G +
Sbjct: 9 IGRGAFGEVAVVKMKNTGQVYAMKILNKW----EMLKRAETACFREERDVLVNG----DR 60
Query: 69 KW-----YGVDGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLAD----QMIARIE 117
+W Y E+N+ LV+D +G L L KF + +A +M+ I+
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLL----SKFEDRLPEDMARFYLAEMVLAID 116
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151
VH G++HRDIKPDN L+ K + + DFG
Sbjct: 117 SVHQLGYVHRDIKPDNVLLD---KNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 24/75 (32%), Positives = 38/75 (50%), Gaps = 18/75 (24%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--------------- 155
QM+ I+++HS G +HRD+KP N ++ + + I+DFGLA+
Sbjct: 126 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRY 182
Query: 156 YRDPTTNRHIPYREN 170
YR P + Y+EN
Sbjct: 183 YRAPEVILGMGYKEN 197
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 49/182 (26%), Positives = 72/182 (39%), Gaps = 53/182 (29%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK--IENSGTKHPQLLYEAKVYKILQGG 62
+G +Y R +G GS G +F A D ++ VAVK + L E K+ + L
Sbjct: 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD-- 60
Query: 63 SGIPNIKWYGVDGEDNVL-VLDLLGPSLEDLFVYCRRKFSLKTV-----LMLAD------ 110
DN++ V ++LGPS DL L +V M D
Sbjct: 61 -------------HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLE 107
Query: 111 --------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ----VYIIDFGL 152
Q++ ++Y+HS LHRD+KP N + N + I DFGL
Sbjct: 108 QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFI------NTEDLVLKIGDFGL 161
Query: 153 AK 154
A+
Sbjct: 162 AR 163
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 63/241 (26%), Positives = 102/241 (42%), Gaps = 51/241 (21%)
Query: 11 LGRKIGSGSFGEIFLASHV-----DTNEI--VAVKIENSGTKH---PQLLYEAKVYKILQ 60
LG+ +G G FG++ +A + N + VAVK+ S L+ E ++ K++
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK------------------FSL 102
I N+ G +D L + + S +L Y R + S
Sbjct: 82 KHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF 139
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KYR 157
K ++ A Q+ +EY+ S+ +HRD+ N L+ + N + I DFGLA+ Y
Sbjct: 140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYY 196
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQG 215
TTN +P K + A + TH + D+ S G VLL+ F G P+ G
Sbjct: 197 KKTTNGRLPV---KWMAPEALFDRIYTH-------QSDVWSFG-VLLWEIFTLGGSPYPG 245
Query: 216 L 216
+
Sbjct: 246 V 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-05
Identities = 50/188 (26%), Positives = 82/188 (43%), Gaps = 34/188 (18%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK----------IENSGTKHPQLLYEAKVYKILQGGS 63
KIG G++G ++ A + T E+VA+K + ++ + LL E
Sbjct: 7 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-------- 58
Query: 64 GIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLA--DQMIARIEY 118
PNI K V +N LV + L L+ F+ + L+ + Q++ + +
Sbjct: 59 --PNIVKLLDVIHTENKLYLVFEFLHQDLKK-FMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT-TNRH----IPYRENKNL 173
HS LHRD+KP N L+ + + DFGLA+ + P T H + YR + L
Sbjct: 116 CHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 172
Query: 174 TGTARYAS 181
G Y++
Sbjct: 173 LGCKYYST 180
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 31/107 (28%), Positives = 51/107 (47%), Gaps = 8/107 (7%)
Query: 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 139
LV + L L+ C ++ V + Q++ + Y H R LHRD+KP N L+
Sbjct: 81 LVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN-- 138
Query: 140 RKANQVYIIDFGLAKKYRDPT---TNRHIP--YRENKNLTGTARYAS 181
+ ++ + DFGLA+ PT +N + YR L G+ Y++
Sbjct: 139 -ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYST 184
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 40/154 (25%), Positives = 80/154 (51%), Gaps = 27/154 (17%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIK----- 69
I G+FG+++L + +++ AVK+ K ++ + V+++ + K
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKV----VKKADMINKNMVHQVQAERDALALSKSPFIV 67
Query: 70 --WYGVDGEDNV-LVLD-LLG---PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+Y + +NV LV++ L+G SL ++ Y + ++K + ++ ++Y+H
Sbjct: 68 HLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYI----SEVALALDYLHRH 123
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYI--IDFGLAK 154
G +HRD+KPDN L+ +N+ +I DFGL+K
Sbjct: 124 GIIHRDLKPDNMLI-----SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 17/219 (7%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPNI--KWY 71
+G G FGE+ T ++ A K ++ K + A K + I Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 72 GVDGEDNV-LVLDLL-GPSLE-DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
+ +D++ LV+ L+ G L+ ++ F + A Q+I +E++H R ++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
+KP+N L+ V I D GLA + + K GT Y + G
Sbjct: 121 LKPENVLLD---DHGNVRISDLGLAVELKGGKK--------IKGRAGTPGYMAPEVLQGE 169
Query: 189 EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227
D +LG L + G P++ K +K++ +
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR 208
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 42/149 (28%), Positives = 69/149 (46%), Gaps = 11/149 (7%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIK 69
L ++IGSG FG ++L ++ ++ I + EA+V L S ++
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKL---SHPKLVQ 63
Query: 70 WYGVDGEDN--VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLH 126
YGV E + LV + + L D R KFS +T+L + + + Y+ S +H
Sbjct: 64 LYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIH 123
Query: 127 RDIKPDNFLMGLGRKANQVY-IIDFGLAK 154
RD+ N L+G NQV + DFG+ +
Sbjct: 124 RDLAARNCLVG----ENQVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 52/221 (23%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
++L +G+G++G+++ HV T ++ A+K+ + T+ + + ++ +L+ S NI
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TEDEEEEIKLEI-NMLKKYSHHRNI 75
Query: 69 -KWYGV------DGEDNV--LVLDLLGP-SLEDLFVYCRRKFSLKT--VLMLADQMIARI 116
+YG G D+ LV++ G S+ DL V + +LK + + +++ +
Sbjct: 76 ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDL-VKNTKGNALKEDWIAYICREILRGL 134
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
++H+ +HRDIK N L+ + +V ++DFG++ + D T R GT
Sbjct: 135 AHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQL-DRTVGRR------NTFIGT 184
Query: 177 ARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
+ +C+ + R D+ SLG + G+ P
Sbjct: 185 PYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 3e-05
Identities = 36/146 (24%), Positives = 75/146 (51%), Gaps = 9/146 (6%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKV-YKILQGGSGIPNIKWYG 72
++G G+FG+++ A + +T + A K+ TK + L + V +IL + +K G
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYMVEIEILATCNHPYIVKLLG 76
Query: 73 V---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129
DG+ +++ G +++ + + R + + ++ QM+ ++Y+HS +HRD+
Sbjct: 77 AFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDL 136
Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKK 155
K N L+ L + + DFG++ K
Sbjct: 137 KAGNVLLTLD---GDIKLADFGVSAK 159
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-05
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 34/229 (14%)
Query: 11 LGRKIGSGSFGEIFLASHVD-----TNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGS 63
L R++G G+FG++FLA + +VAVK + S EA++ LQ
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEH 68
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR---------------RKFSLKTVLML 108
+K+YGV E + L++ DL + R + + +L +
Sbjct: 69 ---IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
A Q+ A + Y+ S+ F+HRD+ N L+G + V I DFG++ RD + + YR
Sbjct: 126 AQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMS---RDVYSTDY--YR 177
Query: 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPWQGL 216
+ R+ + + + + D+ SLG VL F G PW L
Sbjct: 178 VGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 4e-05
Identities = 44/165 (26%), Positives = 79/165 (47%), Gaps = 28/165 (16%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTN--EIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGI 65
Y+L +++G G++G + A + +T+ E VA+K I N +K + K+L+ G
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 66 PNIKWYGVDGEDNVLVLDLLGPS-LEDLFVY-----CRRKFSLKTVLMLAD--------Q 111
NI D +D++ P +L++Y +++ L D Q
Sbjct: 62 KNITCL-YD-------MDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQ 113
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
++ ++Y+HS LHRD+KP N L+ ++ I DFGLA+ +
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNAD---CELKICDFGLARGF 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-05
Identities = 20/67 (29%), Positives = 34/67 (50%), Gaps = 5/67 (7%)
Query: 91 DLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148
DLF Y R L+ + + +++ + Y+H RG +HRD+K +N + + +
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD---EPENAVLG 227
Query: 149 DFGLAKK 155
DFG A K
Sbjct: 228 DFGAACK 234
|
Length = 392 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 50/189 (26%), Positives = 77/189 (40%), Gaps = 37/189 (19%)
Query: 8 KYKLGRKIGSGSFGEIF--LASHVDTNEI---VAVKIEN---SGTKHPQLLYEAKVYKIL 59
K L R++G GSFG ++ LA V E VA+K N S + + L EA V K
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF 66
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCR------RKFSLKTVLMLAD 110
++ + GV G+ ++V++L+ DL Y R L
Sbjct: 67 N----CHHVVRLLGVVSTGQPTLVVMELMA--KGDLKSYLRSRRPEAENNPGLGPPTLQK 120
Query: 111 --QMIARI----EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KYRDP 159
QM A I Y+ ++ F+HRD+ N ++ + V I DFG+ + Y
Sbjct: 121 FIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMTRDIYETDYYRK 177
Query: 160 TTNRHIPYR 168
+P R
Sbjct: 178 GGKGLLPVR 186
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 4e-05
Identities = 51/227 (22%), Positives = 84/227 (37%), Gaps = 32/227 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTK-HPQLLYEAKVYKILQGGSG 64
+++ KIG GSFG +F + A+K + + + + EA+V L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 65 IPNIKWYGVDGEDNVLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I + + G+ N+++ L L + R V Q++ + ++HS+
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK----------------YRDPTTNRHIPY 167
LHRDIK N + + V I D G+AK Y P PY
Sbjct: 122 ILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY 178
Query: 168 RENKNL--TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
E ++ G Y C D + G ++L +RG P
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPF------DANNQGALILKIIRGVFP 219
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 5e-05
Identities = 42/170 (24%), Positives = 72/170 (42%), Gaps = 41/170 (24%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----EN------------SGTKHPQL--LYEAKV 55
+G G+FG+++ A H +T A KI E S KHP + LYEA
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 56 YKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
Y+ N W ++++ G +L+ + + R + + + QM+
Sbjct: 73 YE---------NKLW---------ILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+ ++HS +HRD+K N L+ L V + DFG++ K + R
Sbjct: 115 ALNFLHSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKSTLQKRD 161
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 5e-05
Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 31/221 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYK-------I 58
++L + +G+G++G++FL V DT ++ A+K+ + L+ +AK + +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKV----LQKAALVQKAKTVEHTRTERNV 57
Query: 59 LQGGSGIPNIK--WYGVDGEDNV-LVLDLLGPSLEDLF--VYCRRKFSLKTVLMLADQMI 113
L+ P + Y E + L+LD + S ++F +Y R FS V + ++I
Sbjct: 58 LEHVRQSPFLVTLHYAFQTEAKLHLILDYV--SGGEMFTHLYQRDNFSEDEVRFYSGEII 115
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+E++H G ++RDIK +N L+ V + DFGL+K++ R +
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLD---SEGHVVLTDFGLSKEFLSEEKERTYSF------ 166
Query: 174 TGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPW 213
GT Y + G + D SLG ++ L G+ P+
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|225023 COG2112, COG2112, Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 5e-05
Identities = 42/192 (21%), Positives = 72/192 (37%), Gaps = 38/192 (19%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
+++ G+ ++L VA+K+ + L EAK+ +IL G P + +Y
Sbjct: 28 KELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY- 84
Query: 73 VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTV--LMLADQMIARIEYVHSRGFLHRDI- 129
GED + + + G L L + RK L+ + D++ G H ++
Sbjct: 85 --GEDFIRMEYIDGRPLGKLEIGGDRKHLLRVLEKAYKLDRL----------GIEHGELS 132
Query: 130 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE 189
+P ++ VYIIDF A + P +N+T L E
Sbjct: 133 RPWKNVLV---NDRDVYIIDFDSATFKKKP-----------RNVTQALSL------LFRE 172
Query: 190 QSRRDDLESLGY 201
R + GY
Sbjct: 173 GLRIEKTILRGY 184
|
Length = 201 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-05
Identities = 47/204 (23%), Positives = 90/204 (44%), Gaps = 29/204 (14%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIK---- 69
++G G+FG+++ A + +T + A K+ + TK + L + V + PNI
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVID--TKSEEELEDYMVEIDILASCDHPNIVKLLD 69
Query: 70 --WYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
+Y E+N+ +L G +++ + + R + + ++ Q + + Y+H +
Sbjct: 70 AFYY----ENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII 125
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---- 181
HRD+K N L L + + DFG++ K R I R+ + GT + +
Sbjct: 126 HRDLKAGNILFTLD---GDIKLADFGVSAK-----NTRTIQRRD--SFIGTPYWMAPEVV 175
Query: 182 -CNTHLGIEQSRRDDLESLGYVLL 204
C T + D+ SLG L+
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLI 199
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 6e-05
Identities = 59/223 (26%), Positives = 88/223 (39%), Gaps = 40/223 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----------ENSGTKHPQLLYEAKVYK 57
KY + R +GSG+ G + A V E AVK+ +N L +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFS 92
Query: 58 ILQGGSGIPNIKWYGVDGEDNV----LVLDLLGPSLEDLFVYCR------RKFSLKTVLM 107
I++ + +NV LVLD DL + R F +
Sbjct: 93 IVKCHE---DFAKKDPRNPENVLMIALVLDYANAG--DLRQEIKSRAKTNRTFREHEAGL 147
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFGLAKKYRDPTTNRH 164
L Q++ + +VHS+ +HRDIK N L+ GL V + DFG +K Y ++
Sbjct: 148 LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL------VKLGDFGFSKMYAATVSD-- 199
Query: 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 207
+ GT Y + S++ D+ SLG VLLY L
Sbjct: 200 ---DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLG-VLLYEL 238
|
Length = 496 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 7e-05
Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 36/228 (15%)
Query: 14 KIGSGSFGEIFLA--SHVDTNE---IVAVKIENSGTKHPQLLY--EAKVYKILQGGSGIP 66
++G G+FG++FLA ++ + +VAVK ++ + + EA++ +LQ
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH--- 68
Query: 67 NIKWYGV--DGEDNVLVLDLL------------GPS---LEDLFVYCRRKFSLKTVLMLA 109
+++YGV +G ++V + + GP L + +L +L +A
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
Q+ + + Y+ S F+HRD+ N L+G G V I DFG++ RD + + YR
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGL---VVKIGDFGMS---RDIYSTDY--YRV 180
Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL-YFLRGSLPWQGL 216
R+ + L + + D+ S G VL F G PW L
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL 228
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 45/174 (25%), Positives = 68/174 (39%), Gaps = 40/174 (22%)
Query: 12 GRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGT--------------KHPQLLYEAK 54
G K+G G++G ++ A D E +IE +G KHP ++ K
Sbjct: 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQK 65
Query: 55 VYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
V+ S W L+ D L + + R + K + L M+
Sbjct: 66 VFL-----SHSDRKVW---------LLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK 111
Query: 115 R--------IEYVHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDP 159
I Y+H+ LHRD+KP N L MG G + +V I D G A+ + P
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 7e-05
Identities = 33/110 (30%), Positives = 53/110 (48%), Gaps = 10/110 (9%)
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165
+L Q++ ++ VHSR +HRD+K N FLM G + + DFG +K+Y D +
Sbjct: 173 LLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG----IIKLGDFGFSKQYSDS-----V 223
Query: 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
+ GT Y + S++ D+ SLG +L L P++G
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-05
Identities = 41/162 (25%), Positives = 70/162 (43%), Gaps = 16/162 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN- 67
+++ + IG G+FGE+ + T I A+KI N ++L A+ + + + N
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW----EMLKRAETACFREERNVLVNG 58
Query: 68 -IKW-----YGVDGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
+W Y E+ + LV+D +G L L + +M+ I +
Sbjct: 59 DCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSI 118
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
H ++HRDIKPDN L+ + + + DFG K T
Sbjct: 119 HQLHYVHRDIKPDNVLLDMN---GHIRLADFGSCLKMNQDGT 157
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 8e-05
Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 16/150 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
Y + + + GS G +F+A+ + V +KI GT L EA + + + S I +
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTT----LIEAMLLQNVNHPSVI-RM 122
Query: 69 KWYGVDGEDNVLVLDLLGPSLE-DLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGF 124
K V G +VL P DL+ Y R + L++ Q++ + Y+H++
Sbjct: 123 KDTLVSGAITCMVL----PHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRI 178
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+HRD+K +N + +QV I D G A+
Sbjct: 179 IHRDVKTENIFI---NDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 9e-05
Identities = 46/203 (22%), Positives = 85/203 (41%), Gaps = 64/203 (31%)
Query: 11 LGRKIGSGSFGEIFLASHVDTNE-----IVAVKI--ENSGTKH-PQLLYEAKVYKILQGG 62
LG+ +G G+FG++ A V + VAVK+ +++ K L+ E ++ K++
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI--- 72
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLED--LFV---YCR----RKF------------- 100
G+ + +++LLG ++ L+V Y R F
Sbjct: 73 ------------GK-HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASP 119
Query: 101 ----------SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 150
+ K ++ A Q+ +E++ S+ +HRD+ N L+ + + I DF
Sbjct: 120 DDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED---HVMKIADF 176
Query: 151 GLAK-----KYRDPTTNRHIPYR 168
GLA+ Y TTN +P +
Sbjct: 177 GLARDIHHIDYYRKTTNGRLPVK 199
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 24/78 (30%), Positives = 40/78 (51%), Gaps = 18/78 (23%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--------------- 155
QM+ I+++HS G +HRD+KP N ++ + + I+DFGLA+
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRY 190
Query: 156 YRDPTTNRHIPYRENKNL 173
YR P + Y+EN ++
Sbjct: 191 YRAPEVILGMGYKENVDI 208
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 21/50 (42%), Positives = 30/50 (60%), Gaps = 1/50 (2%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDP 159
Q++ I Y+H+ LHRD+KP N L MG G + +V I D G A+ + P
Sbjct: 116 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 1e-04
Identities = 49/202 (24%), Positives = 90/202 (44%), Gaps = 28/202 (13%)
Query: 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135
+D LV++L+ +L + + + + + L QM+ I+++HS G +HRD+KP N +
Sbjct: 95 QDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIV 151
Query: 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDD 195
+ + + I+DFGLA+ T+ PY T Y + LG+ D
Sbjct: 152 V---KSDCTLKILDFGLART--AGTSFMMTPY------VVTRYYRAPEVILGMGYKENVD 200
Query: 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC 255
+ S+G ++ +R + + G +++K+ E ++ TP K +Y
Sbjct: 201 IWSVGCIMGEMVRHKILFPGRDYI---DQWNKVIE-QLGTPCPEFMKKLQPTVRNY---- 252
Query: 256 QSLTFDQRPDYGFLK--RLFHD 275
+ RP Y L +LF D
Sbjct: 253 ----VENRPKYAGLTFPKLFPD 270
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 1e-04
Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 31/178 (17%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEA-KVYKILQGGSGIPNI-KWY 71
+G G++G ++ A + T +A+K I +++ Q L+E ++ L+ NI ++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHR----NIVQYL 71
Query: 72 GVDGEDN---VLVLDLLGPSLEDLFVYCRRKFS-LK----TVLMLADQMIARIEYVHSRG 123
G D E+ + + + G SL L R K+ LK T++ Q++ ++Y+H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ 128
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR--DPTTNRHIPYRENKNLTGTARY 179
+HRDIK DN L + + V I DFG +K+ +P T + TGT +Y
Sbjct: 129 IVHRDIKGDNVL--VNTYSGVVKISDFGTSKRLAGINPCT---------ETFTGTLQY 175
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 67/242 (27%), Positives = 107/242 (44%), Gaps = 53/242 (21%)
Query: 11 LGRKIGSGSFGEIFLA-------SHVDTNEIVAVKI--ENSGTKH-PQLLYEAKVYKILQ 60
LG+ +G G FG++ A S D VAVK+ +N+ K L+ E ++ K++
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG 75
Query: 61 GGSGIPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRR----------------KFS 101
I N+ GV +G V+V +L + F+ RR + S
Sbjct: 76 KHKNIINL--LGVCTQEGPLYVIVEYAAKGNLRE-FLRARRPPGPDYTFDITKVPEEQLS 132
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-----KY 156
K ++ A Q+ +EY+ SR +HRD+ N L+ + N + I DFGLA+ Y
Sbjct: 133 FKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT---EDNVMKIADFGLARGVHDIDY 189
Query: 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQ 214
T+N +P K + A + TH QS D+ S G +L++ F G P+
Sbjct: 190 YKKTSNGRLPV---KWMAPEALFDRVYTH----QS---DVWSFG-ILMWEIFTLGGSPYP 238
Query: 215 GL 216
G+
Sbjct: 239 GI 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 60/244 (24%), Positives = 105/244 (43%), Gaps = 51/244 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVKI--ENSGTKH-PQLLYEAKVYK 57
K LG+ +G G FG++ +A + ++ VAVK+ +++ K L+ E ++ K
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 75
Query: 58 ILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK------------------ 99
++ I N+ G +D L + + S +L Y R +
Sbjct: 76 MIGKHKNIINL--LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK----- 154
+ K ++ Q+ +EY+ S+ +HRD+ N L+ + N + I DFGLA+
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDVNNI 190
Query: 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLP 212
Y TTN +P K + A + TH + D+ S G VL++ F G P
Sbjct: 191 DYYKKTTNGRLPV---KWMAPEALFDRVYTH-------QSDVWSFG-VLMWEIFTLGGSP 239
Query: 213 WQGL 216
+ G+
Sbjct: 240 YPGI 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 50/211 (23%), Positives = 85/211 (40%), Gaps = 31/211 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS---GTKHPQLLYEAKVYKILQGGSG 64
+Y L +++G GSFG ++L +K+ G +P +A L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 65 IPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIE 117
P I K++ ++ + ++ + G L+ + + S V Q++ +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR---DPTTNRHIPYRENKNLT 174
Y+H R LHRD+K N + K N + I DFG+++ D T T
Sbjct: 121 YMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLAT----------TFT 166
Query: 175 GTARYASCN--THLGIEQSRRDDLESLGYVL 203
GT Y S H G + + D+ SLG +L
Sbjct: 167 GTPYYMSPEALKHQGYDS--KSDIWSLGCIL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 2e-04
Identities = 28/107 (26%), Positives = 54/107 (50%), Gaps = 21/107 (19%)
Query: 49 LLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLM 107
LL EA+ +G+P Y VD E+ +V++ + G L+D+ ++
Sbjct: 389 LLSEAR-------RAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLEG------NPELVR 435
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+++A++ H G +H D+ NF++ + +++Y+IDFGL K
Sbjct: 436 KVGEIVAKL---HKAGIVHGDLTTSNFIV----RDDRLYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 2e-04
Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 21/152 (13%)
Query: 14 KIGSGSFGEI------FLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
++GSG+FG + +D I +K EN + +++ EA++ L P
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDV-AIKVLKNENEKSVRDEMMREAEIMHQLDN----PY 56
Query: 68 I-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I + GV + E +LV+++ G L + + ++ V+ L Q+ ++Y+ + F
Sbjct: 57 IVRMIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 125 LHRDIKPDNFLMGLGRKANQVY--IIDFGLAK 154
+HRD+ N L+ NQ Y I DFGL+K
Sbjct: 117 VHRDLAARNVLL-----VNQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 3e-04
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 26/205 (12%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNIKWY 71
+G G+ G ++ A H+ T I+AVK+ + + Q++ E +IL I +Y
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSE---LEILYKCDSPYIIGFY 65
Query: 72 G---VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRD 128
G V+ ++ + G SL+ VY RK + +A ++ + Y+ S LHRD
Sbjct: 66 GAFFVENRISICTEFMDGGSLD---VY--RKIPEHVLGRIAVAVVKGLTYLWSLKILHRD 120
Query: 129 IKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI 188
+KP N L+ QV + DFG++ + + K GT Y + G
Sbjct: 121 VKPSNMLVN---TRGQVKLCDFGVSTQLVNSIA---------KTYVGTNAYMAPERISGE 168
Query: 189 EQSRRDDLESLGYVLLYFLRGSLPW 213
+ D+ SLG + G P+
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 34/126 (26%), Positives = 58/126 (46%), Gaps = 14/126 (11%)
Query: 91 DLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148
+LF + R+ F+ + ++++ +EY+HSR ++RDIK +N ++ K + I
Sbjct: 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKIT 137
Query: 149 DFGLAKK-YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 207
DFGL K+ D T + GT Y + + R D LG V+ +
Sbjct: 138 DFGLCKEGISDGATMK--------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
Query: 208 RGSLPW 213
G LP+
Sbjct: 190 CGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 3e-04
Identities = 65/273 (23%), Positives = 112/273 (41%), Gaps = 45/273 (16%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQGGSGIPNI- 68
+G G+FGE+F + D VAVK PQ L EA++ K PNI
Sbjct: 3 LGKGNFGEVFKGTLKDKTP-VAVK--TCKEDLPQELKIKFLSEARILKQYDH----PNIV 55
Query: 69 KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEYVHSRGFL 125
K GV + + + + D + R+K K ++ A A + Y+ S+ +
Sbjct: 56 KLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCI 115
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN----RHIPYR-ENKNLTGTARYA 180
HRD+ N L+G + N + I DFG++++ D + + IP + RY+
Sbjct: 116 HRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
S D+ S G +LL+ F G P+ G+ +++ +K ++S P
Sbjct: 173 S-----------ESDVWSYG-ILLWETFSLGVCPYPGMTNQQAREQVEK--GYRMSCP-- 216
Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271
+ P + C + RP + L++
Sbjct: 217 ---QKCPDDVYKVMQRCWDYKPENRPKFSELQK 246
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 26/83 (31%), Positives = 41/83 (49%), Gaps = 10/83 (12%)
Query: 105 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG-LGRKANQVYIIDFGLAKKYRDPTTNR 163
V + Q++ + Y+H + LHRD+KP N L+ LG ++ + DFGLA+ P+
Sbjct: 105 VRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG----ELKLADFGLARAKSIPSQTY 160
Query: 164 H-----IPYRENKNLTGTARYAS 181
+ YR L G Y+S
Sbjct: 161 SSEVVTLWYRPPDVLLGATDYSS 183
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 25/80 (31%), Positives = 40/80 (50%), Gaps = 14/80 (17%)
Query: 85 LGP---SLEDLFVYCRR--------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 133
LGP LE+ + ++ K + + + Q++ + +H G +HRDIKP+N
Sbjct: 280 LGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPEN 339
Query: 134 FLMGLGRKANQVYIIDFGLA 153
L+ + QV IIDFG A
Sbjct: 340 LLVTVD---GQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 48/220 (21%), Positives = 88/220 (40%), Gaps = 51/220 (23%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVK---------IENSGTKHPQLLYEAKVYKILQGGSG 64
++G+G+ G + H + I+A K I N + Q+L+E I
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI------ 65
Query: 65 IPNIKWYGV---DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ +YG DGE ++ + + G SL+ + +R + ++++ ++
Sbjct: 66 ---VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---------IPEEILGKVSIAVL 113
Query: 122 RGF---------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
RG +HRD+KP N L+ ++ + DFG++ + D N +
Sbjct: 114 RGLAYLREKHQIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMAN---------S 161
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212
GT Y S G S + D+ S+G L+ G P
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 32/129 (24%), Positives = 57/129 (44%), Gaps = 13/129 (10%)
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
F + L A +++ +E +H ++RD+KP+N L+ + I D GLA K
Sbjct: 99 FEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLD---DYGHIRISDLGLAVK---- 151
Query: 160 TTNRHIPYREN-KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
IP E+ + GT Y + + D LG ++ + G P++G K
Sbjct: 152 -----IPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206
Query: 219 ATKKQKYDK 227
K+++ D+
Sbjct: 207 KVKREEVDR 215
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 68/285 (23%), Positives = 116/285 (40%), Gaps = 41/285 (14%)
Query: 11 LGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENS---GTKHPQLLYEAKVYKILQGG 62
G+ +G+G+FG++ A S D VAVK+ ++ L+ E K+ L
Sbjct: 39 FGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNH 98
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK----FSLKTVLMLADQMIARIEY 118
I N+ G +++ + DL + RRK +L+ +L + Q+ + +
Sbjct: 99 ENIVNLLGACTIGGPILVITEYC--CYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+ S+ +HRD+ N L+ G+ I DFGLA R I N + G AR
Sbjct: 157 LASKNCIHRDLAARNVLLTHGKIVK---ICDFGLA---------RDIMNDSNYVVKGNAR 204
Query: 179 ----YASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEK- 231
+ + + + D+ S G +LL+ F GS P+ G+ +K Y I E
Sbjct: 205 LPVKWMAPESIFNCVYTFESDVWSYG-ILLWEIFSLGSNPYPGMPVDSK--FYKLIKEGY 261
Query: 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
+++ P PAE C +RP + + +L
Sbjct: 262 RMAQPEHA-----PAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 17/46 (36%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
Q++ ++++HS +HRD+KP N L+ Q+ + DFGLA+ Y
Sbjct: 118 QLLRGLDFLHSHRVVHRDLKPQNILVTSS---GQIKLADFGLARIY 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 46/163 (28%), Positives = 68/163 (41%), Gaps = 29/163 (17%)
Query: 15 IGSGSFGEIFLASHVD-----TNEI-VAVKIENSGT---KHPQLLYEAKVYKILQGGSGI 65
+GSG+FGE++ + D + I VAVK G + + L EA L
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAH----LMSNFNH 58
Query: 66 PNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRK---------FSLKTVLMLADQMI 113
PNI K GV E ++++L+ DL Y R +LK +L + +
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGG--DLLSYLRDARVERFGPPLLTLKELLDICLDVA 116
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGL--GRKANQVYIIDFGLAK 154
Y+ F+HRD+ N L+ V I DFGLA+
Sbjct: 117 KGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 5e-04
Identities = 45/158 (28%), Positives = 77/158 (48%), Gaps = 27/158 (17%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI-KWYGV 73
IG G++G+++ ++ + AVKI + + + + EA+ Y ILQ PN+ K+YG+
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEI-EAE-YNILQSLPNHPNVVKFYGM 87
Query: 74 -------DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY------- 118
G LVL+L G S+ +L K L L + MI+ I Y
Sbjct: 88 FYKADKLVGGQLWLVLELCNGGSVTELV-----KGLLICGQRLDEAMISYILYGALLGLQ 142
Query: 119 -VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+H+ +HRD+K +N L+ V ++DFG++ +
Sbjct: 143 HLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQ 177
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 5e-04
Identities = 58/232 (25%), Positives = 91/232 (39%), Gaps = 34/232 (14%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW---- 70
IG GSFG++ LA + AVK+ K L + + + + + + N+K
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQ---KKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 71 ---YGVDGEDNV-LVLDLLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGF 124
Y + + VLD + +LF + + R F A ++ + + Y+HS
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGG--ELFFHLQRERSFPEPRARFYAAEIASALGYLHSINI 117
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTTNRHIPYRENKNLTGTARYAS 181
++RD+KP+N L+ V + DFGL K+ D TT GT Y +
Sbjct: 118 VYRDLKPENILLD---SQGHVVLTDFGLCKEGIAQSDTTT----------TFCGTPEYLA 164
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
D LG VL L G P+ A + YD I K +
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMYDNILHKPL 213
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 6e-04
Identities = 27/110 (24%), Positives = 55/110 (50%), Gaps = 13/110 (11%)
Query: 52 EAKV-YKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLA 109
EA++ + + G +P + Y VD E+ ++V++ + G L+DL +
Sbjct: 49 EARIMSRARKAGVNVPAV--YFVDPENFIIVMEYIEGEPLKDLIN--SNGMEELELSREI 104
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
+++ ++ HS G +H D+ N ++ ++Y+IDFGLA+ +D
Sbjct: 105 GRLVGKL---HSAGIIHGDLTTSNMIL----SGGKIYLIDFGLAEFSKDL 147
|
Length = 211 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 53/225 (23%), Positives = 91/225 (40%), Gaps = 44/225 (19%)
Query: 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI------ 65
G +G G++G ++ + +++AVK T + L E K Y+ LQ +
Sbjct: 5 GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSN-VLAAE-KEYEKLQEEVDLLKSLKH 61
Query: 66 PNIKWY-GVDGEDNVL--------------VLDLLGPSLEDLFVYCRRKFSLKTVLMLAD 110
NI Y G +DN + +L+ GP E V+C+
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE--PVFCK----------YTK 109
Query: 111 QMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
Q++ + Y+H+ +HRDIK +N LM G + +IDFG A++ H +
Sbjct: 110 QILDGVAYLHNNCVVHRDIKGNNVMLMPNG----IIKLIDFGCARRL--AWVGLHGTHSN 163
Query: 170 N-KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
K++ GT + + R+ D+ S+G + G P
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 6e-04
Identities = 36/128 (28%), Positives = 58/128 (45%), Gaps = 13/128 (10%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
Q+I+ +E++H R ++RD+KP+N L+ V I D GLA + +D + +
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLD---NDGNVRISDLGLAVELKDGQS-------KT 154
Query: 171 KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL--RGSLPWQGLKAATKKQKYDKI 228
K GT + + G E D +LG L + RG +G K K+ K +I
Sbjct: 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-QRI 213
Query: 229 CEKKVSTP 236
V+ P
Sbjct: 214 LNDSVTYP 221
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 24/71 (33%), Positives = 41/71 (57%), Gaps = 7/71 (9%)
Query: 90 EDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149
EDL ++ +L+ ++ + Q+ +E++ SR +HRD+ N L+ + N V I D
Sbjct: 169 EDL---YKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICD 222
Query: 150 FGLAKK-YRDP 159
FGLA+ Y+DP
Sbjct: 223 FGLARDIYKDP 233
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 39/157 (24%), Positives = 69/157 (43%), Gaps = 21/157 (13%)
Query: 10 KLGRKIGSGSFGEIFLASHV---DTNEI-VAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
+ + +GSG+FG ++ + + +I VA+K+ E + K + +L EA V
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYV----MAS 65
Query: 63 SGIPNI-KWYGVD-GEDNVLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIARIE 117
P++ + G+ L+ L+ L L Y R + +L Q+ +
Sbjct: 66 VDHPHVVRLLGICLSSQVQLITQLM--PLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ + +HRD+ N L+ + V I DFGLAK
Sbjct: 124 YLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 7e-04
Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 11/164 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
K LG IG G FG + + T + VAVK L E V L + +
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRL 64
Query: 68 IKWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRKF--SLKTVLMLADQMIARIEYVHSRGF 124
+ GV + + +V++L+ F+ R + S+ +L + + +EY+ S+
Sbjct: 65 L---GVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKL 121
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+HRD+ N L+ + + DFGLA+ N +P +
Sbjct: 122 VHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKLPVK 162
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 7e-04
Identities = 48/210 (22%), Positives = 89/210 (42%), Gaps = 28/210 (13%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKW---- 70
+G G+FG++ L + + A+KI K ++ + +V L + N +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKI----LKKEVIIAKDEVAHTLTESRVLKNTRHPFLT 58
Query: 71 ---YGVDGEDNV-LVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGF 124
Y +D + V++ + +LF + R+ FS ++++ ++Y+HS
Sbjct: 59 SLKYSFQTKDRLCFVMEYVNGG--ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKI 116
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDPTTNRHIPYRENKNLTGTARYASCN 183
++RD+K +N ++ K + I DFGL K+ D T K GT Y +
Sbjct: 117 VYRDLKLENLMLD---KDGHIKITDFGLCKEGITDAAT--------MKTFCGTPEYLAPE 165
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
+ R D LG V+ + G LP+
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 8e-04
Identities = 33/151 (21%), Positives = 65/151 (43%), Gaps = 8/151 (5%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
Y + + IG G+FGE+ L H + ++ A+K+ E +E +
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 65 IPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ + D + +V++ + P + + + K +++ ++ +HS G
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYM-PGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGL 163
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+HRD+KPDN L+ K + + DFG K
Sbjct: 164 IHRDVKPDNMLLD---KHGHLKLADFGTCMK 191
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 48/177 (27%), Positives = 75/177 (42%), Gaps = 35/177 (19%)
Query: 11 LGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGG 62
L R++G G+FG++FL + E+VAVK EA++ Q
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH- 67
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL------------GPSLEDLFVYCRRKFSLKTVLM 107
NI K+YGV +G+ ++V + + GP L L +
Sbjct: 68 ---ENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 108 L--ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
L A Q+ + + Y+ S+ F+HRD+ N L+G V I DFG++ RD T
Sbjct: 125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMS---RDVYTT 175
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 29/169 (17%)
Query: 9 YKLGRKIGSGSFG---EIFLASHVDTNEIVAVKIE----NSGTKHPQLLYEAKVYKILQG 61
+ LGR +G G FG E L S + + VAVK+ S + + L EA K
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 62 GSGIPNI-KWYGVD----GEDNVLVLDLLGPSLE--DL--FVYCRR------KFSLKTVL 106
PN+ K GV + + + ++ P ++ DL F+ R L+T++
Sbjct: 61 ----PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV 116
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+ + +EY+ S+ F+HRD+ N ++ + V + DFGL+KK
Sbjct: 117 RFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVADFGLSKK 162
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.001
Identities = 12/48 (25%), Positives = 25/48 (52%), Gaps = 7/48 (14%)
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
++ ++ H G +H D+ N ++ +++Y+IDFGL K +
Sbjct: 102 LVGKL---HKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYSDEI 142
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.001
Identities = 46/177 (25%), Positives = 73/177 (41%), Gaps = 30/177 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKH---PQLLYEAKVYKILQGGS 63
+Y++ +KIG+G FGE+FL H T E K I G K QL+ E V + L+ +
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKN 73
Query: 64 GIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRRKFSL---KTVLMLADQMIARIEY 118
+ I + + +L L C + F ++ + Q++ + Y
Sbjct: 74 IVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAY 133
Query: 119 VHS-------RGFLHRDIKPDNFLMGLG--------RKANQV------YIIDFGLAK 154
H+ LHRD+KP N + G +AN + I DFGL+K
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK 190
|
Length = 1021 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.001
Identities = 42/180 (23%), Positives = 69/180 (38%), Gaps = 60/180 (33%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IEN----------------SGTKHPQLL- 50
+G G FG++ LA + T E+ A+K I + +HP L+
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66
Query: 51 ------YEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKT 104
E V +++ +G G DL+ D+F R F
Sbjct: 67 LFACFQTEDHVCFVMEYAAG----------G-------DLMMHIHTDVFSEPRAVFYAAC 109
Query: 105 VLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTT 161
V++ ++Y+H ++RD+K DN L+ V I DFGL K+ + D T+
Sbjct: 110 VVL-------GLQYLHENKIVYRDLKLDNLLLDT---EGFVKIADFGLCKEGMGFGDRTS 159
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 42/152 (27%), Positives = 62/152 (40%), Gaps = 30/152 (19%)
Query: 106 LMLADQMIARIEYVHSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFG---LAKKYRDP 159
LML Q++ + H++G +HRD+KP N ++ G+ A ++DFG L RD
Sbjct: 84 LML--QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAK---VLDFGIGTLLPGVRDA 138
Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSR------RDDLESLGYVLLYFLRGSLPW 213
LT T T+ EQ R DL + G + L L G
Sbjct: 139 DVAT---------LTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
Query: 214 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245
QG A+ + Y ++ VS P + HP
Sbjct: 190 QG--ASVAEILYQQLSPVDVSLPPWI--AGHP 217
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 18/50 (36%), Positives = 29/50 (58%), Gaps = 3/50 (6%)
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
Q++ + Y H R LHRD+KP N L+ + ++ + DFGLA+ P+
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLIS---ERGELKLADFGLARAKSVPS 157
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.002
Identities = 16/36 (44%), Positives = 25/36 (69%), Gaps = 3/36 (8%)
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151
++ +HS GF+HRD+KPDN L+ K+ + + DFG
Sbjct: 155 LDAIHSMGFIHRDVKPDNMLLD---KSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.002
Identities = 20/66 (30%), Positives = 33/66 (50%), Gaps = 4/66 (6%)
Query: 91 DLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148
DLF + K S V + Q++ + +H +H DIK +N L R +++Y+
Sbjct: 95 DLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL--YDRAKDRIYLC 152
Query: 149 DFGLAK 154
D+GL K
Sbjct: 153 DYGLCK 158
|
Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 39/150 (26%), Positives = 79/150 (52%), Gaps = 14/150 (9%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVK-IENS--GTKHPQLLYEAKVYKILQGGSGIPNIK 69
++G G++G + HV T I+AVK I + + +LL + + ++ +
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDIS--MRSVDCPYTVT 64
Query: 70 WYG-VDGEDNVLV-LDLLGPSLEDLF--VYCRRKFSLKTVL-MLADQMIARIEYVHSR-G 123
+YG + E +V + ++++ SL+ + VY + + +L +A ++ +EY+HS+
Sbjct: 65 FYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
+HRD+KP N L+ + QV + DFG++
Sbjct: 125 VIHRDVKPSNVLIN---RNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 38.8 bits (91), Expect = 0.002
Identities = 19/75 (25%), Positives = 39/75 (52%), Gaps = 7/75 (9%)
Query: 91 DLFVYCRRK----FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146
+LF +R+ S + A +++ +EY+H G ++RD+KP+N L+ ++ +
Sbjct: 87 ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL---HESGHIM 143
Query: 147 IIDFGLAKKYRDPTT 161
+ DF L+K+
Sbjct: 144 LSDFDLSKQSDVEPP 158
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 45/152 (29%), Positives = 60/152 (39%), Gaps = 33/152 (21%)
Query: 11 LGRKIGSGSFGE--IFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGSG 64
L IG + LA H TN +VAVK N S L E + LQ
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQH--- 58
Query: 65 IPNIKWYG---VDGEDNVLVLDLLG-PSLEDLFVYCRRKFSLKTVLM--LADQMIARI-- 116
PNI Y + + +V L+ S EDL LKT L + IA I
Sbjct: 59 -PNILPYVTSFIVDSELYVVSPLMAYGSCEDL---------LKTHFPEGLPELAIAFILK 108
Query: 117 ------EYVHSRGFLHRDIKPDNFLMGLGRKA 142
+Y+HS+GF+HR +K + L+ K
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSGDGKV 140
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.002
Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 15/152 (9%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
KL + IG G FG++ L + VAVK I+N T L EA V L+ + +
Sbjct: 9 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQ-AFLAEASVMTQLRHSN---LV 62
Query: 69 KWYGVDGEDN---VLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
+ GV E+ +V + + G ++ L R +L + + +EY+ +
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN 122
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
F+HRD+ N L+ + N + DFGL K+
Sbjct: 123 FVHRDLAARNVLVS---EDNVAKVSDFGLTKE 151
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.003
Identities = 41/159 (25%), Positives = 73/159 (45%), Gaps = 23/159 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASH-VDTNEIVAVKI--ENSGTKHPQLL-YEAKVYKILQGGSG 64
Y R +G GS+GE+ L H D + V K+ N+ + + EA++ L+
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKH--- 58
Query: 65 IPNIKWY--GVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI-------AR 115
PNI Y +GED +L + + DL+ + K L+ +Q++
Sbjct: 59 -PNIVAYRESWEGEDGLLYIVMGFCEGGDLY---HKLKEQKGKLLPENQVVEWFVQIAMA 114
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
++Y+H + LHRD+K N + + N + + D G+A+
Sbjct: 115 LQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIAR 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.003
Identities = 20/57 (35%), Positives = 33/57 (57%), Gaps = 3/57 (5%)
Query: 99 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
K L+T+L + +EY+ +R F+HRD+ N ++ R+ V + DFGL+KK
Sbjct: 109 KLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKK 162
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 25/69 (36%), Positives = 36/69 (52%), Gaps = 10/69 (14%)
Query: 106 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YRDP 159
L +A Q+ A +EY+ S F+HRD+ N L+G G V I DFGL++ YR
Sbjct: 127 LHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL---TVKISDFGLSRDIYSADYYRVQ 183
Query: 160 TTNRHIPYR 168
+ +P R
Sbjct: 184 -SKSLLPVR 191
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 36/168 (21%), Positives = 63/168 (37%), Gaps = 48/168 (28%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG 72
R +G GSFG++ LA ++ + AVK+ K +L + V +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKV----LKKDVILQDDDVECTMT------------ 44
Query: 73 VDGEDNVLVLDLLGPSLEDLFVYC-------------------------RRKFSLKTVLM 107
E +L L P L L+ C R+F
Sbjct: 45 ---EKRILSLARNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF 100
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
A ++ + + ++H +G ++RD+K DN L+ + DFG+ K+
Sbjct: 101 YAAEITSALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKE 145
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.004
Identities = 32/126 (25%), Positives = 54/126 (42%), Gaps = 14/126 (11%)
Query: 91 DLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148
+LF + R+ FS ++++ + Y+HS ++RD+K +N ++ K + I
Sbjct: 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLD---KDGHIKIT 137
Query: 149 DFGLAKKYRDPTTNRHIPY-RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 207
DFGL K+ I K GT Y + + R D LG V+ +
Sbjct: 138 DFGLCKE--------GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
Query: 208 RGSLPW 213
G LP+
Sbjct: 190 CGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.004
Identities = 19/59 (32%), Positives = 31/59 (52%), Gaps = 5/59 (8%)
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDP 159
LK + Q++ +EY+H + +HRDIK +N FL G+ + + DFG A +
Sbjct: 266 LKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK----IVLGDFGTAMPFEKE 320
|
Length = 501 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.004
Identities = 37/161 (22%), Positives = 63/161 (39%), Gaps = 26/161 (16%)
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
F + A ++ +E +H ++RD+KP+N L+ + I D GLA
Sbjct: 99 FEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLD---DHGHIRISDLGLAV----- 150
Query: 160 TTNRHIPYREN-KNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
H+P + K GT Y + + D +LG +L + G P+Q K
Sbjct: 151 ----HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 206
Query: 219 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYC-QSL 258
K+++ +E L K E++ F +SL
Sbjct: 207 KIKREE------------VERLVKEVQEEYSEKFSPDARSL 235
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 21/76 (27%), Positives = 37/76 (48%), Gaps = 5/76 (6%)
Query: 91 DLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148
DL+ Y +R ++ +L + ++ I+Y+H +HRDIK +N + V +
Sbjct: 168 DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN---HPGDVCLG 224
Query: 149 DFGLAKKYRDPTTNRH 164
DFG A D N++
Sbjct: 225 DFGAACFPVDINANKY 240
|
Length = 391 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 318 | |||
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.57 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.38 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.32 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.29 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.26 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.22 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.02 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.9 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.9 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.78 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.78 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.77 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.6 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.58 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.55 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.37 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.27 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.98 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.93 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.84 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.79 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.79 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.75 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.71 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.68 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.58 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.55 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.51 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.48 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.45 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.45 | |
| PLN02236 | 344 | choline kinase | 97.37 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.36 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.3 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.26 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.22 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.18 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.91 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.87 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.76 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.59 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.44 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.39 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.18 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.98 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.96 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 95.53 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.27 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.23 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.05 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.0 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.88 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.69 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.76 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 92.58 |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=349.28 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=219.2
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
-++|.+++.||+|+|++|++|+++.+++.||||++.+. .+..-...|-.+|.+|.+|+.+..++.-+++....|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 36899999999999999999999999999999986643 3344567788899999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
|+||+ +|+|.+++.+. +.+++...+.++.+|+.||+|||++|||||||||+|||+ |.+++++|.|||.+..+...
T Consensus 152 vLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE---cCCCcEEEeeccccccCChh
Confidence 99999 99999999985 459999999999999999999999999999999999999 69999999999999887644
Q ss_pred CCCccc------cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 160 TTNRHI------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 160 ~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
...... .......++||..|.+||++.....++.+|+|+||||+|+|+.|++||.+.++.. .+++|+....
T Consensus 228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---iFqkI~~l~y 304 (604)
T KOG0592|consen 228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---IFQKIQALDY 304 (604)
T ss_pred hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---HHHHHHHhcc
Confidence 332111 1111256899999999999999999999999999999999999999999987753 4445544444
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
..| ..+|+...+|+.+.|..||.+|++.++|.++
T Consensus 305 ~fp-----~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 305 EFP-----EGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred cCC-----CCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 333 5678899999999999999999999988875
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=341.39 Aligned_cols=256 Identities=26% Similarity=0.341 Sum_probs=213.6
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---------CChhHHHHHHHHHHHcCCCCCCeeeeccc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---------KHPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~e~~~l~~l~~~~~~~~i~~~~~ 73 (318)
..+.+.|.+.+.||+|+||.|-+|..+++++.||||++++.. ......+|+++|++|+| |+++.+..++.
T Consensus 168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~H-P~IV~~~d~f~ 246 (475)
T KOG0615|consen 168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSH-PNIVRIKDFFE 246 (475)
T ss_pred chhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCC-CCEEEEeeeee
Confidence 346788999999999999999999999999999999877542 12245799999999977 77888888888
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
.....|+||||+ +|+|.+++.. .+.+.+...+.+++|++.|+.|||+.||+||||||+|||++.++++..+||+|||+
T Consensus 247 ~~ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 247 VPDSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred cCCceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence 888899999999 9999999887 45588899999999999999999999999999999999998666779999999999
Q ss_pred eeeecCCCCCccccccCCCCCcccccccccccccCCC---CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHH
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~ 229 (318)
|+...... .....+||+.|.|||++.+.. ++.++|+||+||+||-+++|.+||....... ...+.|.
T Consensus 326 AK~~g~~s--------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~ 395 (475)
T KOG0615|consen 326 AKVSGEGS--------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQIL 395 (475)
T ss_pred hhccccce--------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHh
Confidence 98765332 345679999999999998775 3458899999999999999999998654322 1233343
Q ss_pred HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+...- +..|..++++..++|.++|..||++||++.++.+
T Consensus 396 ~G~y~f~-p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 396 KGRYAFG-PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred cCccccc-ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 3333322 3456789999999999999999999999998765
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-50 Score=322.53 Aligned_cols=274 Identities=22% Similarity=0.277 Sum_probs=220.8
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
.+|...+.||+|.||.||+|++.++|+.||||.++..+.. -.+.+|++.|+.++| +++..+.+++......-+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h-~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKH-PNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccC-cchhhhhhhccCCCceEEEE
Confidence 5899999999999999999999999999999987765433 368999999999986 66666666777777899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
||+..+|...+......++..+++.++.++++||.|||++.|.||||||.|+|++ ++|.+||+|||+++...++...
T Consensus 81 Efm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis---~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 81 EFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLIS---SDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred EeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEc---CCCcEEeecccchhccCCCCcc
Confidence 9999999999998777799999999999999999999999999999999999995 9999999999999988766543
Q ss_pred ccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
. ...+-|..|+|||++.|.. |+..+||||+|||+.||+.|.+.|.+.++-++. ..|++ .+.+|.+..|
T Consensus 158 ~-------~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL---~~If~-~LGTP~~~~W 226 (318)
T KOG0659|consen 158 Q-------THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL---SKIFR-ALGTPTPDQW 226 (318)
T ss_pred c-------ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH---HHHHH-HcCCCCcccC
Confidence 2 2226689999999999876 999999999999999999999999998775544 44443 3446666544
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCchhHHHhhhcCCccccccccee
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
..+. .+-+...--.-+.|..+- .|. ...+++.+|+.+|+++||.+|+|+.+++.
T Consensus 227 P~~~-~lpdY~~~~~~P~~~~~~-------lf~-aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 227 PEMT-SLPDYVKIQQFPKPPLNN-------LFP-AASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred cccc-ccccHHHHhcCCCCcccc-------ccc-cccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 4433 233333222223333221 222 23556689999999999999999999886
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=360.12 Aligned_cols=287 Identities=22% Similarity=0.286 Sum_probs=224.9
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-hhHHHHHHHHHHHcCC-----CCCCeeeeccccC
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGG-----SGIPNIKWYGVDG 75 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~~~-----~~~~~i~~~~~~~ 75 (318)
.+.++.||++.+.||+|+||.|.+|.|.++++.||||++++.... .+...|+.+|+.++.+ .+++.+..++...
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 456778999999999999999999999999999999999876543 5678899999999832 3466668888899
Q ss_pred cceEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
++.|||+|.+..+|.+++.... .+++...++.++.||+.||..||+.||||+||||+|||+... ....+||+|||+|+
T Consensus 261 ~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~-~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 261 NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP-KRSRIKVIDFGSSC 339 (586)
T ss_pred cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC-CcCceeEEeccccc
Confidence 9999999999999999998754 358999999999999999999999999999999999999643 55689999999998
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
....... ....+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+..++...+.+++ .
T Consensus 340 ~~~q~vy----------tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l---G- 405 (586)
T KOG0667|consen 340 FESQRVY----------TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL---G- 405 (586)
T ss_pred ccCCcce----------eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh---C-
Confidence 7543322 4467899999999999999999999999999999999999999988766555444433 3
Q ss_pred CchHHHhhcCchhHHHHHHH-------HhhcC-------------------CCCCC-ChHHHHHHHHHHHHhcCCchhHH
Q 021053 235 TPIEVLCKSHPAEFASYFHY-------CQSLT-------------------FDQRP-DYGFLKRLFHDLFSREGSLLLQF 287 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~-------cl~~~-------------------p~~Rp-~~~~l~~~l~~~~~~~~~~~~~~ 287 (318)
.|++...+..+.. ..++.. |-..+ -...| ....+...++..-...-++|+.+
T Consensus 406 ~Pp~~mL~~~~~~-~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~ 484 (586)
T KOG0667|consen 406 LPPPKMLDTAKKA-HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR 484 (586)
T ss_pred CCCHHHHHhcccc-ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence 3333333222211 222221 21111 11224 44444444443434455899999
Q ss_pred HhhhcCCccccccccee
Q 021053 288 IMSYCSLHSITFQTNII 304 (318)
Q Consensus 288 ~l~~~p~~r~t~~~~~~ 304 (318)
||.|||++|+|+.+|+.
T Consensus 485 ~L~~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 485 CLEWDPAERITPAQALN 501 (586)
T ss_pred HhccCchhcCCHHHHhc
Confidence 99999999999999986
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-50 Score=336.20 Aligned_cols=247 Identities=23% Similarity=0.308 Sum_probs=204.1
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
-++|.+.+.||.|+|++||+|+++.++..||||.+.... ..+.+.+|+.+|+.++| ++++.+..+....+..|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H-~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKH-PNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCC-cceeeEEEEEecCCeEEEE
Confidence 368999999999999999999999999999999776553 23467899999999995 7777888888888899999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCC---CeEEEEeccceeeec
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA---NQVYIIDFGLAKKYR 157 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~---~~~kL~dfg~~~~~~ 157 (318)
|||| +|+|.++++.. +.+++.+++.++.||+.||++||+++|+||||||+|||++..... ..+||+|||+++.+.
T Consensus 88 MEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~ 166 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ 166 (429)
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence 9999 89999999984 459999999999999999999999999999999999999854222 679999999999887
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
...- .....|++.|||||++...+|+-|+|+||+|+++|++++|++||......+ .+..+.... ..+
T Consensus 167 ~~~~--------a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e---L~~~~~k~~--~~~ 233 (429)
T KOG0595|consen 167 PGSM--------AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE---LLLYIKKGN--EIV 233 (429)
T ss_pred chhH--------HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH---HHHHHhccc--ccc
Confidence 4432 346789999999999999999999999999999999999999998766543 333222211 112
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYG 267 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 267 (318)
.......+....+++...+..+|.+|.++.
T Consensus 234 ~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~ 263 (429)
T KOG0595|consen 234 PVLPAELSNPLRELLISLLQRNPKDRISFE 263 (429)
T ss_pred CchhhhccCchhhhhhHHHhcCccccCchH
Confidence 222234456677888888999999997765
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-51 Score=349.97 Aligned_cols=279 Identities=25% Similarity=0.328 Sum_probs=222.6
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-h--hHHHHHHHHHHHcCCCCCCeeeeccccCc-ceE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-P--QLLYEAKVYKILQGGSGIPNIKWYGVDGE-DNV 79 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~--~~~~e~~~l~~l~~~~~~~~i~~~~~~~~-~~~ 79 (318)
++-+||.+.++||+|+||.||+|+...++..||||.++..... + .-++|++.|+++..|+++..+.....+.. ..+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4568999999999999999999999999999999988765432 2 35789999999996788888865555555 999
Q ss_pred EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 80 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
+|||||...|.+++...+..|++..++.|+.||++||+|+|.+|+.|||+||+|||++ ....+||+|||+|+...+.
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~---~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILIS---GNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEec---ccceeEecccccccccccC
Confidence 9999999999999998888899999999999999999999999999999999999994 5899999999999976543
Q ss_pred CCCccccccCCCCCccccccccccccc-CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
.. | ...+.|..|+|||++. ..-|+.+.||||+|||++|+.+-++.|.|.++. +++.+||... ..|..
T Consensus 164 pP-----Y---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~---Dqi~KIc~VL-GtP~~ 231 (538)
T KOG0661|consen 164 PP-----Y---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI---DQIYKICEVL-GTPDK 231 (538)
T ss_pred CC-----c---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH---HHHHHHHHHh-CCCcc
Confidence 22 2 3567899999999876 455999999999999999999999999997764 4555666533 44443
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCchhHHHhhhcCCccccccccee
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
. .++. -..+.+.+=-.-|.--|+ .+...+.+ ...++.+++.+|+.|||.+||||.+++.
T Consensus 232 ~---~~~e-g~~La~~mnf~~P~~~~~--~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 232 D---SWPE-GYNLASAMNFRFPQVKPS--PLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred c---cchh-HHHHHHHhccCCCcCCCC--ChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 3 2232 233443332222333332 24455555 5677888999999999999999998875
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=332.26 Aligned_cols=277 Identities=25% Similarity=0.367 Sum_probs=227.4
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeee--eccccCcceEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIK--WYGVDGEDNVL 80 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~--~~~~~~~~~~l 80 (318)
+.|+.+..|++|+||.||+|+|+++++.||+|.++-.... -..++|+.++.+++| ++|+.+. ..+.+.+..|+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H-~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARH-PNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCC-CCeeeeEEEEeccccceeee
Confidence 4689999999999999999999999999999987754433 267999999999985 7777773 55666778999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||||.-+|.++++....+|...+++.++.|+++||.|||.+.|+||||||+|+|++ ..|.+|++|||+++...++.
T Consensus 155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~---~~G~lKiaDFGLAR~ygsp~ 231 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLS---HKGILKIADFGLAREYGSPL 231 (419)
T ss_pred eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeec---cCCcEEecccchhhhhcCCc
Confidence 999999999999998888899999999999999999999999999999999999995 99999999999999887763
Q ss_pred CCccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
. .....+-|..|+|||++.+.. |+.+.|+||+|||+.||+++++.|.+.+..+ ++.+|+. .+..|.+.
T Consensus 232 k-------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d---Ql~~If~-llGtPte~ 300 (419)
T KOG0663|consen 232 K-------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID---QLDKIFK-LLGTPSEA 300 (419)
T ss_pred c-------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH---HHHHHHH-HhCCCccc
Confidence 3 223556799999999999876 9999999999999999999999999977654 4455553 55677777
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH-HHhcCCchhHHHhhhcCCccccccccee
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL-FSREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~-~~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
.|..++. ....+ ...-.+-| ...+++.|... +++.+.+|+..+|++||++|.||.+++.
T Consensus 301 iwpg~~~--lp~~k---~~~f~~~p-yn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 301 IWPGYSE--LPAVK---KMTFSEHP-YNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cCCCccc--cchhh---ccccCCCC-chhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 6655541 11111 11222223 34577777766 6788899999999999999999999986
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=332.58 Aligned_cols=241 Identities=26% Similarity=0.360 Sum_probs=207.3
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
-.+.|++.+.||.|+||+||.|+.+.+++.+|+|++++.. .......|..++..++| |.++.+.+.+++....|
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~h-PFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKH-PFIVKLIYSFQTEEKLY 101 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCC-CcEeeeEEecccCCeEE
Confidence 3578999999999999999999999999999999876543 34567889999999766 66777778889999999
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+|++|+ +|.|...+++ .+.+++..++.++.+|+.||.|||++||+||||||+|||+ |..|.++|+|||+|+..-.
T Consensus 102 lVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee---cCCCcEEEeccccchhccc
Confidence 999999 8899999987 4559999999999999999999999999999999999999 6999999999999986544
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
.... ....+||+.|+|||++.+..|+.++|+||+|+++|+|++|.+||.+.+. ...+++|...+...++
T Consensus 178 ~~~~-------t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~---~~~~~~I~~~k~~~~p- 246 (357)
T KOG0598|consen 178 DGDA-------TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV---KKMYDKILKGKLPLPP- 246 (357)
T ss_pred CCCc-------cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH---HHHHHHHhcCcCCCCC-
Confidence 4332 2457999999999999999999999999999999999999999998765 4555666655533332
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCC
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRP 264 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp 264 (318)
..++...+++++..+..+|++|.
T Consensus 247 ---~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 247 ---GYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---ccCCHHHHHHHHHHhccCHHHhc
Confidence 23578899999999999999995
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-50 Score=325.74 Aligned_cols=254 Identities=22% Similarity=0.308 Sum_probs=209.1
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCCh----hHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
++|+.+.++|+|+||.||+|+++.+|+.||||.+....+.+ -+.+|+++|++|+|++ ++.+...+......++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~N-LVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHEN-LVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccch-HHHHHHHHHhcceeEEEe
Confidence 57999999999999999999999999999999877655433 4789999999998854 555555556667899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
|||.-++.+-+.....+++...++.+++|++.|+.|+|+++++||||||+|||++ ..+.+||+|||+++.+..++..
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit---~~gvvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILIT---QNGVVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEe---cCCcEEeccchhhHhhcCCcch
Confidence 9999999999998888899999999999999999999999999999999999996 8999999999999988764432
Q ss_pred ccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc--------
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV-------- 233 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~-------- 233 (318)
....+.|..|+|||++.+ -+|++.+||||+||++.||++|++.|.+.++.++.-.+....+...
T Consensus 158 -------YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 158 -------YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred -------hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 245688999999999998 5699999999999999999999999999888766655444332111
Q ss_pred ----------cCch-----HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 234 ----------STPI-----EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 234 ----------~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+.|. +.-....+.-+.++++.||+.||++|++.+++..
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1110 1111123345789999999999999999887654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-50 Score=345.59 Aligned_cols=278 Identities=25% Similarity=0.316 Sum_probs=222.0
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeecccc-CcceEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD-GEDNVL 80 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~-~~~~~l 80 (318)
.+.|+.+++||+|+||.||+|++..+|+.||+|.+.-+.. .....+|+.+|++|.|++.+......... ....|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4678899999999999999999999999999997654432 23578999999999986655554444443 578999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|+|||.-+|..++....-.|++.+++.+++||+.||.|+|++||+|||||..|||+ |..|.+||+|||+++......
T Consensus 196 VFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 196 VFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred EEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE---cCCCCEEeccccceeeccCCC
Confidence 99999999999998765579999999999999999999999999999999999999 699999999999999776554
Q ss_pred CCccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
... ....+-|..|+|||++.|.. |+.++|+||+|||+.||++|++.|++..+.++...+.++| ..|.+.
T Consensus 273 ~~~------~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklc----GSP~e~ 342 (560)
T KOG0600|consen 273 SAP------YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLC----GSPTED 342 (560)
T ss_pred Ccc------cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHh----CCCChh
Confidence 432 23456799999999999886 9999999999999999999999999977766555555544 355555
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCchhHHHhhhcCCccccccccee
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
.|. ..+|- .+-...| .+|.-..+++.+.. +...+.+|++.||.+||.+|.||..++.
T Consensus 343 ~W~-----~~kLP-~~~~~kp-~~~y~r~l~E~~~~-~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 343 YWP-----VSKLP-HATIFKP-QQPYKRRLRETFKD-FPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccc-----cccCC-cccccCC-CCcccchHHHHhcc-CCHHHHHHHHHHhccCccccccHHHHhc
Confidence 443 11111 1111112 22444456666544 5888999999999999999999998876
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=332.77 Aligned_cols=248 Identities=23% Similarity=0.325 Sum_probs=210.6
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCc-ceEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE-DNVLV 81 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~-~~~lv 81 (318)
..+.+.+..||+|..|+||+|+++.+++.+|+|++....+ ..++.+|+++++.. .++.++.++..+.... ...|+
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~~isI~ 156 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGEEISIC 156 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCceEEee
Confidence 3477889999999999999999999999999998843332 34789999999999 4577778877777777 59999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
|||| +|||.+++... +.+++.....++.++++||.|||. ++|+||||||+|||++ ..|.+||+|||.+..+-..
T Consensus 157 mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN---skGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN---SKGEVKICDFGVSGILVNS 232 (364)
T ss_pred hhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec---cCCCEEeccccccHHhhhh
Confidence 9999 99999999874 559999999999999999999995 8999999999999994 9999999999999876544
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccch--hHhhhHHHHHHHHHhhccCch
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL--KAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~--~~~~~~~~~~~i~~~~~~~~~ 237 (318)
. .....||..|||||.+.+..|+.++||||||++++|+.+|+.||... ......+++..|+.. |+
T Consensus 233 ~---------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~----pp 299 (364)
T KOG0581|consen 233 I---------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE----PP 299 (364)
T ss_pred h---------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC----CC
Confidence 2 24678999999999999999999999999999999999999999764 223445666666643 33
Q ss_pred HHHhh-cCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 238 EVLCK-SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 238 ~~~~~-~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+..+. .+++++++++..||.+||.+||+++++.+
T Consensus 300 P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 300 PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 33334 48999999999999999999999998876
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-49 Score=345.71 Aligned_cols=245 Identities=28% Similarity=0.400 Sum_probs=213.6
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecC-----CCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
.+|+.++.||+|||+.||++++..+|+.||+|++.+ ....+...+|+++.++|+| ++++.++.++.+..+.|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~H-pnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKH-PNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCC-CcEEeeeeEeecCCceEEE
Confidence 689999999999999999999999999999998654 3345578999999999987 7888999999999999999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
+|+| .++|..++.. .+.+++.+++.+++||+.||.|||+.+|+|||||..|+|+ +++..+||+|||+|..+..+.
T Consensus 97 LELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 97 LELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EEecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee---cCcCcEEecccceeeeecCcc
Confidence 9999 8899888884 6779999999999999999999999999999999999999 589999999999999887553
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
- ......||+.|.|||++.....+..+||||+||++|-|+.|+|||+..+- .+.+..|.......|
T Consensus 173 E-------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v---kety~~Ik~~~Y~~P---- 238 (592)
T KOG0575|consen 173 E-------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV---KETYNKIKLNEYSMP---- 238 (592)
T ss_pred c-------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH---HHHHHHHHhcCcccc----
Confidence 3 22466899999999999988899999999999999999999999987544 344455443333333
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..++...++||.++|+.+|.+|||++++..
T Consensus 239 -~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 239 -SHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -cccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 256788999999999999999999998776
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-49 Score=327.92 Aligned_cols=280 Identities=23% Similarity=0.279 Sum_probs=217.3
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccc----cCc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGE 76 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~----~~~ 76 (318)
+..+|...+.||.|+||.|+.|.++.+|+.||||.+.... ...+..+|+++++.++|.+.+........ ...
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4567777899999999999999999999999999765333 34478999999999996554444443333 345
Q ss_pred ceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 77 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
..|+|+|+|+.+|...+.. +..++...+..+++|+++||+|+|+.+|+||||||.|+++ +.+..+|++|||+++..
T Consensus 100 DvYiV~elMetDL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 100 DVYLVFELMETDLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL---NADCDLKICDFGLARYL 175 (359)
T ss_pred eeEEehhHHhhHHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheee---ccCCCEEeccccceeec
Confidence 7899999999999999986 3349999999999999999999999999999999999999 58999999999999987
Q ss_pred cCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
....... .....+.|..|+|||++.. ..|+.+.||||+|||+.||++|++.|.+.+..++... |.... +.
T Consensus 176 ~~~~~~~-----~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~l---I~~~l-Gt 246 (359)
T KOG0660|consen 176 DKFFEDG-----FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQL---ILELL-GT 246 (359)
T ss_pred cccCccc-----chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHH---HHHhc-CC
Confidence 5431111 2245678999999998764 4599999999999999999999999999776554444 44333 34
Q ss_pred chHH-HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCchhHHHhhhcCCccccccccee
Q 021053 236 PIEV-LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 236 ~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
|.++ +..--++..+..++++ |...+ ..+.+.|.++ ++++++++++||.+||.+|+|+++|+.
T Consensus 247 P~~e~l~~i~s~~ar~yi~sl----p~~p~--~~f~~~fp~a-~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 247 PSEEDLQKIRSEKARPYIKSL----PQIPK--QPFSSIFPNA-NPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred CCHHHHHHhccHHHHHHHHhC----CCCCC--CCHHHHcCCC-CHHHHHHHHHHhccCccccCCHHHHhc
Confidence 4444 3333345566666544 22211 1244555543 778999999999999999999999985
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-50 Score=323.62 Aligned_cols=253 Identities=24% Similarity=0.295 Sum_probs=207.4
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC----CCChhHHHHHHHHHHHcCCCCCCeee-eccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIK-WYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~i~-~~~~~~~~~~lv 81 (318)
..|++.++||.|+||+||+|++..++..+|.|.++-. ...+...+|+.+|++|+|++.+.... .+..+....+||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 3599999999999999999999999999999976522 22346889999999999866555544 333344458999
Q ss_pred Eecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHS--RG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~--~~--i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
||+| .|+|.+.++.. .+.+++.++++++.|++.||.++|+ .+ |.||||||.|||+ +.+|.+||+|||++
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~ 175 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGLG 175 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE---cCCCceeeccchhH
Confidence 9999 99999998754 3359999999999999999999999 55 9999999999999 49999999999999
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
+.+....+. ....+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+.+- .+.-.+|.+...
T Consensus 176 r~l~s~~tf-------A~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~---~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 176 RFLSSKTTF-------AHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL---LSLCKKIEQGDY 245 (375)
T ss_pred hHhcchhHH-------HHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH---HHHHHHHHcCCC
Confidence 988766552 3577999999999999999999999999999999999999999998632 344455555443
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
++-+. ..++.++..++..|+..||+.||+...+...+.+
T Consensus 246 ~~~p~---~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 246 PPLPD---EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCcH---HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 32222 3678999999999999999999985545444443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=319.94 Aligned_cols=276 Identities=22% Similarity=0.325 Sum_probs=220.1
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCc------c
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE------D 77 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~------~ 77 (318)
.|+.+++||+|+||+||+|+.+.+|+.||+|.+.-... .....+|+.+++.++|.+++..+........ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 47788899999999999999999999999997665433 3467999999999999887666655544433 7
Q ss_pred eEEEEeccCCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 78 NVLVLDLLGPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 78 ~~lv~e~~~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
.++|+|+...+|..++.... ..++...++.+++||+.||.|||++||+||||||+||+++ +.|.+||+|||+++
T Consensus 92 l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~---~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 92 LYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLIS---SSGVLKLADFGLAR 168 (323)
T ss_pred EEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEEC---CCCcEeeeccchHH
Confidence 89999999999999999876 3588889999999999999999999999999999999995 89999999999998
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
....+.. .......|..|+|||++.+. .|+...||||+|||++||+++++.|.+.++ ..++.+|.. ..
T Consensus 169 a~~ip~~-------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~-~l 237 (323)
T KOG0594|consen 169 AFSIPMR-------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFR-LL 237 (323)
T ss_pred HhcCCcc-------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHH-Hc
Confidence 6553332 33566789999999999988 599999999999999999999999999877 445555554 44
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCchhHHHhhhcCCccccccccee
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
..|.+.. || .+..+... +....++++...+...+.+. ..+..+++.+||+++|++|.||..++.
T Consensus 238 GtP~e~~---Wp-~v~~~~~~--k~~f~~~~~~~~l~~~~~~~-~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 238 GTPNEKD---WP-GVSSLPDY--KAPFPKWPGPKDLSSILPKL-DPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred CCCCccC---CC-Cccccccc--cccCcCCCCccchHHhcccc-CccHHHHHHHHhccCcccCcCHHHHhc
Confidence 5555542 23 22222211 11233344455566666654 368899999999999999999999886
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=326.03 Aligned_cols=255 Identities=25% Similarity=0.364 Sum_probs=206.5
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcE-EEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEI-VAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~-vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
.....+.+.||.|+||+||+|.+. |+. ||+|++..... ...+.+|+.++.+++|++++..+..+.......++
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 455567788999999999999985 444 99998876442 23789999999999886555544444444337899
Q ss_pred EEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCceeeccCCCCC-eEEEEeccceeee
Q 021053 81 VLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRG-FLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKY 156 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dl~p~Nil~~~~~~~~-~~kL~dfg~~~~~ 156 (318)
||||+ +|+|.+++... ...++...+..++.||++|+.|||+++ |+||||||+|||+ +..+ .+||+|||+++..
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~ 194 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV---DLKGKTLKIADFGLSREK 194 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE---cCCCCEEEECCCccceee
Confidence 99999 99999999873 567999999999999999999999999 9999999999999 4776 9999999999876
Q ss_pred cCCCCCccccccCCCCCccccccccccccc--CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHL--GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
..... ......||+.|||||++. ...|+.++||||||+++|||+||+.||....+. +....+......
T Consensus 195 ~~~~~-------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~---~~~~~v~~~~~R 264 (362)
T KOG0192|consen 195 VISKT-------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV---QVASAVVVGGLR 264 (362)
T ss_pred ccccc-------cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhcCCC
Confidence 54321 123468999999999999 558999999999999999999999999987762 222333323333
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
++.+ ..+++.+..++.+||+.||++||++.++...|+.+..
T Consensus 265 p~~p---~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 265 PPIP---KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCC---ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 3323 2478899999999999999999999999999987754
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=332.16 Aligned_cols=256 Identities=24% Similarity=0.372 Sum_probs=213.5
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
..+.+.+.||+|.||+||.|.+..+ ..||+|.++...- .+.+.+|++++++|+| ++++.++.+.......||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H-~~lV~l~gV~~~~~piyIVtE~m 283 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSMSPEAFLREAQIMKKLRH-EKLVKLYGVCTKQEPIYIVTEYM 283 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCC-CcccceEEeccccChhHHHHHHHHHHhCcc-cCeEEEEEEEecCCceEEEEEec
Confidence 3456788999999999999998643 4689998877543 4678899999999988 55556655555555899999999
Q ss_pred -CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 86 -GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 86 -~~~L~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
.|+|.+++.. .+..++..+...++.||+.|+.||+++++|||||..+|||| +++..+||+|||+++...++...
T Consensus 284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~Y~- 359 (468)
T KOG0197|consen 284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV---DEDLVVKISDFGLARLIGDDEYT- 359 (468)
T ss_pred ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee---ccCceEEEcccccccccCCCcee-
Confidence 9999999987 45568999999999999999999999999999999999999 48899999999999954443332
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
......-+..|.|||.+....++.+||||||||+|||++| |+.||.++...+..+.+.+ +.+++.| .
T Consensus 360 -----~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~--GyRlp~P-----~ 427 (468)
T KOG0197|consen 360 -----ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLER--GYRLPRP-----E 427 (468)
T ss_pred -----ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhc--cCcCCCC-----C
Confidence 2233344667999999999999999999999999999999 9999999888766666655 4455555 4
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhc
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~ 280 (318)
.+|+.+.++|..||+.+|++|||++.+...++++....
T Consensus 428 ~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 428 GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 67999999999999999999999999999998876543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=325.71 Aligned_cols=255 Identities=27% Similarity=0.363 Sum_probs=213.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC----C---CChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----T---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~----~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
...++|++++.||.|+||+|+.|.+..++..||+|++... . ......+|+.+++.+.+|+++..+..+.....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4567999999999999999999999999999999976653 1 23356689999999997788888887777777
Q ss_pred ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCC-CeEEEEecccee
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA-NQVYIIDFGLAK 154 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~-~~~kL~dfg~~~ 154 (318)
..|+||||+ +|+|.+++.. .+.+.+..++.+++|++.|+.|+|++||+||||||+||++ +.. +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill---d~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL---DGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe---cCCCCCEEEecccccc
Confidence 899999999 7899999998 6679999999999999999999999999999999999999 466 999999999998
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCC-CC-CcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QS-RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~ 232 (318)
....... ......||+.|+|||++.+.. |+ .++||||+||+||.|++|..||...+. ...+..+....
T Consensus 170 ~~~~~~~-------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~---~~l~~ki~~~~ 239 (370)
T KOG0583|consen 170 ISPGEDG-------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV---PNLYRKIRKGE 239 (370)
T ss_pred ccCCCCC-------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH---HHHHHHHhcCC
Confidence 7631111 235678999999999999987 84 889999999999999999999988544 33444444444
Q ss_pred ccCchHHHhhcC-chhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 233 VSTPIEVLCKSH-PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 233 ~~~~~~~~~~~~-~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
...| ..+ +.++..++.+|+..+|.+|+++.++. .+.++..
T Consensus 240 ~~~p-----~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~--~h~w~~~ 280 (370)
T KOG0583|consen 240 FKIP-----SYLLSPEARSLIEKMLVPDPSTRITLLEIL--EHPWFQK 280 (370)
T ss_pred ccCC-----CCcCCHHHHHHHHHHcCCCcccCCCHHHHh--hChhhcc
Confidence 4433 233 88999999999999999999999988 3556554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=303.13 Aligned_cols=235 Identities=23% Similarity=0.341 Sum_probs=208.9
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
-.+|++.+.||.|+||.|.+++.+.++..+|+|+++...- .+...+|..+|+.+.| +.+..+..-+.+....|+
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~-PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSH-PFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccC-ceeEEEEEeeccCCeEEE
Confidence 3689999999999999999999999999999999876532 2357889999999885 556666666778889999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
||||. +|.|.+++.+.+ ++++..++.++.||+.||+|||+++|++|||||+|||+ |..|.+||.|||+++.....
T Consensus 122 vmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee---ccCCcEEEEeccceEEecCc
Confidence 99999 899999998854 59999999999999999999999999999999999999 79999999999999987655
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
+. ..+||+.|+|||+++..+++.++|+|||||++|||+.|.+||...++ .+.+.+|+......|
T Consensus 198 T~----------TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---~~iY~KI~~~~v~fP--- 261 (355)
T KOG0616|consen 198 TW----------TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---IQIYEKILEGKVKFP--- 261 (355)
T ss_pred EE----------EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---HHHHHHHHhCcccCC---
Confidence 32 45899999999999999999999999999999999999999998666 678888988888777
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCC
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQR 263 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~R 263 (318)
..++.++++|++..++.|-.+|
T Consensus 262 --~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 262 --SYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --cccCHHHHHHHHHHHhhhhHhh
Confidence 4458899999999999999999
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=315.18 Aligned_cols=210 Identities=25% Similarity=0.335 Sum_probs=173.0
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeecccc----CcceEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDNVLV 81 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~----~~~~~lv 81 (318)
.-.|+-.+.+|.|+||.||+|...++++.||||..-.+.+. ..+|+.++..+.|++.+..+..+... .-...+|
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~--knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY--KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc--CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 34689999999999999999999999999999976554443 34699999988775544444433321 2256799
Q ss_pred EeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 82 LDLLGPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 82 ~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
|||+..+|.+.+... +..++...++-++.||++||.|||+.||+||||||+|+|+. .+.+.+||+|||+|+.+..
T Consensus 101 leymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 101 LEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc--CCCCeEEeccCCcceeecc
Confidence 999999999998853 45588889999999999999999999999999999999995 5679999999999998765
Q ss_pred CCCCccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHH
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (318)
...+ ....+|..|+|||++.|.. |+.+.||||.||++.||+-|++.|.+.+..++...+.+
T Consensus 179 ~epn--------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik 240 (364)
T KOG0658|consen 179 GEPN--------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIK 240 (364)
T ss_pred CCCc--------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHH
Confidence 5443 4668899999999999886 99999999999999999999999999776554444333
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=314.09 Aligned_cols=256 Identities=26% Similarity=0.371 Sum_probs=201.8
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeec-cccCc-ceEEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWY-GVDGE-DNVLVL 82 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~-~~~~~-~~~lv~ 82 (318)
.+|..++.||+|+||.||++.+.+++...|+|.+..... .+.+.+|+.++.+++| ++++..... ..... .++++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~-p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNH-PNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCC-CCEEeeCCccccccCeeeEeee
Confidence 458889999999999999999999899999997654321 3457899999999994 555444333 22333 699999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCC-CCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~-~~~~kL~dfg~~~~~~~~~ 160 (318)
||+ +|+|.+++...+..+++..++.+.+||+.||.|||++|++||||||+|||+. . ++.+||+|||.+.......
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~---~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD---PSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe---CCCCeEEeccCcccccccccc
Confidence 999 9999999998665799999999999999999999999999999999999994 6 6999999999988765311
Q ss_pred CCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. ........||+.|+|||++.++ ...+++||||+||++.||+||++||... ......+..+.... ..| .
T Consensus 173 ~~----~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~-~~P--~ 243 (313)
T KOG0198|consen 173 TK----SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGRED-SLP--E 243 (313)
T ss_pred cc----ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccC-CCC--C
Confidence 11 1233467899999999999953 3456999999999999999999999863 11122222332222 122 4
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
++..+|...++++..|+..+|++|||+.++.++-..
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 556789999999999999999999999998886643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=318.19 Aligned_cols=250 Identities=24% Similarity=0.310 Sum_probs=204.1
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
-++|++++.||+|+||.||+|+-+.+|..+|+|++++.. .......|-.+|.. ...+.++.+++.+++..+.|+
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~-~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE-VDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh-cCCCcEEEEEEEecCCCeeEE
Confidence 478999999999999999999999999999999987653 23456778888887 556888899999999999999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
||||. ||++..++... ..+++..++.++.+++.|+..+|+.|++||||||+|+|+ |..|.+||+|||+|..+...
T Consensus 219 iMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee---cCCCCEeeccccccchhhhh
Confidence 99999 99999999874 459999999999999999999999999999999999999 79999999999998643210
Q ss_pred C--------------CCccccccCC--------------------------CCCcccccccccccccCCCCCCcchHHHH
Q 021053 160 T--------------TNRHIPYREN--------------------------KNLTGTARYASCNTHLGIEQSRRDDLESL 199 (318)
Q Consensus 160 ~--------------~~~~~~~~~~--------------------------~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl 199 (318)
. .....+...+ -..+|||.|+|||++.+..|+..+|+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0 0000000011 12479999999999999999999999999
Q ss_pred HHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCC
Q 021053 200 GYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265 (318)
Q Consensus 200 G~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~ 265 (318)
|||+|||+.|-+||.+.++.+....+..-. ..+..|.+. ..+++.++||.+|+. ||++|..
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr-~~l~fP~~~---~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWR-ETLKFPEEV---DLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHh-hhccCCCcC---cccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999887754443333221 224455443 556889999999999 9999975
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=324.35 Aligned_cols=246 Identities=23% Similarity=0.320 Sum_probs=211.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
+-|++++.||.|+.|.|-+|++-.||+.+|||++..... ...+.+|+.+++.+.|++ +..++....+..++|+|
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~Hpn-Vl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPN-VLRLYDVWENKQHLYLV 90 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCC-eeeeeeeeccCceEEEE
Confidence 458999999999999999999999999999998765522 346788999999888855 55555666777899999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
+||+ +|.|.+++.+ .+++++.++.++++||+.|+.|+|..+|+||||||+|+|+ |..+++||+|||.|.......
T Consensus 91 lEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EEecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh---hcccCEeeeccceeecccCCc
Confidence 9999 9999999988 4569999999999999999999999999999999999999 688889999999998654433
Q ss_pred CCccccccCCCCCcccccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
. ....+|+++|.|||++.|.+| +.++||||+|||||.++||+.||.+.+- ...+.++.......|
T Consensus 167 l--------LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLlKV~~G~f~MP--- 232 (786)
T KOG0588|consen 167 L--------LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLLKVQRGVFEMP--- 232 (786)
T ss_pred c--------ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHHHHHcCcccCC---
Confidence 2 245689999999999999997 6899999999999999999999986554 566777777666666
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
..+|.+..+|+..+++.||++|.|.+++.++-
T Consensus 233 --s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 233 --SNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred --CcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 56799999999999999999999999888753
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-47 Score=315.90 Aligned_cols=290 Identities=19% Similarity=0.249 Sum_probs=222.7
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCC-----CCCeeeeccccC
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS-----GIPNIKWYGVDG 75 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~-----~~~~i~~~~~~~ 75 (318)
.+++.+||.+...+|+|+||.|-.+.|.+++..||||++++... .+...-|+.+++++.++. -+..+..++...
T Consensus 84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 57889999999999999999999999999999999999887654 456777999999995432 234446778888
Q ss_pred cceEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCC--------------
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-------------- 140 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~-------------- 140 (318)
++.|||+|.+|.|+.+++...+ .+++..+++.+++|++.++.+||+.+++|.||||+||++..++
T Consensus 164 ghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 164 GHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred CceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 9999999999999999998633 3589999999999999999999999999999999999997321
Q ss_pred ---CCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchh
Q 021053 141 ---KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (318)
Q Consensus 141 ---~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~ 217 (318)
....++|+|||++....... ...+.|.+|+|||++.+..|+..+||||+||||+|++||...|++.+
T Consensus 244 r~~ks~~I~vIDFGsAtf~~e~h----------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDHEHH----------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred ccCCCcceEEEecCCcceeccCc----------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 14568999999998655433 24577999999999999999999999999999999999999999988
Q ss_pred HhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCC--CChHHHHHHHHHH------HHhcCCchhHHHh
Q 021053 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR--PDYGFLKRLFHDL------FSREGSLLLQFIM 289 (318)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R--p~~~~l~~~l~~~------~~~~~~~~~~~~l 289 (318)
+.++..++++|++ +.|.......-..+...--..-|.....+| -...+..+.+... ...+.++++++||
T Consensus 314 n~EHLaMMerIlG---p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL 390 (415)
T KOG0671|consen 314 NLEHLAMMERILG---PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRML 390 (415)
T ss_pred cHHHHHHHHHhhC---CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHH
Confidence 8788888888765 444444322212111111112222222333 1111122222222 2223478999999
Q ss_pred hhcCCccccccccee
Q 021053 290 SYCSLHSITFQTNII 304 (318)
Q Consensus 290 ~~~p~~r~t~~~~~~ 304 (318)
.+||++|+|+.||+.
T Consensus 391 ~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 391 EFDPARRITLREALS 405 (415)
T ss_pred ccCccccccHHHHhc
Confidence 999999999999986
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=320.31 Aligned_cols=245 Identities=23% Similarity=0.316 Sum_probs=209.6
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+..+. .+..+|+++++.++|+ ++..+...+....+.++|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHp-niv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHP-NIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCc-chhhHHHhhcccceEEEEe
Confidence 5799999999999999999999999999999987765443 3688999999999984 4555555556777999999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
||+.|+|..++.. ...++++.+..++.+++.||.|||+.+|+|||+||+||++ +..+.+|++|||+++.......
T Consensus 81 e~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~- 155 (808)
T KOG0597|consen 81 EYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTS- 155 (808)
T ss_pred hhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee---cCCCceeechhhhhhhcccCce-
Confidence 9998899999987 5669999999999999999999999999999999999999 5999999999999987654332
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
......||+.|||||+..+.+|+..+|+||+||++||+++|++||... +..+.+..|......+|.
T Consensus 156 ------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv~~I~~d~v~~p~----- 221 (808)
T KOG0597|consen 156 ------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLVKSILKDPVKPPS----- 221 (808)
T ss_pred ------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHHHHHhcCCCCCcc-----
Confidence 235678999999999999999999999999999999999999999764 335566666655555443
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+..+..++...|.+||.+|.+...+..
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 55789999999999999999998876554
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=304.26 Aligned_cols=257 Identities=20% Similarity=0.286 Sum_probs=208.9
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
..+.|++...||.|..++||+|+...++..||||+++-+. ....+.+|+..+..+.| +|+......+......|+|
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~H-PNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDH-PNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCC-CCcceEEEEEEecceeEEe
Confidence 4578999999999999999999999999999999876443 34568899999987766 6666777777778899999
Q ss_pred Eecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 82 LDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
|++| +||+.+++... ..++++..++.+++++++||.|||.+|-||||||+.|||+ +++|.+||+|||.+..+...
T Consensus 103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI---DSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE---cCCCcEEEcCceeeeeeccc
Confidence 9999 99999998764 4469999999999999999999999999999999999999 69999999999998876654
Q ss_pred CCCccccccCCCCCcccccccccccccCC--CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc---
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS--- 234 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~--- 234 (318)
..... ++. ....+++.|+|||++... .|+.|+||||||++..|+.+|+.||..+.+. +.+...++...+
T Consensus 180 G~R~~--~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm---kvLl~tLqn~pp~~~ 253 (516)
T KOG0582|consen 180 GDRQV--TRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM---KVLLLTLQNDPPTLL 253 (516)
T ss_pred Cceee--Eee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH---HHHHHHhcCCCCCcc
Confidence 42221 222 567899999999995533 4999999999999999999999999887653 222222222222
Q ss_pred --CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 235 --TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 235 --~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.........++..+++++..||..||.+|||+.++.+
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 1122334466778999999999999999999997765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=315.62 Aligned_cols=262 Identities=19% Similarity=0.323 Sum_probs=201.4
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeee-ccc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKW-YGV 73 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~-~~~ 73 (318)
++-.++|++.+.||.|+||.||+|.+. .++..||+|++..... ...+.+|+.++..+.+|+++..+.. +..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 455689999999999999999999753 3456899998865432 2357889999999966677766654 444
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhc-------------------------------------------------------
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCR------------------------------------------------------- 97 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~------------------------------------------------------- 97 (318)
.....+++|||+ +++|.+++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 455689999999 899999887531
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCC
Q 021053 98 ------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171 (318)
Q Consensus 98 ------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~ 171 (318)
..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++........ ....
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~kl~DfG~a~~~~~~~~~-----~~~~ 234 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----VRKG 234 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcEEEeecccccccccCcch-----hccc
Confidence 236677888999999999999999999999999999999 47889999999998764322111 1112
Q ss_pred CCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHH
Q 021053 172 NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFAS 250 (318)
Q Consensus 172 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 250 (318)
...++..|+|||++.+..++.++|||||||++|+|++ |..||.+..... .....+.. ..... .....++.+.+
T Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~-~~~~~---~~~~~~~~l~~ 308 (338)
T cd05102 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQRLKD-GTRMR---APENATPEIYR 308 (338)
T ss_pred CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHhc-CCCCC---CCCCCCHHHHH
Confidence 3345678999999999899999999999999999997 999998744321 11111111 11111 12356788999
Q ss_pred HHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 251 YFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 251 li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
++..||..+|++||++.++.+.|++++.
T Consensus 309 li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 309 IMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=305.94 Aligned_cols=276 Identities=23% Similarity=0.294 Sum_probs=202.2
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
++|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+|+.++..++| +++..+..++......++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH-ANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCC-CCEeeEEEEEcCCCeEEEEEe
Confidence 57999999999999999999999999999999876432 23357789999999976 556666666667778999999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
++.++|.+++......++...+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+........
T Consensus 84 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 84 YLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred CCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEECcCcceeeccCCCc--
Confidence 99889999987755568899999999999999999999999999999999999 4889999999999876433221
Q ss_pred cccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
......++..|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..... ..+... ...|....+.
T Consensus 159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~-~~~~~~~~~~ 229 (288)
T cd07871 159 -----TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL---HLIFRL-LGTPTEETWP 229 (288)
T ss_pred -----cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHH-hCCCChHHhh
Confidence 1123467889999998875 45899999999999999999999999876554333 333322 2333333222
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCchhHHHhhhcCCccccccccee
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
... ...++.... .|..++.. ...... -++.+..+++++||++||.+|+|+.+.+.
T Consensus 230 ~~~-~~~~~~~~~---~~~~~~~~--~~~~~~-~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 230 GIT-SNEEFRSYL---FPQYRAQP--LINHAP-RLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccc-cchhhhccc---cCccCCCc--hHHhCC-CCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 221 011111111 12222111 111111 12445578899999999999999888764
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=306.86 Aligned_cols=201 Identities=24% Similarity=0.348 Sum_probs=169.6
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
.++|++.+.||.|+||.||+|++..+++.||+|++..... .....+|+.+++.+.| +++..+..+.......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKH-ANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCC-CCcCeEEEEEecCCeEEEEE
Confidence 4789999999999999999999999999999998764332 2356789999999976 55666666666777899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
||+.++|.+++......+++..+..++.|++.||.|||++||+||||||+||++ ++.+.+||+|||.+........
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 83 EYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI---SDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred ECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECCCCcceeccCCCc-
Confidence 999999999988755668999999999999999999999999999999999999 4889999999999875433221
Q ss_pred ccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~ 217 (318)
......+++.|+|||++.+. .++.++||||+||++|+|++|..||.+..
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 208 (303)
T cd07869 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMK 208 (303)
T ss_pred ------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 11234678899999998754 58889999999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=320.21 Aligned_cols=243 Identities=23% Similarity=0.349 Sum_probs=208.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+--++|.+.+.||.|+||+|++|..+.+++.+|||++++.. ..+....|..++.....||.+..+..+++...+.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34478999999999999999999999999999999988654 3446788999999999889999999999999999
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+||||. ||++....+ ...+++..++.|+..++.||.|||++|||+||||.+|||+ |..|.+||+|||+|+...
T Consensus 445 ~fvmey~~Ggdm~~~~~--~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH--TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGM 519 (694)
T ss_pred EEEEEecCCCcEEEEEe--cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE---cccCcEEecccccccccC
Confidence 9999999 666332222 3569999999999999999999999999999999999999 799999999999998755
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
.... ......||+.|+|||++.+..|+.++|+|||||++|||+.|+.||.+.+. .+.++.|.......|
T Consensus 520 ~~g~-------~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE---ee~FdsI~~d~~~yP- 588 (694)
T KOG0694|consen 520 GQGD-------RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE---EEVFDSIVNDEVRYP- 588 (694)
T ss_pred CCCC-------ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHhcCCCCCC-
Confidence 3332 23577999999999999999999999999999999999999999998665 455666665444444
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCCh
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 266 (318)
..++.+...+++.+|.++|++|...
T Consensus 589 ----~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 589 ----RFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CcccHHHHHHHHHHhccCcccccCC
Confidence 4568899999999999999999755
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=288.65 Aligned_cols=267 Identities=19% Similarity=0.213 Sum_probs=212.0
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC--CCChhHHHHHHHHHHHcCCCCCCeeeec----cccCc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWY----GVDGE 76 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~i~~~----~~~~~ 76 (318)
.|.++||++.+.||.|||+.||+++...++..+|+|.+... ...+...+|+...+++++++.+..+... .....
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 36689999999999999999999999999999999965543 3456789999999999996665554322 22334
Q ss_pred ceEEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeeccCCCCCeEEEEec
Q 021053 77 DNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDF 150 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~kL~df 150 (318)
..|++++|+ .|||.+.+... +..+++.++..++.++++||.+||+.. .+||||||.||+++ +.+.++|.||
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls---~~~~~vl~D~ 173 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLS---DSGLPVLMDL 173 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEec---CCCceEEEec
Confidence 589999999 99999998865 234899999999999999999999999 99999999999996 6899999999
Q ss_pred cceeeecCCCCC--ccccccCCCCCccccccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHH
Q 021053 151 GLAKKYRDPTTN--RHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY 225 (318)
Q Consensus 151 g~~~~~~~~~~~--~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~ 225 (318)
|++........+ .....+......+|..|+|||++. ++..+.++|||||||++|.|+.|.-||..... ......
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSla 252 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLA 252 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEE
Confidence 998765432211 111222334557899999999886 44578999999999999999999999976433 122223
Q ss_pred HHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 226 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
..+.......|... .+|+.+.++++.|+..||.+||++.++...+.++
T Consensus 253 LAv~n~q~s~P~~~---~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 LAVQNAQISIPNSS---RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred EeeeccccccCCCC---CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 34444555555443 5889999999999999999999999999988876
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=316.21 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=210.8
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeec--CCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
..|....+||+|+.|.||.|....+++.||||.+. .....+-..+|+.+++..+|.+.+..+..|... ...+.||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEee
Confidence 57888999999999999999999999999999755 444566789999999999886666555555444 789999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+ +|+|.+.+.. ..+++.+++.+++++++||.|||.+||+|||||.+|||++ .++.+||+|||+|.........
T Consensus 352 m~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~---~~g~vKltDFGFcaqi~~~~~K- 425 (550)
T KOG0578|consen 352 MEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT---MDGSVKLTDFGFCAQISEEQSK- 425 (550)
T ss_pred cCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec---cCCcEEEeeeeeeeccccccCc-
Confidence 9 8999999885 3489999999999999999999999999999999999995 8899999999999988766653
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhc
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (318)
....+||+.|||||+.....|++++||||||+++.||+.|++||..+++-. .+..|. ....|.-..+..
T Consensus 426 ------R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr---AlyLIa--~ng~P~lk~~~k 494 (550)
T KOG0578|consen 426 ------RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR---ALYLIA--TNGTPKLKNPEK 494 (550)
T ss_pred ------cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH---HHHHHh--hcCCCCcCCccc
Confidence 357899999999999999999999999999999999999999998766542 222222 223343344567
Q ss_pred CchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 244 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
++..+++++.+||..|+++|+++.+|.++
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 88999999999999999999999988774
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=303.90 Aligned_cols=204 Identities=24% Similarity=0.347 Sum_probs=169.5
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.++..++| +++..+..+.......++||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQ-ENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCC-ccccchhhhEecCCEEEEEE
Confidence 579999999999999999999999999999998765422 2356789999999977 45555655556677899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
||+.+++.+.+......+++..++.++.|++.||.|||+.|++||||||+||++ +.++.+||+|||.+.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccCcccccccccc
Confidence 999666666666545568999999999999999999999999999999999999 48889999999998765432211
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 220 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~ 220 (318)
......++..|+|||++.+..++.++|||||||++|+|++|++||.+.+..+
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~ 208 (287)
T cd07848 157 ------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEID 208 (287)
T ss_pred ------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 1123467889999999998889999999999999999999999998765443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=308.81 Aligned_cols=240 Identities=22% Similarity=0.288 Sum_probs=197.5
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+|++.+.||.|+||.||+|++..+++.||+|++... .....+..|..++..+.+++++..+..++......|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999987643 223356778888888888888888877777778899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCC
Confidence 999 8899888876 3458999999999999999999999999999999999999 4789999999999864322111
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
......|++.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.. ..+..+....... .
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~~-----~ 221 (324)
T cd05587 157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSIMEHNVSY-----P 221 (324)
T ss_pred -------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCC-----C
Confidence 112446889999999999999999999999999999999999999875543 2333333322222 2
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCCh
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~ 266 (318)
..++..+.+++.+||..+|.+|++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 3567889999999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=310.75 Aligned_cols=247 Identities=21% Similarity=0.304 Sum_probs=205.8
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
...|...+.||.|.||.||+|.+..+++.||+|++.-.. ..++..+|+.++.++++ +++...+.....+...+++|
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~-~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDS-PNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCc-chHHhhhhheeecccHHHHH
Confidence 356888899999999999999999999999999876543 33478899999999987 44444444445667899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
||| +|++.+.+.. +..+++..+..++++++.||.|+|+++.+|||||+.||+++ ..|.+||+|||.+........
T Consensus 91 ey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s---~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS---ESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe---ccCcEEEEecceeeeeechhh
Confidence 999 8999999986 33348888889999999999999999999999999999996 669999999999988776544
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
. ...+.||+.|||||++.+..|+.++||||||++.+||.+|.+|+...++.... -.....+++.+.
T Consensus 167 r-------r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-------flIpk~~PP~L~ 232 (467)
T KOG0201|consen 167 R-------RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-------FLIPKSAPPRLD 232 (467)
T ss_pred c-------cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-------EeccCCCCCccc
Confidence 2 25779999999999999889999999999999999999999999987763111 111122233333
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+++.+++++..||++||+.||++.++.+
T Consensus 233 ~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 233 GDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 488989999999999999999999998877
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=305.30 Aligned_cols=242 Identities=24% Similarity=0.339 Sum_probs=197.3
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+|+.++..+.| +++..+.....+....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH-PFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCC-CcHhhhHhhhccCCeEEEE
Confidence 47999999999999999999999999999999875432 22356789999999977 5555565666677789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +++|.+++.. .+.+++.....++.|++.||.|||++|++||||||+||++ +.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~~ 155 (291)
T cd05612 80 MEYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL---DKEGHIKLTDFGFAKKLRDRT 155 (291)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEEecCcchhccCCc
Confidence 9999 8899999876 4458999999999999999999999999999999999999 488999999999987653321
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......|
T Consensus 156 ----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~---- 218 (291)
T cd05612 156 ----------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYEKILAGKLEFP---- 218 (291)
T ss_pred ----------ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCcCCC----
Confidence 1346789999999999888999999999999999999999999875543 23333333332222
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCC-----hHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~-----~~~l~~ 271 (318)
..++..+.+++++||..||.+||+ +.++.+
T Consensus 219 -~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 219 -RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred -ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 345778999999999999999995 665554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=312.27 Aligned_cols=279 Identities=17% Similarity=0.172 Sum_probs=206.8
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
..++|++.+.||.|+||.||+|.+..+++.||+|... .....+|+.+++.++| +++..+..++......++++++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~----~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ----RGGTATEAHILRAINH-PSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh----hhhhHHHHHHHHhCCC-CCCCCEeEEEEECCeeEEEEec
Confidence 3478999999999999999999999999999999653 2346889999999987 5566666666667789999999
Q ss_pred cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 85 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
+.++|..++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +..+.+||+|||++.........
T Consensus 165 ~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~~-- 238 (391)
T PHA03212 165 YKTDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI---NHPGDVCLGDFGAACFPVDINAN-- 238 (391)
T ss_pred CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE---cCCCCEEEEeCCccccccccccc--
Confidence 99999888876 3458999999999999999999999999999999999999 48899999999998643222111
Q ss_pred ccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHh----hhHHHHHHHHHhhccCchHHH
Q 021053 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA----TKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~----~~~~~~~~i~~~~~~~~~~~~ 240 (318)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...... +....+..+.......| ..+
T Consensus 239 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p-~~~ 313 (391)
T PHA03212 239 ----KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHP-NEF 313 (391)
T ss_pred ----ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCCh-hhc
Confidence 112457899999999999989999999999999999999999887543211 11223333333332222 221
Q ss_pred hhcCchhHHHH---HHHHhhcCCCCCCChHHHHHHHHHHHHhcCCchhHHHhhhcCCccccccccee
Q 021053 241 CKSHPAEFASY---FHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 241 ~~~~~~~~~~l---i~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
.......+..+ ........|..||....+.. ...+..+++.+||.+||.+|+|+.|.+.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYE-----LPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhh-----hhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 11111112222 22333456667776554332 2334567899999999999999998775
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=307.52 Aligned_cols=255 Identities=22% Similarity=0.287 Sum_probs=193.6
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccc-----cCcce
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DGEDN 78 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~-----~~~~~ 78 (318)
+|++.+.||.|+||.||+|.+..++..||+|.+.... ....+.+|+.++..++|++ +..+..+.. .....
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD-IVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCC-EeeecceEeccCCCCCceE
Confidence 6999999999999999999999999999999876422 2235778999999998754 444432221 22358
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 79 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
|+|||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+.....
T Consensus 80 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 80 YVVFELMESDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA---NADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEEecCCCCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCcEEEccCcccccccc
Confidence 99999999999998876 3458999999999999999999999999999999999999 5889999999999875432
Q ss_pred CCCCccccccCCCCCcccccccccccccC--CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHH-------
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC------- 229 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~------- 229 (318)
..... .......++..|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+....
T Consensus 156 ~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (338)
T cd07859 156 DTPTA----IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET 231 (338)
T ss_pred ccCcc----ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 22111 01134568899999999876 568999999999999999999999997754432222111110
Q ss_pred ----------------HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 230 ----------------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 230 ----------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
....+.+........++.+.+++.+||..+|++||++.++.+
T Consensus 232 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 232 ISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 111112222222345677899999999999999999988776
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=310.02 Aligned_cols=250 Identities=21% Similarity=0.310 Sum_probs=200.8
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+|+.++..++| +++..+..++......|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS-EWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCC-CCCccEEEEEEcCCEEEEE
Confidence 47999999999999999999999999999999876432 22356789999998875 6666666666777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +..+.+||+|||++......
T Consensus 80 ~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~~- 154 (333)
T cd05600 80 MEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGLSKGIVTY- 154 (333)
T ss_pred EeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEEEeCcCCcccccc-
Confidence 9999 8899999876 3458999999999999999999999999999999999999 48899999999998755331
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch-HH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI-EV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~-~~ 239 (318)
.....+++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+.... .....|. ..
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~ 224 (333)
T cd05600 155 ---------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK-ETLQRPVYDD 224 (333)
T ss_pred ---------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc-ccccCCCCCc
Confidence 124468899999999998899999999999999999999999998765543322222111 1111111 10
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
....++..+.+++..||..+|.+||++.++.+.
T Consensus 225 ~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 225 PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 012457889999999999999999999988764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=299.10 Aligned_cols=203 Identities=22% Similarity=0.311 Sum_probs=164.5
Q ss_pred ceeeEeeeeccCcccEEEEEEEcC-CCcEEEEEeecCCCC----ChhHHHHHHHHHHHc--CCCCCCeeeecc-----cc
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTK----HPQLLYEAKVYKILQ--GGSGIPNIKWYG-----VD 74 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~-~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~--~~~~~~~i~~~~-----~~ 74 (318)
++|++.+.||+|+||.||+|++.. ++..||+|.+..... .....+|+.+++.+. .|+++..+..+. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 489999999999999999999864 467899998764332 235667888888775 345665554332 23
Q ss_pred CcceEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 75 GEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
....++|+|++.++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||.+
T Consensus 81 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~ 157 (290)
T cd07862 81 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLA 157 (290)
T ss_pred CCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccce
Confidence 45689999999999999987643 348899999999999999999999999999999999999 48899999999998
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhh
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 220 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~ 220 (318)
........ .....++..|+|||++.+..++.++|||||||++|+|++|.+||.+.++.+
T Consensus 158 ~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~ 216 (290)
T cd07862 158 RIYSFQMA--------LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 216 (290)
T ss_pred EeccCCcc--------cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 76543211 134467899999999998889999999999999999999999998765543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=308.62 Aligned_cols=238 Identities=23% Similarity=0.343 Sum_probs=196.2
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
.-++|++.+.||.|+||.||+|++..+++.||+|++.... ....+.+|+.++..+.| +++..+...+......+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH-PFIVNMMCSFQDENRVY 94 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEcCCEEE
Confidence 3478999999999999999999999999999999876432 23457889999999976 55666666666777899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
++|||+ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 95 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL---DNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE---CCCCCEEEeeccCceEcCC
Confidence 999999 8899998876 4458899999999999999999999999999999999999 5889999999999876543
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
.. ....|++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......|
T Consensus 171 ~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~~p-- 235 (329)
T PTZ00263 171 RT----------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF---RIYEKILAGRLKFP-- 235 (329)
T ss_pred Cc----------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH---HHHHHHhcCCcCCC--
Confidence 22 1346789999999999999999999999999999999999999875543 23333333332222
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCC
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPD 265 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~ 265 (318)
..++..+.+++..||..||.+||+
T Consensus 236 ---~~~~~~~~~li~~~L~~dP~~R~~ 259 (329)
T PTZ00263 236 ---NWFDGRARDLVKGLLQTDHTKRLG 259 (329)
T ss_pred ---CCCCHHHHHHHHHHhhcCHHHcCC
Confidence 346778999999999999999997
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=302.12 Aligned_cols=262 Identities=19% Similarity=0.277 Sum_probs=198.0
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcC----------------CCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCC
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVD----------------TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSG 64 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~----------------~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~ 64 (318)
+..++|++.+.||+|+||.||+|.+.. ++..||+|++...... ..+.+|+.++.+++| ++
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKD-PN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCC-CC
Confidence 557899999999999999999998642 3347999987754322 357889999999976 55
Q ss_pred CCeeeeccccCcceEEEEecc-CCCHHHHHHHhc------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 021053 65 IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR------------------RKFSLKTVLMLADQMIARIEYVHSRGFL 125 (318)
Q Consensus 65 ~~~i~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~------------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~ 125 (318)
+..+..++......+++|||+ +++|.+++.... ..+++.....++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 666666666667899999999 889999886531 1356778899999999999999999999
Q ss_pred ccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHH
Q 021053 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY 205 (318)
Q Consensus 126 H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~ 205 (318)
||||||+||++ +.++.+||+|||.+......... .......++..|+|||++.+..++.++|||||||++|+
T Consensus 161 H~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~e 232 (304)
T cd05096 161 HRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYY-----RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWE 232 (304)
T ss_pred ccCcchhheEE---cCCccEEECCCccceecccCcee-----EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHH
Confidence 99999999999 47899999999998765332211 01123345678999999988889999999999999999
Q ss_pred HHh--CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 206 FLR--GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 206 l~t--g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
|++ +..||...+..........................+|..+.+++.+||+.+|++||++.++.+.|+
T Consensus 233 l~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 233 ILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 987 678887755443332222211111111111112356788999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=300.34 Aligned_cols=248 Identities=19% Similarity=0.265 Sum_probs=195.2
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
.|++.+.||+|+||.||+|.+..+++.||+|.+.... ....+.+|+.++..+.|+ ++..+..........++++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~-~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR-FVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCC-cEEEEEEEEccCCeEEEEE
Confidence 3889999999999999999999999999999865432 123467899999999774 4555555555667899999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|++ +++|.+.+.... ..+++..+..++.|++.||.|||++||+||||||+||++ ++++.++|+|||++.......
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCC
Confidence 999 788987775433 358899999999999999999999999999999999999 588999999999987643221
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
. .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.... .......
T Consensus 157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~ 224 (285)
T cd05631 157 T--------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV----KEDQEEY 224 (285)
T ss_pred e--------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh----hcccccC
Confidence 1 123467899999999999999999999999999999999999998754332222222211 1222233
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCC-----hHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~-----~~~l~~ 271 (318)
...++..+.+++.+||..+|.+||+ ++++.+
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 4467889999999999999999997 565554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=319.37 Aligned_cols=283 Identities=19% Similarity=0.253 Sum_probs=197.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCC-----CCCeeeecc-ccCcc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS-----GIPNIKWYG-VDGED 77 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~-----~~~~i~~~~-~~~~~ 77 (318)
..++|++.+.||.|+||.||+|.+..+++.||||+++.... ......|+.+++.+++.. ++..+..++ ....+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~ 206 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH 206 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence 35789999999999999999999999999999999865322 234567888888887643 233343333 34467
Q ss_pred eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeeccCC-------------CCC
Q 021053 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGR-------------KAN 143 (318)
Q Consensus 78 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~Nil~~~~~-------------~~~ 143 (318)
.|+||++++++|.+++.. ...+++..+..++.||+.||.|||+ .||+||||||+|||+...+ +..
T Consensus 207 ~~iv~~~~g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 207 MCIVMPKYGPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred EEEEEeccCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 999999999999998876 3458999999999999999999998 5999999999999995211 112
Q ss_pred eEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHH
Q 021053 144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223 (318)
Q Consensus 144 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~ 223 (318)
.+||+|||.+...... .....+|+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+...
T Consensus 286 ~vkl~DfG~~~~~~~~----------~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~ 355 (467)
T PTZ00284 286 RVRICDLGGCCDERHS----------RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH 355 (467)
T ss_pred eEEECCCCccccCccc----------cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 5999999987542211 124578999999999999999999999999999999999999998766544343
Q ss_pred HHHHHHHhhccCchHHHhhcCc-hhHHHHHHHHhhcCCCCCCChHHHHHHH-----HHH-HHhcCCchhHHHhhhcCCcc
Q 021053 224 KYDKICEKKVSTPIEVLCKSHP-AEFASYFHYCQSLTFDQRPDYGFLKRLF-----HDL-FSREGSLLLQFIMSYCSLHS 296 (318)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~-~~~~~li~~cl~~~p~~Rp~~~~l~~~l-----~~~-~~~~~~~~~~~~l~~~p~~r 296 (318)
.+... ...++..+...+. ....++........|...|. .+.... .+. ......+|+++||++||.+|
T Consensus 356 ~i~~~----~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 356 LMEKT----LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPK--HLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred HHHHH----cCCCCHHHHhhccchhHHHHhhhcccccccCCHH--HHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 33332 2222233222211 11222222221222221111 111100 011 12334588899999999999
Q ss_pred ccccccee
Q 021053 297 ITFQTNII 304 (318)
Q Consensus 297 ~t~~~~~~ 304 (318)
+|+.+.+.
T Consensus 430 ~ta~e~L~ 437 (467)
T PTZ00284 430 LNARQMTT 437 (467)
T ss_pred CCHHHHhc
Confidence 99988774
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=301.62 Aligned_cols=257 Identities=21% Similarity=0.265 Sum_probs=203.8
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----------------ChhHHHHHHHHHHHcCCCCCC
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------------HPQLLYEAKVYKILQGGSGIP 66 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----------------~~~~~~e~~~l~~l~~~~~~~ 66 (318)
+..-++|++.+.||+|.||.|-+|++..+++.||||++.+... .+...+|+.+++++.| +|++
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H-~nVV 171 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH-PNVV 171 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC-cCee
Confidence 3445899999999999999999999999999999998764321 2367899999999988 5555
Q ss_pred eeeeccc--cCcceEEEEecc-CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCC
Q 021053 67 NIKWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (318)
Q Consensus 67 ~i~~~~~--~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~ 142 (318)
.+..+-. .....|||+||| .|.+... .. ..+ +++.+++.|+++++.||.|||..||+||||||.|+|++ +.
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w~-p~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~---~~ 246 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKWC-PP-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLS---SD 246 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCccccC-CC-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEc---CC
Confidence 5543333 456899999999 5554222 11 233 88999999999999999999999999999999999995 88
Q ss_pred CeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCC----CCCcchHHHHHHHHHHHHhCCCCccchhH
Q 021053 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (318)
Q Consensus 143 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~tg~~pf~~~~~ 218 (318)
+.+||+|||.+........... ........||+.|+|||...+.. .+.+.||||+||+||.|+.|+.||.+...
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~--d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGS--DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CcEEeeccceeeecccCCcccc--HHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 9999999999986633221111 01223468999999999887632 36789999999999999999999987543
Q ss_pred hhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 219 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
.+.+.+|.+..+..|... ...+.++++|.++|.+||++|.+..++..+.
T Consensus 325 ---~~l~~KIvn~pL~fP~~p---e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 325 ---LELFDKIVNDPLEFPENP---EINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ---HHHHHHHhcCcccCCCcc---cccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 677888887777766443 4567899999999999999999998877644
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=304.08 Aligned_cols=240 Identities=21% Similarity=0.305 Sum_probs=197.3
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+|++.+.||+|+||.||+|++..+++.||+|++..... ......|..++..+.+++++..+..++......++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999998764321 1235667777877878888888877777888899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
||+ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE---CCCCcEEEccCCCceecCCCCC
Confidence 999 8899888876 3458999999999999999999999999999999999999 5889999999999875432211
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.. ..+..+.......|
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~~~~~~~p----- 221 (323)
T cd05616 157 -------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIMEHNVAYP----- 221 (323)
T ss_pred -------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-----
Confidence 112446889999999999999999999999999999999999999876543 33334443333222
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCCh
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~ 266 (318)
..++..+.+++.+||..+|++|++.
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 3567889999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=307.20 Aligned_cols=258 Identities=20% Similarity=0.330 Sum_probs=201.4
Q ss_pred cceeeEeeeeccCcccEEEEEEEcC-----CCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
.++|++++.||.|+||.||+|.+.. ++..||+|.+..... ...+.+|+.+++.+.+|++++.+..++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 4679999999999999999998643 335799998875433 23577899999999666777777777777788
Q ss_pred eEEEEecc-CCCHHHHHHHhc-----------------------------------------------------------
Q 021053 78 NVLVLDLL-GPSLEDLFVYCR----------------------------------------------------------- 97 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~----------------------------------------------------------- 97 (318)
.++||||+ +++|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999 899999886421
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccccc
Q 021053 98 ----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (318)
Q Consensus 98 ----------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 167 (318)
..+++..+..++.||+.||.|||++|++||||||+||++ ++++.+||+|||++.........
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~---~~~~~~kL~DfGla~~~~~~~~~----- 268 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL---TDGRVAKICDFGLARDIMNDSNY----- 268 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE---eCCCeEEEeeceeeeeccCCcce-----
Confidence 136778889999999999999999999999999999999 47889999999998765432211
Q ss_pred cCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCch
Q 021053 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (318)
Q Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (318)
.......++..|+|||++.+..++.++|||||||++|+|++ |+.||....... .+..........+ .....|+
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---~~~~~~~~~~~~~---~~~~~~~ 342 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---KFYKMVKRGYQMS---RPDFAPP 342 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---HHHHHHHcccCcc---CCCCCCH
Confidence 01122234567999999998889999999999999999998 999998754322 1112222111111 1124578
Q ss_pred hHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 247 EFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 247 ~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
.+.+++..||..+|++||++.++.+.|++++
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 8999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=305.84 Aligned_cols=239 Identities=21% Similarity=0.292 Sum_probs=192.1
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||+|+||.||+|++..+++.||+|++.... ......+|+.++..+.| +++..+..++......++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRH-PFLTALKYSFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCCCEEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999876432 22356778899998876 55666666667777899999999 8
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~----- 150 (323)
T cd05571 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCC-----
Confidence 899888876 4568999999999999999999999999999999999999 5889999999999865322211
Q ss_pred ccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCch
Q 021053 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (318)
......|++.|+|||++.+..++.++||||+||++|+|++|..||...+.. .....+....... ...++.
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~~~~~~~~~-----p~~~~~ 220 (323)
T cd05571 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMEEIRF-----PRTLSP 220 (323)
T ss_pred --cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHHHHHcCCCCC-----CCCCCH
Confidence 123456899999999999999999999999999999999999999765432 2222332222222 245688
Q ss_pred hHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 247 EFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 247 ~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
.+.+++..||..||++|| ++.++.+
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 999999999999999999 6776654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=293.31 Aligned_cols=256 Identities=14% Similarity=0.237 Sum_probs=202.2
Q ss_pred cccceeeEeeeeccCcccEEEEEEEc---CCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~---~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
+-.++|++.+.||+|+||.||+|.+. ..+..||+|.++..... ..+.+|+..+..++| +++..+..++.....
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDH-SNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEecCCC
Confidence 45678999999999999999999875 44678999988765322 356789999988866 566666666667788
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++||||+ +++|.+++......+++..+..++.|++.||.|||++|++||||||+||++ +.++.++++|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili---~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV---NSDLVCKISGFRRLQED 157 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE---cCCCcEEECCCcccccc
Confidence 99999999 778988887655568999999999999999999999999999999999999 48889999999986543
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
...... ......++..|+|||.+.+..++.++|||||||++|++++ |..||...+.... ...+.. ....
T Consensus 158 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~~-~~~~ 227 (266)
T cd05064 158 KSEAIY------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKAVED-GFRL 227 (266)
T ss_pred cccchh------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHHHC-CCCC
Confidence 221110 1112234568999999998899999999999999999875 9999987655432 222221 2222
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
+. ...+|..+.+++..||..+|++||++.++.+.|+++
T Consensus 228 ~~---~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 228 PA---PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CC---CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 21 245788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=312.36 Aligned_cols=253 Identities=22% Similarity=0.251 Sum_probs=192.4
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccc-------cCc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-------DGE 76 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~-------~~~ 76 (318)
...++|++++.||.|+||.||+|.+..+++.||||.+.... ....+|+.+++.++|++.+.....+.. ...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~--~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP--QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc--chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 34578999999999999999999999999999999775432 234579999999987555443332211 122
Q ss_pred ceEEEEeccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 77 DNVLVLDLLGPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 77 ~~~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
..++||||+.+++.+++... ...+++..++.++.||+.||.|||++||+||||||+||++. ...+.+||+|||++
T Consensus 141 ~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla 218 (440)
T PTZ00036 141 FLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSA 218 (440)
T ss_pred EEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEc--CCCCceeeeccccc
Confidence 46799999988998887642 34588999999999999999999999999999999999994 23457999999999
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~ 232 (318)
........ .....+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 219 ~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~--- 287 (440)
T PTZ00036 219 KNLLAGQR--------SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVL--- 287 (440)
T ss_pred hhccCCCC--------cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh---
Confidence 76543221 1234678999999998764 58999999999999999999999998765543333322211
Q ss_pred ccCchH------------------------HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 233 VSTPIE------------------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 233 ~~~~~~------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..++.+ .+....|.++.+++.+||..+|.+||++.++.+
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 111110 112235678999999999999999999998764
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=296.97 Aligned_cols=247 Identities=22% Similarity=0.344 Sum_probs=211.3
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
+..||++.+.||.|.||.|-+|.....|+.||||.+.++.- .-.+.+|++++..|+| ++|..|+..+.+....+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNH-PhII~IyEVFENkdKIv 129 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNH-PHIIQIYEVFENKDKIV 129 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCC-CceeehhhhhcCCceEE
Confidence 35689999999999999999999999999999997665432 2367899999999987 67778888888888999
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
|||||. +|.|++++.+++ .+++.+++.+++||++|+.|+|.++++|||||.+|||+ |.++++||+|||++-....
T Consensus 130 ivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL---D~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 130 IVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL---DQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhccceecccchhheee---cCCCCeeeeccchhhhhcc
Confidence 999999 999999999854 59999999999999999999999999999999999999 7999999999999866543
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
.. ..+.++|++.|.+||++.|.+| ++.+|-||||++||-++.|.+||.+.+. ..++..|.......|
T Consensus 206 ~k--------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQIs~GaYrEP- 273 (668)
T KOG0611|consen 206 KK--------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQISRGAYREP- 273 (668)
T ss_pred cc--------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHHhhcccccCC-
Confidence 33 3457799999999999999997 7899999999999999999999998654 344444444443333
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
..|.+..-||+.+|-.||++|.|++++..+.
T Consensus 274 -----~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 -----ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -----CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 3356788999999999999999999887765
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=306.54 Aligned_cols=250 Identities=22% Similarity=0.284 Sum_probs=211.9
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
.++|+.++++|.|+||.+++++++.++..+|+|.+.-.. ....+.+|+.++.+++|++.+.....+..++...+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 368999999999999999999999999999999765332 2336889999999988765555555555565569999
Q ss_pred Eecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
|+|| +|++.+.+...+ ..+++..+..|+.|++.|+.|||+++|+|||||+.|||++ .+..++|+|||+++....+
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt---k~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT---KDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc---ccCceeecchhhhhhcCCc
Confidence 9999 999999998765 4589999999999999999999999999999999999996 7788899999999988766
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. ......||+.|++||++.+.+|+.|+|||||||++|||++-+++|...+. .....+|...... |.+
T Consensus 160 ~~-------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---~~Li~ki~~~~~~-Plp- 227 (426)
T KOG0589|consen 160 DS-------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---SELILKINRGLYS-PLP- 227 (426)
T ss_pred hh-------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---HHHHHHHhhccCC-CCC-
Confidence 52 23567999999999999999999999999999999999999999988654 4556666655532 322
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
..++.+++.+|+.|+..+|+.||++.++...
T Consensus 228 --~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 228 --SMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --ccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 3567899999999999999999999998877
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=301.80 Aligned_cols=240 Identities=22% Similarity=0.310 Sum_probs=197.7
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+|++.+.||.|+||.||+|.+..+++.||+|++.... .......|..++..+.|++++..+..++......|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4788999999999999999999999999999876431 22346678888888888888888877777778899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
||+ +++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++........
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeccccccccCCCCc
Confidence 999 8899888875 3458999999999999999999999999999999999999 5889999999999875432221
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.. .....+.......|
T Consensus 157 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~~~~~~~p----- 221 (323)
T cd05615 157 -------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSIMEHNVSYP----- 221 (323)
T ss_pred -------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-----
Confidence 113446889999999999888999999999999999999999999876543 33334443333222
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCCh
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~ 266 (318)
..++..+.+++.+||..+|.+|++.
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCC
Confidence 3567889999999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=297.53 Aligned_cols=205 Identities=24% Similarity=0.356 Sum_probs=170.0
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
++|.+.+.||.|+||.||+|.+..+++.||+|.+.... ......+|+.++..++| +++..+..+.......++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCC-CCcceEEEEEeeCCeEEEEEe
Confidence 67999999999999999999999999999999876432 22356789999999976 556666666666778999999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
|+.++|.+++......++...+..++.|++.||.|||++||+||||||+||++ +..+.+||+|||.+.........
T Consensus 85 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~- 160 (309)
T cd07872 85 YLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSVPTKT- 160 (309)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECccccceecCCCccc-
Confidence 99889999987765668899999999999999999999999999999999999 48899999999998754332221
Q ss_pred cccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhH
Q 021053 164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK 222 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~ 222 (318)
.....++..|+|||++.+ ..++.++||||+||++|+|+||++||.+.+..+..
T Consensus 161 ------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 214 (309)
T cd07872 161 ------YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL 214 (309)
T ss_pred ------cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 123456889999998865 45889999999999999999999999876554333
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=275.49 Aligned_cols=247 Identities=24% Similarity=0.327 Sum_probs=213.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+--++|++++.||.|-||.||+|+.++++-.||+|++.+.. ...++.+|+++...|+| ++|..++.++-+....
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~h-pnilrlY~~fhd~~ri 97 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRH-PNILRLYGYFHDSKRI 97 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCC-ccHHhhhhheecccee
Confidence 34478999999999999999999999999999999865432 34468889999999987 6666777888888899
Q ss_pred EEEEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 79 VLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
|+++||. .|++...+... ...+++.....++.|++.||.|+|.++|+||||||+|+|++ ..+.+|++|||.+...
T Consensus 98 yLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg---~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 98 YLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLG---SAGELKIADFGWSVHA 174 (281)
T ss_pred EEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccC---CCCCeeccCCCceeec
Confidence 9999999 89998888843 33499999999999999999999999999999999999995 9999999999998764
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
. +. ......||..|++||+..+...+..+|+|++|++.||++.|.+||...+ ..+.+.+|.......|
T Consensus 175 p--~~-------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~~~~p 242 (281)
T KOG0580|consen 175 P--SN-------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVDLKFP 242 (281)
T ss_pred C--CC-------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHccccCC
Confidence 3 22 3456789999999999999999999999999999999999999998755 4667777777676666
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..++....++|+.|+..+|.+|....++..
T Consensus 243 -----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 243 -----STISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -----cccChhHHHHHHHHhccCccccccHHHHhh
Confidence 467889999999999999999998887655
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=308.23 Aligned_cols=260 Identities=22% Similarity=0.295 Sum_probs=205.8
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+|..+...++..||+|.||+||+|++.+ .||||+++-.... +.|.+|+.++++-+|. |+..+..+.-....
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~-NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHE-NILLFMGACMNPPL- 462 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchh-hheeeehhhcCCce-
Confidence 4566778899999999999999999965 4999988765443 4688899999998874 45555555444444
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
.||+.+| +.+|+.+++-....|+......|++||++|+.|||.++|||+|||..|||+ .+++.+||+|||++....
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE---ccCCcEEEecccceeeee
Confidence 8999999 778999998777779999999999999999999999999999999999999 477999999999986543
Q ss_pred CCCCCccccccCCCCCccccccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
--... .......+...|+|||++. ..+|++.+|||||||++|||++|..||...+... .+..+-...+.
T Consensus 540 ~w~g~-----~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq---IifmVGrG~l~ 611 (678)
T KOG0193|consen 540 RWSGE-----QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ---IIFMVGRGYLM 611 (678)
T ss_pred eeccc-----cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh---eEEEecccccC
Confidence 22111 1224557788999999886 3368999999999999999999999999543322 22222233334
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
+.........|.++++|+..||..++++||.+.+|...|+.+..
T Consensus 612 pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 612 PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 44455556788899999999999999999999999998887643
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=303.85 Aligned_cols=246 Identities=24% Similarity=0.315 Sum_probs=198.9
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCC-cEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN-EIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~-~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
+.-++|++.+.||.|+||.||+|.+..++ ..||+|.+... .....+.+|+.++..++| +++..+..++.....
T Consensus 27 ~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 27 MKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH-PFCVNLYGSFKDESY 105 (340)
T ss_pred CChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCCcceEEEEEeCCE
Confidence 34578999999999999999999876554 68999976532 223456789999999976 566666666677788
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++||||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEecCCCCeec
Confidence 99999999 8899999876 4458999999999999999999999999999999999999 58899999999998765
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
.... ....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.++. ..+..+.......|
T Consensus 182 ~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~~i~~~~~~~p 248 (340)
T PTZ00426 182 DTRT----------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIYQKILEGIIYFP 248 (340)
T ss_pred CCCc----------ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHHHHHhcCCCCCC
Confidence 3221 2346889999999999888999999999999999999999999875543 23333433332222
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCC-----ChHHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKRL 272 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~l~~~ 272 (318)
..++..+.+++++||..+|.+|+ +++++.++
T Consensus 249 -----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 249 -----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred -----CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 34677899999999999999995 67776653
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=292.64 Aligned_cols=201 Identities=22% Similarity=0.323 Sum_probs=163.9
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHc--CCCCCCeeeeccc-----cCc
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQ--GGSGIPNIKWYGV-----DGE 76 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~--~~~~~~~i~~~~~-----~~~ 76 (318)
+|++.+.||.|+||.||+|.+..+++.||+|.+..... .....+|+.+++.+. .|+++..+..++. ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999998764322 234667888888775 3455555543322 234
Q ss_pred ceEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 77 DNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 77 ~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..++++|++.++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||.+..
T Consensus 81 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~ 157 (288)
T cd07863 81 KVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGQVKLADFGLARI 157 (288)
T ss_pred eEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccCcccc
Confidence 589999999889999887643 348999999999999999999999999999999999999 4889999999999876
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHh
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~ 219 (318)
...... .....++..|+|||++.+..++.++||||+||++|+|++|.+||.+....
T Consensus 158 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~ 213 (288)
T cd07863 158 YSCQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 213 (288)
T ss_pred ccCccc--------CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH
Confidence 542211 12345688999999999888999999999999999999999999775543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=299.53 Aligned_cols=255 Identities=18% Similarity=0.295 Sum_probs=198.6
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
+..++|++.+.||.|+||.||+|++..++..+|+|++..... ...+.+|+.++..++| +++..+..+.......++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECCEEEE
Confidence 567899999999999999999999999999999998765432 2357889999999976 556566555566678999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
||||+ +++|.+++.. ...+++..+..++.|++.||.|||++ +|+||||||+||++ +.++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred EeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE---cCCCcEEEccCcccccccc
Confidence 99999 7899999876 34588999999999999999999986 69999999999999 4888999999999875533
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHH-----------
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK----------- 227 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~----------- 227 (318)
... ....++..|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 157 ~~~---------~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (331)
T cd06649 157 SMA---------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227 (331)
T ss_pred ccc---------ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCcc
Confidence 221 234678999999999988899999999999999999999999975433211111000
Q ss_pred ----------------------------HHHhhccCc-hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 228 ----------------------------ICEKKVSTP-IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 228 ----------------------------i~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
........+ .......++.++.+++.+||..||++||++.++.+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 000011356789999999999999999999988764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=305.03 Aligned_cols=257 Identities=21% Similarity=0.325 Sum_probs=200.3
Q ss_pred cceeeEeeeeccCcccEEEEEEE-----cCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~-----~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
.++|++++.||.|+||.||+|.+ ..++..||+|+++.... ...+.+|+.++..+.+|+++..+..++.....
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45899999999999999999975 24566899998865432 23577899999999777888888777778888
Q ss_pred eEEEEecc-CCCHHHHHHHhc-----------------------------------------------------------
Q 021053 78 NVLVLDLL-GPSLEDLFVYCR----------------------------------------------------------- 97 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~----------------------------------------------------------- 97 (318)
.++||||+ +|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 99999999 899999886422
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 98 ---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 98 ---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
..+++..+..++.||+.||.|||++|++||||||+||+++ ..+.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~---~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEE---CCCcEEEecCccceeccCcccc
Confidence 1367778889999999999999999999999999999994 7889999999998765432211
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
. ......++..|+|||++.+..++.++|||||||++|+|++ |..||......... . ........... .
T Consensus 271 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~--~-~~~~~~~~~~~---~ 339 (375)
T cd05104 271 V-----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF--Y-KMIKEGYRMLS---P 339 (375)
T ss_pred c-----ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHH--H-HHHHhCccCCC---C
Confidence 0 1122334567999999999999999999999999999998 99999765332211 1 11111111111 1
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
...|.++.+++..||..+|++||++.++.+.|++.
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 23467899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=300.86 Aligned_cols=235 Identities=18% Similarity=0.289 Sum_probs=191.8
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||+|+||.||+|++..+++.||+|++... ........|..++..+.+|+++..+..++......|+||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4689999999999999999999999987642 122356678888888777788888877778888899999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++........
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~----- 151 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGK----- 151 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCC-----
Confidence 899888876 3458999999999999999999999999999999999999 4889999999999875322211
Q ss_pred ccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCch
Q 021053 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (318)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.. ..+..+.......| ..++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~~i~~~~~~~~-----~~~~~ 221 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAILNDEVVYP-----TWLSQ 221 (320)
T ss_pred --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHhcCCCCCC-----CCCCH
Confidence 112446899999999999888999999999999999999999999876543 23333333222222 34678
Q ss_pred hHHHHHHHHhhcCCCCCCCh
Q 021053 247 EFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 247 ~~~~li~~cl~~~p~~Rp~~ 266 (318)
.+.+++..||..||.+||++
T Consensus 222 ~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred HHHHHHHHHcccCHHHCCCC
Confidence 89999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=304.74 Aligned_cols=254 Identities=22% Similarity=0.299 Sum_probs=200.8
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEe-ecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-ENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~-~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
+-+..|+++++||.||.+.||+|..... +.||+|. .....+ ...+.+|+..|.+|+++..+..+.+|....+..|
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY 436 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY 436 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence 4578899999999999999999987544 4555553 322222 2468999999999999988989999988899999
Q ss_pred EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 80 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
+|||+-..+|..++.......+.-.++.+.+|++.|+.++|..||||.||||.|+|+ -.|.+||+|||.+.....+
T Consensus 437 mvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 437 MVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCcc
Confidence 999999999999999766555555888999999999999999999999999999999 7899999999999887766
Q ss_pred CCCccccccCCCCCcccccccccccccCCC-----------CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIE-----------QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----------~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i 228 (318)
++.. .....+||+.||+||.+.... .+.++||||||||||+|+.|++||..... ....+..|
T Consensus 513 TTsI-----~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~aI 585 (677)
T KOG0596|consen 513 TTSI-----VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLHAI 585 (677)
T ss_pred ccce-----eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHHhh
Confidence 6543 234678999999999876432 36789999999999999999999986532 23444444
Q ss_pred HHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..-.-..+.+... -+..+.++++.||.+||.+||+..++.+
T Consensus 586 ~~P~~~Iefp~~~--~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 586 TDPNHEIEFPDIP--ENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred cCCCccccccCCC--CchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 3211111111111 1123899999999999999999987765
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=283.61 Aligned_cols=254 Identities=24% Similarity=0.292 Sum_probs=211.4
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
..+.++|++.+.||+|.|+.|+++.+..+|+.+|+|+++.. ...+.+.+|+.+-+.|+| ++|..+..-.......
T Consensus 7 ~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqH-P~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 7 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFH 85 (355)
T ss_pred cccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCC-CcEeehhhhhccccee
Confidence 35778999999999999999999999999999999976533 245678889999999887 5566665555666789
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+|+|++ +++|-.-+.. +.-+++..+..+++||+.+|.|+|++||+|||+||.|+++-..+...-+||+|||++...+
T Consensus 86 ylvFe~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred EEEEecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999 7777655543 2447899999999999999999999999999999999999655566778999999999887
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
... ......||+.|+|||++...+|+..+||||.||+||-++.|.+||.+++. ...++.|.......|.
T Consensus 165 -~g~-------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rlye~I~~g~yd~~~ 233 (355)
T KOG0033|consen 165 -DGE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYEQIKAGAYDYPS 233 (355)
T ss_pred -Ccc-------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHHHHHHhccccCCCC
Confidence 222 23467899999999999999999999999999999999999999998544 4566666666665555
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~ 270 (318)
+. |..++++.++|+++||..||.+|.|+.+..
T Consensus 234 ~~-w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 234 PE-WDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred cc-cCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 44 468889999999999999999999988644
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=298.30 Aligned_cols=236 Identities=22% Similarity=0.315 Sum_probs=190.2
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||+|+||.||+|.+..+++.||+|+++... .......|..++....+|+++..+...+......++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999876432 22345567777776667788888777777778899999999 8
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~----- 151 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEG----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCC-----
Confidence 899888876 3458999999999999999999999999999999999999 4889999999999875432221
Q ss_pred ccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCch
Q 021053 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (318)
......||..|+|||++.+..++.++|||||||++|+|++|..||.+.+.. +.+..+...... ....++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~~i~~~~~~-----~~~~~~~ 221 (316)
T cd05592 152 --KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFDSILNDRPH-----FPRWISK 221 (316)
T ss_pred --ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCC-----CCCCCCH
Confidence 123456899999999999988999999999999999999999999876543 223333322211 1235678
Q ss_pred hHHHHHHHHhhcCCCCCCChH
Q 021053 247 EFASYFHYCQSLTFDQRPDYG 267 (318)
Q Consensus 247 ~~~~li~~cl~~~p~~Rp~~~ 267 (318)
.+.+++..||+.+|.+||++.
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~ 242 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVD 242 (316)
T ss_pred HHHHHHHHHccCCHHHcCCCh
Confidence 899999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=300.76 Aligned_cols=240 Identities=20% Similarity=0.289 Sum_probs=194.4
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||.|+||.||+|++..+++.||+|++.... ....+..|..++..+.+|+++..+..++......|+||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46899999999999999999999999876432 22346678888887777888888887778888899999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~----- 151 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGV----- 151 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEeecccceecccCCc-----
Confidence 899888875 4458999999999999999999999999999999999999 5889999999999875432221
Q ss_pred ccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCch
Q 021053 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (318)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.. ..+..+.......| ..++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~~i~~~~~~~p-----~~~~~ 221 (321)
T cd05591 152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFESILHDDVLYP-----VWLSK 221 (321)
T ss_pred --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCC-----CCCCH
Confidence 112346789999999999889999999999999999999999999876543 23334433222222 24578
Q ss_pred hHHHHHHHHhhcCCCCCC-------ChHHHHH
Q 021053 247 EFASYFHYCQSLTFDQRP-------DYGFLKR 271 (318)
Q Consensus 247 ~~~~li~~cl~~~p~~Rp-------~~~~l~~ 271 (318)
.+.+++..||..+|++|| ++.++.+
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 899999999999999999 5665554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=300.45 Aligned_cols=238 Identities=23% Similarity=0.327 Sum_probs=189.4
Q ss_pred eccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCC
Q 021053 15 IGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (318)
Q Consensus 15 lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~ 88 (318)
||+|+||.||+|.+..+++.||+|++... .....+.+|+.++..++| +++..+..........++||||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNC-PFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 69999999999999999999999987532 122356789999999876 55555555556677899999999 889
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccccc
Q 021053 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (318)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 168 (318)
|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 80 L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~------- 148 (312)
T cd05585 80 LFHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDD------- 148 (312)
T ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCC-------
Confidence 9998876 4458999999999999999999999999999999999999 5889999999999875322211
Q ss_pred CCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhH
Q 021053 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF 248 (318)
Q Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (318)
......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+.. +....+...... +...+++.+
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~---~~~~~~~~~~~~-----~~~~~~~~~ 220 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN---EMYRKILQEPLR-----FPDGFDRDA 220 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH---HHHHHHHcCCCC-----CCCcCCHHH
Confidence 112346899999999999999999999999999999999999999875432 233333322222 224567899
Q ss_pred HHHHHHHhhcCCCCCCChHHHHHH
Q 021053 249 ASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 249 ~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
.+++.+||..+|.+||++..+.+.
T Consensus 221 ~~li~~~L~~dp~~R~~~~~~~e~ 244 (312)
T cd05585 221 KDLLIGLLSRDPTRRLGYNGAQEI 244 (312)
T ss_pred HHHHHHHcCCCHHHcCCCCCHHHH
Confidence 999999999999999875444333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=298.73 Aligned_cols=237 Identities=22% Similarity=0.314 Sum_probs=189.5
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHc--CCCCCCeeeeccccCcceEEE
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~--~~~~~~~i~~~~~~~~~~~lv 81 (318)
|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+|..++..++ .|+++..+..++......|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 789999999999999999999999999999876432 2234566766665443 346677777777777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +++|...+.. ..+++..+..++.||+.||.|||++|++||||||+||++ +.++.+||+|||++.......
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCC
Confidence 9999 7888877763 458999999999999999999999999999999999999 588999999999986432221
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
. ......+++.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+.......|
T Consensus 156 ~-------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~~~~~i~~~~~~~p---- 221 (324)
T cd05589 156 D-------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---EVFDSIVNDEVRYP---- 221 (324)
T ss_pred C-------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC----
Confidence 1 123456889999999999988999999999999999999999999875443 22333333222222
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCC
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPD 265 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~ 265 (318)
..++..+.+++.+||..+|.+||+
T Consensus 222 -~~~~~~~~~li~~~L~~dP~~R~~ 245 (324)
T cd05589 222 -RFLSREAISIMRRLLRRNPERRLG 245 (324)
T ss_pred -CCCCHHHHHHHHHHhhcCHhHcCC
Confidence 356788999999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=308.04 Aligned_cols=238 Identities=21% Similarity=0.312 Sum_probs=198.4
Q ss_pred EeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCCH
Q 021053 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSL 89 (318)
Q Consensus 11 ~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~L 89 (318)
-+++||+|+.|.||+|+. .++.||||.++.- ...+++-|++|+|+++| .+..+......+||+|||| .|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~el-----kETdIKHLRkLkH~NII-~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVREL-----KETDIKHLRKLKHPNII-TFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec--cCceehhHHHhhh-----hhhhHHHHHhccCccee-eEeeeecCCceeEEeeeccccccH
Confidence 367899999999999988 5688999976532 24578899999985544 5544445566899999999 9999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccccccC
Q 021053 90 EDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169 (318)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~ 169 (318)
..++.. +..+.......|.++|+.|+.|||.+.|||||||.-|||++ .+..+||+|||.++....-.+.
T Consensus 200 ~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs---~~d~VKIsDFGTS~e~~~~STk------- 268 (904)
T KOG4721|consen 200 YEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILIS---YDDVVKISDFGTSKELSDKSTK------- 268 (904)
T ss_pred HHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEee---ccceEEeccccchHhhhhhhhh-------
Confidence 999987 55688999999999999999999999999999999999996 7789999999999887655442
Q ss_pred CCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHH
Q 021053 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFA 249 (318)
Q Consensus 170 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (318)
-.+.||+.|||||++.+.+.+.|+|||||||+||||+||..||...+.. ..+..+....+..|++ ..+|+.++
T Consensus 269 -MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AIIwGVGsNsL~LpvP---stcP~Gfk 341 (904)
T KOG4721|consen 269 -MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AIIWGVGSNSLHLPVP---STCPDGFK 341 (904)
T ss_pred -hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---eeEEeccCCcccccCc---ccCchHHH
Confidence 3668999999999999999999999999999999999999999875442 2333333344445544 37899999
Q ss_pred HHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 250 SYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 250 ~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
-|+++||...|..||++.+++.+|.
T Consensus 342 lL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 342 LLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred HHHHHHHhcCCCCCccHHHHHHHHh
Confidence 9999999999999999999998884
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=302.01 Aligned_cols=249 Identities=22% Similarity=0.328 Sum_probs=195.5
Q ss_pred eeeEeeeeccCcccEEEEEEEc---CCCcEEEEEeecCCC------CChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 8 KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~---~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+|++.+.||+|+||.||+|++. .+++.||+|++.... .......|+.++..+++|+++..+..++......
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 478899999875321 1235677899999998888888887777777889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili---~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE---CCCCCEEEeeCcCCcccc
Confidence 9999999 8899988875 4458999999999999999999999999999999999999 488999999999987543
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHH-HHHHHhhccC
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY-DKICEKKVST 235 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~-~~i~~~~~~~ 235 (318)
...... .....||..|+|||++.+.. ++.++|||||||++|+|++|+.||...........+ ..+.... .
T Consensus 157 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~ 228 (332)
T cd05614 157 SEEKER------TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD--P 228 (332)
T ss_pred ccCCCc------cccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCC--C
Confidence 222211 12346899999999988654 788999999999999999999999754322222222 2222111 1
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
.+...++..+.+++..||..||++|| +++++.+
T Consensus 229 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 229 ---PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ---CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 12235678899999999999999999 4555544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=299.26 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=217.6
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
+...|++.+.||.|.||.||+|..+.+|+.+|+|++.+... .....+|+.+++++.+|+++..+...+.....++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 55789999999999999999999999999999998765443 2478999999999998899999988888888999
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCC-CCeEEEEeccceeeec
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAKKYR 157 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~-~~~~kL~dfg~~~~~~ 157 (318)
+|||++ +|.|.+.+... .+++..+..++.|++.++.|||+.||+||||||+|+|+...+. .+.+|++|||++....
T Consensus 113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 999999 89999999875 4999999999999999999999999999999999999964433 3589999999998876
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
.... .....||+.|+|||++...+|+..+||||+|+++|.|+.|.+||.+.... .....+.......+
T Consensus 191 ~~~~--------~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~---~~~~~i~~~~~~f~- 258 (382)
T KOG0032|consen 191 PGER--------LHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF---EIFLAILRGDFDFT- 258 (382)
T ss_pred CCce--------EeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh---HHHHHHHcCCCCCC-
Confidence 5221 24668999999999999999999999999999999999999999986643 23335554444333
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
...|..++...++++..++..||.+|+++.++.++
T Consensus 259 ~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 259 SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 44456889999999999999999999999988773
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=298.32 Aligned_cols=239 Identities=21% Similarity=0.291 Sum_probs=191.1
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||+|+||.||+|++..++..||+|+++.. ........|..++....+|+++..+...+......|+||||+ +
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999987643 223345667777777667788888877777788999999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDN----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCC-----
Confidence 899888876 3458999999999999999999999999999999999999 4888999999999864321111
Q ss_pred ccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCch
Q 021053 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (318)
......|+..|+|||++.+..++.++||||+||++|+|++|..||.+.+... ....+..... .....++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~~~~~~~~~-----~~~~~~~~ 221 (316)
T cd05620 152 --RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LFESIRVDTP-----HYPRWITK 221 (316)
T ss_pred --ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCC-----CCCCCCCH
Confidence 1234568999999999999999999999999999999999999998755432 2222221111 11234677
Q ss_pred hHHHHHHHHhhcCCCCCCChH-HHH
Q 021053 247 EFASYFHYCQSLTFDQRPDYG-FLK 270 (318)
Q Consensus 247 ~~~~li~~cl~~~p~~Rp~~~-~l~ 270 (318)
++.+++.+||..||++||++. ++.
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHH
Confidence 899999999999999999974 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=299.01 Aligned_cols=239 Identities=22% Similarity=0.300 Sum_probs=190.5
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||.|+||.||+|++..++..||+|++.... ....+.+|+.++..+.| +++..+..++......|+||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCcceeeEEecCCEEEEEEeCCCC
Confidence 46899999999999999999999999876432 22345678899998876 55666666666777899999999 8
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
++|...+.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~----- 150 (323)
T cd05595 80 GELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---cCCCCEEecccHHhccccCCCC-----
Confidence 889887765 4468999999999999999999999999999999999999 4889999999999865322211
Q ss_pred ccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCch
Q 021053 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (318)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+... ....+....... ...+++
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~~~~~~~~~~-----p~~~~~ 220 (323)
T cd05595 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELILMEEIRF-----PRTLSP 220 (323)
T ss_pred --ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHhcCCCCC-----CCCCCH
Confidence 1123468899999999998899999999999999999999999997654432 222222222222 235688
Q ss_pred hHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 247 EFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 247 ~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
.+.+++..||..+|.+|| ++.++.+
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred HHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 999999999999999998 6665543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=300.45 Aligned_cols=249 Identities=23% Similarity=0.271 Sum_probs=189.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeecccc-----C
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVD-----G 75 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~-----~ 75 (318)
+.++|++.+.||.|+||.||+|.+..++..||+|++.... ....+.+|+.++..++|++.+..+..+... .
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 5689999999999999999999999999999999876432 234577899999999875544444333221 2
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
...|+|||++.++|.+.+.. .++...+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 99 QDVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 172 (359)
T ss_pred ceeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEecCCCccc
Confidence 35799999998888887652 37888999999999999999999999999999999999 4889999999999875
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
...... .....+|..|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+ .... ..
T Consensus 173 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~---~~~~-~~ 240 (359)
T cd07876 173 ACTNFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV---IEQL-GT 240 (359)
T ss_pred cccCcc--------CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhc-CC
Confidence 432211 12346788999999999999999999999999999999999999876543322211 1111 11
Q ss_pred chHHH--------------------------------------hhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 PIEVL--------------------------------------CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 ~~~~~--------------------------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
|...+ ....+..+.+++.+||..||++||++.++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 11100 0112456788888888888888888887765
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=287.62 Aligned_cols=256 Identities=19% Similarity=0.314 Sum_probs=203.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+....|++.+.||.|++|.||+|.+.+++..|++|++..... ...+.+|+.++..+.| +++..+..+.......++++
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCC-CChhheEEEEcCCCCcEEEE
Confidence 456789999999999999999999998899999998765432 3467889999999977 45555555555667889999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|++ +++|.+++.... ..+++..+..++.|++.||.|||++|++||||+|+||+++ +++.+||+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~---~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc---CCCcEEeCCCccccccccce
Confidence 998 889999987543 3488899999999999999999999999999999999994 88999999999987654332
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. .......+..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+..... ..+.. .... .
T Consensus 159 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~---~~~~~-~~~~---~ 225 (263)
T cd05052 159 YT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---ELLEK-GYRM---E 225 (263)
T ss_pred ee------ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHHC-CCCC---C
Confidence 21 1112233567999999998889999999999999999998 99999875443222 22211 1111 2
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
.....|..+.+++.+||..+|++||++.++.+.|+.+
T Consensus 226 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 226 RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2346788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=289.74 Aligned_cols=255 Identities=21% Similarity=0.335 Sum_probs=209.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
+.|++++.||.|.-|+||+|+...++..+|+|++.+.. +..++..|-+||..+.| +.++.++..++.....|++
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDH-PFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDH-PFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCC-CccchhhheeeccceeEEE
Confidence 56788999999999999999999999999999976542 34467788899998877 6677888888888899999
Q ss_pred Eecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
|||| +|+|..+.++.. +.++++.++.++.+++.||+|||-.|||.|||||+|||+ .++|.+.|+||.++......
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE---ecCCcEEeeeccccccCCCC
Confidence 9999 999999988754 459999999999999999999999999999999999999 59999999999987654210
Q ss_pred -C------------------------------C-Cc-----------------cccccCCCCCcccccccccccccCCCC
Q 021053 160 -T------------------------------T-NR-----------------HIPYRENKNLTGTARYASCNTHLGIEQ 190 (318)
Q Consensus 160 -~------------------------------~-~~-----------------~~~~~~~~~~~~~~~y~aPE~~~~~~~ 190 (318)
. . .. ...-.....++||..|+|||++.|..-
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 0 00 000012345689999999999999999
Q ss_pred CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCC----h
Q 021053 191 SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD----Y 266 (318)
Q Consensus 191 ~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~ 266 (318)
+.++|+|+|||++|||+.|..||.+.+. .+.+..|..+....|... ..+...++||+..|.+||.+|.. +
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~---~~Tl~NIv~~~l~Fp~~~---~vs~~akDLIr~LLvKdP~kRlg~~rGA 386 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNN---KETLRNIVGQPLKFPEEP---EVSSAAKDLIRKLLVKDPSKRLGSKRGA 386 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCc---hhhHHHHhcCCCcCCCCC---cchhHHHHHHHHHhccChhhhhccccch
Confidence 9999999999999999999999999766 455666666666555443 45678999999999999999987 5
Q ss_pred HHHHH
Q 021053 267 GFLKR 271 (318)
Q Consensus 267 ~~l~~ 271 (318)
.+|.+
T Consensus 387 ~eIK~ 391 (459)
T KOG0610|consen 387 AEIKR 391 (459)
T ss_pred HHhhc
Confidence 56555
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=291.02 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=201.1
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCC-----cEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN-----EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~-----~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
+.-++|++.+.||.|+||.||+|.+...+ ..|++|.+..... ...+.+|+.++..+.| +++..+..+....
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH-PNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCC-cccceEEEEEcCC
Confidence 34568999999999999999999876544 6799998765432 2356789999999876 5555555555566
Q ss_pred cceEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccC
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 139 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~ 139 (318)
...++++|++ +++|.+++.... ..++...+..++.|++.||.|||++|++|+||||+||+++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~-- 158 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG-- 158 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc--
Confidence 7789999999 789999987532 3477888999999999999999999999999999999994
Q ss_pred CCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhH
Q 021053 140 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKA 218 (318)
Q Consensus 140 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~ 218 (318)
+++.++|+|||++......... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+.+.
T Consensus 159 -~~~~~~L~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 159 -EGLTVKISDFGLSRDIYSADYY-----RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred -CCCcEEECCCcceeeccccccc-----cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 7889999999998764332211 11223355788999999998889999999999999999998 9999987654
Q ss_pred hhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 219 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
.+. ...+..... .+ ....+|..+.+++..||+.+|++||++.++.+.|++
T Consensus 233 ~~~---~~~i~~~~~-~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 233 QEV---IEMIRSRQL-LP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHH---HHHHHcCCc-CC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 322 222222111 11 234678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=296.23 Aligned_cols=255 Identities=21% Similarity=0.305 Sum_probs=198.2
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
++..++|++.+.||.|+||.||+|.+..++..+|+|++..... ...+.+|+.++..++| +++..+..++......+
T Consensus 1 ~l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEIS 79 (333)
T ss_pred CcchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCC-CcccceeEEEEECCEEE
Confidence 4677999999999999999999999999999999998765432 2357889999999976 55666666666677899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
+||||+ +++|.+++.. ...++...+..++.|++.||.|||++ +++|+||||+||++ +.++.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 80 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE---cCCCCEEEeeCCcchhhh
Confidence 999999 8899999876 34588999999999999999999985 79999999999999 478899999999986543
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHH-----------
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD----------- 226 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~----------- 226 (318)
.... ....++..|+|||++.+..++.++|||||||++|+|++|+.||...........+.
T Consensus 156 ~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (333)
T cd06650 156 DSMA---------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE 226 (333)
T ss_pred hhcc---------ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccc
Confidence 2211 23467889999999998889999999999999999999999997643322111100
Q ss_pred --------------------------HHHHhhccCchHHH-hhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 227 --------------------------KICEKKVSTPIEVL-CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 227 --------------------------~i~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+.......+.+.. ....+..+.+++.+||..||++||++.++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 227 TSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred cCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 00000000010000 1124667899999999999999999998865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=296.77 Aligned_cols=235 Identities=21% Similarity=0.296 Sum_probs=191.3
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||.|+||.||+|.+..+++.||+|++... ........|..++..+.+|+++..+..+.......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999987643 223356678888888877788888877777778899999999 8
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
++|.+.+.. ...+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++........
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGV----- 151 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCC-----
Confidence 899888876 3458999999999999999999999999999999999999 4889999999999865322211
Q ss_pred ccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCch
Q 021053 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (318)
......++..|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+....... ...++.
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~~i~~~~~~~-----~~~~~~ 221 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQSILEDEVRY-----PRWLSK 221 (318)
T ss_pred --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHHHHHcCCCCC-----CCcCCH
Confidence 112345789999999999999999999999999999999999999865442 2223333222222 235678
Q ss_pred hHHHHHHHHhhcCCCCCCCh
Q 021053 247 EFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 247 ~~~~li~~cl~~~p~~Rp~~ 266 (318)
.+.+++.+||..+|++||++
T Consensus 222 ~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred HHHHHHHHHccCCHHHcCCC
Confidence 89999999999999999998
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=299.22 Aligned_cols=239 Identities=21% Similarity=0.318 Sum_probs=191.4
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.++..+.| +++..+...+......++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRH-PFLTSLKYSFQTKDRLCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999876432 22356778889988876 56666666667778899999999 8
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||++ +..+.+||+|||++........
T Consensus 80 g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~----- 150 (328)
T cd05593 80 GELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAA----- 150 (328)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE---CCCCcEEEecCcCCccCCCccc-----
Confidence 889888765 4458999999999999999999999999999999999999 5889999999999875322211
Q ss_pred ccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCch
Q 021053 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (318)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.. .....+...... +...++.
T Consensus 151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~---~~~~~~~~~~~~-----~p~~~~~ 220 (328)
T cd05593 151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMEDIK-----FPRTLSA 220 (328)
T ss_pred --ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH---HHHHHhccCCcc-----CCCCCCH
Confidence 112346889999999999888999999999999999999999999765432 222222222222 2245688
Q ss_pred hHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 247 EFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 247 ~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
++.+++..||..+|++|+ ++.++.+
T Consensus 221 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred HHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 999999999999999997 6777665
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=295.60 Aligned_cols=239 Identities=23% Similarity=0.312 Sum_probs=191.1
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||+|+||.||+|++..+++.||+|++... ........|..++....+|+++..+..++......++||||+ +
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999987643 223345667777777666788888877777778899999999 8
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++........
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDA----- 151 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCC-----
Confidence 899998876 3458899999999999999999999999999999999999 4888999999999875322111
Q ss_pred ccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCch
Q 021053 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (318)
......+|..|+|||++.+..++.++||||+||++|+|++|..||...+... .+..+...... ....++.
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i~~~~~~-----~~~~~~~ 221 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSIRMDNPC-----YPRWLTR 221 (316)
T ss_pred --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCC-----CCccCCH
Confidence 1123467899999999999899999999999999999999999998755432 22222211111 1234677
Q ss_pred hHHHHHHHHhhcCCCCCCChH-HHH
Q 021053 247 EFASYFHYCQSLTFDQRPDYG-FLK 270 (318)
Q Consensus 247 ~~~~li~~cl~~~p~~Rp~~~-~l~ 270 (318)
.+.+++.+||..+|++||++. ++.
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHH
Confidence 899999999999999999986 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=304.73 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=197.3
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||.|+||.||+|++..+++.||||++.... ....+.+|+.++..++| +++..+...+......++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN-PWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceEEEEEcCCeEEEE
Confidence 47999999999999999999999999999999876432 12346779999999875 6666777677778899999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 80 ~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 80 MEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred ECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEeecccceeccccc
Confidence 9999 8899998876 4458999999999999999999999999999999999999 588999999999987543221
Q ss_pred CCccc-----------------c---------c-----cCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhC
Q 021053 161 TNRHI-----------------P---------Y-----RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 209 (318)
Q Consensus 161 ~~~~~-----------------~---------~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg 209 (318)
..... + + .......||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 10000 0 0 000124689999999999988899999999999999999999
Q ss_pred CCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCC---hHHHHH
Q 021053 210 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD---YGFLKR 271 (318)
Q Consensus 210 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~---~~~l~~ 271 (318)
.+||...+... ....+.......+.+. ...+++.+.+++..|+. +|.+|++ +.++.+
T Consensus 236 ~~Pf~~~~~~~---~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDNPQE---TYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCHHH---HHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99998765432 2233322111111111 12457889999999996 9999998 666554
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=305.29 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=201.1
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||.|+||.||+|.+..+++.||+|++... .....+..|+.++..+.| +++..+...+.+....++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS-PWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCC-CCccchhhheecCCeEEEE
Confidence 5799999999999999999999999999999987643 223356778889988875 5666666666677889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 80 MEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI---DADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEeecCCCCccCcccC
Confidence 9999 88999998874 568999999999999999999999999999999999999 588999999999987654332
Q ss_pred CCc----------------------cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhH
Q 021053 161 TNR----------------------HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (318)
Q Consensus 161 ~~~----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~ 218 (318)
... ...........||+.|+|||++.+..++.++|||||||++|+|++|..||...+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 000 0000112345689999999999999999999999999999999999999987654
Q ss_pred hhhHHHHHHHHH--hhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCC-hHHHHHH
Q 021053 219 ATKKQKYDKICE--KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-YGFLKRL 272 (318)
Q Consensus 219 ~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~-~~~l~~~ 272 (318)
.. ....+.. .....|.. ..+++.+.+++..||. +|.+||+ +.++.+.
T Consensus 236 ~~---~~~~i~~~~~~~~~p~~---~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QE---TYNKIINWKESLRFPPD---PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH---HHHHHhccCCcccCCCC---CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 32 2223332 12222211 1368899999999997 9999999 8887763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=309.43 Aligned_cols=255 Identities=24% Similarity=0.248 Sum_probs=196.3
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccc-----
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGV----- 73 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~----- 73 (318)
+..+++|++.+.||.|+||.||+|++..+++.||+|++...... ..+.+|+..+..+.|++.+.....+..
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 34568999999999999999999999999999999987654322 245677777777766443332222111
Q ss_pred --cCcceEEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEE
Q 021053 74 --DGEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 147 (318)
Q Consensus 74 --~~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL 147 (318)
.....++||||+ +++|.+++... ...+++..+..++.|++.||.|+|++||+||||||+||++ +.++.+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL 184 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKL 184 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEE
Confidence 112368999999 88999988643 2358899999999999999999999999999999999999 48899999
Q ss_pred EeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHH
Q 021053 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (318)
Q Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (318)
+|||+++......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.. ..+..
T Consensus 185 ~DFGls~~~~~~~~~~-----~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~---~~~~~ 256 (496)
T PTZ00283 185 GDFGFSKMYAATVSDD-----VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME---EVMHK 256 (496)
T ss_pred EecccCeecccccccc-----ccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHH
Confidence 9999987654322111 123456899999999999999999999999999999999999999875442 22233
Q ss_pred HHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
+...... .....+++.+.+++..||..+|.+||++.++.+.
T Consensus 257 ~~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAGRYD----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcCCCC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 2222111 1234568899999999999999999999987653
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=288.65 Aligned_cols=268 Identities=25% Similarity=0.437 Sum_probs=186.5
Q ss_pred CCccccceeeEeeeeccCcccEEEEEEEcCC---CcEEEEEeecCCCCChhH----------HHHHHHHHHHc--CCCCC
Q 021053 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKHPQL----------LYEAKVYKILQ--GGSGI 65 (318)
Q Consensus 1 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~---~~~vaiK~~~~~~~~~~~----------~~e~~~l~~l~--~~~~~ 65 (318)
+.++.+++|++.+.||+|+||.||+|.+..+ +..+++|+.......... ..++..+..+. .|.++
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 3578889999999999999999999998776 667788864332211100 01111122221 22344
Q ss_pred CeeeeccccC----cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCC
Q 021053 66 PNIKWYGVDG----EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (318)
Q Consensus 66 ~~i~~~~~~~----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~ 141 (318)
+.+..++... ...+++++.+..++.+.+... ...++..+..++.|++.||.|||+++++||||||+||++ +.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill---~~ 161 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV---DG 161 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cC
Confidence 4444333222 245788888888888887753 336788889999999999999999999999999999999 47
Q ss_pred CCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhh
Q 021053 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221 (318)
Q Consensus 142 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~ 221 (318)
.+.++|+|||+++....................||+.|+|||+..+..++.++|||||||++|+|++|++||.+......
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 88999999999987643221111111112234689999999999999999999999999999999999999987632211
Q ss_pred HHH-HHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 222 KQK-YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 222 ~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
... ...-.-.....+ .......|..+.+++..||..+|++||++.++.+.|
T Consensus 242 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKCDFIKRLHEG-KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHHHHHHHhhhh-hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 110 000000111111 111235577899999999999999999999998866
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=264.08 Aligned_cols=279 Identities=70% Similarity=1.194 Sum_probs=266.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
-+.+++|+++++||+|+||.+|+|....+|..||||+..+....+.+..|.++...|++...++.+..++.+..+.++||
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 46789999999999999999999999999999999999998999999999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
+..+.||.+++..+.+.++..++.-++.|++.-++|+|.++++||||||+|+|++.......+.|+|||+++...+..+.
T Consensus 91 dLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 91 DLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred eccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 99999999999999999999999999999999999999999999999999999987778889999999999999999999
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
.++|++......||.+|.+--...+...+...|+=|+|.++.++.-|..||++....++.+.+++|.+.+.+.|++.+++
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~ 250 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCK 250 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhC
Confidence 99999999999999999998888888888899999999999999999999999999999999999999999999999999
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcC
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~ 281 (318)
.+|.++.-.+.-|-..-.++-|+..-+++.|.-++....
T Consensus 251 G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 251 GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 999999999999999999999999999999988776544
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=292.75 Aligned_cols=262 Identities=21% Similarity=0.281 Sum_probs=202.2
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCc----EEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~----~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
.+-..+|++.+.||+|+||.||+|.+..++. .||+|++..... ...+.+|+.+++.+.|++.+ .+..+...
T Consensus 3 ~~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~g~~~~- 80 (316)
T cd05108 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC-RLLGICLT- 80 (316)
T ss_pred ccchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCC-eEEEEEcC-
Confidence 3456889999999999999999999865554 389998764432 23577888999998775544 44433333
Q ss_pred cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
...+++++++ +++|.+++......++......++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 81 ~~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill---~~~~~~kl~DfG~a~ 157 (316)
T cd05108 81 STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV---KTPQHVKITDFGLAK 157 (316)
T ss_pred CCceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe---cCCCcEEEccccccc
Confidence 3467888888 899999998755568889999999999999999999999999999999999 478899999999998
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
......... .......+..|+|||++.+..++.++|||||||++|++++ |..||.+..... +..+.....
T Consensus 158 ~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----~~~~~~~~~ 228 (316)
T cd05108 158 LLGADEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSILEKGE 228 (316)
T ss_pred cccCCCcce-----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----HHHHHhCCC
Confidence 654332211 0112234567999999999899999999999999999998 999998754432 222232222
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcC
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~ 281 (318)
..+.+ ..++.++.+++..||..+|++||++.++...+..+.....
T Consensus 229 ~~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 229 RLPQP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred CCCCC---CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 22221 2456789999999999999999999999999988765443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=302.87 Aligned_cols=204 Identities=22% Similarity=0.306 Sum_probs=164.8
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCc-----ce
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE-----DN 78 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~-----~~ 78 (318)
+|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+|+.++..++|++ +..+..+..... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDN-VLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCC-cCCHhheecCCCccccceE
Confidence 47899999999999999999999999999998754321 235788999999998754 444433333322 68
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 79 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
|+|+|++.++|.+.+.. ...++...+..++.||+.||.|||++|++||||||+||++ +.++.+||+|||++.....
T Consensus 80 ~lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 80 YVVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE---CCCCCEEeccccceeeccc
Confidence 99999998899888865 4458999999999999999999999999999999999999 4889999999999876543
Q ss_pred CCCCccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHhhhH
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK 222 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~ 222 (318)
.... ......++..|+|||++.+.. ++.++||||+||++|+|++|++||.+.++....
T Consensus 156 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 214 (372)
T cd07853 156 DESK------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL 214 (372)
T ss_pred Cccc------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 2211 112345688899999988754 789999999999999999999999876654433
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=301.89 Aligned_cols=214 Identities=19% Similarity=0.267 Sum_probs=172.8
Q ss_pred cccceeeEeeeeccCcccEEEEEEEc--CCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++..+|++.+.||.|+||.||+|... .++..|++|.+... ....+|+.+++.++| +++..+...+......+++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~---~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KTPGREIDILKTISH-RAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc---ccHHHHHHHHHhcCC-CCccceeeeEeeCCEEEEE
Confidence 45678999999999999999999764 35678999987643 245689999999987 4555555555566789999
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|+++.++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +..+.++|+|||++........
T Consensus 165 ~e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill---~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 165 MPKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL---DEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred ehhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---cCCCCEEEccCccccccCcccc
Confidence 99999999998854 4568999999999999999999999999999999999999 5889999999999876543322
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~ 230 (318)
.. ......||..|+|||++.+..++.++|||||||++|+|++|..||.+.........+..+..
T Consensus 241 ~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~ 304 (392)
T PHA03207 241 TP-----QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR 304 (392)
T ss_pred cc-----cccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH
Confidence 11 12245789999999999998999999999999999999999999987554433444444443
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=300.11 Aligned_cols=258 Identities=20% Similarity=0.273 Sum_probs=202.2
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCC-----CcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~-----~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
.++|++++.||.|+||.||+|.+... ...||+|++..... .+.+.+|+.++..+..|++++.+..+......
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 57888999999999999999987532 34699998865433 23578899999999866888888777777788
Q ss_pred eEEEEecc-CCCHHHHHHHhc-----------------------------------------------------------
Q 021053 78 NVLVLDLL-GPSLEDLFVYCR----------------------------------------------------------- 97 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~----------------------------------------------------------- 97 (318)
.++||||+ +++|.+++....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999 899998876421
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCC
Q 021053 98 ------------------------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (318)
Q Consensus 98 ------------------------------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~ 141 (318)
..+++..+..++.|++.||.|||+.+++|+||||+||+++ .
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~---~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA---Q 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe---C
Confidence 1366777889999999999999999999999999999994 7
Q ss_pred CCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhh
Q 021053 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (318)
Q Consensus 142 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~ 220 (318)
++.+||+|||++......... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~ 347 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNY-----VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS 347 (400)
T ss_pred CCEEEEEeCCcceeccccccc-----cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH
Confidence 889999999998765432211 11123345678999999998889999999999999999997 999997653321
Q ss_pred hHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
. ....+. .....+ ....+|..+.+++.+||..+|++||++.++.+.|+.++
T Consensus 348 ~--~~~~~~-~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 348 T--FYNKIK-SGYRMA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred H--HHHHHh-cCCCCC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1 111111 111111 12356888999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=295.55 Aligned_cols=284 Identities=19% Similarity=0.229 Sum_probs=192.8
Q ss_pred eeeeccCcccEEEEEEEc--CCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeecc-ccCcceEEEEeccCCC
Q 021053 12 GRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNVLVLDLLGPS 88 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~-~~~~~~~lv~e~~~~~ 88 (318)
+++||+|+||.||+|++. .+++.||+|.+..........+|+.+++.++|++.+.....+. ......++++|+++++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHD 85 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCC
Confidence 578999999999999965 4678899998876655667889999999998755544444332 2345689999999999
Q ss_pred HHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccC-CCCCeEEEEeccceeeecCC
Q 021053 89 LEDLFVYCR--------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 89 L~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~-~~~~~~kL~dfg~~~~~~~~ 159 (318)
|.+++.... ..++...++.++.||+.||.|||++||+||||||+||++... +..+.+||+|||++......
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07868 86 LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCC
Confidence 988876421 247889999999999999999999999999999999999422 35678999999999765432
Q ss_pred CCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHh------hhHHHHHHHHHhh
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAA------TKKQKYDKICEKK 232 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~------~~~~~~~~i~~~~ 232 (318)
... ........+|+.|+|||++.+. .++.++||||+||++|+|++|++||...... .....+..+....
T Consensus 166 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07868 166 LKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241 (317)
T ss_pred Ccc----ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence 211 1112345678999999998875 5899999999999999999999999753321 1122333333322
Q ss_pred ccCchHHHhhcCc--hhHHHHHHHHhhcCCCCCCChHHHHHHHHHH---HHhcCCchhHHHhhhcCCccccccccee
Q 021053 233 VSTPIEVLCKSHP--AEFASYFHYCQSLTFDQRPDYGFLKRLFHDL---FSREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 233 ~~~~~~~~~~~~~--~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~---~~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
. .|....+.... +....++... ..+...... +...++.. .+.+..+++.+||++||.+|+|+++++.
T Consensus 242 ~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 242 G-FPADKDWEDIKKMPEHSTLMKDF-RRNTYTNCS---LIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred C-CCChHHhHHHhhccchhhhhhhh-hccccCccc---ccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 2 22222111110 0111111111 111111111 11111111 1223468999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=299.21 Aligned_cols=239 Identities=19% Similarity=0.286 Sum_probs=191.2
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||+|+||.||+|++..+++.||+|++..... ...+.+|..++.++.+|+++..+..++......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999998875321 2346788889999988888888888878888899999999 8
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
++|...+.. .+.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~----- 151 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGD----- 151 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---eCCCCEEEeccccceeccCCCC-----
Confidence 899888765 3459999999999999999999999999999999999999 4889999999999875322211
Q ss_pred ccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHh----hhHHHHHHHHHhhccCchHHHhh
Q 021053 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA----TKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~----~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........+...... ...
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-----~p~ 224 (327)
T cd05617 152 --TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR-----IPR 224 (327)
T ss_pred --ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC-----CCC
Confidence 112346899999999999999999999999999999999999999642211 111122222222111 223
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYG 267 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~ 267 (318)
.++..+.+++.+||..||.+|+++.
T Consensus 225 ~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 225 FLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCC
Confidence 5678899999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=297.47 Aligned_cols=238 Identities=19% Similarity=0.291 Sum_probs=190.0
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||+|+||.||+|++..+++.||+|+++... ....+..|..++..+.+|+++..+..++......|+||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999886432 12346778889988877788888887777888899999999 8
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+||++ +..+.+||+|||++........
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~----- 151 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGD----- 151 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEECcCccccccccCCC-----
Confidence 899888765 4569999999999999999999999999999999999999 4889999999999864322211
Q ss_pred ccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHh------hhHHHHHHHHHhhccCchHHH
Q 021053 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA------TKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~------~~~~~~~~i~~~~~~~~~~~~ 240 (318)
......||..|+|||++.+..++.++|+|||||++|+|++|+.||...... ........+.......
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 224 (329)
T cd05588 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRI----- 224 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCC-----
Confidence 112456899999999999989999999999999999999999999632111 1111222222222222
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCCh
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~ 266 (318)
...++..+.+++.+||..+|.+|+++
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 23567789999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=300.20 Aligned_cols=255 Identities=21% Similarity=0.297 Sum_probs=193.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||.|+||+||+|.+..+++.||+|++.... ....+.+|+.++..+.| +++..+...+.+....|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~-~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS-LWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCeEEEE
Confidence 47999999999999999999999999999999876432 12356778889988876 5566666666777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 80 MEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE---CCCCCEEEeeccCcccccccc
Confidence 9999 8899999876 4568999999999999999999999999999999999999 588999999999987543211
Q ss_pred CCc-------cc---------------------cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCC
Q 021053 161 TNR-------HI---------------------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212 (318)
Q Consensus 161 ~~~-------~~---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~p 212 (318)
... .. .........||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 000 00 00001234789999999999999999999999999999999999999
Q ss_pred ccchhHhhhHHHHHHHHHhh--ccCchHHHhhcCchhHHHHHHHHhh--cCCCCCCChHHHHHH
Q 021053 213 WQGLKAATKKQKYDKICEKK--VSTPIEVLCKSHPAEFASYFHYCQS--LTFDQRPDYGFLKRL 272 (318)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~li~~cl~--~~p~~Rp~~~~l~~~ 272 (318)
|.+.+.. ..+..+.... ...|.. ..+++...+++.+++. .++..||+++++.+.
T Consensus 236 f~~~~~~---~~~~~i~~~~~~~~~p~~---~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSETPQ---ETYKKVMNWKETLIFPPE---VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCHH---HHHHHHHcCcCcccCCCc---CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9875543 2333333211 112211 1356788888887543 233456888887764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=295.68 Aligned_cols=261 Identities=21% Similarity=0.322 Sum_probs=200.2
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcC-----CCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeee-ecccc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIK-WYGVD 74 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~-~~~~~ 74 (318)
+-+++|++.+.||.|+||.||+|.+.. +++.||+|++...... ..+.+|+.++.++.+|+++..+. .+...
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 446799999999999999999997543 3478999987654322 35678999999996666666664 44445
Q ss_pred CcceEEEEecc-CCCHHHHHHHhc--------------------------------------------------------
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCR-------------------------------------------------------- 97 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~-------------------------------------------------------- 97 (318)
....++++||+ +++|.+++....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 56788999999 889998886421
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCC
Q 021053 98 ----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173 (318)
Q Consensus 98 ----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~ 173 (318)
..+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++......... ......
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL~DfG~a~~~~~~~~~-----~~~~~~ 235 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----VRKGDA 235 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEEeccccchhcccCcch-----hhccCC
Confidence 147888899999999999999999999999999999999 47889999999998765322111 111233
Q ss_pred cccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHH
Q 021053 174 TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYF 252 (318)
Q Consensus 174 ~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li 252 (318)
.++..|+|||++.+..++.++|||||||++|+|++ |..||.+....+ .+........... .....++.+.+++
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~---~~~~~~~~~~~~~---~~~~~~~~~~~l~ 309 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---EFCRRLKEGTRMR---APEYATPEIYSIM 309 (337)
T ss_pred CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH---HHHHHHhccCCCC---CCccCCHHHHHHH
Confidence 45678999999999999999999999999999998 999997643221 1111111111111 1134567899999
Q ss_pred HHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 253 HYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 253 ~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
.+||..+|++||++.++.+.|++++.
T Consensus 310 ~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 310 LDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=297.25 Aligned_cols=238 Identities=20% Similarity=0.297 Sum_probs=189.2
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||+|+||.||+|++..+++.||+|++..... ...+..|..++.++.+|+++..+..++......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999998765321 2245678888888877788888877777888999999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
++|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~----- 151 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGD----- 151 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCC-----
Confidence 889887765 4568999999999999999999999999999999999999 5889999999999875322211
Q ss_pred ccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHh------hhHHHHHHHHHhhccCchHHH
Q 021053 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA------TKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~------~~~~~~~~i~~~~~~~~~~~~ 240 (318)
......||..|+|||++.+..++.++|||||||++|+|++|..||...... ........+.......
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~----- 224 (329)
T cd05618 152 --TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI----- 224 (329)
T ss_pred --ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCC-----
Confidence 112456899999999999999999999999999999999999999532111 1111222232222222
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCCh
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~ 266 (318)
+...+..+.+++.+||..||++||++
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 23567789999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=289.46 Aligned_cols=202 Identities=23% Similarity=0.351 Sum_probs=168.7
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... .....+|+.++..+.| +++..+..++......++|+|
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCC-CCcceEEEEEecCCeEEEEEe
Confidence 679999999999999999999999999999998764322 2356789999999977 556666666667778999999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
|+.++|.+++......++...+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+.....+..
T Consensus 85 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~-- 159 (301)
T cd07873 85 YLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK-- 159 (301)
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE---CCCCcEEECcCcchhccCCCCC--
Confidence 99889999988766668999999999999999999999999999999999999 4888999999999875432221
Q ss_pred cccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHh
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~ 219 (318)
......++..|+|||++.+. .++.++|||||||++|+|++|++||...+..
T Consensus 160 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~ 211 (301)
T cd07873 160 -----TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE 211 (301)
T ss_pred -----cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 11233567889999988754 4788999999999999999999999876543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=313.41 Aligned_cols=260 Identities=23% Similarity=0.339 Sum_probs=214.6
Q ss_pred cccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
+-..+.+..+.||+|+||+||+|+.. +..+.||||.++..... .+|.+|++++..|.| ++++.+......+
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H-~nIVrLlGVC~~~ 561 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQH-PNIVRLLGVCREG 561 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccC-CCeEEEEEEEccC
Confidence 33456678899999999999999865 34468999998876654 479999999999988 5566666555677
Q ss_pred cceEEEEecc-CCCHHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCC
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRR-------------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~-------------~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~ 141 (318)
...++|+||| .|+|.+|+..... +++..+...++.||+.|+.||-++.++||||-.+|+||+ +
T Consensus 562 ~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg---e 638 (774)
T KOG1026|consen 562 DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG---E 638 (774)
T ss_pred CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec---c
Confidence 8899999999 9999999975421 267889999999999999999999999999999999996 9
Q ss_pred CCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhh
Q 021053 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (318)
Q Consensus 142 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~ 220 (318)
...+||+|||+++..-+... |+......-..+||+||.++...++.+|||||+||+|||+++ |+.||.+..+++
T Consensus 639 ~l~VKIsDfGLsRdiYssDY-----Yk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E 713 (774)
T KOG1026|consen 639 NLVVKISDFGLSRDIYSSDY-----YKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE 713 (774)
T ss_pred ceEEEecccccchhhhhhhh-----hcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH
Confidence 99999999999987654433 222334455788999999999999999999999999999999 999999987765
Q ss_pred hHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
..+.+. ..+. .+.+ +.+|.++++||..||..+|.+||++.+|..+|.++...
T Consensus 714 VIe~i~---~g~l-L~~P---e~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 714 VIECIR---AGQL-LSCP---ENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred HHHHHH---cCCc-ccCC---CCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 444333 2333 3322 47899999999999999999999999999999998643
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=288.39 Aligned_cols=248 Identities=19% Similarity=0.250 Sum_probs=195.0
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
.|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++| +++..+...+......++||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCC-CCEeeeeeeecCCCeEEEEE
Confidence 48999999999999999999998999999998764321 2345679999999976 45555555556667899999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||+ +++|.+.+.... ..+++..+..++.|++.||.|||+.|++|+||+|+||++ ++.+.++|+|||++.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE---CCCCCEEEeeCCCceecCCCC
Confidence 999 788988876532 358999999999999999999999999999999999999 478999999999987643221
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
. .....++..|+|||++.+..++.++||||+||++|++++|..||.+.+.....+.+...... .....
T Consensus 157 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~----~~~~~ 224 (285)
T cd05605 157 T--------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE----DQEEY 224 (285)
T ss_pred c--------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh----ccccc
Confidence 1 12346788999999999888999999999999999999999999875543322222221111 11112
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
...++..+.+++..||..||++|| +++++.+
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 235688899999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=299.95 Aligned_cols=252 Identities=21% Similarity=0.278 Sum_probs=198.4
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
-.++|++.+.||.|+||.||+|++..+++.||+|++... .....+.+|+.++..++| +++..+..++......+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h-~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS-EWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCcceEEEEEecCCEEE
Confidence 347899999999999999999999999999999987532 122346678889988866 56666666667778899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||.+.....
T Consensus 120 lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---cCCCCEEEEeccceeeccC
Confidence 999999 8899998874 358889999999999999999999999999999999999 5889999999999876543
Q ss_pred CCCCccccccCCCCCcccccccccccccCC----CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
.... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.. ..+..+......
T Consensus 195 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~~~ 265 (370)
T cd05596 195 NGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMDHKNS 265 (370)
T ss_pred CCcc------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---HHHHHHHcCCCc
Confidence 2211 11244689999999998754 3788999999999999999999999875543 233333322211
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCC--CCChHHHHHH
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKRL 272 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~--Rp~~~~l~~~ 272 (318)
...+. ...++..+.+++..||..+|.+ |+++.++.+.
T Consensus 266 ~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 266 LTFPD-DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCCC-cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11111 1246788999999999999987 9999988663
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=275.91 Aligned_cols=249 Identities=22% Similarity=0.226 Sum_probs=209.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----------ChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
..|+-.+.||.|..+.|.++.++.++..+|+|++..... .+...+|+.+|+++.+|++|..+........
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 567788999999999999999999999999997552211 1246789999999999999999988777888
Q ss_pred ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..++|++.| .|.|.|++.+.. .+++...+.+++|++.|+.|||.++|+||||||+|||+ |++.++||+|||+++.
T Consensus 97 F~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl---ddn~~i~isDFGFa~~ 172 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL---DDNMNIKISDFGFACQ 172 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee---ccccceEEeccceeec
Confidence 899999999 999999998744 38999999999999999999999999999999999999 7999999999999998
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCC------CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHH
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI------EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~ 229 (318)
+..... .....||+.|+|||.+... .|+..+|+||+|||+|-++.|-+||..... .-++..|.
T Consensus 173 l~~Gek--------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---mlMLR~Im 241 (411)
T KOG0599|consen 173 LEPGEK--------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---MLMLRMIM 241 (411)
T ss_pred cCCchh--------HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---HHHHHHHH
Confidence 765433 2466899999999987532 488899999999999999999999986433 34455555
Q ss_pred HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+.+.....++ |.+++...++||++||..||.+|.|+.+...
T Consensus 242 eGkyqF~spe-Wadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 242 EGKYQFRSPE-WADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred hcccccCCcc-hhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 5555555444 4688899999999999999999999987554
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=286.90 Aligned_cols=256 Identities=20% Similarity=0.271 Sum_probs=198.1
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
.+...++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.++..+.|++ +..+..........+
T Consensus 4 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~-ii~~~~~~~~~~~~~ 82 (267)
T cd06646 4 RRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCN-IVAYFGSYLSREKLW 82 (267)
T ss_pred ccCchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCC-eeeeeEEEEeCCEEE
Confidence 45567889999999999999999999998999999998765432 235678999999987754 445544455667899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+|+|++ +++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||++ ++++.++|+|||.+.....
T Consensus 83 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06646 83 ICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL---TDNGDVKLADFGVAAKITA 158 (267)
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCCEEECcCccceeecc
Confidence 999999 7789888875 4458999999999999999999999999999999999999 4788999999999886543
Q ss_pred CCCCccccccCCCCCccccccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
... ......++..|+|||.+. ...++.++|+||+||++|+|++|..||....+..... .+.......
T Consensus 159 ~~~-------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---~~~~~~~~~ 228 (267)
T cd06646 159 TIA-------KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LMSKSNFQP 228 (267)
T ss_pred ccc-------ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---eeecCCCCC
Confidence 221 112345778899999875 3347789999999999999999999997654322111 111112222
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
+.......++..+.+++.+||..+|++||+++++.+.
T Consensus 229 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 2111123567889999999999999999999987764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=287.81 Aligned_cols=247 Identities=21% Similarity=0.193 Sum_probs=194.4
Q ss_pred ceeeEe--eeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-----hhHHHHHHHHHHHcCCCCCCeeeecccc----C
Q 021053 7 VKYKLG--RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVD----G 75 (318)
Q Consensus 7 ~~y~~~--~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~i~~~~~~----~ 75 (318)
++++.. ..||.|+++.||+|.+ +++.||+|.+...... ..+.+|+.++.+++|+ ++..+..++.+ .
T Consensus 18 ~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~~~g~~~~~~~~~ 94 (283)
T PHA02988 18 DDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSN-NILKIYGFIIDIVDDL 94 (283)
T ss_pred HHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCC-CEEEEeeeEEecccCC
Confidence 334444 6789999999999988 6889999987654322 3456899999999885 55555443332 3
Q ss_pred cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
...+++|||+ +++|.+++.. ...+++.....++.|++.||.|+|+. +++||||||+||++ +.++.+||+|||++
T Consensus 95 ~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill---~~~~~~kl~dfg~~ 170 (283)
T PHA02988 95 PRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIICHGLE 170 (283)
T ss_pred CceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE---CCCCcEEEcccchH
Confidence 5689999999 8899999876 34588999999999999999999985 99999999999999 48899999999998
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccC--CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~ 231 (318)
........ ...++..|+|||++.+ ..++.++|||||||++|+|++|+.||...+.. .....+...
T Consensus 171 ~~~~~~~~----------~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~---~~~~~i~~~ 237 (283)
T PHA02988 171 KILSSPPF----------KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK---EIYDLIINK 237 (283)
T ss_pred hhhccccc----------cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhc
Confidence 75433221 2356788999999876 57899999999999999999999999876543 223333222
Q ss_pred hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
....+ ....+|+.+.+++.+||+.||++||++.++.+.|+.+
T Consensus 238 ~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 238 NNSLK---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CCCCC---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 22222 1125688999999999999999999999999998875
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=283.07 Aligned_cols=248 Identities=20% Similarity=0.277 Sum_probs=197.5
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
.++|++.+.||+|++|.||+|.. .+..|++|..........+.+|+.+++.+.|++.+..+..+.......++++|++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46899999999999999999976 4678999988766555678899999999987554444444445556789999999
Q ss_pred -CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 86 -GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 86 -~~~L~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+++|.+++..... .+++..+..++.|++.||.|||++|++||||+|+||++ ++++.+||+|||++........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~-- 157 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE---cCCCcEEecCCccceeccccCC--
Confidence 7899999876433 37889999999999999999999999999999999999 4889999999999875433221
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
....+..|+|||++.+..++.++|||||||++|+|++ |+.||...+.... ...+.. .... ....
T Consensus 158 --------~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~~~-~~~~---~~~~ 222 (256)
T cd05082 158 --------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEK-GYKM---DAPD 222 (256)
T ss_pred --------CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHhc-CCCC---CCCC
Confidence 2233567999999988889999999999999999998 9999976543221 112211 1111 1224
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
.+|..+.+++.+||..+|++||++.++.+.|.+
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 668899999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=296.80 Aligned_cols=201 Identities=22% Similarity=0.317 Sum_probs=165.6
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccc-----cC
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DG 75 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~-----~~ 75 (318)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+.|++.+..+..+.. ..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4589999999999999999999999999999999876432 22357789999999877554444333322 22
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
...|+|||++.++|.+.+.. .++...+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 102 ~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 102 QDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 175 (364)
T ss_pred CeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccc
Confidence 45799999998898888753 37888999999999999999999999999999999999 4889999999999875
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHh
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~ 219 (318)
...... .....++..|+|||++.+..++.++|||||||++|+|++|+.||.+.+..
T Consensus 176 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 231 (364)
T cd07875 176 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 231 (364)
T ss_pred cCCCCc--------ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 433221 12346789999999999999999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=305.62 Aligned_cols=245 Identities=22% Similarity=0.308 Sum_probs=206.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
+.|.=++.||.|+||.||.|++..+.+.||||.+.-. .++.++++|+..|.+++| ++......|.......++|
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~H-PntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRH-PNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccC-CCcccccceeeccchHHHH
Confidence 3466678899999999999999999999999987633 346689999999999988 4455666676677778999
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
||||-||-.|++.-..+++.+..+..++.+.+.||.|||+.+.||||||..|||++ +.|.+||+|||++.....
T Consensus 105 MEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs---e~g~VKLaDFGSAsi~~P--- 178 (948)
T KOG0577|consen 105 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS---EPGLVKLADFGSASIMAP--- 178 (948)
T ss_pred HHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec---CCCeeeeccccchhhcCc---
Confidence 99999999999988788899999999999999999999999999999999999996 999999999999876542
Q ss_pred CccccccCCCCCccccccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
...++||+.|||||++. .+.|+-++||||||+++.|+..+++|+..++..+ .+..|.+ +.++.
T Consensus 179 --------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS---ALYHIAQ---NesPt 244 (948)
T KOG0577|consen 179 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS---ALYHIAQ---NESPT 244 (948)
T ss_pred --------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH---HHHHHHh---cCCCC
Confidence 23679999999999876 4469999999999999999999999999988753 3334443 22222
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
.....|+..+..++..||.+-|.+|||.+++.++
T Consensus 245 Lqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 245 LQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 2345789999999999999999999999876654
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=295.73 Aligned_cols=250 Identities=21% Similarity=0.256 Sum_probs=189.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccc-----cC
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV-----DG 75 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~-----~~ 75 (318)
+.++|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+|+.+++.++|++.+..+..+.. ..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45899999999999999999999999999999998765322 2356789999999987554444433322 22
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
...+++||++.+++.+.+.. .++...+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 95 ~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~~~~ 168 (355)
T cd07874 95 QDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 168 (355)
T ss_pred ceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---CCCCCEEEeeCccccc
Confidence 35799999998888887753 47888999999999999999999999999999999999 4889999999999875
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
...... .....++..|+|||++.+..++.++|||||||++|+|++|+.||.+.+...... .+..... .
T Consensus 169 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~-~ 236 (355)
T cd07874 169 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN---KVIEQLG-T 236 (355)
T ss_pred CCCccc--------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhC-C
Confidence 433221 123467899999999999899999999999999999999999998754332221 1111111 1
Q ss_pred chHHH--------------------------------------hhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 236 PIEVL--------------------------------------CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 236 ~~~~~--------------------------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
+.... ....+..+.+++.+||..||++|||+.++.+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 11100 01123456788888888888888888877663
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=293.89 Aligned_cols=253 Identities=23% Similarity=0.272 Sum_probs=194.1
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|..++..++| +++..+..++......|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR-RWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCCCceEEEEecCCeEEEE
Confidence 5799999999999999999999999999999987532 122346678888877754 6677777777777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCC
Confidence 9999 899999998655668999999999999999999999999999999999999 488999999999987654332
Q ss_pred CCccccccCCCCCcccccccccccccC-----CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
.. ......+|+.|+|||++.. ..++.++||||+||++|+|++|+.||...+... .+..+.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~---~~~~i~~~~~~~ 227 (331)
T cd05597 157 TV------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKIMNHKEHF 227 (331)
T ss_pred Cc------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH---HHHHHHcCCCcc
Confidence 21 1123458999999999873 347889999999999999999999998754432 223333222111
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCC--CCCCChHHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTF--DQRPDYGFLKRL 272 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p--~~Rp~~~~l~~~ 272 (318)
+.+.....++..+.+++.+|+...+ ..|+++.++.+.
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 1111123468889999999886433 336777766653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=293.23 Aligned_cols=240 Identities=23% Similarity=0.329 Sum_probs=190.0
Q ss_pred eeeeccCcccEEEEEEEc---CCCcEEEEEeecCCC------CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 12 GRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~---~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
++.||+|+||.||+|++. .+++.||+|++.... ....+..|+.+++.++| +++..+...+......|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH-PFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCC-CchhceeeEEecCCeEEEEE
Confidence 368999999999999874 467899999876421 22346789999999987 55556655556677899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
||+ +++|.+.+.. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 80 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 80 EYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL---DAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred eCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCC
Confidence 999 7899888876 4457888999999999999999999999999999999999 5889999999999875332221
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+.. ..+..+.......|
T Consensus 156 -------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~---~~~~~~~~~~~~~~----- 220 (323)
T cd05584 156 -------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK---KTIDKILKGKLNLP----- 220 (323)
T ss_pred -------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCC-----
Confidence 112346889999999999888999999999999999999999999875543 23333333332222
Q ss_pred hcCchhHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
..+++.+.+++..||..+|++|| +++++..
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 35678899999999999999999 6676655
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=295.62 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=189.9
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeecc-----ccC
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYG-----VDG 75 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~-----~~~ 75 (318)
+.++|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+|+.+++.++|++.+..+..+. ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 56899999999999999999999999999999998764321 235678999999998754443332221 122
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
...|+++++++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 93 ~~~~~~~~~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 93 NEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV---NEDCELRILDFGLARQ 167 (343)
T ss_pred CcEEEEeecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE---CCCCCEEEcCCcccee
Confidence 45799999999999888763 459999999999999999999999999999999999999 4889999999999876
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
..... ....++..|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....... +......
T Consensus 168 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---~~~~~~~ 234 (343)
T cd07878 168 ADDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKR---IMEVVGT 234 (343)
T ss_pred cCCCc----------CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH---HHHHhCC
Confidence 54321 23467899999999877 4689999999999999999999999976543322222 2111111
Q ss_pred CchH--------------------------HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 235 TPIE--------------------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 235 ~~~~--------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+.. ......++.+.+++.+||..||++|||+.++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1111 111233455778888888888888888887765
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=287.12 Aligned_cols=242 Identities=20% Similarity=0.279 Sum_probs=187.1
Q ss_pred eccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCC
Q 021053 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (318)
Q Consensus 15 lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~ 88 (318)
||.|+||+||+|.+..+++.||+|.+..... ...+..|+.++..++| +++..+..++......++||||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHS-RFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCC-CcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 6999999999999999999999998754321 1345678899998855 56666666666667899999999 889
Q ss_pred HHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccc
Q 021053 89 LEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (318)
Q Consensus 89 L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~ 165 (318)
|.+.+... ...+++..+..++.||+.||.|||++||+||||||+||++ +..+.++|+|||.+........
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~---- 152 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQS---- 152 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCc----
Confidence 98776432 3358899999999999999999999999999999999999 4788999999999876543221
Q ss_pred cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCc
Q 021053 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (318)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (318)
......+++.|+|||++.+..++.++|||||||++|+|++|+.||...+......... ......+ ......++
T Consensus 153 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~---~~~~~~~-~~~~~~~~ 225 (280)
T cd05608 153 ---KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK---QRILNDS-VTYPDKFS 225 (280)
T ss_pred ---cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH---HhhcccC-CCCcccCC
Confidence 1123467889999999999999999999999999999999999997643321111111 1111111 12234578
Q ss_pred hhHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 246 AEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 246 ~~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
..+.+++..||+.+|++|| +++++.+
T Consensus 226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 8999999999999999999 4455554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=299.18 Aligned_cols=248 Identities=22% Similarity=0.323 Sum_probs=196.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.++..+.| +++..+..++......++|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~-~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS-PWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCcceeeEEecCCeEEEE
Confidence 579999999999999999999999999999998764321 2345677777777654 6666676666677789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +++|.+++......+++..+..++.|++.||.|||++||+||||||+||++ +..+.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE---CCCCCEEeccCCCCeECCCCC
Confidence 9999 899999998765679999999999999999999999999999999999999 588999999999997654332
Q ss_pred CCccccccCCCCCccccccccccccc------CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh--
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHL------GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-- 232 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~-- 232 (318)
.. ......+|+.|+|||++. ...++.++|||||||++|+|++|..||....... .+..+....
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~i~~~~~~ 227 (330)
T cd05601 157 MV------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK---TYNNIMNFQRF 227 (330)
T ss_pred ce------eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH---HHHHHHcCCCc
Confidence 21 112346789999999987 4457899999999999999999999997654432 223332211
Q ss_pred ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...|. ...++..+.+++..||. +|.+||++.++.+
T Consensus 228 ~~~~~---~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 LKFPE---DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cCCCC---CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11111 12467889999999997 9999999998765
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=310.88 Aligned_cols=260 Identities=18% Similarity=0.218 Sum_probs=208.0
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC--hhHHHHHHHHHHHcCCCCCCeeee--cc----cc-Cc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKW--YG----VD-GE 76 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~i~~--~~----~~-~~ 76 (318)
..+++|.+.|.+|||+.||+|++...+..||+|++...+.. ....+|+.+++.|++|++|+.+.+ +. .. ..
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 35789999999999999999999988899999976655432 367899999999998888877644 11 12 24
Q ss_pred ceEEEEecc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 77 DNVLVLDLL-GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
++++.|||| +++|.++|.. ....|++.++++|+.++++|+.+||... |||||||-+|||++ .++..||||||+
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls---~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLS---ADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEc---CCCCEEeCcccc
Confidence 689999999 6899999974 3455999999999999999999999998 99999999999995 889999999999
Q ss_pred eeeecCCC-CCccc-cccCCCCCccccccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHH
Q 021053 153 AKKYRDPT-TNRHI-PYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (318)
Q Consensus 153 ~~~~~~~~-~~~~~-~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (318)
+.-..... ..... -....-....|+.|+|||++. +.+.++|+|||+|||+||.++....||+.... .+
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------la 265 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------LA 265 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------ee
Confidence 86533221 11000 000111235789999999764 77899999999999999999999999987533 24
Q ss_pred HHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
|+......|+. ..++..+..||..||..||++||++-++...+..+..
T Consensus 266 Ilng~Y~~P~~---p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 266 ILNGNYSFPPF---PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred EEeccccCCCC---ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 55566666653 3567899999999999999999999998888877643
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=301.24 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=194.4
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
.|++++.||+|+||+||+|.+..+++.||+|++.... ....+.+|+.++..+.| ++++.+..++.+....++||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADN-EWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCC-CCeeeeEEEEecCCEEEEEE
Confidence 6899999999999999999999999999999876432 12356789999999876 56666766667778899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
||+ +++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||++ +..+.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 81 DYIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred ecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE---CCCCCEEEeeCcCCcccccccc
Confidence 999 8899999876 3458899999999999999999999999999999999999 5889999999998754321100
Q ss_pred Ccc----------------------------------------ccccCCCCCcccccccccccccCCCCCCcchHHHHHH
Q 021053 162 NRH----------------------------------------IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGY 201 (318)
Q Consensus 162 ~~~----------------------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~ 201 (318)
... ..........||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 000 0000012346899999999999888999999999999
Q ss_pred HHHHHHhCCCCccchhHhhhHHHHHHHHH--hhccCchHHHhhcCchhHHHHHHH--HhhcCCCCCCChHHHHH
Q 021053 202 VLLYFLRGSLPWQGLKAATKKQKYDKICE--KKVSTPIEVLCKSHPAEFASYFHY--CQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 202 il~~l~tg~~pf~~~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~~li~~--cl~~~p~~Rp~~~~l~~ 271 (318)
++|+|++|.+||...++... ...+.. .....|. ...+++...+++.+ |+..++..||++.++..
T Consensus 237 il~elltG~~Pf~~~~~~~~---~~~i~~~~~~~~~~~---~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTET---QLKVINWENTLHIPP---QVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHH---HHHHHccccccCCCC---CCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 99999999999987554321 222221 1111221 12467789999988 55666677999998876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=286.01 Aligned_cols=260 Identities=23% Similarity=0.323 Sum_probs=204.6
Q ss_pred cccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
|-..+|.+.+.||.|+||.||+|.+. .++..+++|.+..... ...+.+|+.++..+.| +++..+..++....
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 80 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH-EHIVKFYGVCVEGD 80 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEecCC
Confidence 44678999999999999999999863 3456788998765432 3357889999999976 66667766667778
Q ss_pred ceEEEEecc-CCCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCC
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCR------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 143 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~ 143 (318)
..++++|++ +++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++ ++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~ 157 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GENL 157 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---ccCC
Confidence 899999999 889999987532 238899999999999999999999999999999999999 4889
Q ss_pred eEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhH
Q 021053 144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKK 222 (318)
Q Consensus 144 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~ 222 (318)
.++|+|||.+......... .......++..|+|||++.+..++.++|+|||||++|+|++ |.+||...+...
T Consensus 158 ~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-- 230 (288)
T cd05093 158 LVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-- 230 (288)
T ss_pred cEEeccCCccccccCCcee-----ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 9999999998754322211 01122334678999999998889999999999999999999 999998765432
Q ss_pred HHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
....+...... ......+..+.+++.+||..+|.+||++.++.+.|+++...
T Consensus 231 -~~~~i~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 231 -VIECITQGRVL----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -HHHHHHcCCcC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 22233222111 11235678899999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=286.33 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=200.5
Q ss_pred cceeeEeeeeccCcccEEEEEEEcC-----CCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
.++|.+.+.||.|+||.||+|.+.. ++..||+|++...... ..+.+|+++++.+.| +++..+..++.....
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~ 82 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQH-ENIVKFYGVCTEGDP 82 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCC-CCchheeeEEecCCC
Confidence 4679999999999999999998753 3578999988765433 467889999999976 456666666666688
Q ss_pred eEEEEecc-CCCHHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCC
Q 021053 78 NVLVLDLL-GPSLEDLFVYCR-------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 143 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~-------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~ 143 (318)
.+++||++ +++|.+++...+ ..+++..+..++.|++.||.+||++|++|+||+|+||++ +.++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~ 159 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV---GYDL 159 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE---cCCC
Confidence 99999999 899999987532 236788899999999999999999999999999999999 4889
Q ss_pred eEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhH
Q 021053 144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKK 222 (318)
Q Consensus 144 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~ 222 (318)
.++|+|||.+......... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...+...
T Consensus 160 ~~kl~d~g~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-- 232 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-- 232 (280)
T ss_pred eEEECCcccceecccCcce-----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--
Confidence 9999999998754322210 11123345678999999999999999999999999999999 999997755432
Q ss_pred HHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
....+.......+ ....|..+.+++.+||..+|++||++.++.+.|+
T Consensus 233 -~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 233 -VIECITQGRLLQR----PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -HHHHHHcCCcCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 2222222222222 2356889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=287.33 Aligned_cols=259 Identities=19% Similarity=0.228 Sum_probs=201.9
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcE--EEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~--vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
-++|++.+.||.|+||.||+|.+..++.. +++|....... ...+.+|+.++.++.+|+++..+..++......++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 46899999999999999999998776654 56666543222 23567899999999777888888777777788999
Q ss_pred EEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCe
Q 021053 81 VLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~ 144 (318)
++||+ +++|.+++.... ..++...+..++.|++.||.|||++|++||||||+||++ +.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe---cCCCc
Confidence 99999 889999987532 247888999999999999999999999999999999999 48889
Q ss_pred EEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHH
Q 021053 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ 223 (318)
Q Consensus 145 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~ 223 (318)
+||+|||++........ ......+..|+|||++.+..++.++|||||||++|+|+| |..||...+..+
T Consensus 163 ~kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 231 (303)
T cd05088 163 AKIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--- 231 (303)
T ss_pred EEeCccccCcccchhhh--------cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---
Confidence 99999999853221100 111233567999999988889999999999999999998 999997654432
Q ss_pred HHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCC
Q 021053 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGS 282 (318)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~ 282 (318)
....+.. .... ......+..+.+++.+||..+|++||++.++...+++++.....
T Consensus 232 ~~~~~~~-~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~ 286 (303)
T cd05088 232 LYEKLPQ-GYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 286 (303)
T ss_pred HHHHHhc-CCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhh
Confidence 2222211 1111 11234577899999999999999999999999999887665543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=286.49 Aligned_cols=255 Identities=18% Similarity=0.241 Sum_probs=200.5
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCc--EEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNE--IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~--~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||.|+||.||+|.+..++. .+++|.++.... ...+.+|+.++.++.+|+++..+..+.......+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 589999999999999999999876654 468887664222 235778999999997778888887777777789999
Q ss_pred Eecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeE
Q 021053 82 LDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~ 145 (318)
+|++ +++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV---GENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCeE
Confidence 9999 789999987532 247788999999999999999999999999999999999 478899
Q ss_pred EEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHH
Q 021053 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQK 224 (318)
Q Consensus 146 kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~ 224 (318)
||+|||++........ ......+..|+|||+..+..++.++|||||||++|+|++ |..||....... .
T Consensus 159 kl~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~ 227 (297)
T cd05089 159 KIADFGLSRGEEVYVK--------KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---L 227 (297)
T ss_pred EECCcCCCccccceec--------cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H
Confidence 9999999864321111 011223456999999988889999999999999999998 999998755432 2
Q ss_pred HHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
...+.. ....+ ....++..+.+++.+||..+|.+||+++++.+.++++...
T Consensus 228 ~~~~~~-~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 228 YEKLPQ-GYRME---KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred HHHHhc-CCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 222221 11111 1235678899999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=296.69 Aligned_cols=239 Identities=21% Similarity=0.302 Sum_probs=189.9
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||+|+||.||+|.+..++..||+|++.... .......|+.++..+.| +++..+..++......++||||+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~h-p~i~~~~~~~~~~~~~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALKYSFQTHDRLCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46899999999999999999999999876432 12345678888888766 56666666667777899999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~ 165 (318)
++|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+||++ +.++.+||+|||++........
T Consensus 80 ~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~---- 151 (325)
T cd05594 80 GELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGA---- 151 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCc----
Confidence 888888765 4458999999999999999999998 799999999999999 5889999999999875332221
Q ss_pred cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCc
Q 021053 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (318)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (318)
......+++.|+|||++.+..++.++|||||||++|+|++|..||...+.. .....+....... ...++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~i~~~~~~~-----p~~~~ 220 (325)
T cd05594 152 ---TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMEEIRF-----PRTLS 220 (325)
T ss_pred ---ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHHHhcCCCCC-----CCCCC
Confidence 112346899999999999989999999999999999999999999775442 2222222222222 23567
Q ss_pred hhHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 246 AEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 246 ~~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
+.+.+++..||..||++|+ ++.++.+
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 221 PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 8999999999999999997 7777654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=282.44 Aligned_cols=260 Identities=21% Similarity=0.270 Sum_probs=200.2
Q ss_pred CCccccceeeEeeeeccCcccEEEEEEEcCCCc----EEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccc
Q 021053 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (318)
Q Consensus 1 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~----~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~ 73 (318)
|+-+..++|++.+.||.|+||.||+|.+..++. .||+|++..... ...+.+|+.++..+.|+ ++..+..++.
T Consensus 1 ~~~l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~-~i~~~~~~~~ 79 (279)
T cd05109 1 MRILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSP-YVCRLLGICL 79 (279)
T ss_pred CcccchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCC-CCceEEEEEc
Confidence 566778999999999999999999999876655 489998765433 23566788888888764 4444444333
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
. ...+++++++ +++|.+++......+++..+..++.|++.||.|||++|++||||||+||++. +.+.+||+|||+
T Consensus 80 ~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~---~~~~~kL~dfG~ 155 (279)
T cd05109 80 T-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVK---SPNHVKITDFGL 155 (279)
T ss_pred C-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEc---CCCcEEECCCCc
Confidence 3 3477899988 8899999876555689999999999999999999999999999999999994 778899999999
Q ss_pred eeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHh
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEK 231 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~ 231 (318)
+.......... ......++..|+|||...+..++.++|||||||++|||++ |..||.......... ....
T Consensus 156 ~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~----~~~~ 226 (279)
T cd05109 156 ARLLDIDETEY-----HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD----LLEK 226 (279)
T ss_pred eeeccccccee-----ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHC
Confidence 88764332211 0112234567999999998889999999999999999998 999997654332222 2222
Q ss_pred hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
....+. ...++..+.+++..||..+|++||++.++...+.++.
T Consensus 227 ~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 227 GERLPQ---PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred CCcCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 222221 1356788999999999999999999999999887753
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=279.44 Aligned_cols=289 Identities=22% Similarity=0.316 Sum_probs=215.5
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCC----cEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~----~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
..|++...||+|+||.||+|...+++ ..+|||.++... -...+.+|+.+++.++|++.+.....+-......
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46999999999999999999665443 268999887663 3457899999999999866665555554446789
Q ss_pred EEEEeccCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccC-CCCCeEEEEeccce
Q 021053 79 VLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLA 153 (318)
Q Consensus 79 ~lv~e~~~~~L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~-~~~~~~kL~dfg~~ 153 (318)
+++++|..-+|+..++..+ +.++...++.++.||+.|+.|||++-|+||||||.||++..+ ...|++||+|||++
T Consensus 104 ~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 104 WLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred EEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 9999999999999987543 348889999999999999999999999999999999999521 23599999999999
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHh------hhHHHHH
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAA------TKKQKYD 226 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~------~~~~~~~ 226 (318)
+...++.. |+......+-|..|+|||++.|.. |+++.||||+|||+.||+|-++.|.+.... -+..++.
T Consensus 184 R~~~~plk----pl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 184 RLFNNPLK----PLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred HHhhcccc----ccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 98765532 222334567799999999999876 999999999999999999999999764322 2345666
Q ss_pred HHHHhhccCchHHHhh---cCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH--HhcCCchhHHHhhhcCCccccccc
Q 021053 227 KICEKKVSTPIEVLCK---SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF--SREGSLLLQFIMSYCSLHSITFQT 301 (318)
Q Consensus 227 ~i~~~~~~~~~~~~~~---~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~--~~~~~~~~~~~l~~~p~~r~t~~~ 301 (318)
+|++ .+..|....|. .+| +...+++..-. ..+ +-..+.+.+++.- ++.+.+++.+||++||.+|+|+.+
T Consensus 260 rIf~-vLG~Pt~~~Wp~lkk~P-e~q~~ls~f~~---~~~-~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~q 333 (438)
T KOG0666|consen 260 RIFE-VLGTPTDKDWPDLKKMP-EYQTLLSDFRR---HYY-DNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQ 333 (438)
T ss_pred HHHH-HcCCCccccchhhhhCc-chHHHHHHhHH---hhc-CcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHH
Confidence 7764 44555554322 223 33344433211 111 1112444444432 233679999999999999999999
Q ss_pred ceee
Q 021053 302 NIIN 305 (318)
Q Consensus 302 ~~~~ 305 (318)
|+..
T Consensus 334 Aleh 337 (438)
T KOG0666|consen 334 ALEH 337 (438)
T ss_pred Hhcc
Confidence 9873
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=280.91 Aligned_cols=255 Identities=23% Similarity=0.371 Sum_probs=199.5
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+..++|++.+.||+|+||.||+|.+..+ ..|++|.+..... ...+.+|+.++..+.| +++..+.... .....+++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~-~~i~~~~~~~-~~~~~~lv~ 79 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRH-EKLVQLYAVV-SEEPIYIVT 79 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCC-CCcceEEEEE-CCCCcEEEE
Confidence 4568999999999999999999988655 4599998875433 3467889999999976 4455554433 334689999
Q ss_pred ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|++ +++|.+++... ...+++..+..++.|++.||.|+|+++++|+||+|+||+++ +++.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~---~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEc---CCCcEEeccCCceeeccccc
Confidence 999 78999998753 23478899999999999999999999999999999999994 78899999999987654322
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. ......++..|+|||+..+..++.++|||||||++|+++| |++||....... ....+.. ....+.
T Consensus 157 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~~~~~~-~~~~~~-- 224 (262)
T cd05071 157 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVER-GYRMPC-- 224 (262)
T ss_pred cc------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HHHHHhc-CCCCCC--
Confidence 11 1122345677999999988889999999999999999999 899997654432 2222211 111221
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
....|..+.+++.+||..+|++||++.++.+.+++.+
T Consensus 225 -~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 225 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred -ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 2356788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=297.96 Aligned_cols=246 Identities=23% Similarity=0.303 Sum_probs=189.3
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
-.+|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.++..++| +++..+..+.......++|+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH-PNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCC-CCcceeeeEeccCCeEEEEE
Confidence 3578899999999999999999999999999998865432 2357889999999976 55666666666777899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
||+ +++|.+. ...++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 152 e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 152 EFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred ecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEcccccceecccccc
Confidence 999 6777543 225677788899999999999999999999999999999 4889999999999876543221
Q ss_pred CccccccCCCCCcccccccccccccC-----CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
......|+..|+|||++.. ...+.++|||||||++|+|++|+.||......+.......+.. . .+
T Consensus 224 -------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-~--~~ 293 (353)
T PLN00034 224 -------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM-S--QP 293 (353)
T ss_pred -------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc-c--CC
Confidence 1123468999999998743 2345689999999999999999999974332221222222211 1 11
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
......++..+.+++..||..+|++||++.++.+
T Consensus 294 -~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 -PEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred -CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122356788999999999999999999998876
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=293.31 Aligned_cols=235 Identities=24% Similarity=0.330 Sum_probs=185.2
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHH-HHHHcCCCCCCeeeeccccCcceEEEEecc-
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKV-YKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~-l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~- 85 (318)
+.||+|+||+||+|.+..+++.||+|++.... ....+..|... ++.++| +++..+...+......++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~h-p~iv~~~~~~~~~~~~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKH-PFLVGLHYSFQTADKLYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCC-CCCCCeeEEEEeCCEEEEEEcCCC
Confidence 46899999999999999999999999876432 11234445444 344544 66667766667777899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccc
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~ 165 (318)
+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 80 ~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~---- 151 (323)
T cd05575 80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGIEHSK---- 151 (323)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE---CCCCcEEEeccCCCcccccCCC----
Confidence 8899888876 4468999999999999999999999999999999999999 5889999999999864322111
Q ss_pred cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCc
Q 021053 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (318)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (318)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.. .....+....... ....+
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~-----~~~~~ 220 (323)
T cd05575 152 ---TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA---EMYDNILNKPLRL-----KPNIS 220 (323)
T ss_pred ---ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH---HHHHHHHcCCCCC-----CCCCC
Confidence 123446899999999999989999999999999999999999999875442 2333333322222 23567
Q ss_pred hhHHHHHHHHhhcCCCCCCChH
Q 021053 246 AEFASYFHYCQSLTFDQRPDYG 267 (318)
Q Consensus 246 ~~~~~li~~cl~~~p~~Rp~~~ 267 (318)
..+.+++.+||..+|.+||++.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCC
Confidence 8899999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=284.41 Aligned_cols=197 Identities=26% Similarity=0.370 Sum_probs=164.0
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+|++.+.||.|++|.||+|.+..++..|++|.+..... ...+.+|+.+++.++| +++..+.....+....++++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCC-CCeeeHHHHhccCCceEEEEe
Confidence 69999999999999999999999999999998764322 2356789999999976 555566556667778999999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
|+.++|.+++......+++..++.++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~-- 154 (284)
T cd07839 80 YCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI---NKNGELKLADFGLARAFGIPVR-- 154 (284)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---cCCCcEEECccchhhccCCCCC--
Confidence 99889999887656668999999999999999999999999999999999999 4789999999999875433221
Q ss_pred cccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccc
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQG 215 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~ 215 (318)
......++..|+|||++.+.. ++.++|||||||++|+|+||..||..
T Consensus 155 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 155 -----CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred -----CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 112335678899999987654 78999999999999999998888643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=301.56 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=193.8
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.++..+.| +++..+..++......|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS-PWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCC-CCcceEEEEEEcCCeeEEE
Confidence 47999999999999999999999999999999875421 12356778999988876 5666777777777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||++ +..+.+||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 80 MEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEEeeccccccccccc
Confidence 9999 8899999876 4558999999999999999999999999999999999999 488999999999986322110
Q ss_pred CCc-----------ccc------------------------c-----cCCCCCcccccccccccccCCCCCCcchHHHHH
Q 021053 161 TNR-----------HIP------------------------Y-----RENKNLTGTARYASCNTHLGIEQSRRDDLESLG 200 (318)
Q Consensus 161 ~~~-----------~~~------------------------~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 200 (318)
... ..+ + .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 000 000 0 000124689999999999988999999999999
Q ss_pred HHHHHHHhCCCCccchhHhhhHHHHHHHHHh--hccCchHHHhhcCchhHHHHHHHHhhcCCCCC---CChHHHHH
Q 021053 201 YVLLYFLRGSLPWQGLKAATKKQKYDKICEK--KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR---PDYGFLKR 271 (318)
Q Consensus 201 ~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R---p~~~~l~~ 271 (318)
|++|+|++|.+||...+... .+..+... ....|.. ..++..+.+++.+|+. +|.+| +++.++..
T Consensus 236 vil~elltG~~Pf~~~~~~~---~~~~i~~~~~~~~~p~~---~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHE---TYRKIINWRETLYFPDD---IHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHH---HHHHHHccCCccCCCCC---CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhc
Confidence 99999999999998755432 22333221 1111211 1457789999999997 77766 47776655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=281.60 Aligned_cols=255 Identities=25% Similarity=0.343 Sum_probs=198.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||.|+||.||+|++..+++.||+|.+..... ...+.+|+.+++.++| +++..+..++......+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH-PNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCC-cceeeeeeeEEECCeEEEE
Confidence 589999999999999999999999999999997653221 2256789999999976 4555555555566789999
Q ss_pred Eecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
+|++ +++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++ .++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~---~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc---CCCCEEECccccceecc
Confidence 9999 67998887642 23478889999999999999999999999999999999994 78899999999987654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
..... .....++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... .......+ ......+.
T Consensus 158 ~~~~~-------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~ 228 (267)
T cd08228 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKI-EQCDYPPL 228 (267)
T ss_pred chhHH-------HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHHH-hcCCCCCC
Confidence 32211 12345778899999998888999999999999999999999999654321 11222222 11111221
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
.....+..+.+++.+||..+|++||++.++.+.+..+
T Consensus 229 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 229 --PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 1124577899999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=288.39 Aligned_cols=275 Identities=20% Similarity=0.284 Sum_probs=207.9
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcC-------CCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~-------~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~ 73 (318)
+-.++|.+.+.||+|+||.||+|++.. ....+|+|.+...... ..+.+|+.++..+..|+++..+..+..
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 345789999999999999999998642 3457899987754332 356789999999876677777776666
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~ 137 (318)
.....++++||+ +++|.+++.... ..++...+..++.|++.||.|||++|++|+||||+||+++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 677899999999 889999987532 2377888999999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccch
Q 021053 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (318)
Q Consensus 138 ~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~ 216 (318)
.++.+||+|||.+.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 169 ---~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 169 ---EDNVMKIADFGLARGVHDIDYYK-----KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred ---CCCcEEEcccccccccccccccc-----ccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 78899999999987654221110 0112233467999999998889999999999999999999 99999775
Q ss_pred hHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh---cCCchhHHHhhhcC
Q 021053 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR---EGSLLLQFIMSYCS 293 (318)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~---~~~~~~~~~l~~~p 293 (318)
...... ..+.. .... .....++.++.+++.+||..+|++||++.++.+.|.++... +...+...+++++|
T Consensus 241 ~~~~~~---~~~~~-~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~~~~~~~~~~~ 313 (314)
T cd05099 241 PVEELF---KLLRE-GHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYLDLSMPFEQYSP 313 (314)
T ss_pred CHHHHH---HHHHc-CCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcCCceeeEEehhhcCC
Confidence 443222 22211 1111 11235577899999999999999999999999999887542 33344444444444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=301.01 Aligned_cols=255 Identities=23% Similarity=0.312 Sum_probs=194.4
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
.+|++.+.||+|+||.||+|++..+++.||+|++... .....+.+|+.++..+.| +++..+...+......++|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h-~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN-EWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCC-CCcceEEEEEEcCCEEEEE
Confidence 4799999999999999999999999999999987542 223457789999999977 5555666666677889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +..+.+||+|||++.......
T Consensus 80 ~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 80 MDYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE---CCCCCEEEEeCCCCccccccc
Confidence 9999 8899999876 3458899999999999999999999999999999999999 588999999999975321100
Q ss_pred CCc------------------------------------cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHH
Q 021053 161 TNR------------------------------------HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLL 204 (318)
Q Consensus 161 ~~~------------------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ 204 (318)
... ...........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000 00000112346899999999999999999999999999999
Q ss_pred HHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCC---ChHHHHH
Q 021053 205 YFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP---DYGFLKR 271 (318)
Q Consensus 205 ~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp---~~~~l~~ 271 (318)
+|++|+.||.+.++.... ..+.......+.+ ....++..+.+++..|+ .+|.+|+ ++.++.+
T Consensus 236 ell~G~~Pf~~~~~~~~~---~~i~~~~~~~~~~-~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 236 EMLVGQPPFLADTPAETQ---LKVINWETTLHIP-SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred ehhhCCCCCCCCCHHHHH---HHHhccCccccCC-CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999999876543222 2222111111111 11346778899999976 5999999 7776665
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=281.76 Aligned_cols=254 Identities=22% Similarity=0.355 Sum_probs=200.5
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+-.++|++.+.||+|++|.||+|.+. ++..|++|.+..... ...+.+|+.+++.++| +++..+..........++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQH-DKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCCC-CCeeeEEEEEcCCCCcEEEE
Confidence 44578999999999999999999865 456799998765332 3467889999999976 45555555556677899999
Q ss_pred ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|++ +++|.+++... ...++...+..++.|++.||.|||+.+++|+||+|+||++ +..+.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV---SESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe---cCCCcEEECCCccceecCCCc
Confidence 999 88999998753 3457888999999999999999999999999999999999 488999999999997654322
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. ......++..|+|||++.+..++.++|||||||++|+|++ |..||......... ..+.. ....+.
T Consensus 158 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~~-~~~~~~-- 225 (261)
T cd05072 158 YT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM---SALQR-GYRMPR-- 225 (261)
T ss_pred ee------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH---HHHHc-CCCCCC--
Confidence 11 1112344667999999988889999999999999999998 99999775443222 22221 112221
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
...+|..+.+++.+||..+|++||++.++.+.|++
T Consensus 226 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 226 -MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 13567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=283.06 Aligned_cols=250 Identities=20% Similarity=0.232 Sum_probs=189.6
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+|++.+.||.|++|.||+|.+..+++.||+|.+..... ...+.+|+.++..+.| +++..+..+.......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQH-PNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCC-CCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999998999999998754322 2457789999999986 556666666667778999999
Q ss_pred ccCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 84 LLGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
++.++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+.....+..
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 80 FLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred cCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---cCCCcEEECcccceeecCCCcc
Confidence 99889988887543 458899999999999999999999999999999999999 4889999999999876543221
Q ss_pred CccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc----
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP---- 236 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~---- 236 (318)
......++..|+|||++.+. .++.++|||||||++|+|+||++||.+.......... ........
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 226 (285)
T cd07861 157 -------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI---FRILGTPTEDVW 226 (285)
T ss_pred -------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---HHHhCCCChhhh
Confidence 11233557889999988754 4788999999999999999999999865433222111 11111100
Q ss_pred --------------------hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 --------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 --------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.......+++++.+++++||..||++||++.++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 01112235566777777888777888877776543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=283.35 Aligned_cols=259 Identities=20% Similarity=0.291 Sum_probs=199.5
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcC-----CCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
++-.++|++.+.||.|++|.||+|.+.. ++..|++|....... ...+.+|+.++..+.| +++..+..++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~ 80 (277)
T cd05036 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNH-QNIVRLIGVSFE 80 (277)
T ss_pred CCCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEcc
Confidence 4556889999999999999999999976 678899997764332 2357889999999976 455566555556
Q ss_pred CcceEEEEecc-CCCHHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEE
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCRR------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 147 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~~------~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL 147 (318)
....+++||++ +++|.+++..... .+++..+..++.||+.||.|||+++++|+||+|+||++..+.....+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 66789999999 8899999876432 4788999999999999999999999999999999999953223457999
Q ss_pred EeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHH
Q 021053 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYD 226 (318)
Q Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~ 226 (318)
+|||.+.......... .......+..|+|||++.+..++.++|||||||++|+|++ |..||........ ..
T Consensus 161 ~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~ 232 (277)
T cd05036 161 ADFGMARDIYRASYYR-----KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---ME 232 (277)
T ss_pred ccCccccccCCcccee-----cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH
Confidence 9999987653221110 1112233567999999998889999999999999999997 9999987544322 22
Q ss_pred HHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 227 ~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
.+.. .... .....+|..+.+++.+||..+|++||++.++.+.|.
T Consensus 233 ~~~~-~~~~---~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 FVTG-GGRL---DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHc-CCcC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 2211 1111 122456889999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=293.69 Aligned_cols=236 Identities=24% Similarity=0.324 Sum_probs=185.2
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHH-HHHHcCCCCCCeeeeccccCcceEEEEecc-
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKV-YKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~-l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~- 85 (318)
+.||.|+||.||+|++..+++.||+|++.... .......|... ++.+.| +++..+...+......++||||+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-~~Iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH-PFLVGLHFSFQTADKLYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCC-CCCCceeEEEEcCCeEEEEEeCCC
Confidence 46999999999999999999999999876422 11233444443 444544 66767766667778899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccc
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~ 165 (318)
+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 80 ~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~---- 151 (325)
T cd05602 80 GGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNG---- 151 (325)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE---CCCCCEEEccCCCCcccccCCC----
Confidence 7899888876 4458888999999999999999999999999999999999 4888999999999865332211
Q ss_pred cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCc
Q 021053 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (318)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (318)
......|++.|+|||++.+..++.++|||||||++|+|++|.+||...+.. ..+..+...... ....++
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~-----~~~~~~ 220 (325)
T cd05602 152 ---TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNILNKPLQ-----LKPNIT 220 (325)
T ss_pred ---CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH---HHHHHHHhCCcC-----CCCCCC
Confidence 123446899999999999999999999999999999999999999875543 233333322221 223567
Q ss_pred hhHHHHHHHHhhcCCCCCCChHH
Q 021053 246 AEFASYFHYCQSLTFDQRPDYGF 268 (318)
Q Consensus 246 ~~~~~li~~cl~~~p~~Rp~~~~ 268 (318)
..+.+++.+||..+|.+||++.+
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCC
Confidence 88999999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=303.40 Aligned_cols=250 Identities=20% Similarity=0.224 Sum_probs=197.7
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCC-CcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDT-NEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~-~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
...|.+.+.||.|++|.||+|.+..+ ++.||+|....... ...+.+|+.++..+.| ++++.+..++......|+||
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDH-FGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEEECCEEEEEE
Confidence 34599999999999999999998877 77888886544332 2346679999999876 55666666667778899999
Q ss_pred ecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 83 DLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 83 e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
||+ +++|.+.+... ...+++..+..++.|++.||.|+|++||+||||||+||++ +..+.+||+|||++.....
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCC
Confidence 999 89999887542 2358899999999999999999999999999999999999 4889999999999986543
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+.. ..+..+...... +
T Consensus 222 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~~~~~~~~~-~-- 290 (478)
T PTZ00267 222 SVSL-----DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQQVLYGKYD-P-- 290 (478)
T ss_pred cccc-----ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCC-C--
Confidence 2211 1123456899999999999989999999999999999999999999865432 233333222211 1
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
....++..+.+++..||..+|++||++.++..
T Consensus 291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 12356788999999999999999999987653
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=286.36 Aligned_cols=261 Identities=20% Similarity=0.303 Sum_probs=202.8
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcC-------CCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~-------~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~ 73 (318)
+..++|.+++.||+|+||.||+|++.. +...+|+|.+..... ...+..|+.++..+..|+++..+..+..
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 445899999999999999999998743 234699998875432 2356779999999966677777776767
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~ 137 (318)
.....++|+|++ +++|.+++.... ..++...+..++.|++.||.|||++|++|+||||+||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill- 173 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 173 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE-
Confidence 777899999999 789999997632 237788899999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccch
Q 021053 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (318)
Q Consensus 138 ~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~ 216 (318)
+.++.++|+|||.+.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 174 --~~~~~~kL~dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 174 --TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred --cCCCcEEECCCcccccccccchhh-----ccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 478899999999987543221110 0111233467999999998889999999999999999998 89999764
Q ss_pred hHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
.... .... ....... ......+..+.+++.+||..+|++||++.++.+.|..++..
T Consensus 247 ~~~~---~~~~-~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 247 PVEE---LFKL-LKEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred CHHH---HHHH-HHcCCCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 4322 1111 1111111 12235678999999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=278.41 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=202.5
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++..++|++.+.||.|++|.||+|.+.. ++.||+|.+..... ...+.+|+.++..+.| +++..+..++......+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLRH-PKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCCC-CCccceeEEEecCCCeeee
Confidence 3556889999999999999999998754 46799998765432 3467889999999986 5566666666677789999
Q ss_pred Eecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
+|++ +++|.+++.... ..+++..+..++.|++.||.+||++|++|+||+|+||+++ +++.++|+|||.+......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKED 156 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc---CCCCEEECCcceEEEccCC
Confidence 9999 899999987643 3588999999999999999999999999999999999994 8899999999998876532
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
.... ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+....... ..+. .....+.
T Consensus 157 ~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~-~~~~~~~- 225 (261)
T cd05068 157 IYEA------REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL---QQVD-QGYRMPC- 225 (261)
T ss_pred cccc------cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHH-cCCCCCC-
Confidence 2211 111223457999999998889999999999999999999 99999875543222 2221 1111221
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
....+..+.+++.+||..+|++||++.++.+.|++
T Consensus 226 --~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 --PPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 13567889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=299.92 Aligned_cols=253 Identities=22% Similarity=0.306 Sum_probs=193.3
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
.+|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.++.++.| +++..+...+......|+|
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h-~~iv~~~~~~~~~~~~~lv 79 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADN-EWVVRLYYSFQDKDNLYFV 79 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCC-CcCCeEEEEEEeCCEEEEE
Confidence 36999999999999999999999999999999876432 12356789999999876 5666666666777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 80 MDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEeECCCCccccccc
Confidence 9999 88999988763 458899999999999999999999999999999999999 588999999999975321100
Q ss_pred CCc----------------------------------------cccccCCCCCcccccccccccccCCCCCCcchHHHHH
Q 021053 161 TNR----------------------------------------HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLG 200 (318)
Q Consensus 161 ~~~----------------------------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG 200 (318)
... ...-.......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 000 0000001234689999999999998999999999999
Q ss_pred HHHHHHHhCCCCccchhHhhhHHHHHHHHHh--hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCC---hHHHHH
Q 021053 201 YVLLYFLRGSLPWQGLKAATKKQKYDKICEK--KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD---YGFLKR 271 (318)
Q Consensus 201 ~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~---~~~l~~ 271 (318)
|++|+|++|++||.+.++.. ....+... ....|. ...+++...+++.+++ .+|.+|++ ++++.+
T Consensus 236 vil~elltG~~Pf~~~~~~~---~~~~i~~~~~~~~~p~---~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLE---TQMKVINWQTSLHIPP---QAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHH---HHHHHHccCCCcCCCC---cccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 99999999999998755432 22222221 111221 1245778889888876 59999987 665544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=297.87 Aligned_cols=253 Identities=21% Similarity=0.275 Sum_probs=195.8
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+..++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|+.++..+.| +++..+..++......
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~h-p~iv~~~~~~~~~~~~ 118 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEE
Confidence 34578999999999999999999999999999999875321 22346678888887766 5666666666777889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||++ +..+.+||+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl---~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL---DKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEEecccceecc
Confidence 9999999 8899998874 358899999999999999999999999999999999999 588999999999988654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCC----CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
..... ......||+.|+|||++.+.. ++.++||||+||++|+|++|..||...+.. ..+..+.....
T Consensus 194 ~~~~~------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~---~~~~~i~~~~~ 264 (370)
T cd05621 194 ETGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV---GTYSKIMDHKN 264 (370)
T ss_pred cCCce------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCc
Confidence 32211 113456899999999987543 788999999999999999999999875543 23333332221
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCC--CCChHHHHHH
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKRL 272 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~--Rp~~~~l~~~ 272 (318)
....+. ...++..+.+++..|+..++.+ |+++.++.++
T Consensus 265 ~~~~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 SLNFPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ccCCCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 111111 1245778999999999755443 7888887763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=294.67 Aligned_cols=252 Identities=22% Similarity=0.254 Sum_probs=193.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||+|+||.||+|++..+++.||+|++.... ....+.+|..++..+.| +++..+..++......|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC-QWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEEEEE
Confidence 57999999999999999999999999999999875421 12235667777776654 6677777777778899999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +++|.+++......+++..+..++.|++.||.|||++||+||||||+||++ +..+.+||+|||++.......
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE---cCCCCEEEEeccceeeccCCC
Confidence 9999 899999998755678999999999999999999999999999999999999 488999999999987654332
Q ss_pred CCccccccCCCCCcccccccccccccC-----CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
.. ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...+... .+..+.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~---~~~~i~~~~~~~ 227 (331)
T cd05624 157 TV------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKIMNHEERF 227 (331)
T ss_pred ce------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH---HHHHHHcCCCcc
Confidence 21 1123468999999999875 457889999999999999999999998755432 233333222112
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCC--CCChHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKR 271 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~--Rp~~~~l~~ 271 (318)
+.+.....++..+.+++.+|+...+.+ |++++++.+
T Consensus 228 ~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 228 QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 222222356789999999999865543 346665554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=310.95 Aligned_cols=263 Identities=27% Similarity=0.357 Sum_probs=201.7
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.++..+.| +++..+..+.......+++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~H-PNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-PGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCC-cCcCeEEEEEeeCCEEEEE
Confidence 689999999999999999999999999999998764322 2357889999999987 5555666666667789999
Q ss_pred Eecc-CCCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEec
Q 021053 82 LDLL-GPSLEDLFVYCR----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 150 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~df 150 (318)
|||+ +++|.+++.... ...+...+..++.||+.||.|||++||+||||||+||++ +..+.++|+||
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDF 157 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDW 157 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE---cCCCCEEEEec
Confidence 9999 889999886421 224566788899999999999999999999999999999 48899999999
Q ss_pred cceeeecCCCCCc-----------cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHh
Q 021053 151 GLAKKYRDPTTNR-----------HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (318)
Q Consensus 151 g~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~ 219 (318)
|++.......... ...........||+.|+|||++.+..++.++|||||||++|+|+||..||......
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ 237 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 9997652111000 00111223456899999999999999999999999999999999999999764332
Q ss_pred hhHHHHHHHHHhhccCchHH-HhhcCchhHHHHHHHHhhcCCCCCC-ChHHHHHHHHHHHHh
Q 021053 220 TKKQKYDKICEKKVSTPIEV-LCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLFSR 279 (318)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp-~~~~l~~~l~~~~~~ 279 (318)
.. .. ......|... ....+|+.+.+++.+||..+|++|| +++++.+.++..+..
T Consensus 238 ki---~~---~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 238 KI---SY---RDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred hh---hh---hhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11 11 1111222111 1235788899999999999999996 567788888776543
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=282.86 Aligned_cols=256 Identities=20% Similarity=0.294 Sum_probs=196.9
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcC-----CCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
++.+++|++.+.||.|+||.||+|.+.. ++..||+|.+..... ...+.+|+.+++.++| +++..+..+...
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~ 80 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQ 80 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcC
Confidence 3567899999999999999999998752 356799998754332 2246788999998876 555566666667
Q ss_pred CcceEEEEecc-CCCHHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCe
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCRR---------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~ 144 (318)
....++|||++ +++|.+++..... .++...+..++.|++.||.|||+.|++|+||||+||+++ +++.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~---~~~~ 157 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFT 157 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEc---CCCC
Confidence 77899999998 8899999875321 246778888999999999999999999999999999994 7899
Q ss_pred EEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHH
Q 021053 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ 223 (318)
Q Consensus 145 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~ 223 (318)
++|+|||++.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+...
T Consensus 158 ~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~--- 229 (277)
T cd05062 158 VKIGDFGMTRDIYETDYYR-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ--- 229 (277)
T ss_pred EEECCCCCccccCCcceee-----cCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999987543322110 1112344678999999998889999999999999999999 799998765432
Q ss_pred HHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
....+....... .....+..+.+++.+||..+|++||++.++.+.++
T Consensus 230 ~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 230 VLRFVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 222222211111 12356778999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=285.07 Aligned_cols=259 Identities=21% Similarity=0.308 Sum_probs=202.3
Q ss_pred cccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
+..++|++.+.||.|+||.||+|.+. .++..||+|.++.... .+.+.+|+.+++++.+|+++..+..++...
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 111 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG 111 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence 45578999999999999999999863 3455799998765432 235778999999996667777776666777
Q ss_pred cceEEEEecc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
...++++||+ +++|.+++..... .+++.++..++.|++.||.|||+++++|+||+|+||++ +..+.++|+|||.+
T Consensus 112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~ 188 (302)
T cd05055 112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL---THGKIVKICDFGLA 188 (302)
T ss_pred CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE---cCCCeEEECCCccc
Confidence 7899999998 7899999875332 37899999999999999999999999999999999999 47889999999998
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhh
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKK 232 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~ 232 (318)
.......... ......++..|+|||.+.+..++.++||||+||++|+|++ |..||........ +.......
T Consensus 189 ~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~---~~~~~~~~ 260 (302)
T cd05055 189 RDIMNDSNYV-----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK---FYKLIKEG 260 (302)
T ss_pred ccccCCCcee-----ecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH---HHHHHHcC
Confidence 7554322110 1122345678999999998889999999999999999998 9999976543221 11111111
Q ss_pred ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
...+ .....+..+.+++.+||..+|++||++.++.+.|.++
T Consensus 261 ~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 YRMA---QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CcCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111 1124577899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=282.92 Aligned_cols=244 Identities=22% Similarity=0.297 Sum_probs=192.4
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
.|+..+.||.|+||+||+|.+..+++.||+|.+..... ...+.+|+.++..++|+ ++..+..++......++++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~-~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQ-FVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCc-CceeEEEEEecCCEEEEEE
Confidence 47889999999999999999999999999998764321 22467799999999774 4555555556667899999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|++ +++|.+.+.... ..+++..+..++.|++.||.|||++||+||||+|+||++ ++.+.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 80 TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred EeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE---CCCCCEEEecCCcceecCCCC
Confidence 999 778888776533 358999999999999999999999999999999999999 477899999999987543221
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
. .....++..|+|||++.+..++.++|+|||||++|+|++|..||....+......+... ........
T Consensus 157 ~--------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~----~~~~~~~~ 224 (285)
T cd05632 157 S--------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR----VLETEEVY 224 (285)
T ss_pred c--------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh----hhcccccc
Confidence 1 12346789999999999888999999999999999999999999875443322222221 11111223
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYG 267 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~ 267 (318)
...++..+.+++..||..+|++||++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 225 SAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred CccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 345778899999999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=281.23 Aligned_cols=250 Identities=27% Similarity=0.439 Sum_probs=197.9
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChh----HHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~----~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
|++++.||+|+||.||+|++..+++.||+|++........ ..+|+.+++.++| +++..+..+.......+++|++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRH-PNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTB-TTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccc-cccccccccccccccccccccc
Confidence 8999999999999999999999999999999887654332 2458899999955 6666676666667889999999
Q ss_pred cCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 LGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+.+ +|.+++.. ...++...+..++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~-- 153 (260)
T PF00069_consen 80 CPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL---DENGEVKLIDFGSSVKLSENNE-- 153 (260)
T ss_dssp ETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE---STTSEEEESSGTTTEESTSTTS--
T ss_pred cccccccccccc-cccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccc--
Confidence 955 99999984 4568999999999999999999999999999999999999 5899999999999876421111
Q ss_pred cccccCCCCCccccccccccccc-CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 164 HIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
......++..|+|||++. +..++.++|+||+|+++|+|++|..||...........+..........+.. ...
T Consensus 154 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 227 (260)
T PF00069_consen 154 -----NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-QSR 227 (260)
T ss_dssp -----EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-SHT
T ss_pred -----ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-ccc
Confidence 123456788999999998 7789999999999999999999999998763333333333332211111110 011
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+..+.+++..||+.+|++||++.++.+
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12368999999999999999999988764
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=279.64 Aligned_cols=246 Identities=23% Similarity=0.279 Sum_probs=197.2
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
+|++.+.||.|+||.||++.+..+++.+++|.+.... .......|+.++..+.| +++..+...+......++++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKH-PNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCC-CCcceEEEEEEECCEEEEEEee
Confidence 5899999999999999999999999999999875432 23456778889988876 5566666666777889999999
Q ss_pred c-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 85 L-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 85 ~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
+ +++|.+++... ...++...+..++.|++.||.+||++|++|+||+|+||++ ++.+.++|+|||.+........
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE---CCCCcEEEcccCcceeeccccc-
Confidence 9 78998888653 3347899999999999999999999999999999999999 4889999999999876543322
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
......++..|+|||++.+..++.++|+||||+++|+|++|..||...+... ....+...... + ...
T Consensus 156 ------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~---~~~~~~~~~~~-~---~~~ 222 (255)
T cd08219 156 ------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN---LILKVCQGSYK-P---LPS 222 (255)
T ss_pred ------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH---HHHHHhcCCCC-C---CCc
Confidence 1123467888999999998889999999999999999999999998654322 22222222111 1 123
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.++..+.+++.+||..+|++||++.++..
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 46778999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=279.51 Aligned_cols=254 Identities=23% Similarity=0.381 Sum_probs=197.8
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++..++|++.+.||.|++|.||+|.+. ++..+++|.+..... ...+.+|+.++++++|++.+ .+..+.. ....+++
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~-~~~~~~~-~~~~~lv 78 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV-QLYAVVS-EEPIYIV 78 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceE-EEEeEEC-CCCcEEE
Confidence 356789999999999999999999875 456689998775433 34678999999999875444 4433332 3457899
Q ss_pred Eecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
||++ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++ +++.++|+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~---~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEe---CCceEEeCCceeeeeccCc
Confidence 9999 789999987532 3488999999999999999999999999999999999994 7889999999998765432
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
... ......++..|+|||++.+..++.++|+||||+++|+|++ |.+||.+.+..+ ....+.. ....+.
T Consensus 156 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~-~~~~~~- 224 (260)
T cd05070 156 EYT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQVER-GYRMPC- 224 (260)
T ss_pred ccc------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHc-CCCCCC-
Confidence 211 1112234567999999988889999999999999999999 999998755432 2222221 112221
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
....|..+.+++.+||..+|++||++.++.+.|++
T Consensus 225 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 225 --PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 23567889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=277.49 Aligned_cols=246 Identities=21% Similarity=0.332 Sum_probs=192.9
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCC
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~ 88 (318)
+.||.|+||.||+|.+..+++.||+|....... ...+.+|+.+++.+.| +++..+..++......++|+||+ +++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 468999999999999998999999998664332 2357889999999876 55666666666677899999999 889
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccccc
Q 021053 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (318)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 168 (318)
|.+++......+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.+||+|||.+..........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~----- 151 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYAS----- 151 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE---cCCCcEEECccccCcccccccccc-----
Confidence 999987655568899999999999999999999999999999999999 478899999999987543221110
Q ss_pred CCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchh
Q 021053 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (318)
Q Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (318)
.......+..|+|||.+.+..++.++|||||||++|+|++ |..||............ ......+ ....+|..
T Consensus 152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~----~~~~~~~---~~~~~~~~ 224 (252)
T cd05084 152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI----EQGVRLP---CPELCPDA 224 (252)
T ss_pred cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH----HcCCCCC---CcccCCHH
Confidence 0111123456999999998889999999999999999998 99999765443222211 1122222 22356789
Q ss_pred HHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 248 FASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 248 ~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
+.+++.+||..+|++||++.++.+.|.
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=295.44 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=195.0
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+..++|++.+.||.|+||.||+|++..+++.||+|++.... ....+.+|..++..++| +++..+...+......
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~h-p~iv~~~~~~~~~~~~ 118 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFYAFQDDRYL 118 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEcCCEE
Confidence 44589999999999999999999999999999999875321 12245678888887765 6666666666777889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
++||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll---~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE---CCCCCEEEEeCCceeEcC
Confidence 9999999 8899998874 348899999999999999999999999999999999999 488999999999988654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCC----CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||...+.. ..+..+.....
T Consensus 194 ~~~~~------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~ 264 (371)
T cd05622 194 KEGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMNHKN 264 (371)
T ss_pred cCCcc------cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCC
Confidence 32211 112456899999999987543 788999999999999999999999875543 23333332221
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCC---CCChHHHHHH
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQ---RPDYGFLKRL 272 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~---Rp~~~~l~~~ 272 (318)
..+.+. ...++..+.+++..|+. +|.. |++++++.+.
T Consensus 265 ~~~~~~-~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 265 SLTFPD-DNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRH 304 (371)
T ss_pred cccCCC-cCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcC
Confidence 111111 13567889999999998 4444 6677776664
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=284.33 Aligned_cols=259 Identities=20% Similarity=0.297 Sum_probs=201.8
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCC-----CcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~-----~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
+-.++|++.+.||+|+||.||+|.+... ...+++|.+...... ..+.+|+.++..+..|+++..+..+....
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 3457899999999999999999987643 368999987654322 34678999999996567777776666667
Q ss_pred cceEEEEecc-CCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccC
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 139 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~ 139 (318)
...+++|||+ +++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||+++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~-- 166 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT-- 166 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc--
Confidence 7899999998 88999998642 23478889999999999999999999999999999999994
Q ss_pred CCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhH
Q 021053 140 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKA 218 (318)
Q Consensus 140 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~ 218 (318)
+++.+||+|||.+.......... ......++..|+|||++.+..++.++|||||||++|++++ |..||.....
T Consensus 167 -~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 167 -EDHVMKIADFGLARDIHHIDYYR-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred -CCCeEEeCcccccccccccccee-----ccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 78999999999987654322111 1112234567999999988889999999999999999998 9999987544
Q ss_pred hhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 219 ATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 219 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
..... .+. ..... ......+..+.+++.+||..+|++|||+.++.+.|++++
T Consensus 241 ~~~~~---~~~-~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 241 EELFK---LLK-EGYRM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHH---HHH-cCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 32221 111 11111 112355778999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=289.75 Aligned_cols=260 Identities=22% Similarity=0.317 Sum_probs=198.9
Q ss_pred ccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeee-eccccC
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIK-WYGVDG 75 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~-~~~~~~ 75 (318)
-.++|++.+.||.|+||.||+|.+. .+++.||+|.+...... ..+.+|+.++..+.+|+++..+. .+....
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 4579999999999999999999853 45678999988654322 35778999999997777776664 344455
Q ss_pred cceEEEEecc-CCCHHHHHHHhc---------------------------------------------------------
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCR--------------------------------------------------------- 97 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~--------------------------------------------------------- 97 (318)
...+++|||+ +++|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 6789999999 889999886421
Q ss_pred ---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccccc
Q 021053 98 ---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (318)
Q Consensus 98 ---------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 168 (318)
..++......++.|++.||.|||++|++||||||+||++ +.++.+||+|||++......... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~-----~ 236 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SENNVVKICDFGLARDIYKDPDY-----V 236 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cCCCcEEEEecccccccccCcch-----h
Confidence 125677788899999999999999999999999999999 47889999999998764322110 0
Q ss_pred CCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchh
Q 021053 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (318)
Q Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (318)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..... .......+.+ ...++.
T Consensus 237 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~-~~~~~~~~~~---~~~~~~ 310 (343)
T cd05103 237 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRR-LKEGTRMRAP---DYTTPE 310 (343)
T ss_pred hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHHH-HhccCCCCCC---CCCCHH
Confidence 1122344567999999988889999999999999999997 999997643321 11111 1111111111 234678
Q ss_pred HHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 248 FASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 248 ~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
+.+++..||..+|++||++.++.+.|+.++.
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=277.49 Aligned_cols=253 Identities=22% Similarity=0.374 Sum_probs=197.1
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+..++|++.+.||.|++|.||+|.+..++ .+++|.+..... ...+.+|+.+++.+.|++.+. +..+.. ....+++|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~-~~~~~~-~~~~~~v~ 79 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVP-LYAVVS-EEPIYIVT 79 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCccHHHHHHHHHHHHhCCCCCeee-EEEEEc-CCCcEEEE
Confidence 45688999999999999999999886554 589998765433 346788999999998765554 433332 34688999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|++ +++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||++ ++++.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV---GDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE---cCCCeEEECCCccceEccCCc
Confidence 999 679999987532 347889999999999999999999999999999999999 488999999999987653322
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. ......++..|+|||...+..++.++|+||||+++|+|+| |.+||.+..+..... .+.. ....+
T Consensus 157 ~~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~~~~-~~~~~--- 223 (260)
T cd05069 157 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE---QVER-GYRMP--- 223 (260)
T ss_pred cc------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHc-CCCCC---
Confidence 11 1122345677999999988889999999999999999999 999998765433222 2221 11122
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
.....|..+.+++.+||..+|++||+++++.+.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 123567889999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=292.78 Aligned_cols=253 Identities=22% Similarity=0.276 Sum_probs=194.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||+|+||.||++++..+++.+|+|++.... ....+.+|..++..+.| +++..+..++......++|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN-QWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCC-CCEeeEEEEEecCCEEEEE
Confidence 47999999999999999999999999999999875321 12235667777777655 6666666666777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE---CCCCCEEEeecchheecccCC
Confidence 9999 899999998755668999999999999999999999999999999999999 588999999999987643322
Q ss_pred CCccccccCCCCCcccccccccccccC-----CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.. +.+..+.......
T Consensus 157 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~ 227 (332)
T cd05623 157 TV------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV---ETYGKIMNHKERF 227 (332)
T ss_pred cc------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH---HHHHHHhCCCccc
Confidence 21 1123468999999999863 35788999999999999999999999875543 2333333322222
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCC--CCChHHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKRL 272 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~--Rp~~~~l~~~ 272 (318)
+.+.....++..+.+++.+|+..++++ |+++.++.++
T Consensus 228 ~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 222222456889999999988654443 5777776654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=282.78 Aligned_cols=253 Identities=19% Similarity=0.273 Sum_probs=196.4
Q ss_pred ceeeEeeeeccCcccEEEEEEEc----CCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
.+|++.+.||+|+||.||+|.+. .++..|++|.+...... ..+.+|+.+++.+.| +++..+..+.......+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHH-PNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC-CCeeeEEEEEecCCceE
Confidence 57899999999999999999853 45678999987643322 357789999999976 55555655556667899
Q ss_pred EEEecc-CCCHHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCC
Q 021053 80 LVLDLL-GPSLEDLFVYCR----------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~----------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~ 142 (318)
++||++ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||++ +++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili---~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEE---cCC
Confidence 999999 789999885321 236788889999999999999999999999999999999 478
Q ss_pred CeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhh
Q 021053 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATK 221 (318)
Q Consensus 143 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~ 221 (318)
+.+||+|||++.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.++...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~ 235 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYR-----VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV 235 (283)
T ss_pred CcEEeccccccccccCCccee-----cccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 899999999987654322111 1123345677999999988889999999999999999999 9999987554322
Q ss_pred HHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
.+.. . .....+ ....++..+.+++..||..+|++||++.++.+.+..
T Consensus 236 ~~~~---~-~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 236 IEMV---R-KRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHH---H-cCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 2221 1 111111 224568899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=284.08 Aligned_cols=261 Identities=19% Similarity=0.292 Sum_probs=195.8
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCC--------------cEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCe
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTN--------------EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPN 67 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~--------------~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~ 67 (318)
-.++|++.+.||+|+||.||+|.+.+++ ..||+|.+...... ..+.+|++++..++| +++..
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h-~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKN-PNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCcCe
Confidence 3579999999999999999999875432 35899987654322 357789999999987 45666
Q ss_pred eeeccccCcceEEEEecc-CCCHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcee
Q 021053 68 IKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR-----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135 (318)
Q Consensus 68 i~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil 135 (318)
+..++......++||||+ +++|.+++.... ..++...+..++.|++.||.|||++|++|+||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 655556667899999999 889999886431 12577888999999999999999999999999999999
Q ss_pred eccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh--CCCCc
Q 021053 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR--GSLPW 213 (318)
Q Consensus 136 ~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t--g~~pf 213 (318)
++ +++.+||+|||++......... .......++..|+|||++.+..++.++|+|||||++|+|++ |..||
T Consensus 162 l~---~~~~~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~ 233 (295)
T cd05097 162 VG---NHYTIKIADFGMSRNLYSGDYY-----RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY 233 (295)
T ss_pred Ec---CCCcEEecccccccccccCcce-----eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 94 7889999999998754322211 11123344678999999988889999999999999999998 77888
Q ss_pred cchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 214 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
...+...........................|..+.+++.+||+.+|++||++.++.+.|.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 234 SLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred cccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 7654432222221111111111101112345788999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=277.83 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=200.1
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
.++|++.+.||.|++|.||+|.+..++..+++|++.... ....+.+|+.++..++| +++..+..+.......+++||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRH-PNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCC-CChhceEEEEEeCCEEEEEEe
Confidence 478999999999999999999999888999999876543 23567889999999976 555566666667778999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
++ +++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||++ ++++.++|+|||.+........
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE---CCCCCEEECccccchhhhhhhh-
Confidence 99 678988887754679999999999999999999999999999999999999 4889999999999876543221
Q ss_pred ccccccCCCCCcccccccccccccCC---CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
......++..|+|||.+.+. .++.++|+|||||++|+|++|.+||...+...... .+.......+...
T Consensus 157 ------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~---~~~~~~~~~~~~~ 227 (262)
T cd06613 157 ------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF---LISKSNFPPPKLK 227 (262)
T ss_pred ------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhccCCCcccc
Confidence 11234567889999998877 78899999999999999999999998755432221 1211211222212
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
....++..+.+++.+||..+|.+||++.++..
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 228 DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 22345778999999999999999999988764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=283.87 Aligned_cols=260 Identities=18% Similarity=0.302 Sum_probs=203.1
Q ss_pred cccceeeEeeeeccCcccEEEEEEEc-------CCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHV-------DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~-------~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~ 73 (318)
+..++|++.+.||.|+||.||+|++. .++..|++|....... ...+.+|+.++..+.+|+++..+.....
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 45689999999999999999999753 2345799998764322 2467889999999966677877776667
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~ 137 (318)
.....+++|||+ +++|.+++.... ..++...+..++.||+.||.|||++|++||||||+||+++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~ 171 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT 171 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEc
Confidence 777899999999 789999987532 2367788899999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccch
Q 021053 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (318)
Q Consensus 138 ~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~ 216 (318)
.++.+||+|||.+.......... ......++..|+|||++.+..++.++||||||+++|++++ |..||...
T Consensus 172 ---~~~~~kl~D~g~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 172 ---ENNVMKIADFGLARDVNNIDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred ---CCCcEEECCCccceecccccccc-----cccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 78899999999987654322211 1122344567999999998889999999999999999998 89999765
Q ss_pred hHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
..... ...+. ...... ....++..+.+++.+||..+|++||++.++.+.|.+++.
T Consensus 244 ~~~~~---~~~~~-~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 244 PVEEL---FKLLK-EGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred CHHHH---HHHHH-cCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 43322 22221 111111 123567889999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=282.78 Aligned_cols=260 Identities=23% Similarity=0.307 Sum_probs=204.2
Q ss_pred cccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCCCC--hhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
+-.++|.+.+.||.|+||.||+|.+. .++..+++|.+...... ..+.+|+.++..+.| +++..+..++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 80 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH-EHIVKFYGVCGDGD 80 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCC-CCcceEEEEEccCC
Confidence 34578999999999999999999864 24456888987654432 357889999999876 56666666666777
Q ss_pred ceEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCC
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 140 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~ 140 (318)
..++|||++ +++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||++ +
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~---~ 157 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV---G 157 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE---c
Confidence 899999999 899999987532 237888999999999999999999999999999999999 4
Q ss_pred CCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHh
Q 021053 141 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAA 219 (318)
Q Consensus 141 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~ 219 (318)
.++.++|+|||.+......... .......++..|+|||++.+..++.++|||||||++|+|++ |..||...+..
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 232 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232 (291)
T ss_pred cCCcEEECCCCcccccCCCcee-----ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 8899999999998754432211 01223455788999999998889999999999999999999 99999775543
Q ss_pred hhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 220 TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 220 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
. ....+...... ......|..+.+++.+||..+|++||++.++.+.|.++...
T Consensus 233 ~---~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 233 E---VIECITQGRVL----ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred H---HHHHHhCCCCC----CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 2 22222221111 11234678899999999999999999999999999988553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=294.38 Aligned_cols=236 Identities=24% Similarity=0.366 Sum_probs=189.2
Q ss_pred eeeccCcccEEEEEEEc---CCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 13 RKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~---~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
+.||+|+||.||++++. .+++.||+|++.... ......+|+.++.+++| +++..+..++......|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNH-PFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCC-CCcccEEEEEEcCCEEEEEEcCC
Confidence 67999999999999874 578899999876432 22356778999999976 55666666666778899999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 86 -~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~--- 153 (318)
T cd05582 81 RGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEK--- 153 (318)
T ss_pred CCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCC---
Confidence 7899988875 4458999999999999999999999999999999999999 4888999999999875433211
Q ss_pred ccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcC
Q 021053 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (318)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+.. ..+..+.......| ..+
T Consensus 154 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~i~~~~~~~p-----~~~ 221 (318)
T cd05582 154 ----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK---ETMTMILKAKLGMP-----QFL 221 (318)
T ss_pred ----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH---HHHHHHHcCCCCCC-----CCC
Confidence 112346789999999999888999999999999999999999999875443 22333333332222 346
Q ss_pred chhHHHHHHHHhhcCCCCCCChHH
Q 021053 245 PAEFASYFHYCQSLTFDQRPDYGF 268 (318)
Q Consensus 245 ~~~~~~li~~cl~~~p~~Rp~~~~ 268 (318)
+..+.+++..||+.||++||++.+
T Consensus 222 ~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 222 SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 788999999999999999999654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=282.00 Aligned_cols=240 Identities=20% Similarity=0.256 Sum_probs=186.5
Q ss_pred eccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCC
Q 021053 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (318)
Q Consensus 15 lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~ 88 (318)
||.|+||.||++++..+++.||+|.+.... .......|+++++.++| +++..+...+......+++|||+ +++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCC-CcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 699999999999999999999999875322 12345668999999966 55656655666677899999999 889
Q ss_pred HHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccccc
Q 021053 89 LEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (318)
Q Consensus 89 L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 167 (318)
|.+++.... ..+++..+..++.|++.||.|||++|++||||+|+||++ +..+.++|+|||.+........
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~------ 150 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKT------ 150 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE---cCCCCEEEeeceeeeecCCCce------
Confidence 988876433 358888999999999999999999999999999999999 4888999999999876543221
Q ss_pred cCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhh-HHHHHHHHHhhccCchHHHhhcCch
Q 021053 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKICEKKVSTPIEVLCKSHPA 246 (318)
Q Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (318)
.....++..|+|||++.+..++.++||||+||++|+|++|..||........ ............ ......++.
T Consensus 151 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 224 (277)
T cd05607 151 --ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV----KFEHQNFTE 224 (277)
T ss_pred --eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc----ccccccCCH
Confidence 1234678899999999988899999999999999999999999976432211 112222111111 111235688
Q ss_pred hHHHHHHHHhhcCCCCCCChHHHH
Q 021053 247 EFASYFHYCQSLTFDQRPDYGFLK 270 (318)
Q Consensus 247 ~~~~li~~cl~~~p~~Rp~~~~l~ 270 (318)
.+.++++.||..+|++||++.++.
T Consensus 225 ~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 225 ESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHHHHhccCHhhCCCCccch
Confidence 899999999999999999996543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=282.91 Aligned_cols=248 Identities=20% Similarity=0.268 Sum_probs=193.1
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
.|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+|+.++..+.|++ +..+...+......+++|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~-i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF-VVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCC-eeeeeEEEecCCEEEEEE
Confidence 47889999999999999999999999999998754321 124567999999997754 444444445567899999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|++ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||++ +..+.++|+|||++.......
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE---CCCCCEEEeeccceeecCCCc
Confidence 999 789988886433 358899999999999999999999999999999999999 488899999999987543221
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
. .....++..|+|||++.+..++.++|+||+||++|+|++|..||................. ......
T Consensus 157 ~--------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~----~~~~~~ 224 (285)
T cd05630 157 T--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK----EVQEEY 224 (285)
T ss_pred c--------ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh----hhhhhc
Confidence 1 1233678999999999988899999999999999999999999986432211112222111 111223
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCC-----hHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~-----~~~l~~ 271 (318)
...+++.+.+++..||..+|++||+ +.++.+
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 3467788999999999999999999 566655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=278.18 Aligned_cols=255 Identities=16% Similarity=0.278 Sum_probs=201.1
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCC---CcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
.++|++.+.||+|+||.||+|.+..+ ...|++|.+...... ..+.+|+.++..++| +++..+..........+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDH-PNIIRLEGVVTKSRPVM 81 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCC-CCcceEeEEEecCCceE
Confidence 46899999999999999999998643 457999987654322 356779999999976 55666655556677899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
++||++ +++|.+++......+++..+..++.|++.||.|||+++++|+||+|+||++ ++++.++|+|||.+.....
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCCEEECccchhhcccc
Confidence 999999 789999998755568999999999999999999999999999999999999 4888999999999887642
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
..... ......++..|+|||.+.+..++.++||||||+++|++++ |..||....... ....+.. ....+.
T Consensus 159 ~~~~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~-~~~~~~ 229 (266)
T cd05033 159 SEATY-----TTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAVED-GYRLPP 229 (266)
T ss_pred cccce-----eccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHHHc-CCCCCC
Confidence 11110 0112234567999999998889999999999999999998 999997654332 2222221 112221
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
. ...|..+.+++.+||..+|++||++.++.+.|.++
T Consensus 230 ~---~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 P---MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 35688999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=312.66 Aligned_cols=259 Identities=20% Similarity=0.278 Sum_probs=211.1
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCC-----cEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTN-----EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~-----~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
-..+-++.+.||.|.||.||.|...... ..||+|.+..... ...+.+|..++..+.|++.+..+..+.. ..
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~ 768 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SG 768 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CC
Confidence 3456789999999999999999876332 3488997765543 3478999999999999666666666655 77
Q ss_pred ceEEEEecc-CCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEe
Q 021053 77 DNVLVLDLL-GPSLEDLFVYC------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~d 149 (318)
..+|++||| +|+|..|+.+. ...++..+...++.+|++|+.||++++++||||..+|+|++ ....+|++|
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~---~~r~VKIaD 845 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLD---ERRVVKIAD 845 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeec---ccCcEEEcc
Confidence 899999999 99999999987 55688999999999999999999999999999999999994 889999999
Q ss_pred ccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHH
Q 021053 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKI 228 (318)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i 228 (318)
||+|+....... |+......-...|||||.+....++.++|||||||++||++| |..||...++.+....+.+
T Consensus 846 FGlArDiy~~~y-----yr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~- 919 (1025)
T KOG1095|consen 846 FGLARDIYDKDY-----YRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE- 919 (1025)
T ss_pred cchhHhhhhchh-----eeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh-
Confidence 999984332222 112222234578999999999999999999999999999999 9999998776544433322
Q ss_pred HHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
+.++..| ..+|+.++++|.+||+.+|++||++..+.+.+++..+.
T Consensus 920 -ggRL~~P-----~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 920 -GGRLDPP-----SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred -CCccCCC-----CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 3355544 46799999999999999999999999999988876543
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=280.83 Aligned_cols=251 Identities=18% Similarity=0.309 Sum_probs=195.7
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeecccc------Ccc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVD------GED 77 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~------~~~ 77 (318)
.+++|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+..|+.++..+.+|+++..+..++.. ...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~ 83 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 83 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence 35789999999999999999999999999999998765433 34678899999998766777666444332 245
Q ss_pred eEEEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
.++++|++ +++|.+++.... ..+++..+..++.|++.||.|||+++|+|+||+|+||++ ++++.++|+|||++..
T Consensus 84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCcee
Confidence 89999999 779999887633 358899999999999999999999999999999999999 4888999999999876
Q ss_pred ecCCCCCccccccCCCCCccccccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHH
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~ 230 (318)
...... ......++..|+|||++. +..++.++||||+||++|+|++|..||............ ..
T Consensus 161 ~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~---~~ 230 (272)
T cd06637 161 LDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PR 230 (272)
T ss_pred cccccc-------cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH---hc
Confidence 533221 123456788999999986 335788999999999999999999999765433222111 11
Q ss_pred hhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..........++..+.+++.+||..+|.+||++.++.+
T Consensus 231 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 ---NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ---CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11111112356788999999999999999999988764
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=291.03 Aligned_cols=278 Identities=19% Similarity=0.257 Sum_probs=194.7
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
..+|++.+.||.|+||.||+|.+..++..||+|+.... ....|+.++..++| +++..+..++......++|++++
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~----~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~ 139 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG----TTLIEAMLLQNVNH-PSVIRMKDTLVSGAITCMVLPHY 139 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc----ccHHHHHHHHhCCC-CCCcChhheEEeCCeeEEEEEcc
Confidence 45799999999999999999999999999999975432 34679999999987 55666655556677899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccc
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~ 165 (318)
.++|.+++......+++..+..++.||+.||.|||++||+||||||+||++ +..+.+||+|||.+........
T Consensus 140 ~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~---- 212 (357)
T PHA03209 140 SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPA---- 212 (357)
T ss_pred CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEecCccccccccCcc----
Confidence 999999988766679999999999999999999999999999999999999 4889999999999864322111
Q ss_pred cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhC-CCCccchhHh------hhHHHHHHHHHhhccCchH
Q 021053 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAA------TKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg-~~pf~~~~~~------~~~~~~~~i~~~~~~~~~~ 238 (318)
.....+|..|+|||++.+..++.++|||||||++|+|+++ +++|...... .....+..+.......| .
T Consensus 213 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~-~ 287 (357)
T PHA03209 213 ----FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHP-E 287 (357)
T ss_pred ----cccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccCh-h
Confidence 1234678999999999998999999999999999999985 4444431110 01111222222111111 1
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH-HHHhcCCchhHHHhhhcCCccccccccee
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD-LFSREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~-~~~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
.+.... ...+....+......|..... ...+.. -+..+..+++.+||++||++|||+.|.+.
T Consensus 288 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~ 350 (357)
T PHA03209 288 EFPRDP---GSRLVRGFIEYASLERQPYTR-YPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN 350 (357)
T ss_pred hcCCCC---ccHHHHHHHhhcccCCCcccc-cHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence 111100 112222222222222221111 111111 12345567889999999999999887654
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=277.54 Aligned_cols=254 Identities=21% Similarity=0.361 Sum_probs=200.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++..++|++.+.||+|+||.||+|... +++.||+|.+..... ...+.+|+.++..+.| +++..+..+. .....+++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~-~~~~~~~v 78 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQH-PRLVRLYAVV-TQEPIYII 78 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcCC-cCeeeEEEEE-ccCCcEEE
Confidence 467899999999999999999999865 467899998775443 3467889999999976 4554554443 34568999
Q ss_pred Eecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 82 LDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
+|++ +++|.+++... +..++......++.|++.||.|||+.|++|+||+|+||++ ++++.++|+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV---SETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE---cCCCCEEEccCcceeecCCC
Confidence 9999 88999988653 3357889999999999999999999999999999999999 48889999999998765422
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
... ......++..|+|||++.+..++.++||||||+++|++++ |.+||.+.+.......+. .....+
T Consensus 156 ~~~------~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~----~~~~~~-- 223 (260)
T cd05067 156 EYT------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE----RGYRMP-- 223 (260)
T ss_pred Ccc------cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH----cCCCCC--
Confidence 211 1122344678999999988889999999999999999999 999998765433222221 121222
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
.....|..+.+++.+||..+|++||+++++...|++
T Consensus 224 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 -RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 123567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=281.76 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=201.5
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
..+|++.+.||.|++|.||+|.+.. +..+++|++..... ...+..|+.+++.++| +++..+..+.......+++||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRH-KHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCC-cchhheeeeEecCCCeEEEEe
Confidence 4679999999999999999999987 78899998765543 3467889999999976 556566666667778999999
Q ss_pred cc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 84 LL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 84 ~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
++ +++|.+++... +..++...+..++.|++.||.|||++|++|+||+|+||+++ .++.+||+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~---~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG---EDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc---CCceEEEccccchhhcCCccc
Confidence 99 78999998753 33588999999999999999999999999999999999994 888999999999876543221
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
. .....++..|++||.+.+..++.++||||||+++|+|++ |+.||...+... .+..+.. ....+.
T Consensus 160 ~-------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~-~~~~~~--- 225 (261)
T cd05148 160 L-------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQITA-GYRMPC--- 225 (261)
T ss_pred c-------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHHh-CCcCCC---
Confidence 1 112344667999999988889999999999999999998 899998755432 2222221 111221
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
....|..+.+++.+||..+|.+||++.++.+.|++
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 23567889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=279.68 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=193.0
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
++|++.+.||+|++|.||+|.+..+++.||+|++..... ...+.+|+.++..+.| +++..+..+.......++++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKH-PNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCC-CCEeeeeeEEeeCCEEEEEE
Confidence 589999999999999999999998999999997754322 2346789999999986 45555555556677899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
||+.+++.+.+......+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI---TKQGQIKLCDFGFARILTGPGDD 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE---cCCCcEEECccccceecCCCccc
Confidence 999555555544434568999999999999999999999999999999999999 47889999999998865433211
Q ss_pred ccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh---------
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--------- 232 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~--------- 232 (318)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|.+||.+.++.+....+.......
T Consensus 157 -------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 157 -------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred -------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcc
Confidence 123356788999999876 457889999999999999999999998765543332222211100
Q ss_pred --------------ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 233 --------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 233 --------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+.+......+..+.+++.+||..+|++||++.++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 001112223456778889999999999999999887654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=278.98 Aligned_cols=259 Identities=17% Similarity=0.214 Sum_probs=196.4
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCc----EEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~----~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
+-.++|++.+.||.|+||.||+|.+..++. .+++|........ ..+..|+..+..+.|+ ++..+..+.. ..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~-~iv~~~~~~~-~~ 81 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHA-YIVRLLGICP-GA 81 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCC-CcceEEEEEC-CC
Confidence 345789999999999999999999876665 4677766543221 2345556666777664 4555544433 34
Q ss_pred ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..++++|++ +++|.+++......+++..+..++.||+.||.|||++|++|+||||+||++ +.++.+||+|||.+..
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili---~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL---KSDSIVQIADFGVADL 158 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE---cCCCcEEEcCCcccee
Confidence 567888888 899999998756678999999999999999999999999999999999999 5889999999999876
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
........ ......++..|+|||.+.+..++.++|||||||++||+++ |..||.+........ +......
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~----~~~~~~~ 229 (279)
T cd05111 159 LYPDDKKY-----FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD----LLEKGER 229 (279)
T ss_pred ccCCCccc-----ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHCCCc
Confidence 53222111 1123446678999999998889999999999999999998 999998765432222 2222222
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
.+.. ..++..+..++.+||..+|++||++.++.+.|..+..+
T Consensus 230 ~~~~---~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 230 LAQP---QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CCCC---CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 2211 23567899999999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=281.59 Aligned_cols=248 Identities=25% Similarity=0.430 Sum_probs=190.9
Q ss_pred eEeeeeccCcccEEEEEEEc----CCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 10 KLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 10 ~~~~~lg~G~~~~v~~~~~~----~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
.+.+.||.|.||.||+|... ..+..|+||.++.... ...+.+|+..+.+++| +++..+..+.......++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRH-PNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSB-TTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccc-cccccccccccccccccccc
Confidence 57899999999999999987 3457899999865433 3478889999999955 66666665555667799999
Q ss_pred ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|++ .++|.+++... ...++...+..++.||+.||.|||+++++|+||+++||++ +.++.+||+|||.+.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccc
Confidence 999 68999999986 4568999999999999999999999999999999999999 488999999999987763221
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. ...........|+|||.+.+..++.++||||||+++||+++ |+.||...+..... ..+. .....+
T Consensus 158 ~~-----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~---~~~~-~~~~~~--- 225 (259)
T PF07714_consen 158 KY-----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEII---EKLK-QGQRLP--- 225 (259)
T ss_dssp SE-----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHH---HHHH-TTEETT---
T ss_pred cc-----cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccc-ccccce---
Confidence 11 11223456778999999998889999999999999999999 78999876543322 2222 122222
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
....+|..+.+++..||+.+|++||++.++.+.|
T Consensus 226 ~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2245788999999999999999999999998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=283.58 Aligned_cols=262 Identities=19% Similarity=0.286 Sum_probs=196.0
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcC----------------CCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCC
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVD----------------TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSG 64 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~----------------~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~ 64 (318)
+..++|++.+.||.|+||.||+|.+.. +...||+|++..... ...+.+|+.++..++| ++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~-~~ 80 (296)
T cd05095 2 FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKD-PN 80 (296)
T ss_pred CChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CC
Confidence 446789999999999999999986532 344689998765432 2357789999999976 55
Q ss_pred CCeeeeccccCcceEEEEecc-CCCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 021053 65 IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 133 (318)
Q Consensus 65 ~~~i~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~N 133 (318)
+..+..++......+++||++ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 666666666677899999999 789999987532 125677899999999999999999999999999999
Q ss_pred eeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh--CCC
Q 021053 134 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR--GSL 211 (318)
Q Consensus 134 il~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t--g~~ 211 (318)
|+++ .++.++|+|||.+.......... ......++..|++||...+..++.++|+|||||++|+|++ |..
T Consensus 161 ili~---~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~ 232 (296)
T cd05095 161 CLVG---KNYTIKIADFGMSRNLYSGDYYR-----IQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ 232 (296)
T ss_pred EEEc---CCCCEEeccCcccccccCCccee-----ccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCC
Confidence 9994 78899999999987543322110 1122234577999999888889999999999999999998 789
Q ss_pred CccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 212 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 212 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
||...+..........................+|..+.+++.+||..+|++||++.++.+.|.
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 233 PYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 997654433222221111110000000011245778999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=293.01 Aligned_cols=235 Identities=24% Similarity=0.299 Sum_probs=184.1
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHH-HHHHcCCCCCCeeeeccccCcceEEEEecc-
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKV-YKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~-l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~- 85 (318)
+.||.|+||.||+|.+..+++.||+|++.... .......|..+ ++.++ |+++..+...+......++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEEEcCCC
Confidence 46899999999999999999999999876431 11234455544 44444 466667766667778899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccc
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~ 165 (318)
+++|...+.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~---- 151 (325)
T cd05604 80 GGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSD---- 151 (325)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCC----
Confidence 7888888765 4568999999999999999999999999999999999999 4889999999999864322111
Q ss_pred cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCc
Q 021053 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (318)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (318)
......|+..|+|||++.+..++.++|||||||++|+|++|.+||...+.. +.+..+....... ....+
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~~~~~~~~~-----~~~~~ 220 (325)
T cd05604 152 ---TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EMYDNILHKPLVL-----RPGAS 220 (325)
T ss_pred ---CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HHHHHHHcCCccC-----CCCCC
Confidence 112446889999999999999999999999999999999999999875443 2333333222211 12457
Q ss_pred hhHHHHHHHHhhcCCCCCCChH
Q 021053 246 AEFASYFHYCQSLTFDQRPDYG 267 (318)
Q Consensus 246 ~~~~~li~~cl~~~p~~Rp~~~ 267 (318)
..+.+++..|+..+|.+||++.
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCC
Confidence 7899999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=281.63 Aligned_cols=252 Identities=19% Similarity=0.270 Sum_probs=196.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
..++|++.+.||.|+||.||+|.+..+++.||+|+++.... ...+.+|+.++..+.| +++..+..........++++
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h-~~ii~~~~~~~~~~~~~lv~ 85 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH-SNIVAYFGSYLRRDKLWICM 85 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCC-CCeeeEEEEEEeCCEEEEEE
Confidence 45789999999999999999999999999999998765432 2356778889988866 55555555556677899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|++ +++|.+++.. .+.+++..+..++.|++.||.|||+.|++|+||+|+||++ +..+.++|+|||.+........
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06645 86 EFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL---TDNGHVKLADFGVSAQITATIA 161 (267)
T ss_pred eccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEECcceeeeEccCccc
Confidence 999 7799998876 4458999999999999999999999999999999999999 4888999999999876543221
Q ss_pred CccccccCCCCCccccccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
......++..|+|||++. ...++.++|+|||||++|+|++|..||....+.... ..........+..
T Consensus 162 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~ 231 (267)
T cd06645 162 -------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---FLMTKSNFQPPKL 231 (267)
T ss_pred -------ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH---HhhhccCCCCCcc
Confidence 123446788999999875 445788999999999999999999999764432211 1111111112211
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.....++..+.+++.+||..+|++||++.++.+
T Consensus 232 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 232 KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 111246778999999999999999999988764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=296.33 Aligned_cols=197 Identities=25% Similarity=0.296 Sum_probs=165.8
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
.+.+|.+.+.||.|+||.||+|.+..+++.||+|... .....+|+.+++++.| +++..+..++......++++++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~----~~~~~~E~~iL~~L~H-pnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW----YASSVHEARLLRRLSH-PAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc----ccCHHHHHHHHHHCCC-CCCCcEEEEEEECCEEEEEEEc
Confidence 4568999999999999999999999999999999532 2346789999999987 5555665566667789999999
Q ss_pred cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 85 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
+.++|.+++......+++..+..++.|++.||.|||++||+||||||+|||+ +..+.+||+|||+++.........
T Consensus 242 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~- 317 (461)
T PHA03211 242 YRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV---NGPEDICLGDFGAACFARGSWSTP- 317 (461)
T ss_pred cCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE---CCCCCEEEcccCCceecccccccc-
Confidence 9999999987655569999999999999999999999999999999999999 478899999999987654322110
Q ss_pred ccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 021053 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 214 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~ 214 (318)
......||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 318 ----~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 318 ----FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ----cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 1123468999999999999999999999999999999999876653
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=282.78 Aligned_cols=248 Identities=22% Similarity=0.313 Sum_probs=197.0
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
..+|++.+.||.|++|.||+|.+..+++.|++|.+..... ...+.+|+.+++.+.| +++..+...+......++|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h-~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCC-CCEeeEEEEEEeCCEEEEeec
Confidence 4799999999999999999999998999999997765332 3467789999988876 455555555556778999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
|+ +++|.+++.. ..++...+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 98 ~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred ccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEEECccccchhccccccc
Confidence 99 8899998864 458899999999999999999999999999999999999 47889999999988754322211
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
.....++..|+|||.+.+..++.++|||||||++|+|++|+.||...++...... ... ...+......
T Consensus 173 -------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~---~~~--~~~~~~~~~~ 240 (296)
T cd06654 173 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IAT--NGTPELQNPE 240 (296)
T ss_pred -------cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH---Hhc--CCCCCCCCcc
Confidence 1234678899999999888889999999999999999999999987554322211 111 1111111123
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.++..+.+++.+||..+|++||++.++.+
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 56778999999999999999999998776
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=276.54 Aligned_cols=249 Identities=19% Similarity=0.261 Sum_probs=196.4
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
++|++.+.||.|+||.||+|.+.. +..+|+|.+..... ...+.+|+.+++.+.| +++..+..++......+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLSH-PKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCCC-CCceeEEEEEccCCCEEEEEEcC
Confidence 679999999999999999998754 45789997765433 3578889999999976 55656665666677899999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 86 -~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
+++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||++ ++++.++|+|||.+.........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~~-- 156 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEYT-- 156 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE---cCCCeEEECCCCCccccCCCcee--
Confidence 789999987644558899999999999999999999999999999999999 48889999999988754322211
Q ss_pred ccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhc
Q 021053 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (318)
......++..|+|||++.+..++.++|+||||+++|+|++ |+.||...+.... +..+.... ..+. ...
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~---~~~i~~~~-~~~~---~~~ 225 (256)
T cd05114 157 ----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV---VEMISRGF-RLYR---PKL 225 (256)
T ss_pred ----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHHHCCC-CCCC---CCC
Confidence 1112234567999999988889999999999999999999 9999987654322 22222211 1111 123
Q ss_pred CchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 244 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
.+..+.+++.+||..+|.+||++.++.+.|
T Consensus 226 ~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 567899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=278.72 Aligned_cols=251 Identities=22% Similarity=0.249 Sum_probs=190.6
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccC--cceEEEEe
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDNVLVLD 83 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~--~~~~lv~e 83 (318)
|++.+.||.|+||.||+|.+..++..||+|.+..... .....+|+.++.++..|+++..+..++... +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 7889999999999999999999999999998765322 223457888888887667777776555554 78999999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
++.+++.+.+......+++..+..++.|++.||.|||++|++|+||+|+||++. . +.+||+|||.+.........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~---~-~~~kl~dfg~~~~~~~~~~~- 155 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIK---D-DILKLADFGSCRGIYSKPPY- 155 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEc---C-CCeEEEecccccccccCCCc-
Confidence 998899998876555689999999999999999999999999999999999994 5 99999999998765432221
Q ss_pred cccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc---------
Q 021053 164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV--------- 233 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~--------- 233 (318)
....++..|+|||++.. ..++.++||||+||++|+|++|.+||.+.+..+.............
T Consensus 156 -------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 156 -------TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred -------CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 12356788999997654 4578899999999999999999999987654332222211110000
Q ss_pred ------c------CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 234 ------S------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 234 ------~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
. ..........|..+.+++.+||..+|++||++.++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 0 0011112345677888888888888888888877654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=280.58 Aligned_cols=253 Identities=21% Similarity=0.257 Sum_probs=190.6
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcc-----
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED----- 77 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~----- 77 (318)
++|++.+.||.|+||.||+|.+..+++.||+|....... ...+.+|+.++..+.+|+++..+..+......
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 479999999999999999999999999999997654322 24678899999999887888777655444333
Q ss_pred eEEEEeccCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 78 NVLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 78 ~~lv~e~~~~~L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
.|++|||+.++|.+++.... ..+++..+..++.||+.||.|||++|++||||+|+||+++ ++.+.++|+|||.+
T Consensus 81 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~ 158 (295)
T cd07837 81 LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLG 158 (295)
T ss_pred EEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccc
Confidence 79999999889999887542 2478999999999999999999999999999999999995 23889999999998
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~ 232 (318)
........ ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|.+||.+.++..... .+....
T Consensus 159 ~~~~~~~~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~---~~~~~~ 228 (295)
T cd07837 159 RAFSIPVK-------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL---HIFKLL 228 (295)
T ss_pred eecCCCcc-------ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHHh
Confidence 75533211 1122345778999998865 457899999999999999999999998754432222 222111
Q ss_pred ccCc-----------------------hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 233 VSTP-----------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 233 ~~~~-----------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..++ .......++..+.+++..||..+|.+||++.++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 1000 11111245667778888888888888888776543
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=282.91 Aligned_cols=251 Identities=18% Similarity=0.294 Sum_probs=196.4
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
.++.|++.+.||.|+||.||+|++..++..+++|.+..... ...+.+|+.+++.+.| +++..+...+......++||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 88 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH-PYIVKLLGAFYWDGKLWIMI 88 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCC-CcEeeeEEEEEeCCeEEEEE
Confidence 45779999999999999999999999999999998765432 2356778999999886 55556655555667899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
||+ +++|..++......+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE---cCCCCEEEccCccceecccccc
Confidence 999 778877776655668999999999999999999999999999999999999 4788999999998865432211
Q ss_pred CccccccCCCCCccccccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
......++..|+|||++. ...++.++|+|||||++|+|++|.+||...+.. ..+..+.. ...+
T Consensus 166 -------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~---~~~~~~~~--~~~~ 233 (292)
T cd06644 166 -------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM---RVLLKIAK--SEPP 233 (292)
T ss_pred -------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH---HHHHHHhc--CCCc
Confidence 112345678899999885 334688999999999999999999999765432 22222211 1112
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.......++.++.+++.+||..+|++||++.++.+
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11222356778999999999999999999988765
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=275.14 Aligned_cols=255 Identities=23% Similarity=0.317 Sum_probs=199.7
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||.|++|.||+|.+..+++.|++|.++... ....+.+|+++++.+.| +++..+..++......+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~-~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH-PNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCC-CCeeeeeeeeecCCeEEEE
Confidence 58999999999999999999999899999999765321 13467889999999976 4555555555566789999
Q ss_pred Eecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
+||+ +++|.+++... ...++...+..++.+++.||.+||+.|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE---CCCCcEEEeccceeeecc
Confidence 9999 78999988643 2347899999999999999999999999999999999999 478899999999987654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
..... .....++..|+|||.+.+..++.++|+|||||++|+|++|..||...... .......+.... ..+.
T Consensus 158 ~~~~~-------~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~-~~~~ 228 (267)
T cd08224 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEKCD-YPPL 228 (267)
T ss_pred CCCcc-------cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhhhhcCC-CCCC
Confidence 32211 12335678899999998888999999999999999999999999653311 111122211111 1111
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
+ ....+..+.+++..||..+|++||++.++.+.+.++
T Consensus 229 ~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 P--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred C--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1 125677899999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=291.70 Aligned_cols=260 Identities=22% Similarity=0.300 Sum_probs=200.9
Q ss_pred cccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
+-.++|.+.+.||.|+||.||+|.+. .++..||+|++...... ..+.+|+.++..+..|++++.+..+....
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34467899999999999999999864 34568999988754332 25778999999998567777777666777
Q ss_pred cceEEEEecc-CCCHHHHHHHhcC--------------------------------------------------------
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRR-------------------------------------------------------- 98 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~-------------------------------------------------------- 98 (318)
...++|+||+ +++|.+++.....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 7899999999 8999999865321
Q ss_pred -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec
Q 021053 99 -----------------------------------------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (318)
Q Consensus 99 -----------------------------------------~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~ 137 (318)
.+++.....++.||+.||.|||+++++||||||+||+++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 245667788999999999999999999999999999994
Q ss_pred cCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccch
Q 021053 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (318)
Q Consensus 138 ~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~ 216 (318)
+.+.+||+|||++......... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 274 ---~~~~~kL~DfGla~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 274 ---EGKLVKICDFGLARDIMRDSNY-----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred ---CCCEEEEEecCcceeccccccc-----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 7889999999998764322110 01123345788999999998889999999999999999998 89999764
Q ss_pred hHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
.... ............+ .....+..+.+++.+||..+|.+||++.++.+.|++++
T Consensus 346 ~~~~---~~~~~~~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 346 PMNE---QFYNAIKRGYRMA---KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred CchH---HHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 3222 1112111111111 12345788999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=290.12 Aligned_cols=235 Identities=26% Similarity=0.343 Sum_probs=184.1
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHH-HHHHHcCCCCCCeeeeccccCcceEEEEecc-
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAK-VYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~-~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~- 85 (318)
+.||.|+||.||+|++..+++.||+|++.... ....+..|.. +++.++| +++..+...+......++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h-~~iv~~~~~~~~~~~~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKH-PFLVGLHYSFQTAEKLYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCC-CCccceeeEEEcCCEEEEEEcCCC
Confidence 46999999999999999999999999875422 1223445554 4555554 66666766667778899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccc
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~ 165 (318)
+++|...+.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 80 ~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~---- 151 (321)
T cd05603 80 GGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEE---- 151 (321)
T ss_pred CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEccCCCCccCCCCCC----
Confidence 7888887765 4558899999999999999999999999999999999999 5889999999999865322211
Q ss_pred cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCc
Q 021053 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (318)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (318)
......+++.|+|||++.+..++.++|||||||++|+|++|..||...+.. .....+.......| ...+
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~~~~~-----~~~~ 220 (321)
T cd05603 152 ---TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDNILHKPLQLP-----GGKT 220 (321)
T ss_pred ---ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHHHHhcCCCCCC-----CCCC
Confidence 113446789999999999888999999999999999999999999875432 23333333322222 3456
Q ss_pred hhHHHHHHHHhhcCCCCCCChH
Q 021053 246 AEFASYFHYCQSLTFDQRPDYG 267 (318)
Q Consensus 246 ~~~~~li~~cl~~~p~~Rp~~~ 267 (318)
..+.+++..||..+|.+||++.
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCC
Confidence 7899999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=279.25 Aligned_cols=256 Identities=20% Similarity=0.291 Sum_probs=199.5
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCC-----CcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~-----~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
++..++|++.+.||.|+||.||+|.+... +..|++|.+...... ..+.+|+.++..+.| +++..+..+...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~ 80 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNC-HHVVRLLGVVST 80 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCC-CceeEEEEEEcC
Confidence 45678999999999999999999988643 378999987654322 256788888888876 566667666666
Q ss_pred CcceEEEEecc-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCe
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~---------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~ 144 (318)
....+++||++ +++|.+++.... ..+++..+..++.|++.||.|||+++++|+||+|+||++ +.++.
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill---~~~~~ 157 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV---AEDLT 157 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---cCCCC
Confidence 78899999999 789999986532 125778899999999999999999999999999999999 48899
Q ss_pred EEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHH
Q 021053 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ 223 (318)
Q Consensus 145 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~ 223 (318)
+||+|||.++........ .......++..|+|||.+.+..++.++|||||||++|++++ |+.||...+......
T Consensus 158 ~kl~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 232 (277)
T cd05032 158 VKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK 232 (277)
T ss_pred EEECCcccchhhccCccc-----ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHH
Confidence 999999998754332211 11123345678999999988889999999999999999998 999997755433222
Q ss_pred HHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
.+.. ....+ ....++..+.+++.+||..+|++||++.++.+.|+
T Consensus 233 ---~~~~-~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 233 ---FVID-GGHLD---LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ---HHhc-CCCCC---CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 2221 11111 12345889999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=284.03 Aligned_cols=254 Identities=18% Similarity=0.219 Sum_probs=196.6
Q ss_pred cceeeEeeeeccCcccEEEEEEEcC-----CCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
..+|++.+.||.|+||.||+|.+.. .+..||+|++...... ..+.+|..++..+.| +++..+.........
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~~~ 82 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH-PNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEcCCCc
Confidence 4578899999999999999998754 3578999988754432 346678888888876 555566555566677
Q ss_pred eEEEEecc-CCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCC
Q 021053 78 NVLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~ 141 (318)
.+++++++ +++|.+++... ...+++..+..++.|++.||.|+|++|++||||||+||++. +
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~---~ 159 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---D 159 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEec---C
Confidence 89999998 78898887531 12377888899999999999999999999999999999994 7
Q ss_pred CCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhh
Q 021053 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (318)
Q Consensus 142 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~ 220 (318)
++.+||+|||++.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.....
T Consensus 160 ~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 234 (283)
T cd05091 160 KLNVKISDLGLFREVYAADYYK-----LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234 (283)
T ss_pred CCceEecccccccccccchhee-----eccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 8889999999987653322110 1123345678999999988889999999999999999998 899998755432
Q ss_pred hHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
....+.... ..+ ....+|..+.+++..||+.+|++||++.++...|+.
T Consensus 235 ---~~~~i~~~~-~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 ---VIEMIRNRQ-VLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ---HHHHHHcCC-cCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222222221 111 224678889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=277.28 Aligned_cols=250 Identities=20% Similarity=0.294 Sum_probs=196.8
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
..+|++.+.||+|++|.||+|.+. ++..+++|++..... ...+.+|+.+++.+.| +++..+..++......++++|+
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSH-PNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCC-CCEEEEEEEEcCCCceEEEEec
Confidence 457899999999999999999876 456789998765432 3467889999999976 5566666666667789999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+ +++|.+++......+++..+..++.|++.||.|||+.|++|+||+|+||++ ++++.+||+|||.+.........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~- 156 (256)
T cd05059 81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYT- 156 (256)
T ss_pred CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE---CCCCcEEECCcccceeccccccc-
Confidence 9 889999987655568999999999999999999999999999999999999 48899999999998765432211
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
......++..|+|||.+.+..++.++|+||||+++|++++ |..||...++.... ..+.. ....+ ...
T Consensus 157 -----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~-~~~~~---~~~ 224 (256)
T cd05059 157 -----SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---ESVSA-GYRLY---RPK 224 (256)
T ss_pred -----ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---HHHHc-CCcCC---CCC
Confidence 0112223457999999998889999999999999999999 89999765443222 22211 11111 123
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
..|..+.+++.+||..+|++||++.++.+.|
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 5688999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=274.57 Aligned_cols=247 Identities=19% Similarity=0.247 Sum_probs=194.5
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+|++.+.||.|++|.||+|.+..+++.|++|.+..... ...+.+|+.++++++|.+.+.....+.......++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 59999999999999999999998899999998754322 23567788899998775544333333334446899999
Q ss_pred cc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 84 LL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 84 ~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
++ +++|.+++... ...+++.++..++.|++.||.+||++|++|+||+|+||++ +..+.++|+|||.+........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE---ecCCcEEEecccceEEecccCC
Confidence 99 78998888753 3348899999999999999999999999999999999999 4889999999999876643322
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
......+++.|+|||++.+..++.++|+||+||++|++++|+.||...+... ....+.....+. ..
T Consensus 158 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~---~~~~~~~~~~~~----~~ 223 (257)
T cd08223 158 -------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS---LVYRIIEGKLPP----MP 223 (257)
T ss_pred -------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHhcCCCC----Cc
Confidence 1234467889999999999889999999999999999999999997644322 222222222211 12
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+..+.+++.+||..+|++||++.++.+
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 356788999999999999999999988765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=276.10 Aligned_cols=250 Identities=25% Similarity=0.328 Sum_probs=196.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-------ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
++|++.+.||.|++|.||.|.+..+++.|++|.+..... ...+.+|+.++.++.| +++..+..+.......+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH-ERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCC-CCeeeeEEEEccCCeEE
Confidence 579999999999999999999998999999997654321 1356778899999876 55666666666667899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+++|++ +++|.+.+.. ...++...+..++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 81 ~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 81 IFMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceeccc
Confidence 999999 7899998876 3458899999999999999999999999999999999999 4788999999999876432
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
...... ......++..|+|||++.+..++.++||||||+++|++++|+.||....... .......... ..
T Consensus 157 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~---~~ 226 (263)
T cd06625 157 ICSSGT----GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA---AIFKIATQPT---NP 226 (263)
T ss_pred cccccc----cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH---HHHHHhccCC---CC
Confidence 211100 0023456788999999999889999999999999999999999997654322 1122211111 11
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
......+..+.+++.+||..+|++||++.++.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 227 QLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 233467889999999999999999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=277.60 Aligned_cols=253 Identities=21% Similarity=0.353 Sum_probs=193.1
Q ss_pred eeEeeeeccCcccEEEEEEEcC---CCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccC-----c
Q 021053 9 YKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG-----E 76 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~---~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~-----~ 76 (318)
|++++.||.|+||.||+|.... ++..||+|.++..... ..+.+|+..++.+.|++.+..+..+.... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 6789999999999999998764 3478999987754322 35778899999987754443333332211 2
Q ss_pred ceEEEEecc-CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEec
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 150 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~df 150 (318)
..++++||+ +++|..++.... ..+++.....++.|++.||.|||+++++||||||+||++ ++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE---CCCCeEEECCc
Confidence 479999999 889988875432 247889999999999999999999999999999999999 48889999999
Q ss_pred cceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHH
Q 021053 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKIC 229 (318)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~ 229 (318)
|.+.......... .......+..|+|||.+.+..++.++|||||||++|+|++ |.+||.+..... .+..+.
T Consensus 158 g~~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYR-----QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLR 229 (273)
T ss_pred cceeecccccccc-----ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH
Confidence 9988654332211 1112234567999999988889999999999999999999 999997654432 222222
Q ss_pred HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
... .. .....++..+.+++.+||..+|++||++.++.+.|.++
T Consensus 230 ~~~-~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGN-RL---KQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCC-CC---CCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 11 12245678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=273.48 Aligned_cols=246 Identities=25% Similarity=0.315 Sum_probs=197.0
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+|.+.+.||+|++|.||+|.+..++..|++|.+.... ....+.+|+.++..++| +++..+..++......++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDS-SYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCC-CCeehheeeeccCCEEEEEEE
Confidence 4889999999999999999999999999999875432 23467788999999876 445555555566678999999
Q ss_pred cc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 84 LL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 84 ~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
++ +++|.+++... ...++...+..++.|++.||.|||++|++|+||+|+||+++ ..+.++|+|||.+........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~---~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLD---AYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEe---CCCCEEEcccccceeccCccc
Confidence 99 88999998764 34588999999999999999999999999999999999994 789999999999876543322
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
. .....++..|+|||++.+..++.++|+|||||++|+|++|+.||...+.. .....+.....+ + ..
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~-~---~~ 222 (256)
T cd08529 157 F-------ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKIIRGVFP-P---VS 222 (256)
T ss_pred h-------hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCC-C---Cc
Confidence 1 12345778899999999888999999999999999999999999865532 222222222211 1 11
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..++..+.+++.+||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 256788999999999999999999998765
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=280.03 Aligned_cols=248 Identities=21% Similarity=0.289 Sum_probs=189.3
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
++|++.+.||.|++|.||+|.+..+++.||+|++..... ...+.+|+.++.++.| +++..+...+......++++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDS-PYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCC-CCeeeEEEEEEECCEEEEEEe
Confidence 468999999999999999999999999999998764322 2356789999998876 555555555556677899999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
|+ +++|..+ ..+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~~~- 150 (279)
T cd06619 80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNSIA- 150 (279)
T ss_pred cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE---CCCCCEEEeeCCcceecccccc-
Confidence 99 6666443 237888899999999999999999999999999999999 4889999999999876543221
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc-cCchHHHh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV-STPIEVLC 241 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~-~~~~~~~~ 241 (318)
....++..|+|||++.+..++.++|+|||||++|+|++|+.||.................... ..+.....
T Consensus 151 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (279)
T cd06619 151 --------KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV 222 (279)
T ss_pred --------cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCC
Confidence 234678899999999988899999999999999999999999975332211111111111100 11111111
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
...+..+.+++.+||..+|++||+++++.+.
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 2456789999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=295.70 Aligned_cols=258 Identities=26% Similarity=0.357 Sum_probs=207.4
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCC----cEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~----~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
.+-.+.++||+|+||.||+|..+..+ ..||+|..+... ....+.+|..++++++| ++++.++.+......
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H-~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNH-PNVVRFYGVAVLEEP 235 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEcCCCc
Confidence 34456799999999999999987432 238999777422 23368899999999877 667777777778889
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++|||+| +|+|.+++...+..++..+...++.+.+.||+|||+++++||||-.+|+|++ ..+.+|++|||+++..
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~---~~~~vKISDFGLs~~~ 312 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYS---KKGVVKISDFGLSRAG 312 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheec---CCCeEEeCccccccCC
Confidence 99999999 9999999998766799999999999999999999999999999999999995 6777899999998765
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
...... .....-+..|+|||.+....+++++|||||||++||+++ |..||.+....+....+. ....+.
T Consensus 313 ~~~~~~-------~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~---~~~~r~ 382 (474)
T KOG0194|consen 313 SQYVMK-------KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV---KNGYRM 382 (474)
T ss_pred cceeec-------cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH---hcCccC
Confidence 311110 012234678999999999999999999999999999999 899999987764443331 222222
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcC
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~ 281 (318)
+.+. ..|..+..++.+||..+|+.||++.++.+.++.+.....
T Consensus 383 ~~~~---~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 383 PIPS---KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred CCCC---CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 2222 557889999999999999999999999999999865533
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=295.38 Aligned_cols=248 Identities=22% Similarity=0.326 Sum_probs=191.2
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+..|+.++..+.| +++..+...+......++|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG-AWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCEEEEE
Confidence 47999999999999999999999999999999876421 22356778889988876 5555665666777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++ +..+.++|+|||++.......
T Consensus 80 ~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 80 MEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred EeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE---CCCCCEEEeeccCCccccccc
Confidence 9999 8899999876 4458999999999999999999999999999999999999 588999999999986543211
Q ss_pred CCcc----------------------------ccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCC
Q 021053 161 TNRH----------------------------IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212 (318)
Q Consensus 161 ~~~~----------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~p 212 (318)
.... ..........||+.|+|||++.+..++.++|||||||++|+|++|.+|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 1000 000001134689999999999999999999999999999999999999
Q ss_pred ccchhHhhhHHHHHHHHHhh--ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCCh
Q 021053 213 WQGLKAATKKQKYDKICEKK--VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 266 (318)
|...++.. .+..+.... ...|.. ..++....+++.+++ .+|.+|++.
T Consensus 236 f~~~~~~~---~~~~i~~~~~~~~~p~~---~~~s~~~~~li~~l~-~~p~~R~~~ 284 (360)
T cd05627 236 FCSETPQE---TYRKVMNWKETLVFPPE---VPISEKAKDLILRFC-TDSENRIGS 284 (360)
T ss_pred CCCCCHHH---HHHHHHcCCCceecCCC---CCCCHHHHHHHHHhc-cChhhcCCC
Confidence 98765432 223332211 111211 135678999998876 499999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=277.31 Aligned_cols=258 Identities=18% Similarity=0.266 Sum_probs=201.6
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCc---EEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~---~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
+..++|+..+.||.|++|.||+|.+..++. .+++|....... ...+..|+.++..+.|+ ++..+..++.....
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHH-NIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCC-CeeEEEEEEccCCC
Confidence 556789999999999999999999875544 789998764422 23577888999888764 55566666667778
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.+++||++ +++|.+++......+++.....++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||.+...
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~---~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVN---SNLECKVSDFGLSRVL 157 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEc---CCCcEEECCCccceec
Confidence 99999999 7899999876555689999999999999999999999999999999999994 7889999999998765
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
........ .......+..|+|||++.+..++.++|||||||++|++++ |+.||...+... ....+.. ....
T Consensus 158 ~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i~~-~~~~ 229 (268)
T cd05063 158 EDDPEGTY----TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAIND-GFRL 229 (268)
T ss_pred ccccccce----eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHhc-CCCC
Confidence 43222110 0111223457999999988889999999999999999998 999997654432 2222221 1222
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
|. ....+..+.+++.+||..+|++||++.++.+.|.++
T Consensus 230 ~~---~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 PA---PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 22 125678899999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=278.84 Aligned_cols=260 Identities=22% Similarity=0.315 Sum_probs=201.9
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcC----CCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVD----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~----~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
+-+++|++.+.||+|+||.||+|.+.. ++..|++|.+..... ...+.+|+.+++.+.|++.+..+..+.....
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 457899999999999999999999875 357889998765432 2356789999999977555554454555567
Q ss_pred ceEEEEecc-CCCHHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEE
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCR-------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~-------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~ 148 (318)
..+++++++ +++|.+++.... ..++...+..++.|++.||.|||+++++|+||+|+||+++ +++.+||+
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~---~~~~~kl~ 159 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID---EELQVKIT 159 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEc---CCCcEEEC
Confidence 789999998 789999987532 3478999999999999999999999999999999999994 78999999
Q ss_pred eccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHH
Q 021053 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDK 227 (318)
Q Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~ 227 (318)
|||+++......... ......++..|+|||++.+..++.++|||||||++|++++ |++||...++.... ..
T Consensus 160 d~g~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~ 231 (280)
T cd05043 160 DNALSRDLFPMDYHC-----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA---AY 231 (280)
T ss_pred CCCCcccccCCceEE-----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH---HH
Confidence 999987543222110 0112344667999999998889999999999999999999 99999875543221 11
Q ss_pred HHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
+ ......+ ....+|+.+.+++.+||..+|++||++.++.+.|+++..
T Consensus 232 ~-~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 232 L-KDGYRLA---QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred H-HcCCCCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1 1111111 123457889999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=276.85 Aligned_cols=250 Identities=17% Similarity=0.265 Sum_probs=197.2
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
.++|++.+.||.|++|.||.|.+.. +..+|+|.+..... ...+.+|+.++..+.| +++..+..+.......+++||+
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSH-EKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCC-CCeeeEEEEEccCCCcEEEEEc
Confidence 4679999999999999999998754 34599997765432 3467889999999976 5666776666666778999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+ +++|.+++......+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.+||+|||.+.....+...
T Consensus 81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05113 81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYT- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE---cCCCCEEECCCccceecCCCcee-
Confidence 9 789999987655568999999999999999999999999999999999999 47889999999998765432211
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
......++..|++||++.+..++.++|||||||++|+|++ |..||...+... ....+..... .+. ..
T Consensus 157 -----~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~~~-~~~---~~ 224 (256)
T cd05113 157 -----SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVSQGLR-LYR---PH 224 (256)
T ss_pred -----ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHhcCCC-CCC---CC
Confidence 1112334567999999988889999999999999999999 999997655432 2222222211 111 12
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
..+..+.+++.+||..+|.+||++.++.+.+
T Consensus 225 ~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 225 LASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred CCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 4577899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=279.32 Aligned_cols=258 Identities=24% Similarity=0.318 Sum_probs=192.9
Q ss_pred ccee-eEeeeeccCcccEEEEEEE----cCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeec-cc-cC
Q 021053 6 GVKY-KLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWY-GV-DG 75 (318)
Q Consensus 6 ~~~y-~~~~~lg~G~~~~v~~~~~----~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~-~~-~~ 75 (318)
.+|| ++.+.||.|+||+||++.. ..++..||+|.+..... ...+.+|+.+++.+.|+ ++..+..+ .. ..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~~~~~ 80 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHE-NIVKYKGCCSEQGG 80 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCC-CEeeEEEEEecCCC
Confidence 3566 9999999999999988753 35678899998765432 34567899999999764 44444433 22 23
Q ss_pred cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
...+++||++ +++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++ .++.++|+|||.+.
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~ 155 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLD---NDRLVKIGDFGLAK 155 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEc---CCCcEEEeeccccc
Confidence 4689999999 8899999875 3489999999999999999999999999999999999994 78899999999987
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhH-----------H
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK-----------Q 223 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~-----------~ 223 (318)
........ ........++..|+|||.+.+..++.++|||||||++|+|++|..||......... .
T Consensus 156 ~~~~~~~~----~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05080 156 AVPEGHEY----YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV 231 (283)
T ss_pred ccCCcchh----hccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchh
Confidence 65432211 00112234566799999998888999999999999999999999998643211000 0
Q ss_pred HHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
............+ ....+|..+.+++..||..+|++||++.++.+.|+++
T Consensus 232 ~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 232 RLIELLERGMRLP---CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhhhcCCCCC---CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 0001111111111 1235678999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=282.52 Aligned_cols=261 Identities=19% Similarity=0.293 Sum_probs=197.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCC----------------cEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCC
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTN----------------EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGI 65 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~----------------~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~ 65 (318)
-.++|++.+.||.|+||.||+|.+...+ ..||+|.+..... ...+.+|+.++.++.| +++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSD-PNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCC-CCE
Confidence 3578999999999999999999876533 4579998765432 2356789999999976 555
Q ss_pred CeeeeccccCcceEEEEecc-CCCHHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 021053 66 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR----------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 134 (318)
Q Consensus 66 ~~i~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Ni 134 (318)
..+..++......++++|++ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 56655556667899999999 789999987643 1478999999999999999999999999999999999
Q ss_pred eeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh--CCCC
Q 021053 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR--GSLP 212 (318)
Q Consensus 135 l~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t--g~~p 212 (318)
+++ ..+.++|+|||.+.......... ......++..|+|||++.+..++.++|||||||++|++++ |..|
T Consensus 162 li~---~~~~~~l~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 233 (296)
T cd05051 162 LVG---KNYTIKIADFGMSRNLYSSDYYR-----VQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQP 233 (296)
T ss_pred eec---CCCceEEccccceeecccCccee-----ecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCC
Confidence 994 77999999999987654322111 1123345678999999988889999999999999999998 7888
Q ss_pred ccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 213 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
|......................+........|.++.+++.+||+.+|.+||++.++.+.|+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 234 YEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 87654433222222111000011111112345678999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=279.99 Aligned_cols=255 Identities=22% Similarity=0.313 Sum_probs=198.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
+..++|.+.+.||.|+||.||+|... .++..+++|.+..... ...+.+|+.++..+.| +++..+..++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 80 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQH-QHIVRFYGVCTEGR 80 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCC-CCCceEEEEEecCC
Confidence 56788999999999999999999753 3456788997664332 2467889999999976 56666666666677
Q ss_pred ceEEEEecc-CCCHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCC
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCR--------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~--------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~ 141 (318)
..++++|++ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++ +
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~---~ 157 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---Q 157 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc---C
Confidence 899999999 889999987532 2378899999999999999999999999999999999994 7
Q ss_pred CCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhh
Q 021053 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (318)
Q Consensus 142 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~ 220 (318)
++.++|+|||++......... .......++..|+|||++.+..++.++|||||||++|+|++ |.+||.......
T Consensus 158 ~~~~kL~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 232 (280)
T cd05092 158 GLVVKIGDFGMSRDIYSTDYY-----RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE 232 (280)
T ss_pred CCCEEECCCCceeEcCCCcee-----ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH
Confidence 899999999998754322110 11123344678999999998889999999999999999998 999997654432
Q ss_pred hHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
. +..+... ... .....+|+.+.+++.+||..+|++||++.++.+.|+
T Consensus 233 ~---~~~~~~~-~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 233 A---IECITQG-REL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred H---HHHHHcC-ccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 2 2222211 111 112356788999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=278.66 Aligned_cols=255 Identities=24% Similarity=0.311 Sum_probs=199.5
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||.|++|.||+|.+..++..+++|.+.... ....+.+|+.+++.+.| +++..+..++......+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccC-CchhhhhheeEeCCeEEEE
Confidence 47899999999999999999999899999999765422 12356789999999876 5555555555666789999
Q ss_pred Eecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
+|++ +++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccc
Confidence 9999 78999988642 2347899999999999999999999999999999999999 478899999999887654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
..... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.... .......+.. ....+.
T Consensus 158 ~~~~~-------~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~-~~~~~~ 228 (267)
T cd08229 158 SKTTA-------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQ-CDYPPL 228 (267)
T ss_pred cCCcc-------cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhhc-CCCCCC
Confidence 32221 12345788899999998888999999999999999999999999764321 1122222211 111111
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
.....+..+.+++.+||..+|++|||+.++.+.++++
T Consensus 229 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 --PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred --CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1134677899999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=277.72 Aligned_cols=250 Identities=21% Similarity=0.329 Sum_probs=201.3
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
.++|++.+.||.|++|.||+|.+..+++.+++|.+........+.+|+.++++++| +++..+...+......++++|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDS-PYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCC-CcEeeeeeeeecCCcEEEEEecC
Confidence 36899999999999999999999888899999988765545678899999999955 55666666666678899999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 86 -~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
+++|.+++......+++..+..++.|++.||.|||+.+++|+||+|+||+++ .++.++|+|||.+.........
T Consensus 81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~---~~~~~~l~dfg~~~~~~~~~~~-- 155 (256)
T cd06612 81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN---EEGQAKLADFGVSGQLTDTMAK-- 155 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC---CCCcEEEcccccchhcccCccc--
Confidence 7899999876566789999999999999999999999999999999999994 7889999999998765433211
Q ss_pred ccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcC
Q 021053 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (318)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||....+..... .+. ....+.......+
T Consensus 156 -----~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~---~~~--~~~~~~~~~~~~~ 225 (256)
T cd06612 156 -----RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF---MIP--NKPPPTLSDPEKW 225 (256)
T ss_pred -----cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh---hhc--cCCCCCCCchhhc
Confidence 123446788999999998889999999999999999999999998654432111 111 1111111112346
Q ss_pred chhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 245 PAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 245 ~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+..+.+++.+||..+|++||++.++.+
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 778999999999999999999988765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=284.62 Aligned_cols=263 Identities=19% Similarity=0.297 Sum_probs=203.5
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCC-------CcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeecc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT-------NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYG 72 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~-------~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~ 72 (318)
++...+|++++.||.|+||.||+|.+... +..||+|.+..... ...+.+|+.++.++.+|+++..+..++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 35567899999999999999999986432 23689998765432 236788999999996667787777766
Q ss_pred ccCcceEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee
Q 021053 73 VDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 136 (318)
Q Consensus 73 ~~~~~~~lv~e~~-~~~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~ 136 (318)
......++++||+ +++|.+++.... ..++...+..++.|++.||.|||++|++||||+|+||++
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 7777899999999 889999987532 136778888999999999999999999999999999999
Q ss_pred ccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccc
Q 021053 137 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQG 215 (318)
Q Consensus 137 ~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~ 215 (318)
+ .++.+||+|||.++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 168 ~---~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 168 T---EDNVMKIADFGLARDVHNIDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred c---CCCcEEECCcccceecccccccc-----cccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 4 78899999999987654321110 1112233567999999999889999999999999999998 8999987
Q ss_pred hhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhc
Q 021053 216 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (318)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~ 280 (318)
.+..... ..+.. ....+ .....+..+.+++.+||..+|++||++.++.+.|.++....
T Consensus 240 ~~~~~~~---~~~~~-~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 240 IPVEELF---KLLKE-GHRMD---KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred CCHHHHH---HHHHc-CCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 5543222 22211 11111 12355778999999999999999999999999998876443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=279.08 Aligned_cols=201 Identities=25% Similarity=0.357 Sum_probs=167.4
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
-++|++.+.||.|++|.||+|.+..+++.||+|.+..... ...+.+|+.+++.++| +++..+..++......++|+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKH-ANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCC-cceeeEEEEEecCCeEEEEE
Confidence 3689999999999999999999998899999998754322 2346789999999976 56666666667778899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
||+.++|.+++......+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+.....+...
T Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~ 159 (291)
T cd07844 83 EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI---SERGELKLADFGLARAKSVPSKT 159 (291)
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE---cCCCCEEECccccccccCCCCcc
Confidence 999889999988765668999999999999999999999999999999999999 48899999999998654322111
Q ss_pred ccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~ 217 (318)
.....++..|+|||++.+ ..++.++||||+||++|+|++|..||....
T Consensus 160 -------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 160 -------YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred -------ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 112245778999999875 458899999999999999999999997654
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=279.18 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=197.2
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
..+|++.+.||.|++|.||+|.+..+++.|++|.+.... ....+.+|+.+++.++|+ ++..+..........++|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNP-NIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCC-ceeeeeeeEecCceEEEEEE
Confidence 367999999999999999999999999999999775432 234677899999998764 45555555566778999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
++ +++|..++.. ..+++..+..++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 97 YLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred ecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccchhccccccc
Confidence 99 8899888864 358999999999999999999999999999999999999 47899999999988754432211
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
.....++..|+|||.+.+..++.++|+|||||++|++++|..||...++...... +.. . ..+......
T Consensus 172 -------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~---~~~-~-~~~~~~~~~ 239 (296)
T cd06655 172 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IAT-N-GTPELQNPE 239 (296)
T ss_pred -------CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh-c-CCcccCCcc
Confidence 1234577889999999988899999999999999999999999987654322221 111 1 111111223
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.++..+.+++.+||..+|.+||++.++..
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 56778999999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=254.39 Aligned_cols=273 Identities=23% Similarity=0.324 Sum_probs=217.3
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+|.-.++||+|.||+||+|+..++++.||+|.+.-+.. .....+|+-+++.++|. +++.+...--......+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhk-nivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK-NIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhc-ceeehhhhhccCceeEEeHH
Confidence 57778899999999999999999999999997664432 34789999999999984 45555544445567899999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+|..+|..++.+.++.++.+.++.++.|+++||.++|++++.|||+||+|.++ +.+|.+||+|||+++....+.
T Consensus 82 ~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli---n~ngelkladfglarafgipv--- 155 (292)
T KOG0662|consen 82 FCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI---NRNGELKLADFGLARAFGIPV--- 155 (292)
T ss_pred HhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe---ccCCcEEecccchhhhcCCce---
Confidence 99999999999999889999999999999999999999999999999999999 499999999999998765442
Q ss_pred cccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
+..+...-|..|++|.++.+.. |+...|+||.|||+.|+.. |.+.|.+.+..+ ++.+|+. .+..|.+..|
T Consensus 156 ----rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd---qlkrif~-~lg~p~ed~w 227 (292)
T KOG0662|consen 156 ----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFR-LLGTPTEDQW 227 (292)
T ss_pred ----EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH---HHHHHHH-HhCCCccccC
Confidence 2334567789999999999887 8999999999999999988 899999876654 4445553 3445555533
Q ss_pred hcCchhHHHHHHHHhhcCC-CCCCChHHHHHHHHHHHHhcCCchhHHHhhhcCCccccccccee
Q 021053 242 KSHPAEFASYFHYCQSLTF-DQRPDYGFLKRLFHDLFSREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p-~~Rp~~~~l~~~l~~~~~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
| .+..+- ++.| .--|....+.+..+++ +....++++++|.-+|+.|++|++++.
T Consensus 228 ---p-s~t~lp----dyk~yp~ypattswsqivp~l-ns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 228 ---P-SMTKLP----DYKPYPIYPATTSWSQIVPKL-NSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ---C-ccccCC----CCcccCCccccchHHHHhhhh-cchhHHHHHHHhccCcccccCHHHHhc
Confidence 3 221211 1111 1123334566666665 678899999999999999999999875
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=275.85 Aligned_cols=247 Identities=19% Similarity=0.288 Sum_probs=189.6
Q ss_pred eeccCcccEEEEEEEc--CCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CC
Q 021053 14 KIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GP 87 (318)
Q Consensus 14 ~lg~G~~~~v~~~~~~--~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~ 87 (318)
.||+|+||.||+|.+. .++..||+|+....... ..+.+|+.+++++.|++.+..+..+ . ....++||||+ ++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~-~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-E-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEE-c-CCCeEEEEEeCCCC
Confidence 4899999999999775 44557999987654332 3577899999999775444443333 2 34689999999 88
Q ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccccc
Q 021053 88 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (318)
Q Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 167 (318)
+|.+++......+++..+..++.|++.||.|||++|++|+||||+||++ +.++.+||+|||.+..........
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~---- 152 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYY---- 152 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE---cCCCcEEeccCCccccccCCccce----
Confidence 9999987655668999999999999999999999999999999999999 488899999999987543322110
Q ss_pred cCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCch
Q 021053 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (318)
Q Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (318)
.......++..|+|||.+.+..++.++|||||||++|++++ |..||......+... .+. .....+ .....++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~-~~~~~~---~~~~~~~ 225 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS---FIE-QGKRLD---CPAECPP 225 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH---HHH-CCCCCC---CCCCCCH
Confidence 01112233567999999988889999999999999999996 999998765543222 221 111111 2235678
Q ss_pred hHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 247 EFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 247 ~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
++.+++.+||..+|++||++.++.+.|++.
T Consensus 226 ~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 226 EMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=277.23 Aligned_cols=253 Identities=19% Similarity=0.318 Sum_probs=191.7
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCc--EEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccc-----cCcc
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNE--IVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DGED 77 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~--~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~-----~~~~ 77 (318)
|.+++.||+|+||.||+|.+..++. .+|+|.++... ....+.+|+.++..++|++.+..+..+.. ....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3578999999999999999876665 68999776432 22357788999999977554444433322 1235
Q ss_pred eEEEEecc-CCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecc
Q 021053 78 NVLVLDLL-GPSLEDLFVYC-----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg 151 (318)
.+++++|+ +++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCCC
Confidence 78999999 78998887532 2237889999999999999999999999999999999999 488999999999
Q ss_pred ceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHH
Q 021053 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICE 230 (318)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~ 230 (318)
.+......... .......++..|+|||...+..++.++|||||||++|+|++ |..||....... ....+..
T Consensus 158 ~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~ 229 (272)
T cd05075 158 LSKKIYNGDYY-----RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDYLRQ 229 (272)
T ss_pred cccccCcccce-----ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHc
Confidence 98765432211 11123345678999999998889999999999999999999 899998754432 2222221
Q ss_pred hhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
. ...+ ....++..+.+++.+||..+|++||++.++.+.|+++
T Consensus 230 ~-~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 G-NRLK---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C-CCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 1111 1235678899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=276.59 Aligned_cols=260 Identities=19% Similarity=0.271 Sum_probs=202.5
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCc----EEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~----~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
..+...+|++.+.||+|+||.||+|.+..++. .+++|........ ..+.+|+.++..+.|++ +..+..+...
T Consensus 2 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~-i~~~~~~~~~ 80 (279)
T cd05057 2 RILKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPH-VVRLLGICLS 80 (279)
T ss_pred cccCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCC-cceEEEEEec
Confidence 45677899999999999999999999876554 5889977654432 35678999999997754 4444333333
Q ss_pred CcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
...++++|++ +++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||++ ++++.+||+|||.+
T Consensus 81 -~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~---~~~~~~kL~dfg~~ 156 (279)
T cd05057 81 -SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV---KTPQHVKITDFGLA 156 (279)
T ss_pred -CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE---cCCCeEEECCCccc
Confidence 6789999999 889999998765668999999999999999999999999999999999999 48889999999998
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhh
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKK 232 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~ 232 (318)
.......... ......++..|+|||.+....++.++|+|||||++|++++ |..||......+... .+. ..
T Consensus 157 ~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~-~~ 227 (279)
T cd05057 157 KLLDVDEKEY-----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD---LLE-KG 227 (279)
T ss_pred ccccCcccce-----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH---HHh-CC
Confidence 7654322110 1112223567999999988889999999999999999999 999998765433222 221 11
Q ss_pred ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
...+.+ ...+..+.+++.+||..+|++||++.++.+.|.++..
T Consensus 228 ~~~~~~---~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 228 ERLPQP---PICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCCCCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 112211 2356789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=290.29 Aligned_cols=258 Identities=21% Similarity=0.342 Sum_probs=215.2
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
.+....++||.|.||.||.|.+++-.-.||||.++.+.- .++|++|..+++.++|++.+..+..| ..+..+||++|||
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVC-T~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-THEPPFYIITEFM 345 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhh-ccCCCeEEEEecc
Confidence 345678999999999999999999999999999887653 46899999999999885544444444 5667899999999
Q ss_pred -CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 86 -GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 86 -~~~L~~~~~~~~~~-~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
.|.|.+++.++++. ++......++.||..|+.||..+++|||||-.+|.|++ .+..+|++|||+++....+....
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVg---EnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhcccc---ccceEEeeccchhhhhcCCceec
Confidence 99999999988654 66677888999999999999999999999999999996 88999999999999887776644
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
+ ....-..-|.|||-+....++.++|||+|||+|||+.| |..||.+.+-...-..+.+ +.+... .+
T Consensus 423 H------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEk--gyRM~~-----Pe 489 (1157)
T KOG4278|consen 423 H------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEK--GYRMDG-----PE 489 (1157)
T ss_pred c------cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhc--cccccC-----CC
Confidence 3 23344566999999999999999999999999999999 9999999765433333333 122222 25
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcC
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~ 281 (318)
.+|+.+++||..||.++|.+||++.++.+.|+.++.+..
T Consensus 490 GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 490 GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 889999999999999999999999999999999886544
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=283.61 Aligned_cols=247 Identities=20% Similarity=0.316 Sum_probs=208.8
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
-|.++.+||+|+||.||+|.++++|+.+|||.+-...+.+...+|+.++++...+..+.+...|+ .+...++||||| .
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYF-K~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYF-KHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhc-cCCceEeehhhcCC
Confidence 46788999999999999999999999999999888888899999999999988744443334443 455799999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
|+..+.+.-.++++++.++..+++.-+.||.|||...-+|||||..|||+ +..|..||+|||.+-.+......+
T Consensus 113 GSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMAKR--- 186 (502)
T KOG0574|consen 113 GSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMAKR--- 186 (502)
T ss_pred CcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE---cccchhhhhhccccchhhhhHHhh---
Confidence 89999998878889999999999999999999999999999999999999 499999999999998776654432
Q ss_pred ccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH--hhcC
Q 021053 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL--CKSH 244 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~--~~~~ 244 (318)
....||+.|+|||++....|+.++||||||++..||..|++||.+..+.. .|+ .....|++.+ +..|
T Consensus 187 ----NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR------AIF-MIPT~PPPTF~KPE~W 255 (502)
T KOG0574|consen 187 ----NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR------AIF-MIPTKPPPTFKKPEEW 255 (502)
T ss_pred ----CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc------eeE-eccCCCCCCCCChHhh
Confidence 46689999999999999999999999999999999999999998876632 222 1112222222 3467
Q ss_pred chhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 245 PAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 245 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
+.++.+++++||-++|++|.++..++++
T Consensus 256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 8899999999999999999998877764
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=276.06 Aligned_cols=258 Identities=18% Similarity=0.292 Sum_probs=200.3
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCc---EEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~---~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
...|++.+.||.|+||.||+|.+..++. .|++|.+..... ...+..|+.++..+.| +++..+..+.......+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH-PNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-cCcceEEEEECCCCceE
Confidence 3569999999999999999999876554 699998765432 2367789999999876 55666666667777899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+|+|++ +++|.+++....+.++...+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE---cCCCcEEECCCcccccccc
Confidence 999999 779999987655668999999999999999999999999999999999999 4788999999999875533
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
...... +........+..|+|||.+.+..++.++|||||||++||+++ |..||...+...... .+. .....+.
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~---~i~-~~~~~~~ 232 (269)
T cd05065 159 DTSDPT--YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN---AIE-QDYRLPP 232 (269)
T ss_pred Cccccc--cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHH---HHH-cCCcCCC
Confidence 221110 000011112457999999998889999999999999999887 999998755432222 221 1222222
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
. ..+|..+.+++.+||..+|++||++.++...|+++
T Consensus 233 ~---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 P---MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred c---ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 35678899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=277.42 Aligned_cols=251 Identities=22% Similarity=0.333 Sum_probs=196.2
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeecccc------Ccce
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVD------GEDN 78 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~------~~~~ 78 (318)
.++|++.+.||.|++|.||+|.+..+++.+++|++..... ...+.+|+.++.++..|+++..+..++.. ....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 84 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQL 84 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEE
Confidence 5899999999999999999999998899999998775443 34678899999999766777777555432 3458
Q ss_pred EEEEecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 79 VLVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
++++|++ +++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||.+.
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~---~~~~~~l~d~~~~~ 161 (275)
T cd06608 85 WLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEc---cCCeEEECCCccce
Confidence 9999999 779988887533 4689999999999999999999999999999999999994 78999999999987
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCC-----CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHH
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~ 229 (318)
....... ......++..|+|||++... .++.++|||||||++|++++|+.||...+.... ...+.
T Consensus 162 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~ 231 (275)
T cd06608 162 QLDSTLG-------RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA---LFKIP 231 (275)
T ss_pred ecccchh-------hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH---HHHhh
Confidence 6543222 11234578889999987643 367889999999999999999999976543222 22222
Q ss_pred HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
... .+.-.....++..+.+++.+||..||++||++.++.+
T Consensus 232 ~~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 RNP--PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccC--CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111 1111111236778999999999999999999998765
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=292.18 Aligned_cols=234 Identities=22% Similarity=0.296 Sum_probs=183.6
Q ss_pred eccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHc--CCCCCCeeeeccccCcceEEEEecc-C
Q 021053 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 15 lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~--~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
||+|+||.||+|++..+++.||+|++.... .......|..++.... +|+++..+...+......|+||||+ +
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999875321 1123445666666554 6778888877777788899999999 8
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||++........
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~----- 151 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL---DATGHIALCDFGLSKANLTDNK----- 151 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCC-----
Confidence 899888876 4558999999999999999999999999999999999999 4888999999999865322111
Q ss_pred ccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCc
Q 021053 167 YRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (318)
......||..|+|||++.+. .++.++|||||||++|+|++|..||...+.. +.+..+.......+. ..++
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~----~~~~ 222 (330)
T cd05586 152 --TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---QMYRNIAFGKVRFPK----NVLS 222 (330)
T ss_pred --CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---HHHHHHHcCCCCCCC----ccCC
Confidence 11245689999999998765 4899999999999999999999999875442 223333322222221 2357
Q ss_pred hhHHHHHHHHhhcCCCCCCCh
Q 021053 246 AEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 246 ~~~~~li~~cl~~~p~~Rp~~ 266 (318)
..+.+++.+||..+|.+||++
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~ 243 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGA 243 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCC
Confidence 789999999999999999853
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=278.64 Aligned_cols=253 Identities=20% Similarity=0.288 Sum_probs=195.6
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeecc-----ccCcce
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYG-----VDGEDN 78 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~-----~~~~~~ 78 (318)
..++|++.+.||.|+||.||+|.+..+++.+++|+...... ...+.+|+.++..+..|+++..+..++ ..+...
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 95 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQL 95 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeE
Confidence 45799999999999999999999999999999998765333 345778999999996556666664443 234578
Q ss_pred EEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 79 VLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
+++|||+ +++|.+++... ...+++..+..++.|++.||.|||+.+++||||+|+||+++ +.+.++|+|||.+.
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~---~~~~~kl~dfg~~~ 172 (286)
T cd06638 96 WLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKLVDFGVSA 172 (286)
T ss_pred EEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEEC---CCCCEEEccCCcee
Confidence 9999999 88998887532 34578889999999999999999999999999999999994 77889999999987
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccC-----CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHH
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~ 229 (318)
........ .....++..|+|||++.. ..++.++||||+||++|+|++|..||...+..... ....
T Consensus 173 ~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~---~~~~ 242 (286)
T cd06638 173 QLTSTRLR-------RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL---FKIP 242 (286)
T ss_pred ecccCCCc-------cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH---hhcc
Confidence 65432211 123457889999998753 34788999999999999999999999875443221 1111
Q ss_pred HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
. ...+.......++..+.+++.+||..+|++||++.++.+.
T Consensus 243 ~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 243 R--NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred c--cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 1 1111111223456789999999999999999999988764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=276.87 Aligned_cols=201 Identities=25% Similarity=0.363 Sum_probs=169.0
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+|++.+.||.|++|.||+|.+..++..|++|++..... ...+.+|+.+++.++| +++..+..+.......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH-PYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCC-CCCcceeeEEecCCeeEEEec
Confidence 69999999999999999999998999999998765432 3467889999999985 566666666666778999999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+++++|.+++......+++..+..++.||+.||.|||+.|++|+||+|+||+++ ..+.++|+|||.+.........
T Consensus 80 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~---~~~~~~l~dfg~~~~~~~~~~~- 155 (286)
T cd07832 80 YMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPR- 155 (286)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEc---CCCcEEEeeeeecccccCCCCC-
Confidence 999999999876666789999999999999999999999999999999999994 7899999999998765433210
Q ss_pred cccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhH
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~ 218 (318)
......++..|+|||++.+.. ++.++||||+||++|+|++|.+||.+..+
T Consensus 156 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 206 (286)
T cd07832 156 -----LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND 206 (286)
T ss_pred -----ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH
Confidence 112346788999999987544 68999999999999999999999876554
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=280.16 Aligned_cols=249 Identities=17% Similarity=0.306 Sum_probs=194.5
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
+-|++.+.||.|+||.||+|.+..++..+++|.+..... ...+.+|+.++..+.| +++..+...+......++|+||
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCC-CCeeeEEEEEeeCCEEEEEEEe
Confidence 346889999999999999999999999999998765432 2357789999999876 5555565555666789999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+ +++|..++.....++++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~-- 158 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ-- 158 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---ccCCCEEEcccccccccccccc--
Confidence 9 778888776545668999999999999999999999999999999999999 4888999999999865432211
Q ss_pred cccccCCCCCccccccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 164 HIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
......++..|+|||++. +..++.++|||||||++|+|++|.+||...++. ..+..+.... .+..
T Consensus 159 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~---~~~~~~~~~~--~~~~ 228 (282)
T cd06643 159 -----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM---RVLLKIAKSE--PPTL 228 (282)
T ss_pred -----ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH---HHHHHHhhcC--CCCC
Confidence 112346788999999984 344778999999999999999999999875442 2222222211 1111
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.....++..+.+++..||..+|++||++.++.+
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 229 AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 123457889999999999999999999987665
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=273.66 Aligned_cols=246 Identities=22% Similarity=0.325 Sum_probs=189.3
Q ss_pred eeccCcccEEEEEEE--cCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 14 KIGSGSFGEIFLASH--VDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 14 ~lg~G~~~~v~~~~~--~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
.||+|+||.||+|.+ ..++..+|+|+++..... ..+..|+.++..+.| +++..+..+.. ....+++||++ +
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN-PYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCC-CCcceEEEEEc-CCCcEEEEecCCC
Confidence 689999999999965 356789999987654432 356778889999876 45555544332 44679999999 7
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
++|.+++.. ...+++..+..++.|++.||.|+|++|++||||||.||++ +.++.++|+|||.+..........
T Consensus 80 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~--- 152 (257)
T cd05116 80 GPLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYY--- 152 (257)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE---cCCCeEEECCCccccccCCCCCee---
Confidence 889998875 3458999999999999999999999999999999999999 478899999999987654322110
Q ss_pred ccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCc
Q 021053 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (318)
.......++..|+|||.+....++.++|+|||||++|+|++ |..||...+..... ..+.. ....+ ....+|
T Consensus 153 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~i~~-~~~~~---~~~~~~ 224 (257)
T cd05116 153 -KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT---QMIES-GERME---CPQRCP 224 (257)
T ss_pred -eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHC-CCCCC---CCCCCC
Confidence 01112233578999999988888999999999999999998 99999875543222 22221 11111 223578
Q ss_pred hhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 246 AEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 246 ~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
..+.+++..||..+|++||++..+.+.|.+.
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 8999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=273.52 Aligned_cols=254 Identities=22% Similarity=0.371 Sum_probs=198.0
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++..++|++.+.||+|+||.||+|.+. .+..+++|.+..... ...+.+|+.+++.+.|. ++..+...... ...+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD-KLVKLHAVVTK-EPIYII 78 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCC-CcceEEEEEcC-CCeEEE
Confidence 467899999999999999999999865 445689998765432 34678899999999764 45555444444 678999
Q ss_pred Eecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 82 LDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
+|++ +++|.+++... ...++...+..++.|++.||.|||++|++|+||+|+||+++ ..+.++|+|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCCcceeeccCC
Confidence 9999 78999998763 33477888999999999999999999999999999999994 8899999999998765432
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
... ......++..|+|||++.+..++.++|+|||||++|++++ |++||...+...... .+. .....+
T Consensus 156 ~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~---~~~-~~~~~~-- 223 (260)
T cd05073 156 EYT------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR---ALE-RGYRMP-- 223 (260)
T ss_pred Ccc------cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHh-CCCCCC--
Confidence 211 1122234567999999988889999999999999999999 999998755432222 211 111111
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
.....+..+.+++.+||..+|++||++.++.+.|++
T Consensus 224 -~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 -RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 123567889999999999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=281.58 Aligned_cols=250 Identities=19% Similarity=0.315 Sum_probs=198.6
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
.++|++.+.||.|++|.||+|.+..++..+++|+...... ...+..|+.++..++| +++..+...+......++|||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH-PNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCC-CceeEEEEEEecCCeEEEEee
Confidence 3689999999999999999999988899999998764432 2357789999999985 666666666666778999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
++ +++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---CCCCCEEEccCccchhhccccc-
Confidence 99 779999888766679999999999999999999999999999999999999 4889999999998765433221
Q ss_pred ccccccCCCCCccccccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 163 RHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
......++..|+|||++. ...++.++|+|||||++|+|++|.+||...+... .+..+.. ...+.
T Consensus 159 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~--~~~~~ 227 (280)
T cd06611 159 ------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR---VLLKILK--SEPPT 227 (280)
T ss_pred ------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH---HHHHHhc--CCCCC
Confidence 112345788899999875 3346789999999999999999999998764432 2222221 11111
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
......++..+.+++..||..+|++||++.++.+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 1112356789999999999999999999998766
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=298.30 Aligned_cols=243 Identities=22% Similarity=0.288 Sum_probs=197.6
Q ss_pred eeccCcccEEEEEEEcCCCcEEEEEeecCC--CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCCHH
Q 021053 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLE 90 (318)
Q Consensus 14 ~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~L~ 90 (318)
.||.|.||+||-|+|..++...|||-+... ...+-+..|+..-+.|+|.+++.++..+. .++.+-|+||.. ||||.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s-enGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS-ENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC-CCCeEEEEeecCCCCcHH
Confidence 689999999999999999999999965433 33456889999999999866666666554 445788899988 99999
Q ss_pred HHHHHhcCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccccc
Q 021053 91 DLFVYCRRKF--SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (318)
Q Consensus 91 ~~~~~~~~~~--~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 168 (318)
+++.+..+++ ++.+...+.+||+.||.|||.+.|+|||||.+|+|++ -..|.+||+|||.++.+-.-..
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP------- 731 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINP------- 731 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEe--eccceEEecccccchhhccCCc-------
Confidence 9999887777 7899999999999999999999999999999999996 5789999999999987643222
Q ss_pred CCCCCcccccccccccccCCC--CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCch
Q 021053 169 ENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (318)
Q Consensus 169 ~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (318)
....+.||..|||||++..++ |++++|||||||++.||.||++||....... . .+.++.-.+..+|.++ .++.
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-A-AMFkVGmyKvHP~iPe---elsa 806 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-A-AMFKVGMYKVHPPIPE---ELSA 806 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-H-hhhhhcceecCCCCcH---HHHH
Confidence 124678999999999998665 8999999999999999999999997655432 2 2222222333444443 4578
Q ss_pred hHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 247 EFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 247 ~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+.+.+|.+|+.++|.+||++.++..
T Consensus 807 eak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 807 EAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHcCCCcccCccHHHhcc
Confidence 8999999999999999999986554
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=275.26 Aligned_cols=257 Identities=18% Similarity=0.281 Sum_probs=201.0
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCC---cEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~---~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
-..+|++.+.||.|+||.||+|.+..++ ..+++|.++.... ...+.+|+.++..++| +++..+..++......
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDH-PNIIHLEGVVTKSKPV 80 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCC-CCcceEEEEEecCCcc
Confidence 3578999999999999999999986443 3789998765332 2357788999999876 5666676666677789
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
+++||++ +++|.+++......++...+..++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE---CCCCeEEeCCCCcccccc
Confidence 9999999 789999998755568999999999999999999999999999999999999 478899999999987654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
....... ......++..|+|||.+.+..++.++|+|||||++|++++ |..||...+.... ...+.+ ....+
T Consensus 158 ~~~~~~~----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~~-~~~~~ 229 (267)
T cd05066 158 DDPEAAY----TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIEE-GYRLP 229 (267)
T ss_pred cccceee----ecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHhC-CCcCC
Confidence 3221110 0112233567999999998889999999999999999887 9999987554322 222222 11222
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
. ....|..+.+++.+||..+|.+||++.++.+.|.++
T Consensus 230 ~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 A---PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred C---CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1 135678899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=273.52 Aligned_cols=258 Identities=22% Similarity=0.323 Sum_probs=200.3
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCC---CcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~---~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
+-.++|.+.+.||.|+||.||+|.+... ...|++|....... ...+.+|+.+++.+.|++ +..+..+... ..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~-i~~~~~~~~~-~~ 80 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPH-IVKLIGVITE-NP 80 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCc-hhceeEEEcC-CC
Confidence 4567899999999999999999987643 34688997765432 235778999999998754 4444433333 45
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.+++||++ +++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||+++ ..+.++|+|||++...
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~---~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVS---SPDCVKLGDFGLSRYL 157 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEe---cCCCeEEccCceeeec
Confidence 78999999 8899999987555689999999999999999999999999999999999994 7889999999998765
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
...... ......++..|+|||.+....++.++|||||||++|++++ |..||......+.. ..+.. ....
T Consensus 158 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~---~~~~~-~~~~ 227 (270)
T cd05056 158 EDESYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI---GRIEN-GERL 227 (270)
T ss_pred ccccce------ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHc-CCcC
Confidence 433211 0112234567999999988889999999999999999997 99999876543222 22221 1111
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
+ .....|..+.+++.+||..+|++||++.++...|.++..+
T Consensus 228 ~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 P---MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1 1235678999999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=314.41 Aligned_cols=250 Identities=26% Similarity=0.349 Sum_probs=208.1
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecC-----CCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+-.++|++++.||.|+||.|.+++.+.+++.||+|++++ .....-|..|-.++.. ....=+..+.+.+++..+.
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~-~ns~Wiv~LhyAFQD~~~L 150 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVF-GNSEWIVQLHYAFQDERYL 150 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHc-CCcHHHHHHHHHhcCccce
Confidence 456789999999999999999999999999999998875 2333456666667653 3335566778899999999
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+||+|| ||+|..++.... .+++..++.|+..|+.||..+|+.|+|||||||+|||+ |..|.+||+|||.|....
T Consensus 151 YlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 151 YLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred EEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe---cccCcEeeccchhHHhcC
Confidence 9999999 999999999866 69999999999999999999999999999999999999 699999999999999888
Q ss_pred CCCCCccccccCCCCCccccccccccccc----C-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh-
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHL----G-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK- 231 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~- 231 (318)
.++... ....+|||.|.+||++. + +.|++.+|+||+||++|||+.|..||...+- .+.+.+|...
T Consensus 227 ~dG~V~------s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl---veTY~KIm~hk 297 (1317)
T KOG0612|consen 227 ADGTVR------SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL---VETYGKIMNHK 297 (1317)
T ss_pred CCCcEE------eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH---HHHHHHHhchh
Confidence 776643 35678999999999986 3 4589999999999999999999999987554 3455566654
Q ss_pred -hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCC---hHHHHH
Q 021053 232 -KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD---YGFLKR 271 (318)
Q Consensus 232 -~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~---~~~l~~ 271 (318)
.+..|.+. .+|...++||...+. +|+.|.. ++++..
T Consensus 298 ~~l~FP~~~---~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 298 ESLSFPDET---DVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred hhcCCCccc---ccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 55555222 478999999998874 7888876 666555
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=279.02 Aligned_cols=275 Identities=19% Similarity=0.256 Sum_probs=205.4
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCc----EEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~----~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
.+-.++|+..+.||.|+||.||+|.+..++. .||+|.+...... ..+.+|+.++..+.| +++..+......
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~- 80 (303)
T cd05110 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH-PHLVRLLGVCLS- 80 (303)
T ss_pred ccchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcccEEEEEcC-
Confidence 4556889999999999999999999876665 4688877654332 256788889998876 444444333332
Q ss_pred cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
...+++++++ +++|.+++......+++..+..++.|++.||.|||++|++|+||||+||++. .++.+||+|||.+.
T Consensus 81 ~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~---~~~~~kL~Dfg~~~ 157 (303)
T cd05110 81 PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVK---SPNHVKITDFGLAR 157 (303)
T ss_pred CCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeec---CCCceEEccccccc
Confidence 3467889998 7899999887555688999999999999999999999999999999999994 77889999999987
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
......... ......++..|+|||++.+..++.++|||||||++|++++ |..||.+........ ......
T Consensus 158 ~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~----~~~~~~ 228 (303)
T cd05110 158 LLEGDEKEY-----NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD----LLEKGE 228 (303)
T ss_pred cccCccccc-----ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHCCC
Confidence 654322110 1122344678999999998889999999999999999998 999997754332222 222222
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCchhHHHhhhcCCccccc
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMSYCSLHSITF 299 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~l~~~p~~r~t~ 299 (318)
..+.. ...+.++..++..||..+|++||++.++.+.+..+...... .+.+.++.|+.+
T Consensus 229 ~~~~~---~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~-----~~~~~~~~~~~~ 286 (303)
T cd05110 229 RLPQP---PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDPQR-----YLVIQGDDRMKL 286 (303)
T ss_pred CCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhchhh-----heeeccCCcCCC
Confidence 22211 24567899999999999999999999999999886543222 234556666433
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=306.62 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=195.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeecc-ccCcc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYG-VDGED 77 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~-~~~~~ 77 (318)
+..-++|++.+.||.|+||.||+|++..++..||+|++..... ...+..|+.++..+.|++.+..+..+. .....
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 4556899999999999999999999999999999998764322 235788999999998855554444332 33457
Q ss_pred eEEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-------CccccCCCCCceeeccC-------
Q 021053 78 NVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSR-------GFLHRDIKPDNFLMGLG------- 139 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-------~i~H~dl~p~Nil~~~~------- 139 (318)
+|+||||+ +++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||+...
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 89999999 78999998753 24589999999999999999999984 49999999999999521
Q ss_pred -------CCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccC--CCCCCcchHHHHHHHHHHHHhCC
Q 021053 140 -------RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGS 210 (318)
Q Consensus 140 -------~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~tg~ 210 (318)
+....+||+|||++........ .....+|+.|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--------~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIESM--------AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccccc--------ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 1234589999999876533221 124468999999999864 34889999999999999999999
Q ss_pred CCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 211 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 211 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.||...+... ..+ .........+ ....+..+.++|..||..+|.+||++.++..
T Consensus 241 ~PF~~~~~~~--qli-~~lk~~p~lp----i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 241 TPFHKANNFS--QLI-SELKRGPDLP----IKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCCcCCcHH--HHH-HHHhcCCCCC----cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9997644322 122 2221111111 1245778999999999999999999998774
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=283.43 Aligned_cols=259 Identities=20% Similarity=0.230 Sum_probs=193.6
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeecc----ccCcc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYG----VDGED 77 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~----~~~~~ 77 (318)
++++|++.+.||.|++|.||+|.+..+++.||+|.+.... ....+.+|+.+++.++|++.+.....+. .....
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 5689999999999999999999999999999999876432 2235677999999998654443332221 12245
Q ss_pred eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 78 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
.++++|++.+++.+.+.. ..+++..+..++.|++.||.+||+.|++||||||+||++ +..+.++|+|||++....
T Consensus 83 ~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 83 VYIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---CCCCCEEECcccceeecc
Confidence 899999998899888763 458999999999999999999999999999999999999 488999999999987654
Q ss_pred CCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh-----
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK----- 231 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~----- 231 (318)
....... ......++..|+|||.+.+ ..++.++||||+||++|+|++|++||.+.+.......+..+...
T Consensus 158 ~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~ 233 (336)
T cd07849 158 PEHDHTG----FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQED 233 (336)
T ss_pred ccccccC----CcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 3222111 1223467889999998654 46889999999999999999999999765432222211111100
Q ss_pred ------------------hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 232 ------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 232 ------------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
....+........+..+.+++.+||..+|++||++.++.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 234 LNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00001111223456778999999999999999999987774
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=274.53 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=197.0
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-----------hhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----------PQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
+|.+++.||.|++|.||+|.+..++..+++|.+...... ..+.+|+.++..+.| +++..+..++....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH-ENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEeCC
Confidence 588999999999999999999888999999977543321 246778899999976 55666666666777
Q ss_pred ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..++++|++ +++|.+++... ..++...+..++.|++.||.|||++|++||||+|+||++ ++++.++|+|||.+..
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~---~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 80 HLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV---DNKGGIKISDFGISKK 155 (267)
T ss_pred ccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE---cCCCCEEecccCCCcc
Confidence 899999999 78999998763 458899999999999999999999999999999999999 4889999999999876
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
.......... ........++..|+|||.+.+..++.++|+||+||++|+|++|+.||...+.. ..+..+...
T Consensus 156 ~~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~---- 227 (267)
T cd06628 156 LEANSLSTKT-NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL---QAIFKIGEN---- 227 (267)
T ss_pred cccccccCCc-cccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH---HHHHHHhcc----
Confidence 6532211100 01112345788899999999888999999999999999999999999875432 222222211
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+.....++..+.+++++||..+|.+||++.++.+
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 111122456889999999999999999999988765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=277.92 Aligned_cols=255 Identities=18% Similarity=0.295 Sum_probs=197.4
Q ss_pred eeeEeeeeccCcccEEEEEEEcC-----CCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
+|++.+.||+|+||.||+|.+.. ....+++|.+..... ...+.+|+.++..+.| +++..+...+......+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH-PHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCC-CCEeeEEEEEecCCCcE
Confidence 58899999999999999998753 225688887765432 2357789999999976 55555555556667789
Q ss_pred EEEecc-CCCHHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCcee
Q 021053 80 LVLDLL-GPSLEDLFVYCR-----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFL 135 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~-----------------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil 135 (318)
+++|++ +++|.+++.... ..+++..+..++.|++.||.|||+.|++||||+|+||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 999999 789999876421 23678889999999999999999999999999999999
Q ss_pred eccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCcc
Q 021053 136 MGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQ 214 (318)
Q Consensus 136 ~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~ 214 (318)
+. +.+.++|+|||++.......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 160 l~---~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 231 (290)
T cd05045 160 VA---EGRKMKISDFGLSRDVYEEDSYV-----KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 231 (290)
T ss_pred Ec---CCCcEEeccccccccccCccchh-----cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCC
Confidence 94 78899999999987543222110 1122344667999999988889999999999999999998 999998
Q ss_pred chhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 215 GLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
+..+.... .........+. ...++..+.+++..||+.+|++||++.++.+.|++++.
T Consensus 232 ~~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 232 GIAPERLF----NLLKTGYRMER---PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred CCCHHHHH----HHHhCCCCCCC---CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 75543222 22222222221 23567899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=278.43 Aligned_cols=250 Identities=18% Similarity=0.321 Sum_probs=195.8
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-CChhHHHHHHHHHHHcCCCCCCeeeeccc------cCcce
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGV------DGEDN 78 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~i~~~~~------~~~~~ 78 (318)
.++|++.+.||.|+||.||+|.+..+++.+|+|+..... ....+..|+.++.++.+|+++..+..++. .....
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 94 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL 94 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence 478999999999999999999999999999999876543 23467778889999877777777655543 24578
Q ss_pred EEEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 79 VLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
+++|||+ +++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||++. +.+.++|+|||.+...
T Consensus 95 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~---~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 95 WLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQL 171 (282)
T ss_pred EEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEeeCcchhhh
Confidence 9999999 679999887533 3478888999999999999999999999999999999994 7889999999998754
Q ss_pred cCCCCCccccccCCCCCccccccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~ 231 (318)
..... ......++..|+|||++. ...++.++|+|||||++|+|++|..||....+.... ..+.
T Consensus 172 ~~~~~-------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~---~~~~-- 239 (282)
T cd06636 172 DRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL---FLIP-- 239 (282)
T ss_pred hcccc-------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh---hhHh--
Confidence 32211 123456788999999876 345788999999999999999999999765432211 1111
Q ss_pred hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+.......+|..+.+++..||..+|.+||++.++.+
T Consensus 240 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 240 -RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 112222223457889999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=278.41 Aligned_cols=250 Identities=21% Similarity=0.285 Sum_probs=193.4
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-------hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-------PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
+|++.+.||.|++|.||+|.+..+++.|++|.+...... ..+..|+.++..++| +++..+..+.......++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH-PNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCC-CCChhhhheeecCCEEEE
Confidence 589999999999999999999988999999987654322 245678999999886 555556555566778999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+++++|.+++......+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||.+.......
T Consensus 80 v~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 80 VFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred EEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE---cCCCCEEEccceeeeeccCCC
Confidence 99999999999987644368999999999999999999999999999999999999 488999999999987654432
Q ss_pred CCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC----
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST---- 235 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~---- 235 (318)
.. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.++.... ..+.......
T Consensus 157 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 226 (298)
T cd07841 157 RK-------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL---GKIFEALGTPTEEN 226 (298)
T ss_pred cc-------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH---HHHHHHcCCCchhh
Confidence 11 122345778999998865 45788999999999999999998888775543322 2222211111
Q ss_pred -------------------chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 -------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 -------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+........+..+.+++.+||..+|++||++.++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 227 WPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 111122334667888899999999999998888776
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=278.76 Aligned_cols=252 Identities=20% Similarity=0.220 Sum_probs=189.0
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeecc-ccCcceEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNVL 80 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~-~~~~~~~l 80 (318)
-++|++.+.||.|+||.||+|.+..+++.||+|.+..... .....+|+.++.+++|.+.+.....+. ......++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4689999999999999999999999999999998764322 224568999999998755444333332 23356899
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|+|++.++|.+++......+++..+..++.|++.||.|||+.|++|+||+|+||++ +..+.++|+|||.+.......
T Consensus 86 v~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 86 VMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL---TDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECccceeeecCCcc
Confidence 99999889999988755668999999999999999999999999999999999999 488899999999988664332
Q ss_pred CCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. .....++..|+|||.+.+ ..++.++||||+||++|+|++|.+||...++......+.... ..+...
T Consensus 163 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~----~~~~~~ 231 (309)
T cd07845 163 KP-------MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLL----GTPNES 231 (309)
T ss_pred CC-------CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc----CCCChh
Confidence 11 122344778999999876 457899999999999999999999998766543333322211 111111
Q ss_pred H--------------------------hhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 240 L--------------------------CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 240 ~--------------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
. ....++.+.+++..||..||++||++.++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 0113455667777777777777777766554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=276.98 Aligned_cols=249 Identities=20% Similarity=0.343 Sum_probs=193.0
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
++|++.+.||.|+||.||+|.+..++..||+|.+..... ......|+....+..+|+++..+..+.......++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 479999999999999999999999999999998765432 22455676665566666777777666666778999999
Q ss_pred ccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 84 LLGPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 84 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
++.++|.+++... ...+++..+..++.|++.||.|||++ +++||||+|+||++ +.++.+||+|||.+......
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecccccccccc
Confidence 9999998888653 23588999999999999999999997 99999999999999 58899999999998765322
Q ss_pred CCCccccccCCCCCcccccccccccccC----CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLG----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
.. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...... .+.+..+......
T Consensus 158 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~- 226 (283)
T cd06617 158 VA--------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQLKQVVEEPSP- 226 (283)
T ss_pred cc--------cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHHHHHHhcCCC-
Confidence 11 112356788999998865 44688999999999999999999999643211 1222222221111
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
......+|..+.+++..||..+|++||++.++.+
T Consensus 227 --~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 227 --QLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111246888999999999999999999998776
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=274.45 Aligned_cols=202 Identities=22% Similarity=0.340 Sum_probs=167.0
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
.++|.+.+.||+|+||.||+|.+..++..|++|++...... ....+|+.+++.+.| +++..+..++......++++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH-ANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCC-CCEeEEEEEEecCCeEEEEE
Confidence 36899999999999999999999989999999987654322 256789999999976 55666666667777899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
|++.+++.+.+......++...+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||.+.........
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 83 EYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI---SYLGELKLADFGLARAKSIPSQT 159 (291)
T ss_pred ecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE---cCCCcEEEeccccccccCCCCCC
Confidence 999889988876544557888889999999999999999999999999999999 48889999999998754332211
Q ss_pred ccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhH
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~ 218 (318)
.....++..|+|||.+.+. .++.++|||||||++|+|++|..||...++
T Consensus 160 -------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 160 -------YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred -------CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 1233568889999998764 478899999999999999999999986543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=276.58 Aligned_cols=258 Identities=21% Similarity=0.308 Sum_probs=197.8
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcC-----CCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
+..++|++.+.||.|+||.||+|.++. .+..||+|.+...... ..+.+|+.+++.+.| +++..+.......
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~ 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTC-HHVVRLLGVVSKG 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEcCC
Confidence 556899999999999999999997642 3457999987644322 246678888988876 5666666666666
Q ss_pred cceEEEEecc-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeE
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~---------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~ 145 (318)
...+++|||+ +++|.+++.... ..++...+..++.|++.||.|||+++++||||||+||+++ +++.+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~---~~~~~ 158 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTV 158 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEc---CCCcE
Confidence 7899999999 899999997532 1245677888999999999999999999999999999994 78999
Q ss_pred EEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHH
Q 021053 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQK 224 (318)
Q Consensus 146 kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~ 224 (318)
+|+|||+++......... ......++..|+|||.+.+..++.++|+|||||++|+|++ |..||.+....+ .
T Consensus 159 ~L~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~ 230 (288)
T cd05061 159 KIGDFGMTRDIYETDYYR-----KGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---V 230 (288)
T ss_pred EECcCCcccccccccccc-----ccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 999999987543322111 1122234667999999998889999999999999999999 899997754432 2
Q ss_pred HHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
...+..... .+ .....+..+.+++..||+.+|++||++.++.+.+.+.+
T Consensus 231 ~~~~~~~~~-~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 231 LKFVMDGGY-LD---QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHHHcCCC-CC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 222221111 11 12345778999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=276.03 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=190.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
++|++.+.||.|++|.||+|.+..+++.||+|.+..... ...+.+|+.++..++| +++..+..++......++++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRH-ENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCC-cchhhHHHhcccCCeEEEEE
Confidence 579999999999999999999988899999997654332 2356789999999876 55666666666778899999
Q ss_pred eccCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
||+.+ +|..+... ...+++..+..++.|++.||.|||+.|++|+||+|+||++ ++++.++|+|||.+........
T Consensus 80 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 80 EFVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred ecCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCcc
Confidence 99954 55544433 4458999999999999999999999999999999999999 4889999999999876543322
Q ss_pred CccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh--------
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-------- 232 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~-------- 232 (318)
. .....++..|+|||++.+. .++.++||||||+++|+|++|.+||......+....+.......
T Consensus 156 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 156 V-------YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred c-------cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 1 1234567889999998754 47889999999999999999999997654322221111111000
Q ss_pred ---------------ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 233 ---------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 233 ---------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+.......++..+.+++.+||..+|++||++.++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000111122356778999999999999999999887654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=283.96 Aligned_cols=201 Identities=21% Similarity=0.290 Sum_probs=158.3
Q ss_pred eeeeccCcccEEEEEEEc--CCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeecc-ccCcceEEEEeccCCC
Q 021053 12 GRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNVLVLDLLGPS 88 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~-~~~~~~~lv~e~~~~~ 88 (318)
+..||.|+||.||+|.+. .++..||+|.+........+.+|+.+++.++|++.+.....+. ......++++|+++++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 468999999999999965 3567899998876655567889999999998755444333332 3445789999999999
Q ss_pred HHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccC-CCCCeEEEEeccceeeecCC
Q 021053 89 LEDLFVYCR--------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 89 L~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~-~~~~~~kL~dfg~~~~~~~~ 159 (318)
|.+++.... ..+++..+..++.||+.||.|||+.|++||||||+||++... +..+.+||+|||+++.....
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~ 165 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence 988875321 237788899999999999999999999999999999999422 35678999999999865433
Q ss_pred CCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccch
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGL 216 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~ 216 (318)
... ........+|..|+|||++.+. .++.++|||||||++|+|+||++||...
T Consensus 166 ~~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 166 LKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccc----ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 221 1112344678899999998764 4899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=273.81 Aligned_cols=255 Identities=24% Similarity=0.391 Sum_probs=201.6
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++..++|++.+.||.|++|.||+|.+. ++..|++|.+..... ...+.+|+.+++.+.| +++..+..++......+++
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v 79 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRH-DKLVQLYAVCSEEEPIYIV 79 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCC-CCEeeeeeeeecCCceEEE
Confidence 356789999999999999999999975 457799998775433 3568889999999986 5555665555666789999
Q ss_pred Eecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
+|++ +++|.+++.... ..++...+..++.|++.||.|||++|++|+||+|+||+++ +++.++|+|||.+......
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~---~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc---CCCCEEECccccceeccch
Confidence 9998 789999987633 3588999999999999999999999999999999999994 8899999999998765432
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
... .......+..|+|||.+.+..++.++|+||+|+++|++++ |+.||.+..... .+..+.. ....+.+
T Consensus 157 ~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~-~~~~~~~ 226 (261)
T cd05034 157 EYT------AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVER-GYRMPRP 226 (261)
T ss_pred hhh------hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc-CCCCCCC
Confidence 111 1112234567999999998889999999999999999999 999997754432 2223221 1122211
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
...|..+.+++.+||..+|++||++.++.+.|++
T Consensus 227 ---~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 ---PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 2457889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=273.30 Aligned_cols=253 Identities=19% Similarity=0.266 Sum_probs=190.4
Q ss_pred eeeccCcccEEEEEEEcC---CCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-
Q 021053 13 RKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~- 85 (318)
+.||+|+||.||+|.+.. .+..||+|.+..... ...+.+|+.+++.+.|++.+..+..+.......++++|++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998753 345799998754332 2356778888888877555544444444556688999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccc
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~ 165 (318)
+++|.+++.......+......++.|++.||.|||+.+++||||+|+||+++ +.+.+||+|||++..........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~---~~~~~kl~dfg~~~~~~~~~~~~-- 155 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLD---ESFTVKVADFGLARDIYDKEYYS-- 155 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc---CCCcEEECCccccccccCCccee--
Confidence 8999999986555567788888999999999999999999999999999994 78899999999987543321110
Q ss_pred cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcC
Q 021053 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (318)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (318)
........++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+... ....+... ...+. ....
T Consensus 156 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~~~~-~~~~~---~~~~ 227 (262)
T cd05058 156 -VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYLLQG-RRLLQ---PEYC 227 (262)
T ss_pred -ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHhcC-CCCCC---CCcC
Confidence 011123345678999999988889999999999999999999 577787654332 22222211 11111 1245
Q ss_pred chhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 245 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
|..+.+++..||..+|++||++.++.+.|++++.
T Consensus 228 ~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 228 PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 7789999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=282.98 Aligned_cols=248 Identities=24% Similarity=0.310 Sum_probs=211.8
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
|++=|.+.+.||.|.|..|-+|++.=+|..||||++.+..- ...+.+|+..++..+| ++++.++.........|+
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQH-pNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQH-PNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcC-cCeeeeeehhcccceEEE
Confidence 56779999999999999999999999999999999876542 3468899999987766 677777777777788999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
|+|.- +|+|.+++.+...++.+...++|+.||+.|+.|+|+..++||||||+|++|. ..-|.+||.|||++-.+...
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~PG 172 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQPG 172 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe--eecCceEeeeccccccCCCc
Confidence 99999 8899999988778899999999999999999999999999999999999886 67899999999998765432
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCC-CcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQS-RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
. ......|+..|-|||++.|..|+ +++||||||||||-++-|++||+..++.+-.. .|+.-+...|.
T Consensus 173 ~--------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---mImDCKYtvPs- 240 (864)
T KOG4717|consen 173 K--------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---MIMDCKYTVPS- 240 (864)
T ss_pred c--------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---hhhcccccCch-
Confidence 2 23456889999999999999985 78999999999999999999999887754444 44445555553
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+.+.++||..||..||.+|.+.++|..
T Consensus 241 ----hvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 241 ----HVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ----hhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 34779999999999999999999987765
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=275.98 Aligned_cols=260 Identities=24% Similarity=0.271 Sum_probs=194.5
Q ss_pred cceeeEeeeeccCcccEEEEEEE----cCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeec--cccCcc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWY--GVDGED 77 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~----~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~--~~~~~~ 77 (318)
..+|++.+.||.|+||.||+|.. ..++..|++|.+..... ...+.+|+.++..+.|+ ++..+..+ ......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~-~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHD-NIVKYKGVCYSAGRRN 81 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCC-CeeEEEEEEccCCCCc
Confidence 46899999999999999999974 45788999998765443 23577899999999774 45454332 233456
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++|+||+ +++|.+++......+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||.+...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKVL 158 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE---CCCCeEEECCCcccccc
Confidence 89999999 899999997655568999999999999999999999999999999999999 47889999999998865
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhh------------HHH
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK------------KQK 224 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~------------~~~ 224 (318)
....... .......++..|+|||++.+..++.++|||||||++|+|++|..|+........ ...
T Consensus 159 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 159 PQDKEYY----KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred cCCCcce----eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 4322110 011122334569999999888899999999999999999998777543211100 000
Q ss_pred HHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
+..........+ ....++..+.+++.+||..+|++|||+.++.+.|+++
T Consensus 235 ~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLP---APPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 111111111111 1235678899999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=269.99 Aligned_cols=247 Identities=24% Similarity=0.316 Sum_probs=200.1
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+|++.+.||.|+||.||.+++..+++.+++|.+.... ....+.+|+.++++++| +++..+..++......++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH-PNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCC-CCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999765432 22357889999999865 666666666677788999999
Q ss_pred cc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 84 LL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 84 ~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
++ +++|.+++... ...++...+..++.|++.||.|||+.|++|+||+|+||++. ..+.+||+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~---~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEe---CCCCEEECcCcceEEcccccc
Confidence 99 78999998764 34588999999999999999999999999999999999994 788999999999876543332
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
. .....++..|+|||++.+..++.++|+||||+++|+|++|..||...... +....+...... + ..
T Consensus 157 ~-------~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~~~~~~~~~-~---~~ 222 (256)
T cd08221 157 M-------AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVVKIVQGNYT-P---VV 222 (256)
T ss_pred c-------ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCCCC-C---Cc
Confidence 1 12345788999999999888999999999999999999999999765432 223333222221 1 11
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
...+..+.+++.+||..+|++||++.++.+.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 4567889999999999999999999987764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=276.06 Aligned_cols=246 Identities=22% Similarity=0.325 Sum_probs=197.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
++|++.+.||.|++|.||+|.+..+++.|++|.+..... ...+.+|+.+++.+.| +++..+..+.......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRS-PYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCC-CCeeeeeEEEEECCeEEEEEE
Confidence 579999999999999999999999999999998765432 2357789999999986 455555555566678999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
++ +++|.+++... .+++..+..++.|++.||.|||+.+++|+||+|+||++ ++++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~ 154 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMSK 154 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEcccccceeecccccc
Confidence 99 78999998753 68999999999999999999999999999999999999 48899999999999876544221
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
.....++..|+|||.+.+..++.++|||||||++|+|++|..||...++.. ....+... ....... .
T Consensus 155 -------~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~~-~~~~~~~--~ 221 (274)
T cd06609 155 -------RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VLFLIPKN-NPPSLEG--N 221 (274)
T ss_pred -------cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HHHHhhhc-CCCCCcc--c
Confidence 123456788999999998889999999999999999999999997654322 22222211 1111111 1
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.++..+.+++.+||..+|++||+++++.+
T Consensus 222 ~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 26788999999999999999999998866
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=271.88 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=198.1
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
-.++|++.+.||.|++|.||+|.. .++.|++|.+..... ...+.+|+.++..+.|+ ++..+..+.......++++|
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~-~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHP-NLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCc-ceeeeEEEEcCCCCeEEEEE
Confidence 457899999999999999999987 478899998876554 45788899999999864 45555555555778999999
Q ss_pred cc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 84 LL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
++ +++|.+++..... .+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE---eCCCCEEEcccccccccccccc
Confidence 99 6899999876432 58999999999999999999999999999999999999 4889999999999876532211
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
....+..|+|||.+.+..++.++|+||||+++|++++ |..||........ ...+ ...... ..
T Consensus 158 ----------~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~-~~~~~~---~~ 220 (256)
T cd05039 158 ----------SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPHV-EKGYRM---EA 220 (256)
T ss_pred ----------cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHH-hcCCCC---CC
Confidence 1233557999999988889999999999999999998 9999976543321 1111 111111 11
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
....|+.+.+++.+||..+|++||++.++.+.|.+
T Consensus 221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 23567899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=279.96 Aligned_cols=252 Identities=20% Similarity=0.293 Sum_probs=194.4
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
++|++.+.||.|+||.||+|.+..++..+++|.+..... ...+.+|++++.+++| +++..+..++......++++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNS-PYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCCEEEEEee
Confidence 479999999999999999999999999999998765432 2357789999999976 566666666667788999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|+ +++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 y~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~ 155 (308)
T cd06615 80 HMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDSMA 155 (308)
T ss_pred ccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE---ecCCcEEEccCCCccccccccc
Confidence 99 78999998764 558999999999999999999998 599999999999999 4788999999998865432211
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHH-------------
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI------------- 228 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i------------- 228 (318)
....++..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+...
T Consensus 156 ---------~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 156 ---------NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred ---------ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence 2346788999999998888999999999999999999999999754432211111100
Q ss_pred ----------------HHhhccCchHHH-hhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 229 ----------------CEKKVSTPIEVL-CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 229 ----------------~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
.........+.. ...++..+.+++.+||..+|++||++.++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 11256679999999999999999999887764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=276.52 Aligned_cols=247 Identities=21% Similarity=0.304 Sum_probs=196.9
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
...|+..+.||.|+||.||.|.+..++..||+|++..... ...+.+|+.++..+.| +++..+...+......++||
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCEEEEEE
Confidence 3568899999999999999999998899999998764332 2357788899988876 55666665666777899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|++ +++|.+++.. .+++...+..++.|++.||.++|+.+++|+||+|+||+++ ..+.++|+|||.+........
T Consensus 82 e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~---~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 82 EYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred ecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc---CCCCEEEcccccceeccCCcc
Confidence 999 8899998864 4588999999999999999999999999999999999994 788999999999876543221
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
......++..|+|||++.+..++.++|+|||||++|+|++|+.||....+..... .+.. .. .+...
T Consensus 157 -------~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~~~~-~~---~~~~~ 222 (277)
T cd06640 157 -------KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF---LIPK-NN---PPTLT 222 (277)
T ss_pred -------ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh---hhhc-CC---CCCCc
Confidence 1123356778999999988889999999999999999999999998755432211 1111 11 11222
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
...+..+.+++..||..+|++||++.++.+.
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 3567789999999999999999999988664
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=272.35 Aligned_cols=246 Identities=21% Similarity=0.281 Sum_probs=194.1
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
-++|++.+.||.|+||.||+|.. ++..||+|..........+.+|+.++..++|++.+ .+..+... ...+++||++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~-~~~~~~~~-~~~~~v~e~~ 80 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLV-RLLGVILH-NGLYIVMELM 80 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcC-eEEEEEcC-CCcEEEEECC
Confidence 36899999999999999999964 67789999887655556788899999999875544 44433333 3479999999
Q ss_pred -CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 86 -GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 86 -~~~L~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+++|.+++..... .++...+..++.|++.||.|||++|++||||+|+||+++ .++.++|+|||.+........
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~---~~~~~kl~Dfg~~~~~~~~~~-- 155 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVD-- 155 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc---CCCcEEECCCccceeccccCC--
Confidence 7899999876432 478899999999999999999999999999999999994 788999999999875432211
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
....+..|+|||.+.+..++.++|+|||||++|+|++ |.+||...+...... .+.. ....+ ...
T Consensus 156 --------~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~~-~~~~~---~~~ 220 (254)
T cd05083 156 --------NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE---CVEK-GYRME---PPE 220 (254)
T ss_pred --------CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH---HHhC-CCCCC---CCC
Confidence 1233567999999988889999999999999999998 999998755432222 2211 11111 123
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
..|..+.+++.+||..+|++||++.++.+.|++
T Consensus 221 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 567889999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=279.70 Aligned_cols=248 Identities=22% Similarity=0.313 Sum_probs=197.0
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
.++|++.+.||.|++|.||+|.+..+++.||+|.+..... ...+.+|+.+++.+.| +++..+..++......++|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCEEEEeec
Confidence 4789999999999999999999998999999998764332 3456778888888866 555566555566778999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
++ +++|.+++.. ..++...+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 97 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~~ 171 (297)
T cd06656 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSK 171 (297)
T ss_pred ccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEECcCccceEccCCccC
Confidence 99 8899998864 447889999999999999999999999999999999999 48899999999998765432221
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
.....++..|+|||.+.+..++.++|+|||||++|++++|..||...++..... .+. ....+......
T Consensus 172 -------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~---~~~--~~~~~~~~~~~ 239 (297)
T cd06656 172 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIA--TNGTPELQNPE 239 (297)
T ss_pred -------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee---eec--cCCCCCCCCcc
Confidence 123457888999999998889999999999999999999999997654322111 111 11111111223
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+..+.+++.+||..+|++||++.++.+
T Consensus 240 ~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 240 RLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 56778999999999999999999998776
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=281.91 Aligned_cols=201 Identities=24% Similarity=0.338 Sum_probs=165.5
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccc-----c
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----D 74 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~-----~ 74 (318)
.+.++|++.+.||.|+||.||+|.+..+++.||+|.+.... ....+.+|+.+++.+.|++.+..+..+.. .
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 45789999999999999999999999999999999876432 12356789999999987554444433322 2
Q ss_pred CcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
....|+|+|++.++|.+.+.. .++...+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||.+.
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLAR 166 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCccce
Confidence 235799999999899888864 28889999999999999999999999999999999999 488999999999997
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhH
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~ 218 (318)
....... .....++..|+|||++.+..++.++|||||||++|+|++|+.||...+.
T Consensus 167 ~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~ 222 (353)
T cd07850 167 TAGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDH 222 (353)
T ss_pred eCCCCCC--------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 6543221 1233567889999999998999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=276.80 Aligned_cols=248 Identities=17% Similarity=0.251 Sum_probs=194.3
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
++|++.+.||.|+||.||+|.+..++..||+|.+..... ...+.+|+.++.++.| +++..+...+......++++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVS-PYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCC-CcHHhhhhheecCCeEEEEEe
Confidence 479999999999999999999998999999997764322 2467789999999876 555555555566778999999
Q ss_pred cc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 84 LL-GPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 84 ~~-~~~L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
|+ +++|.+++... ...+++..+..++.|++.||.|||+ .|++|+||+|+||+++ ..+.++|+|||.+......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVN---GNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEEC---CCCCEEEeecCCcccccCC
Confidence 99 77898887753 2258999999999999999999997 5999999999999994 7889999999998755332
Q ss_pred CCCccccccCCCCCcccccccccccccCC------CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGI------EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
.. ....++..|+|||.+.+. .++.++|+|||||++|+|++|..||...........+..+..
T Consensus 157 ~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--- 224 (286)
T cd06622 157 LA---------KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--- 224 (286)
T ss_pred cc---------ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhh---
Confidence 22 123467789999988544 357899999999999999999999976443322223332222
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+.......++.++.+++.+||..+|++||++.++..
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 225 -GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred -cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1111223357889999999999999999999998776
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=277.11 Aligned_cols=251 Identities=18% Similarity=0.303 Sum_probs=197.0
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
-.++|++.+.||+|+||+||+|.+..+++.||+|++..... ...+.+|+.++..++| +++..+..+......+++|
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRS-PYIVSFYGAFLNENNICMC 81 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCC-CCcceEeeeEecCCEEEEE
Confidence 35789999999999999999999998899999997654332 2467889999999875 5566666666666889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
+||+ +++|.+++.. .+.+++..+..++.+++.||.|||+ .+++|+||+|+||++ ++++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 82 MEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred EecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh
Confidence 9999 7888888776 3458999999999999999999997 599999999999999 48889999999987654322
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhh-----h---HHHHHHHHHh
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-----K---KQKYDKICEK 231 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~-----~---~~~~~~i~~~ 231 (318)
.. ....++..|+|||++.+..++.++|+|||||++|++++|..||....... . ......+...
T Consensus 158 ~~---------~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd06620 158 IA---------DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE 228 (284)
T ss_pred cc---------CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc
Confidence 21 23467889999999988889999999999999999999999998644320 0 1111221111
Q ss_pred hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
..+.. ....++..+.+++.+||..+|++||++.++.+.
T Consensus 229 ~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 229 PPPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred cCCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11111 011367789999999999999999999988774
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=276.07 Aligned_cols=202 Identities=26% Similarity=0.352 Sum_probs=166.7
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccC--cceEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDNVL 80 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~--~~~~l 80 (318)
++|++.+.||.|+||.||+|.+..+++.+++|.++..... ..+.+|+.++.+++| +++..+..+.... ...|+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h-~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQH-PNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCC-CCEEEEEEEEEecCCCcEEE
Confidence 5799999999999999999999989999999987643322 245689999999985 5555554444433 78999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
++|++.++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||++ +..+.++|+|||.+.......
T Consensus 84 v~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 84 VMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL---NNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCcEEEeecCceeeccCCc
Confidence 99999889999988755568999999999999999999999999999999999999 488999999999988655432
Q ss_pred CCccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHh
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~ 219 (318)
. ......++..|+|||.+.+.. ++.++|+||+|+++|+|++|.+||......
T Consensus 161 ~-------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~ 213 (293)
T cd07843 161 K-------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213 (293)
T ss_pred c-------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChH
Confidence 1 112345678899999887654 688999999999999999999999875543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=275.26 Aligned_cols=242 Identities=24% Similarity=0.357 Sum_probs=197.1
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||.|++|.||+|.+..+++.||+|++.... ....+.+|+++++.+.| +++..+...+......+++
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH-PFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCC-CCccceeeEEEcCCeEEEE
Confidence 47999999999999999999999999999999875422 23457789999999985 6666776666777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||++ +++|.+++... ..++...+..++.|++.||.|||++|++|+||+|+||++ +.++.+||+|||++.......
T Consensus 80 ~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~ 155 (290)
T cd05580 80 MEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL---DSDGYIKITDFGFAKRVKGRT 155 (290)
T ss_pred EecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEeeCCCccccCCCC
Confidence 9999 89999998774 568999999999999999999999999999999999999 478899999999987654331
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+.. .....+.......
T Consensus 156 ----------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~----- 217 (290)
T cd05580 156 ----------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYEKILEGKVRF----- 217 (290)
T ss_pred ----------CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHhcCCccC-----
Confidence 2335788899999998888899999999999999999999999765432 2222333222222
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
...++..+.+++.+||..+|.+|+ +++++.+
T Consensus 218 ~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 234578999999999999999998 5555543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=275.12 Aligned_cols=247 Identities=19% Similarity=0.241 Sum_probs=192.1
Q ss_pred eeeccCcccEEEEEEEcCCCc--EEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHVDTNE--IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~--~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||.|+||.||+|.+.+++. .+++|.+..... ...+.+|+.++.++.+|+++..+..++......+++||++ +
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999987765 467887664322 2357789999999977788888877777777899999999 8
Q ss_pred CCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecc
Q 021053 87 PSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (318)
Q Consensus 87 ~~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg 151 (318)
++|.+++.... ..++...+..++.|++.||.|||++|++|+||||+||++ +.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCC
Confidence 89999987532 136788999999999999999999999999999999999 488999999999
Q ss_pred ceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHH
Q 021053 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICE 230 (318)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~ 230 (318)
++....... .......+..|+|||++.+..++.++|||||||++|+|++ |..||.+.+... ....+..
T Consensus 158 l~~~~~~~~--------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~~~~~ 226 (270)
T cd05047 158 LSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKLPQ 226 (270)
T ss_pred Cccccchhh--------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHHHHhC
Confidence 975322110 0111233567999999988889999999999999999997 999997654332 2222211
Q ss_pred hhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
....+ .....+..+.+++.+||..+|.+||++.++.+.|++++
T Consensus 227 -~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 -GYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred -CCCCC---CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11111 11245678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=273.52 Aligned_cols=254 Identities=21% Similarity=0.305 Sum_probs=195.7
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--------CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
+|+..+.||.|++|.||+|.+..+++.||+|++.... ....+.+|+.+++.++| +++..+..........+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH-PHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCC-CceehhhceeccCCeEE
Confidence 5889999999999999999999999999999876432 12357789999999977 44555555556677899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+++|++ +++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||++. .....++|+|||.+.....
T Consensus 80 ~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 80 LFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLID--STGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccccccccccc
Confidence 999999 7899998876 34588999999999999999999999999999999999994 2334699999999876654
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
....... ......++..|+|||++.+..++.++|+||+||++|++++|..||..............+...... .
T Consensus 157 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~ 230 (268)
T cd06630 157 KGTGAGE---FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA---P 230 (268)
T ss_pred ccccCCc---cccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCC---C
Confidence 3221110 112345788899999998888999999999999999999999999754332222222222111111 1
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
......+..+.+++.+||..+|++||++.++.+
T Consensus 231 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 231 SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 222346778999999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=271.46 Aligned_cols=245 Identities=25% Similarity=0.355 Sum_probs=197.0
Q ss_pred eeeccCcccEEEEEEEcCC---CcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-
Q 021053 13 RKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~---~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~- 85 (318)
+.||.|+||.||+|.+... +..|++|.+..... ...+.+|+..+..+.| +++..+..+.......++++|++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGH-PNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCC-CChheeeeeecCCCceEEEEEecc
Confidence 4689999999999999865 88999998876544 3467889999999984 66666655555677899999999
Q ss_pred CCCHHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 86 GPSLEDLFVYC--------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 86 ~~~L~~~~~~~--------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
+++|.+++... ...+++..+..++.|++.||.+||++|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE---CCCCcEEEcccccccccc
Confidence 99999999875 3568999999999999999999999999999999999999 477999999999998765
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
..... .......++..|+|||.+.+..++.++||||+||++|+|++ |..||......... ..+.. ....
T Consensus 157 ~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~-~~~~- 226 (262)
T cd00192 157 DDDYY-----RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL---EYLRK-GYRL- 226 (262)
T ss_pred ccccc-----ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHHc-CCCC-
Confidence 43211 11234456788999999988889999999999999999999 69999876443222 22221 1111
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
.....+|..+.+++..||..+|.+||++.++.+.|
T Consensus 227 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 227 --PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred --CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 12235578999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=281.03 Aligned_cols=259 Identities=20% Similarity=0.220 Sum_probs=191.6
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeecccc--------
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVD-------- 74 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~-------- 74 (318)
++.+|++.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+|+.+++.++|++.+..+..+...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 46899999999999999999999999999999997654432 34578899999999775544333333222
Q ss_pred -----CcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEe
Q 021053 75 -----GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (318)
Q Consensus 75 -----~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~d 149 (318)
....++++|++.++|.+++.. ..+++..++.++.||+.||.|||+.|++||||+|+||+++ .+++.++|+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~d 158 (342)
T cd07854 83 GSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGD 158 (342)
T ss_pred ccccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECC
Confidence 235789999998899888863 4589999999999999999999999999999999999995 3567899999
Q ss_pred ccceeeecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHH
Q 021053 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (318)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i 228 (318)
||.+.......... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...++..........
T Consensus 159 fg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 159 FGLARIVDPHYSHK----GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred cccceecCCccccc----cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99987654322111 01123356788999998654 45888999999999999999999999765443222111110
Q ss_pred H----------------------HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 229 C----------------------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 229 ~----------------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
. ......+........+..+.+++.+||..+|.+||++.++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 001111122223356677888999999999999998887764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=272.55 Aligned_cols=249 Identities=20% Similarity=0.249 Sum_probs=186.6
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+|++.+.||.|++|.||+|.+..+++.|++|.+..... ...+.+|+.++++++| +++..+..+.......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCC-CCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999998764332 2357889999999976 555566555567778999999
Q ss_pred ccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
|+.++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||++ ++++.++|+|||.+........
T Consensus 80 ~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 80 FLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred ccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEeeccchhhcccCcc-
Confidence 99888988886533 458899999999999999999999999999999999999 5889999999999875432211
Q ss_pred ccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc-----
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP----- 236 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~----- 236 (318)
......++..|+|||++.+.. ++.++|||||||++|+|+||+.||...+..... .++.......+
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~ 226 (284)
T cd07860 156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL---FRIFRTLGTPDEVVWP 226 (284)
T ss_pred ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHhCCCChhhhh
Confidence 112234577899999887654 688999999999999999999999765433222 12221111111
Q ss_pred -------------------hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHH
Q 021053 237 -------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (318)
Q Consensus 237 -------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~ 270 (318)
.......++..+.+++.+||..||.+||+++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 279 (284)
T cd07860 227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL 279 (284)
T ss_pred hhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 0111123455566777777777777777766554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=278.29 Aligned_cols=252 Identities=20% Similarity=0.292 Sum_probs=194.4
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
++|+..+.||.|+||.||++.+..+++.||+|.+..... ...+.+|+.++.++..|+++..+..+.......+++||
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 467788899999999999999999999999998764332 23567888899888756777777666666778999999
Q ss_pred ccCCCHHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 84 LLGPSLEDLFVY----CRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 84 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
++..++.++... ....+++..+..++.|++.||.|||+. +++||||+|+||+++ ..+.++|+|||++.....
T Consensus 84 ~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~---~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc---cCCcEEEeecchhHHhcc
Confidence 998887776532 134589999999999999999999975 999999999999994 788999999999865433
Q ss_pred CCCCccccccCCCCCcccccccccccccCC---CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
.... ....++..|+|||++.+. .++.++||||+||++|+|++|++||..... ....+..+.....+.
T Consensus 161 ~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~ 230 (288)
T cd06616 161 SIAK--------TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPI 230 (288)
T ss_pred CCcc--------ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCc
Confidence 2211 223567889999998876 588999999999999999999999976442 122222222111111
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
........++..+.+++..||..+|++||+++++.+
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 231 LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111112346788999999999999999999998776
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=278.08 Aligned_cols=251 Identities=23% Similarity=0.264 Sum_probs=194.1
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeee-ccccCcceE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKW-YGVDGEDNV 79 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~-~~~~~~~~~ 79 (318)
++++|++.+.||.|+||.||+|.+..++..||+|.+.... ....+.+|+.++..++|++ +..+.. +.......+
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHEN-IISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCC-eeeEeeeEecCCCcEE
Confidence 5789999999999999999999999999999999765322 2346778999999998754 444544 434456789
Q ss_pred EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 80 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
+++|+++++|.+++.. ..++...+..++.|++.||.|||+.|++|+||+|+||++ ++.+.++|+|||.+......
T Consensus 87 lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~~ 161 (328)
T cd07856 87 FVTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDPQ 161 (328)
T ss_pred EEeehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE---CCCCCEEeCccccccccCCC
Confidence 9999999899888763 457888888999999999999999999999999999999 48889999999998753221
Q ss_pred CCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHH---------
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC--------- 229 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~--------- 229 (318)
. ....++..|+|||.+.+ ..++.++|+|||||++|++++|.+||...........+.+..
T Consensus 162 ~----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (328)
T cd07856 162 M----------TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231 (328)
T ss_pred c----------CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 1 23356778999998766 568999999999999999999999997654322222111111
Q ss_pred --------------HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 230 --------------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 230 --------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
......|........+..+.+++++||..+|++||++.++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 001122223333456788999999999999999999987655
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=274.53 Aligned_cols=251 Identities=19% Similarity=0.305 Sum_probs=193.8
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeecccc-----CcceE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVD-----GEDNV 79 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~-----~~~~~ 79 (318)
.++|++.+.||.|+||.||+|.+..+++.+|+|++..... .....+|+.++.++.+|+++..+..++.. ....+
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~ 100 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW 100 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence 4789999999999999999999999999999998765433 34567889999998666777666544332 24689
Q ss_pred EEEecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 80 LVLDLL-GPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
+|+||+ +++|.+++.. ....+++..+..++.|++.||.|||++|++|+||+|+||+++ ..+.++|+|||.+..
T Consensus 101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~---~~~~~kl~dfg~~~~ 177 (291)
T cd06639 101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLT---TEGGVKLVDFGVSAQ 177 (291)
T ss_pred EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEc---CCCCEEEeecccchh
Confidence 999999 7899888763 234588999999999999999999999999999999999994 788899999999876
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCC-----CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHH
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~ 230 (318)
....... .....++..|+|||++... .++.++|||||||++|+|++|++||...++... +..+..
T Consensus 178 ~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~---~~~~~~ 247 (291)
T cd06639 178 LTSTRLR-------RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT---LFKIPR 247 (291)
T ss_pred ccccccc-------ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH---HHHHhc
Confidence 5432211 1233568889999987643 267899999999999999999999987554322 222211
Q ss_pred hhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
. ..+.......++..+.+++.+||..+|++||++.++.+
T Consensus 248 ~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 248 N--PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred C--CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 11111112345678999999999999999999998765
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=277.87 Aligned_cols=255 Identities=21% Similarity=0.305 Sum_probs=198.2
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-----hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||.|++|.||+|.+..+++.||+|.+...... ..+..|+.++..+.| +++..+..........+++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH-PFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCC-CCchhheeeeecCCEEEEE
Confidence 4799999999999999999999999999999987654322 356788999999886 5566665566667789999
Q ss_pred Eecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 82 LDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
+|++ +++|.+++... ...+++.....++.|++.||.|||+.|++|+||||+||++. .++.++|+|||.+......
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc---CCCCEEEeecchhhccccc
Confidence 9998 88999998753 24589999999999999999999999999999999999994 7889999999998754322
Q ss_pred CCCccc----------------------cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchh
Q 021053 160 TTNRHI----------------------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (318)
Q Consensus 160 ~~~~~~----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~ 217 (318)
...... .........++..|+|||++.+..++.++||||||+++|+|++|+.||.+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110000 0001123467888999999998889999999999999999999999998755
Q ss_pred HhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCC----hHHHHH
Q 021053 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD----YGFLKR 271 (318)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~l~~ 271 (318)
.. ..+..+.......+.. ...+..+.+++.+||..+|++||+ ++++..
T Consensus 237 ~~---~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RD---ETFSNILKKEVTFPGS---PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hH---HHHHHHhcCCccCCCc---cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 43 2233333322222221 125788999999999999999999 665555
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=274.15 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=195.1
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
++|++.+.||.|++|.||+|.+..+++.|++|.++... ....+.+|+++++.+.| +++..+..++......++++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRH-ENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCC-CCeeehhheEEECCEEEEEE
Confidence 47999999999999999999999999999999876432 23467889999999986 55555655556677899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
|++.+++.+.+......++...+..++.|++.||.|||+.|++|+||+|+||++ ++++.++|+|||.+.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV---SESGVLKLCDFGFARALRARPAS 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccc
Confidence 999777777666555668999999999999999999999999999999999999 47899999999998765443221
Q ss_pred ccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc--------
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV-------- 233 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~-------- 233 (318)
......++..|+|||++.+. .++.++|+||||+++|+|++|++||.+.+..+.............
T Consensus 157 ------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 157 ------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcc
Confidence 11234567889999999888 789999999999999999999999986544332222222111000
Q ss_pred ----------cCc-----h-HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 234 ----------STP-----I-EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 234 ----------~~~-----~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+ . ......++..+.+++.+||..+|++||++.++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 0 0011123677889999999999999998887654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=268.53 Aligned_cols=246 Identities=21% Similarity=0.277 Sum_probs=196.5
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+|++.+.||.|++|.||+|.+..+++.+++|.+.... ....+.+|+.+++.+.| +++..+...+......++|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH-PNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCC-CchhheeeeEecCCEEEEEEe
Confidence 6999999999999999999999999999999876432 22357789999999976 455555555556678999999
Q ss_pred cc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 84 LL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
++ +++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||+++ ++.+.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCcc
Confidence 99 789999987643 3478999999999999999999999999999999999995 3556789999999886643322
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||...+... ....+...... ...
T Consensus 158 --------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~~~~~----~~~ 222 (256)
T cd08220 158 --------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKIMSGTFA----PIS 222 (256)
T ss_pred --------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHHHhcCCC----CCC
Confidence 123457888999999998888999999999999999999999997754432 22222221111 122
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..++..+.+++..||..+|++||++.++..
T Consensus 223 ~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 356788999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=276.75 Aligned_cols=216 Identities=26% Similarity=0.328 Sum_probs=167.6
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccc-------c
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV-------D 74 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~-------~ 74 (318)
-++|++.+.||.|++|.||+|.+..+++.+++|.+..... .....+|+++++.++|++.+........ .
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4799999999999999999999999999999997643322 2356789999999987544433322211 2
Q ss_pred CcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
....+++++|+.+++...+......+++..+..++.|++.||.|||++|++|+||+|+||++ ++++.++|+|||.+.
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~ 163 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI---DNQGILKIADFGLAR 163 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEECcCccch
Confidence 33579999999888988887655569999999999999999999999999999999999999 588999999999987
Q ss_pred eecCCCCCccc----cccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHH
Q 021053 155 KYRDPTTNRHI----PYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK 224 (318)
Q Consensus 155 ~~~~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~ 224 (318)
........... .........++..|+|||.+.+. .++.++|||||||++|+|++|++||.+.++......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 65433221110 00011233567889999987654 578999999999999999999999987665543333
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=277.03 Aligned_cols=248 Identities=21% Similarity=0.291 Sum_probs=197.2
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
...++|++.+.||+|++|.||+|.+..+++.|++|.+..... ...+.+|+.++..++| +++..+..+.......
T Consensus 12 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~niv~~~~~~~~~~~~ 90 (307)
T cd06607 12 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH-PNTIEYKGCYLREHTA 90 (307)
T ss_pred CcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEEeCCeE
Confidence 345789999999999999999999998899999998753322 1356789999999976 5566665555667789
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 79 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
++|+|++.+++.+++......+++..+..++.|++.||.|||+.|++|+||+|+||++ ++++.++|+|||++.....
T Consensus 91 ~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 91 WLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL---TEPGTVKLADFGSASLVSP 167 (307)
T ss_pred EEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE---CCCCCEEEeecCcceecCC
Confidence 9999999999988887656668999999999999999999999999999999999999 4889999999999865432
Q ss_pred CCCCccccccCCCCCccccccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
. ....++..|+|||++. ...++.++||||||+++|+|++|.+||...+..... ..+... .
T Consensus 168 ~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~---~~~~~~---~ 230 (307)
T cd06607 168 A-----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQN---D 230 (307)
T ss_pred C-----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH---HHHhcC---C
Confidence 2 1235677899999875 345888999999999999999999999876543221 111111 1
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
+.......++..+.+++.+||..+|++||++.++...
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 231 SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1111123467889999999999999999999988763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=272.95 Aligned_cols=252 Identities=21% Similarity=0.249 Sum_probs=192.7
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
++|++.+.||.|++|.||+|.+..+++.||+|.+..... ...+.+|+.+++.+.| +++..+..++......++|+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH-GNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccC-CCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999998999999997654322 2357789999999976 56666766667778999999
Q ss_pred eccCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLLGPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
||++++|.+.+..... .+++..+..++.||+.||.|||++|++|+||+|+||+++ ..++.+||+|||.+........
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 81 EYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred ecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE--CCCCEEEEcccccccccCCCcc
Confidence 9998899888865332 257888889999999999999999999999999999995 3456899999999875432211
Q ss_pred CccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC-----
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST----- 235 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~----- 235 (318)
......++..|+|||.+.+. .++.++||||+||++|+|+||.+||......+... ++.......
T Consensus 159 -------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~---~~~~~~~~~~~~~~ 228 (294)
T PLN00009 159 -------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF---KIFRILGTPNEETW 228 (294)
T ss_pred -------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChhhc
Confidence 11233567889999988654 57889999999999999999999997654332221 211111000
Q ss_pred -------------------chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 -------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 -------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.........+..+.+++.+|++.+|++||++.++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 229 PGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred cccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011112345677889999999999999999887765
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=281.32 Aligned_cols=256 Identities=21% Similarity=0.235 Sum_probs=195.1
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccc-----cC
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DG 75 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~-----~~ 75 (318)
++++|.+.+.||.|+||.||+|.+..++..||+|.+.... ......+|+.++..++|+ ++..+..+.. ..
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHE-NVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCC-CccchHHheeccccccc
Confidence 5789999999999999999999999999999999866432 223567899999998764 4444433222 12
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
...++++|+++++|.+++.. ...+++..+..++.|++.||.|||+++++|+||+|+||++ +.++.+||+|||++..
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 82 NDVYIVYELMDTDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLART 157 (337)
T ss_pred CcEEEEEeCCCCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcCccccc
Confidence 45899999999999988876 3458999999999999999999999999999999999999 4789999999999876
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh---
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK--- 231 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~--- 231 (318)
...... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+............+.
T Consensus 158 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 158 TSEKGD-------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred cCCCcc-------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 543221 1123456788999998765 45889999999999999999999999765432222222111100
Q ss_pred --------------------hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 232 --------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 232 --------------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
....+........+..+.+++.+||..+|++||++.++.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 00111122234567889999999999999999999987765
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=280.12 Aligned_cols=247 Identities=21% Similarity=0.277 Sum_probs=206.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecC-----CCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+-.+.|...+.||.|+||.|+-++-..+|+.+|.|.+.+ .....-.++|-.+++++... .++.+.+.+......
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~-FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSP-FIVSLAYAFETKDAL 260 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccC-cEEEEeeeecCCCce
Confidence 345778999999999999999999999999999996543 33344678899999998874 566666666777889
Q ss_pred EEEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 79 VLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
|+|+..| +|+|...+-..+ ..+++..+..++.+|+.||.+||.++|+.|||||+|||+ |+.|.++|+|+|++...
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL---DDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee---ccCCCeEeeccceEEec
Confidence 9999999 778766655433 359999999999999999999999999999999999999 79999999999999877
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
..... ....+||..|||||++.+..|+..+|+||+||++|+|+.|+.||.........+.+++ +....
T Consensus 338 ~~g~~--------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdr----r~~~~ 405 (591)
T KOG0986|consen 338 PEGKP--------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDR----RTLED 405 (591)
T ss_pred CCCCc--------cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHH----HHhcc
Confidence 54433 1344899999999999999999999999999999999999999988766655544443 33345
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCCh
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 266 (318)
.+++...++++.+++.+..|..||++|...
T Consensus 406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 566678899999999999999999999643
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=275.15 Aligned_cols=254 Identities=21% Similarity=0.310 Sum_probs=197.1
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcC-----CCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~-----~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
-.++|++.+.||.|+||.||+|.+.. ++..|++|.+..... ...+.+|+.++..+.| +++..+..+.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h-~~iv~~~~~~~~~~ 81 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH-PNIVKLLGVCAVGK 81 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCC-CchheEEEEEcCCC
Confidence 45789999999999999999998753 567899998765432 2357789999999876 55666655666667
Q ss_pred ceEEEEecc-CCCHHHHHHHhc---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCR---------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 134 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~---------------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Ni 134 (318)
..++++|++ +++|.+++.... ..++...+..++.|++.||.|||++|++||||+|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 899999999 789999987421 1367788899999999999999999999999999999
Q ss_pred eeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCc
Q 021053 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPW 213 (318)
Q Consensus 135 l~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf 213 (318)
++ +.++.++|+|||.+......... ........+..|+|||.+.+..++.++|||||||++|+|++ |..||
T Consensus 162 l~---~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~ 233 (288)
T cd05050 162 LV---GENMVVKIADFGLSRNIYSADYY-----KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233 (288)
T ss_pred Ee---cCCCceEECccccceecccCccc-----cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCC
Confidence 99 48899999999998754332211 01122234567999999988889999999999999999998 88999
Q ss_pred cchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 214 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 214 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
.+.+... ....+...... + .....|..+.+++.+||..+|++||++.++.+.|+
T Consensus 234 ~~~~~~~---~~~~~~~~~~~-~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 234 YGMAHEE---VIYYVRDGNVL-S---CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred CCCCHHH---HHHHHhcCCCC-C---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 7655432 22222221111 1 11345788999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=269.23 Aligned_cols=247 Identities=23% Similarity=0.292 Sum_probs=191.2
Q ss_pred eeeccCcccEEEEEEEcCCC---cEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-
Q 021053 13 RKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~---~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~- 85 (318)
+.||.|+||.||+|.+...+ ..+|+|.+..... ...+.+|+.+++.+.| +++..+..+.. ....+++++++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH-PCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEc-CCceEEEEEeCC
Confidence 47999999999999876544 7899998775543 2357789999999876 44555544333 44689999998
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccc
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~ 165 (318)
+++|.+++.... .+++..+..++.|++.||.|||+++++|+||+|+||++ +.++.+||+|||.+.........
T Consensus 79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~--- 151 (257)
T cd05060 79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDY--- 151 (257)
T ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE---cCCCcEEeccccccceeecCCcc---
Confidence 789999998633 58999999999999999999999999999999999999 48899999999998765432221
Q ss_pred cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcC
Q 021053 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (318)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (318)
+.......++..|+|||.+.+..++.++|||||||++|++++ |.+||...+.... ...+.. ....+ ....+
T Consensus 152 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~~~~~~-~~~~~---~~~~~ 223 (257)
T cd05060 152 -YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---IAMLES-GERLP---RPEEC 223 (257)
T ss_pred -cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHHc-CCcCC---CCCCC
Confidence 111112223467999999998889999999999999999998 9999977654322 222221 11111 22356
Q ss_pred chhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 245 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
+..+.+++.+||..+|++||++.++.+.|.+.
T Consensus 224 ~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 224 PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 78899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=281.00 Aligned_cols=254 Identities=19% Similarity=0.231 Sum_probs=186.3
Q ss_pred EeeeeccC--cccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 11 LGRKIGSG--SFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 11 ~~~~lg~G--~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
+++.||+| ++++||++.+..+++.||+|.+...... ..+.+|+.+++.++| +++..+..++......++|+||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNH-PNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEEECCEEEEEEec
Confidence 56789999 6789999999999999999988654322 245668888888866 5666666666677789999999
Q ss_pred c-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 85 L-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 85 ~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
+ +++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||+++ .++.++++||+...........
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~---~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEe---cCCcEEEcccchhhcccccccc
Confidence 9 78999998653 34588999999999999999999999999999999999994 7889999999865443221111
Q ss_pred ccccccCCCCCcccccccccccccC--CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc------
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS------ 234 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~------ 234 (318)
............++..|+|||++.+ ..++.++|||||||++|+|++|..||......... ... .....+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~-~~~~~~~~~~~~ 234 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEK-LNGTVPCLLDTT 234 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHH-hcCCcccccccc
Confidence 0000011123356677999999876 35899999999999999999999999764432111 111 100000
Q ss_pred -Cch----------------------------------HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 235 -TPI----------------------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 235 -~~~----------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+. ......+++.+.+++.+||..||++|||+.++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 0011234567889999999999999999998776
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=275.86 Aligned_cols=205 Identities=22% Similarity=0.310 Sum_probs=164.1
Q ss_pred eeeEeeeeccCcccEEEEEEEcC--CCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccC--cce
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVD--TNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDN 78 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~--~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~--~~~ 78 (318)
+|++.+.||+|++|.||+|.+.. ++..||+|.+... .......+|+.++..++| +++..+..+.... ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH-ENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCC-CCccceEEEEeCCCCceE
Confidence 58999999999999999999987 8899999987762 234567889999999987 4555554444444 679
Q ss_pred EEEEeccCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecc-CCCCCeEEEEeccce
Q 021053 79 VLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL-GRKANQVYIIDFGLA 153 (318)
Q Consensus 79 ~lv~e~~~~~L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~-~~~~~~~kL~dfg~~ 153 (318)
++|+|++++++.+++.... ..+++..+..++.|++.||.|||+++++||||+|+||++.. ++..+.+||+|||++
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999999888988876432 24788999999999999999999999999999999999941 111899999999998
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchh
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~ 217 (318)
......... ........++..|+|||++.+. .++.++|||||||++|+|++|.+||.+..
T Consensus 160 ~~~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 160 RLFNAPLKP----LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred cccCCCccc----ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 765433221 0112334568889999987764 57899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=271.93 Aligned_cols=201 Identities=24% Similarity=0.357 Sum_probs=167.0
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
+|++.+.||.|++|.||+|.+..++..||+|.+.... ....+.+|+.+++.++| +++..+..++......++|+|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKH-ENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcC-CCEeeeeeeEeeCCcEEEEEec
Confidence 5899999999999999999999999999999876443 23456789999999965 6677776776777889999999
Q ss_pred cCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 85 LGPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 85 ~~~~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
+.++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||++ ++++.++|+|||.+........
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 80 MDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred CCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCcc-
Confidence 9889999887543 358899999999999999999999999999999999999 4889999999999865433211
Q ss_pred ccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~ 219 (318)
......++..|++||++.+. .++.++|+|||||++|++++|++||.+.+..
T Consensus 156 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~ 207 (284)
T cd07836 156 ------TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE 207 (284)
T ss_pred ------ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 11233457889999988664 4788999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=274.57 Aligned_cols=260 Identities=22% Similarity=0.260 Sum_probs=193.4
Q ss_pred ceeeEeeeeccCcccEEEEEEE----cCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeecccc-Ccce
Q 021053 7 VKYKLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD-GEDN 78 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~----~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~-~~~~ 78 (318)
+-|++.+.||+|+||.||+|.. ..++..|++|.+..... ...+.+|+.+++.+.|++.+.....+... ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3468999999999999999974 35678899998764432 23578899999999774444333333332 3568
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
++||||+ +++|.+++......+++..+..++.|++.||.|+|++|++||||||+||+++ .++.++|+|||.+....
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~---~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc---CCCCEEECCCccccccc
Confidence 9999999 8999999876545689999999999999999999999999999999999994 78899999999987654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhH-----------hhhHHHHH
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA-----------ATKKQKYD 226 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~-----------~~~~~~~~ 226 (318)
...... .......++..|+|||++.+..++.++|||||||++|+++++..|+..... ........
T Consensus 161 ~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 161 TDKEYY----TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cCccce----eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 322210 111234566779999999888899999999999999999998766532100 00001111
Q ss_pred HHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 227 ~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
.........+ ....++..+.+++.+||..+|++||++.++.+.++++
T Consensus 237 ~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGKRLP---RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCccCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111111111 1235678999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=280.06 Aligned_cols=259 Identities=20% Similarity=0.274 Sum_probs=196.6
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeecc----ccCc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYG----VDGE 76 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~----~~~~ 76 (318)
++.+|++.+.||.|++|.||+|.+..+++.||+|++.... ....+.+|+.++..++| ++++.+..++ ....
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKH-DNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCC-CCccCHHHhccccCCCCc
Confidence 4689999999999999999999999999999999876532 22356789999999986 5555543322 2345
Q ss_pred ceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 77 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
..++|+||++++|.+++.. ...+++..+..++.||+.||.|||++|++||||+|+||++ +.++.+||+|||.+...
T Consensus 82 ~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 82 DVYVVMDLMESDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV---NEDCELRIGDFGMARGL 157 (334)
T ss_pred eEEEEEehhhhhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEecccccceee
Confidence 6899999998899888875 3458999999999999999999999999999999999999 48899999999998765
Q ss_pred cCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHH------
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC------ 229 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~------ 229 (318)
....... ........++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+.......+....
T Consensus 158 ~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 158 SSSPTEH---KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred cccCcCC---CcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 4332211 001123467888999999866 458899999999999999999999997755432222211110
Q ss_pred -----------------HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 230 -----------------EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 230 -----------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
......+........+..+.+++.+||..+|++||++.++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011111112223456788999999999999999999987665
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=274.92 Aligned_cols=260 Identities=23% Similarity=0.309 Sum_probs=199.4
Q ss_pred cceeeEeeeeccCcccEEEEEEEc----CCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeecccc--Cc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHV----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD--GE 76 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~----~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~--~~ 76 (318)
.+.|++.+.||+|+||.||+|... .++..+|+|++..... ...+.+|+.+++.+.| +++..+..+... ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~-~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDH-ENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCC-CChheEEeeeecCCCC
Confidence 467889999999999999999864 3478899998876554 3468889999999976 455555444433 55
Q ss_pred ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..++++|++ +++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+..
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFGLAKV 158 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccccccc
Confidence 789999999 789999998755568999999999999999999999999999999999999 4789999999999886
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhh-----------hHHH
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-----------KKQK 224 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~-----------~~~~ 224 (318)
....... +.......++..|++||.+.+..++.++|||||||++|+|++|..||....... ....
T Consensus 159 ~~~~~~~----~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05038 159 LPEDKDY----YYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234 (284)
T ss_pred cccCCcc----eeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHH
Confidence 6422211 001112344566999999988889999999999999999999999986532211 0111
Q ss_pred HHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
+..........+. ...+|..+.+++.+||..+|++||++.++.+.|+++
T Consensus 235 ~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 235 LLELLKEGERLPR---PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHcCCcCCC---CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1122221111111 235577899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=275.22 Aligned_cols=215 Identities=25% Similarity=0.326 Sum_probs=168.4
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccc-------cC
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV-------DG 75 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~-------~~ 75 (318)
++|++.+.||.|+||.||+|.+..+++.||+|.+..... .....+|+.+++++.|++.+..+..+.. ..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 579999999999999999999999999999997654322 2245679999999987655544433322 22
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
...++|+|+++++|.+.+......+++..+..++.|++.||.|||++|++|+||+|+||++ +..+.+||+|||.+..
T Consensus 92 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 92 GSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI---TKDGILKLADFGLARA 168 (310)
T ss_pred ceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE---CCCCcEEECcCCCccc
Confidence 4569999999889999887655568999999999999999999999999999999999999 4889999999999876
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHH
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (318)
......... .......++..|+|||.+.+.. ++.++|+||||+++|+|++|.+||...+.......+..
T Consensus 169 ~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~ 238 (310)
T cd07865 169 FSLSKNSKP---NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ 238 (310)
T ss_pred ccCCcccCC---CCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 543322110 0112345678899999887654 78899999999999999999999987665444444433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=267.14 Aligned_cols=244 Identities=19% Similarity=0.302 Sum_probs=190.0
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCC
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~ 88 (318)
+.||.|+||.||+|... ++..+|+|.+...... ..+.+|+.++..+.| +++..+..........++|||++ +++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDH-PNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCC-CCcCeEEEEEecCCccEEEEECCCCCc
Confidence 36899999999999864 6788999987654332 256789999999866 55666655556667899999999 899
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccccc
Q 021053 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (318)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 168 (318)
|.+++......+++..+..++.|++.||.|+|++|++|+||+|+||++ +.++.++|+|||++.........
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~------ 149 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYS------ 149 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE---cCCCeEEECCCccceeccccccc------
Confidence 999887655568899999999999999999999999999999999999 48889999999998654322111
Q ss_pred CCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchh
Q 021053 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (318)
Q Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (318)
......++..|+|||++.+..++.++||||||+++|++++ |..||.......... .+.. .... .....++..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~---~~~~-~~~~---~~~~~~~~~ 222 (250)
T cd05085 150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQARE---QVEK-GYRM---SCPQKCPDD 222 (250)
T ss_pred cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH---HHHc-CCCC---CCCCCCCHH
Confidence 1112233567999999988889999999999999999998 999998754432222 2111 1111 112356789
Q ss_pred HHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 248 FASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 248 ~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
+.+++.+||..+|++||++.++.+.|.
T Consensus 223 ~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 223 VYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=274.48 Aligned_cols=259 Identities=20% Similarity=0.290 Sum_probs=197.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||.|+||.||+|.+..+++.|++|.+..... ...+.+|+.++..++| +++..+...+......+++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN-PFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCC-CCeeeeEEEEecCCEEEEE
Confidence 479999999999999999999999999999998764431 2356688888888866 5666666666667789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||++ +++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++ +..+.++|+|||.+.......
T Consensus 80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 80 MEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred EecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE---CCCCCEEEeeCCCccccCcCc
Confidence 9999 78999998763 458899999999999999999999999999999999999 488999999999886422111
Q ss_pred CCccc--------cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh
Q 021053 161 TNRHI--------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (318)
Q Consensus 161 ~~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~ 232 (318)
..... .........++..|+|||.+.+..++.++|+|||||++|++++|..||.+.... +....+....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~---~~~~~~~~~~ 232 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE---ELFGQVISDD 232 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhcc
Confidence 11000 000011235677899999998888999999999999999999999999865432 2223322222
Q ss_pred ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
...|... ...|..+.+++.+||..+|++||+...+.+.+..
T Consensus 233 ~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 233 IEWPEGD--EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cCCCCcc--ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 2222221 2567889999999999999999997666555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=272.27 Aligned_cols=252 Identities=23% Similarity=0.276 Sum_probs=194.8
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
|++.+.||.|++|.||+|.+..+++.+++|.+..... ...+.+|+.+++.+.| +++..+..........++++|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNH-PNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcC-CCcchHHHhhccCCCEEEEEec
Confidence 6788999999999999999998999999998765433 2457789999999985 6666666555666889999999
Q ss_pred cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 85 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
+.+++.+++......+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~--- 153 (283)
T cd05118 80 MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVR--- 153 (283)
T ss_pred cCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCcc---
Confidence 9889999988755678999999999999999999999999999999999999 4789999999999877654331
Q ss_pred ccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh------------
Q 021053 165 IPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK------------ 231 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~------------ 231 (318)
......++..|+|||.+.+. .++.++|+||+|+++|++++|+.||...+..+...........
T Consensus 154 ----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 154 ----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence 11234567889999998876 6899999999999999999999999775543322222111100
Q ss_pred ----------hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 232 ----------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 232 ----------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
....+........+..+.+++.+||..+|.+||++.++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0001111222345677888888888888888888877654
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=269.36 Aligned_cols=252 Identities=19% Similarity=0.276 Sum_probs=194.4
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--------ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
+|++++.||.|+||.||+|.+. +++.+|+|.+..... ...+.+|+.+++.++| +++..+..++......+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH-VNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCC-CCEeeEeeEeecCCeEE
Confidence 5889999999999999999864 678899997764321 1346778999999976 55656665666668899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+++|++ +++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++ ++.+.++|+|||.+.....
T Consensus 79 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 79 IFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML---MPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE---CCCCeEEeccchhhHhhhh
Confidence 999999 88999998763 458899999999999999999999999999999999999 5889999999999875432
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
....... ........++..|+|||++.+..++.++|+|||||++|++++|..||...+..... ..+... ..+.+
T Consensus 155 ~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~---~~~~~~--~~~~~ 228 (265)
T cd06631 155 VGLHGTH-SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM---FYIGAH--RGLMP 228 (265)
T ss_pred ccccccc-cccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH---HHhhhc--cCCCC
Confidence 1111000 01123446788999999999888999999999999999999999999765432211 111111 11112
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.....++..+.+++.+||..+|++||++.++..
T Consensus 229 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 229 RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 233467888999999999999999999987754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=274.04 Aligned_cols=249 Identities=20% Similarity=0.319 Sum_probs=196.6
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
++|++.+.||.|++|.||+|.+..+++.+++|.+..... ...+.+|+.+++.+.| +++..+..........++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNS-PYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCC-CchhhhheeeecCCEEEEEEE
Confidence 478899999999999999999999999999998765432 2357889999999885 556566555556678999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
++ +++|.+++......+++..+..++.|++.||.|+|+ .|++|+||+|+||+++ ..+.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~---~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVN---SRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEEC---CCCCEEEeecccchhhHHHHh
Confidence 99 589999998754668999999999999999999999 9999999999999994 788999999999865533221
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhH--hhhHHHHHHHHHhhccCchHH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA--ATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~--~~~~~~~~~i~~~~~~~~~~~ 239 (318)
....++..|+|||.+.+..++.++||||||+++|+|++|..||...+. ......+..+.....+....
T Consensus 157 ---------~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 226 (265)
T cd06605 157 ---------KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS- 226 (265)
T ss_pred ---------hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh-
Confidence 124667889999999988999999999999999999999999975421 11122222222211111111
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..++..+.+++..||..+|++||++.++..
T Consensus 227 --~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 227 --GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred --hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 126788999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=271.23 Aligned_cols=253 Identities=19% Similarity=0.305 Sum_probs=198.8
Q ss_pred cceeeEeeeeccCcccEEEEEEEcC-----CCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
.++|++.+.||.|+||.||+|+.+. +.+.|++|.+...... ..+.+|+.+++++.| +++..+..+......
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 82 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH-KNVVRLLGLCREAEP 82 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCC-cceeeeEEEECCCCc
Confidence 4789999999999999999999753 3467999987654433 468889999999976 556666666666678
Q ss_pred eEEEEecc-CCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEE
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRR--------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~ 148 (318)
.++|||++ +++|.+++..... .+++..+..++.|++.||.|||++|++|+||||+||+++ ..+.++++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~---~~~~~~l~ 159 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS---SQREVKVS 159 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe---CCCcEEEc
Confidence 99999999 7899999876431 488999999999999999999999999999999999994 78899999
Q ss_pred eccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHH
Q 021053 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDK 227 (318)
Q Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~ 227 (318)
|||.+......... ......++..|+|||.+.+..++.++||||||+++|++++ |..||....... .+..
T Consensus 160 ~~~~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~~ 230 (275)
T cd05046 160 LLSLSKDVYNSEYY------KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLNR 230 (275)
T ss_pred ccccccccCccccc------ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHHH
Confidence 99997644322111 1123355677999999988888999999999999999999 899997654322 2222
Q ss_pred HHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
+.......+. ...+|..+.+++.+||..+|++||++.++...+.
T Consensus 231 ~~~~~~~~~~---~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLELPV---PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcCCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 2222222221 2356789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=270.82 Aligned_cols=249 Identities=21% Similarity=0.249 Sum_probs=190.9
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
|++.+.||.|++|.||+|.+..++..|++|++..... ...+.+|+.+++.++| +++..+..+.......++++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~-~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNH-PNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCC-CCccCHhheeccCCeEEEEEec
Confidence 6789999999999999999998999999998764331 2357789999999986 5555555555666889999999
Q ss_pred cCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 LGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
++++|.+++.... ..+++..+..++.|++.||.|||+++++|+||+|+||+++ .++.++|+|||.+.........
T Consensus 80 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~---~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 80 LDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID---REGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred cCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc---CCCcEEEeecccccccCCCccc-
Confidence 9889999987643 3589999999999999999999999999999999999994 7899999999998654322111
Q ss_pred cccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc---------
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV--------- 233 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~--------- 233 (318)
.....++..|+|||++.+. .++.++|+||||+++|+|++|++||...++..... .+.....
T Consensus 156 ------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~ 226 (283)
T cd07835 156 ------YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF---RIFRTLGTPDEDVWPG 226 (283)
T ss_pred ------cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCChHHhhh
Confidence 1122457889999987764 47889999999999999999999997654432211 1111100
Q ss_pred ---------------cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 234 ---------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 234 ---------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+.......++..+.+++.+||+.+|.+||++.++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 227 VTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 01111223345677888999999999999998887654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=268.73 Aligned_cols=246 Identities=21% Similarity=0.240 Sum_probs=198.0
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+|++.+.||.|+||.+|.+.+..+++.|++|.+.... ....+.+|+.+++.+.| +++..+..++......++|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH-PNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCC-CCeeeeEeeecCCCeEEEEEe
Confidence 6999999999999999999999999999999875322 22367889999999977 556666666677788999999
Q ss_pred cc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 84 LL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
++ +++|.+.+.... ..+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchh
Confidence 99 789999887533 347889999999999999999999999999999999999 4788999999999876543221
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
. .....++..|+|||++.+..++.++|+|||||++|++++|..||...+.. .....+.....+ + ..
T Consensus 157 ~-------~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~---~~~~~~~~~~~~-~---~~ 222 (256)
T cd08218 157 L-------ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK---NLVLKIIRGSYP-P---VS 222 (256)
T ss_pred h-------hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH---HHHHHHhcCCCC-C---Cc
Confidence 1 12335678899999999888999999999999999999999999765433 223333222211 1 12
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..++.++.+++.+||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 356788999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=266.56 Aligned_cols=250 Identities=20% Similarity=0.306 Sum_probs=195.8
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
..+|++.+.||.|+||.||+|.+.. +..+++|.+..... ...+..|+.+++.+.| +++..+..++......++++|+
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSEEDFIEEAQVMMKLSH-PKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCHHHHHHHHHHHHhCCC-CCeeeEEEEEccCCceEEEEEc
Confidence 3579999999999999999998753 56799998765433 3568889999999976 4555565556666789999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+ +++|.+++......+++..+..++.|++.||.+||+++++|+||+|+||+++ .++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~---~~~~~~l~d~g~~~~~~~~~~~- 156 (256)
T cd05112 81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQYT- 156 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc---CCCeEEECCCcceeecccCccc-
Confidence 9 7899988876555688999999999999999999999999999999999994 7889999999998765432211
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
.......+..|+|||.+.+..++.++||||||+++|++++ |..||......... ..+.. ...... ..
T Consensus 157 -----~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~-~~~~~~---~~ 224 (256)
T cd05112 157 -----SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV---ETINA-GFRLYK---PR 224 (256)
T ss_pred -----ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH---HHHhC-CCCCCC---CC
Confidence 1112234568999999998889999999999999999998 99999765433222 22111 111111 12
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
..+..+.+++.+||..+|++||++.++.+.+
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 3477899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=259.10 Aligned_cols=278 Identities=59% Similarity=1.041 Sum_probs=262.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+++-.|+++++||.|+||.++.|...-+++.||||..--..+.+++.-|...++.|.+...++.+++++..+.+..+|++
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 78899999999999999999999999999999999766666777899999999999999999999999999999999999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccC--CCCCeEEEEeccceeeecCCCC
Q 021053 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~--~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
.++.||.|++..+++.|+..+++.++.|++.-++++|++.+|.|||||+|+|++.. .+...+.++|||.++...++.+
T Consensus 105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 99999999999999999999999999999999999999999999999999999742 2345688999999999999999
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
..++||++.....||.+||+-....+...+...|+=|+|-++++++-|..||++.......+.+++|...+..+|++.++
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc 264 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLC 264 (449)
T ss_pred cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999888899999999999999999999
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcC
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~ 281 (318)
..+|.++...+.-.-..+.++-|+.+-++..|.+++....
T Consensus 265 ~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 265 EGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred hcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 9999999999999999999999999999999999887654
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=274.61 Aligned_cols=246 Identities=22% Similarity=0.295 Sum_probs=195.1
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
.+.|+..+.||.|+||.||+|.+..++..||+|.+..... ...+.+|+.++..+.| +++..+..++......++|+
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYITRYYGSYLKGTKLWIIM 81 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCC-CccHhhhcccccCCceEEEE
Confidence 4568888999999999999999998899999998764332 2357789999999876 55666655666677899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|++ +++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||++. +++.++|+|||.+........
T Consensus 82 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 82 EYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEe---CCCCEEEccccccccccCcch
Confidence 999 7888888763 4588999999999999999999999999999999999994 788999999999876543221
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
......++..|+|||++.+..++.++|+|||||++|+|++|+.||....+..... .+.. .. . ....
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~---~~~~-~~-~--~~~~ 222 (277)
T cd06642 157 -------KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF---LIPK-NS-P--PTLE 222 (277)
T ss_pred -------hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh---hhhc-CC-C--CCCC
Confidence 1123356788999999998889999999999999999999999997654322111 1111 11 1 1122
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+..+.+++.+||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 346778999999999999999999999887
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=269.81 Aligned_cols=250 Identities=21% Similarity=0.275 Sum_probs=184.9
Q ss_pred eeeccCcccEEEEEEEc--CCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~--~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||+|+||.||+|.+. .++..+++|.+...... ..+.+|+.++..++|+ ++..+..+.......++||||+ +
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHS-NLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCC-CEeeEEEEEcCCCCcEEEEECCCC
Confidence 46899999999999865 34567899977654322 2577799999999874 4555555555666789999999 7
Q ss_pred CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 87 PSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 87 ~~L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
++|.+++.... ...+...+..++.|++.||.|||++|++|+||||+||+++ ..+.++|+|||.+.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~---~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLT---ADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc---CCCcEEECCccccccccCccee
Confidence 89999987532 1356677888999999999999999999999999999994 7889999999998643222110
Q ss_pred ccccccCCCCCcccccccccccccCC-------CCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGI-------EQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
.......++..|+|||++.+. .++.++|+|||||++|+|++ |..||....+..... ..+......
T Consensus 157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~--~~~~~~~~~ 229 (269)
T cd05087 157 -----VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT--YTVREQQLK 229 (269)
T ss_pred -----ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH--HHhhcccCC
Confidence 112234567789999988642 35789999999999999997 999997654432221 122222233
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
.+.+......+..+.+++..|| .+|++||++.++.+.|+
T Consensus 230 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 3333333356778999999999 68999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=263.58 Aligned_cols=256 Identities=22% Similarity=0.311 Sum_probs=211.0
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC--hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCC
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~ 88 (318)
.+.||+|+|+.|-.+....++..||||++.+.... .+..+|++++.+.+.|.++..+..++.+...+|+|||-+ +|+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 46789999999999999999999999998876543 478999999999999999999988889999999999999 999
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec--CCCCCcccc
Q 021053 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR--DPTTNRHIP 166 (318)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~--~~~~~~~~~ 166 (318)
|.+.++. ...|++.++..++++|+.||.+||.+||.||||||+|||....+.---+||+||.+..... .+..-..+|
T Consensus 163 lLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 163 LLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred HHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 9999987 4569999999999999999999999999999999999999755555568999998765533 222211122
Q ss_pred ccCCCCCccccccccccccc---CC--CCCCcchHHHHHHHHHHHHhCCCCccchhH------------hhhHHHHHHHH
Q 021053 167 YRENKNLTGTARYASCNTHL---GI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKA------------ATKKQKYDKIC 229 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~---~~--~~~~~~DvwslG~il~~l~tg~~pf~~~~~------------~~~~~~~~~i~ 229 (318)
......|+..|||||+.. +. .|+.++|.||||||+|-|+.|.+||.+... .=+...+..|.
T Consensus 242 --~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ 319 (463)
T KOG0607|consen 242 --ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ 319 (463)
T ss_pred --cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence 223457899999999754 22 489999999999999999999999976422 23456677777
Q ss_pred HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+.....|...| ..++..-+++++..+..++.+|.++.++..
T Consensus 320 EGkYeFPdkdW-ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 320 EGKYEFPDKDW-AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCcCChhhh-HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 77777776664 688889999999999999999988776554
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=267.39 Aligned_cols=249 Identities=26% Similarity=0.372 Sum_probs=201.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
++|++.+.||.|++|.||+|.+..+++.|++|.+..... ...+.+|+..+..++| +++..+..+.......++++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCES-PYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCC-CCeeeEEEEEccCCeEEEEEE
Confidence 478999999999999999999999999999998776543 4568889999999985 566666666666688999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
++ +++|.+++... ..+++..+..++.|++.||.+||+ .|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 80 YMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred ecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE---CCCCCEEEccCccceecccCCC
Confidence 99 69999998763 558999999999999999999999 999999999999999 4889999999999876543322
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
. .....++..|+|||.+.+..++.++|+||||+++|++++|+.||...+..........+... ......
T Consensus 156 ~-------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~ 224 (264)
T cd06623 156 Q-------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG----PPPSLP 224 (264)
T ss_pred c-------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC----CCCCCC
Confidence 1 12335678899999999888999999999999999999999999776422223333333321 111222
Q ss_pred hc-CchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 242 KS-HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 242 ~~-~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.. +|..+.+++..||..+|++||++.++.+
T Consensus 225 ~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 225 AEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 34 7889999999999999999999998776
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=270.27 Aligned_cols=241 Identities=28% Similarity=0.353 Sum_probs=195.4
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+|++.+.||.|+||.||+|.+..++..|++|++.... ....+.+|+.++++++| +++..+..+.......++++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH-PFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCC-CChHHHHHhhcCCCeEEEEE
Confidence 5899999999999999999999899999999876432 23467889999999976 55666666666777899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|++ +++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++ ++++.++|+|||.+........
T Consensus 80 e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~ 155 (258)
T cd05578 80 DLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTL 155 (258)
T ss_pred eCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---cCCCCEEEeecccccccCCCcc
Confidence 999 88999998764 468999999999999999999999999999999999999 5889999999999876543321
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
.....++..|+|||.+.+..++.++|+||||+++|++++|..||...+............. ......
T Consensus 156 --------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~ 222 (258)
T cd05578 156 --------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-----ADVLYP 222 (258)
T ss_pred --------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-----ccccCc
Confidence 1234567889999999888899999999999999999999999987654222222222111 112223
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCCh
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~ 266 (318)
..+|..+.+++++||..+|.+||++
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 223 ATWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred ccCcHHHHHHHHHHccCChhHcCCc
Confidence 4568899999999999999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=295.34 Aligned_cols=261 Identities=17% Similarity=0.290 Sum_probs=219.0
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCC---cEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~---~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
|-.....|.+.||.|.||+|++|+.+..+ ..||||.++.... ..+|+.|..|+-++.| +|+..+.........
T Consensus 626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH-PNIIrLEGVVTks~P 704 (996)
T KOG0196|consen 626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH-PNIIRLEGVVTKSKP 704 (996)
T ss_pred cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC-CcEEEEEEEEecCce
Confidence 34455689999999999999999987444 5799999886543 3479999999999987 556677777777888
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.-|++||| .|+|..|+....+.|+..+...+++.|+.|++||-+.|.+||||..+|||+ +.+-.+|++|||+++.+
T Consensus 705 vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV---NsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 705 VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV---NSNLVCKVSDFGLSRVL 781 (996)
T ss_pred eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee---ccceEEEeccccceeec
Confidence 99999999 999999999888889999999999999999999999999999999999999 59999999999999987
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
.++.... +.. ..-.-..+|.|||.+.-..++.++||||+|+++||.++ |..||..+++++....++. +.++++
T Consensus 782 edd~~~~---ytt-~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~--gyRLPp 855 (996)
T KOG0196|consen 782 EDDPEAA---YTT-LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ--GYRLPP 855 (996)
T ss_pred ccCCCcc---ccc-cCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh--ccCCCC
Confidence 6554221 111 12223578999999999999999999999999999887 9999999988765555544 344444
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
| . ++|..+..||..||++|..+||.+.+|...|.+++..
T Consensus 856 P--m---DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 856 P--M---DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred C--C---CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 4 3 6799999999999999999999999999999998744
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=274.82 Aligned_cols=257 Identities=19% Similarity=0.265 Sum_probs=193.3
Q ss_pred eeeEeeeeccCcccEEEEEEEcCC--CcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeecc----ccCcc
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDT--NEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYG----VDGED 77 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~--~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~----~~~~~ 77 (318)
+|++.+.||.|+||.||+|.+..+ +..||+|.+..... ...+.+|+.++.++.+|+++..+.... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999877 88999998764321 235678999999997667777764432 22345
Q ss_pred eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 78 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
.++++++++++|.+.+.. ...+++..++.++.||+.||.|||+.|++||||||+||++ +.++.++|+|||.+....
T Consensus 81 ~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 81 LYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV---NADCELKICDFGLARGFS 156 (332)
T ss_pred EEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE---cCCCCEEeCcCCCceecc
Confidence 789999999999998875 4558999999999999999999999999999999999999 488899999999987654
Q ss_pred CCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHH------
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE------ 230 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~------ 230 (318)
....... .......++..|+|||.+.+ ..++.++|+||+||++|++++|.+||...+.......+....+
T Consensus 157 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 157 ENPGENA---GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ccccccc---ccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 3222110 01223467889999998765 4689999999999999999999999976543322222111110
Q ss_pred -----------------hhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 231 -----------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 231 -----------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.....+........+..+.+++.+||..+|.+||++.++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00001111222234678999999999999999999887654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=266.90 Aligned_cols=247 Identities=23% Similarity=0.310 Sum_probs=195.0
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeecc-ccCcceEEEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNVLVL 82 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~-~~~~~~~lv~ 82 (318)
+|++.+.||.|+||.||+|.+..+++.|++|.+..... ...+..|+.+++.++|++.+..+..+. ......++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 58999999999999999999999999999998764332 235677889999998754443333222 2445689999
Q ss_pred ecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 83 DLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVH-----SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 83 e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH-----~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
|++ +++|.+++... ...+++..+..++.||+.||.+|| +.+++|+||+|+||+++ ..+.++|+|||.+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~---~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLD---ANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEe---cCCCEEEeccccc
Confidence 999 88999998764 345889999999999999999999 89999999999999994 7899999999998
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
......... .....++..|+|||++.+..++.++|+||||+++|+|++|..||...+.. .....+....
T Consensus 158 ~~~~~~~~~-------~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~- 226 (265)
T cd08217 158 KILGHDSSF-------AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKIKEGK- 226 (265)
T ss_pred ccccCCccc-------ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHHhcCC-
Confidence 765433210 12345788899999999888999999999999999999999999875432 2222222111
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.......++..+.+++..||..+|++||++.++.+
T Consensus 227 ---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 ---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred ---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11223466789999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=274.39 Aligned_cols=250 Identities=22% Similarity=0.304 Sum_probs=196.8
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
..+.|+..+.||+|+||.||+|.+..++..|++|.+..... ...+.+|+.+++.+.| +++..+..+.......+
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~ 101 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH-PNSIEYKGCYLREHTAW 101 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCC-CCEEEEEEEEeeCCeEE
Confidence 34568899999999999999999998999999998764322 1256788999999876 55555555556667899
Q ss_pred EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 80 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
+|+||+.+++.+.+......+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+......
T Consensus 102 lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 102 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASIASPA 178 (317)
T ss_pred EEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE---CCCCCEEEecCCCccccCCc
Confidence 999999889988887656668999999999999999999999999999999999999 47899999999987643321
Q ss_pred CCCccccccCCCCCccccccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
....++..|+|||++. ...++.++|||||||++|+|++|..||...+.... ...+........
T Consensus 179 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~---~~~~~~~~~~~~ 244 (317)
T cd06635 179 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIAQNESPTL 244 (317)
T ss_pred -----------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHhccCCCC
Confidence 2335678899999874 34588899999999999999999999977543222 222222111111
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
. ...++..+.+++.+||..+|.+||++.++.+....
T Consensus 245 ~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 245 Q---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred C---CccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 1 12467789999999999999999999998886543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=265.40 Aligned_cols=245 Identities=21% Similarity=0.333 Sum_probs=192.1
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCC
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~ 88 (318)
+.||.|++|.||+|.+.. ++.|++|....... ...+.+|+.+++.+.| +++..+..++......++++|++ +++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDH-PNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 468999999999999877 89999998765433 2367889999999876 55656666666777899999999 889
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccccc
Q 021053 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (318)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 168 (318)
|.+++......++...+..++.+++.||.|||+++++||||+|+||++ +.++.++|+|||.+..........
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~----- 150 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTV----- 150 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE---cCCCcEEEeeccccccccCCccee-----
Confidence 999987655568899999999999999999999999999999999999 488899999999987543221110
Q ss_pred CCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchh
Q 021053 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (318)
Q Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (318)
.......+..|+|||.+.+..++.++|+|||||++|+|++ |..||............. .....+ .....|..
T Consensus 151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~----~~~~~~---~~~~~~~~ 223 (251)
T cd05041 151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE----SGYRMP---APQLCPEE 223 (251)
T ss_pred ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh----cCCCCC---CCccCCHH
Confidence 0011223566999999988889999999999999999999 899997755432222221 111111 12356788
Q ss_pred HHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 248 FASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 248 ~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
+.+++.+||..+|++||++.++.+.|.
T Consensus 224 ~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 224 IYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=268.25 Aligned_cols=249 Identities=18% Similarity=0.248 Sum_probs=183.8
Q ss_pred eeeccCcccEEEEEEEcC--CCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHVD--TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~--~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||+|+||.||+|.... ....+++|.+...... ..+.+|+..++.++| +++..+...+......++|||++ +
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h-~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNH-PNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCC-CCcceEEEEECCCCceEEEEEeCCC
Confidence 368999999999997543 3457888876543322 246788888888876 55556555556667899999999 7
Q ss_pred CCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 87 PSLEDLFVYCRR----KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 87 ~~L~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
++|.+++..... ..++.....++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~ 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDYY 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe---cCCCcEEEeccccccccccchhe
Confidence 899999876432 24577788999999999999999999999999999999 48899999999998653222110
Q ss_pred ccccccCCCCCcccccccccccccC-------CCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLG-------IEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
.......++..|+|||++.. ..++.++|||||||++|+|++ |..||....+.+..... +......
T Consensus 157 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--~~~~~~~ 229 (269)
T cd05042 157 -----ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV--VREQDIK 229 (269)
T ss_pred -----eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH--hhccCcc
Confidence 01123345677999998642 356889999999999999999 88999765443222211 1222233
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
.+.+.....++..+.+++..|| .+|++||++.++.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 230 LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 3333444567888999999999 5999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=270.10 Aligned_cols=252 Identities=21% Similarity=0.270 Sum_probs=191.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeecc--ccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYG--VDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~--~~~~~~~lv 81 (318)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... ...+.+|++++..+.| +++..+..+. ......++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKS-PYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCC-CCeeeeeeEEEccCCCeEEEE
Confidence 579999999999999999999999999999998765432 2467889999999976 4455553332 334568999
Q ss_pred Eecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
||++ +++|.+++... ...++...+..++.|++.||.|||+.|++|+||+|+||++ ++.+.++|+|||.+....
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---ecCCeEEEeecccccccc
Confidence 9999 78998886542 3447889999999999999999999999999999999999 478899999999976543
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhH--hhhHHHHHHHHHhhccC
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA--ATKKQKYDKICEKKVST 235 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~--~~~~~~~~~i~~~~~~~ 235 (318)
.... ....++..|+|||.+.+..++.++|||||||++|+|++|..||..... ....+....+.....+.
T Consensus 157 ~~~~---------~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd06621 157 NSLA---------GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPE 227 (287)
T ss_pred cccc---------ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchh
Confidence 2221 133567789999999988899999999999999999999999976522 11112222211111110
Q ss_pred chHHH--hhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 PIEVL--CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 ~~~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..... ...+++.+.+++.+||+.+|++||++.++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 00000 0134568999999999999999999998776
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=267.94 Aligned_cols=249 Identities=24% Similarity=0.326 Sum_probs=190.1
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-------ChhHHHHHHHHHHHcCCCCCCeeeeccc--cCcc
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGV--DGED 77 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~i~~~~~--~~~~ 77 (318)
.+|++.+.||+|+||.||+|.+..++..|++|.+..... ...+.+|+.++..++| +++..+..+.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH-ERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCC-CCeeeEEEEEEcCCCCE
Confidence 479999999999999999999999999999997654321 1246778999999976 44544443332 2356
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++++|++ +++|.+++... ..++......++.|++.||.|||+++++|+||+|+||++ +.++.++|+|||++...
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE---CCCCCEEEccCCCcccc
Confidence 88999999 78999998763 458899999999999999999999999999999999999 58889999999998765
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
....... .......++..|+|||.+.+..++.++|+||+||++|++++|+.||...... ........ ...
T Consensus 157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~---~~~~~~~~---~~~ 226 (266)
T cd06651 157 QTICMSG----TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM---AAIFKIAT---QPT 226 (266)
T ss_pred ccccccC----CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH---HHHHHHhc---CCC
Confidence 4321110 0112345788899999999888999999999999999999999999765332 22222211 111
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
........++.+..++ .||..+|++||+++++.+
T Consensus 227 ~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1122234567788888 688899999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=277.77 Aligned_cols=264 Identities=20% Similarity=0.272 Sum_probs=199.2
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC----CCChhHHHHHHHHHHHcCCCCCCeeeeccc--cC
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGV--DG 75 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~--~~ 75 (318)
+..+.++|++.+.||.|+||.||+|.+..++..+|+|.+... .......+|+.++.++.+|+++..+..++. +.
T Consensus 2 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 2 DKHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred CchhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 456789999999999999999999999988999999976432 223356789999999945566666654433 34
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
...++|+|++.++|..++... .+++.....++.|++.||.|||++|++|+||+|+||++ +.++.+||+|||.+..
T Consensus 82 ~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 82 KDIYLVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARS 156 (337)
T ss_pred ceEEEEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCcEEEeeccchhc
Confidence 468999999988998888752 57888999999999999999999999999999999999 5889999999999876
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHH----
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE---- 230 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~---- 230 (318)
.......... .......++..|+|||++.+ ..++.++|+||||+++|+|++|++||.+..+......+.....
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 157 LSELEENPEN--PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred cccccccccC--cchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 5433221000 01123457888999998765 4578899999999999999999999976544332222111110
Q ss_pred -------------------hhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 231 -------------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 231 -------------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
.....+.......++..+.+++..||..+|++||++.++.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 001111222233467889999999999999999999987763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=268.60 Aligned_cols=255 Identities=21% Similarity=0.270 Sum_probs=197.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
++|++.+.||.|++|.||+|.+..++..+++|++..... ...+.+|++.++.+.| +++..+..........++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNH-PNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCC-CCEEEEEEEEeeCCEEEEEEe
Confidence 579999999999999999999988899999998765432 3467889999998876 455555555566678999999
Q ss_pred cc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 84 LL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
++ +++|.+++.... ..+++..+..++.|++.||.+||+.|++|+||+|+||++ ++++.++|+|||.+.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCc
Confidence 99 889999987632 358899999999999999999999999999999999999 478899999999987655432
Q ss_pred CCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc-hH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP-IE 238 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~-~~ 238 (318)
... ........++..|+|||++... .++.++|+|||||++|+|++|+.||...+.. +.+........+.. ..
T Consensus 157 ~~~---~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~ 230 (267)
T cd06610 157 DRT---RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM---KVLMLTLQNDPPSLETG 230 (267)
T ss_pred ccc---ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh---hhHHHHhcCCCCCcCCc
Confidence 211 0112344678889999998877 6889999999999999999999999765442 22222222111111 11
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.....+++.+.+++..||..+|++||++.++.+
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 231 ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 111356788999999999999999999988765
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=266.38 Aligned_cols=247 Identities=23% Similarity=0.306 Sum_probs=190.8
Q ss_pred eeeccCcccEEEEEEEcC-CC--cEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-
Q 021053 13 RKIGSGSFGEIFLASHVD-TN--EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~-~~--~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~- 85 (318)
+.||+|++|.||+|.+.. .+ ..||+|.+..... ...+.+|+.++.+++|++ +..+...... ...++++|++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHEN-LIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCC-ccceeEEEcC-CeEEEEEEecC
Confidence 468999999999999865 33 3689998776544 236778999999998754 4444433334 7789999999
Q ss_pred CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 86 GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 86 ~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
+++|.+.+.... ..+++..+..++.|++.||.|||++|++|+||+|+||++. .++.+||+|||.+.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~---~~~~~kl~dfg~~~~~~~~~~~-- 153 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA---SDDKVKIGDFGLMRALPQNEDH-- 153 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEe---cCCEEEeccccccccccccccc--
Confidence 899999987644 4588999999999999999999999999999999999994 7799999999998766432211
Q ss_pred ccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhc
Q 021053 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (318)
+.......++..|+|||.+.+..++.++|||||||++|+|++ |..||...+..... ..+.......+ ....
T Consensus 154 --~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~~~~~~~~---~~~~ 225 (257)
T cd05040 154 --YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL---KKIDKEGERLE---RPEA 225 (257)
T ss_pred --eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHhcCCcCC---CCcc
Confidence 111123345678999999998889999999999999999999 99999765443322 22221111111 1235
Q ss_pred CchhHHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 244 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
.|..+.+++.+||..+|++||++.++.+.|.
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 6789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=279.88 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=195.5
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCc-ceEEEEe
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE-DNVLVLD 83 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~-~~~lv~e 83 (318)
++|.-...||.|+||.||+|....+ ..||||.+..... ..++.+|+.++.+++| +|+..+..|..+.. +.++|+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H-~Nlv~LlGyC~e~~~~~~LVYE 152 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRH-PNLVKLLGYCLEGGEHRLLVYE 152 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCC-cCcccEEEEEecCCceEEEEEE
Confidence 5667778999999999999987654 8899998877655 3569999999999995 55666655555555 6999999
Q ss_pred cc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 84 LL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG---FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
|+ .|+|.+.+..... .++|..+.+|+.++|+||.|||... |+||||||.|||+ |.++.+||+|||+++....
T Consensus 153 ym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 153 YMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred ccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCc
Confidence 99 8999999987555 7899999999999999999999864 9999999999999 7999999999999965443
Q ss_pred -CCCCccccccCCCCC-cccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhh---HH---------H
Q 021053 159 -PTTNRHIPYRENKNL-TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK---KQ---------K 224 (318)
Q Consensus 159 -~~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~---~~---------~ 224 (318)
.... ... .||..|+|||+......+.++||||||+++.|++||+.|.....+... .. .
T Consensus 230 ~~~~~--------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~ 301 (361)
T KOG1187|consen 230 GDTSV--------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGK 301 (361)
T ss_pred cccce--------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcc
Confidence 2111 112 789999999999998999999999999999999999988764321111 11 1
Q ss_pred HHHHHHhhcc---CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 225 YDKICEKKVS---TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 225 ~~~i~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
+..+....+. .+.. ..-..+..+...|+..+|.+||++.++.+.|+..
T Consensus 302 ~~eiiD~~l~~~~~~~~----~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 302 LREIVDPRLKEGEYPDE----KEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred hhheeCCCccCCCCChH----HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 1122221111 0100 0112477888999999999999999998888544
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=268.32 Aligned_cols=252 Identities=21% Similarity=0.260 Sum_probs=189.4
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHc--CCCCCCeeeeccccCcc-----
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQ--GGSGIPNIKWYGVDGED----- 77 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~--~~~~~~~i~~~~~~~~~----- 77 (318)
|++.+.||.|++|.||+|.+..+++.||+|.+...... ..+.+|+.++.++. .|+++..+..++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 78999999999999999999888999999987643322 24567888887775 34566666555444443
Q ss_pred eEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++++|++.++|.+++.... ..+++..+..++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||.+...
T Consensus 81 ~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~~~ 157 (287)
T cd07838 81 LTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIY 157 (287)
T ss_pred eEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcceec
Confidence 89999999889999887643 358999999999999999999999999999999999999 47799999999998765
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHH------
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE------ 230 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~------ 230 (318)
..... .....++..|+|||++.+..++.++|+|||||++|+|++|.+||......+....+.....
T Consensus 158 ~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 158 SFEMA--------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229 (287)
T ss_pred cCCcc--------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHh
Confidence 43322 1223467889999999988899999999999999999999999987654332222211100
Q ss_pred -------------hhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 231 -------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 231 -------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.....+........+..+.+++.+||..+|++||++.++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00011111122234566778888888888888888877653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=290.85 Aligned_cols=248 Identities=18% Similarity=0.315 Sum_probs=206.0
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC--CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
-|+|+..||.|+||.||+|..+.++...|-|++... ...+++.-|+.+|....| +.+..+.......+..+|..|||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdH-P~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDH-PVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCC-hHHHHHHHHHhccCceEEEEeec
Confidence 467888999999999999999988888888876544 345678899999999885 66666654445566799999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 86 -~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
||....++...+..+.+.++..+++|++.||.|||+++|||||||..|||++ -+|.++|+|||.+.........
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~T---ldGdirLADFGVSAKn~~t~qk-- 186 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLT---LDGDIRLADFGVSAKNKSTRQK-- 186 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEE---ecCcEeeecccccccchhHHhh--
Confidence 7778888888899999999999999999999999999999999999999996 8999999999999876554432
Q ss_pred ccccCCCCCccccccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 165 IPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
...+.||+.|||||+.. ..+|+.++||||||++|.+|..+.+|-...++.. .+.+| .+..+|.-.
T Consensus 187 -----RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR---VllKi--aKSePPTLl 256 (1187)
T KOG0579|consen 187 -----RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR---VLLKI--AKSEPPTLL 256 (1187)
T ss_pred -----hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH---HHHHH--hhcCCCccc
Confidence 34779999999999875 4479999999999999999999999987776642 22222 234455455
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+..|+..+.+++..||..||..||++.++.+
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 56789999999999999999999999887654
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=269.72 Aligned_cols=240 Identities=25% Similarity=0.337 Sum_probs=181.1
Q ss_pred eeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-----hhHHHHHHHHHHHc--CCCCCCeeeeccccCcceEEEEecc-
Q 021053 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVLDLL- 85 (318)
Q Consensus 14 ~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~--~~~~~~~i~~~~~~~~~~~lv~e~~- 85 (318)
.||+|+||.||+|.+..+++.+|+|.+...... ....+|..++..+. +++++..+...+......++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999987543211 12344444444443 3455655666666667899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccc
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~ 165 (318)
+++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||++........
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~~---- 152 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP---- 152 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE---CCCCCEEEccCCcceeccccCc----
Confidence 7889888775 4458999999999999999999999999999999999999 5888999999999865432211
Q ss_pred cccCCCCCccccccccccccc-CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcC
Q 021053 166 PYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (318)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (318)
....++..|+|||.+. +..++.++|+||+||++|+|++|..||......... ...... ...+ ......+
T Consensus 153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~---~~~~-~~~~~~~ 222 (279)
T cd05633 153 -----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMT---LTVN-VELPDSF 222 (279)
T ss_pred -----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHh---hcCC-cCCcccc
Confidence 2346788999999886 455889999999999999999999999764332211 111111 1111 1123456
Q ss_pred chhHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 245 PAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 245 ~~~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
+..+.+++.+||..+|.+|| ++.++.+
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 78999999999999999999 4776655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=275.87 Aligned_cols=263 Identities=21% Similarity=0.267 Sum_probs=196.9
Q ss_pred CCccccceeeE-eeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCCh----------------hHHHHHHHHHHHcCCC
Q 021053 1 MERIIGVKYKL-GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----------------QLLYEAKVYKILQGGS 63 (318)
Q Consensus 1 ~~~~~~~~y~~-~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~----------------~~~~e~~~l~~l~~~~ 63 (318)
|..-+.+||.. .+.||.|+||.||+|.+..+++.||+|.+....... .+.+|+.++..+.| +
T Consensus 2 ~~~~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ 80 (335)
T PTZ00024 2 MSFSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH-E 80 (335)
T ss_pred CccccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCC-c
Confidence 34456788864 577999999999999999999999999865432211 46789999999976 5
Q ss_pred CCCeeeeccccCcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCC
Q 021053 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 143 (318)
Q Consensus 64 ~~~~i~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~ 143 (318)
++..+..++......+++||++.++|.+++.. ...++......++.|++.||.|||+.|++|+||+|+||++ +..+
T Consensus 81 ~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill---~~~~ 156 (335)
T PTZ00024 81 NIMGLVDVYVEGDFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI---NSKG 156 (335)
T ss_pred ceeeeeEEEecCCcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE---CCCC
Confidence 56666666667778999999998899999875 3458999999999999999999999999999999999999 4888
Q ss_pred eEEEEeccceeeecCCCCCccc------c-ccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccc
Q 021053 144 QVYIIDFGLAKKYRDPTTNRHI------P-YRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQG 215 (318)
Q Consensus 144 ~~kL~dfg~~~~~~~~~~~~~~------~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~ 215 (318)
.++|+|||.+............ . -.......++..|+|||.+.+.. ++.++|+|||||++|+|++|.+||..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999998765422111000 0 00112234577899999987654 68899999999999999999999987
Q ss_pred hhHhhhHHHHHHHHHhhccCchH-----------------------HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 216 LKAATKKQKYDKICEKKVSTPIE-----------------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.++.... ..+......++.. ......+..+.+++..||+.+|++||+++++..
T Consensus 237 ~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 237 ENEIDQL---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCHHHHH---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 6554322 2222221111111 112234667889999999999999999887765
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=282.13 Aligned_cols=263 Identities=21% Similarity=0.319 Sum_probs=213.0
Q ss_pred eeeEeeeeccCcccEEEEEEEcC--C--CcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVD--T--NEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~--~--~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
...+.+.||.|-||.||.|.... . .--||||..+.+. ..+.+..|..+++.+.|+.++..|..+.. ...+|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e--~P~Wi 467 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE--QPMWI 467 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec--cceeE
Confidence 34567789999999999997642 2 2358899887643 34578999999999988555555555543 35899
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
|||.+ -|.|..+++.....++......++.||+.||.|||+++.+||||..+|||++ +...+||+|||+++....+
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVs---Sp~CVKLaDFGLSR~~ed~ 544 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVS---SPQCVKLADFGLSRYLEDD 544 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeec---Ccceeeecccchhhhcccc
Confidence 99999 8999999998777799999999999999999999999999999999999996 8999999999999987765
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
.... .+...-..-|||||-+.-..++.++|||-|||++||++. |..||++..+.+....++. +.+++-|
T Consensus 545 ~yYk------aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn--GeRlP~P-- 614 (974)
T KOG4257|consen 545 AYYK------ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN--GERLPCP-- 614 (974)
T ss_pred chhh------ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC--CCCCCCC--
Confidence 4421 122333556999999999999999999999999999988 9999998765543333322 2333333
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCchhHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFI 288 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~ 288 (318)
..+|+.++.++++||+++|.+||.+.++...|++.+.++.+.--+++
T Consensus 615 ---~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~~Eq~ 661 (974)
T KOG4257|consen 615 ---PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINSSEQL 661 (974)
T ss_pred ---CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhhHHHH
Confidence 47899999999999999999999999999999999877666555554
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=264.09 Aligned_cols=255 Identities=19% Similarity=0.211 Sum_probs=206.6
Q ss_pred ccceeeEe-eeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccc----cCcceE
Q 021053 5 IGVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGEDNV 79 (318)
Q Consensus 5 ~~~~y~~~-~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~----~~~~~~ 79 (318)
+.++|.+. +.||.|-.|.|..+.++.+++.+|+|++.. .+.+.+|++.--....|++++.|..... ......
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D---s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLL 135 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD---SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLL 135 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc---CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeE
Confidence 34556554 578999999999999999999999998753 4557888888777788888888744433 334578
Q ss_pred EEEecc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 80 LVLDLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
+|||++ ||.|.+.++..+. .|++.++..+++||..|+.|||+.+|+||||||+|+|.+....+..+||+|||+++...
T Consensus 136 iVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~ 215 (400)
T KOG0604|consen 136 IVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ 215 (400)
T ss_pred eeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccC
Confidence 999999 9999999987543 49999999999999999999999999999999999999877788899999999998765
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHH-HHHHHhhccCc
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY-DKICEKKVSTP 236 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~-~~i~~~~~~~~ 236 (318)
.+... .....|+.|.|||++-...|+..+|+||+||++|-|+-|.+||..........-+ .+|.......|
T Consensus 216 ~~~~L--------~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP 287 (400)
T KOG0604|consen 216 EPGDL--------MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP 287 (400)
T ss_pred CCccc--------cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence 43321 2345689999999999999999999999999999999999999765433322222 34444555555
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.++ |...|+..+++|+.+|..+|.+|.+++++..
T Consensus 288 ~pE-Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 288 EPE-WSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred Chh-HhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 555 4688999999999999999999999887654
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=270.39 Aligned_cols=246 Identities=21% Similarity=0.311 Sum_probs=194.0
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHc--CCCCCCeeeeccccCcceEEEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~--~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
.|++.+.||.|+||.||+|.+..++..|++|.+..... ...+.+|+.+++.+. .|+++..+..+.......+++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 58889999999999999999999999999998764322 245778999999997 2455655555556677899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|++ +++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++ +.+.++|+|||.+........
T Consensus 82 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~---~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT---NTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc---CCCCEEEccCCceeecCCCcc
Confidence 999 8899988864 3588999999999999999999999999999999999994 789999999999877654332
Q ss_pred CccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
. .....++..|+|||.+.+. .++.++|+|||||++|+|++|..||....... ....+.. . .+....
T Consensus 157 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~---~~~~~~~-~--~~~~~~ 223 (277)
T cd06917 157 K-------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR---AMMLIPK-S--KPPRLE 223 (277)
T ss_pred c-------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh---hhhcccc-C--CCCCCC
Confidence 1 1234578889999988754 47889999999999999999999997654321 1111111 1 111111
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...++.++.+++..||..+|++||++.++.+
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 224 DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1236788999999999999999999998876
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=272.68 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=210.5
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
++-..+|.++..||.|+||.|.+|..+.+.+.+|||+++++. +.+-...|-.+|.....++.+..+..+++....
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 455678999999999999999999999999999999877653 333456777888878888888888999999999
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.|+||||+ +|+|-..++..+ .+.+..+..++.+|+-||-+||++||+.||||.+||++ |..|.+||.|||.+...
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe---ccCCceEeeeccccccc
Confidence 99999999 888888887644 48899999999999999999999999999999999999 79999999999999764
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
-.+.. ......||+.|.|||++...+|+.++|+||+||+||||+.|++||.+++. .+.+..|.+.....|
T Consensus 501 i~~~~-------TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE---~elF~aI~ehnvsyP 570 (683)
T KOG0696|consen 501 IFDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQAIMEHNVSYP 570 (683)
T ss_pred ccCCc-------ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHccCcCc
Confidence 33222 23567899999999999999999999999999999999999999999765 466777777777666
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCC
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPD 265 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~ 265 (318)
+.++.+..+++...+...|.+|..
T Consensus 571 -----KslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 571 -----KSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -----ccccHHHHHHHHHHhhcCCccccC
Confidence 456888999999999999999953
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=271.53 Aligned_cols=259 Identities=22% Similarity=0.286 Sum_probs=195.4
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeecccc----
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD---- 74 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~---- 74 (318)
....++|++.+.||+|++|.||+|.+..+++.|++|.+..... ...+.+|+.++..++|+ ++..+..+...
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~-~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHR-NIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCC-CeeeeeheecCcchh
Confidence 4556899999999999999999999998899999998764322 23567799999999765 44444333222
Q ss_pred ------CcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEE
Q 021053 75 ------GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148 (318)
Q Consensus 75 ------~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~ 148 (318)
....++++|++.+++.+++......+++..+..++.|++.||.|||+.||+|+||+|+||++ ++.+.+||+
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili---~~~~~~kl~ 158 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL---NNKGQIKLA 158 (302)
T ss_pred hhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCcEEeC
Confidence 23789999999889988887654568999999999999999999999999999999999999 488999999
Q ss_pred eccceeeecCCCCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHH
Q 021053 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (318)
Q Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (318)
|||.+......... ......++..|+|||.+.+. .++.++|||||||++|+|++|++||...+.......+..
T Consensus 159 dfg~~~~~~~~~~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 159 DFGLARLYNSEESR------PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred cccccccccCCccc------ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 99998765433211 11123456789999988654 478899999999999999999999987655444444433
Q ss_pred HHHhhccC----------------------chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 228 ICEKKVST----------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 228 i~~~~~~~----------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+....+. ........+|..+.+++..||..+|.+||++.++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 32211100 000112245778889999999999999998877654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=275.28 Aligned_cols=252 Identities=20% Similarity=0.237 Sum_probs=196.4
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccC-----cce
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG-----EDN 78 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~-----~~~ 78 (318)
+|++.+.||.|++|.||+|.+..++..|++|.+.... ....+.+|+.+++.++| +++..+..+.... ...
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRH-ENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCC-cchhhhhhhhcccCcccccce
Confidence 6999999999999999999998889999999876533 33468889999999976 5554554333332 378
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 79 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
|+++++++++|.+++.. ...+++..+..++.|++.||.+||+.|++|+||||+||++ +.++.++|+|||.+.....
T Consensus 80 ~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 80 YIVTELMETDLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEEecchhhhHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeecc
Confidence 99999998889888875 3368999999999999999999999999999999999999 4779999999999987654
Q ss_pred CCCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
..... .......++..|+|||++.+. .++.++|+||+|+++|+|++|.+||...+...... .+.......+.
T Consensus 156 ~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~ 228 (330)
T cd07834 156 DEDEK----GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN---LIVEVLGTPSE 228 (330)
T ss_pred ccccc----ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHH---HHHHhcCCCCh
Confidence 32110 011234568889999999888 78999999999999999999999998765533222 22221111111
Q ss_pred --------------------------HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 238 --------------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 238 --------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.......+..+.+++.+||..+|++||+++++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1112235778899999999999999999998776
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=275.54 Aligned_cols=248 Identities=19% Similarity=0.294 Sum_probs=193.3
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
+.|.....||.|+||.||++.+..++..||||.+..... ...+.+|+.++..+.| +++..+...+......++++|+
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHH-ENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCC-CcHHHHHHheecCCeEEEEEeC
Confidence 556677889999999999999988899999998754332 2357789999988876 5555554445566789999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+ +++|.+++.. ..+++..+..++.||+.||.|||++|++||||+|+||++ +.++.++|+|||++........
T Consensus 101 ~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~-- 173 (292)
T cd06658 101 LEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVP-- 173 (292)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE---cCCCCEEEccCcchhhcccccc--
Confidence 9 7788887753 458899999999999999999999999999999999999 4788999999999865432221
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhc
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (318)
......++..|+|||.+.+..++.++|+||||+++|++++|..||...+..... ..+.. ...... .....
T Consensus 174 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---~~~~~-~~~~~~-~~~~~ 243 (292)
T cd06658 174 -----KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM---RRIRD-NLPPRV-KDSHK 243 (292)
T ss_pred -----cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh-cCCCcc-ccccc
Confidence 112345788899999998888999999999999999999999999875543222 22111 111111 11224
Q ss_pred CchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 244 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
.+..+.+++..||..+|.+||++.++.+.
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 57789999999999999999999988763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=265.25 Aligned_cols=249 Identities=24% Similarity=0.324 Sum_probs=189.7
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-------ChhHHHHHHHHHHHcCCCCCCeeeecccc--Ccc
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGVD--GED 77 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~--~~~ 77 (318)
.+|++.+.||.|+||.||.|.+..++..|++|.+..... ...+.+|+.+++.+.|++ +..+..++.. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER-IVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCC-eeeEEeEeccCCCce
Confidence 579999999999999999999999999999997653221 124667999999997644 4444443332 346
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++++|++ +++|.+++... ..+++..+..++.|++.||.+||+++++|+||+|+||++ +.++.++|+|||.+...
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR---DSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe---cCCCCEEECcCcccccc
Confidence 78999999 78999988753 447888999999999999999999999999999999999 48899999999998765
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
....... .......++..|+|||++.+..++.++|+|||||++|++++|+.||....... ........ ..
T Consensus 157 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~---~~ 226 (265)
T cd06652 157 QTICLSG----TGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA---AIFKIATQ---PT 226 (265)
T ss_pred ccccccc----cccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH---HHHHHhcC---CC
Confidence 4221110 01123457888999999988889999999999999999999999997653321 12222211 11
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
........+..+.+++.+|| .+|++||+++++.+
T Consensus 227 ~~~~~~~~~~~~~~~i~~~l-~~p~~Rp~~~~il~ 260 (265)
T cd06652 227 NPVLPPHVSDHCRDFLKRIF-VEAKLRPSADELLR 260 (265)
T ss_pred CCCCchhhCHHHHHHHHHHh-cChhhCCCHHHHhc
Confidence 11122345677899999999 59999999988764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=265.62 Aligned_cols=245 Identities=24% Similarity=0.352 Sum_probs=194.6
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-------CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
+|+..+.||.|++|.||+|.+..++..|++|.+.... ....+.+|+.+++.++| +++..+..+.......++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCC-CCchheeeeEecCCeEEE
Confidence 5888999999999999999998889999999765433 22357789999999876 556666656666778999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
++|++ +++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||++ +.++.+||+|||.+......
T Consensus 80 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 80 FLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEccCccceecccc
Confidence 99999 78999998763 458899999999999999999999999999999999999 48899999999998765433
Q ss_pred CCCccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
.. .....++..|++||.+.... ++.++|+|||||++|++++|..||....+.. ....+.. .. ...
T Consensus 156 ~~--------~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~-~~--~~~ 221 (258)
T cd06632 156 SF--------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA---AVFKIGR-SK--ELP 221 (258)
T ss_pred cc--------ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH---HHHHHHh-cc--cCC
Confidence 21 12345788899999987766 8999999999999999999999997654322 1222111 01 111
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.....++..+.+++.+||..+|++||++.++..
T Consensus 222 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 222 PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 223456788999999999999999999988764
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=264.38 Aligned_cols=252 Identities=27% Similarity=0.419 Sum_probs=195.4
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
||++.+.||.|++|.||+|.+..+++.|++|.+..... ...+..|+.+++.++| +++..+..........++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKH-PNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCC-CChhheeeeEecCCEEEEEEe
Confidence 69999999999999999999988899999998765543 2367889999999977 455555555566678999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
++ +++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++ +.+.+||+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~---~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 80 YCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLD---HNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred cCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC---CCCCEEEcccccccccCCCCCc
Confidence 99 7899998876 33478889999999999999999999999999999999994 7899999999998776543321
Q ss_pred ccccccCCCCCcccccccccccccCCC---CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
... ......++..|++||++.+.. .+.++||||||+++|++++|..||...+... .....+.. ......+
T Consensus 156 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~~~~~~~-~~~~~~~- 228 (264)
T cd06626 156 MGE---EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QIMFHVGA-GHKPPIP- 228 (264)
T ss_pred ccc---cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HHHHHHhc-CCCCCCC-
Confidence 100 012345678899999988766 7899999999999999999999997653221 11112221 1111111
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.....+..+.+++..||..+|++||++.++..
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 229 DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11234778999999999999999999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=270.27 Aligned_cols=254 Identities=20% Similarity=0.328 Sum_probs=197.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
+-.++|++.+.||.|++|.||+|.+..+++.||+|.+..... .....+|+.++.....|+++..+..++......++
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 91 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFI 91 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEE
Confidence 345789999999999999999999998899999998765432 22456677767676656777777777777788999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
++|++++++.+++......+++..+..++.|++.||.|||+ .|++||||+|+||++ +.++.++|+|||.+......
T Consensus 92 v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 92 CMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE---cCCCCEEECccccchhccCC
Confidence 99999888988887766678999999999999999999997 599999999999999 48899999999998654322
Q ss_pred CCCccccccCCCCCcccccccccccccCCC----CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...... .+.+..+.......
T Consensus 169 ~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~ 238 (296)
T cd06618 169 KAK--------TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKILQEEPPS 238 (296)
T ss_pred Ccc--------cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHHHHhcCCCCC
Confidence 211 1234677899999987653 788999999999999999999999753221 12222322222111
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
.. ....++..+.+++.+||..+|++||++.++...
T Consensus 239 ~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 LP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 112467889999999999999999999987663
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=265.76 Aligned_cols=247 Identities=23% Similarity=0.296 Sum_probs=195.0
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+|++.+.||.|++|.||+|.+..++..+|+|.+... .....+.+|+.+++.++| +++..+..........++++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKH-PNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCC-CChhhhhheeccCCeEEEEEe
Confidence 689999999999999999999999999999987543 233467789999999976 455555555566678999999
Q ss_pred cc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 84 LL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
++ +++|.+++..... .+++..+..++.|++.||.|||+.+++|+||+|+||+++ ++...++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEc--CCCCeEEecccccchhccCCcc
Confidence 99 8899998875332 478999999999999999999999999999999999995 3335679999998876543221
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
......++..|+|||++.+..++.++|+||||+++|++++|..||...+.. .....+...... ...
T Consensus 158 -------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~----~~~ 223 (257)
T cd08225 158 -------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH---QLVLKICQGYFA----PIS 223 (257)
T ss_pred -------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHhcccCC----CCC
Confidence 112345788899999998888999999999999999999999999765432 222222222211 112
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+..+.+++.+||..+|++||++.++.+
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 356778999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=265.20 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=196.0
Q ss_pred eeEeeeeccCcccEEEEEEEcCCC----cEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~----~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
+++.+.||.|+||.||+|.+...+ ..||+|.+..... ...+..|+..+..+. |+++..+..........+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeEEE
Confidence 367899999999999999998765 8899998876543 346788999999995 46666666666666789999
Q ss_pred Eecc-CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 82 LDLL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~-~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
||++ +++|.+++...... +++..+..++.|++.||.+||+.|++|+||+|+||++ ++.+.++|+|||.+......
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV---GENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE---ccCCeEEEcccCCceecccc
Confidence 9999 78999998764444 8999999999999999999999999999999999999 48889999999998766543
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
.... .....++..|+|||.+.+..++.++|+||+|+++|+|++ |.+||...+... ....+.... ..+
T Consensus 157 ~~~~------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~~~~-~~~-- 224 (258)
T smart00219 157 DYYK------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYLKKGY-RLP-- 224 (258)
T ss_pred cccc------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcCC-CCC--
Confidence 2211 112235678999999988889999999999999999998 899997644322 222222111 111
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
.....|..+.+++.+||..+|++||++.++.+.|
T Consensus 225 -~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 -KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1234688999999999999999999999887653
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=272.24 Aligned_cols=249 Identities=23% Similarity=0.318 Sum_probs=196.5
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
.++|++.+.||+|+||.||+|.+..++..|++|.+.... ....+.+|+.++..++| +++..+..........++|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKH-PNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCC-CCeeehhheeeeCCcEEEEEe
Confidence 478999999999999999999998889999999875432 23457788899998875 566666555566678999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
++ +++|.+++.. ..++...+..++.|++.||.|||++|++|+||+|+||+++ .++.++|+|||.+.........
T Consensus 97 ~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~---~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 97 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred cCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc---CCCCEEEccCcceecccccccc
Confidence 99 8899998874 3478889999999999999999999999999999999994 7889999999988755432221
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
.....++..|++||.+....++.++|+|||||++|++++|..||...+....... +. ....+......
T Consensus 172 -------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~---~~--~~~~~~~~~~~ 239 (293)
T cd06647 172 -------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IA--TNGTPELQNPE 239 (293)
T ss_pred -------cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee---hh--cCCCCCCCCcc
Confidence 1234577889999999888889999999999999999999999976543221111 11 11111111123
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
..+..+.+++.+||..+|++||++.++..+
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 240 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 456789999999999999999999987763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=266.46 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=193.9
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC------------ChhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------------HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
+|.+.+.||.|++|.||+|.+..+++.+|+|.+..... .+.+.+|+.++..+.| +++..+..+....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH-LNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCC-CCcceEEEEeccC
Confidence 68999999999999999999988899999997653211 1235678888998876 5555665566667
Q ss_pred cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
...++|+|++ +++|.+++... ..++...+..++.|++.||.+||+.+++|+||+|+||++ +.++.++|+|||.+.
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~---~~~~~~~l~d~~~~~ 156 (272)
T cd06629 81 EYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGISK 156 (272)
T ss_pred CceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE---cCCCeEEEeeccccc
Confidence 7899999999 88999998764 458899999999999999999999999999999999999 488999999999987
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCC--CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~ 232 (318)
......... ......++..|+|||.+.... ++.++|+||||+++|++++|..||....... ....+....
T Consensus 157 ~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~ 228 (272)
T cd06629 157 KSDDIYDND-----QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA---AMFKLGNKR 228 (272)
T ss_pred ccccccccc-----ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH---HHHHhhccc
Confidence 543221110 112345678899999987654 7899999999999999999999996543321 111211111
Q ss_pred -ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 233 -VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 233 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...........++..+.+++.+||..+|++||++.++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 111122233456889999999999999999999988765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=264.30 Aligned_cols=287 Identities=22% Similarity=0.255 Sum_probs=212.9
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEe-ec---CCCCChhHHHHHHHHHHHcCCCCCCeeeeccc-------c
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-EN---SGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-------D 74 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~-~~---~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~-------~ 74 (318)
...|+-..+||+|.||+||+|+.+++++.|++|+ +. +.......++|+++++.++|.+....+..+.. +
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 4678888999999999999999999999999884 32 22234578999999999998766555543322 2
Q ss_pred CcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
...+|+|+.+|.-+|..++....-.++..++.+++++++.||.|+|+..|+|||+||.|+|++ .++.+||+|||+++
T Consensus 96 r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt---~dgilklADFGlar 172 (376)
T KOG0669|consen 96 RATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLIT---KDGILKLADFGLAR 172 (376)
T ss_pred cceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEc---CCceEEeecccccc
Confidence 345899999999999999987555699999999999999999999999999999999999994 88999999999997
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
.+.......... ....+-|..|+.||.+.|.. |+++.|||+.||++.+|+||.+.|++.....+...+...++
T Consensus 173 ~fs~~~n~~kpr---ytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG--- 246 (376)
T KOG0669|consen 173 AFSTSKNVVKPR---YTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG--- 246 (376)
T ss_pred ceecccccCCCC---cccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc---
Confidence 765443332211 12334589999999988765 99999999999999999999999999766555554444443
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH-HhcCCchhHHHhhhcCCcccccccceee
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF-SREGSLLLQFIMSYCSLHSITFQTNIIN 305 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~-~~~~~~~~~~~l~~~p~~r~t~~~~~~~ 305 (318)
+...+.| ..+. -..+.++. +..|--.-+...+...+.-.. ++++.+++++||.+||++|+++.+++.-
T Consensus 247 s~tkevW-P~~d--~lpL~~si-e~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 247 SITKEVW-PNVD--NLPLYQSI-ELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCcccC-CCcc--cchHHHhc-cCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 3333322 1221 11233322 233322223333444443222 4577899999999999999999999873
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=266.64 Aligned_cols=250 Identities=20% Similarity=0.344 Sum_probs=194.5
Q ss_pred eeeEeeeeccCcccEEEEEEEcC-CCcEEEEEeecCCCC------------ChhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTK------------HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~-~~~~vaiK~~~~~~~------------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
.|++.+.||.|+||.||+|.+.. +++.+++|.+..... ...+..|+.++.+...|+++..+..+...
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 678899997643211 12356677777664455677677666667
Q ss_pred CcceEEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeeccCCCCCeEEEEe
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIID 149 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~kL~d 149 (318)
....++++||+ +++|.+++... ...++...++.++.|++.||.+||+ .+++|+||+|+||++ +..+.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---GEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE---CCCCcEEEec
Confidence 77899999999 78998887542 3458899999999999999999996 689999999999999 4889999999
Q ss_pred ccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHH
Q 021053 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (318)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~ 229 (318)
||.+........ .....++..|++||.+.+..++.++|+||||+++|++++|.+||...+... ....+.
T Consensus 158 fg~~~~~~~~~~--------~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~~~~~ 226 (269)
T cd08528 158 FGLAKQKQPESK--------LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LATKIV 226 (269)
T ss_pred ccceeecccccc--------cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HHHHHh
Confidence 999876543321 123457888999999998889999999999999999999999997654332 222222
Q ss_pred HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
..... +... ..++..+.+++.+||..||++||++.++..++.
T Consensus 227 ~~~~~-~~~~--~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 EAVYE-PLPE--GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred hccCC-cCCc--ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 22222 2111 246788999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=266.13 Aligned_cols=242 Identities=22% Similarity=0.351 Sum_probs=188.8
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-----hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||.|+||.||+|.+..+++.||+|++...... .....|..++.....|+++..+...+......++++||+ +
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999989999999987643211 123445444444445677777777767778899999999 8
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||+++ .++.++|+|||++......
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~---~~~~~~l~dfg~~~~~~~~------- 150 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID---QTGHLKLTDFGLSRNGLEN------- 150 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCcEEEeecccceecccc-------
Confidence 8999998763 4589999999999999999999999999999999999994 7889999999988754321
Q ss_pred ccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCch
Q 021053 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (318)
....++..|+|||.+.+..++.++||||||+++|+|++|..||...+... ....+.......+. .....++.
T Consensus 151 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~-~~~~~~~~ 222 (260)
T cd05611 151 ----KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFDNILSRRINWPE-EVKEFCSP 222 (260)
T ss_pred ----ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHhcccCCCC-cccccCCH
Confidence 23356788999999988888999999999999999999999997654432 22222222222221 22235688
Q ss_pred hHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 247 EFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 247 ~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
.+.+++.+||..+|++||++..+.+.+
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 999999999999999999887665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=268.44 Aligned_cols=246 Identities=21% Similarity=0.324 Sum_probs=187.4
Q ss_pred eeeccCcccEEEEEEEcCCC------cEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 13 RKIGSGSFGEIFLASHVDTN------EIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~------~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+.||.|+||.||+|++.... +.+++|.+.... ....+.+|+.+++.+.| +++..+..++......++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNH-PNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCC-CCeeeEeeeecCCCCeEEEEe
Confidence 36899999999999986433 678999765432 23467889999999977 455555555556667999999
Q ss_pred cc-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCC-----eEEEEecc
Q 021053 84 LL-GPSLEDLFVYCR------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-----QVYIIDFG 151 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~-----~~kL~dfg 151 (318)
++ +++|.+++.... ..+++..+..++.|++.||.|||+++++|+||+|+||+++ ..+ .++|+|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVS---EKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEe---cCCCCCCcceEECCcc
Confidence 98 889999987521 2367888999999999999999999999999999999995 444 89999999
Q ss_pred ceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHH
Q 021053 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICE 230 (318)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~ 230 (318)
++......... .......++..|+|||.+.+..++.++|||||||++|+|++ |+.||...+..... ..+..
T Consensus 157 ~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~---~~~~~ 228 (269)
T cd05044 157 LARDIYKSDYY-----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL---QHVTA 228 (269)
T ss_pred ccccccccccc-----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH---HHHhc
Confidence 98755332211 11123345678999999998889999999999999999998 99999765443222 22111
Q ss_pred hhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
. ... ......|..+.+++.+||..+|.+||++.++.+.|.
T Consensus 229 ~-~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 G-GRL---QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred C-Ccc---CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 111 112356788999999999999999999999988775
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=265.05 Aligned_cols=247 Identities=21% Similarity=0.271 Sum_probs=188.3
Q ss_pred eEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 10 ~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
.....||+|+||.||+|.+..++..|++|.+..... ...+.+|+.+++.++| +++..+..+.......++++|++ +
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKH-RNIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCC-CCeeeeeeeeccCCEEEEEEecCCC
Confidence 345689999999999999998899999997765432 3367889999999976 45555555556667899999999 7
Q ss_pred CCHHHHHHHhcCCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 87 PSLEDLFVYCRRKF--SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 87 ~~L~~~~~~~~~~~--~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
++|.+++......+ +...+..++.|++.||.|||++||+|+||+|+||++. .+.+.++|+|||.+........
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~--- 164 (268)
T cd06624 90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINP--- 164 (268)
T ss_pred CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCC---
Confidence 89999987644445 7888889999999999999999999999999999994 3467999999999875432211
Q ss_pred ccccCCCCCcccccccccccccCCC--CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 165 IPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
......++..|+|||++.+.. ++.++|+||||+++|++++|..||......... .. ........ ..+..
T Consensus 165 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-~~-~~~~~~~~---~~~~~ 235 (268)
T cd06624 165 ----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-MF-KVGMFKIH---PEIPE 235 (268)
T ss_pred ----ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-Hh-hhhhhccC---CCCCc
Confidence 112335788999999987543 788999999999999999999999754321111 11 11000111 11223
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..++.+.+++.+||+.+|.+||++.++..
T Consensus 236 ~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 236 SLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 56778999999999999999999998765
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=269.88 Aligned_cols=240 Identities=18% Similarity=0.245 Sum_probs=180.5
Q ss_pred eeeccCcccEEEEEEEcCCCc-------EEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 13 RKIGSGSFGEIFLASHVDTNE-------IVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~-------~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+.||.|+||.||+|.+...+. .+++|....... ...+.+|..+++.+.| +++..+...+......++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h-~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSH-KHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCC-CChhheeeEEEeCCCcEEEEe
Confidence 468999999999998865443 378887654332 2356778888888876 555566555566678999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCC-----CCCeEEEEeccceeeec
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-----KANQVYIIDFGLAKKYR 157 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~-----~~~~~kL~dfg~~~~~~ 157 (318)
|+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++.++ ..+.++++|||.+....
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~ 159 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL 159 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence 99 7899999886555689999999999999999999999999999999999995211 11237999999876433
Q ss_pred CCCCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhC-CCCccchhHhhhHHHHHHHHHhhccC
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg-~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
.. ....++..|+|||++.+. .++.++|||||||++|+|++| .+||....+..... ........
T Consensus 160 ~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~----~~~~~~~~ 224 (258)
T cd05078 160 PK-----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ----FYEDRHQL 224 (258)
T ss_pred Cc-----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH----HHHccccC
Confidence 21 123567789999999874 478999999999999999998 56766544332211 11222222
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
| ...+.++.+++.+||+.+|++||+++++.+.|
T Consensus 225 ~-----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 225 P-----APKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred C-----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 2 23346799999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=266.42 Aligned_cols=245 Identities=21% Similarity=0.288 Sum_probs=194.3
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
-|++.+.||.|+||.||+|.+..++..||+|....... ...+.+|+.++..+.| +++..+..++......++|+||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCC-CCEeEEEEEEEeCCeEEEEEEe
Confidence 47889999999999999999988899999998654322 2357788899998876 4555555555667789999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+ +++|.+++.. ..++...+..++.|++.|+.+||++|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 84 ~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06641 84 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIK- 157 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE---CCCCCEEEeecccceecccchhh-
Confidence 9 7788888863 458899999999999999999999999999999999999 47889999999998765432111
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhc
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (318)
.....++..|+|||.+.+..++.++|+|||||++|++++|..||....... ....+... ..+.....
T Consensus 158 ------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~----~~~~~~~~ 224 (277)
T cd06641 158 ------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLFLIPKN----NPPTLEGN 224 (277)
T ss_pred ------hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHHHHhcC----CCCCCCcc
Confidence 123356788999999988888999999999999999999999997654322 11122111 11112235
Q ss_pred CchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 244 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
.+..+.+++.+||..+|.+||++.++.+.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 67889999999999999999999998884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=265.00 Aligned_cols=242 Identities=20% Similarity=0.302 Sum_probs=188.3
Q ss_pred ceeeEeeee--ccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 7 VKYKLGRKI--GSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 7 ~~y~~~~~l--g~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
++|++.+.+ |.|+||.||++.+..++..+|+|......... .|......+.+|+++..+...+......++||||
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~ 90 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDY 90 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEc
Confidence 567777776 99999999999999999999999876533221 2344444455667787777777777789999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCC-eEEEEeccceeeecCCCCC
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~-~~kL~dfg~~~~~~~~~~~ 162 (318)
+ +++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||++. ..+ .++|+|||.+.......
T Consensus 91 ~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~~~-- 164 (267)
T PHA03390 91 IKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD---RAKDRIYLCDYGLCKIIGTPS-- 164 (267)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---CCCCeEEEecCccceecCCCc--
Confidence 9 88999998864 3689999999999999999999999999999999999995 555 89999999987653221
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhh-HHHHHHHHHhhccCchHHHh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~-~~~~~~i~~~~~~~~~~~~~ 241 (318)
...++..|+|||++.+..++.++||||+|+++|+|++|..||........ ...+... . ..+. ...
T Consensus 165 ---------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~-~~~~-~~~ 230 (267)
T PHA03390 165 ---------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR---Q-QKKL-PFI 230 (267)
T ss_pred ---------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh---h-cccC-Ccc
Confidence 23568889999999988899999999999999999999999975433211 1111111 1 1111 122
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCC-hHHHHH
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPD-YGFLKR 271 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~-~~~l~~ 271 (318)
+..+..+.+++.+||..+|.+||+ ++++.+
T Consensus 231 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 231 KNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred cccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 367889999999999999999996 476653
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=290.60 Aligned_cols=200 Identities=21% Similarity=0.258 Sum_probs=153.2
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCC-cEEEEE------------------eecCCC-CChhHHHHHHHHHHHcCCC
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN-EIVAVK------------------IENSGT-KHPQLLYEAKVYKILQGGS 63 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~-~~vaiK------------------~~~~~~-~~~~~~~e~~~l~~l~~~~ 63 (318)
.+.++|++.+.||+|+||+||+|..+... ..++.| .+.... ....+.+|+.++..++| +
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H-p 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH-E 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC-C
Confidence 34578999999999999999998765322 111212 111111 12346789999999977 5
Q ss_pred CCCeeeeccccCcceEEEEeccCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccC
Q 021053 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 139 (318)
Q Consensus 64 ~~~~i~~~~~~~~~~~lv~e~~~~~L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~ 139 (318)
++..+..++......|++++++.++|.+++.... .......++.++.||+.||.|||++||+||||||+|||+
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl--- 300 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL--- 300 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---
Confidence 5666666667777899999999888888875421 123456678899999999999999999999999999999
Q ss_pred CCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCc
Q 021053 140 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213 (318)
Q Consensus 140 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf 213 (318)
+..+.+||+|||++......... ......|+..|+|||++.+..++.++|||||||++|+|++|..++
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA------FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc------ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 48899999999999765433221 112356899999999999999999999999999999999987543
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=272.08 Aligned_cols=247 Identities=19% Similarity=0.297 Sum_probs=194.6
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
..|+....||.|+||.||+|.+..+++.||+|.+.... ....+.+|+.++..+.| +++..+...+..+...++++|+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-p~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH-QNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCC-CchhhhhhheeeCCeEEEEEec
Confidence 34556678999999999999998889999999875432 23467788888988876 5565665555667789999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+ +++|.+++.. ..+++..+..++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 100 ~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~~- 173 (297)
T cd06659 100 LQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPK- 173 (297)
T ss_pred CCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE---ccCCcEEEeechhHhhccccccc-
Confidence 9 7788887754 458999999999999999999999999999999999999 58899999999998654332211
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhc
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (318)
.....++..|+|||++.+..++.++|||||||++|+|++|+.||...++.... ..+... ..+.......
T Consensus 174 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~--~~~~~~~~~~ 242 (297)
T cd06659 174 ------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KRLRDS--PPPKLKNAHK 242 (297)
T ss_pred ------ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHhcc--CCCCccccCC
Confidence 12346788999999999888999999999999999999999999865443222 222111 1111122335
Q ss_pred CchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 244 HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 244 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
++..+.+++.+||..+|++||++.++.+
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 6778999999999999999999998887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=264.90 Aligned_cols=236 Identities=18% Similarity=0.255 Sum_probs=181.5
Q ss_pred eeeccCcccEEEEEEEcCCC----------cEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 13 RKIGSGSFGEIFLASHVDTN----------EIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~----------~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
+.||.|+||.||+|.+..++ ..+++|++..... ...+.+|+.+++.+.|+ ++..+..+... ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHK-HLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCc-chhheeeEEec-CCcEEE
Confidence 46899999999999998666 3578887665443 45778889999998764 44444433333 568999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCC-------eEEEEeccce
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-------QVYIIDFGLA 153 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~-------~~kL~dfg~~ 153 (318)
+|++ +++|.+++......++...+..++.||+.||.|||++|++|+||||+||+++ ..+ .++|+|||.+
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~---~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVA---RYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEe---cCccccCCceeEEeCCCCcc
Confidence 9999 8899999887554689999999999999999999999999999999999995 444 7999999998
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCC--CCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHH
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICE 230 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~ 230 (318)
...... ....++..|+|||++.+. .++.++|||||||++|++++ |..||...+.......+.
T Consensus 156 ~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---- 220 (259)
T cd05037 156 ITVLSR-----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---- 220 (259)
T ss_pred cccccc-----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh----
Confidence 764321 123456679999998876 68999999999999999999 688887654322111111
Q ss_pred hhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
.....+. .....+.+++.+||..+|.+||++.++.+.|
T Consensus 221 ~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 DQHRLPM-----PDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred cCCCCCC-----CCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 1111111 1125899999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=265.26 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=190.1
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
|++.+.||.|++|.||+|.+..+++.|+||.+..... .....+|+..+.++..|+++..+..+.......++|||++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 7889999999999999999988899999998764432 1234568888888884577777766666678899999999
Q ss_pred CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 86 GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 86 ~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
+++|.+.+.... ..+++..+..++.|++.+|.|||++|++|+||+|+||++ ++.+.++|+|||.+........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 81 EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCCEEEeecccceeccCCCC---
Confidence 999999887643 358999999999999999999999999999999999999 4889999999999876543221
Q ss_pred ccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc----------
Q 021053 165 IPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV---------- 233 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~---------- 233 (318)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|++||......+.............
T Consensus 155 -----~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 155 -----YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred -----cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 123456788999998754 4578999999999999999999999976544332222211111000
Q ss_pred ------------cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 234 ------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 234 ------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...........+..+.++++.||..+|++||++.++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00011111122466888888888888888888776653
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=268.03 Aligned_cols=267 Identities=26% Similarity=0.311 Sum_probs=212.5
Q ss_pred CCccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHH--HcCCCCCCeeeecccc---C
Q 021053 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKI--LQGGSGIPNIKWYGVD---G 75 (318)
Q Consensus 1 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~--l~~~~~~~~i~~~~~~---~ 75 (318)
|+|.++++..+.+.||+|.||.||+|.+ .|+.||||++.+.++ ..+.+|.++++. |+|.+++-.|..--.+ -
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE-~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~ 281 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDE-RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW 281 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccch-hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence 4678899999999999999999999999 577899999988554 456677776655 5665544444222222 2
Q ss_pred cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceeeccCCCCCeEE
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--------GFLHRDIKPDNFLMGLGRKANQVY 146 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--------~i~H~dl~p~Nil~~~~~~~~~~k 146 (318)
.+.++|++|. .|||.|++.+ ..++.....+++..++.||.|||.. .|+|||||..|||+. .++.+-
T Consensus 282 TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK---kn~~C~ 356 (513)
T KOG2052|consen 282 TQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCC 356 (513)
T ss_pred EEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc---cCCcEE
Confidence 4689999998 9999999996 4589999999999999999999953 499999999999995 899999
Q ss_pred EEeccceeeecCCCCCccccccCCCCCcccccccccccccCCC----C--CCcchHHHHHHHHHHHHhC----------C
Q 021053 147 IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE----Q--SRRDDLESLGYVLLYFLRG----------S 210 (318)
Q Consensus 147 L~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~--~~~~DvwslG~il~~l~tg----------~ 210 (318)
|+|+|++............+ +...+||.+|||||++...- + -..+||||||.++||+.-+ +
T Consensus 357 IADLGLAv~h~~~t~~idi~---~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIP---PNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred EeeceeeEEecccCCcccCC---CCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 99999998877665544443 34678999999999987431 1 1358999999999998753 7
Q ss_pred CCccch--hHhhhHHHHHHHHHhhccCchHHHhhcCc--hhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 211 LPWQGL--KAATKKQKYDKICEKKVSTPIEVLCKSHP--AEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 211 ~pf~~~--~~~~~~~~~~~i~~~~~~~~~~~~~~~~~--~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
+||.+. ++....++.+-++..+..++++..|+..| ..+.++|+.||..||..|.++-.+.+.+.++.+
T Consensus 434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 898763 34455666666777788877777666555 568899999999999999999999999998863
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=266.48 Aligned_cols=201 Identities=26% Similarity=0.374 Sum_probs=164.5
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccC--cceEEEE
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDNVLVL 82 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~--~~~~lv~ 82 (318)
|++.+.||.|++|.||+|.+..+++.+++|.+.... ....+.+|+.++..+.| +++..+....... ...++|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccC-CCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999889999999877543 22357789999999986 4444444343444 7899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
+|+.++|.+++......+++..+..++.|++.||.+||+.|++|+||+|+||++ ++++.++|+|||.+.........
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 80 EYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred ccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---cCCCCEEEccccceeeccCCCcc
Confidence 999889999987654568999999999999999999999999999999999999 48899999999998876544321
Q ss_pred ccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~ 219 (318)
. .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..
T Consensus 157 ~------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~ 208 (287)
T cd07840 157 D------YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL 208 (287)
T ss_pred c------ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 0 1123457789999987654 5789999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=271.87 Aligned_cols=249 Identities=21% Similarity=0.303 Sum_probs=190.7
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccC-----
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG----- 75 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~----- 75 (318)
+.++|++.+.||.|+||.||+|.+..++..||+|.+..... ...+.+|+.+++.+.|++.+.....+....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 57899999999999999999999999999999998754322 235678999999998755444333332222
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..+++|+++++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++ ..+.++|+|||.+..
T Consensus 93 ~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~---~~~~~kl~dfg~~~~ 167 (343)
T cd07880 93 HDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQ 167 (343)
T ss_pred ceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeecccccc
Confidence 24689999999899888863 4589999999999999999999999999999999999994 788999999999875
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
..... ....++..|+|||.+.+ ..++.++|+||+||++|++++|.+||...+.... +..+......
T Consensus 168 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~---~~~~~~~~~~ 234 (343)
T cd07880 168 TDSEM----------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ---LMEIMKVTGT 234 (343)
T ss_pred cccCc----------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCC
Confidence 43221 13356788999998876 3578899999999999999999999986543222 1121111111
Q ss_pred Cc--------------------------hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 235 TP--------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 235 ~~--------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+ ........+..+.+++.+|+..+|++||++.++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11 11122355677889999999999999999887663
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=275.28 Aligned_cols=247 Identities=22% Similarity=0.317 Sum_probs=190.8
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccC-----
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG----- 75 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~----- 75 (318)
+.++|++.+.||.|++|.||+|.+..+++.||+|++.... ....+.+|+.+++.+.|+ ++..+..+....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE-NVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCC-CHHHHHHHhhccccccc
Confidence 6789999999999999999999999999999999876432 123466799999998764 444443332222
Q ss_pred -cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 76 -EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 76 -~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
...++|+++++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++ .++.++|+|||.+.
T Consensus 92 ~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~---~~~~~kL~dfg~~~ 166 (343)
T cd07851 92 FQDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCELKILDFGLAR 166 (343)
T ss_pred cccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEC---CCCCEEEccccccc
Confidence 34899999999999999874 4589999999999999999999999999999999999994 78999999999987
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
...... ....++..|+|||.+.+ ..++.++|||||||++|++++|..||...+..... ..+....
T Consensus 167 ~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~---~~i~~~~- 232 (343)
T cd07851 167 HTDDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL---KRIMNLV- 232 (343)
T ss_pred cccccc----------cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHhc-
Confidence 653321 23356788999998765 35788999999999999999999999765443222 2222211
Q ss_pred cCchH---------------------------HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 234 STPIE---------------------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 234 ~~~~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+.+ ......+..+.+++.+||..+|++||++.++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 11111 111234677889999999999999999888765
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=268.28 Aligned_cols=251 Identities=23% Similarity=0.322 Sum_probs=200.9
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
..+.|++.+.||.|++|.||+|.+..++..+++|++..... ...+.+|+..+..++| +++..+...+......++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKH-PNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCC-CCeeEEEEEEEECCEEEEEEe
Confidence 35779999999999999999999998899999998876543 4567889999999976 566666666666688999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
++ +++|.+++......++...+..++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||.+.........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE---cCCCCEEECccchhhhhccchhh
Confidence 99 699999998754368999999999999999999999999999999999999 47889999999987654332211
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
.....++..|++||++.+..++.++|+|||||++|+|++|..||...++.... ..+..... .+ .....
T Consensus 173 -------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~---~~~~~~~~-~~-~~~~~ 240 (286)
T cd06614 173 -------RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL---FLITTKGI-PP-LKNPE 240 (286)
T ss_pred -------hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhcCC-CC-Ccchh
Confidence 12334677899999998888999999999999999999999999875543221 22211111 11 11123
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.++..+.+++.+||+.+|.+||++.++.+
T Consensus 241 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 241 KWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 47889999999999999999999998865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=272.10 Aligned_cols=249 Identities=21% Similarity=0.288 Sum_probs=186.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccc-----cC
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV-----DG 75 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~-----~~ 75 (318)
+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.++.+++|++.+.....+.. ..
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 56899999999999999999999998999999998764321 2356789999999987544433333221 22
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
...++++++++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+||++ +.++.++|+|||.+..
T Consensus 95 ~~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~~~ 169 (345)
T cd07877 95 NDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH 169 (345)
T ss_pred ccEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE---cCCCCEEEeccccccc
Confidence 35789999999999888764 358999999999999999999999999999999999999 4788999999999875
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
..... ....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||...+...... .+......
T Consensus 170 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~ 236 (345)
T cd07877 170 TDDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRLVGT 236 (345)
T ss_pred ccccc----------cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCC
Confidence 43221 23356788999998876 458889999999999999999999997654332222 21111111
Q ss_pred Cch--------------------------HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 235 TPI--------------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 235 ~~~--------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+. .......+..+.+++..|+..+|.+||++.++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 111 1111124556778888888888888888776554
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=266.13 Aligned_cols=253 Identities=28% Similarity=0.399 Sum_probs=201.2
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||.|++|.||+|.+..+++.|++|++.... ......+|..++.++..|+++..+...+......+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999876422 2245678888999887467777776666777789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||++ +++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||+++ .++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~---~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC---CCCCEEecCCccccccCCcc
Confidence 9999 99999999863 3599999999999999999999999999999999999994 78899999999987654433
Q ss_pred CCccc-------------cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHH
Q 021053 161 TNRHI-------------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (318)
Q Consensus 161 ~~~~~-------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (318)
..... .........++..|+|||...+..++.++|+||||++++++++|..||...+.. ..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~ 233 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY---LTFQK 233 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHH
Confidence 21000 011223446788899999998888999999999999999999999999865432 22223
Q ss_pred HHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCCh----HHHHH
Q 021053 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY----GFLKR 271 (318)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~----~~l~~ 271 (318)
+.......| ..+++.+.+++.+||+.+|++||++ +++.+
T Consensus 234 ~~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 ILKLEYSFP-----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHhcCCCCC-----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 222222222 3557889999999999999999999 66543
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=271.69 Aligned_cols=250 Identities=21% Similarity=0.292 Sum_probs=188.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccc------c
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV------D 74 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~------~ 74 (318)
+.++|.+.+.||.|+||.||+|.+..+++.||+|.+..... ...+.+|+.++..+.|++ +..+..++. .
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~ 91 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHEN-VIGLLDVFTSAVSGDE 91 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCC-ccchhheecccccCCC
Confidence 46899999999999999999999998999999998764321 235678999999997754 444433322 2
Q ss_pred CcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
...+++|++++..+|.... +..++...+..++.|++.||.|||+.|++||||+|+||++ +.++.++|+|||.+.
T Consensus 92 ~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~ 165 (342)
T cd07879 92 FQDFYLVMPYMQTDLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV---NEDCELKILDFGLAR 165 (342)
T ss_pred CceEEEEecccccCHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCCCCc
Confidence 2357999999987777665 3358899999999999999999999999999999999999 488999999999986
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHH---
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE--- 230 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~--- 230 (318)
...... ....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+.......+....+
T Consensus 166 ~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 166 HADAEM----------TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235 (342)
T ss_pred CCCCCC----------CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 542211 23356788999999876 4588999999999999999999999987543322221111100
Q ss_pred -----------------hh---ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 231 -----------------KK---VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 231 -----------------~~---~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.. ............+..+.+++.+||..+|++||++.++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 000011112245677899999999999999999998875
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=268.90 Aligned_cols=244 Identities=24% Similarity=0.340 Sum_probs=193.4
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
+.|...+.||.|+||.||+|.+..++..|++|.+..... ...+.+|+.+++.++| +++..+..+.......+++
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv 99 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKH-PNTIEYKGCYLKEHTAWLV 99 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCC-CCCccEEEEEEeCCEEEEE
Confidence 457778899999999999999998999999998764322 1356788999999976 5566666666667789999
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
+|++.+++.+++......+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+.....
T Consensus 100 ~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 100 MEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL---TEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE---CCCCCEEEeecCCCcccCC---
Confidence 9999889998887656678999999999999999999999999999999999999 4788999999998754321
Q ss_pred CccccccCCCCCccccccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
.....++..|+|||++. ...++.++|||||||++|+|++|..||...+..... ..+.... ++.
T Consensus 174 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~~~~~~~---~~~ 239 (313)
T cd06633 174 --------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQND---SPT 239 (313)
T ss_pred --------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhcC---CCC
Confidence 12345778899999974 345788999999999999999999999775443222 2222111 111
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.....++..+.+++.+||..+|.+||++.++..
T Consensus 240 ~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 240 LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 112356778999999999999999999997775
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=264.63 Aligned_cols=237 Identities=15% Similarity=0.199 Sum_probs=177.9
Q ss_pred eeeccCcccEEEEEEEcC------------CCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 13 RKIGSGSFGEIFLASHVD------------TNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~------------~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+.||.|+||.||+|.... ....|++|++..... ...+.+|+.++..+.| +++..+..+.......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~h-p~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSH-KHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCCC
Confidence 468999999999998532 223588887665432 2356677888888876 5566666555666778
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCC-------eEEEEec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-------QVYIIDF 150 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~-------~~kL~df 150 (318)
++++|++ +++|..++......+++..+..++.||+.||.|||++||+||||||+||++. ..+ .++++||
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~---~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLA---REGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEe---cCCccCCCCceeEeCCC
Confidence 9999999 6788777765455689999999999999999999999999999999999995 333 3899999
Q ss_pred cceeeecCCCCCccccccCCCCCccccccccccccc-CCCCCCcchHHHHHHHHHHHH-hCCCCccchhHhhhHHHHHHH
Q 021053 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKI 228 (318)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~-tg~~pf~~~~~~~~~~~~~~i 228 (318)
|.+...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||.......... .
T Consensus 157 g~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~----~ 221 (262)
T cd05077 157 GIPITVLSR-----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER----F 221 (262)
T ss_pred CCCccccCc-----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH----H
Confidence 987644221 2235677899999887 456899999999999999998 5899987644322111 1
Q ss_pred HHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
....... ....+.++.+++.+||..+|++||++.++.+.+
T Consensus 222 ~~~~~~~-----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 222 YEGQCML-----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HhcCccC-----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1111111 112346799999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=269.14 Aligned_cols=248 Identities=20% Similarity=0.283 Sum_probs=193.9
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
..++|+..+.||.|++|.||+|.+..++..+++|.+..... ...+.+|+.+++.+.|+ ++..+..+.......+
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP-NTIQYRGCYLREHTAW 91 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCC-CcccEEEEEEcCCeeE
Confidence 44678889999999999999999998999999997753221 23567899999999764 4445545555567899
Q ss_pred EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 80 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
+|+|++.+++.+.+......++...+..++.|++.||.|||+++++|+||+|+||+++ ..+.++|+|||.+......
T Consensus 92 lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~---~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEEC---CCCcEEECCcccceeecCc
Confidence 9999998899888776566689999999999999999999999999999999999994 7889999999998754322
Q ss_pred CCCccccccCCCCCccccccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
....++..|+|||.+. ...++.++|||||||++|+|++|..||...+..... ..+.....+..
T Consensus 169 -----------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~~~~~~~~ 234 (308)
T cd06634 169 -----------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---YHIAQNESPAL 234 (308)
T ss_pred -----------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH---HHHhhcCCCCc
Confidence 1235678899999875 345788999999999999999999999765433212 22221111111
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
....++..+.+++.+||..+|++||++.++.+..
T Consensus 235 ---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 235 ---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred ---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 1235677899999999999999999999877653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=261.58 Aligned_cols=246 Identities=24% Similarity=0.328 Sum_probs=197.8
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+|++.+.||.|++|.||+|.+..++..|++|++..... ...+.+|++++..++| +++..+..........++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNH-PNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCC-CChhheEEEEecCCEEEEEEE
Confidence 68999999999999999999998899999998765432 3457789999999986 455555544555678999999
Q ss_pred cc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 84 LL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
++ +++|.+.+.... ..++...+..++.+++.||.+||+.|++|+||+|+||+++ ..+.++|+|||.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~---~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT---SNGLVKLGDFGISKVLSST 156 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc---CCCcEEECCccceeecccC
Confidence 99 679999988642 5689999999999999999999999999999999999994 7899999999998765443
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. ......+++.|+|||...+..++.++|+||+|+++|+|++|..||...+.. ........... .+
T Consensus 157 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~~~~-~~--- 222 (258)
T cd08215 157 VD-------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELALKILKGQY-PP--- 222 (258)
T ss_pred cc-------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHHHHhcCCC-CC---
Confidence 21 112346788899999998888999999999999999999999999765432 22222222111 11
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
....++..+.+++.+||..+|++||++.++.+
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 22356789999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=261.65 Aligned_cols=249 Identities=19% Similarity=0.261 Sum_probs=180.5
Q ss_pred eeeccCcccEEEEEEEcCC--CcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 13 RKIGSGSFGEIFLASHVDT--NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~--~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
+.||+|+||.||+|....+ ...+++|.+..... ...+.+|+.++..++| +++..+...+......++||||+ +
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQH-PNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCC-cchhheEEEecCCCccEEEEecCCC
Confidence 3699999999999975433 34567776654332 2467888888888876 55555554555667899999999 7
Q ss_pred CCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 87 PSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 87 ~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
++|.+++.... ...+...+..++.||+.||.|||+.+++|+||||+||++ +.++.++|+|||.+.........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~- 155 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYI- 155 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE---cCCccEEecccccccccCcchhh-
Confidence 89999987532 235667788899999999999999999999999999999 48899999999987542211110
Q ss_pred cccccCCCCCcccccccccccccC-------CCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHH-hhcc
Q 021053 164 HIPYRENKNLTGTARYASCNTHLG-------IEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICE-KKVS 234 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~-~~~~ 234 (318)
.......++..|+|||++.. ..++.++|||||||++|+|++ |..||...++.... ..+.. ....
T Consensus 156 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~---~~~~~~~~~~ 228 (268)
T cd05086 156 ----ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL---NHVIKDQQVK 228 (268)
T ss_pred ----hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHhhcccc
Confidence 01123456788999998753 235789999999999999997 67888765443222 22221 1222
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
.+.+.....+++.+.+++..|| .+|++||+++++.+.|.
T Consensus 229 ~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 229 LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222333456788999999999 68999999999988764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=259.65 Aligned_cols=247 Identities=24% Similarity=0.404 Sum_probs=198.2
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
.|++.+.||.|++|.||+|.+..++..+++|++.... ....+.+|+..+..+.| +++..+...+......++++|++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKH-PNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCCeEEEEEecC
Confidence 4889999999999999999999889999999887655 34578889999999885 55556655556667899999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 86 -~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
+++|.+++......+++..+..++.|++.||.+||++|++|+||+|+||+++ +.+.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~--- 153 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTKA--- 153 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEc---cCCeEEEeecccccccccccc---
Confidence 6999999887545689999999999999999999999999999999999994 789999999999876543321
Q ss_pred ccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcC
Q 021053 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (318)
.....++..|++||.+.+..++.++|+||||+++|+|++|..||...+.......... ...+.......+
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 223 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-----NGPPGLRNPEKW 223 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-----cCCCCcCccccc
Confidence 1234678889999999888889999999999999999999999987543322222111 111111111234
Q ss_pred chhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 245 PAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 245 ~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+..+.+++..||..+|++||++.++.+
T Consensus 224 ~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 224 SDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 778999999999999999999998764
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=265.94 Aligned_cols=247 Identities=21% Similarity=0.294 Sum_probs=194.6
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
.+|...+.||.|++|.||+|.+..+++.+++|.+.... ....+.+|+.++..+.| +++..+..++......++++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h-~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH-PNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCC-CChheEEEEEEcCCeEEEEEec
Confidence 36677789999999999999998889999999875432 22356788899998876 5565665555667789999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+ +++|.+++.. ..++...+..++.|++.||.+||++|++||||+|+||++ +.++.++|+|||.+.........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~~- 171 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPR- 171 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE---cCCCcEEEcccccchhhccCCcc-
Confidence 9 8899998875 458999999999999999999999999999999999999 48899999999987654332211
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhc
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (318)
.....++..|+|||.+.+..++.++|+|||||++|+|++|..||...++.. .+..+... ..+.......
T Consensus 172 ------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~---~~~~~~~~--~~~~~~~~~~ 240 (285)
T cd06648 172 ------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ---AMKRIRDN--LPPKLKNLHK 240 (285)
T ss_pred ------cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH---HHHHHHhc--CCCCCccccc
Confidence 123457889999999988889999999999999999999999997654322 22222221 1111111223
Q ss_pred CchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 244 HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 244 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+..+.+++.+||..+|++||++.++.+
T Consensus 241 ~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 241 VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 6788999999999999999999987775
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=267.58 Aligned_cols=136 Identities=27% Similarity=0.528 Sum_probs=116.3
Q ss_pred Ccccc-ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-CChhHHHHHHHHHHHcCCC-------CCCeee---
Q 021053 2 ERIIG-VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGS-------GIPNIK--- 69 (318)
Q Consensus 2 ~~~~~-~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~-------~~~~i~--- 69 (318)
++.+. +||.+.++||+|.|++||+|+|....+.||+|+.++.. ..+....|+++|++++.+. +++.+.
T Consensus 72 GD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 72 GDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred cccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 34555 99999999999999999999999999999999988754 4567889999999997654 233332
Q ss_pred -eccccCcceEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeec
Q 021053 70 -WYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMG 137 (318)
Q Consensus 70 -~~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~Nil~~ 137 (318)
.-+.++.++|+|+|+++-+|..++.+.. ++++...++.|++||+.||.|||.+ ||||.||||+|||+.
T Consensus 152 khsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred eecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 3355778999999999999999998764 3599999999999999999999965 999999999999997
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=261.97 Aligned_cols=249 Identities=24% Similarity=0.332 Sum_probs=191.8
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-------CChhHHHHHHHHHHHcCCCCCCeeeeccc--cCcc
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSGIPNIKWYGV--DGED 77 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~i~~~~~--~~~~ 77 (318)
.+|++.+.||.|++|.||+|.+..++..|++|.+.... ....+.+|+.+++.++|.+ +..+..+.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~-i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDR-IVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCC-cceEEEEEEcCCCCE
Confidence 57999999999999999999999999999999764221 1125677999999998754 444443333 2356
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++++|++ +++|.+++... ..+++.....++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+...
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR---DSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE---cCCCCEEECcccccccc
Confidence 88999999 78999988763 448899999999999999999999999999999999999 47889999999998765
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
........ ......++..|+|||++.+..++.++|+|||||++|++++|+.||...... ..+..+ .....
T Consensus 157 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~---~~~~~ 226 (264)
T cd06653 157 QTICMSGT----GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---AAIFKI---ATQPT 226 (264)
T ss_pred ccccccCc----cccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---HHHHHH---HcCCC
Confidence 43211100 112345788899999999888899999999999999999999999764332 222222 11222
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+..+..+++.+.+++.+||. +|.+||++.++..
T Consensus 227 ~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 227 KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 233345677889999999999 5799999987654
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=263.54 Aligned_cols=240 Identities=24% Similarity=0.285 Sum_probs=181.7
Q ss_pred eeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-----hhHHHHHHHHHHHc--CCCCCCeeeeccccCcceEEEEecc-
Q 021053 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVLDLL- 85 (318)
Q Consensus 14 ~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~--~~~~~~~i~~~~~~~~~~~lv~e~~- 85 (318)
.||+|+||.||+|.+..+++.||+|.+...... .....|..++..++ +++++..+..++......++|+||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999999989999999977543211 12344444444443 3455656666666777899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccc
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~ 165 (318)
+++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||.+........
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili---~~~~~~kl~dfg~~~~~~~~~~---- 152 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSKKKP---- 152 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE---CCCCCEEEccCcCccccCccCC----
Confidence 8889888765 4468999999999999999999999999999999999999 4788999999999865432211
Q ss_pred cccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcC
Q 021053 166 PYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (318)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (318)
....++..|+|||++.+. .++.++|+||+||++|+|++|..||................. ....++...
T Consensus 153 -----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 222 (278)
T cd05606 153 -----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-----MAVELPDSF 222 (278)
T ss_pred -----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc-----cCCCCCCcC
Confidence 234678899999998754 589999999999999999999999976532221211111111 111223356
Q ss_pred chhHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 245 PAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 245 ~~~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
+..+.+++.+||..+|.+|| ++.++.+
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 78999999999999999999 7777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=262.66 Aligned_cols=252 Identities=19% Similarity=0.319 Sum_probs=189.4
Q ss_pred eeEeeeeccCcccEEEEEEEc---CCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeecccc---C---
Q 021053 9 YKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD---G--- 75 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~---~--- 75 (318)
|++.+.||+|+||.||+|.+. .+++.||+|++..... ...+.+|+.+++.+.| +++..+..++.. .
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH-PNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCC-CCcceEEEEEccCCCCCcc
Confidence 678899999999999999865 3568899998765432 2356789999999976 455555443321 1
Q ss_pred cceEEEEecc-CCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEe
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~d 149 (318)
...+++++++ +++|.+++.... ..++...+..++.|++.||.|||++|++||||||+||+++ .++.+||+|
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~---~~~~~kl~d 156 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN---ENMTVCVAD 156 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEc---CCCCEEECc
Confidence 1347888888 788888765321 1368889999999999999999999999999999999994 788999999
Q ss_pred ccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHH
Q 021053 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKI 228 (318)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i 228 (318)
||++.......... ......++..|++||.+.+..++.++|||||||++|+|++ |.+||...+... ....+
T Consensus 157 fg~~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~ 228 (273)
T cd05074 157 FGLSKKIYSGDYYR-----QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYL 228 (273)
T ss_pred ccccccccCCccee-----cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHH
Confidence 99987653322110 1122344567999999988889999999999999999999 999998754432 12222
Q ss_pred HHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
.... ..+ .....+..+.+++.+||..+|++||++.++.+.|+++
T Consensus 229 ~~~~-~~~---~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 229 IKGN-RLK---QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HcCC-cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 111 1124567899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=263.34 Aligned_cols=252 Identities=21% Similarity=0.242 Sum_probs=191.6
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
|++.+.||.|++|.||+|.+..+++.|++|++.... ....+..|+.+++.+.| +++..+..+.......++|+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~-~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKH-PNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCC-CCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999877542 23456789999998875 5555665555566789999999
Q ss_pred cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 85 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
+.++|.+++......+++..+..++.|++.||.+||+.|++|+||+|+||++ ++++.++|+|||.+........
T Consensus 80 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~--- 153 (282)
T cd07829 80 CDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLR--- 153 (282)
T ss_pred cCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE---cCCCCEEEecCCcccccCCCcc---
Confidence 9889999998754568999999999999999999999999999999999999 4789999999999876543221
Q ss_pred ccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh-----------
Q 021053 165 IPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK----------- 232 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~----------- 232 (318)
.......+..|+|||.+.+. .++.++|||||||++|++++|.+||...........+.......
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 ----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred ----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence 11223456779999998776 68899999999999999999999997755432222222111000
Q ss_pred ----------ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 233 ----------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 233 ----------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+........+..+.+++.+||..+|++||++.++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000011111233567888888888888888888877654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=264.14 Aligned_cols=237 Identities=22% Similarity=0.290 Sum_probs=184.3
Q ss_pred eccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCC
Q 021053 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (318)
Q Consensus 15 lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~ 88 (318)
||.|+||+||+|.+..+++.|++|.+.... ....+..|+.++..++| +++..+...+......|+|+||+ +++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSS-RFIVSLAYAFETKDDLCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCC-CCEeeeeeEEecCCeEEEEEecCCCCc
Confidence 689999999999999899999999875422 12345679999999975 66666665556667899999999 789
Q ss_pred HHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccccc
Q 021053 89 LEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (318)
Q Consensus 89 L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 167 (318)
|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~------ 150 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKK------ 150 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCc------
Confidence 999887643 258999999999999999999999999999999999999 4888999999998865432111
Q ss_pred cCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchh
Q 021053 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (318)
Q Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (318)
.....++..|++||.+.+..++.++|+||+||++|+|++|+.||...........+.. .....+ ......+++.
T Consensus 151 --~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~-~~~~~~~~~~ 224 (277)
T cd05577 151 --IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR---RTLEMA-VEYPDKFSPE 224 (277)
T ss_pred --cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh---cccccc-ccCCccCCHH
Confidence 1234567789999999888899999999999999999999999976543221222111 111111 1123456889
Q ss_pred HHHHHHHHhhcCCCCCCChH
Q 021053 248 FASYFHYCQSLTFDQRPDYG 267 (318)
Q Consensus 248 ~~~li~~cl~~~p~~Rp~~~ 267 (318)
+.+++.+||..+|++||++.
T Consensus 225 ~~~li~~~l~~~p~~R~~~~ 244 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCR 244 (277)
T ss_pred HHHHHHHHccCChhHccCCC
Confidence 99999999999999999433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=262.31 Aligned_cols=241 Identities=21% Similarity=0.322 Sum_probs=201.9
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+.-++|+.++.||.|.||+|-+++.+.+++.+|+|++++.. .....+.|-.+|+..+| +.+..+.+.++.....
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~H-PFLt~LKYsFQt~drl 243 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRH-PFLTSLKYSFQTQDRL 243 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccC-cHHHHhhhhhccCceE
Confidence 34467899999999999999999999999999999877543 23356677788887766 5555667778888899
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+||||. +|.|.-.+++ .+.+++...+.+-..|+.||.|||+++|+.||||.+|.++ |.+|.+|+.|||+|+..-
T Consensus 244 CFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL---DKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee---ccCCceEeeecccchhcc
Confidence 9999999 8888777776 4459999999999999999999999999999999999999 799999999999997643
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
.... ....+.||+.|+|||++....|+.++|+|.+||++|||+.|+.||...+. ...+.-|.-..+..|
T Consensus 320 ~~g~-------t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~ed~kFP- 388 (516)
T KOG0690|consen 320 KYGD-------TTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILMEDLKFP- 388 (516)
T ss_pred cccc-------eeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHhhhccCC-
Confidence 3332 23567999999999999999999999999999999999999999986443 445555544444444
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCC
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRP 264 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp 264 (318)
..++++.+.|+.-.|.+||.+|.
T Consensus 389 ----r~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 389 ----RTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ----ccCCHHHHHHHHHHhhcChHhhc
Confidence 46688999999999999999995
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=265.00 Aligned_cols=253 Identities=21% Similarity=0.328 Sum_probs=196.2
Q ss_pred eeeEeeeeccCcccEEEEEEEc---CCCcEEEEEeecCCC------CChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 8 KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~---~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+|++.+.||.|++|.||+|.+. .++..||+|++.... ....+.+|+.++..+.+|+++..+...+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 456789999876322 1235678999999998888888887777777789
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
++|+||+ +++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE---CCCCCEEEEECccccccc
Confidence 9999999 7899888875 3458899999999999999999999999999999999999 478899999999987644
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCC--CCCcchHHHHHHHHHHHHhCCCCccchhHhhh-HHHHHHHHHhhcc
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-KQKYDKICEKKVS 234 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~-~~~~~~i~~~~~~ 234 (318)
..... ......++..|+|||.+.+.. .+.++|+||||+++|+|++|..||........ ......+.....
T Consensus 157 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~- 229 (288)
T cd05583 157 AEEEE------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP- 229 (288)
T ss_pred ccccc------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC-
Confidence 33211 112345788899999987665 67899999999999999999999964322111 111122222111
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
+ ....++..+.+++.+||..+|++||++.++...++.
T Consensus 230 -~---~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 230 -P---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -C---CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 1 123467789999999999999999998877776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=263.43 Aligned_cols=243 Identities=21% Similarity=0.345 Sum_probs=190.0
Q ss_pred eeeEeeeeccCcccEEEEEEEc---CCCcEEEEEeecCCC------CChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 8 KYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~---~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
.|++.+.||.|+||.||+|.+. .++..||+|++.... ....+.+|+.++..+.+|+++..+..++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999875 478899999876432 1235677999999998888888887777777789
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
++|+|++ +++|.+++.. ...++...+..++.|++.||.|||+.|++||||+|+||++ +.++.++|+|||.+....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE---CCCCCEEEeeCccceecc
Confidence 9999999 7899998876 3458899999999999999999999999999999999999 478999999999987654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCC--CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHH-HHHHHHHhhcc
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ-KYDKICEKKVS 234 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~-~~~~i~~~~~~ 234 (318)
..... ......++..|+|||.+.+. .++.++||||||+++|+|++|..||...+...... ....+....
T Consensus 157 ~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-- 228 (290)
T cd05613 157 EDEVE------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-- 228 (290)
T ss_pred ccccc------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC--
Confidence 32211 11234578889999998753 36789999999999999999999996432221111 122221111
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCC
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~ 265 (318)
.+ ....++..+.+++.+||..+|++||+
T Consensus 229 ~~---~~~~~~~~~~~ll~~~l~~~p~~R~~ 256 (290)
T cd05613 229 PP---YPQEMSALAKDIIQRLLMKDPKKRLG 256 (290)
T ss_pred CC---CCccCCHHHHHHHHHHhcCCHHHhcC
Confidence 11 12356778999999999999999973
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=274.46 Aligned_cols=264 Identities=18% Similarity=0.258 Sum_probs=208.5
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
++-..+..++++||+|-||.|.+|.-.. +..||+|.++.... ..++.+|+++|.+++|++.+..+..| ...+..+
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC-~~DePic 611 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVC-VQDDPLC 611 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeee-ecCCchH
Confidence 4556778899999999999999998643 68999999886543 34799999999999775544444454 4445799
Q ss_pred EEEecc-CCCHHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~-~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
+++||+ .|+|.+|+.....+. +-.....++.||+.|++||.+.+++||||.++|+|+ |..+.+|++|||.++.+-
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLY 688 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee---cCcccEEecCcccccccc
Confidence 999999 999999998753332 444556799999999999999999999999999999 699999999999998655
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh--CCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR--GSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t--g~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
+... ++......-..+|+|+|.+....++.++|+|+||+++||+++ ...||....++...+..........+.
T Consensus 689 sg~y-----y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~ 763 (807)
T KOG1094|consen 689 SGDY-----YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQ 763 (807)
T ss_pred cCCc-----eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcc
Confidence 4333 233445566789999999999999999999999999999988 899998877654444443333322222
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
.....+.-+|..+.+++..||..+..+||+++++...|.+.
T Consensus 764 ~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 764 VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 22223456789999999999999999999999999888764
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=264.21 Aligned_cols=239 Identities=17% Similarity=0.240 Sum_probs=178.8
Q ss_pred eeccCcccEEEEEEEcC------------------------CCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCe
Q 021053 14 KIGSGSFGEIFLASHVD------------------------TNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPN 67 (318)
Q Consensus 14 ~lg~G~~~~v~~~~~~~------------------------~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~ 67 (318)
.||+|+||.||+|.... ....|++|++..... ...+.+|+.++..+.| +++..
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h-~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSH-IHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCC-CCeee
Confidence 58999999999997532 123588887754332 2246667777877766 66667
Q ss_pred eeeccccCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccC----CCC
Q 021053 68 IKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG----RKA 142 (318)
Q Consensus 68 i~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~----~~~ 142 (318)
+..+.......++||||+ +++|..++......+++..+..++.|++.||.|||++||+||||||+||+++.. ...
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~ 160 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS 160 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence 766667777899999999 788888887655668999999999999999999999999999999999999521 123
Q ss_pred CeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHH-hCCCCccchhHhh
Q 021053 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAAT 220 (318)
Q Consensus 143 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~-tg~~pf~~~~~~~ 220 (318)
..++++|||.+...... ....++..|+|||.+.+ ..++.++|||||||++|+++ +|..||....+..
T Consensus 161 ~~~kl~d~g~~~~~~~~-----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 161 PFIKLSDPGVSFTALSR-----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ceeeecCCccccccccc-----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 35899999987543211 12245677999998875 45899999999999999995 6999998754432
Q ss_pred hHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
... ........| ...+..+.+++.+||..+|++||++.++.+.|
T Consensus 230 ~~~----~~~~~~~~~-----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KER----FYEKKHRLP-----EPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHH----HHHhccCCC-----CCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 221 122222222 12345799999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=253.47 Aligned_cols=249 Identities=21% Similarity=0.348 Sum_probs=197.9
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
..+.+.-||+|+.|.||+++.+.+|...|||.+...... .+++.++.++..-...+.|+....|+.....+++.||.
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel 172 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL 172 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence 345677899999999999999999999999987654433 34566666665444345566667777777789999999
Q ss_pred cCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
|...+..++.+..+++++..+-++...++.||.||..+ ||+|||+||+|||+ |..|.+||+|||.+-.+....
T Consensus 173 Ms~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSk--- 246 (391)
T KOG0983|consen 173 MSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSK--- 246 (391)
T ss_pred HHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE---ccCCCEEeecccccceeeccc---
Confidence 99888888888888899999999999999999999976 89999999999999 799999999999987664332
Q ss_pred cccccCCCCCcccccccccccccCC---CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
......|-+.|||||.+... .|+..+||||||++++|+.||+.||.+.+.+ .+.+-++.+. .+ |.-..
T Consensus 247 -----AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvln~-eP-P~L~~ 317 (391)
T KOG0983|consen 247 -----AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVLNE-EP-PLLPG 317 (391)
T ss_pred -----ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHHhc-CC-CCCCc
Confidence 23456788899999998744 4889999999999999999999999985432 3444455441 11 21111
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+++.+.+++..||.+|+.+||...++.+
T Consensus 318 ~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2348999999999999999999999887655
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=256.85 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=197.1
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+|++.+.||.|++|.||+|.+..+++.|++|.+..... ...+.+|++++.++.| +++..+..+.......+++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH-PNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCC-CCccEEEEEEEeCCEEEEEEe
Confidence 58999999999999999999998899999998766543 2467889999999976 455566555566678999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
++ +++|.+++... ..+++..+..++.|++.||.+||++|++|+||+|+||+++ ..+.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 80 YAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTT---KDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred cCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEC---CCCCEEEeccccceecCCCccc
Confidence 99 77999988764 5689999999999999999999999999999999999995 6889999999998876543221
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
.....++..|+|||...+..++.++|+||+|+++|+|++|..||...++.... ....... . .....
T Consensus 156 -------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~-~---~~~~~ 221 (254)
T cd06627 156 -------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL---FRIVQDD-H---PPLPE 221 (254)
T ss_pred -------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH---HHHhccC-C---CCCCC
Confidence 12346788899999988877899999999999999999999999765432211 1211111 1 11234
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+..+.+++.+||..+|++||++.++..
T Consensus 222 ~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 222 GISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 56788999999999999999999987754
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=259.94 Aligned_cols=240 Identities=20% Similarity=0.262 Sum_probs=188.4
Q ss_pred eccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCC
Q 021053 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (318)
Q Consensus 15 lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~ 88 (318)
||.|++|.||+|.+..+++.|++|++..... ...+.+|+.+++.+.| +++..+..........++++|++ +++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNH-PFIVKLYRTFKDKKYIYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCC-CCEeeeeeeEEcCCccEEEEecCCCCc
Confidence 6899999999999998899999998764332 2357889999999976 55555555556777899999998 889
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccccc
Q 021053 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (318)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 168 (318)
|.+++... ..++...+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 80 L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~------- 148 (262)
T cd05572 80 LWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQK------- 148 (262)
T ss_pred HHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccc-------
Confidence 99998763 458899999999999999999999999999999999999 4789999999999876543321
Q ss_pred CCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhH
Q 021053 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF 248 (318)
Q Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (318)
.....++..|++||.+.+..++.++|+||+|+++|++++|..||..... +....+..+......... ....+..+
T Consensus 149 -~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~~~~ 223 (262)
T cd05572 149 -TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGKLEF---PNYIDKAA 223 (262)
T ss_pred -cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCCCCC---CcccCHHH
Confidence 1233567889999999888899999999999999999999999976542 112233333311111111 12347789
Q ss_pred HHHHHHHhhcCCCCCCC-----hHHHHH
Q 021053 249 ASYFHYCQSLTFDQRPD-----YGFLKR 271 (318)
Q Consensus 249 ~~li~~cl~~~p~~Rp~-----~~~l~~ 271 (318)
.+++.+||..+|++||+ +.++.+
T Consensus 224 ~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 224 KDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 99999999999999999 565554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=268.64 Aligned_cols=252 Identities=17% Similarity=0.194 Sum_probs=181.8
Q ss_pred eeeccC--cccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-
Q 021053 13 RKIGSG--SFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (318)
Q Consensus 13 ~~lg~G--~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~- 85 (318)
..||.| +||+||+|++..+++.||+|+....... ..+.+|+.+++.++| +++..+..++......++++|++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h-~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRH-PNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCcceEeeeEecCCceEEEEeccc
Confidence 456666 9999999999999999999987654322 345677777777766 66767766777778899999999
Q ss_pred CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 86 GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 86 ~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
++++.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++. ..+.++++||+.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~---~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILIS---GDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEe---CCCcEEEechHHHhhhhccCcccc
Confidence 789998887532 3488999999999999999999999999999999999994 788999999976543322111111
Q ss_pred ccccCCCCCcccccccccccccCC--CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc------
Q 021053 165 IPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP------ 236 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~------ 236 (318)
..+.......++..|+|||++.+. .++.++||||+||++|+|++|.+||....... .+..........|
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ---MLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH---HHHHHhcCCCCCCcccccc
Confidence 111111223445679999998764 47899999999999999999999997654321 1111110000000
Q ss_pred ------------------------------------hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 ------------------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ------------------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.......++..+.+++.+||..+|++|||+.++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00011234567889999999999999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=279.50 Aligned_cols=246 Identities=21% Similarity=0.315 Sum_probs=199.2
Q ss_pred cee-eEeeeeccCcccEEEEEEEcCCCcEEEEE------eecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccc-cCcce
Q 021053 7 VKY-KLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-DGEDN 78 (318)
Q Consensus 7 ~~y-~~~~~lg~G~~~~v~~~~~~~~~~~vaiK------~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~-~~~~~ 78 (318)
+|| +....||+|+|-+||+|.|..+|..||-- +.+.....+++..|+++|+.|+|++++.....+.. .....
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 445 66788999999999999999999888833 23344445789999999999998555544433332 33457
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
.+|+|.+ .|+|..++.+.+ .++...++.|++||+.||.|||++. |+|||||.+|||++ ...|.+||+|+|+|..
T Consensus 119 n~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl 195 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATL 195 (632)
T ss_pred eeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc--CCcCceeecchhHHHH
Confidence 8999999 999999998844 4899999999999999999999996 99999999999997 6889999999999988
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
...... ...+|||.|||||+.. ..|+..+||||||+++.||+|+..||...... .+.+.++.....+
T Consensus 196 ~r~s~a---------ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~--AQIYKKV~SGiKP- 262 (632)
T KOG0584|consen 196 LRKSHA---------KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP--AQIYKKVTSGIKP- 262 (632)
T ss_pred hhcccc---------ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH--HHHHHHHHcCCCH-
Confidence 765544 3469999999999988 78999999999999999999999999765433 4556665544333
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+.+--.+.++++|..|+.. .++||++.+|.+
T Consensus 263 --~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 263 --AALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred --HHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 333334467899999999998 999999998766
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=275.24 Aligned_cols=214 Identities=21% Similarity=0.272 Sum_probs=181.7
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-hhHHHHHHHHHHHcCC-----CCCCeeeeccccC
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGG-----SGIPNIKWYGVDG 75 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~~~-----~~~~~i~~~~~~~ 75 (318)
.+++.++|.+....|.|-|+.|.+|.|...++.||||++.+.... ..-++|+++|++|... .|+..+...+...
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 578999999999999999999999999988999999998876543 3568899999999743 2344444455677
Q ss_pred cceEEEEeccCCCHHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~--~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
.++|+|+|.+...|.+++...+.+ +....+..|++|+..||..|-.+||+|+||||+|||++ .....+||||||++
T Consensus 507 nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 507 NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGSA 584 (752)
T ss_pred ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec--cCcceeeeccCccc
Confidence 899999999999999999986654 77899999999999999999999999999999999997 67788999999999
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHH
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 226 (318)
........ ....-+..|+|||++.|.+|+...|+||+||+|||+.||+..|.+......+..+.
T Consensus 585 ~~~~enei---------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 585 SFASENEI---------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred cccccccc---------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 87654433 23355788999999999999999999999999999999999999866544444443
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=257.68 Aligned_cols=244 Identities=20% Similarity=0.314 Sum_probs=196.2
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+|++.+.||.|++|.||+|.+..+++.+++|.+.... ....+.+|+.+++.+.| +++..+...+......++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNH-PNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCC-CCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999876432 22356788889999875 566666666666688999999
Q ss_pred cc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 84 LL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 84 ~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
++ +++|.+++... ...+++..+..++.|++.||.+||+.|++|+||+|+||+++ +.+.+||+|||.+......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~---~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV---ANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe---cCCcEEEeeccchhhhccC
Confidence 99 88999888652 24588899999999999999999999999999999999995 7889999999998765443
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. ....++..|++||.+.+..++.++|+||+|+++|++++|+.||...+..... ..+.....+ +.
T Consensus 157 ~~---------~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~---~~~~~~~~~-~~-- 221 (256)
T cd08530 157 MA---------KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR---YKVQRGKYP-PI-- 221 (256)
T ss_pred Cc---------ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHhcCCCC-CC--
Confidence 11 2235678899999999888999999999999999999999999876543222 222222211 11
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...++.++.+++..||..+|++||++.++.+
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 -PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1256788999999999999999999998765
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=259.84 Aligned_cols=245 Identities=21% Similarity=0.275 Sum_probs=188.9
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-------CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
||.+.+.||.|+||.||+|.+...+..+++|+.+... ....+..|+.++..++| +++..+..+.......++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH-PAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCC-CcHHHHHHHHhcCCceEE
Confidence 6999999999999999999998777666666654321 12245678888888876 555556555566678999
Q ss_pred EEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 81 VLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
++||+ +++|.+++... ...+++..+..++.|++.||.|||++|++|+||+|+||++. .+.++|+|||.+...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~ 155 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLL 155 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEee----cCCEeecccCceeec
Confidence 99999 78998887642 34588999999999999999999999999999999999993 456999999998765
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
..... ......++..|+|||.+.+..++.++|+||||+++|++++|..||...... .....+.. .+
T Consensus 156 ~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~~~~~~----~~ 221 (260)
T cd08222 156 MGSCD-------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---SVVLRIVE----GP 221 (260)
T ss_pred CCCcc-------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHc----CC
Confidence 43322 112345678899999998888899999999999999999999999754332 22222221 11
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.......++..+.+++.+||..+|++||++.++.+
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 11223456788999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=255.66 Aligned_cols=249 Identities=27% Similarity=0.372 Sum_probs=198.5
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccC--cceEEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG--EDNVLV 81 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~--~~~~lv 81 (318)
+|++.+.||.|++|.||+|.+..++..|++|+...... ...+.+|+..++++.| +++..+....... ...+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~-~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH-PNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCC-CCEeeEEEEEecCCCCeEEEE
Confidence 58899999999999999999998999999998766543 4567889999999986 4454554444444 679999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
+|++ +++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++ ..+.++|+|||.+.......
T Consensus 80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~---~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD---SDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc---CCCCEEEcccccEEeccccc
Confidence 9999 889999988643 689999999999999999999999999999999999995 78999999999988765443
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
.. .......++..|++||.+.+...+.++||||||+++|++++|..||...+.. ......+.. .......
T Consensus 156 ~~-----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~---~~~~~~~ 225 (260)
T cd06606 156 TG-----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP--MAALYKIGS---SGEPPEI 225 (260)
T ss_pred cc-----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch--HHHHHhccc---cCCCcCC
Confidence 21 0112446788899999998888999999999999999999999999875521 222222221 1111223
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
....+..+.+++.+||..+|++||++.++..
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 3455889999999999999999999998765
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=262.73 Aligned_cols=245 Identities=19% Similarity=0.287 Sum_probs=191.6
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~- 85 (318)
|+....||.|+||.||+|.+..++..||+|.+.... ....+.+|+.++..+.| +++..+...+......+++||++
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCC-cchhheeeEEEeCCEEEEEEecCC
Confidence 334467999999999999999999999999865432 23357789999999876 55666655666677899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccc
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~ 165 (318)
+++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||.+........
T Consensus 101 ~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~---- 171 (292)
T cd06657 101 GGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP---- 171 (292)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCCEEEcccccceecccccc----
Confidence 7788887653 458899999999999999999999999999999999999 4788999999998875543221
Q ss_pred cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCc
Q 021053 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (318)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (318)
......++..|++||.+.+..++.++|+||+|+++|+|++|..||.+........... ...+.... .....+
T Consensus 172 ---~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~ 243 (292)
T cd06657 172 ---RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR----DNLPPKLK-NLHKVS 243 (292)
T ss_pred ---cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hhCCcccC-CcccCC
Confidence 1123457888999999888888999999999999999999999998754432222211 11111111 123567
Q ss_pred hhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 246 AEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 246 ~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+.+++.+||..+|.+||++.++..
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 78999999999999999999998776
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=272.20 Aligned_cols=241 Identities=22% Similarity=0.339 Sum_probs=203.0
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEeccCC
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGP 87 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~~~ 87 (318)
.+.||+|.||+||-|+++++|+.||||++.+-. ....+.+|+.+|+.+.| +.++++...+...+..+.|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~H-PGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHH-PGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCC-CCeeEEEEeecCCceEEEEehhhcc
Confidence 468999999999999999999999999876432 33578899999999866 7888888888888899999999988
Q ss_pred CHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 88 SLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 88 ~L~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
+..+.+.+ ..+.+++...+.++.||+.||.|||.++|+|+||||+|||+...+....+||+|||+++.......
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF----- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF----- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-----
Confidence 87777654 455699999999999999999999999999999999999998777788999999999998765443
Q ss_pred ccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCch
Q 021053 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (318)
.....||+.|+|||++.+..|+..-|+||+|||+|--++|..||.... +.. +.|.+.....|+.. |..++.
T Consensus 723 ---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIn---dQIQNAaFMyPp~P-W~eis~ 793 (888)
T KOG4236|consen 723 ---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DIN---DQIQNAAFMYPPNP-WSEISP 793 (888)
T ss_pred ---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chh---HHhhccccccCCCc-hhhcCH
Confidence 357799999999999999999999999999999999999999996532 112 23333444444444 357788
Q ss_pred hHHHHHHHHhhcCCCCCCChH
Q 021053 247 EFASYFHYCQSLTFDQRPDYG 267 (318)
Q Consensus 247 ~~~~li~~cl~~~p~~Rp~~~ 267 (318)
...++|...|+..-.+|-+.+
T Consensus 794 ~AidlIn~LLqVkm~kRysvd 814 (888)
T KOG4236|consen 794 EAIDLINNLLQVKMRKRYSVD 814 (888)
T ss_pred HHHHHHHHHHHHHHHHhcchH
Confidence 899999999999999997766
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=276.26 Aligned_cols=254 Identities=20% Similarity=0.269 Sum_probs=205.8
Q ss_pred cceeeEeeeeccCcccEEEEEEEcC---CCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
.++..+.+.||+|+||.|++|.+.. +...||||.+..... ..+|++|+.++.+|.| +++..++....+ ...-
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H-~hliRLyGvVl~-qp~m 186 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQH-PHLIRLYGVVLD-QPAM 186 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccC-cceeEEeeeecc-chhh
Confidence 3566788999999999999999873 234699998876654 3589999999999987 444444433333 5677
Q ss_pred EEEecc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 80 LVLDLL-GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
+|+|.+ .|||.+.+.. ....|-....+.|+.||+.|+.||.++++|||||-.+|+++- ....+||+|||+.+.+.
T Consensus 187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNllla---sprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLA---SPRTVKICDFGLMRALG 263 (1039)
T ss_pred HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheec---ccceeeeecccceeccC
Confidence 999999 9999999987 445588899999999999999999999999999999999994 78899999999999876
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
..... |.......-...|.|||.+.-..++.++|||++||++|||+| |..||.+......++.+++ +++++.|
T Consensus 264 ~ned~----Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~--~erLpRP 337 (1039)
T KOG0199|consen 264 ENEDM----YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDA--GERLPRP 337 (1039)
T ss_pred CCCcc----eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccc--cccCCCC
Confidence 54332 112223344567999999999999999999999999999999 9999999887766666652 4455555
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
+.+|+++++++..||..+|.+||++..|++.+..
T Consensus 338 -----k~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 338 -----KYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred -----CCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 4679999999999999999999999999865543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=248.58 Aligned_cols=276 Identities=20% Similarity=0.328 Sum_probs=206.4
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccc--cCcceEEEEe
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV--DGEDNVLVLD 83 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~--~~~~~~lv~e 83 (318)
.++|++.+++|.|-|++||.|....+++.++||++++.. .....+|+++|+.|.+++++..+..... ....+-+++|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 478999999999999999999998899999999998754 4567899999999998888877754433 3456789999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
+. ..+...+... ++...++.++.+++.||.|+||.||.|||+||.|+++. -....++|+|+|++.......
T Consensus 116 ~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~-- 187 (338)
T KOG0668|consen 116 YVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGK-- 187 (338)
T ss_pred hhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCc--
Confidence 99 6666666553 77888999999999999999999999999999999995 356789999999987653221
Q ss_pred ccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCcc-chhHhhhHHHHHHHHHhhccCchHH-
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQ-GLKAATKKQKYDKICEKKVSTPIEV- 239 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~-~~~~~~~~~~~~~i~~~~~~~~~~~- 239 (318)
.......+..|-.||++...+ |+.+-|+|||||++..|+..+.||. +.++.++.-.+.++++ ......
T Consensus 188 ------eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLG---t~el~~Y 258 (338)
T KOG0668|consen 188 ------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLG---TDELYAY 258 (338)
T ss_pred ------eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhC---hHHHHHH
Confidence 123446678889999988766 8999999999999999999888875 4555555555444432 111111
Q ss_pred ---HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCchhHHHhhhcCCccccccccee
Q 021053 240 ---LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 240 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
+.-.+++.+.+++.+- .++|-...+-..-.-+..+++++|++++|++|..+|+||+|+..
T Consensus 259 l~KY~i~Ldp~~~~i~~~~-----~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRH-----SRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHccCCChhHhhHhhcc-----ccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 2223455555555321 22221111111112345678899999999999999999999864
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=257.38 Aligned_cols=248 Identities=25% Similarity=0.375 Sum_probs=190.5
Q ss_pred eccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCC
Q 021053 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (318)
Q Consensus 15 lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~ 88 (318)
||.|++|.||+|.+..+++.+++|++.... ....+.+|+.++..+.| +++..+..........++++|++ +++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQS-PYVVKLYYSFQGKKNLYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCC-cchhHHHHheecCcEEEEEEecCCCCc
Confidence 689999999999999889999999876543 23467788889998875 55555655556677899999999 779
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc-cccc
Q 021053 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR-HIPY 167 (318)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~-~~~~ 167 (318)
|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||++.......... ....
T Consensus 80 L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 80 LASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE---cCCCCEEEEecccchhcccCccccccccc
Confidence 999988644 58999999999999999999999999999999999999 488999999999987543321100 0000
Q ss_pred cCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchh
Q 021053 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247 (318)
Q Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 247 (318)
.......++..|++||...+...+.++|+||||+++|++++|..||....... ....+.......+.. ...+..
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~---~~~~~~ 229 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---IFQNILNGKIEWPED---VEVSDE 229 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhcCCcCCCcc---ccCCHH
Confidence 01123456788999999988888999999999999999999999997655432 222322222222211 124788
Q ss_pred HHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 248 FASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 248 ~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
+.+++.+||..+|++||++..+.+.+
T Consensus 230 ~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 230 AIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred HHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 99999999999999999996555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=280.59 Aligned_cols=200 Identities=24% Similarity=0.356 Sum_probs=167.0
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecC---CCCChhHHHHHHHHHHHcCCCCCCeeeeccc------cCcc
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS---GTKHPQLLYEAKVYKILQGGSGIPNIKWYGV------DGED 77 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~------~~~~ 77 (318)
.-+...+.||.|+||.||+++++.+|+.||||.+.. ....+...+|++++++|+| +||+....... ....
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh-~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNH-PNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCc-hhhhhhcccCCccccCccccc
Confidence 345678899999999999999999999999998776 3344578899999999995 55555433222 2457
Q ss_pred eEEEEecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCC-CeEEEEeccce
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA-NQVYIIDFGLA 153 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~-~~~kL~dfg~~ 153 (318)
.++||||| +|||...+.+..+ ++++.++..++..+..||.|||++||+||||||.||++....+. -.-||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 89999999 9999999986432 49999999999999999999999999999999999988644322 33599999999
Q ss_pred eeecCCCCCccccccCCCCCccccccccccccc-CCCCCCcchHHHHHHHHHHHHhCCCCccc
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQG 215 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~~l~tg~~pf~~ 215 (318)
+.+..... .....||..|++||++. ...|+.-+|.|||||++|+.+||..||..
T Consensus 172 rel~d~s~--------~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 172 RELDDNSL--------FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred ccCCCCCe--------eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 98766543 35779999999999999 47799999999999999999999999954
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=269.83 Aligned_cols=268 Identities=21% Similarity=0.263 Sum_probs=209.0
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---------ChhHHHHHHHHHHHcCCCCCCeeeecc
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---------HPQLLYEAKVYKILQGGSGIPNIKWYG 72 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~e~~~l~~l~~~~~~~~i~~~~ 72 (318)
++.+.+||-+++.||.|+|+.||+|.|...++.||+|+-..... ...+.+|..+-+.|.|+.++....++.
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 35788999999999999999999999999999999997543322 235678888888888866555555666
Q ss_pred ccCcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeeccCCCCCeEEEEec
Q 021053 73 VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDF 150 (318)
Q Consensus 73 ~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~kL~df 150 (318)
.+...+|-|+|||.|...+|.....+-+++.+++.|+.||+.||.||.... |+|-||||.|||+......|.+||.||
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 678889999999965555665554566899999999999999999999875 999999999999987777899999999
Q ss_pred cceeeecCCCCCccccccCCCCCcccccccccccccCC----CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHH
Q 021053 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226 (318)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 226 (318)
|++.....+..+.+......+...||..|++||.+.-. ..+.++||||+|||+|+.+.|+.||...-.+...-...
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 99999888777755545555677899999999987633 36889999999999999999999997643332222233
Q ss_pred HHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 227 ~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.|+....-..+. ....+.....+|++||.+--++|.+..++..
T Consensus 698 TIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 698 TILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred chhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 333222111111 1245678999999999999999988776544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=276.34 Aligned_cols=251 Identities=20% Similarity=0.353 Sum_probs=209.6
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-hhHHHHHHHHHHHcCCCCCCeeeeccc-----cCcceE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGV-----DGEDNV 79 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~~~~~~~~i~~~~~-----~~~~~~ 79 (318)
.+.+++.+.||.|.+|.||+++.+.+++..|+|+....... ++...|..+++.+.+|+|.+.++.++. .++..+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 36789999999999999999999999999999998876554 467778899999999999988866554 456899
Q ss_pred EEEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 80 LVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
+||||| +||..|++... +..+.+..+..|++.++.||.+||.+.++|||||-.|||++ ..+.+||.|||.+..+.
T Consensus 98 LVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT---~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLD 174 (953)
T ss_pred EEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEe---ccCcEEEeeeeeeeeee
Confidence 999999 89999998864 44588999999999999999999999999999999999996 89999999999999887
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCC-----CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE-----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~ 232 (318)
..-.. ....+||+.|||||++...+ |+..+|+||||++..||.-|.+|+.++.+.- .++ .| -+
T Consensus 175 sT~gr-------RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--aLF-~I--pR 242 (953)
T KOG0587|consen 175 STVGR-------RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--ALF-LI--PR 242 (953)
T ss_pred ccccc-------ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh--hhc-cC--CC
Confidence 65443 34668999999999987442 5678999999999999999999999987742 111 11 12
Q ss_pred ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.++|.-.-+..|+.++.++|..||.+|.++||+..++.+
T Consensus 243 NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 243 NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 222323336688999999999999999999999886654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=271.98 Aligned_cols=242 Identities=20% Similarity=0.244 Sum_probs=199.0
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
+...|++...+|.|+|+.|-.+.+..+++..++|++... ..+..+|+.++....+|+++........+..+.|+|||.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~--~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR--ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc--ccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 356899999999999999999999999999999998775 334567888888889999999988888888999999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+ ++-+.+.+.+. ..+. ..+..|+.+|+.|+.|||++|++||||||+|||+. ++.+.++|+|||.++.......
T Consensus 398 l~g~ell~ri~~~-~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~~~-- 471 (612)
T KOG0603|consen 398 LDGGELLRRIRSK-PEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD--GSAGHLRLTYFGFWSELERSCD-- 471 (612)
T ss_pred ccccHHHHHHHhc-chhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec--CCCCcEEEEEechhhhCchhhc--
Confidence 9 66666666542 2233 67778999999999999999999999999999993 3889999999999987765522
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhc
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (318)
...-|..|.|||++....|+++|||||||++||+|++|+.||...... .+.+.+ ....+.. ..
T Consensus 472 --------tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~----i~~~~~s---~~ 534 (612)
T KOG0603|consen 472 --------TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTR----IQMPKFS---EC 534 (612)
T ss_pred --------ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHh----hcCCccc---cc
Confidence 123478899999999888999999999999999999999999864332 222222 2222222 46
Q ss_pred CchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 244 HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 244 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+|+..++|+++||+.||.+||++.++..
T Consensus 535 vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 535 VSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred cCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 7889999999999999999999998776
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=261.43 Aligned_cols=254 Identities=18% Similarity=0.225 Sum_probs=181.4
Q ss_pred eEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 10 ~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
.+++.+|.| +.||.+++..+++.||+|++.... ....+.+|+.++..++| +++..+..++......++++|++
T Consensus 5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h-~~i~~~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQH-PNILPYVTSFIVDSELYVVSPLM 81 (314)
T ss_pred hhhHhhcCC--ceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCC-cchhhhhheeecCCeEEEEEecc
Confidence 344445444 556666667789999999876542 22367889999999986 45555555556667899999999
Q ss_pred -CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 86 -GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 86 -~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+++|.+++... ...+++..+..++.|++.||.|||+++|+|+||+|+||+++ .++.++|+|||.+..........
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~---~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLS---GDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEe---cCCceEEecCccceeeccccccc
Confidence 78898888753 34588999999999999999999999999999999999994 78999999999887654322211
Q ss_pred cccccCCCCCcccccccccccccCC--CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh---------
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--------- 232 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~--------- 232 (318)
...........++..|+|||++.+. .++.++|+|||||++|+|++|..||....... .....+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCch
Confidence 1111122344567789999998763 58899999999999999999999997643321 1111111000
Q ss_pred -------------------ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 233 -------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 233 -------------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...........++..+.+++.+||..+|++||++.++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 000000111233456888999999999999999987766
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=295.24 Aligned_cols=252 Identities=24% Similarity=0.342 Sum_probs=201.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecC----CCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
-|++-+..||.|.||.||.|.+..+|...|+|-++- ........+|..+++.++| ++++..+....+....+|.|
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnH-pNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNH-PNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccC-ccccccCceeecHHHHHHHH
Confidence 467788999999999999999999999999994332 1223567889999999987 44555555556677899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
||| +|+|.+++.. ++..++.....+..|++.|+.|||+.||+||||||.||++ +.+|.+|++|||.+.....+..
T Consensus 1314 EyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee---ecCCcEEeecccceeEecCchh
Confidence 999 9999999986 5557888888899999999999999999999999999999 6899999999999998776531
Q ss_pred CccccccCCCCCcccccccccccccCCC---CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
++| ...+...||+.|||||++.+-. -+-++||||+||+..||+||+.||...+.. .+.+.++.-...+..+
T Consensus 1390 --~~~-~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V~~gh~Pq~P- 1463 (1509)
T KOG4645|consen 1390 --TMP-GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHVAAGHKPQIP- 1463 (1509)
T ss_pred --cCC-HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHHhccCCCCCc-
Confidence 122 2445778999999999998653 467899999999999999999999876653 4444454433322222
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
.+++..=++++..||..||.+|=++.++++.
T Consensus 1464 ---~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1464 ---ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2467888999999999999999777666554
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=280.13 Aligned_cols=143 Identities=23% Similarity=0.465 Sum_probs=123.0
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+..|+.++..++| +++..+...+......|+|
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS-PFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCC-CCcCeEEEEEEECCEEEEE
Confidence 689999999999999999999999999999998865332 1356778888888766 5566666666677789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 9999 8899999876 3458899999999999999999999999999999999999 478899999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=266.64 Aligned_cols=245 Identities=24% Similarity=0.332 Sum_probs=203.7
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+.|.+.+.||+|.|+.|.+|++..++..||||++++.... ....+|+.+++.+.| ++++.+..+.......|+||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~H-PnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNH-PNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCC-cceeeeeeeeeecceeEEEE
Confidence 5799999999999999999999999999999988765432 346899999999987 66666666666677899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
||+ ++.+.+++...+. ..+..++.++.|+++|++|||+++|+|||||.+|+++ +.+.++||+|||++..+....
T Consensus 135 eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~~- 209 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL---DENMNIKIADFGFSTFFDYGL- 209 (596)
T ss_pred EeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc---ccccceeeeccccceeecccc-
Confidence 999 9999999987544 6668899999999999999999999999999999999 588999999999998776333
Q ss_pred CccccccCCCCCcccccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
..+...|++.|.|||++.+..| ++.+|+||+|+++|-++.|..||.+.+-. ..-.++...+...|.
T Consensus 210 -------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk---~Lr~rvl~gk~rIp~--- 276 (596)
T KOG0586|consen 210 -------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK---ELRPRVLRGKYRIPF--- 276 (596)
T ss_pred -------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc---cccchheeeeecccc---
Confidence 2356789999999999999985 68999999999999999999999875432 222233334444442
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
.++-+..+++.+.+-.+|.+|++.+++-+.
T Consensus 277 --~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 277 --YMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred --eeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 335689999999999999999999876653
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=247.95 Aligned_cols=234 Identities=25% Similarity=0.362 Sum_probs=187.0
Q ss_pred eccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCC
Q 021053 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (318)
Q Consensus 15 lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~ 88 (318)
||.|++|.||+|.+..+++.+++|++..... ...+..|+.+++.+.| +++..+...+......+++||++ +++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINH-PFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCC-CcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 6899999999999988899999998765432 2367788899999885 55555555556777899999999 999
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccccc
Q 021053 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168 (318)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 168 (318)
|.+++... ..+++.....++.|++.||.++|+++++|+||+|+||+++ ..+.++|+|||.+........
T Consensus 80 L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~---~~~~~~l~d~~~~~~~~~~~~------- 148 (250)
T cd05123 80 LFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGS------- 148 (250)
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEc---CCCcEEEeecCcceecccCCC-------
Confidence 99998863 3589999999999999999999999999999999999994 788999999999876543321
Q ss_pred CCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhH
Q 021053 169 ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF 248 (318)
Q Consensus 169 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (318)
......++..|++||...+...+.++|+||||+++|++++|..||...+. ......+...... .....+..+
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~~~~~-----~~~~~~~~l 220 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILKDPLR-----FPEFLSPEA 220 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhcCCCC-----CCCCCCHHH
Confidence 11244567889999999888889999999999999999999999976443 2223333222221 223457889
Q ss_pred HHHHHHHhhcCCCCCCChHH
Q 021053 249 ASYFHYCQSLTFDQRPDYGF 268 (318)
Q Consensus 249 ~~li~~cl~~~p~~Rp~~~~ 268 (318)
.+++.+||..+|++||++.+
T Consensus 221 ~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 221 RDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHHhcCCHhhCCCccc
Confidence 99999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=246.00 Aligned_cols=242 Identities=20% Similarity=0.306 Sum_probs=204.1
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++++.||.|+|++|.+++.+++.+.+|+|++++. ........|..+.++..+++.++-+..|++.+...++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 6799999999999999999999999999999986643 33445677888999988888888889999999999999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
.||. +|+|--.++. ++.++++.++.+...|..||.|||++||+.||||.+|+++ |..|.+||.|+|.++..-.+.
T Consensus 330 ieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll---daeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE---ccCCceeecccchhhcCCCCC
Confidence 9999 8888777776 5569999999999999999999999999999999999999 799999999999998755444
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccc--hh---HhhhHHHHHHHHHhhccC
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG--LK---AATKKQKYDKICEKKVST 235 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~--~~---~~~~~~~~~~i~~~~~~~ 235 (318)
. ..+.+.||+.|.|||++.+..|+..+|+|++|+++|||+.|+.||.- ++ ..+..-.+.-|+++.+..
T Consensus 406 d-------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri 478 (593)
T KOG0695|consen 406 D-------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI 478 (593)
T ss_pred c-------ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc
Confidence 4 23577999999999999999999999999999999999999999952 11 112233444555666666
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCC
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP 264 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp 264 (318)
|. .++-....+++..|.+||.+|.
T Consensus 479 pr-----slsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 479 PR-----SLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cc-----eeehhhHHHHHHhhcCCcHHhc
Confidence 63 3355677889999999999994
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=272.04 Aligned_cols=260 Identities=21% Similarity=0.322 Sum_probs=205.4
Q ss_pred cceeeEeeeeccCcccEEEEEEEc---C----CCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHV---D----TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~---~----~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
.++..+.+.||+|.||.|++|.-. . ....||||.++.... ...+..|++++..+.+|+++..+..+....
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 345567789999999999999754 1 145799998775543 357899999999999999988887666668
Q ss_pred cceEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccC
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG 139 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~ 139 (318)
+..++|+||+ .|+|..++...+ ..++..+...++.||+.|++||++..++||||-.+|||++
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~-- 452 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT-- 452 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec--
Confidence 8899999999 999999998766 2388889999999999999999999999999999999995
Q ss_pred CCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhH
Q 021053 140 RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKA 218 (318)
Q Consensus 140 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~ 218 (318)
.+..+|++|||+++.......... ......-...|||||.+....|+.++||||||++|||++| |..||.+...
T Consensus 453 -~~~~~kIaDFGlar~~~~~~~y~~----~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 453 -KNKVIKIADFGLARDHYNKDYYRT----KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred -CCCEEEEccccceeccCCCCceEe----cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 778999999999986443322110 0001012456999999999899999999999999999999 9999987431
Q ss_pred hhhHHHHHHHH-HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 219 ATKKQKYDKIC-EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 219 ~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
.... +..+. +.+...| ..++.+++++|..||+.+|++||++.++.+.|.+.+..
T Consensus 528 ~~~l--~~~l~~G~r~~~P-----~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 528 TEEL--LEFLKEGNRMEQP-----EHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred HHHH--HHHHhcCCCCCCC-----CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 1111 22111 2233333 45688999999999999999999999999999986543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=252.91 Aligned_cols=257 Identities=23% Similarity=0.295 Sum_probs=195.2
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHH-cCCCCCCeeeecccc----CcceEEEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL-QGGSGIPNIKWYGVD----GEDNVLVL 82 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~i~~~~~~----~~~~~lv~ 82 (318)
..++.+.||+|.||.||+|+. +++.||||++.... .+.+..|..++... ..|++|..+..+... ...+++|+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~-kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE-KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred chhhHHHhhcCccceeehhhc--cCceeEEEecCHHH-HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 456788999999999999987 56999999886533 45677777777654 234555554444332 34799999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR---------GFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---------~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
+|. .|+|.+++.. ..+++....+++..+++||+|||+. .|+|||||.+|||+. ++....|+|||+
T Consensus 288 ~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK---~DlTccIaDFGL 362 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK---NDLTCCIADFGL 362 (534)
T ss_pred eeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc---cCCcEEeeccce
Confidence 998 9999999995 4589999999999999999999964 499999999999994 899999999999
Q ss_pred eeeecCCCCCccccccCCCCCcccccccccccccCCC-CC-----CcchHHHHHHHHHHHHhC------------CCCcc
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QS-----RRDDLESLGYVLLYFLRG------------SLPWQ 214 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-----~~~DvwslG~il~~l~tg------------~~pf~ 214 (318)
+..+........ .-..+||.+|||||++.+.- +. ...||||+|.++|||+++ ++||+
T Consensus 363 Al~~~p~~~~~d-----~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 363 ALRLEPGKPQGD-----THGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eEEecCCCCCcc-----hhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 998874433322 23478999999999998764 22 358999999999999985 34554
Q ss_pred ch--hHhhhHHHHHHHHHhhccCchHHHhhcC--chhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 215 GL--KAATKKQKYDKICEKKVSTPIEVLCKSH--PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 215 ~~--~~~~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
.. +.....++..-+..++.++-.+..|... ..-+.+.+..||+.||+.|.|+..+.+++..+.
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 21 2223334444444555555544433332 356899999999999999999999999998874
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=243.94 Aligned_cols=220 Identities=17% Similarity=0.175 Sum_probs=170.2
Q ss_pred CcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCCHHHHHHHh
Q 021053 18 GSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYC 96 (318)
Q Consensus 18 G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~L~~~~~~~ 96 (318)
|.++.||+|++..+++.||+|.+..... ..+|...+.... ++++..+..++......+++||++ +++|.+++...
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~---~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 79 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE---YSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF 79 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh---hhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence 8899999999999999999998765432 223333333333 466666666667778899999999 78999988763
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCccc
Q 021053 97 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176 (318)
Q Consensus 97 ~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (318)
..+++..+..++.|++.||.|+|++|++||||||+||++ +.++.++|+|||.+........ ...++
T Consensus 80 -~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~df~~~~~~~~~~~----------~~~~~ 145 (237)
T cd05576 80 -LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVEDSCD----------GEAVE 145 (237)
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cCCCCEEEecccchhccccccc----------cCCcC
Confidence 358999999999999999999999999999999999999 4888999999998765432211 22346
Q ss_pred ccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHh
Q 021053 177 ARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQ 256 (318)
Q Consensus 177 ~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl 256 (318)
..|+|||...+..++.++|+||+||++|+|++|..||...... ... ..... ....+++.+.+++.+||
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~--~~~~~-----~~~~~~~~~~~li~~~l 213 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INT--HTTLN-----IPEWVSEEARSLLQQLL 213 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----ccc--ccccC-----CcccCCHHHHHHHHHHc
Confidence 6799999998888899999999999999999999988642211 000 00111 11345778999999999
Q ss_pred hcCCCCCCChH
Q 021053 257 SLTFDQRPDYG 267 (318)
Q Consensus 257 ~~~p~~Rp~~~ 267 (318)
+.||++||++.
T Consensus 214 ~~dp~~R~~~~ 224 (237)
T cd05576 214 QFNPTERLGAG 224 (237)
T ss_pred cCCHHHhcCCC
Confidence 99999999863
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=250.94 Aligned_cols=279 Identities=19% Similarity=0.241 Sum_probs=204.4
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccc----cCcceE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGEDNV 79 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~----~~~~~~ 79 (318)
+.+-.+.||.|+||.||.+.|.++|+.|++|.+-+.. ....+.+|++++..++|.+.+..+..... ...+.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3455688999999999999999999999999755432 23468899999999998766554432211 123578
Q ss_pred EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 80 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
.++|.+..+|-..+.+ ...++.+.++-+++||++||.|||+.||.||||||.|.++ +++..+||+|||+++.-...
T Consensus 134 V~TELmQSDLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 134 VLTELMQSDLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HHHHHHHhhhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe---ccCceEEecccccccccchh
Confidence 8899999899888776 4569999999999999999999999999999999999999 49999999999999864433
Q ss_pred CCCccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
.... .....-|..|+|||++.|.. |+.+.||||+|||+.|++.++..|+..++..+.+++-. .+.+|.-
T Consensus 210 ~~~h------MTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItd----LLGTPs~ 279 (449)
T KOG0664|consen 210 DRLN------MTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIID----LLGTPSQ 279 (449)
T ss_pred hhhh------hHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHH----HhCCCcH
Confidence 2211 12345688899999999876 99999999999999999999999998887655544433 3345543
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHH-HHHHhcCCchhHHHhhhcCCccccccccee
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH-DLFSREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~-~~~~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
+-.+.--+..+.-+ | ..|.+-|+..-+...-. +.-+.+...++.+|+.+||.+|.+..+++.
T Consensus 280 EaMr~ACEGAk~H~---L-R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~ 342 (449)
T KOG0664|consen 280 EAMKYACEGAKNHV---L-RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQ 342 (449)
T ss_pred HHHHHHhhhhHHHh---h-ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcc
Confidence 31111111222222 1 23444566554443221 112335578889999999999999988875
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=268.34 Aligned_cols=248 Identities=19% Similarity=0.205 Sum_probs=162.6
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCC----CcEEEEEeecCCCCChhHHHHHHHHHHHcCC---CCCCeeee----c-c
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDT----NEIVAVKIENSGTKHPQLLYEAKVYKILQGG---SGIPNIKW----Y-G 72 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~----~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~---~~~~~i~~----~-~ 72 (318)
-.++|++.+.||+|+||.||+|.+..+ +..||+|.+...... |..+.+.+.+. .....+.. . .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~-----e~~~~e~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV-----EIWMNERVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh-----HHHHHHHHHhhchhhHHHHHHhhhccccc
Confidence 347899999999999999999999888 899999987543322 22222222221 11111111 1 2
Q ss_pred ccCcceEEEEecc-CCCHHHHHHHhcCCC-------------------CHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 021053 73 VDGEDNVLVLDLL-GPSLEDLFVYCRRKF-------------------SLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 132 (318)
Q Consensus 73 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~-------------------~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~ 132 (318)
......++|++|+ +++|.+++....... ....+..++.||+.||.|||++||+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 3456799999999 788998887532111 12345678999999999999999999999999
Q ss_pred ceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCC----------------------CC
Q 021053 133 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI----------------------EQ 190 (318)
Q Consensus 133 Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~ 190 (318)
|||++ ++.+.+||+|||++......... ......+++.|+|||.+... .+
T Consensus 285 NILl~--~~~~~~KL~DFGlA~~l~~~~~~------~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~ 356 (566)
T PLN03225 285 NIIFS--EGSGSFKIIDLGAAADLRVGINY------IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNL 356 (566)
T ss_pred HEEEe--CCCCcEEEEeCCCcccccccccc------CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccC
Confidence 99994 34688999999999755432221 12345678899999965422 23
Q ss_pred CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh------------------hcCchhHHHHH
Q 021053 191 SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC------------------KSHPAEFASYF 252 (318)
Q Consensus 191 ~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~------------------~~~~~~~~~li 252 (318)
+.++||||+||++|||+++..|+.... ..+....... ......+. .......++|+
T Consensus 357 ~~k~DVwSlGviL~el~~~~~~~~~~~-----~~~~~~l~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi 430 (566)
T PLN03225 357 PDRFDIYSAGLIFLQMAFPNLRSDSNL-----IQFNRQLKRN-DYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELL 430 (566)
T ss_pred CCCcccHHHHHHHHHHHhCcCCCchHH-----HHHHHHHHhc-CCcHHHHHHhhccccchhhhhhhhhccccchHHHHHH
Confidence 446799999999999999877654321 1111111110 01111100 01112244788
Q ss_pred HHHhhcCCCCCCChHHHHH
Q 021053 253 HYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 253 ~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+||..||.+|||+.++.+
T Consensus 431 ~~mL~~dP~kR~ta~e~L~ 449 (566)
T PLN03225 431 KSMMRFKGRQRISAKAALA 449 (566)
T ss_pred HHHccCCcccCCCHHHHhC
Confidence 8888888888888777665
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=237.87 Aligned_cols=293 Identities=18% Similarity=0.251 Sum_probs=216.6
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-CCChhHHHHHHHHHHHcCCCCCCee-eeccccCcceEEEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TKHPQLLYEAKVYKILQGGSGIPNI-KWYGVDGEDNVLVL 82 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~i-~~~~~~~~~~~lv~ 82 (318)
+.+.|.+.+.||.|.||.+-+|+++.+++.+|+|.+... ....++.+|+..--.|.+|.||..- ...++..+.+++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 467899999999999999999999999999999976543 4456889999877777777666443 55667778899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|++ .|+|.+-+.. .++.+...+.++.|+++|+.|+|+++++|||||.+|||+... +..++||+|||.++.....-.
T Consensus 102 E~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~-df~rvKlcDFG~t~k~g~tV~ 178 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDA-DFYRVKLCDFGLTRKVGTTVK 178 (378)
T ss_pred ccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecC-CccEEEeeecccccccCceeh
Confidence 999 8999888874 458899999999999999999999999999999999999644 566999999999876543221
Q ss_pred CccccccCCCCCcccccccccccccCC-----CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhH-HHHHHHHHhhccC
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK-QKYDKICEKKVST 235 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~-~~~~~i~~~~~~~ 235 (318)
...-+..|.+||+.... ...+.+|+|.||+++|..+||.+||+.....+.. .....- .++..+
T Consensus 179 ----------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w-~~rk~~ 247 (378)
T KOG1345|consen 179 ----------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW-LKRKNP 247 (378)
T ss_pred ----------hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH-hcccCc
Confidence 22335568889876533 2467899999999999999999999853322211 111222 223333
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh--------------cCCchhHHHhhhcCCccccccc
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR--------------EGSLLLQFIMSYCSLHSITFQT 301 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~--------------~~~~~~~~~l~~~p~~r~t~~~ 301 (318)
..+.....+++....+.++-++.+|++|-...+..+....++.+ ..++--+++..-.|+.|.+..+
T Consensus 248 ~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~t~k~~ee~~~tn~d~~S~iysrq~~~~~sg~~ 327 (378)
T KOG1345|consen 248 ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIKTVKRPEEDYYTNIDTASKIYSRQTATSSSGEP 327 (378)
T ss_pred cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhccccChhhccccccCCcchhhhcCcCcCCCCCc
Confidence 44444567888999999999999999995544444443333222 1234445555666777777777
Q ss_pred ceeeeeeeEe
Q 021053 302 NIINIKKVFH 311 (318)
Q Consensus 302 ~~~~~~~~~~ 311 (318)
.....+++|.
T Consensus 328 ~kp~~pamms 337 (378)
T KOG1345|consen 328 QKPSAPAMMS 337 (378)
T ss_pred CCCCchhhhh
Confidence 7776666554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=240.65 Aligned_cols=251 Identities=20% Similarity=0.329 Sum_probs=194.5
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
.+..+-+..||.|+||+|++-.++.+|+..|||.+..... ..+++.|.....+-...++|+.++.....++..++.|
T Consensus 63 ~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM 142 (361)
T KOG1006|consen 63 SDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM 142 (361)
T ss_pred cchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence 3445556789999999999999999999999998765543 3467777777766666666666666666778899999
Q ss_pred eccCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 83 DLLGPSLEDLFVYC----RRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 83 e~~~~~L~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|.|..|+..+.... ...+++...-.+.--.+.||.||... .|+|||+||+|||+ +..|.+||+|||.|-.+.
T Consensus 143 ELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 143 ELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLV 219 (361)
T ss_pred HHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHH
Confidence 99999998876543 34588888888888889999999976 89999999999999 699999999999987654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCC--CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
...- .....|-..|+|||.+... .|+.+|||||||++|||+.||+.||.+-++ .++.++......
T Consensus 220 ~SiA--------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gd 286 (361)
T KOG1006|consen 220 DSIA--------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGD 286 (361)
T ss_pred HHHH--------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCC
Confidence 3321 1234677889999988744 488999999999999999999999987554 233333333333
Q ss_pred chHH-Hh---hcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 236 PIEV-LC---KSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 236 ~~~~-~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
|+.. .. -.++..+..++..|+.+|.+.||....+.+.
T Consensus 287 pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 287 PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 3222 11 2367789999999999999999999987663
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=283.56 Aligned_cols=248 Identities=13% Similarity=0.167 Sum_probs=183.3
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-C
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-G 86 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~ 86 (318)
.|...+.||+|+||.||+|.+..++..||+|.+..... ....|++.+.+++| ++++.+..+.......++||||+ +
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~l~~l~H-pnIv~~~~~~~~~~~~~lv~Ey~~~ 767 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS--IPSSEIADMGKLQH-PNIVKLIGLCRSEKGAYLIHEYIEG 767 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc--ccHHHHHHHhhCCC-CCcceEEEEEEcCCCCEEEEeCCCC
Confidence 45667789999999999999988999999998764332 23456888888866 66666666666677899999999 8
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH---SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
++|.+++.. +++..+..++.|++.||.||| +.+|+||||||+||++ +..+..++. |+........
T Consensus 768 g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~---~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 768 KNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII---DGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE---CCCCceEEE-eccccccccC----
Confidence 999999863 788999999999999999999 6799999999999999 466666664 4443221111
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhh-hHHHHHHH----------HHhh
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-KKQKYDKI----------CEKK 232 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~-~~~~~~~i----------~~~~ 232 (318)
....++..|+|||++.+..++.++|||||||++|||+||+.||....... ......+. ....
T Consensus 836 -------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 836 -------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred -------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 12356889999999999899999999999999999999999985421110 00000000 0000
Q ss_pred ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
...... ........+.+++.+||+.+|++||++.++.+.+++...
T Consensus 909 ~~~~~~-~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 909 IRGDVS-VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccCCCC-ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 000000 000112357789999999999999999999999988754
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=272.90 Aligned_cols=256 Identities=21% Similarity=0.259 Sum_probs=184.7
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeec------------
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWY------------ 71 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~------------ 71 (318)
.+|+..+.||+||||.||+|+++-+|+.||||.+.... ......+|++.+.+|+|++.+.+...+
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei 558 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEI 558 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccc
Confidence 46788899999999999999999999999999765432 233678899999999886553111000
Q ss_pred ---------------------------------------------c--------------------------c-------
Q 021053 72 ---------------------------------------------G--------------------------V------- 73 (318)
Q Consensus 72 ---------------------------------------------~--------------------------~------- 73 (318)
. .
T Consensus 559 ~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~ 638 (1351)
T KOG1035|consen 559 VASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEG 638 (1351)
T ss_pred cccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCC
Confidence 0 0
Q ss_pred --------------------cC--------cceEEEEeccCCCHHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCc
Q 021053 74 --------------------DG--------EDNVLVLDLLGPSLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSRGF 124 (318)
Q Consensus 74 --------------------~~--------~~~~lv~e~~~~~L~~~~~~~~~~~-~~~~~~~~~~qi~~~L~~lH~~~i 124 (318)
.+ ...||-||||..++++.+...+... .....++++++|+.||.|+|+.||
T Consensus 639 ~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~gi 718 (1351)
T KOG1035|consen 639 SVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGI 718 (1351)
T ss_pred ccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCce
Confidence 00 2358999999666655555433323 477889999999999999999999
Q ss_pred cccCCCCCceeeccCCCCCeEEEEeccceeeec----------CCCCCc-cccccCCCCCcccccccccccccCCC---C
Q 021053 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR----------DPTTNR-HIPYRENKNLTGTARYASCNTHLGIE---Q 190 (318)
Q Consensus 125 ~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~----------~~~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~---~ 190 (318)
+||||||.|||+ +++..+||+|||++.... .+.... ..+.......+||..|+|||++.+.. |
T Consensus 719 IHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y 795 (1351)
T KOG1035|consen 719 IHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY 795 (1351)
T ss_pred eeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence 999999999999 699999999999998621 111111 11112345678999999999998665 9
Q ss_pred CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHH
Q 021053 191 SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (318)
Q Consensus 191 ~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~ 270 (318)
+.|+|+||+|+++|||+. ||...-.. ...+.......++.+...+....+ .=.++|+.+++.||++|||+.++.
T Consensus 796 n~KiDmYSLGIVlFEM~y---PF~TsMER--a~iL~~LR~g~iP~~~~f~~~~~~-~e~slI~~Ll~hdP~kRPtA~eLL 869 (1351)
T KOG1035|consen 796 NSKIDMYSLGIVLFEMLY---PFGTSMER--ASILTNLRKGSIPEPADFFDPEHP-EEASLIRWLLSHDPSKRPTATELL 869 (1351)
T ss_pred cchhhhHHHHHHHHHHhc---cCCchHHH--HHHHHhcccCCCCCCcccccccch-HHHHHHHHHhcCCCccCCCHHHHh
Confidence 999999999999999995 46543221 223333333444444111222333 567999999999999999999876
Q ss_pred H
Q 021053 271 R 271 (318)
Q Consensus 271 ~ 271 (318)
+
T Consensus 870 ~ 870 (1351)
T KOG1035|consen 870 N 870 (1351)
T ss_pred h
Confidence 5
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=251.46 Aligned_cols=285 Identities=24% Similarity=0.324 Sum_probs=214.0
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcC---CCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~---~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
.+.+.|.+.++||.|.|++||++.+.. .+..||+|.+...........|++++..+.++.++..+..+...++..++
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~i 112 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAI 112 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEE
Confidence 356789999999999999999999886 77899999988888888999999999999999999999999999999999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC-
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD- 158 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~- 158 (318)
|+||+ .....+++.. ++...+..+++.++.||.++|++||+||||||.|++++ ...+.-.|.|||++.....
T Consensus 113 vlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 113 VLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred EecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc--cccCCceEEechhHHHHHhh
Confidence 99999 7888888764 77899999999999999999999999999999999997 6778889999999872100
Q ss_pred ------CC-------C--C------------------c---cccccCCCCCcccccccccccccCCC-CCCcchHHHHHH
Q 021053 159 ------PT-------T--N------------------R---HIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGY 201 (318)
Q Consensus 159 ------~~-------~--~------------------~---~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~ 201 (318)
.. . . . .+.-.......||+.|+|||++..++ .++++||||.|+
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 00 0 0 0 00001123346999999999999776 789999999999
Q ss_pred HHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH-----
Q 021053 202 VLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL----- 276 (318)
Q Consensus 202 il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~----- 276 (318)
|+..++++..||....+. ...+.++........... ...+....+-..++.+|++.++...++.+
T Consensus 267 I~Lslls~~~PFf~a~dd--~~al~ei~tifG~~~mrk--------~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~ 336 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFKAKDD--ADALAEIATIFGSAEMRK--------CAALPGRILLWQKSNIPTIPELRVNFETLHIESI 336 (418)
T ss_pred eeehhhccccccccCccc--cchHHHHHHHhChHHHHH--------HhhcCCceeeeccccccccHHHHhchhccChhhc
Confidence 999999999999654322 222333333232222222 11111111111223355555554444433
Q ss_pred ----------------HHhcCCchhHHHhhhcCCccccccccee
Q 021053 277 ----------------FSREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 277 ----------------~~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
++....++++++|..||.+|+||+|++.
T Consensus 337 ~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 337 YKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 1123358999999999999999999986
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=237.85 Aligned_cols=276 Identities=21% Similarity=0.273 Sum_probs=209.8
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC----CCChhHHHHHHHHHHHcCCCCCCeeeeccc-----c
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG----TKHPQLLYEAKVYKILQGGSGIPNIKWYGV-----D 74 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~-----~ 74 (318)
.+..||.-++.+|.|.. .|..|.|.-.++.|++|..... ....++.+|...+..+.|.+.+..+..+.. .
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 34578999999999998 8888999889999999965433 344578999999999998666655544433 2
Q ss_pred CcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
....|+|||++..+|...+.. .++-.....+..|++.|++|+|+.||+||||||+||++ .....+|+.|||+++
T Consensus 93 ~~e~y~v~e~m~~nl~~vi~~---elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 93 FQEVYLVMELMDANLCQVILM---ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLAR 166 (369)
T ss_pred HHhHHHHHHhhhhHHHHHHHH---hcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee---cchhheeeccchhhc
Confidence 346899999999999999872 37888999999999999999999999999999999999 499999999999998
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
...... .....+.+..|+|||++.+..+...+||||+||++.||++|...|.+.+.-++ ..++.+ .+.
T Consensus 167 ~e~~~~--------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ---~~ki~~-~lg 234 (369)
T KOG0665|consen 167 TEDTDF--------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQ---WNKIIE-QLG 234 (369)
T ss_pred ccCccc--------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHH---HHHHHH-Hhc
Confidence 654431 23456789999999999999999999999999999999999999998665444 444443 445
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH-----------HHhcCCchhHHHhhhcCCcccccccce
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL-----------FSREGSLLLQFIMSYCSLHSITFQTNI 303 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~-----------~~~~~~~~~~~~l~~~p~~r~t~~~~~ 303 (318)
.|.+.+...+.+..+-.+. ..|.. .+-...+.|++. -...+.+++.+||-.||++|.|+++++
T Consensus 235 tpd~~F~~qL~~~~r~yv~----~~~~y--~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 235 TPDPSFMKQLQPTVRNYVE----NRPQY--QAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred CCCHHHHHHhhHHHHHHhh----cChHh--hccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 6666655555544444443 11110 011122222221 112335899999999999999999998
Q ss_pred e
Q 021053 304 I 304 (318)
Q Consensus 304 ~ 304 (318)
.
T Consensus 309 ~ 309 (369)
T KOG0665|consen 309 R 309 (369)
T ss_pred c
Confidence 6
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=258.68 Aligned_cols=252 Identities=22% Similarity=0.288 Sum_probs=206.5
Q ss_pred eeEeeeeccCcccEEEEEEEcCCC----cEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~----~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
.+..++||+|+||+||+|.+.-.+ .+||||++.... ...+++.|.-++.++.|++.+..+..+-... .-||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HHHH
Confidence 355789999999999999886444 368888766543 3457889999999999866665554443322 6788
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
++++ .|+|.+++...+.++.......|..||++|+.|||.++++||||-.+|+|+. +...+|+.|||+++.+..+.
T Consensus 776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVk---sP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVK---SPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeec---CCCeEEEEecchhhccCccc
Confidence 9999 9999999998888899999999999999999999999999999999999995 89999999999999887665
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
..-.++ ...-..-|+|-|.+....|+.++|||||||++||++| |..|+.+....+....++. ..+++-|
T Consensus 853 ~ey~~~-----~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~--geRLsqP--- 922 (1177)
T KOG1025|consen 853 KEYSAP-----GGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEK--GERLSQP--- 922 (1177)
T ss_pred cccccc-----ccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhc--cccCCCC---
Confidence 543222 2233456999999999999999999999999999999 9999999877665555543 2334444
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
..++.+++-++.+||..|++.||++.++...|....
T Consensus 923 --piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 923 --PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred --CCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 356789999999999999999999999999998764
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=253.82 Aligned_cols=252 Identities=21% Similarity=0.295 Sum_probs=203.4
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
.+.+++..||-|+||.|=+++.......+|+|++++.. ..+....|-.++....+ +.|+.++--+.+..+.|+.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s-~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRS-DFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCc-hHHHHHHHHhccchhhhhh
Confidence 45678889999999999999987666668888766432 23467888888888774 5566666666788899999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||-| +|.++..+.. ++.|+..+.+.++.-++.|+.|||++||+.|||||+|.++ |.+|-+||.|||+++......
T Consensus 499 mEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 499 MEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee---ccCCceEEeehhhHHHhccCC
Confidence 9998 9999999987 4569999999999999999999999999999999999999 699999999999999876554
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
... .+.||+.|.|||++.+..-+.++|.||||+++||+++|.+||.+.++. ..+..|+... ..-.+
T Consensus 575 KTw--------TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm---ktYn~ILkGi---d~i~~ 640 (732)
T KOG0614|consen 575 KTW--------TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM---KTYNLILKGI---DKIEF 640 (732)
T ss_pred cee--------eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH---HHHHHHHhhh---hhhhc
Confidence 432 568999999999999999999999999999999999999999997764 3333333221 11223
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCC-----hHHHHHHHHHHHHh
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKRLFHDLFSR 279 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~-----~~~l~~~l~~~~~~ 279 (318)
+..++....++|......+|.+|.. +.++.+ +.++..
T Consensus 641 Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk--H~Wf~g 682 (732)
T KOG0614|consen 641 PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK--HRWFEG 682 (732)
T ss_pred ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh--hhhhhc
Confidence 3566778889999988999999965 445655 445543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=226.69 Aligned_cols=236 Identities=25% Similarity=0.342 Sum_probs=184.7
Q ss_pred cccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCCHHHHHH
Q 021053 19 SFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFV 94 (318)
Q Consensus 19 ~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~L~~~~~ 94 (318)
+||.||+|.+..+++.+++|++..... ...+.+|+..+.+++| +++..+..........++++|++ +++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKH-PNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCC-CcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 578999999988899999998876554 4578889999999854 56666655555567899999999 559999987
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCc
Q 021053 95 YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174 (318)
Q Consensus 95 ~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~ 174 (318)
... .++......++.+++.++.+||+.+++|+||+|+||+++ +.+.++|+|||.+........ .....
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~--------~~~~~ 147 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLD---EDGHVKLADFGLARQLDPGGL--------LTTFV 147 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEEC---CCCcEEEccccceeeeccccc--------ccccc
Confidence 633 388999999999999999999999999999999999994 779999999999887654321 12445
Q ss_pred ccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHH
Q 021053 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHY 254 (318)
Q Consensus 175 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ 254 (318)
++..|++||...+..++.++|+||+|++++++++|..||...... ...... .......+ ......++..+.+++.+
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~-~~~~~~~~-~~~~~~~~~~~~~~i~~ 223 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKK-IGKPKPPF-PPPEWKISPEAKDLIRK 223 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHH-HhccCCCC-ccccccCCHHHHHHHHH
Confidence 678899999998888899999999999999999999999763221 111221 11111111 11111267889999999
Q ss_pred HhhcCCCCCCChHHHHH
Q 021053 255 CQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 255 cl~~~p~~Rp~~~~l~~ 271 (318)
||..+|++||++.++.+
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999998765
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-33 Score=255.10 Aligned_cols=245 Identities=21% Similarity=0.191 Sum_probs=184.6
Q ss_pred eeeeccCccc-EEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEeccCCCHH
Q 021053 12 GRKIGSGSFG-EIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLE 90 (318)
Q Consensus 12 ~~~lg~G~~~-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~~~~L~ 90 (318)
.+.+|.|+.| .||+|.. .++.||||.+-... ..-+.+|+..++.-..|+|+...+....+....||..|.|..+|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~-~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~ 590 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF-FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQ 590 (903)
T ss_pred HHHcccCCCCcEEEEEee--CCceehHHHHhhHh-HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHH
Confidence 3556788877 5799987 67899999765422 345789999999888888887777667778889999999999999
Q ss_pred HHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCC--CCCeEEEEeccceeeecCCCCCccc
Q 021053 91 DLFVYCRRK---FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDFGLAKKYRDPTTNRHI 165 (318)
Q Consensus 91 ~~~~~~~~~---~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~--~~~~~kL~dfg~~~~~~~~~~~~~~ 165 (318)
+++...... .........+.|++.||+|||+.+|+||||||+|||++..+ ...+++|+|||+|+........
T Consensus 591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS--- 667 (903)
T KOG1027|consen 591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS--- 667 (903)
T ss_pred HHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch---
Confidence 999863111 11134567889999999999999999999999999997532 3357899999999987654332
Q ss_pred cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcC
Q 021053 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (318)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (318)
+.......||-.|+|||++.....+.++||+|+||++|+.++ |.+||......+ ..|.........-. ..-
T Consensus 668 -~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-----~NIl~~~~~L~~L~--~~~ 739 (903)
T KOG1027|consen 668 -FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-----ANILTGNYTLVHLE--PLP 739 (903)
T ss_pred -hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-----hhhhcCccceeeec--cCc
Confidence 234567789999999999999888889999999999999999 599998643321 22221111111000 000
Q ss_pred chhHHHHHHHHhhcCCCCCCChHHHH
Q 021053 245 PAEFASYFHYCQSLTFDQRPDYGFLK 270 (318)
Q Consensus 245 ~~~~~~li~~cl~~~p~~Rp~~~~l~ 270 (318)
.....+||.++++++|..||++.++.
T Consensus 740 d~eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 740 DCEAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred hHHHHHHHHHhcCCCcccCCCHHHHh
Confidence 01578999999999999999998654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-30 Score=236.89 Aligned_cols=204 Identities=22% Similarity=0.252 Sum_probs=145.5
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEc----------------CCCcEEEEEeecCCCC----------------ChhHH
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHV----------------DTNEIVAVKIENSGTK----------------HPQLL 50 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~----------------~~~~~vaiK~~~~~~~----------------~~~~~ 50 (318)
++-.++|++.++||+|+||.||+|.+. ..++.||||.+..... .+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 455689999999999999999999752 2346799998754321 11233
Q ss_pred HHHHHHHHHcCCCCCC----ee-eecc-------ccCcceEEEEecc-CCCHHHHHHHhcC-------------------
Q 021053 51 YEAKVYKILQGGSGIP----NI-KWYG-------VDGEDNVLVLDLL-GPSLEDLFVYCRR------------------- 98 (318)
Q Consensus 51 ~e~~~l~~l~~~~~~~----~i-~~~~-------~~~~~~~lv~e~~-~~~L~~~~~~~~~------------------- 98 (318)
.|+.++.++++++... .+ ..+. ......++|+||+ +++|.+++.....
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 4666677777655321 11 1111 1234689999999 8899998864211
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCc
Q 021053 99 ----KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174 (318)
Q Consensus 99 ----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~ 174 (318)
.+++..++.++.|++.||.|+|+.+|+||||||+||++ +.++.+||+|||++......... ......
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~------~~~~g~ 371 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINF------NPLYGM 371 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCcc------CccccC
Confidence 13466788899999999999999999999999999999 47789999999998654322111 011223
Q ss_pred ccccccccccccCCC--------------------C--CCcchHHHHHHHHHHHHhCCC-Cccc
Q 021053 175 GTARYASCNTHLGIE--------------------Q--SRRDDLESLGYVLLYFLRGSL-PWQG 215 (318)
Q Consensus 175 ~~~~y~aPE~~~~~~--------------------~--~~~~DvwslG~il~~l~tg~~-pf~~ 215 (318)
.++.|+|||++.... + ..+.||||+||++++|++|.. ||..
T Consensus 372 ~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 372 LDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred CCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 478899999876432 1 124799999999999999875 7754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-32 Score=238.74 Aligned_cols=206 Identities=25% Similarity=0.400 Sum_probs=166.9
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
-|..++.||-|+||+|.+++...+...||.|.+.+..- ......|-.||....+ +-++.+++-+++...+|+||
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn-~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADN-EWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCC-cceEEEEEEeccCCceEEEE
Confidence 36778999999999999999888999999997654331 2245567777776554 45667788888999999999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
+|. +|++-+++.+.+ -|.+..++.++.++..|+++.|..|+|||||||+|||+ |.+|.+||.|||+|..+.=...
T Consensus 709 dYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred eccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE---ccCCceeeeeccccccceeccc
Confidence 999 999999988743 48999999999999999999999999999999999999 7999999999999875531111
Q ss_pred Ccc-----------c-c---cc--------------------CCCCCcccccccccccccCCCCCCcchHHHHHHHHHHH
Q 021053 162 NRH-----------I-P---YR--------------------ENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYF 206 (318)
Q Consensus 162 ~~~-----------~-~---~~--------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l 206 (318)
... + + +. ..-..+||+.|.|||++....|+..||+||.|||||||
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em 864 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEM 864 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHH
Confidence 000 0 0 00 01134699999999999999999999999999999999
Q ss_pred HhCCCCccchhH
Q 021053 207 LRGSLPWQGLKA 218 (318)
Q Consensus 207 ~tg~~pf~~~~~ 218 (318)
+.|++||-...+
T Consensus 865 ~~g~~pf~~~tp 876 (1034)
T KOG0608|consen 865 LVGQPPFLADTP 876 (1034)
T ss_pred hhCCCCccCCCC
Confidence 999999976433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=221.98 Aligned_cols=271 Identities=44% Similarity=0.706 Sum_probs=212.0
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCC-cEEEEEeecCCCC--ChhHHHHHHHHHHHc---CCCCCCeeeecc-ccCcceEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTN-EIVAVKIENSGTK--HPQLLYEAKVYKILQ---GGSGIPNIKWYG-VDGEDNVL 80 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~-~~vaiK~~~~~~~--~~~~~~e~~~l~~l~---~~~~~~~i~~~~-~~~~~~~l 80 (318)
+|.+.+.||+|+||.||.|.+..++ ..+|+|+...... ...+..|..++..+. +..+++.+...+ ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 8999999999999999999987664 6788997665432 226788999999988 446788888888 47778999
Q ss_pred EEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCC--CCCeEEEEecccee--e
Q 021053 81 VLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDFGLAK--K 155 (318)
Q Consensus 81 v~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~--~~~~~kL~dfg~~~--~ 155 (318)
||+.++.+|.++..... +.++..+...++.|++.+|.++|+.|++||||||.|++++... ....+.|.|||+++ .
T Consensus 99 VM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~ 178 (322)
T KOG1164|consen 99 VMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFK 178 (322)
T ss_pred EEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcccc
Confidence 99999999999986654 6799999999999999999999999999999999999997432 12579999999998 4
Q ss_pred ecCCCCCccccccC-CCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 156 YRDPTTNRHIPYRE-NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 156 ~~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
..........+.+. .....||..|.++....+...+.+.|+||++.++.++..|..||...........+.........
T Consensus 179 ~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~ 258 (322)
T KOG1164|consen 179 YVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLT 258 (322)
T ss_pred ccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhcc
Confidence 32222211122222 23456999999999999999999999999999999999999999776544444444443333332
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcC
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~ 281 (318)
.. .....|..+.++...+-..+...+|+...+...+.+.+....
T Consensus 259 ~~---~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~ 302 (322)
T KOG1164|consen 259 DR---FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG 302 (322)
T ss_pred cc---ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence 22 222345667788887777999999999999999988876653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-32 Score=209.43 Aligned_cols=200 Identities=20% Similarity=0.276 Sum_probs=154.6
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
++...-+..||.|+||.|-+-++..+|+..|+|.+...... .+.+.|+.+...-...+..+.++..-......++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 34455677899999999999999999999999977654432 234455554433222222333333334567899999
Q ss_pred eccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 83 DLLGPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 83 e~~~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
|.|..||..+.... +..+++..+-+++..+..||.|||++ .++|||+||.|||+ +..|.+|++|||.|-.+.+
T Consensus 125 E~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehh
Confidence 99999998887543 45588999999999999999999987 89999999999999 5999999999999987654
Q ss_pred CCCCccccccCCCCCcccccccccccccCC----CCCCcchHHHHHHHHHHHHhCCCCccch
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI----EQSRRDDLESLGYVLLYFLRGSLPWQGL 216 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DvwslG~il~~l~tg~~pf~~~ 216 (318)
..-. ....|-..|+|||.+... .|+.++||||||+++.||.++..||..-
T Consensus 202 SiAk--------t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 202 SIAK--------TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hhHH--------HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 3221 223566789999987633 5899999999999999999999999653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-33 Score=247.95 Aligned_cols=251 Identities=19% Similarity=0.274 Sum_probs=207.0
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeec--CCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~--~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
.++|++++.+|+|+||.||+++|+.++...|+|+++ .........+|+-+++..+|++++.++..|-. ....++.||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-RDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-hcCcEEEEE
Confidence 578999999999999999999999999999999765 44455677889999999988777766655533 346899999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
|| +|+|.+..+- .+++++.++...++..++||.|||+.|-+|||||-.||+++ +.+.+||.|||.+........
T Consensus 93 ycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanillt---d~gDvklaDfgvsaqitati~- 167 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLT---DEGDVKLADFGVSAQITATIA- 167 (829)
T ss_pred ecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeec---ccCceeecccCchhhhhhhhh-
Confidence 99 7888888775 45699999999999999999999999999999999999996 999999999999887665544
Q ss_pred ccccccCCCCCccccccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 163 RHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
....+.||+.|+|||+.. ...|...+|+|++|++.-|+..-++|.....+.....++- .....+|.-.
T Consensus 168 ------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT---kS~~qpp~lk 238 (829)
T KOG0576|consen 168 ------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT---KSGFQPPTLK 238 (829)
T ss_pred ------hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh---ccCCCCCccc
Confidence 346789999999999875 4458999999999999999999999988766643333222 1223333333
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
-...|++.+-.+++.|+..+|.+||+++.+..
T Consensus 239 Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 34578889999999999999999999996655
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=223.65 Aligned_cols=256 Identities=18% Similarity=0.269 Sum_probs=200.6
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCC-----CcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~-----~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
..|+++...+-+|.||.||.|.+.+. .+.|.+|.++..... ..++.|...+.-+.|++..+....+..+...
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~ 362 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT 362 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence 46788888999999999999977633 234566766544332 2456777777777765555555666667777
Q ss_pred eEEEEecc-CCCHHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEe
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRR-------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~-------~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~d 149 (318)
.+..+.+. -++|..|+.-++. .++-.+...++.|++.|+.|||+.|++|.||..+|.++ |+.-.+||+|
T Consensus 363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkltD 439 (563)
T KOG1024|consen 363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI---DDQLQVKLTD 439 (563)
T ss_pred ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee---hhheeEEecc
Confidence 88888888 7899999984421 25566778899999999999999999999999999999 6889999999
Q ss_pred ccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHH
Q 021053 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKI 228 (318)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i 228 (318)
=.+++.+....... -......+..||+||.+.+..|+.++|+||||+++|||+| |+.||...++.+....+..
T Consensus 440 saLSRDLFP~DYhc-----LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkd- 513 (563)
T KOG1024|consen 440 SALSRDLFPGDYHC-----LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKD- 513 (563)
T ss_pred chhccccCcccccc-----cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhc-
Confidence 99888765332211 1123345678999999999999999999999999999999 9999999888766666554
Q ss_pred HHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
+.++..| -++|+++..+|.-||...|++||+++++..-|.+.
T Consensus 514 -GyRlaQP-----~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 514 -GYRLAQP-----FNCPDELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred -cceecCC-----CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 3444444 46799999999999999999999999999888764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=234.39 Aligned_cols=195 Identities=24% Similarity=0.353 Sum_probs=166.6
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----------CChhHHHHHHHHHHHcC--CCCCCeeeeccccC
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQG--GSGIPNIKWYGVDG 75 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~e~~~l~~l~~--~~~~~~i~~~~~~~ 75 (318)
.|...+.+|.|+||.|++|.+++....|+||.+.+.+ +....-.|+.+|..++. |++|.++..++.+.
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 5899999999999999999999989999999655432 22245679999999973 35566667777888
Q ss_pred cceEEEEecc--CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 76 EDNVLVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 76 ~~~~lv~e~~--~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
+++|++||-- +.+|.+++.. ...+++..++.+++|++.|+++||+.||+|||||-+|+.+ +.+|.+||+|||++
T Consensus 642 d~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv---d~~g~~klidfgsa 717 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV---DSNGFVKLIDFGSA 717 (772)
T ss_pred CeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEE---ecCCeEEEeeccch
Confidence 8999999987 5678888887 4459999999999999999999999999999999999999 69999999999998
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCccc
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQG 215 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~tg~~pf~~ 215 (318)
....+... ..+.||..|.|||++-|..| +..-|||++|++||.++....||..
T Consensus 718 a~~ksgpf---------d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 718 AYTKSGPF---------DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hhhcCCCc---------ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 76543322 36789999999999999986 7788999999999999999999863
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-29 Score=205.14 Aligned_cols=208 Identities=30% Similarity=0.440 Sum_probs=177.1
Q ss_pred eccCcccEEEEEEEcCCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCCHH
Q 021053 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLE 90 (318)
Q Consensus 15 lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~L~ 90 (318)
||.|++|.||+|.+..+++.+++|++...... ..+.+|+..++.+.+ +++..+..+.......++++|++ +++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNH-PNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCC-CCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 68999999999999888999999998876653 678999999999987 66666666666667899999999 59999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCC-CCeEEEEeccceeeecCCCCCccccccC
Q 021053 91 DLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAKKYRDPTTNRHIPYRE 169 (318)
Q Consensus 91 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~-~~~~kL~dfg~~~~~~~~~~~~~~~~~~ 169 (318)
+++......++......++.+++.+|.+||+.|++|+||+|.||++. . .+.++|+|||.+........ .
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~---~~~~~~~l~d~~~~~~~~~~~~-------~ 149 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD---SDNGKVKLADFGLSKLLTSDKS-------L 149 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe---CCCCcEEEecCCceEEccCCcc-------h
Confidence 99886434588999999999999999999999999999999999994 5 78999999999886654321 1
Q ss_pred CCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhH
Q 021053 170 NKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEF 248 (318)
Q Consensus 170 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 248 (318)
.....+...|++||.+... ..+.++|+||+|++++++ ..+
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------~~~ 190 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------PEL 190 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------HHH
Confidence 1234567889999998877 788999999999999999 368
Q ss_pred HHHHHHHhhcCCCCCCChHHHHHH
Q 021053 249 ASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 249 ~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
.+++..|+..+|++||++.++.+.
T Consensus 191 ~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 191 KDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHHhhCCcccCcCHHHHhhC
Confidence 899999999999999999887753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-29 Score=200.26 Aligned_cols=167 Identities=17% Similarity=0.183 Sum_probs=128.6
Q ss_pred CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccc
Q 021053 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166 (318)
Q Consensus 87 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~ 166 (318)
|+|.+++...+..+++..+..++.|++.||.|||+.+ ||+||++ +.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc------
Confidence 6889999875666999999999999999999999998 9999999 48888998 99987654321
Q ss_pred ccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH--HHhhcC
Q 021053 167 YRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE--VLCKSH 244 (318)
Q Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~ 244 (318)
..+++.|+|||++.+..++.++|||||||++|+|+||..||....... ..+..+.......... .....+
T Consensus 64 ------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 135 (176)
T smart00750 64 ------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADDPRDRSNLESV 135 (176)
T ss_pred ------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCCccccccHHHH
Confidence 256899999999999999999999999999999999999997643321 1222222211111000 011123
Q ss_pred ch--hHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 245 PA--EFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 245 ~~--~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
+. .+.+++..||..+|.+||++.++.+.......
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 33 69999999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-28 Score=200.11 Aligned_cols=197 Identities=32% Similarity=0.489 Sum_probs=162.2
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
|.+.+.||.|+++.||+|.+..++..+++|.+.... ....+.+|+..+..+.+ +++..+..+.......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~-~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKH-PNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCC-CChhhheeeeecCCceEEEEecc
Confidence 678899999999999999998888999999877554 24567889999999966 55555555555567899999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 86 -~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
+++|.+++......++......++.+++.+|.+||+++++|+||+|.||+++ ..+.++|+|||.+.........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~---~~~~~~l~d~g~~~~~~~~~~~-- 154 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLG---MDGLVKLADFGLARFIHRDLAA-- 154 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEeeCceeeEecCcccc--
Confidence 5599999886433378999999999999999999999999999999999994 6799999999998876543210
Q ss_pred ccccCCCCCcccccccccccc-cCCCCCCcchHHHHHHHHHHHHhCCCCccc
Q 021053 165 IPYRENKNLTGTARYASCNTH-LGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~tg~~pf~~ 215 (318)
......++..|++||.. ....++.++|+||||+++++|++|+.||..
T Consensus 155 ----~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 ----LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ----cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 11234567789999998 566678899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-28 Score=238.83 Aligned_cols=187 Identities=14% Similarity=0.172 Sum_probs=132.0
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecc----------------C
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL----------------G 139 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~----------------~ 139 (318)
..++.++|+++++|.+++......++...+..++.||+.||.|||++||+||||||+|||++. .
T Consensus 53 ~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~ 132 (793)
T PLN00181 53 DSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGS 132 (793)
T ss_pred chhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccc
Confidence 457888999999999999765556899999999999999999999999999999999999941 0
Q ss_pred CCCCeEEEEeccceeeecCCCC--------Cccccc-cCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCC
Q 021053 140 RKANQVYIIDFGLAKKYRDPTT--------NRHIPY-RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGS 210 (318)
Q Consensus 140 ~~~~~~kL~dfg~~~~~~~~~~--------~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~ 210 (318)
+..+.+|++|||+++....... ....++ .......+|+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 133 ~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~ 212 (793)
T PLN00181 133 DEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPV 212 (793)
T ss_pred cccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCC
Confidence 2334556666666543211000 000000 0011235788899999999999999999999999999999999
Q ss_pred CCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 211 LPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 211 ~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+|+..... .+..+..... |. ..... ......++..||..+|.+||++.++.+
T Consensus 213 ~~~~~~~~-----~~~~~~~~~~--~~-~~~~~-~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 213 SSREEKSR-----TMSSLRHRVL--PP-QILLN-WPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred CchhhHHH-----HHHHHHHhhc--Ch-hhhhc-CHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 98764321 1111111111 11 11112 235678899999999999999998764
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=194.10 Aligned_cols=180 Identities=19% Similarity=0.206 Sum_probs=133.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcC-CCcEEEEEeecCCC-------CChhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGT-------KHPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~-~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
+.+.++|.+.+.||+|+||+||+|.+.. +++.||||+..... ....+.+|+++++.+.|++.++.+...
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 5678999999999999999999999876 67788999765321 123578999999999988777666543
Q ss_pred CcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCceeeccCCCCCeEEEEeccc
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI-KPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl-~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
...|+||||+ +++|. ... . .. ...++.|++.||.|||++||+|||| ||+||++ +.++.+||+|||+
T Consensus 91 -~~~~LVmE~~~G~~L~-~~~--~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv---~~~~~ikLiDFGl 158 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLH-LAR--P--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM---GPDGEAAVIDFQL 158 (365)
T ss_pred -CCcEEEEEccCCCCHH-HhC--c--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE---cCCCCEEEEECcc
Confidence 3579999999 66675 221 1 11 1457789999999999999999999 9999999 4778999999999
Q ss_pred eeeecCCCCCccc-cccCCCCCcccccccccccccCCC------CCCcchHH
Q 021053 153 AKKYRDPTTNRHI-PYRENKNLTGTARYASCNTHLGIE------QSRRDDLE 197 (318)
Q Consensus 153 ~~~~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~Dvw 197 (318)
++..........+ .+.......++..|+|||.+.... .+..+|-|
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9876544322111 011113456777899999887443 23456766
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-22 Score=177.21 Aligned_cols=256 Identities=30% Similarity=0.423 Sum_probs=187.3
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
|.+.+.||.|+|+.||.+.+. ..+++|.+..... ...+.+|..++..+.+++++..+...+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 789999999999999999986 6788897765443 33588899999999988666666555555556799999
Q ss_pred cc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCC-eEEEEeccceeeecCC
Q 021053 84 LL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDP 159 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~-~~kL~dfg~~~~~~~~ 159 (318)
++ ++++.+++.... ..++......++.|++.++.++|+.+++|||+||+||++. ... .+++.|||.+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~---~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLD---RDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---CCCCeEEEeccCcceecCCC
Confidence 99 778886666533 1588999999999999999999999999999999999994 555 7999999998755433
Q ss_pred CCCccccccCCCCCcccccccccccccC---CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC-
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST- 235 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~- 235 (318)
....... .......++..|++||.+.+ ...+...|+||+|++++++++|..||......................
T Consensus 156 ~~~~~~~-~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (384)
T COG0515 156 GSTSSIP-ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPS 234 (384)
T ss_pred Ccccccc-ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcc
Confidence 2211000 12356688999999999987 568889999999999999999999987654210011111111111111
Q ss_pred chHHHhhcC----chhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 PIEVLCKSH----PAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 ~~~~~~~~~----~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
......... ...+.+++..++..+|..|.+......
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~ 274 (384)
T COG0515 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274 (384)
T ss_pred cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhh
Confidence 011111111 146889999999999999988776554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.7e-25 Score=203.46 Aligned_cols=254 Identities=20% Similarity=0.252 Sum_probs=180.0
Q ss_pred eEeeeeccCcccEEEEEEEcCCCcEEEEEeecC---CCCCh-----hHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS---GTKHP-----QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 10 ~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~---~~~~~-----~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
.....+|.|++|.|+.+.........+.|.... ..... ....|+-+-..+.|++.+..+........ ..-+
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-ILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-chhh
Confidence 467788999999888887765555555553321 11111 23444555555666554444433322222 2233
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
||||..+|..++... ..+....+..+++|++.|+.|+|+.||.|||+||+|+++. ..+.+|++|||.+.....+..
T Consensus 400 mE~~~~Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~---~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPYDLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVT---ENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccHHHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEe---cCCceEEeecCcceeeccCcc
Confidence 999955888888763 3588888999999999999999999999999999999995 888999999999887654433
Q ss_pred CccccccCCCCCcccccccccccccCCCCCC-cchHHHHHHHHHHHHhCCCCccchhHhhhH-HHHHHHHHhhccCchHH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSR-RDDLESLGYVLLYFLRGSLPWQGLKAATKK-QKYDKICEKKVSTPIEV 239 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DvwslG~il~~l~tg~~pf~~~~~~~~~-~~~~~i~~~~~~~~~~~ 239 (318)
.. ........|+..|+|||++.+..|.+ ..||||.|+++..|.+|+.||......+.. .................
T Consensus 476 ~~---~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~ 552 (601)
T KOG0590|consen 476 KN---IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNR 552 (601)
T ss_pred hh---hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHH
Confidence 21 11335678899999999999999865 689999999999999999999654333221 11111112233333445
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
++..+|...+.++-++|+.+|.+|.+++++.+
T Consensus 553 ~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 553 LLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred HHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 56678888999999999999999999887665
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=176.79 Aligned_cols=232 Identities=22% Similarity=0.259 Sum_probs=144.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCCh-----hHHHHHHHHHHHcCC----------CCCCeee--
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP-----QLLYEAKVYKILQGG----------SGIPNIK-- 69 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~e~~~l~~l~~~----------~~~~~i~-- 69 (318)
..+..++.||.|+++.||.|.|.++++.+++|++....... .+.+|.-....+.+. ..+..+.
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 35678899999999999999999999999999765443221 222222111111110 0011110
Q ss_pred ---------eccccCc-----ceEEEEeccCCCHHHHHHHhc---CC---CCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 021053 70 ---------WYGVDGE-----DNVLVLDLLGPSLEDLFVYCR---RK---FSLKTVLMLADQMIARIEYVHSRGFLHRDI 129 (318)
Q Consensus 70 ---------~~~~~~~-----~~~lv~e~~~~~L~~~~~~~~---~~---~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl 129 (318)
....... ..+++|+-+.++|.+++.... .. ........+..|+++.+++||+.|++|+||
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 0011111 357888999999988876431 11 223344566689999999999999999999
Q ss_pred CCCceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccC--------CCCCCcchHHHHHH
Q 021053 130 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--------IEQSRRDDLESLGY 201 (318)
Q Consensus 130 ~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~ 201 (318)
+|+|+++ +.+|.+.|+||+.....+.... ....+..|.+||.... ..++.+.|.|++|+
T Consensus 172 ~~~nfll---~~~G~v~Lg~F~~~~r~g~~~~----------~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 172 KPENFLL---DQDGGVFLGDFSSLVRAGTRYR----------CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp SGGGEEE----TTS-EEE--GGGEEETTEEEE----------GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred ceeeEEE---cCCCCEEEcChHHHeecCceee----------ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 9999999 5899999999988765433211 1233466888886643 24688899999999
Q ss_pred HHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCC
Q 021053 202 VLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR 263 (318)
Q Consensus 202 il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R 263 (318)
++|.++.|..||....+...... .... +..+|+.++.||..+|+++|.+|
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~~-----------~f~~-C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPEW-----------DFSR-CRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSGG-----------GGTT-SS---HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHHccCCCCCCCccccccc-----------cchh-cCCcCHHHHHHHHHHccCCcccC
Confidence 99999999999987544322111 1111 22667889999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.4e-24 Score=197.91 Aligned_cols=248 Identities=18% Similarity=0.120 Sum_probs=174.1
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC------hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH------PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
.|...+.||++.|=+|.+|++.+. .|+||++-+.... .+.++|++ ..+..++|+..+..........|+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHhhHHHHHH
Confidence 788899999999999999998543 3889987665532 13344444 3344445555554444445567788
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
=+|..-+|.|.+... .-+...+.+.|+.|++.||..+|..||+|||||.+|||++ +-.-+.|+||..-+..--+.+
T Consensus 100 RqyvkhnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT---SWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 100 RQYVKHNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT---SWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHhhhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe---eechhhhhcccccCCccCCCC
Confidence 888888999998852 2267888999999999999999999999999999999996 888889999987544333322
Q ss_pred Ccc-ccccCCCCCcccccccccccccCC----------C-CCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHH
Q 021053 162 NRH-IPYRENKNLTGTARYASCNTHLGI----------E-QSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKI 228 (318)
Q Consensus 162 ~~~-~~~~~~~~~~~~~~y~aPE~~~~~----------~-~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i 228 (318)
+.. ..|.+... ..-..|.|||.+... + .+++.||+|+||+++|+++ |.+||... ++.+.
T Consensus 176 NPadf~fFFDTS-rRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-------QL~aY 247 (1431)
T KOG1240|consen 176 NPADFTFFFDTS-RRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-------QLLAY 247 (1431)
T ss_pred CcccceEEEecC-CceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-------HHHhH
Confidence 211 11111111 123359999977531 2 4678999999999999999 89999641 12221
Q ss_pred HHhhccCchHHHhhcC-chhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 229 CEKKVSTPIEVLCKSH-PAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 229 ~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
.... ....+.....+ +..++.++..|++.||++|.++++..+.
T Consensus 248 r~~~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 248 RSGN-ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hccC-ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111 22333333333 3469999999999999999999987776
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=169.47 Aligned_cols=171 Identities=16% Similarity=0.229 Sum_probs=126.1
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChh-----------HHHHHHHHHHHcCCCCCCeeee
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----------LLYEAKVYKILQGGSGIPNIKW 70 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~-----------~~~e~~~l~~l~~~~~~~~i~~ 70 (318)
+++++++|++.+.+|.|+||.||++.+ ++..+|+|++.+...... +.+|+..+.++.| ++++.+..
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~-~GI~~~~d 102 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRS-EGLASLND 102 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHH-CCCCcceE
Confidence 468899999999999999999999766 466899999875433221 4678888999976 45555544
Q ss_pred cccc--------CcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCC
Q 021053 71 YGVD--------GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (318)
Q Consensus 71 ~~~~--------~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~ 141 (318)
++.. ....+++|||+ +.+|.++.. ++. ....+++.+|..+|+.|++|||++|.||+++ .
T Consensus 103 ~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~---~ 170 (232)
T PRK10359 103 FYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVS---K 170 (232)
T ss_pred eeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEe---C
Confidence 4221 24589999999 567877632 333 2456899999999999999999999999994 5
Q ss_pred CCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHH
Q 021053 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 207 (318)
Q Consensus 142 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~ 207 (318)
++ ++|+|||.......+.. ...++....++.++|+||||+++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a-------------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKA-------------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhh-------------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 56 99999998764421111 011334445677999999999887664
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.2e-22 Score=190.12 Aligned_cols=259 Identities=22% Similarity=0.270 Sum_probs=185.4
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHc--CCCCCCeeeeccccCcceEEEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~--~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
=+..|.|.+.||.|+||+||+|.+.+ ++.||+|+-+....++- .--.+++.+|+ -.+.+..+..+-...+..++|+
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEf-YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ 773 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEF-YICLQVMERLKPQMLPSIMHISSAHVFQNASVLVS 773 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceee-eehHHHHHhhchhhhcchHHHHHHHccCCcceeee
Confidence 35789999999999999999999877 99999999888776542 11223344444 1122333344444555688999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecc----CCCCCeEEEEeccceeeec
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL----GRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~----~~~~~~~kL~dfg~~~~~~ 157 (318)
+|. .|||.+++.. .+.+++..+..++.|++.-+.+||..+|||+||||+|+++.. +.+...++|+|||.+.-..
T Consensus 774 ey~~~Gtlld~~N~-~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~ 852 (974)
T KOG1166|consen 774 EYSPYGTLLDLINT-NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK 852 (974)
T ss_pred eccccccHHHhhcc-CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence 999 9999999984 455899999999999999999999999999999999999963 2245678999999987654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
...... .-...++|-.+-.+|+..|++|++.+|.|+++.+++-|+.|+.-= ..-+..+..+.
T Consensus 853 lfp~~~-----~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-------------~~~g~~~~~~~ 914 (974)
T KOG1166|consen 853 LFPDGT-----KFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-------------VKNGSSWMVKT 914 (974)
T ss_pred EcCCCc-----EEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-------------hcCCcceeccc
Confidence 332221 123556788889999999999999999999999999999985321 00001111111
Q ss_pred HHHhhcCc-hhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCchh
Q 021053 238 EVLCKSHP-AEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLL 285 (318)
Q Consensus 238 ~~~~~~~~-~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~ 285 (318)
.+..-+. .-+.+++..+|..+=..=|...+++..|+..+.+-...+.
T Consensus 915 -~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~~~~ 962 (974)
T KOG1166|consen 915 -NFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFTGLR 962 (974)
T ss_pred -cchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHHHHH
Confidence 0111112 2356788888885555557888999999888766444333
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-23 Score=168.13 Aligned_cols=242 Identities=12% Similarity=0.129 Sum_probs=178.6
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
..+..+|.....|+.|+|++. |..++.|+++... ...++..|.-.++.+.|++.++.+..+.. ..+.+++..|
T Consensus 192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-ppnlv~isq~ 268 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-PPNLVIISQY 268 (448)
T ss_pred hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-CCCceEeeee
Confidence 355677888999999999994 4557778766433 23467778888988888777766666644 4678888888
Q ss_pred c-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeeccCCCCCeEEE--EeccceeeecC
Q 021053 85 L-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYI--IDFGLAKKYRD 158 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~kL--~dfg~~~~~~~ 158 (318)
| .+||...++.... -.+..++.+++.++++|+.|||+.. |..--|+...+++ |++...+| +|-.++....
T Consensus 269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi---dedltarismad~kfsfqe~- 344 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSFQEV- 344 (448)
T ss_pred ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe---cchhhhheecccceeeeecc-
Confidence 8 9999999987432 2567788899999999999999974 4445788899999 45555554 4544443211
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCC---CcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQS---RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
...-++.|++||.++..+.+ .++|+|||++++||+.|+..||...++.+..-++. +..
T Consensus 345 -------------gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia------leg 405 (448)
T KOG0195|consen 345 -------------GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA------LEG 405 (448)
T ss_pred -------------ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh------hcc
Confidence 12336789999999877643 57999999999999999999998877654332221 111
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
....++...+..+.++++-|...||.+||.++.+...|+++
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 11223346678999999999999999999999999888875
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=161.14 Aligned_cols=136 Identities=20% Similarity=0.204 Sum_probs=101.7
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-----------hh-----------------HHHHHHHHHHHcCCC
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----------PQ-----------------LLYEAKVYKILQGGS 63 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----------~~-----------------~~~e~~~l~~l~~~~ 63 (318)
...||.|++|.||+|.+. +|+.||+|+++..... .. ..+|+..+..+.+..
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 568999999999999987 8999999987654210 11 234888999987633
Q ss_pred CCCeeeeccccCcceEEEEeccCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCceeeccCCC
Q 021053 64 GIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYV-HSRGFLHRDIKPDNFLMGLGRK 141 (318)
Q Consensus 64 ~~~~i~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l-H~~~i~H~dl~p~Nil~~~~~~ 141 (318)
. .....+.. ...++||||+++ ++...... ...++...+..++.|++.+|.++ |+.||+||||||+||+++
T Consensus 81 v-~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~---- 152 (190)
T cd05147 81 I-PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH---- 152 (190)
T ss_pred C-CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE----
Confidence 2 21111111 224899999954 44433322 35688999999999999999999 799999999999999993
Q ss_pred CCeEEEEeccceeee
Q 021053 142 ANQVYIIDFGLAKKY 156 (318)
Q Consensus 142 ~~~~kL~dfg~~~~~ 156 (318)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.3e-22 Score=167.33 Aligned_cols=188 Identities=18% Similarity=0.238 Sum_probs=135.2
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCC-CCeEEEEecccee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK-ANQVYIIDFGLAK 154 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~-~~~~kL~dfg~~~ 154 (318)
...|+||..+..+|..++-. ...+.....-++.|++.|+.|||++||.|||+|.+||++..+|+ -..+.++|||.|-
T Consensus 316 ~tlylvMkrY~~tLr~yl~~--~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 316 KTLYLVMKRYRQTLREYLWT--RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred ceEEEehhcchhhHHHHHhc--CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 35799999999999999985 33677777888899999999999999999999999999975432 3456789999886
Q ss_pred eecCCCCCcccccc-CCCCCcccccccccccccCCC--C----CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHH
Q 021053 155 KYRDPTTNRHIPYR-ENKNLTGTARYASCNTHLGIE--Q----SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (318)
Q Consensus 155 ~~~~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~----~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (318)
-....... .||. ......|+..-+|||+....+ . -.++|.|+.|.+.||+++...||.......-.. ..
T Consensus 394 Ad~~hGlq--lpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~--r~ 469 (598)
T KOG4158|consen 394 ADDNHGLQ--LPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDT--RT 469 (598)
T ss_pred eccccccc--cccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheech--hh
Confidence 54332211 1111 234556778899999987443 1 248999999999999999999998632211000 01
Q ss_pred HHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
.++..-++ ....+|+.+++++-..|..||++|++..-....+
T Consensus 470 -Yqe~qLPa---lp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 470 -YQESQLPA---LPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred -hhhhhCCC---CcccCChHHHHHHHHHhcCCccccCCccHHHhHH
Confidence 11111222 2346788999999999999999999877444433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.9e-21 Score=153.59 Aligned_cols=138 Identities=22% Similarity=0.242 Sum_probs=103.2
Q ss_pred EeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----------------------------hhHHHHHHHHHHHcCC
Q 021053 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------------------------PQLLYEAKVYKILQGG 62 (318)
Q Consensus 11 ~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----------------------------~~~~~e~~~l~~l~~~ 62 (318)
+.+.||+|++|.||+|.+. +|+.||||++...... .....|...+.++.+.
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 8999999987754211 0124678888888765
Q ss_pred CCCCeeeeccccCcceEEEEeccCCC-HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeeccCC
Q 021053 63 SGIPNIKWYGVDGEDNVLVLDLLGPS-LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGR 140 (318)
Q Consensus 63 ~~~~~i~~~~~~~~~~~lv~e~~~~~-L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~Nil~~~~~ 140 (318)
.. .....+... ..++|||++++. +...... ...++......++.|++.+|.++|+ .||+||||||+||++ +
T Consensus 80 ~i-~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll---~ 152 (190)
T cd05145 80 GV-PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILY---H 152 (190)
T ss_pred CC-CCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEE---E
Confidence 43 222211111 258999999543 4333222 3457888899999999999999999 999999999999999 3
Q ss_pred CCCeEEEEeccceeeec
Q 021053 141 KANQVYIIDFGLAKKYR 157 (318)
Q Consensus 141 ~~~~~kL~dfg~~~~~~ 157 (318)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 6889999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.4e-23 Score=182.03 Aligned_cols=224 Identities=22% Similarity=0.320 Sum_probs=177.9
Q ss_pred eeccCcccEEEEEEEc---CCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-
Q 021053 14 KIGSGSFGEIFLASHV---DTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (318)
Q Consensus 14 ~lg~G~~~~v~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~- 85 (318)
.+|.|+||.|++++-. ..+..+++|+.+.... ......|..++...+.++.+..+...++.....++++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 3789999999988532 4566788887654321 2255667888888887888888888888888999999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccc
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~ 165 (318)
++.+...+.. ...+.....+.+...++.++.++|+.++++||+|++||++ +..|.+++.|||.++..-....
T Consensus 81 gg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill---d~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 81 GGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL---LLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred cchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee---cccCccccCCchhhhHhHhhhh----
Confidence 6677666554 3347788888899999999999999999999999999999 7999999999999986543322
Q ss_pred cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCc
Q 021053 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245 (318)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 245 (318)
..||..|||||++. ....++|.||||++.|+|+||..||.. +.+..|.......|.. ++
T Consensus 153 -------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~~~~p~~-----l~ 211 (612)
T KOG0603|consen 153 -------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAELEMPRE-----LS 211 (612)
T ss_pred -------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhccCCchh-----hh
Confidence 26799999999988 456789999999999999999999987 2344555445555533 35
Q ss_pred hhHHHHHHHHhhcCCCCCCCh
Q 021053 246 AEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 246 ~~~~~li~~cl~~~p~~Rp~~ 266 (318)
....+++..++..+|..|.-.
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhcc
Confidence 678899999999999998543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.7e-21 Score=153.13 Aligned_cols=190 Identities=16% Similarity=0.117 Sum_probs=133.3
Q ss_pred eEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCCh------hHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP------QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 10 ~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~------~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
-+...|++|+||+|+.+.. .+..++.+.+....... .+.+|+++++++.++++++.+..+ ...+++|+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3578899999999998865 66778877666544422 367899999999888888888654 34699999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI-KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl-~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|. +.+|.+.... . ...++.|++.+|.++|+.||+|||| ||+||+++ .++.++|+|||++........
T Consensus 79 yI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~---~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 79 YLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQ---EDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEc---CCCCEEEEECCCceecCCcch
Confidence 98 6666543221 1 1346789999999999999999999 79999994 778999999999985443221
Q ss_pred C------ccccccCCCCCcccccccccccccCC-CCC-CcchHHHHHHHHHHHHhCCCCccch
Q 021053 162 N------RHIPYRENKNLTGTARYASCNTHLGI-EQS-RRDDLESLGYVLLYFLRGSLPWQGL 216 (318)
Q Consensus 162 ~------~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~-~~~DvwslG~il~~l~tg~~pf~~~ 216 (318)
. .+...........++.|++|+...-. ..+ ...++.+.|+-+|.++||..|+.+.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 00000000011135556666643322 233 3567779999999999999988653
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-21 Score=182.37 Aligned_cols=215 Identities=23% Similarity=0.399 Sum_probs=154.8
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
..+|+.++.|..|+||.||.++++.+.+++|+|+-+. +. ..+- ++. .. +..+.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~l---ilRn--ilt------------~a----~npfvv---- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NL---ILRN--ILT------------FA----GNPFVV---- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-ch---hhhc--ccc------------cc----CCccee----
Confidence 4678999999999999999999999999999964222 11 1111 010 00 111222
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC----
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT---- 161 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~---- 161 (318)
|+=...+... +.++. +++.+++|+|+.||+|||+||+|.+++ .-|.+|+.|||++........
T Consensus 136 -gDc~tllk~~-g~lPv--------dmvla~Eylh~ygivhrdlkpdnllIT---~mGhiKlTDfgLsk~GLms~atnl~ 202 (1205)
T KOG0606|consen 136 -GDCATLLKNI-GPLPV--------DMVLAVEYLHSYGIVHRDLKPDNLLIT---SMGHIKLTDFGLSKKGLMSLATNLK 202 (1205)
T ss_pred -chhhhhcccC-CCCcc--------hhhHHhHhhccCCeecCCCCCCcceee---ecccccccchhhhhhhhhhccchhh
Confidence 3333333321 12332 237889999999999999999999996 889999999999876421111
Q ss_pred ----CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 162 ----NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 162 ----~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
+....-.......+|+.|.|||++....|++.+|+|++|+|+|+++-|..||.+..+ ++.+..++......|.
T Consensus 203 eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp---eelfg~visd~i~wpE 279 (1205)
T KOG0606|consen 203 EGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP---EELFGQVISDDIEWPE 279 (1205)
T ss_pred hcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH---HHHHhhhhhhhccccc
Confidence 011111123455899999999999999999999999999999999999999999765 3555555555666665
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCC
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRP 264 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp 264 (318)
.. ...+.+.++++.+.|+.+|..|-
T Consensus 280 ~d--ea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 280 ED--EALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cC--cCCCHHHHHHHHHHHHhChHhhc
Confidence 53 46778999999999999999995
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.3e-20 Score=162.62 Aligned_cols=220 Identities=14% Similarity=0.206 Sum_probs=159.7
Q ss_pred CCCCeeeeccccCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCCCCCceeeccCC
Q 021053 63 SGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF-LHRDIKPDNFLMGLGR 140 (318)
Q Consensus 63 ~~~~~i~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i-~H~dl~p~Nil~~~~~ 140 (318)
.++..+.....++...++|.++| .|+|.+.+......++......++++|+.||.|+|..-| .|+.++..|.++ |
T Consensus 7 ~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nClv---d 83 (484)
T KOG1023|consen 7 DNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNCLV---D 83 (484)
T ss_pred hhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccccee---e
Confidence 55666655556668899999999 999999998755567888888999999999999998865 999999999999 6
Q ss_pred CCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCC-------CCCcchHHHHHHHHHHHHhCCCCc
Q 021053 141 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-------QSRRDDLESLGYVLLYFLRGSLPW 213 (318)
Q Consensus 141 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~~DvwslG~il~~l~tg~~pf 213 (318)
..+.+||+|||+.......... ...........|.|||.+.+.. .+.+.|+||||++++|+++++.||
T Consensus 84 ~~w~lklt~~Gl~~~~~~~~~~-----~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 84 SRWVLKLTDFGLNSLLEETAEP-----EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred eeEEEEechhhhcccccccccc-----cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9999999999998766421000 0112223456799999987642 366799999999999999999999
Q ss_pred cchhHhhh-HHHHHHHHHhhccCchHHH--hhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcC--CchhHHH
Q 021053 214 QGLKAATK-KQKYDKICEKKVSTPIEVL--CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG--SLLLQFI 288 (318)
Q Consensus 214 ~~~~~~~~-~~~~~~i~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~--~~~~~~~ 288 (318)
........ .+.+..+.....+...+.. ....++.+..++.+||..+|+.||+++.+...+..+..... -.+++.|
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~~~~nl~D~m 238 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGSSKGNLMDSL 238 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccccccchhHHHH
Confidence 76332211 2333333221111111111 11556689999999999999999999999999988755432 2555555
Q ss_pred hh
Q 021053 289 MS 290 (318)
Q Consensus 289 l~ 290 (318)
+.
T Consensus 239 ~~ 240 (484)
T KOG1023|consen 239 FR 240 (484)
T ss_pred HH
Confidence 44
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.3e-19 Score=147.79 Aligned_cols=140 Identities=21% Similarity=0.263 Sum_probs=105.6
Q ss_pred eeeEeeeeccCcccEEEEEE-EcCCCcEEEEEeecCCCCC--------------------------hhHHHHHHHHHHHc
Q 021053 8 KYKLGRKIGSGSFGEIFLAS-HVDTNEIVAVKIENSGTKH--------------------------PQLLYEAKVYKILQ 60 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~-~~~~~~~vaiK~~~~~~~~--------------------------~~~~~e~~~l~~l~ 60 (318)
-|.+.+.||.|++|.||+|. +..+|+.||+|++...... .....|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 38899999999999999998 6678999999987643210 12457899999997
Q ss_pred CC-CCCCeeeeccccCcceEEEEeccCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCceeec
Q 021053 61 GG-SGIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG-FLHRDIKPDNFLMG 137 (318)
Q Consensus 61 ~~-~~~~~i~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~-i~H~dl~p~Nil~~ 137 (318)
+. ...+.+..+ ...++|||++++ ++...... ...........++.|++.+|.++|+.| ++||||||+||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli- 182 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV- 182 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE-
Confidence 52 122222222 235899999954 55554422 233556667889999999999999999 9999999999999
Q ss_pred cCCCCCeEEEEeccceeee
Q 021053 138 LGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 138 ~~~~~~~~kL~dfg~~~~~ 156 (318)
+ .+.++|+|||.+...
T Consensus 183 --~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 183 --H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred --E-CCCEEEEEChhhhcc
Confidence 3 678999999987643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.9e-18 Score=136.36 Aligned_cols=135 Identities=16% Similarity=0.177 Sum_probs=98.7
Q ss_pred EeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--CChhHHHHHHHHHHHcC----CCCCCeeeeccccC---cc-eEE
Q 021053 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQG----GSGIPNIKWYGVDG---ED-NVL 80 (318)
Q Consensus 11 ~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~----~~~~~~i~~~~~~~---~~-~~l 80 (318)
-.+.||+|+++.||. ++.++.. +||+..... ......+|+.++..+.| |++++.++.+.... +. +.+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 357899999999995 6666665 689766432 23468999999999953 45666665444433 23 337
Q ss_pred EEecc---CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCceeeccCC-CCCeEEEEeccc
Q 021053 81 VLDLL---GPSLEDLFVYCRRKFSLKTVLMLADQMIARI-EYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGL 152 (318)
Q Consensus 81 v~e~~---~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L-~~lH~~~i~H~dl~p~Nil~~~~~-~~~~~kL~dfg~ 152 (318)
|+|++ +++|.+++.. ..+++. ..++.|++.++ .|||+++|+||||||+||+++..+ ....++|+|++.
T Consensus 83 I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 89995 4799999975 335555 35577888887 899999999999999999996322 345899999543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.8e-17 Score=136.37 Aligned_cols=131 Identities=24% Similarity=0.397 Sum_probs=101.9
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----------hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+.||+|++|.||+|.+ .+..+++|+....... ....+|+.++..+.+.. ++....+.......+++|
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~~~~lv~ 78 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAG-VNVPAVYFVDPENFIIVM 78 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCC-CCCCeEEEEeCCCCEEEE
Confidence 5789999999999987 6677899975543211 24667888998887643 333333333445688999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
|++ +++|.+++... .. ....++.+++.+|.++|+.|++|+|++|.||++ +.+.++|+|||.+..
T Consensus 79 e~~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~----~~~~~~liDf~~a~~ 143 (211)
T PRK14879 79 EYIEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL----SGGKIYLIDFGLAEF 143 (211)
T ss_pred EEeCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE----ECCCEEEEECCcccC
Confidence 999 78998888642 12 778889999999999999999999999999999 367899999998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.3e-19 Score=154.44 Aligned_cols=175 Identities=24% Similarity=0.306 Sum_probs=131.2
Q ss_pred cceEEEEecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
.+.||.|++| ..+|.+++.... ...+......++.|++.|+.| +|.+|+|+||.||++. .+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhh
Confidence 3589999999 889999997432 236678888999999999999 9999999999999995 666899999999
Q ss_pred eeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHh
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEK 231 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~ 231 (318)
........ ....+........+|..|++||.+.+..|+.++||||||++|+|++. =..+|.... .+..+..
T Consensus 403 ~ts~~~~~-~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~------t~~d~r~- 474 (516)
T KOG1033|consen 403 VTSQDKDE-TVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA------TLTDIRD- 474 (516)
T ss_pred eeecccCC-cccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH------hhhhhhc-
Confidence 87665443 11112233456789999999999999999999999999999999998 444443322 1222211
Q ss_pred hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChH
Q 021053 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 267 (318)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 267 (318)
..-++.++...| .=..++.+++...|.+||++.
T Consensus 475 --g~ip~~~~~d~p-~e~~ll~~lls~~p~~RP~~~ 507 (516)
T KOG1033|consen 475 --GIIPPEFLQDYP-EEYTLLQQLLSPSPEERPSAI 507 (516)
T ss_pred --CCCChHHhhcCc-HHHHHHHHhcCCCcccCchHH
Confidence 122223344566 456899999999999999433
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.6e-17 Score=132.10 Aligned_cols=134 Identities=23% Similarity=0.323 Sum_probs=100.6
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC------------------------ChhHHHHHHHHHHHcCCC-
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------------------------HPQLLYEAKVYKILQGGS- 63 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~------------------------~~~~~~e~~~l~~l~~~~- 63 (318)
|.+.+.||.|++|.||+|... +++.||||++..... ......|+.++..+.+..
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 888999999999999999875 789999997653220 012466788888886642
Q ss_pred CCCeeeeccccCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCC
Q 021053 64 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (318)
Q Consensus 64 ~~~~i~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~ 142 (318)
.++.... ....+++||++ +++|..... ......++.+++.++.++|+.|++|+||+|.||++ +.+
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill---~~~ 161 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILV---DDD 161 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEE---cCC
Confidence 1222221 23468999999 666654432 13345688899999999999999999999999999 478
Q ss_pred CeEEEEeccceeeec
Q 021053 143 NQVYIIDFGLAKKYR 157 (318)
Q Consensus 143 ~~~kL~dfg~~~~~~ 157 (318)
+.++|+|||.+....
T Consensus 162 ~~~~liDfg~~~~~~ 176 (198)
T cd05144 162 EKIYIIDWPQMVSTD 176 (198)
T ss_pred CcEEEEECCccccCC
Confidence 999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.6e-17 Score=131.84 Aligned_cols=127 Identities=22% Similarity=0.373 Sum_probs=96.5
Q ss_pred eeccCcccEEEEEEEcCCCcEEEEEeecCCCC----------ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 14 ~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
.||+|++|.||+|.. ++..+++|....... ...+.+|+.++..+.+.. ++....+.......+++||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAG-VNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEECCCCEEEEE
Confidence 379999999999985 567899997543221 124567899999988743 2222223334456789999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
++ +++|.+++.... . .++.+++.+|.++|+.|++|+|++|.||++ + .+.++++|||.+..
T Consensus 78 ~~~g~~l~~~~~~~~--~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~---~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 78 YIEGKPLKDVIEEGN--D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIV---R-DDKLYLIDFGLGKY 138 (199)
T ss_pred EECCccHHHHHhhcH--H------HHHHHHHHHHHHHHHCCeecCCCCcceEEE---E-CCcEEEEECCCCcC
Confidence 99 788888775411 1 678899999999999999999999999999 3 78899999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.3e-16 Score=147.13 Aligned_cols=133 Identities=23% Similarity=0.390 Sum_probs=100.4
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-CC---------ChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TK---------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-~~---------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
..|...+.||+|+||.||+|.+... .+++|+.... .. ...+.+|+.++..++++. +.....+.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~-i~~p~~~~~~~~ 409 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAG-VPTPVIYDVDPE 409 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccC-CCeeEEEEEeCC
Confidence 3456688999999999999987543 3444432111 11 134678999999998755 333333444455
Q ss_pred ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..++||||+ +++|.+++. ....++.+++.+|.+||+.|++||||||+||++ +.+.++|+|||.++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----ECCcEEEEeCccccc
Confidence 678999999 888988775 245688999999999999999999999999999 567899999999864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.1e-15 Score=123.44 Aligned_cols=134 Identities=28% Similarity=0.370 Sum_probs=93.3
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCCh----h----------------------HHHHHHHHHHHcCCC-C
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----Q----------------------LLYEAKVYKILQGGS-G 64 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~----~----------------------~~~e~~~l~~l~~~~-~ 64 (318)
.+.||+|+||+||+|.+. +++.||||++....... . ...|...+..+.+.. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 578999999999999986 78899999876532110 1 124555555554432 1
Q ss_pred CCeeeeccccCcceEEEEeccCC-CHHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeeccCCC
Q 021053 65 IPNIKWYGVDGEDNVLVLDLLGP-SLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRK 141 (318)
Q Consensus 65 ~~~i~~~~~~~~~~~lv~e~~~~-~L~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~Nil~~~~~~ 141 (318)
.+....+ ...+++||++.+ ++.. .+.... . ......++.+++.++.++|+ .||+|+||+|+||++ +
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili---~- 149 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILV---D- 149 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEE---E-
Confidence 2222222 246899999944 3221 122111 1 15677889999999999999 999999999999999 3
Q ss_pred CCeEEEEeccceeeec
Q 021053 142 ANQVYIIDFGLAKKYR 157 (318)
Q Consensus 142 ~~~~kL~dfg~~~~~~ 157 (318)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 7889999999987544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=6e-15 Score=114.41 Aligned_cols=131 Identities=21% Similarity=0.284 Sum_probs=104.1
Q ss_pred EeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCC-CCCCeeeeccccCcceEEEEeccC-CC
Q 021053 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG-SGIPNIKWYGVDGEDNVLVLDLLG-PS 88 (318)
Q Consensus 11 ~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~-~~~~~i~~~~~~~~~~~lv~e~~~-~~ 88 (318)
+.+.||.|.++.||++...+ ..+++|..........+.+|...+..+.++ ..++.+..+....+..++++|++. .+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 46789999999999999844 678999876654445788999999999876 455666555555578999999994 44
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR---GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
+..+ +......++.+++.+|..+|.. +++|+|++|+||+++ ..+.++++|||.+.
T Consensus 80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~---~~~~~~l~Df~~~~ 137 (155)
T cd05120 80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYAG 137 (155)
T ss_pred cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE---CCcEEEEEeccccc
Confidence 4332 4455666788999999999985 799999999999995 57899999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.3e-14 Score=121.15 Aligned_cols=132 Identities=16% Similarity=0.217 Sum_probs=94.5
Q ss_pred eeec-cCcccEEEEEEEcCCCcEEEEEeecCC---------------CCChhHHHHHHHHHHHcCCCC-CCeeeec-ccc
Q 021053 13 RKIG-SGSFGEIFLASHVDTNEIVAVKIENSG---------------TKHPQLLYEAKVYKILQGGSG-IPNIKWY-GVD 74 (318)
Q Consensus 13 ~~lg-~G~~~~v~~~~~~~~~~~vaiK~~~~~---------------~~~~~~~~e~~~l~~l~~~~~-~~~i~~~-~~~ 74 (318)
..|| .|+.|+||.+... +..+++|.+... .....+.+|+.++..+.+... .+....+ ...
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 7888999999773 677888865321 122357889999999987443 2333222 112
Q ss_pred Cc---ceEEEEeccC--CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEe
Q 021053 75 GE---DNVLVLDLLG--PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (318)
Q Consensus 75 ~~---~~~lv~e~~~--~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~d 149 (318)
.. ..++|+|++. .+|.+++.. ..++... +.+++.+|.++|++||+|+||||.|||+. .++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~---~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLD---PDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEc---CCCCEEEEE
Confidence 22 2359999994 488888764 3355443 46899999999999999999999999994 567899999
Q ss_pred ccceee
Q 021053 150 FGLAKK 155 (318)
Q Consensus 150 fg~~~~ 155 (318)
||.+..
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 998764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=2.6e-17 Score=153.46 Aligned_cols=255 Identities=26% Similarity=0.294 Sum_probs=185.0
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCC-CcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDT-NEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~-~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
...|.+.+.||.|+++.|-.+....+ ...++.|.+.... ...+...|..+-..+..|.++.............++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 45789999999999999998887543 3455666444332 122344566777777756777777777777788999
Q ss_pred EEecc-CCCHHHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceeeccCCCCC-eEEEEeccceeee
Q 021053 81 VLDLL-GPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKY 156 (318)
Q Consensus 81 v~e~~-~~~L~~~~-~~~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dl~p~Nil~~~~~~~~-~~kL~dfg~~~~~ 156 (318)
++++. ++++.+.+ .......+......++.|+..++.|+| ..++.|+|++|+|.+++ ..+ .++++|||++...
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~---~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLD---ESGSALKIADFGLATAY 175 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhc---cCCCcccCCCchhhccc
Confidence 99998 77887777 432225677778889999999999999 99999999999999995 666 8999999999876
Q ss_pred cC-CCCCccccccCCCCCcc-cccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 157 RD-PTTNRHIPYRENKNLTG-TARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 157 ~~-~~~~~~~~~~~~~~~~~-~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
.. ..... ......| ++.|.|||...+.. ..+..|+||.|+++.-+++|..|+....... ..+........
T Consensus 176 ~~~~g~~~-----~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~--~~~~~~~~~~~ 248 (601)
T KOG0590|consen 176 RNKNGAER-----SLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD--GRYSSWKSNKG 248 (601)
T ss_pred cccCCcce-----eeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc--ccceeeccccc
Confidence 65 22221 2234455 89999999998854 5778999999999999999999997654332 11111111111
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
......+..++....++...++..+|+.|.+.+++..
T Consensus 249 -~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 -RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 1112234566778889999999899999988776543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.2e-15 Score=133.92 Aligned_cols=253 Identities=18% Similarity=0.150 Sum_probs=189.7
Q ss_pred cccceeeEeeeecc--CcccEEEEEEE--cCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 4 IIGVKYKLGRKIGS--GSFGEIFLASH--VDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 4 ~~~~~y~~~~~lg~--G~~~~v~~~~~--~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
+...++.+.+.+|. |.+|.+|.+.. ..+...+|+|.-+... ....-.+|+..-.++..|.+...........
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccC
Confidence 45567788899999 99999999998 7888899999643322 2334566777777777666666655666677
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHH----HHHHHHhCCccccCCCCCceeeccCCCC-CeEEEEec
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIA----RIEYVHSRGFLHRDIKPDNFLMGLGRKA-NQVYIIDF 150 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~----~L~~lH~~~i~H~dl~p~Nil~~~~~~~-~~~kL~df 150 (318)
+..++-+|.|+.+|..+......-++....+....+... ||.++|+.+++|-|++|.||+.. .+ ...+++||
T Consensus 191 ~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~---~~~~s~~~~df 267 (524)
T KOG0601|consen 191 GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTT---SDWTSCKLTDF 267 (524)
T ss_pred CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecc---cccceeecCCc
Confidence 889999999999999999876665788888888889999 99999999999999999999996 55 88999999
Q ss_pred cceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccch--hHhhhHHHHHHH
Q 021053 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL--KAATKKQKYDKI 228 (318)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~--~~~~~~~~~~~i 228 (318)
|+.............. .....-+...|++||.+.+. ++.+.|++|+|.++.+..++..+.... +.+. .+..
T Consensus 268 ~~v~~i~~~~~~~~~~--~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~---~~r~- 340 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFK--VSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWS---QLRQ- 340 (524)
T ss_pred ceeEEccCCcccccee--eeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCcc---cccc-
Confidence 9988877655332211 11122567789999997764 577899999999999999987776543 2221 1111
Q ss_pred HHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..-..++....+.++...+.++++.+|-.|++++.+..
T Consensus 341 -----~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 341 -----GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11223344455667778999999999999988775443
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.9e-13 Score=121.80 Aligned_cols=139 Identities=23% Similarity=0.357 Sum_probs=95.3
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC------------------------------------------hhH
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH------------------------------------------PQL 49 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~------------------------------------------~~~ 49 (318)
.+.||+|++|+||+|+.+ +|+.||||+..+.... -++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 367999999999999865 6899999987543210 023
Q ss_pred HHHHHHHHHHc----CCCCCCeeeeccccCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 021053 50 LYEAKVYKILQ----GGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA-RIEYVHSRG 123 (318)
Q Consensus 50 ~~e~~~l~~l~----~~~~~~~i~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~-~L~~lH~~~ 123 (318)
.+|...+.+++ +.+.+.....+.......++||||+ +.+|.++........+ ...++.+++. .+..+|..|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 44555555553 2232222233444445689999999 7788777653222233 2345555555 478899999
Q ss_pred ccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 124 i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
++|+|++|.||++ +.++.++++|||.+....
T Consensus 278 ~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFV---LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence 9999999999999 478899999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.5e-12 Score=104.22 Aligned_cols=136 Identities=16% Similarity=0.206 Sum_probs=96.4
Q ss_pred eeeeccCcccEEEEEEEcC------CCcEEEEEeecCCC--------------C----------Ch----hHHHHHHHHH
Q 021053 12 GRKIGSGSFGEIFLASHVD------TNEIVAVKIENSGT--------------K----------HP----QLLYEAKVYK 57 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~------~~~~vaiK~~~~~~--------------~----------~~----~~~~e~~~l~ 57 (318)
...||.|--+.||.|.... .+..+|+|+.+... . .. ...+|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998653 35789999744111 0 00 2348899999
Q ss_pred HHcCCC-CCCeeeeccccCcceEEEEeccCCC-HHH-HHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCc
Q 021053 58 ILQGGS-GIPNIKWYGVDGEDNVLVLDLLGPS-LED-LFVYCRRKFSLKTVLMLADQMIARIEYV-HSRGFLHRDIKPDN 133 (318)
Q Consensus 58 ~l~~~~-~~~~i~~~~~~~~~~~lv~e~~~~~-L~~-~~~~~~~~~~~~~~~~~~~qi~~~L~~l-H~~~i~H~dl~p~N 133 (318)
++.... ..|....+ ...++|||+.+++ +.. .+. ...++......+..+++.+|..+ |..|++|+||++.|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 987642 23344433 4678999999653 211 122 12245556677788999999988 89999999999999
Q ss_pred eeeccCCCCCeEEEEeccceeeec
Q 021053 134 FLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 134 il~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|++ .++.+.++|||.+....
T Consensus 156 IL~----~~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLW----HDGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE----ECCcEEEEECCCceeCC
Confidence 999 45789999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.6e-12 Score=103.13 Aligned_cols=126 Identities=21% Similarity=0.319 Sum_probs=93.7
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCCH
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSL 89 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~L 89 (318)
.+.|+.|.++.||+++.. +..|++|+..... ......+|..+++.+.+....+.+..... ...++|||++ +.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence 467899999999999874 6789999876543 23456889999999876555555544432 3458999999 5555
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 90 EDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF-----LHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 90 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i-----~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
... . . .....+.+++.+|..||+.++ +|+|++|.||++ +.+.++++||+.+.
T Consensus 79 ~~~-~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~----~~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTE-D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL----DDGRLWLIDWEYAG 135 (170)
T ss_pred ccc-c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE----ECCeEEEEeccccc
Confidence 432 0 1 112345789999999999985 999999999999 35679999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.1e-11 Score=110.11 Aligned_cols=138 Identities=20% Similarity=0.296 Sum_probs=91.4
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC------------------------------------------
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------------------------------------------ 45 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~------------------------------------------ 45 (318)
.|+. +.||+|++|+||+|+.+.+|+.||||+..+.-.
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 789999999999999988899999998764310
Q ss_pred ChhHHHHHHHHHHHcC----CCCCCeeeeccccCcceEEEEecc-CCCHHHHHHHhcCCCC-----HHHHHHHHHHHHHH
Q 021053 46 HPQLLYEAKVYKILQG----GSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFS-----LKTVLMLADQMIAR 115 (318)
Q Consensus 46 ~~~~~~e~~~l~~l~~----~~~~~~i~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~-----~~~~~~~~~qi~~~ 115 (318)
.-++.+|...+.++.. .+.+..-..+.......++||||+ |+.+.++-.-...+.+ ...+..++.
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~----- 274 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT----- 274 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH-----
Confidence 0123455555555542 222211234444556789999999 7788764221122233 222333333
Q ss_pred HHHHHhCCccccCCCCCceeeccCCCCC----eEEEEeccceeee
Q 021053 116 IEYVHSRGFLHRDIKPDNFLMGLGRKAN----QVYIIDFGLAKKY 156 (318)
Q Consensus 116 L~~lH~~~i~H~dl~p~Nil~~~~~~~~----~~kL~dfg~~~~~ 156 (318)
.+...|++|+|++|.||++. .++ .+++.|||.....
T Consensus 275 --Qif~~GffHaDpHPGNIlv~---~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 275 --QVFRDGFFHADMHPGNIFVS---YDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred --HHHhCCeeeCCCChHHeEEe---cCCCCCCeEEEEecceEEEC
Confidence 34568999999999999995 555 8999999998755
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.38 E-value=1.7e-11 Score=94.69 Aligned_cols=147 Identities=20% Similarity=0.243 Sum_probs=107.9
Q ss_pred EeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-C---------ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-K---------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 11 ~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-~---------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
....+.+|+-+.|+++.+ .|+.++||.-.+.. + ..+..+|...+.++.-. .+..-..++.+...-.+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~-GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL-GIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh-CCCCceEEEEecCCCeE
Confidence 567888999999999988 67888888422222 1 22567888888887653 34344445555566789
Q ss_pred EEeccCC--CHHHHHHHhcCCCCH-HHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 81 VLDLLGP--SLEDLFVYCRRKFSL-KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 81 v~e~~~~--~L~~~~~~~~~~~~~-~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
+|||..| ++.+++.+.-..-.. .-...++..|-..+.-||.++++|+||..+||++........+.++|||++....
T Consensus 88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s~ 167 (229)
T KOG3087|consen 88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVSR 167 (229)
T ss_pred EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhccc
Confidence 9999966 888888765433333 3336788899999999999999999999999999744455566899999987654
Q ss_pred CCC
Q 021053 158 DPT 160 (318)
Q Consensus 158 ~~~ 160 (318)
.+.
T Consensus 168 ~~E 170 (229)
T KOG3087|consen 168 LPE 170 (229)
T ss_pred Ccc
Confidence 433
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=9.9e-11 Score=106.66 Aligned_cols=181 Identities=15% Similarity=0.142 Sum_probs=125.3
Q ss_pred eeEeeeeccCcccEEE-EEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 9 YKLGRKIGSGSFGEIF-LASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~-~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
|.+ .....++. .+| .|..+.++.+|.+...+.... .....+-++-++.++|++++..+..+. ..+..|+|+|.+
T Consensus 15 Y~l-e~~~~~~~-a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-~~~~~ylvTErV 91 (690)
T KOG1243|consen 15 YDL-EETAFSSE-ALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE-EEGTLYLVTERV 91 (690)
T ss_pred ccc-ccccCCCc-ccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc-ccCceEEEeecc
Confidence 444 44444444 344 356667788888887766554 345677888899999976666665554 445899999988
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
.. |..++.. +....++..+.||+.||.+|| +++++|++|+-+.|+|+ ..|..||++|..+........-
T Consensus 92 ~P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn---~~GeWkLggle~v~~~~~~~~~-- 161 (690)
T KOG1243|consen 92 RP-LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVN---ESGEWKLGGLELVSKASGFNAP-- 161 (690)
T ss_pred cc-HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEc---CCCcEEEeeeEEEeccccCCcc--
Confidence 42 4455554 336677778899999999997 67899999999999995 9999999999987654432210
Q ss_pred ccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhC
Q 021053 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 209 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg 209 (318)
......-..|..|+...... -..|.|.|||++++++.|
T Consensus 162 -----~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 162 -----AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -----cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 01111122345555433222 357999999999999999
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=5.5e-12 Score=105.40 Aligned_cols=196 Identities=12% Similarity=0.162 Sum_probs=125.9
Q ss_pred HHcCCCCCCeeeeccccC-----cceEEEEecc-CCCHHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--ccc
Q 021053 58 ILQGGSGIPNIKWYGVDG-----EDNVLVLDLL-GPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVHSRG--FLH 126 (318)
Q Consensus 58 ~l~~~~~~~~i~~~~~~~-----~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~--i~H 126 (318)
++-|.+ +..++.|+.+. ....++.||+ .+++.+++.+... .+.....++++.||+.||.|||+.. |+|
T Consensus 123 qlvHsn-lvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiih 201 (458)
T KOG1266|consen 123 QLVHSN-LVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIH 201 (458)
T ss_pred HHHHHH-HHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcccc
Confidence 334433 55554444432 3478899999 9999999986533 4777888999999999999999986 999
Q ss_pred cCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHH
Q 021053 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYF 206 (318)
Q Consensus 127 ~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l 206 (318)
+++..+.|++. .++.+|+.--.....- +.. ..+--.......+.+.|.|||.=..-..+-++|||+||+...+|
T Consensus 202 gnlTc~tifiq---~ngLIkig~~ap~s~h--~s~-~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 202 GNLTCDTIFIQ---HNGLIKIGSVAPDSTH--PSV-NSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCcchhheeec---CCceEEecccCccccc--hhh-hhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 99999999995 7787777532111100 000 00000011223456778899876655667789999999999999
Q ss_pred HhCCCC-ccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 207 LRGSLP-WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 207 ~tg~~p-f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.-+..- -...+............ .... ...=+.++..|+...|..||++..+.-
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i---~~le--------n~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVI---IGLE--------NGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHheeccCCCcceeehhhhhhhhe---eecc--------CccccCcCcccccCCCCCCcchhhhhc
Confidence 887644 22222211122222111 1111 112357889999999999999986543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.4e-12 Score=121.94 Aligned_cols=249 Identities=20% Similarity=0.186 Sum_probs=171.7
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-----hhHHHHHHHHHHHcCCCCCCeeee---ccccCcc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKW---YGVDGED 77 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~i~~---~~~~~~~ 77 (318)
.+.+.+.+.+.+|+++.++.++-..++...++|+....... +....+-.++ .++..+.... -+.....
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~----i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNIL----ITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCcc----ccCCCCceecccCCCCCCCC
Confidence 45677888899999999999987777755565643322111 1111111111 1111122211 1234567
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.+++++++ +++|...++..+ +.+...++.+...+.+++.+||+..+.|+|++|.|.+.. ..+..++.||+.....
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~---~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIA---YDGHRPLTDFGTLSKV 954 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhc---ccCCcccCcccccccc
Confidence 89999999 788888888644 466666677777899999999999999999999999994 8899999999833221
Q ss_pred cCC-CC-------C-------------ccc---cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCC
Q 021053 157 RDP-TT-------N-------------RHI---PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212 (318)
Q Consensus 157 ~~~-~~-------~-------------~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~p 212 (318)
..- .. . ... ..+......+|+.|.+||.+.+..-+..+|+|++|+++++.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 00 0 000 11223456789999999999999999999999999999999999999
Q ss_pred ccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChH
Q 021053 213 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG 267 (318)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 267 (318)
|....++ +.+..+.+...+.|.-. ...+....+++...+..+|.+|..+.
T Consensus 1035 ~na~tpq---~~f~ni~~~~~~~p~g~--~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQ---QIFENILNRDIPWPEGP--EEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchh---hhhhccccCCCCCCCCc--cccChhhhhhhhhhhccCchhccCcc
Confidence 9876553 44556665665555322 34567789999999999999996654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.4e-10 Score=88.74 Aligned_cols=128 Identities=22% Similarity=0.358 Sum_probs=93.9
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCC-C---------ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-K---------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-~---------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
..+++|+-+.++.+.+ -+..+++|.-.+.. . .....+|..++.+++.. .++.-..++.+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~-GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREA-GVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHc-CCCCCeEEEEcCCCCEEEE
Confidence 3578899999999976 34457888433222 1 22567888999888763 4545555666667789999
Q ss_pred eccC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 83 DLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 83 e~~~-~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
||.+ ..|.+.+... ...++..+-.-+.-||..||+|+||.++||++ ..+.+.++|||++..
T Consensus 79 e~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl----~~~~i~~IDfGLg~~ 140 (204)
T COG3642 79 EYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIIL----SGGRIYFIDFGLGEF 140 (204)
T ss_pred EEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEE----eCCcEEEEECCcccc
Confidence 9994 4566677653 13455667777889999999999999999999 455599999999864
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.7e-10 Score=97.27 Aligned_cols=252 Identities=13% Similarity=0.203 Sum_probs=158.9
Q ss_pred eEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCe-e-----eeccccCcc-eEEEE
Q 021053 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN-I-----KWYGVDGED-NVLVL 82 (318)
Q Consensus 10 ~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~-i-----~~~~~~~~~-~~lv~ 82 (318)
..++.||+|+.+.+|-.-... ..+-|+.......... +-+..+...-.++.... + ..++.+... ..+.|
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQA-QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCCccccCCccceeeecchhh---chhheeecCCCchHHH-HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 567889999999999764322 2355877665432221 12222222222222222 1 233444443 66778
Q ss_pred eccCC--CHHHHHHHhc--C---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 83 DLLGP--SLEDLFVYCR--R---KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 83 e~~~~--~L~~~~~~~~--~---~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
+...+ ....++.... . ...+....+.++.++.+...||..|-.-+|++++|+|++ +.+.+.|.|-+.-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs---d~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS---DDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee---cCceEEEEcccceee
Confidence 77733 3444433211 1 267889999999999999999999999999999999996 888999987543222
Q ss_pred ecCCCCCccccccCCCCCccccccccccccc-----CCCCCCcchHHHHHHHHHHHHhC-CCCccchhHhhh----HH-H
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATK----KQ-K 224 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~tg-~~pf~~~~~~~~----~~-~ 224 (318)
. .... ...+..|...|..||.-. +..-+...|-+.||+++|+++.| .+||.+...... .+ .
T Consensus 167 ~-~ng~-------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~ 238 (637)
T COG4248 167 N-ANGT-------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD 238 (637)
T ss_pred c-cCCc-------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh
Confidence 2 1111 124567889999999644 33456778999999999999985 999976311000 00 0
Q ss_pred H-------H-HHHHhhccCchHHHhhcCchhHHHHHHHHhhcC--CCCCCChHHHHHHHHHH
Q 021053 225 Y-------D-KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLT--FDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 225 ~-------~-~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~--p~~Rp~~~~l~~~l~~~ 276 (318)
+ . .......++|.+--+.-+|+++..+..+|+... +.-||+++-+...+..+
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al 300 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL 300 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence 0 0 000122233333334456889999999998753 45899999888888765
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.2e-11 Score=111.30 Aligned_cols=242 Identities=18% Similarity=0.113 Sum_probs=163.0
Q ss_pred cceeeEeeeeccCcccEEEEEEEc-CCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHV-DTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~-~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
..+|..+..||.|.|+.|+.+... .++..|++|-+.+... ......|+.+...+..+.+.+.....+....+.|+
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 467889999999999999998755 6788899885543322 12345666666667665555554344444455678
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
-.||| ++++.... .....+++...+.+..|++.++.++|+..++|+|++|+||++. .+.+..+++|||....+...
T Consensus 344 p~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~--~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILIS--NDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred chhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeec--cchhhhhcccccccccccee
Confidence 89999 66655444 3344578888899999999999999999999999999999996 22388899999987642211
Q ss_pred CCCccccccCCCCCccccccc--ccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 160 TTNRHIPYRENKNLTGTARYA--SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
. .......++. ++.......+..++|++|||..+.+..++.+.-..... ...+.....+...
T Consensus 421 ~----------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------~~~i~~~~~p~~~ 484 (524)
T KOG0601|consen 421 S----------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------SLTIRSGDTPNLP 484 (524)
T ss_pred c----------ccccccccccccchhhccccccccccccccccccccccccCcccCccccc------ceeeecccccCCC
Confidence 1 1222233333 45555566788999999999999999998755432111 1122222111111
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+..+..+..-....++..||.+.++..
T Consensus 485 -----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~ 513 (524)
T KOG0601|consen 485 -----GLKLQLQVLLKVMINPDRKRRPSAVELSL 513 (524)
T ss_pred -----chHHhhhhhhhhhcCCccccchhhhhhcc
Confidence 11245667777777888888888776544
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.8e-12 Score=118.25 Aligned_cols=189 Identities=12% Similarity=0.143 Sum_probs=131.0
Q ss_pred HHHHHHHHHHhC-CccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcccccc--CCCCCcccccccccccccC
Q 021053 111 QMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR--ENKNLTGTARYASCNTHLG 187 (318)
Q Consensus 111 qi~~~L~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~ 187 (318)
+++.||.++|.. +++|++|.|++|.+ +..+..||+.|+++.....+.......|. .+........|.|||++.+
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred cccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 455999999965 89999999999999 58999999999998766543221111111 1233345567999999999
Q ss_pred CCCCCcchHHHHHHHHHHHH-hCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCCh
Q 021053 188 IEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 188 ~~~~~~~DvwslG~il~~l~-tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 266 (318)
..-+.++|++|+||.+|.+. .|+.-+...+...... ..........-.....+|.++++-+...+..++..||++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~----~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS----FSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhh----hhhcccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 88899999999999999999 5776665533221111 111122222222235678899999999999999999977
Q ss_pred HHHHHHHH-HHHHhcCCchhHHHhhhcCCcccccccceeee
Q 021053 267 GFLKRLFH-DLFSREGSLLLQFIMSYCSLHSITFQTNIINI 306 (318)
Q Consensus 267 ~~l~~~l~-~~~~~~~~~~~~~~l~~~p~~r~t~~~~~~~~ 306 (318)
..+..... .--.-...++++.+.++||.+.-.+-+.+..+
T Consensus 260 ~~l~~~~ff~D~~~~aLrfLD~l~~kdn~qKs~Flk~Ls~~ 300 (700)
T KOG2137|consen 260 DLLLSIPFFSDPGLKALRFLDDLPQKDNSQKSSFLKGLSKL 300 (700)
T ss_pred hhhhcccccCCchhhhhhhcccccccCcHHHHHHHHHHHHh
Confidence 76554332 11122446888888888998887777665543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.8e-09 Score=89.30 Aligned_cols=136 Identities=21% Similarity=0.321 Sum_probs=95.0
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCC-CCeeeeccccC---cceEEEEecc
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSG-IPNIKWYGVDG---EDNVLVLDLL 85 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~-~~~i~~~~~~~---~~~~lv~e~~ 85 (318)
+.|+.|..+.+|++...+ +..+++|+..... ......+|.++++.+.+... ++.+..+.... +..+++|+++
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 678999999999998743 5789999876543 24578899999999987422 44444443332 3568999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 021053 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS------------------------------------------- 121 (318)
Q Consensus 86 -~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~------------------------------------------- 121 (318)
+.++.+.+.. ..++......++.+++.+|..||+
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 5555554321 235555566666666666666663
Q ss_pred -------------CCccccCCCCCceeeccCCC--CCeEEEEecccee
Q 021053 122 -------------RGFLHRDIKPDNFLMGLGRK--ANQVYIIDFGLAK 154 (318)
Q Consensus 122 -------------~~i~H~dl~p~Nil~~~~~~--~~~~kL~dfg~~~ 154 (318)
..++|+|+.|.||+++ . .+.+.++||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFH---PDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEc---CCCCcEEEEEeccccc
Confidence 2469999999999995 4 4668899998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.9e-09 Score=86.83 Aligned_cols=131 Identities=18% Similarity=0.131 Sum_probs=90.1
Q ss_pred EEEEEEEcCCCcEEEEEeecCCC-------------CChhHHHHHHHHHHHcCCCCC-Ceeeecccc-----CcceEEEE
Q 021053 22 EIFLASHVDTNEIVAVKIENSGT-------------KHPQLLYEAKVYKILQGGSGI-PNIKWYGVD-----GEDNVLVL 82 (318)
Q Consensus 22 ~v~~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~e~~~l~~l~~~~~~-~~i~~~~~~-----~~~~~lv~ 82 (318)
.|.++.. .|+.|.||...... ....+.+|...+..+...... +....++.. ....++|+
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3555554 56678889543222 111377899988888543222 222223321 23578999
Q ss_pred eccCC--CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecc----CCCCCeEEEEecccee
Q 021053 83 DLLGP--SLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL----GRKANQVYIIDFGLAK 154 (318)
Q Consensus 83 e~~~~--~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~----~~~~~~~kL~dfg~~~ 154 (318)
|+.++ +|.+++... ....+......++.+++..+.-||..||+|+|+++.|||+.. .+....+.|+||+.+.
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99954 688887643 233566777789999999999999999999999999999952 1235789999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.6e-09 Score=85.32 Aligned_cols=125 Identities=27% Similarity=0.371 Sum_probs=78.3
Q ss_pred EEEEEEEcCCCcEEEEEeecCCC--------------C--------------ChhHHHHHHHHHHHcCCC-CCCeeeecc
Q 021053 22 EIFLASHVDTNEIVAVKIENSGT--------------K--------------HPQLLYEAKVYKILQGGS-GIPNIKWYG 72 (318)
Q Consensus 22 ~v~~~~~~~~~~~vaiK~~~~~~--------------~--------------~~~~~~e~~~l~~l~~~~-~~~~i~~~~ 72 (318)
.||.|... ++..+|+|+..... . .....+|...|.++.... ..|.+..+
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 38888864 46789999744210 0 114678999999987653 34444433
Q ss_pred ccCcceEEEEeccC--CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCccccCCCCCceeeccCCCCCeEEEEe
Q 021053 73 VDGEDNVLVLDLLG--PSLEDLFVYCRRKFSLKTVLMLADQMIARIE-YVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (318)
Q Consensus 73 ~~~~~~~lv~e~~~--~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~-~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~d 149 (318)
...++||||.+ |.....+.... ++......++.+++..+. .+|..|++|+||++.||+++ .+.+.++|
T Consensus 79 ---~~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~----~~~~~iID 149 (188)
T PF01163_consen 79 ---NRNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD----DGKVYIID 149 (188)
T ss_dssp ---ETTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE----TTCEEE--
T ss_pred ---eCCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee----cceEEEEe
Confidence 24689999997 64444444322 223445566677877555 46899999999999999994 44999999
Q ss_pred ccceeeec
Q 021053 150 FGLAKKYR 157 (318)
Q Consensus 150 fg~~~~~~ 157 (318)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.90 E-value=1.9e-08 Score=82.94 Aligned_cols=133 Identities=20% Similarity=0.301 Sum_probs=94.4
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----------------CC-------ChhHHHHHHHHHHHcCC-C
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----------------TK-------HPQLLYEAKVYKILQGG-S 63 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----------------~~-------~~~~~~e~~~l~~l~~~-~ 63 (318)
+.++..||-|--|.||.|.+. .+..+|+|.-... .. ...+.+|+++|.+|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 357889999999999999986 5788999952200 00 11468899999998754 2
Q ss_pred CCCeeeeccccCcceEEEEeccCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCC
Q 021053 64 GIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (318)
Q Consensus 64 ~~~~i~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~ 142 (318)
.++... ..+...+|||+..| .|...- ++......++..|+.-+..+-..|++|+|+++-||+++ ++
T Consensus 172 ~VP~P~----~~nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~---~d 238 (304)
T COG0478 172 KVPKPI----AWNRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVT---ED 238 (304)
T ss_pred CCCCcc----ccccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEe---cC
Confidence 222222 22457899999955 333221 23444555667777777777799999999999999994 88
Q ss_pred CeEEEEeccceee
Q 021053 143 NQVYIIDFGLAKK 155 (318)
Q Consensus 143 ~~~kL~dfg~~~~ 155 (318)
|.+.++||-.+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999976653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.90 E-value=8.6e-08 Score=77.17 Aligned_cols=137 Identities=14% Similarity=0.117 Sum_probs=97.9
Q ss_pred ccCcccEEEEEEEcCCCcEEEEEeec--------CCCCChhHHHHHHHHHHHcCCCCC-Ceeeecccc----CcceEEEE
Q 021053 16 GSGSFGEIFLASHVDTNEIVAVKIEN--------SGTKHPQLLYEAKVYKILQGGSGI-PNIKWYGVD----GEDNVLVL 82 (318)
Q Consensus 16 g~G~~~~v~~~~~~~~~~~vaiK~~~--------~~~~~~~~~~e~~~l~~l~~~~~~-~~i~~~~~~----~~~~~lv~ 82 (318)
|.||.|-|+..... |+.+-+|... .+...+.+.+|+..+..+...... +.+..+... .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 45899999998763 3357778533 123456899999999999764433 222322211 22468999
Q ss_pred eccC--CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 83 DLLG--PSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 83 e~~~--~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
|..+ .+|.+++.... .+.+......++.+++..+.-||+.|+.|+|+.+.||++... ....++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~-g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE-GKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC-CCeeEEEEEhhccch
Confidence 9886 68888876422 235777788999999999999999999999999999999311 233499999987654
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=8.9e-08 Score=74.04 Aligned_cols=130 Identities=24% Similarity=0.397 Sum_probs=100.8
Q ss_pred eEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCC
Q 021053 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPS 88 (318)
Q Consensus 10 ~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~ 88 (318)
+..+.|+.|++|.||+|.+ .+..+|+|+-..+....++.+|.++++.+.....-+.++.|+.+. +.|||. +..
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G~~ 98 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDGRP 98 (201)
T ss_pred hhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcCcc
Confidence 5567899999999999988 456899999999888899999999999999988888888887543 559999 557
Q ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCC--CceeeccCCCCCeEEEEeccceeeec
Q 021053 89 LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKP--DNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 89 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p--~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|.+.-.. .+..+ +..++..-.-|-..||-|+.|+- .||++ .+..+.|+||..++...
T Consensus 99 L~~~~~~----~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~k~ 157 (201)
T COG2112 99 LGKLEIG----GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLV----NDRDVYIIDFDSATFKK 157 (201)
T ss_pred hhhhhhc----ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEe----cCCcEEEEEccchhhcc
Confidence 8766542 12222 23455665667778999999975 56666 55589999999987543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.78 E-value=1.3e-07 Score=76.50 Aligned_cols=138 Identities=20% Similarity=0.268 Sum_probs=91.7
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCCh-----------hHHHHHHHHHHHcCCC--CCCee
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP-----------QLLYEAKVYKILQGGS--GIPNI 68 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~e~~~l~~l~~~~--~~~~i 68 (318)
+.++.++|.+.+.+-......|.+..- ++..+++|...+..... ...+.+..+.++.... ....+
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 457889999999999988887777755 67889999766544321 2233444444443211 11111
Q ss_pred eec-----cccCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCC
Q 021053 69 KWY-----GVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (318)
Q Consensus 69 ~~~-----~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~ 142 (318)
..+ .......+++|||+ |..|.+... +++ .+...+..++.-+|+.|+.|+|..|.|+++ .+
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv----~~ 170 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLV----SN 170 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEE----EC
Confidence 111 11234567999999 656655532 222 234567788999999999999999999999 45
Q ss_pred CeEEEEecccee
Q 021053 143 NQVYIIDFGLAK 154 (318)
Q Consensus 143 ~~~kL~dfg~~~ 154 (318)
+.++++||+..+
T Consensus 171 ~~i~iID~~~k~ 182 (229)
T PF06176_consen 171 NGIRIIDTQGKR 182 (229)
T ss_pred CcEEEEECcccc
Confidence 669999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.8e-07 Score=76.42 Aligned_cols=110 Identities=21% Similarity=0.295 Sum_probs=80.5
Q ss_pred CChhHHHHHHHHHHHcCCCC-CCeeeecccc----CcceEEEEeccCC--CHHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 021053 45 KHPQLLYEAKVYKILQGGSG-IPNIKWYGVD----GEDNVLVLDLLGP--SLEDLFVYCRRKFSLKTVLMLADQMIARIE 117 (318)
Q Consensus 45 ~~~~~~~e~~~l~~l~~~~~-~~~i~~~~~~----~~~~~lv~e~~~~--~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~ 117 (318)
......+|...+..+..... .+....++.. ....++++|...+ +|.+++..... .+......++.+++..+.
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIA 132 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHH
Confidence 34568889988888865322 2222333322 1345899999843 68888876333 667778889999999999
Q ss_pred HHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 118 ~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
-||..||+|+|++|.|||+...+....+.|+||+.+..
T Consensus 133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999996433345899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.3e-06 Score=72.39 Aligned_cols=71 Identities=18% Similarity=0.141 Sum_probs=53.5
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCC-CCeeeeccccCcceEEEEeccCC
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGVDGEDNVLVLDLLGP 87 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~i~~~~~~~~~~~lv~e~~~~ 87 (318)
..||.|..+.||+. .+..+++|............+|.+++..+..... .+....++.......++|+++.|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 57899999999984 2445788987765555678899999999976544 46666666666667899999955
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.2e-05 Score=72.09 Aligned_cols=208 Identities=16% Similarity=0.198 Sum_probs=134.7
Q ss_pred cccEEEEEEEcCCCcEEEEEeecCCCCCh--hHHHHHHHHHHHcCCCCCCeeeeccc----cCcceEEEEecc--CCCHH
Q 021053 19 SFGEIFLASHVDTNEIVAVKIENSGTKHP--QLLYEAKVYKILQGGSGIPNIKWYGV----DGEDNVLVLDLL--GPSLE 90 (318)
Q Consensus 19 ~~~~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~e~~~l~~l~~~~~~~~i~~~~~----~~~~~~lv~e~~--~~~L~ 90 (318)
-..+.|++....+|..|++|.++-..... ....-+++.+++.|.+.+ .+...+. .....++|++|+ .++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV-~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVV-PFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCcee-ehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 34578999999999999999883322111 123346677777775444 4432222 334689999998 67788
Q ss_pred HHHHHh--------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 91 DLFVYC--------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 91 ~~~~~~--------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
++.-.. +...++...+.++.|+..||.++|+.|+.=+-|.|.+|+++ .+.+++++.-|.....
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~---G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVT---GKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEee---CcceEEEecccceeee
Confidence 775422 12356889999999999999999999999999999999994 6668888877766544
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCc-cchhHhhhHHHHHHHHHhhccC
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW-QGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf-~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
..+.. |.+.+ -.+-|.=-||.+++.+.||..-= ..... +......
T Consensus 444 ~~d~~---------------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~--~~s~~~~-------- 489 (655)
T KOG3741|consen 444 QEDPT---------------------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDST--QSSHLTR-------- 489 (655)
T ss_pred cCCCC---------------------cchhH---HhhhhHHHHHHHHHHHhhcccccccccch--HHHHHHH--------
Confidence 33221 11111 12458889999999999984321 11111 1111111
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l 269 (318)
+-..++.+++.++.-....++++ -+.+++
T Consensus 490 ----I~~~yS~D~rn~v~yl~s~~~~~-ksI~~l 518 (655)
T KOG3741|consen 490 ----ITTTYSTDLRNVVEYLESLNFRE-KSIQDL 518 (655)
T ss_pred ----hhhhhhHHHHHHHHHHHhcCccc-ccHHHH
Confidence 11245667788888887778875 244433
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.7e-06 Score=70.88 Aligned_cols=136 Identities=23% Similarity=0.297 Sum_probs=90.3
Q ss_pred EeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--------------------------ChhHHHHHHHHHHHcCCCC
Q 021053 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------------------------HPQLLYEAKVYKILQGGSG 64 (318)
Q Consensus 11 ~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~~e~~~l~~l~~~~~ 64 (318)
+...|+.|--+.||+|.. .++..+|+|++..... .....+|+..|.++.....
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 344677888889999875 4578899998653321 0134667777777754211
Q ss_pred -CCeeeeccccCcceEEEEeccCCCH--HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeeccCC
Q 021053 65 -IPNIKWYGVDGEDNVLVLDLLGPSL--EDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGR 140 (318)
Q Consensus 65 -~~~i~~~~~~~~~~~lv~e~~~~~L--~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~Nil~~~~~ 140 (318)
.+.-..+ ...++|||+.+... .=.+. .-++.......+..++++.+.-|-. .+++|+||+.-|||+
T Consensus 131 rvP~Pi~~----~~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~---- 200 (268)
T COG1718 131 RVPEPIAF----RNNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILV---- 200 (268)
T ss_pred CCCCceee----cCCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEE----
Confidence 1111111 24689999996541 00011 1112333567777889999988877 899999999999999
Q ss_pred CCCeEEEEeccceeeec
Q 021053 141 KANQVYIIDFGLAKKYR 157 (318)
Q Consensus 141 ~~~~~kL~dfg~~~~~~ 157 (318)
..+.+.++|+|.+....
T Consensus 201 ~~~~p~iID~~QaV~~~ 217 (268)
T COG1718 201 HDGEPYIIDVSQAVTID 217 (268)
T ss_pred ECCeEEEEECccccccC
Confidence 58999999999886543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.2e-05 Score=72.32 Aligned_cols=137 Identities=22% Similarity=0.333 Sum_probs=91.2
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----------------------------Ch--------------hHH
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------------------------HP--------------QLL 50 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----------------------------~~--------------~~~ 50 (318)
..|+.++-|+||+|..+. |+.||||+..+.-. .. ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 678899999999999764 89999998542210 00 345
Q ss_pred HHHHHHHHHcCC----CCCCeeeeccccCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHH-HHHHHhCCc
Q 021053 51 YEAKVYKILQGG----SGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSRGF 124 (318)
Q Consensus 51 ~e~~~l~~l~~~----~~~~~i~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~-L~~lH~~~i 124 (318)
+|...+.+++.. +.+..-..+....+..+++|||+ |..+.+.-.-...+.+...+.. .++.+ +..+-..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~---~~~~~f~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAE---LLVRAFLRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHH---HHHHHHHHHHHhcCc
Confidence 555666665432 22222245555667889999999 6667766432234466433332 22222 344445899
Q ss_pred cccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 125 ~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.|+|..|-||++ +.++.+.+.|||.....
T Consensus 287 fHaDpHpGNi~v---~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 287 FHADPHPGNILV---RSDGRIVLLDFGIVGRL 315 (517)
T ss_pred cccCCCccceEE---ecCCcEEEEcCcceecC
Confidence 999999999999 48899999999997644
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.2e-06 Score=69.02 Aligned_cols=78 Identities=18% Similarity=0.221 Sum_probs=53.0
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCC-CCeeeec---cccCcceEEEEecc-C
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWY---GVDGEDNVLVLDLL-G 86 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~i~~~---~~~~~~~~lv~e~~-~ 86 (318)
++.|+.|..+.||++.... ..+++|............+|..++..+..+.. ++.+... .......+++|++. +
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 5789999999999998754 48899987655333567789999988876543 4444332 22333478999998 4
Q ss_pred CCHHH
Q 021053 87 PSLED 91 (318)
Q Consensus 87 ~~L~~ 91 (318)
.++..
T Consensus 80 ~~~~~ 84 (239)
T PF01636_consen 80 RPLDD 84 (239)
T ss_dssp EEHHH
T ss_pred ccccc
Confidence 44544
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.27 E-value=2.2e-05 Score=65.99 Aligned_cols=74 Identities=23% Similarity=0.306 Sum_probs=50.3
Q ss_pred eeccCcc-cEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCCHH
Q 021053 14 KIGSGSF-GEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLE 90 (318)
Q Consensus 14 ~lg~G~~-~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~L~ 90 (318)
.|..|.+ +.||++... +..+++|+..... .....+|++++..+.....++.+..++...+..++||++. |.++.
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3444554 789999653 3578889776543 4457889999999876544555655555555688999998 54554
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.98 E-value=0.00011 Score=67.66 Aligned_cols=141 Identities=23% Similarity=0.311 Sum_probs=89.9
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---------------------------------------ChhHHHH
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---------------------------------------HPQLLYE 52 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---------------------------------------~~~~~~e 52 (318)
.+.|+.-+.+.|++|+.+. |+.||||+.++.-+ .-++.+|
T Consensus 166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 3678999999999999876 99999998543211 0134555
Q ss_pred HHHHHHHc----CCCCCCe--e-eeccccCcceEEEEecc-CCCHH--HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 021053 53 AKVYKILQ----GGSGIPN--I-KWYGVDGEDNVLVLDLL-GPSLE--DLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122 (318)
Q Consensus 53 ~~~l~~l~----~~~~~~~--i-~~~~~~~~~~~lv~e~~-~~~L~--~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 122 (318)
.+..++++ +...... + ..+.......+++|||+ |..+. +.+.+ .+++...+..-+.+.. +.-+=..
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~--~~qIf~~ 320 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAY--LEQIFKT 320 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHH--HHHHHhc
Confidence 55444443 3221111 1 34445556789999999 44443 44554 3467665443332221 2334456
Q ss_pred CccccCCCCCceeeccC-CCCCeEEEEeccceeeec
Q 021053 123 GFLHRDIKPDNFLMGLG-RKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 123 ~i~H~dl~p~Nil~~~~-~~~~~~kL~dfg~~~~~~ 157 (318)
|++|+|=.|-||++..+ ..++.+.+.|||+.....
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 89999999999999522 247889999999987554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.98 E-value=8.9e-07 Score=81.07 Aligned_cols=185 Identities=10% Similarity=0.057 Sum_probs=129.8
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeecc--ccCcceEEEEecc
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG--VDGEDNVLVLDLL 85 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~--~~~~~~~lv~e~~ 85 (318)
-|...+..++++++++++.+...+...+ .+++... ....-++++|.+.++++ +.+.+.. +.+.+..++++++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~---l~~rl~~eLLdK~n~P~--~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT---LSRRLAIELLDKVNNPN--PVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc---hhhHHHHHHHHHccCCC--CcccccccCCcccccchhhhhh
Confidence 3455667788999999999876554444 4544332 34455788899998866 2332222 3445678889988
Q ss_pred CCC--HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 86 GPS--LEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 86 ~~~--L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
++. ....+....-.+...++....+.-+++|.++|+.-=+|+| ||+. .....++.+|+....+....
T Consensus 317 s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~--- 385 (829)
T KOG0576|consen 317 STGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILG----SEEEVKLLDFAVPPQLTRTM--- 385 (829)
T ss_pred cCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccc----cccccccccccCCcccCccc---
Confidence 433 2222221122244556666777778889999998778888 8887 56888999999877654332
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCcc
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQ 214 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~ 214 (318)
......+++.++|||+.....+....|.||+|.-..++.-|.+|-.
T Consensus 386 -----~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 386 -----KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred -----ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 2345678999999999999999999999999988888888877754
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.0062 Score=54.68 Aligned_cols=73 Identities=27% Similarity=0.315 Sum_probs=49.9
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCC---------CCChhHHHHHHHHHHHcCC--CCCCeeeeccccCcceEE
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSG---------TKHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~e~~~l~~l~~~--~~~~~i~~~~~~~~~~~l 80 (318)
.+.||.|..+.||++.+...++.++||.-.+. -.......|.+.|..+... ..+|.+..+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46899999999999998654457999963211 1223567788888877542 335555555 3355889
Q ss_pred EEeccC
Q 021053 81 VLDLLG 86 (318)
Q Consensus 81 v~e~~~ 86 (318)
|||++.
T Consensus 109 VME~L~ 114 (401)
T PRK09550 109 VMEDLS 114 (401)
T ss_pred EEecCC
Confidence 999983
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00044 Score=68.40 Aligned_cols=78 Identities=14% Similarity=0.194 Sum_probs=50.4
Q ss_pred EeeeeccCcccEEEEEEEcCCC--cEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCC--Ceeeecccc---CcceEE
Q 021053 11 LGRKIGSGSFGEIFLASHVDTN--EIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGI--PNIKWYGVD---GEDNVL 80 (318)
Q Consensus 11 ~~~~lg~G~~~~v~~~~~~~~~--~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~--~~i~~~~~~---~~~~~l 80 (318)
-.+.++.|.++.+|+......+ ..+++|+..... ....+.+|+.+++.+..+..+ +.+..+..+ .+..|+
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 3677899999999998765432 357777653322 223578999999999643333 333333232 246789
Q ss_pred EEeccCCC
Q 021053 81 VLDLLGPS 88 (318)
Q Consensus 81 v~e~~~~~ 88 (318)
|||++.|.
T Consensus 122 VME~v~G~ 129 (822)
T PLN02876 122 IMEYLEGR 129 (822)
T ss_pred EEEecCCc
Confidence 99999543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00024 Score=59.34 Aligned_cols=72 Identities=18% Similarity=0.158 Sum_probs=43.3
Q ss_pred eeeccCccc-EEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCC-C-CCCeeeeccccC---cceEEEEecc-
Q 021053 13 RKIGSGSFG-EIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG-S-GIPNIKWYGVDG---EDNVLVLDLL- 85 (318)
Q Consensus 13 ~~lg~G~~~-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~-~-~~~~i~~~~~~~---~~~~lv~e~~- 85 (318)
+.|+.|+.. .||+.. ..+++|+...........+|.+++..+... . .++.....+... ...+++|++.
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 456755555 588762 347788766544445788899999998753 1 223333322221 2457889998
Q ss_pred CCCH
Q 021053 86 GPSL 89 (318)
Q Consensus 86 ~~~L 89 (318)
|.++
T Consensus 78 G~~l 81 (235)
T cd05155 78 GETA 81 (235)
T ss_pred CCCC
Confidence 4343
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00095 Score=53.90 Aligned_cols=132 Identities=20% Similarity=0.286 Sum_probs=86.2
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCC------------------CChhHHHHHHHHHHHc-CC----CCCCee
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT------------------KHPQLLYEAKVYKILQ-GG----SGIPNI 68 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~------------------~~~~~~~e~~~l~~l~-~~----~~~~~i 68 (318)
...||.|+.-.||.-- .+...+||+..... ...+..+|+.....+. .. .+++.+
T Consensus 6 ~~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3578999999998653 23456789877655 1335677777776666 32 234444
Q ss_pred eeccccCcceEEEEecc---C----CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCC
Q 021053 69 KWYGVDGEDNVLVLDLL---G----PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (318)
Q Consensus 69 ~~~~~~~~~~~lv~e~~---~----~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~ 141 (318)
+..........+|+|.. . .||.+++.. ..++. ... ..+-.-..+|-+.+|+.+|++|.||++...++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 44444455567888765 2 367777753 33555 322 23334456888999999999999999986655
Q ss_pred CC-eEEEEe-ccc
Q 021053 142 AN-QVYIID-FGL 152 (318)
Q Consensus 142 ~~-~~kL~d-fg~ 152 (318)
.. .+.|+| ||.
T Consensus 157 ~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 157 GEFRLVLIDGLGE 169 (199)
T ss_pred CceEEEEEeCCCC
Confidence 55 788887 444
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00086 Score=53.88 Aligned_cols=124 Identities=19% Similarity=0.279 Sum_probs=80.3
Q ss_pred ceeeEeeeeccCcc-cEEEEEEEcCCCcEEEEEeecCC-----------------------CCChhHHHHHHHHHHHcCC
Q 021053 7 VKYKLGRKIGSGSF-GEIFLASHVDTNEIVAVKIENSG-----------------------TKHPQLLYEAKVYKILQGG 62 (318)
Q Consensus 7 ~~y~~~~~lg~G~~-~~v~~~~~~~~~~~vaiK~~~~~-----------------------~~~~~~~~e~~~l~~l~~~ 62 (318)
..++..+.||.|.. |.||+++. .|+.+|+|++..- .....+..|.....+|+..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68899999999999 99999987 6779999983210 0112456677777776543
Q ss_pred CC--C--Ceeeecc------------------ccCcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 021053 63 SG--I--PNIKWYG------------------VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120 (318)
Q Consensus 63 ~~--~--~~i~~~~------------------~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH 120 (318)
.. . +..+.+. .....+.||.++....- .++...+ .+|++-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~~----~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRDI----PQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhHH----HHHHHHHHHHH
Confidence 32 1 1111111 01112456666552111 1233333 46778889999
Q ss_pred hCCccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 121 ~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
..||+-+|+++.|..= -+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~--------G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRG--------GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccC--------CEEEecccC
Confidence 9999999999999863 379999864
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00094 Score=55.69 Aligned_cols=71 Identities=15% Similarity=0.164 Sum_probs=48.2
Q ss_pred eeeeccCcccEEEEEEEcC-CCcEEEEEeecCCCCC-hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEeccC
Q 021053 12 GRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLG 86 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~-~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~~ 86 (318)
.+.|..|-.+.+|++.... ++..|++|+....... ....+|..++..+......+.+..... ..+++||..
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeC
Confidence 4677888899999997543 3567889976543322 344679999999876555666643322 247999983
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00038 Score=58.92 Aligned_cols=131 Identities=16% Similarity=0.144 Sum_probs=75.6
Q ss_pred eeccCcccEEEEEEEcCCCcEEEEEeecCCCCC--hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEeccCC-CHH
Q 021053 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGP-SLE 90 (318)
Q Consensus 14 ~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~~~-~L~ 90 (318)
.+..|-.+.+|+... ++..+++|+....... .+..+|..+++.+......+.+..... .++|+++..| ++.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 456788889999873 5667888975543322 256789999999986544455544332 3689999843 332
Q ss_pred --------------HHHHHh---c---CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCccccCCCCC
Q 021053 91 --------------DLFVYC---R---RKFSLK-TVLMLADQM---------IARIEYVHS--------RGFLHRDIKPD 132 (318)
Q Consensus 91 --------------~~~~~~---~---~~~~~~-~~~~~~~qi---------~~~L~~lH~--------~~i~H~dl~p~ 132 (318)
..+.+. . .+++.. .+..+..++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 111111 1 011211 111221111 111222221 25899999999
Q ss_pred ceeeccCCCCCeEEEEecccee
Q 021053 133 NFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 133 Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
||+++ .++ +.|+||..+.
T Consensus 157 Nil~~---~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 157 NLVVT---PQG-LKLIDWEYAS 174 (256)
T ss_pred cEEEe---CCC-CEEEeccccC
Confidence 99995 444 7899998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00089 Score=57.95 Aligned_cols=137 Identities=14% Similarity=0.127 Sum_probs=78.3
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCC-CCeeee------ccccCcceEEEEec
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKW------YGVDGEDNVLVLDL 84 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~i~~------~~~~~~~~~lv~e~ 84 (318)
.+.+..|....+|++.. .+..+++|+... ........|+.++..+..... ++.+.. .....+..++++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~-~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK-VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC-CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 55677788889999865 334688898765 334567788888888865432 222211 11223456889999
Q ss_pred cCC-CHHH----HHHHh----------cCCC----------CHHHH----------HHHHHHHHHHHHHHHh-------C
Q 021053 85 LGP-SLED----LFVYC----------RRKF----------SLKTV----------LMLADQMIARIEYVHS-------R 122 (318)
Q Consensus 85 ~~~-~L~~----~~~~~----------~~~~----------~~~~~----------~~~~~qi~~~L~~lH~-------~ 122 (318)
..| ++.. ..... ...+ .+... ......+..++.++.. .
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 843 3211 11110 0001 00000 0011112333444443 4
Q ss_pred CccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 123 ~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
+++|+|+.|.||++. +...+.|.||+.+.
T Consensus 176 ~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~ 204 (296)
T cd05153 176 GVIHADLFRDNVLFD---GDELSGVIDFYFAC 204 (296)
T ss_pred cCCccCcCcccEEEe---CCceEEEeehhhhc
Confidence 799999999999994 55556899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.0013 Score=57.39 Aligned_cols=139 Identities=19% Similarity=0.224 Sum_probs=92.7
Q ss_pred eEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----------------------C------ChhHHHHHHHHHHHcC
Q 021053 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------------------K------HPQLLYEAKVYKILQG 61 (318)
Q Consensus 10 ~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----------------------~------~~~~~~e~~~l~~l~~ 61 (318)
++-..|..|--+-||.|.. .+|..+|||+++..- . ...+.+|+..|.++..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 4566788888899999874 457779999755210 0 0145778888888875
Q ss_pred CCCCCeeeeccccCcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCceeeccCC
Q 021053 62 GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV-HSRGFLHRDIKPDNFLMGLGR 140 (318)
Q Consensus 62 ~~~~~~i~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~l-H~~~i~H~dl~p~Nil~~~~~ 140 (318)
.. ++.-.-. .-...++||+|++.+-+-.-.-..-.++...+..+-.|++.-+.-| |.++++|.||+--|+|+
T Consensus 226 aG-IP~PePI--lLk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly---- 298 (520)
T KOG2270|consen 226 AG-IPCPEPI--LLKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY---- 298 (520)
T ss_pred cC-CCCCCce--eeecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE----
Confidence 33 2211100 0124689999996543322111123466666666667777777655 56799999999999999
Q ss_pred CCCeEEEEeccceeee
Q 021053 141 KANQVYIIDFGLAKKY 156 (318)
Q Consensus 141 ~~~~~kL~dfg~~~~~ 156 (318)
..|.+.++|-+.|...
T Consensus 299 hdG~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 299 HDGKLYIIDVSQSVEH 314 (520)
T ss_pred ECCEEEEEEccccccC
Confidence 8899999998877643
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0016 Score=56.64 Aligned_cols=70 Identities=14% Similarity=0.076 Sum_probs=47.4
Q ss_pred eeeeccCcccEEEEEEEcC------CCcEEEEEeecCCCCC-hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 12 GRKIGSGSFGEIFLASHVD------TNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~------~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
.+.+..|-...+|++.... .+..+++|+....... .+..+|..++..+......+.+...... .+|+++
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 4567778888999997543 2578999987664332 4678899999998765555555444332 246777
Q ss_pred c
Q 021053 85 L 85 (318)
Q Consensus 85 ~ 85 (318)
.
T Consensus 79 i 79 (302)
T cd05156 79 I 79 (302)
T ss_pred e
Confidence 6
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.0042 Score=54.40 Aligned_cols=73 Identities=11% Similarity=0.079 Sum_probs=43.7
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCC-CCeeee------ccccCcceEEEEec
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKW------YGVDGEDNVLVLDL 84 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~i~~------~~~~~~~~~lv~e~ 84 (318)
.+.++.|....+|++... +..+++|+.. .........|..++..|..... ++.... +....+..++++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~--~g~~vLK~~~-~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTT--QGEYVLTLFE-RLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred cchhccccccceEEEEeC--CCcEEEEEec-cCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 355677888899998753 3368889876 3333455567777777754322 222211 11234457899999
Q ss_pred cCC
Q 021053 85 LGP 87 (318)
Q Consensus 85 ~~~ 87 (318)
..|
T Consensus 104 l~G 106 (319)
T PRK05231 104 LEG 106 (319)
T ss_pred cCC
Confidence 844
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0028 Score=55.26 Aligned_cols=138 Identities=18% Similarity=0.254 Sum_probs=77.7
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCC-CCee-ee-----ccccCcceEEEEec
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNI-KW-----YGVDGEDNVLVLDL 84 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~i-~~-----~~~~~~~~~lv~e~ 84 (318)
.+.++.|....+|++... +..+++|+............|..++..|..... ++.+ .. +....+..++++++
T Consensus 27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred ccccCCccccceEEEEeC--CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 556777777899998742 335788987654334556677888888854322 2222 11 11224567899999
Q ss_pred cCC-CH-----H------HH---HHHhcCCCC--------HHH-----HH----------HHHHHHHHHHHHHHh-----
Q 021053 85 LGP-SL-----E------DL---FVYCRRKFS--------LKT-----VL----------MLADQMIARIEYVHS----- 121 (318)
Q Consensus 85 ~~~-~L-----~------~~---~~~~~~~~~--------~~~-----~~----------~~~~qi~~~L~~lH~----- 121 (318)
..| ++ . .. ++.....++ ... .. .....+...+.++..
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 843 21 1 11 111011110 000 00 001122334555532
Q ss_pred --CCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 122 --RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 122 --~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
.+++|+|+.+.|+++. .++...++||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFD---GDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEE---CCceEEEeeccccc
Confidence 5899999999999994 55556899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0021 Score=56.52 Aligned_cols=70 Identities=19% Similarity=0.218 Sum_probs=45.6
Q ss_pred eeccCcccEEEEEEEcCCCcEEEEEe----ecC-----CCCChhHHHHHHHHHHHcCC--CCCCeeeeccccCcceEEEE
Q 021053 14 KIGSGSFGEIFLASHVDTNEIVAVKI----ENS-----GTKHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 14 ~lg~G~~~~v~~~~~~~~~~~vaiK~----~~~-----~~~~~~~~~e~~~l~~l~~~--~~~~~i~~~~~~~~~~~lv~ 82 (318)
.||.|....||++.+...++.|+||. +.. .-...+...|...|...... ...+.+ +..+.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~v--y~~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRI--FHFDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeE--EEEccccceehH
Confidence 57999999999999864446799994 121 11233566788888776542 123343 444555678999
Q ss_pred ecc
Q 021053 83 DLL 85 (318)
Q Consensus 83 e~~ 85 (318)
|++
T Consensus 80 EdL 82 (370)
T TIGR01767 80 EDL 82 (370)
T ss_pred hhC
Confidence 988
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0046 Score=54.76 Aligned_cols=139 Identities=16% Similarity=0.169 Sum_probs=81.0
Q ss_pred eEeeeeccCcccEEEEEEEcC----CCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 10 KLGRKIGSGSFGEIFLASHVD----TNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 10 ~~~~~lg~G~~~~v~~~~~~~----~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
.-...+..|-...+|++.... .+..|++|+...... .-+..+|..+++.+.....-+.+...+..+ .+++|
T Consensus 39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~ef 114 (344)
T PLN02236 39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEF 114 (344)
T ss_pred EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEe
Confidence 345566668999999997532 246789998765432 224578999999998766666665554332 46777
Q ss_pred c-CCCHHHH-------H----------HHhc--C-C-CC-HHHHHHHHHHH-----------------HHHHHHH----H
Q 021053 85 L-GPSLEDL-------F----------VYCR--R-K-FS-LKTVLMLADQM-----------------IARIEYV----H 120 (318)
Q Consensus 85 ~-~~~L~~~-------~----------~~~~--~-~-~~-~~~~~~~~~qi-----------------~~~L~~l----H 120 (318)
. +.++... . +... . . .. ...+..+..++ ...+..| .
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 7 3333210 0 1100 0 0 11 12222222111 1111111 1
Q ss_pred ----hCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 121 ----SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 121 ----~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
...++|+|+++.||++. +.++.+.++||..+.
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~ 230 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMID--EETRAITIIDYEYAS 230 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEe--CCCCcEEEEeehhcc
Confidence 22589999999999995 235689999998765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.001 Score=53.43 Aligned_cols=96 Identities=22% Similarity=0.307 Sum_probs=70.7
Q ss_pred HHHHHHHHHcCCCCCCee-eeccccCcceEEEEeccC-CCHHHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHh---C
Q 021053 51 YEAKVYKILQGGSGIPNI-KWYGVDGEDNVLVLDLLG-PSLEDL---FVYCRRKFSLKTVLMLADQMIARIEYVHS---R 122 (318)
Q Consensus 51 ~e~~~l~~l~~~~~~~~i-~~~~~~~~~~~lv~e~~~-~~L~~~---~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~ 122 (318)
.|.-+++.+.+..+.+.+ ..++ .+++.|+.+ +++... +.. -...++..+..++.+++..+.+++. .
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG-----~~~v~E~~~~~~~~~~~~~l~~-~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG-----RFYVVEYVGAGSLYGIYRPLSQ-FLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC-----CEEEEEeecCcccccccccccc-ccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 478888888876655555 4444 467888884 555421 111 0126899999999999999999997 3
Q ss_pred CccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 123 ~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
.+.-+|++|+|+-++ +++++|+.|.+....
T Consensus 82 ~~~lcDv~~~nfgv~---~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVN---DDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEe---CCCcEEEEechhcch
Confidence 477799999999994 788999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.00048 Score=59.00 Aligned_cols=133 Identities=19% Similarity=0.315 Sum_probs=90.6
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEee----------cCCC---------CC-----hhHHHHHHHHHHHcCCCC
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIE----------NSGT---------KH-----PQLLYEAKVYKILQGGSG 64 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~----------~~~~---------~~-----~~~~~e~~~l~~l~~~~~ 64 (318)
|.++.+||-|--+.||.+-+. .|+..++|+- +... .+ -.+.+|+..++.|..+..
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 567899999999999999875 4667788841 1111 01 145788888888865321
Q ss_pred -CCeeeeccccCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCC
Q 021053 65 -IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (318)
Q Consensus 65 -~~~i~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~ 142 (318)
++.. .+....++||++. +..|....+- .+.. .+...+..-+.-|-.+|+||||.+-=||++ +++
T Consensus 173 pVPkp----iD~~RH~Vvmelv~g~Pl~~v~~v----~d~~---~ly~~lm~~Iv~la~~GlIHgDFNEFNimv---~dd 238 (465)
T KOG2268|consen 173 PVPKP----IDHNRHCVVMELVDGYPLRQVRHV----EDPP---TLYDDLMGLIVRLANHGLIHGDFNEFNIMV---KDD 238 (465)
T ss_pred CCCCc----ccccceeeHHHhhcccceeeeeec----CChH---HHHHHHHHHHHHHHHcCceecccchheeEE---ecC
Confidence 2221 2334678999998 5566554331 1222 333455556777889999999999999999 478
Q ss_pred CeEEEEeccceeee
Q 021053 143 NQVYIIDFGLAKKY 156 (318)
Q Consensus 143 ~~~kL~dfg~~~~~ 156 (318)
..++++||-.+...
T Consensus 239 ~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 239 DKIVVIDFPQMVST 252 (465)
T ss_pred CCEEEeechHhhcc
Confidence 89999999876543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0068 Score=53.38 Aligned_cols=70 Identities=14% Similarity=0.083 Sum_probs=46.6
Q ss_pred eeeeccCcccEEEEEEEcCC---CcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 12 GRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~---~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
.+.|..|-...+|++..... +..|++|+...... .-+..+|..+++.+.....-+.+..++..+ ++.+|.
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi 92 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFI 92 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeehhh
Confidence 45555588889999975432 34788998765433 235578999999998766666665544322 467776
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0027 Score=62.87 Aligned_cols=197 Identities=16% Similarity=0.118 Sum_probs=118.2
Q ss_pred HHHHHHHHHHcCCCCCCeeeeccccCc----ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 021053 50 LYEAKVYKILQGGSGIPNIKWYGVDGE----DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124 (318)
Q Consensus 50 ~~e~~~l~~l~~~~~~~~i~~~~~~~~----~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i 124 (318)
..|...+..+.|. +......|..... ...+..+++ ..++.+.+... ...+..+.+.+..++..||.++|+..+
T Consensus 230 E~e~~~l~k~~~~-n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 230 EIELESLSKIAHD-NLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHhhccc-cccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 3455556666653 3333333322211 122333556 66777777763 347888999999999999999999966
Q ss_pred cccCCCCCceeeccCCCCCeEEEE--eccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCC--cchHHHHH
Q 021053 125 LHRDIKPDNFLMGLGRKANQVYII--DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR--RDDLESLG 200 (318)
Q Consensus 125 ~H~dl~p~Nil~~~~~~~~~~kL~--dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~DvwslG 200 (318)
.|.-+......-...+..+....+ ||+.+......... .....+..+-+||......... ..|+|.+|
T Consensus 308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--------~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--------FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred ceeEEecccccccccCccceeecchhhhcccccCCCcccc--------hhhcCccccccccccccccchhhhhhHHHHHH
Confidence 665554442222222345555555 88877665443332 1223445567788776555443 47999999
Q ss_pred HHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 201 YVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 201 ~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
.....+..|..+-... ..+..................|+..++++|+++.++....
T Consensus 380 ll~~~~~~~~~i~~~~-----------------~~~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKS-----------------AVPVSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HHHhhhhhcCcccccc-----------------cchhhhhccccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 9999998876542210 0111111111122567888899999999999988776644
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0035 Score=55.82 Aligned_cols=72 Identities=21% Similarity=0.284 Sum_probs=47.9
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEe----ecCCC----CChhHHHHHHHHHHHcCC--CCCCeeeeccccCcceEEE
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGT----KHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~----~~~~~----~~~~~~~e~~~l~~l~~~--~~~~~i~~~~~~~~~~~lv 81 (318)
.+.||.|.-..||++.+...+..|+||- +.... ...+...|...|+..... ..+|.++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 6789999999999999854456789993 22211 233567788888876542 234444444 44567788
Q ss_pred Eecc
Q 021053 82 LDLL 85 (318)
Q Consensus 82 ~e~~ 85 (318)
||++
T Consensus 112 MEdL 115 (409)
T PRK12396 112 MEDL 115 (409)
T ss_pred HHhC
Confidence 8887
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.007 Score=55.17 Aligned_cols=161 Identities=21% Similarity=0.195 Sum_probs=94.9
Q ss_pred hHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 021053 48 QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127 (318)
Q Consensus 48 ~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~ 127 (318)
...-...+++.+.|.+...++..-........+|+|+++.||.+...... +-.. ++ + .+|+.|
T Consensus 28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~--l~~~-------s~---~----~~~~~~- 90 (725)
T KOG1093|consen 28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN--LKDE-------SL---L----AHGVLH- 90 (725)
T ss_pred HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc--cchh-------hh---c----ccccce-
Confidence 45667788888888777766766655666689999999999999987522 1110 11 1 222222
Q ss_pred CCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHH
Q 021053 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL 207 (318)
Q Consensus 128 dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~ 207 (318)
.|++. .+| .+... | | .+.++++||||+|.++.++.
T Consensus 91 ----~~~~~----------~td-~~~t~-----------------------~--~-----~~~~pKsdVwsl~~i~~el~ 125 (725)
T KOG1093|consen 91 ----LNIIY----------ITD-HFLTK-----------------------Y--P-----SPIGPKSDVWSLGFIILELY 125 (725)
T ss_pred ----ehhhh----------ccc-ccccc-----------------------C--C-----CCCCcchhhhhHHHHHHHHH
Confidence 23322 222 00000 0 0 01124999999999999999
Q ss_pred hCCCCccchhHhhhHHHHHHHHHhhc---cCch-HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHH
Q 021053 208 RGSLPWQGLKAATKKQKYDKICEKKV---STPI-EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLK 270 (318)
Q Consensus 208 tg~~pf~~~~~~~~~~~~~~i~~~~~---~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~ 270 (318)
.|...+...........+.+...... .... ..+.-.++..+.++...|+...|..||...++.
T Consensus 126 L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 126 LGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELS 192 (725)
T ss_pred HhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence 99887765544333333332221000 0000 112224567788999999999999998766543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.034 Score=49.98 Aligned_cols=73 Identities=12% Similarity=0.256 Sum_probs=47.6
Q ss_pred EeeeeccCcccEEEEEEEcCCCcEEEEEeec-----CCC----CChhHHHHHHHHHHHcCC--CCCCeeeeccccCcceE
Q 021053 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGT----KHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 11 ~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~-----~~~----~~~~~~~e~~~l~~l~~~--~~~~~i~~~~~~~~~~~ 79 (318)
..+.||.|....||++.+. +..++||.-. ... ...+...|...|+.+... ..++.+..+.. ...+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4778899999999999873 4468899532 111 234556677777666532 24555555544 4578
Q ss_pred EEEeccCC
Q 021053 80 LVLDLLGP 87 (318)
Q Consensus 80 lv~e~~~~ 87 (318)
++||++.+
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999944
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.015 Score=50.32 Aligned_cols=109 Identities=17% Similarity=0.107 Sum_probs=73.1
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCC--CCCeeeecc---ccCcceEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS--GIPNIKWYG---VDGEDNVL 80 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~--~~~~i~~~~---~~~~~~~l 80 (318)
+..-.-.+.||.|..+.||.....+ ..+++|..+.......+..|...++.+.... .++.+...+ ...+..++
T Consensus 13 ~~~~~~~~~i~~G~~~~vy~~~~~~--~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 13 GEKLSRVECISEQPYAALWALYDSQ--GNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred chhhheeeecCCccceeEEEEEcCC--CCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 3344567789999999999996532 3467787544234457899999999997642 344454332 23456899
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 122 (318)
|||+. +.++.+. . .+......+..+++.+|..||+.
T Consensus 91 VmE~i~G~~~~~~-~-----~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 91 LLERLRGVSVEAP-A-----RTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred EEeccCCEecCCC-C-----CCHHHHHHHHHHHHHHHHHHhCC
Confidence 99999 5555541 1 23344556667888999999985
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.023 Score=48.67 Aligned_cols=46 Identities=13% Similarity=0.096 Sum_probs=30.1
Q ss_pred ccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCC
Q 021053 16 GSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62 (318)
Q Consensus 16 g~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~ 62 (318)
++|-...|+.+.+ .+|..+++|.-..........+|.+++..+..+
T Consensus 20 ~~g~~~~v~~i~~-~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~~~ 65 (276)
T cd05152 20 ESGLDFQVVFAKD-TDGVPWVLRIPRRPDVSERAAAEKRVLALVRKH 65 (276)
T ss_pred CCcceeEEEEEEc-CCCCeEEEEecCCHHHHHHHHHHHHHHHHHHhc
Confidence 4555556666532 246678888765433345678999999999753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.035 Score=48.21 Aligned_cols=76 Identities=11% Similarity=0.028 Sum_probs=42.7
Q ss_pred eEeeeeccCcccEEEEEEEcCCCcEEEEEee---cCCCCChhHHHHHHHHHHHcCCCCCCe--eeeccccC-cceEEEEe
Q 021053 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIE---NSGTKHPQLLYEAKVYKILQGGSGIPN--IKWYGVDG-EDNVLVLD 83 (318)
Q Consensus 10 ~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~---~~~~~~~~~~~e~~~l~~l~~~~~~~~--i~~~~~~~-~~~~lv~e 83 (318)
.+++.+..|....+|...+. ++.++++.- ..........+|+.+++.+.......- +..+.... +..+.||+
T Consensus 28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 28 LIVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred ceeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 45566666666677777653 777888821 111122355677788877765322211 12222222 45699999
Q ss_pred ccCC
Q 021053 84 LLGP 87 (318)
Q Consensus 84 ~~~~ 87 (318)
+..|
T Consensus 106 ~veG 109 (321)
T COG3173 106 WVEG 109 (321)
T ss_pred Eecc
Confidence 9955
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.11 Score=46.78 Aligned_cols=72 Identities=17% Similarity=0.123 Sum_probs=46.7
Q ss_pred EeeeeccCcccEEEEEEEcCCC-c-----EEEEEeecCCC-CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 11 LGRKIGSGSFGEIFLASHVDTN-E-----IVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 11 ~~~~lg~G~~~~v~~~~~~~~~-~-----~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
..+.|..|-.+.+|++...... . .|++++..... ..-+..+|+.+++.+.....-+.+...+.. ++++|
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e 129 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE 129 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence 3456666999999999754321 2 24555432221 122457799999999888777887766643 58888
Q ss_pred ccC
Q 021053 84 LLG 86 (318)
Q Consensus 84 ~~~ 86 (318)
|..
T Consensus 130 fIe 132 (383)
T PTZ00384 130 WVE 132 (383)
T ss_pred Eec
Confidence 883
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.029 Score=45.88 Aligned_cols=31 Identities=39% Similarity=0.642 Sum_probs=21.2
Q ss_pred CccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 123 ~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
.++|+|+.|.||++. +..+.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILIN--NKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEET--SSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEec--cCCCeEEEecHHHHhh
Confidence 589999999999993 4789999999988764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.1 Score=45.79 Aligned_cols=135 Identities=19% Similarity=0.208 Sum_probs=76.7
Q ss_pred eeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCee-------eeccccCc--ceEEEEec
Q 021053 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI-------KWYGVDGE--DNVLVLDL 84 (318)
Q Consensus 14 ~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i-------~~~~~~~~--~~~lv~e~ 84 (318)
.|.+ .-..+|++...+ ..+++|+............|...+..|......+.. ........ ..+-++++
T Consensus 33 ~l~s-~eN~~f~~~~~~--g~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 33 GLNS-EENSNFRVQTED--GRYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred cccc-ccCceEEEEecC--CCeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 3444 566889997643 334899988874556778888888888654432221 11122223 67778888
Q ss_pred cCC-CHHH-----HHH----------HhcCC-----------CCHH----H---------HHHHHHHHHHHHHHHHh---
Q 021053 85 LGP-SLED-----LFV----------YCRRK-----------FSLK----T---------VLMLADQMIARIEYVHS--- 121 (318)
Q Consensus 85 ~~~-~L~~-----~~~----------~~~~~-----------~~~~----~---------~~~~~~qi~~~L~~lH~--- 121 (318)
+.| .+.. .+. ..... ..+. . ......++...+..+.+
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 844 3331 111 00001 1111 0 01122334444554443
Q ss_pred -----CC--ccccCCCCCceeeccCCCCC-eEEEEecccee
Q 021053 122 -----RG--FLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154 (318)
Q Consensus 122 -----~~--i~H~dl~p~Nil~~~~~~~~-~~kL~dfg~~~ 154 (318)
.+ +||+|+.|.||++. ... .+-+.||+-+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d---~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFD---DDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEc---CCCCeeeEEEccccc
Confidence 23 99999999999993 444 47899998765
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.16 Score=43.70 Aligned_cols=75 Identities=19% Similarity=0.249 Sum_probs=49.3
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHc--CCCCCCeeeeccccCcceEEEEeccC
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNVLVLDLLG 86 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~--~~~~~~~i~~~~~~~~~~~lv~e~~~ 86 (318)
.+-.+.++.|..+.+|+.. .+++.+.+|+-. ......+..|..-|+.|. ....++.+..++......++++|+..
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~-~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNS-ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEE-GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecC-hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 4556788999999999987 467788899766 334457888999999994 34446667777766667799999983
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.0023 Score=65.14 Aligned_cols=130 Identities=11% Similarity=-0.002 Sum_probs=95.1
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhC-C----ccccCCCCCceeeccCCCCCe
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIARIEYVHSR-G----FLHRDIKPDNFLMGLGRKANQ 144 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~~~---~~~~~~~~~~~qi~~~L~~lH~~-~----i~H~dl~p~Nil~~~~~~~~~ 144 (318)
....-+.+++++ .|.+.+.+.+.... .+..-+-...++.+.+..-+|+. + .+|+++++-|.++ ..+..
T Consensus 1302 ~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmI---Vtny~ 1378 (2724)
T KOG1826|consen 1302 ESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMI---VTNYN 1378 (2724)
T ss_pred CChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccce---ecCCc
Confidence 334567888888 88888887653222 22222223333446777777754 2 6899999999999 58899
Q ss_pred EEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCc
Q 021053 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213 (318)
Q Consensus 145 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf 213 (318)
++++++|+.+....... ..+...+++.|++|++.....++.++|+|..|+.+|...-|..+|
T Consensus 1379 v~~gk~gLdKIknp~~s-------f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1379 VKLGKGGLDKIKNPVLS-------FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred ccccccccccccCchHh-------hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 99999999884333222 235667888899999888888888899999999999999888887
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.27 E-value=0.48 Score=41.66 Aligned_cols=69 Identities=10% Similarity=-0.029 Sum_probs=40.0
Q ss_pred CcccEEEEEEEcCCCcEEEEEeecCCC-CChhHHHHHHHHHHHcCCCCC--Ceee----eccccCcceEEEEeccCC
Q 021053 18 GSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGI--PNIK----WYGVDGEDNVLVLDLLGP 87 (318)
Q Consensus 18 G~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~--~~i~----~~~~~~~~~~lv~e~~~~ 87 (318)
+.-..||++... ++..+++|+..... .......|...+..|...... ..+. .....++..+.++++..|
T Consensus 36 s~eN~vy~v~~~-~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 36 SYENRVYQFGDE-DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred cccceEEEEecC-CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 445689998753 45678999876443 234566788888877653221 1111 111123456778888743
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.079 Score=47.28 Aligned_cols=60 Identities=23% Similarity=0.259 Sum_probs=43.3
Q ss_pred cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCccccCCCCCceeec
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE-YVHSRGFLHRDIKPDNFLMG 137 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~-~lH~~~i~H~dl~p~Nil~~ 137 (318)
...+++.+|+ +.++..++.... .++...+.++.-.+.||. -+---+.+|.|+.|.||++.
T Consensus 318 ~~~vl~E~~~~Gl~v~~~v~~~~--~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 318 TDLVLVETYERGLSVLRFVKWKS--QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ccceeeeeccccccHHhhhhccc--ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 3467888888 778888888533 455566666666666654 33445899999999999985
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.77 Score=42.13 Aligned_cols=72 Identities=18% Similarity=0.067 Sum_probs=48.4
Q ss_pred EeeeeccCcccEEEEEEEcCC--------CcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 11 LGRKIGSGSFGEIFLASHVDT--------NEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 11 ~~~~lg~G~~~~v~~~~~~~~--------~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
-.+.|..|-...+|++..... ++.|++|+...... ..+...|..+++.+.....-+.+...+. -+.+
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 466677788889999975422 46789998765432 2356779999988887666666654432 2356
Q ss_pred EeccC
Q 021053 82 LDLLG 86 (318)
Q Consensus 82 ~e~~~ 86 (318)
.+|..
T Consensus 185 ~efi~ 189 (442)
T PTZ00296 185 EEWLY 189 (442)
T ss_pred EEeeC
Confidence 77773
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.21 Score=50.81 Aligned_cols=47 Identities=15% Similarity=0.140 Sum_probs=32.0
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcC
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~ 61 (318)
+.|+ |....+|++.. .++..+++|+............|...+..|..
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~ 77 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAA 77 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHh
Confidence 4564 45688899875 34667999998876544455566677776654
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.88 E-value=0.17 Score=41.41 Aligned_cols=84 Identities=19% Similarity=0.211 Sum_probs=55.0
Q ss_pred hHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--Ccc
Q 021053 48 QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--GFL 125 (318)
Q Consensus 48 ~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--~i~ 125 (318)
.+..++.++.++.+ +..+. -.++..+.+++|.|..--.-+.. ++..=+.+|.-+|+. +.+
T Consensus 104 ~y~nky~v~ArmhG---ilrL~--NDn~~~yGvIlE~Cy~~~i~~~N-------------~i~agi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 104 LYFNKYRVFARMHG---ILRLK--NDNNYKYGVILERCYKIKINFSN-------------FITAGIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhhHHHHhhh---eeEee--cCCCceeEEEEeeccCcccchhH-------------HHHHhHHHHHHhhccCCCee
Confidence 45667788877654 33333 22455678899988422111111 111114567788854 699
Q ss_pred ccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 126 HRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 126 H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
|+|..|+||+- |..|.+||.|-+.
T Consensus 166 HGD~np~NiM~---D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 166 HGDCNPDNIMC---DKFGYLKLVDPVC 189 (308)
T ss_pred cCCCChhheee---cCCCCEEecChhh
Confidence 99999999999 7999999999765
|
The function of this family is unknown. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.14 Score=45.03 Aligned_cols=73 Identities=21% Similarity=0.262 Sum_probs=54.8
Q ss_pred cCcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 74 DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 74 ~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
...+.|+++++-++++... . .-...+...++.+.+.-+.-+..+ ..-|||+.-.||++ +.|.+.|+||.+
T Consensus 297 e~~y~yl~~kdhgt~is~i-k----~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI----d~GnvtLIDfkl 367 (488)
T COG5072 297 ETLYLYLHFKDHGTPISII-K----ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI----DEGNVTLIDFKL 367 (488)
T ss_pred CceEEEEEEecCCceeeee-e----cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee----ecCceEEEEeee
Confidence 3345677777777766332 1 134677777878777777766655 58999999999999 599999999999
Q ss_pred eee
Q 021053 153 AKK 155 (318)
Q Consensus 153 ~~~ 155 (318)
++.
T Consensus 368 sRl 370 (488)
T COG5072 368 SRL 370 (488)
T ss_pred eec
Confidence 984
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.76 E-value=0.14 Score=44.46 Aligned_cols=29 Identities=45% Similarity=0.832 Sum_probs=24.2
Q ss_pred CCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 122 ~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
.+++|+|+.+.||++. . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence 4789999999999994 3 668899998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.58 E-value=0.21 Score=42.57 Aligned_cols=44 Identities=23% Similarity=0.388 Sum_probs=32.1
Q ss_pred HHHHHHHHHHHHHhC--CccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 108 LADQMIARIEYVHSR--GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 108 ~~~qi~~~L~~lH~~--~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
.+..+-.++.-.+.. -++|+|+.|+|++.+ +.+.++|+||..|.
T Consensus 137 ~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t---~~~~l~LIDWEyAg 182 (269)
T COG0510 137 KLKELRRALEEVPKDDLVPCHNDLNPGNLLLT---DKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHhhhcCCCceeeecCCCCccceEEc---CCCcEEEEecccCC
Confidence 334444444444444 589999999999994 56999999998764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 318 | ||||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-135 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-121 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 1e-121 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-121 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 1e-94 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 1e-94 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 3e-91 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 1e-90 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 1e-90 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 2e-90 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 8e-88 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 1e-26 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 3e-25 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 3e-25 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 2e-24 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-14 | ||
| 2jii_A | 352 | Structure Of Vaccinia Related Kinase 3 Length = 352 | 4e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-12 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-11 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-11 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-11 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 7e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-11 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-11 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 9e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-10 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-10 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-10 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-10 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-10 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-10 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-10 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-10 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-10 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-10 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-10 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-10 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-10 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-10 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-10 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-09 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-09 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-09 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-09 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-09 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-09 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-09 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-08 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-08 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-08 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-08 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-07 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-07 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-07 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 5e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-07 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 7e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 7e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 7e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 8e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-07 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-06 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-06 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-06 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-06 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 1e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-06 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-06 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-06 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-06 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-06 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-06 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 4e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 4e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-06 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-06 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-06 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 7e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-06 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 8e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 9e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-05 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-05 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-05 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-05 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-05 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-05 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-05 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 3e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 4e-05 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 5e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-05 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-05 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-05 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-05 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-05 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-05 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-05 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-05 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-05 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 7e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 8e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-05 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 8e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 9e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-05 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-04 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-04 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-04 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-04 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-04 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-04 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-04 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-04 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-04 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-04 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-04 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-04 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-04 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-04 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-04 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-04 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-04 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-04 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-04 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-04 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-04 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-04 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-04 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 6e-04 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-04 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-04 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-04 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 6e-04 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-04 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-04 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-04 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-04 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-04 |
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2JII|A Chain A, Structure Of Vaccinia Related Kinase 3 Length = 352 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 513 bits (1321), Expect = 0.0
Identities = 219/281 (77%), Positives = 254/281 (90%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G K++LGRKIGSGSFGEI+L +++ TNE VA+K+EN TKHPQLLYE+K+Y+ILQ
Sbjct: 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG+GIPN++W+GV+G+ NVLV+DLLGPSLEDLF +C RK SLKTVLMLADQMI R+E+VH
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ FLHRDIKPDNFLMGLGR+ANQVYIIDFGLAKKYRD +T++HIPYRENKNLTGTARYA
Sbjct: 121 SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YFLRGSLPWQGLKA TKKQKY+KI EKKV+T IE L
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
C+ +P EFASYFHYC+SL FD +PDY +LKRLF DLF REG
Sbjct: 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG 281
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 503 bits (1296), Expect = 0.0
Identities = 157/282 (55%), Positives = 213/282 (75%), Gaps = 3/282 (1%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
++G +++G+KIG G+FGE+ L ++ TNE VA+K+E ++ PQL E + YK L
Sbjct: 4 VLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGS 63
Query: 62 GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
G GIP + ++G G+ N +VL+LLGPSLEDLF C R FSLKTVLM+A Q+I+R+EYVHS
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 122 RGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
+ ++RD+KP+NFL+G + ++IIDF LAK+Y DP T +HIPYRE+K+LTGTARY
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
S NTHLG EQSRRDDLE+LG++ +YFLRGSLPWQGLKA T K++Y KI + K +TPIEV
Sbjct: 184 MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEV 243
Query: 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
LC++ P E A+Y Y + L F ++PDY +L++LF DLF R+G
Sbjct: 244 LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKG 284
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 501 bits (1291), Expect = 0.0
Identities = 198/281 (70%), Positives = 244/281 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 62
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 63 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 123 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G
Sbjct: 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 499 bits (1288), Expect = 0.0
Identities = 161/283 (56%), Positives = 206/283 (72%), Gaps = 2/283 (0%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
++GV YK+GR+IG GSFG IF +++ N+ VA+K E + PQL E + YK+L
Sbjct: 4 QNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLA 63
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
G +GIPN+ ++G +G NVLV+DLLGPSLEDL C RKFS+KTV M A QM+AR++ +H
Sbjct: 64 GCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123
Query: 121 SRGFLHRDIKPDNFLMGL--GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+ ++RDIKPDNFL+G + AN +Y++DFG+ K YRDP T +HIPYRE KNL+GTAR
Sbjct: 124 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
Y S NTHLG EQSRRDDLE+LG+V +YFLRGSLPWQGLKAAT KQKY++I EKK STP+
Sbjct: 184 YMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 243
Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
LC P EF Y HY ++L FD PDY +L+ LF + R
Sbjct: 244 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 454 bits (1169), Expect = e-161
Identities = 81/307 (26%), Positives = 138/307 (44%), Gaps = 29/307 (9%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLAS-----HVDTNEIVAVKIENSGTKHPQLLYEAKV 55
+ + +K+G IG G FG I+LA V ++ VK+E S + L E K
Sbjct: 29 ITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPS--DNGPLFTELKF 86
Query: 56 YKILQ--------------GGSGIPNIKWYGVDGED----NVLVLDLLGPSLEDLFVYCR 97
Y+ G+P G+ ++ +++D G L+ ++
Sbjct: 87 YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANA 146
Query: 98 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
++FS KTVL L+ +++ +EY+H ++H DIK N L+ +QVY++D+GLA +Y
Sbjct: 147 KRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK-NPDQVYLVDYGLAYRYC 205
Query: 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217
++ + GT + S + H G+ SRR DLE LGY ++ +L G LPW+
Sbjct: 206 PEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265
Query: 218 AATKKQKYDKICEKKVSTPIEVLC---KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274
K + KI ++ + C + P E A Y + L + ++P Y L+ +
Sbjct: 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILL 325
Query: 275 DLFSREG 281
G
Sbjct: 326 QGLKAIG 332
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 451 bits (1163), Expect = e-161
Identities = 89/307 (28%), Positives = 140/307 (45%), Gaps = 28/307 (9%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQLLYEAKVYK 57
++ + G ++ LG+KIGSG FG I+LA + E A VK+E ++ L E K Y+
Sbjct: 31 LDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY--QENGPLFSELKFYQ 88
Query: 58 ILQGGS--------------GIPNIKWYGV----DGEDNVLVLDLLGPSLEDLFVYCRRK 99
+ GIP G+ +V++ LG L+ +
Sbjct: 89 RVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-T 147
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
F TVL L +M+ +EY+H ++H DIK N L+G +QVY+ D+GL+ +Y
Sbjct: 148 FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK-NPDQVYLADYGLSYRYCPN 206
Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL--- 216
++ K GT + S + H G+ SRR D+E LGY +L +L G LPW+
Sbjct: 207 GNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266
Query: 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
A + K + + E S S E A + SL +D++P+Y LK++ +
Sbjct: 267 PVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326
Query: 277 FSREGSL 283
G L
Sbjct: 327 GIPLGPL 333
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 428 bits (1102), Expect = e-151
Identities = 68/306 (22%), Positives = 120/306 (39%), Gaps = 33/306 (10%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT--------NEIVAVKIENSGT----------- 44
G ++KL + G ++ A+ T + ++K++
Sbjct: 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQR 98
Query: 45 --KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED-NVLVLDLLGPSLEDLFVYC-RRKF 100
K Q+ K+Y IP +GV + LVL LG SL+ +
Sbjct: 99 AAKPLQVNKWKKLYST--PLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVL 156
Query: 101 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
S ++VL +A +++ +E++H ++H ++ +N + + +QV + +G A +Y
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ-SQVTLAGYGFAFRYCP-- 213
Query: 161 TNRHIPYRENKN--LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218
+ +H+ Y E G + S + H G SRR DL+SLGY +L +L G LPW
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273
Query: 219 ATKKQKYDKICEKKVSTPIEVLCK---SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275
T+ K P C Y +LT++++P Y L+
Sbjct: 274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333
Query: 276 LFSREG 281
L
Sbjct: 334 LLQDLR 339
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-30
Identities = 53/258 (20%), Positives = 92/258 (35%), Gaps = 43/258 (16%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
+ G Y + ++IGSG ++F + + +I A+K E E
Sbjct: 24 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 82
Query: 59 LQGGSGIPN---IKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
LQ + I+ Y + D +V++ L ++ M+
Sbjct: 83 LQQ----HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNML 137
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+ +H G +H D+KP NFL+ G + +IDFG+A + + TT+ +
Sbjct: 138 EAVHTIHQHGIVHSDLKPANFLIVDGM----LKLIDFGIANQMQPDTTSVVK-----DSQ 188
Query: 174 TGTARYAS-----------CNTHLGIEQSRRDDLESLG---YVLLYFLRGSLPWQGLKAA 219
GT Y N + S + D+ SLG Y + Y G P+Q +
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQI--I 243
Query: 220 TKKQKYDKICEKKVSTPI 237
+ K I +
Sbjct: 244 NQISKLHAIIDPNHEIEF 261
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 1e-29
Identities = 45/269 (16%), Positives = 76/269 (28%), Gaps = 52/269 (19%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQ 60
K KL + G +FL V+ E A+K+ ENS ++ +L L
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 61 G--------------------GSGIPNIKWYGVDGEDN-----VLVLDLLGPSLEDLF-- 93
G P +D +L++ LE LF
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180
Query: 94 ----VYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149
R + + +L Q+I + S+G +H PDN + ++ + D
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM---PDGRLMLGD 237
Query: 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYAS--CNTHLGIEQSRRDDLESLGYVLLYFL 207
K + YA + + LG +
Sbjct: 238 VSALWKVGTRGP----------ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 208 RGSLPWQGLKAATKKQKYDKICEKKVSTP 236
LP+ GL K + + + T
Sbjct: 288 CLFLPF-GLVTPGIKGSWKRPSLRVPGTD 315
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 35/272 (12%), Positives = 72/272 (26%), Gaps = 45/272 (16%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQ 60
G +G A+ +T E V + Q+ E ++L+
Sbjct: 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131
Query: 61 GG---------------------SGIPNIKWYGVDGEDN-----VLVLDLLGPSLEDLFV 94
G + +D D + + +L+
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191
Query: 95 Y------CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148
+ L L Q+I + +H G +H ++P + ++ + V++
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QRGGVFLT 248
Query: 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FL 207
F + + E L S + + D +LG +++Y
Sbjct: 249 GFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG-LVIYWIW 307
Query: 208 RGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
LP + I + P V
Sbjct: 308 CADLPITK---DAALGGSEWIFRSCKNIPQPV 336
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-29
Identities = 53/256 (20%), Positives = 91/256 (35%), Gaps = 39/256 (15%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
+ G Y + ++IGSG ++F + + +I A+K E E
Sbjct: 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 59 LQGGSGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
LQ S I + Y + D +V++ L ++ M+
Sbjct: 64 LQQHS--DKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEA 120
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
+ +H G +H D+KP NFL+ + +IDFG+A + + TT+ + G
Sbjct: 121 VHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVK-----DSQVG 171
Query: 176 TARYAS-----------CNTHLGIEQSRRDDLESLG---YVLLYFLRGSLPWQGLKAATK 221
T Y N + S + D+ SLG Y + Y G P+Q + +
Sbjct: 172 TVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQII--NQ 226
Query: 222 KQKYDKICEKKVSTPI 237
K I +
Sbjct: 227 ISKLHAIIDPNHEIEF 242
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-29
Identities = 51/258 (19%), Positives = 90/258 (34%), Gaps = 43/258 (16%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKI 58
+ G Y + ++IGSG ++F + + +I A+K E E
Sbjct: 52 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110
Query: 59 LQGGSGIPN---IKWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
LQ + I+ Y + D +V++ L ++ M+
Sbjct: 111 LQQ----HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNML 165
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+ +H G +H D+KP NFL+ + +IDFG+A + + TT+ +
Sbjct: 166 EAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQPDTTSVVK-----DSQ 216
Query: 174 TGTARYAS-----------CNTHLGIEQSRRDDLESLG---YVLLYFLRGSLPWQGLKAA 219
G Y N + S + D+ SLG Y + Y G P+Q +
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY---GKTPFQQI--I 271
Query: 220 TKKQKYDKICEKKVSTPI 237
+ K I +
Sbjct: 272 NQISKLHAIIDPNHEIEF 289
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 5e-29
Identities = 34/286 (11%), Positives = 76/286 (26%), Gaps = 61/286 (21%)
Query: 1 MERIIGVKYKL---GRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYE 52
+E +G + + G +G A+ +T E V + Q+ E
Sbjct: 69 VESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEE 128
Query: 53 AKVYKILQG---------------------GSGIPNIKWYGVDGEDN-----VLVLDLLG 86
++L+G + +D D + +
Sbjct: 129 VLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ 188
Query: 87 PSLEDLFVYCRRK------FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 140
+L+ L L Q+I + +H G +H ++P + ++
Sbjct: 189 SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--- 245
Query: 141 KANQVYIIDFGLAKKYRDPT-TNRHIPYRENKNLTGTARYASCNTHLGIEQ-----SRRD 194
+ V++ F + + + + + +
Sbjct: 246 QRGGVFLTGFEHLVRDGASAVSPIGRGF-------APPETTAERMLPFGQHHPTLMTFAF 298
Query: 195 DLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
D +LG + +Y+ LP + I + P V
Sbjct: 299 DTWTLG-LAIYWIWCADLPNTD---DAALGGSEWIFRSCKNIPQPV 340
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 8e-27
Identities = 61/305 (20%), Positives = 113/305 (37%), Gaps = 50/305 (16%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKI 58
+ + L +G G+ +F H T ++ A+K+ + + E +V K
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 59 LQGGSGIPNI-KWYGVDGEDN----VLVLDLL-GPSLEDLFVYCRRKFSL--KTVLMLAD 110
L NI K + ++ E VL+++ SL + + L L++
Sbjct: 64 LNH----KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRE 169
++ + ++ G +HR+IKP N + +G VY + DFG A++ D
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED----------- 168
Query: 170 NKNLT---GTARYAS--------CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
++ GT Y + DL S+G V Y GSLP++ +
Sbjct: 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFE 227
Query: 218 AA-TKKQKYDKICEKKVSTPIEVL--CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274
K+ KI K S I + ++ P +++ SL+ L+ L
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-------RGLQVLLT 280
Query: 275 DLFSR 279
+ +
Sbjct: 281 PVLAN 285
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 9e-27
Identities = 56/277 (20%), Positives = 102/277 (36%), Gaps = 41/277 (14%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKI 58
+ + L +G G+ +F H T ++ A+K+ + + E +V K
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKK 63
Query: 59 LQGGSGIPNI-KWYGVDGEDN----VLVLDLL-GPSLEDLFVYCRRKFSL--KTVLMLAD 110
L NI K + ++ E VL+++ SL + + L L++
Sbjct: 64 LNH----KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY-IIDFGLAKKYRDPTTNRHIPYRE 169
++ + ++ G +HR+IKP N + +G VY + DFG A++ D
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED----------- 168
Query: 170 NKNLT---GTARYAS----CNTHLGIEQSRRDDLE----SLGYVLLY-FLRGSLPWQGLK 217
++ GT Y L + ++ S+G V Y GSLP++ +
Sbjct: 169 DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIG-VTFYHAATGSLPFRPFE 227
Query: 218 AA-TKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFH 253
K+ KI K S I + K+
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGD 264
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-26
Identities = 62/266 (23%), Positives = 102/266 (38%), Gaps = 70/266 (26%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEA 53
E +Y+LG +G G FG +F + VA+K+ + + E
Sbjct: 27 EAFEA-EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 54 KVYKILQGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVY-----------CRRK 99
+ + G G P + + E +LVL+ P+ +DLF Y R
Sbjct: 86 ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPA-QDLFDYITEKGPLGEGPSRCF 144
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
F Q++A I++ HSRG +HRDIK +N L + + +IDFG D
Sbjct: 145 FG---------QVVAAIQHCHSRGVVHRDIKDENIL--IDLRRGCAKLIDFGSGALLHD- 192
Query: 160 TTNRHIPYRENKNLT---GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLR-GS 210
+ T GT Y+ S + + + + SLG +LLY + G
Sbjct: 193 -----------EPYTDFDGTRVYSPPEWISRHQYHALPA----TVWSLG-ILLYDMVCGD 236
Query: 211 LPWQGLKAATKKQKYDKICEKKVSTP 236
+P++ +I E ++ P
Sbjct: 237 IPFER---------DQEILEAELHFP 253
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-25
Identities = 42/220 (19%), Positives = 80/220 (36%), Gaps = 26/220 (11%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGS 63
Y +K+G G F + L + A+K + + EA ++++
Sbjct: 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNH-- 85
Query: 64 GIPNI-KWYGV-----DGEDNV-LVLDL-LGPSLEDLFVYCRRK---FSLKTVLMLADQM 112
PNI + + L+L +L + + K + +L L +
Sbjct: 86 --PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGI 143
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH--IPYREN 170
+E +H++G+ HRD+KP N L+G Q ++D G + + ++
Sbjct: 144 CRGLEAIHAKGYAHRDLKPTNILLG---DEGQPVLMDLGSMNQACIHVEGSRQALTLQDW 200
Query: 171 KNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL 207
T Y + + R D+ SLG +LY +
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLG-CVLYAM 239
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 44/199 (22%), Positives = 77/199 (38%), Gaps = 32/199 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
++ +G G+FG++ A + + A+K I ++ K +L E + L
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH----Q 62
Query: 67 NI-KWYGVDGEDNV---------------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLA 109
+ ++Y E + ++ +L DL L
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP--- 166
Q++ + Y+HS+G +HRD+KP N + ++ V I DFGLAK +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFID---ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 167 -YRENKNLT---GTARYAS 181
+ NLT GTA Y +
Sbjct: 180 LPGSSDNLTSAIGTAMYVA 198
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-24
Identities = 42/225 (18%), Positives = 84/225 (37%), Gaps = 20/225 (8%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
+ + + + +G G+ G I + N VAVK E + +L+
Sbjct: 18 VVIVGKISFCPKDVLGHGAEGTIVYR-GMFDNRDVAVKRILP-ECFSFADREVQ---LLR 72
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
PN+ +++ + ++L +L++ + L Q + +
Sbjct: 73 ESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLA 132
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
++HS +HRD+KP N L+ + + I DFGL KK + + + G
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS----FSRRSGVPG 188
Query: 176 TARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL--RGSLPWQG 215
T + + + + D+ S G + Y++ GS P+
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAG-CVFYYVISEGSHPFGK 232
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 4e-24
Identities = 60/242 (24%), Positives = 97/242 (40%), Gaps = 34/242 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQG 61
+K+G +G GSF ++ A + T VA+K+ +G ++ E K++ L+
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQ-RVQNEVKIHCQLKH 70
Query: 62 GSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
P+I + Y + + V LVL++ + + FS Q+I +
Sbjct: 71 ----PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--G 175
Y+HS G LHRD+ N L+ + + I DFGLA + + P + T G
Sbjct: 127 YLHSHGILHRDLTLSNLLLT---RNMNIKIADFGLATQLKMPHEKHY---------TLCG 174
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVS 234
T Y S D+ SLG + Y L G P+ T K +K+
Sbjct: 175 TPNYISPEIATRSAHGLESDVWSLG-CMFYTLLIGRPPFD---TDTVKNTLNKVVLADYE 230
Query: 235 TP 236
P
Sbjct: 231 MP 232
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 52/257 (20%), Positives = 93/257 (36%), Gaps = 39/257 (15%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKI 58
+ G +++ ++G+G FG + H DT E VA+K E S + E ++ K
Sbjct: 10 TQTCG-PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKK 68
Query: 59 LQGGSGIPNI---------KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSL--KTVL 106
L PN+ + +L ++ G L L +
Sbjct: 69 LNH----PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166
L + + + Y+H +HRD+KP+N ++ G + IID G AK+
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ-------- 176
Query: 167 YRENKNLT---GTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKK 222
+ T GT +Y + + + D S G L + G P+ +
Sbjct: 177 ---GELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFG-TLAFECITGFRPFLP---NWQP 229
Query: 223 QKYDKICEKKVSTPIEV 239
++ +K + I V
Sbjct: 230 VQWHGKVREKSNEHIVV 246
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-24
Identities = 61/249 (24%), Positives = 99/249 (39%), Gaps = 45/249 (18%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKIL 59
+Y GR +G G F + F S DT E+ A KI + ++ E +++ L
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSL 98
Query: 60 QGGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
++ ++G + D V +VL+L SL +L R+ + Q++
Sbjct: 99 AH----QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLG 153
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT- 174
+Y+H +HRD+K N L V I DFGLA K +
Sbjct: 154 CQYLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGLATKVEYDGERKK---------VL 201
Query: 175 -GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDK 227
GT Y S H S D+ S+G ++Y L G P++ + K+ Y +
Sbjct: 202 CGTPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSCLKETYLR 252
Query: 228 ICEKKVSTP 236
I + + S P
Sbjct: 253 IKKNEYSIP 261
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 8e-24
Identities = 55/236 (23%), Positives = 97/236 (41%), Gaps = 45/236 (19%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEA 53
E + +Y++G +GSG FG ++ V N VA+K ++ E
Sbjct: 39 EPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 97
Query: 54 KVYKILQGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVL--ML 108
+ K + SG + + + VL+L+ P +DLF + + +L+ L
Sbjct: 98 VLLKKVS--SGFSGVIRLLDWFERPDSFVLILERPEPV-QDLFDFITERGALQEELARSF 154
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
Q++ + + H+ G LHRDIK +N L + ++ +IDFG +D
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKD---------- 202
Query: 169 ENKNLT---GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQG 215
T GT Y+ + + G + SLG +LLY + G +P++
Sbjct: 203 --TVYTDFDGTRVYSPPEWIRYHRYHGRSA----AVWSLG-ILLYDMVCGDIPFEH 251
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 1e-23
Identities = 61/247 (24%), Positives = 99/247 (40%), Gaps = 45/247 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVYKILQG 61
+Y GR +G G F + F S DT E+ A KI + ++ E +++ L
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE-KMSMEISIHRSLAH 74
Query: 62 GSGIPNI-KWYGV-DGEDNV-LVLDL-LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
++ ++G + D V +VL+L SL +L R+ + Q++ +
Sbjct: 75 ----QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQ 129
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT--G 175
Y+H +HRD+K N L V I DFGLA K + G
Sbjct: 130 YLHRNRVIHRDLKLGNLF--LNEDLE-VKIGDFGLATKVEYDGERKK---------VLCG 177
Query: 176 TARYA-----SCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKIC 229
T Y S H S D+ S+G ++Y L G P++ + K+ Y +I
Sbjct: 178 TPNYIAPEVLSKKGH-----SFEVDVWSIG-CIMYTLLVGKPPFE---TSCLKETYLRIK 228
Query: 230 EKKVSTP 236
+ + S P
Sbjct: 229 KNEYSIP 235
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 1e-23
Identities = 52/239 (21%), Positives = 90/239 (37%), Gaps = 37/239 (15%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
E+ + + +G GS G + VAVK L E K +L
Sbjct: 10 EQSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-FCDIALMEIK---LLTE 64
Query: 62 GSGIPNI-KWYGV-DGEDNV-LVLDLLGPSLEDL------FVYCRRKFSLKTVLMLADQM 112
PN+ ++Y + + + L+L +L+DL + + L Q+
Sbjct: 65 SDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 113 IARIEYVHSRGFLHRDIKPDNFL----------MGLGRKANQVYIIDFGLAKKYRDPTTN 162
+ + ++HS +HRD+KP N L G + ++ I DFGL KK
Sbjct: 125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS---G 181
Query: 163 RHIPYRENKNLTGTARYA-------SCNTHLGIEQSRRDDLESLGYVLLYFL--RGSLP 212
+ N +GT+ + S N +R D+ S+G + Y++ +G P
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG-CVFYYILSKGKHP 239
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 1e-23
Identities = 70/241 (29%), Positives = 112/241 (46%), Gaps = 35/241 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAKVYKILQG 61
+++GR +G G FG ++LA + I+A+K +E +G +H QL E ++ L+
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH-QLRREVEIQSHLRH 68
Query: 62 GSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARI 116
PNI + YG D L+L+ L ++ ++ KF + ++ +
Sbjct: 69 ----PNILRLYGYFHDATRVYLILEYA--PLGTVYRELQKLSKFDEQRTATYITELANAL 122
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
Y HS+ +HRDIKP+N L+G A ++ I DFG + H P +L GT
Sbjct: 123 SYCHSKRVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTDLCGT 170
Query: 177 ARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
Y G + DL SLG VL Y FL G P++ A T ++ Y +I + +
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLG-VLCYEFLVGKPPFE---ANTYQETYKRISRVEFTF 226
Query: 236 P 236
P
Sbjct: 227 P 227
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 2e-23
Identities = 35/154 (22%), Positives = 60/154 (38%), Gaps = 13/154 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGS 63
++ ++G GS+GE+F + + AVK S + P+ L E +
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVG---SHEKVG 114
Query: 64 GIPNI-KWYGVDGEDNVL--VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P + E +L +L GPSL+ V + + ++H
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
S+G +H D+KP N +G + + DFGL
Sbjct: 175 SQGLVHLDVKPANIFLG---PRGRCKLGDFGLLV 205
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 68/248 (27%), Positives = 117/248 (47%), Gaps = 37/248 (14%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQ 60
+ Y+ +K+GSG++GE+ L T+ A+KI S + + +LL E V K+L
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
PNI K Y + + N LV++ G L D ++ R KF+ ++ Q+++ +
Sbjct: 95 H----PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGV 149
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
Y+H +HRD+KP+N L+ K + I+DFGL+ + ++ K GT
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--------NQKKMKERLGT 201
Query: 177 ARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKICE 230
A Y + E R+ D+ S+G V+L+ L G P+ G T ++ K+ +
Sbjct: 202 AYYIA------PEVLRKKYDEKCDVWSIG-VILFILLAGYPPFGG---QTDQEILRKVEK 251
Query: 231 KKVSTPIE 238
K +
Sbjct: 252 GKYTFDSP 259
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 6e-23
Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 20/206 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y + ++G+G+FG + + T A K + + E + +L+
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH---- 213
Query: 66 PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P + + D + V++ + + G L + K S + Q+ + ++H
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
++H D+KP+N + +++N++ +IDFGL P + K TGTA +A+
Sbjct: 274 NNYVHLDLKPENIMF-TTKRSNELKLIDFGLTAHLD--------PKQSVKVTTGTAEFAA 324
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFL 207
G D+ S+G VL Y L
Sbjct: 325 PEVAEGKPVGYYTDMWSVG-VLSYIL 349
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 6e-23
Identities = 70/249 (28%), Positives = 108/249 (43%), Gaps = 38/249 (15%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKIL 59
+YK R +G GSFGE+ L T + AVK+ T LL E ++ K L
Sbjct: 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 60 QGGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
PNI K Y + + LV ++ G L D + R++FS + Q+++
Sbjct: 84 DH----PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSG 138
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
I Y+H +HRD+KP+N L+ K + IIDFGL+ + ++ K+ G
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--------ASKKMKDKIG 190
Query: 176 TARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDKIC 229
TA Y + E D+ S G V+LY L G P+ G A + K+
Sbjct: 191 TAYYIA------PEVLHGTYDEKCDVWSTG-VILYILLSGCPPFNG---ANEYDILKKVE 240
Query: 230 EKKVSTPIE 238
+ K + +
Sbjct: 241 KGKYTFELP 249
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 1e-22
Identities = 62/241 (25%), Positives = 103/241 (42%), Gaps = 35/241 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK------IENSGTKHPQLLYEAKVYKILQG 61
+ +GR +G G FG ++LA I+A+K +E G +H QL E ++ L+
Sbjct: 15 DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH-QLRREIEIQSHLRH 73
Query: 62 GSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRR--KFSLKTVLMLADQMIARI 116
PNI + Y D + L+L+ +L+ ++ +F + +++ +
Sbjct: 74 ----PNILRMYNYFHDRKRIYLMLEFA--PRGELYKELQKHGRFDEQRSATFMEELADAL 127
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
Y H R +HRDIKP+N LMG ++ I DFG + H P + + GT
Sbjct: 128 HYCHERKVIHRDIKPENLLMG---YKGELKIADFGWSV---------HAPSLRRRTMCGT 175
Query: 177 ARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
Y G + DL G VL Y FL G P+ + + + + +I +
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAG-VLCYEFLVGMPPFD---SPSHTETHRRIVNVDLKF 231
Query: 236 P 236
P
Sbjct: 232 P 232
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 44/167 (26%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----------ENSGTKHPQLLYEAKVYK 57
+Y + + +GSG+ GE+ LA T + VA+KI + E ++ K
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 58 ILQGGSGIPNI-KWYGVDGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQ 111
L P I K ++ +VL+L+ G +LF V ++ T + Q
Sbjct: 71 KLNH----PCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQ 122
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
M+ ++Y+H G +HRD+KP+N L+ + + I DFG +K +
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-22
Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 24/167 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----------ENSGTKHPQLLYEAKVYK 57
+Y + + +GSG+ GE+ LA T + VA++I + E ++ K
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 58 ILQGGSGIPNI-KWYGVDGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQ 111
L P I K ++ +VL+L+ G +LF V ++ T + Q
Sbjct: 196 KLNH----PCIIKIKNFFDAEDYYIVLELMEGG----ELFDKVVGNKRLKEATCKLYFYQ 247
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
M+ ++Y+H G +HRD+KP+N L+ + + I DFG +K +
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 44/175 (25%), Positives = 64/175 (36%), Gaps = 22/175 (12%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSGI 65
++G GSFGE+ T AVK +E + E L
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE------ELVACAGLSS---- 109
Query: 66 PNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P I YG E + ++LL G SL L L Q + +EY+H+
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHT 168
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
R LH D+K DN L L ++ + DFG A + + + + GT
Sbjct: 169 RRILHGDVKADNVL--LSSDGSRAALCDFGHALCLQPDGLGKSLLTG--DYIPGT 219
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-22
Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 48/247 (19%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
I + RK+GSG+FG++ L + +K + S Q+ E +V K L
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 62 GSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLF------VYCRRKFSLKTVLMLAD 110
PNI K + V D + +V++ G +L + S V L
Sbjct: 80 ----PNIIKIFEVFEDYHNMYIVMETCEGG----ELLERIVSAQARGKALSEGYVAELMK 131
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
QM+ + Y HS+ +H+D+KP+N L + + IIDFGLA+ ++ +
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--------SDEHS 183
Query: 171 KNLTGTARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLP-W----QGLKAA 219
N GTA Y + E +RD D+ S G V++YF L G LP + ++
Sbjct: 184 TNAAGTALYMA------PEVFKRDVTFKCDIWSAG-VVMYFLLTGCLPFTGTSLEEVQQK 236
Query: 220 TKKQKYD 226
++ +
Sbjct: 237 ATYKEPN 243
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-22
Identities = 54/262 (20%), Positives = 90/262 (34%), Gaps = 75/262 (28%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----------SGTKHPQLLYEAKVYK 57
KY +GSG+FG ++ A + N+ V VK K ++ E +
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 58 ILQGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVY-----------CRRKFSLK 103
++ NI K + + LV++ G L+ LF + F
Sbjct: 85 RVEH----ANIIKVLDIFENQGFFQLVMEKHGSGLD-LFAFIDRHPRLDEPLASYIFR-- 137
Query: 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163
Q+++ + Y+ + +HRDIK +N + + + +IDFG A
Sbjct: 138 -------QLVSAVGYLRLKDIIHRDIKDENIV--IAEDFT-IKLIDFGSAAYLER----- 182
Query: 164 HIPYRENKNLT---GTARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQ 214
K GT Y N + G E ++ SLG V LY L P+
Sbjct: 183 ------GKLFYTFCGTIEYCAPEVLMGNPYRGPEL----EMWSLG-VTLYTLVFEENPFC 231
Query: 215 GLKAATKKQKYDKICEKKVSTP 236
++ E + P
Sbjct: 232 E---------LEETVEAAIHPP 244
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-22
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 19/165 (11%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQ 60
+Y + +G GSFGE+ T + AVK+ N +L E ++ K L
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMI 113
PNI K + + + + +V +L G +LF + R++FS + Q+
Sbjct: 80 H----PNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ I Y+H +HRD+KP+N L+ K + IIDFGL+ ++
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 4e-22
Identities = 64/251 (25%), Positives = 106/251 (42%), Gaps = 43/251 (17%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQ 60
+Y + +G GSFGE+ T + AVK+ N +L E ++ K L
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
PNI K + + + + +V +L G L D + R++FS + Q+ + I
Sbjct: 80 H----PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGI 134
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT-- 174
Y+H +HRD+KP+N L+ K + IIDFGL+ +++N +
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC-----------FQQNTKMKDR 183
Query: 175 -GTARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLPWQGLKAATKKQKYDK 227
GTA Y + E R D+ S G V+LY L G+ P+ G + +
Sbjct: 184 IGTAYYIA------PEVLRGTYDEKCDVWSAG-VILYILLSGTPPFYG---KNEYDILKR 233
Query: 228 ICEKKVSTPIE 238
+ K + +
Sbjct: 234 VETGKYAFDLP 244
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 7e-22
Identities = 33/182 (18%), Positives = 75/182 (41%), Gaps = 18/182 (9%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGS 63
+ KY + +G G FG + + + K ++ GT + E + I +
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-- 60
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
NI + E+ V++ + + G + + + + + ++ Q+ ++++
Sbjct: 61 --RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
HS H DI+P+N + R+++ + II+FG A++ + P + L Y
Sbjct: 119 HSHNIGHFDIRPENIIY-QTRRSSTIKIIEFGQARQLK--------PGDNFRLLFTAPEY 169
Query: 180 AS 181
+
Sbjct: 170 YA 171
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 8e-22
Identities = 48/227 (21%), Positives = 84/227 (37%), Gaps = 32/227 (14%)
Query: 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGS 63
++ ++ R + G F ++ A V + A+K N K+ ++ E K L G
Sbjct: 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGH- 85
Query: 64 GIPNI----------KWYGVDGEDNVLVL-DLLGPSLEDLFVYCRRK--FSLKTVLMLAD 110
PNI K G+ L+L +L L + + S TVL +
Sbjct: 86 --PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 111 QMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
Q ++++H + +HRD+K +N L+ + + DFG A R
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLS---NQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 169 -----ENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL 207
E T Y + + + + D+ +LG +LY L
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG-CILYLL 246
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-21
Identities = 49/162 (30%), Positives = 73/162 (45%), Gaps = 19/162 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGS 63
Y + ++G G+F + H T A KI N S +L EA++ + LQ
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-- 64
Query: 64 GIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARI 116
PNI + + E LV DL+ G +LF + R +S Q++ I
Sbjct: 65 --PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQILESI 118
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
Y HS G +HR++KP+N L+ K V + DFGLA + D
Sbjct: 119 AYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-21
Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 17/163 (10%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGG 62
I Y L IG GS+GE+ +A T A K I + E ++ K L
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH- 65
Query: 63 SGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIAR 115
PNI + Y + ++ LV++L G +LF V +R F + +++
Sbjct: 66 ---PNIIRLYETFEDNTDIYLVMELCTGG----ELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ Y H HRD+KP+NFL + + +IDFGLA +++
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 2e-21
Identities = 37/168 (22%), Positives = 61/168 (36%), Gaps = 21/168 (12%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVY---K 57
KY IG G + H T AVKI +
Sbjct: 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETH 151
Query: 58 ILQGGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLAD 110
IL+ +G P+I + + LV DL+ G +LF + + S K +
Sbjct: 152 ILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG----ELFDYLTEKVALSEKETRSIMR 207
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
++ + ++H+ +HRD+KP+N L L + + DFG +
Sbjct: 208 SLLEAVSFLHANNIVHRDLKPENIL--LDDNMQ-IRLSDFGFSCHLEP 252
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 53/256 (20%), Positives = 101/256 (39%), Gaps = 46/256 (17%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI------ENSGTKHPQLLYEAKVY 56
++IG KY +G +G GS+G++ +T AVKI + E ++
Sbjct: 2 KLIG-KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLL 60
Query: 57 KILQGGSGIPNI-KWYGVDGEDN----VLVLDLLGPSLEDLFVY-CRRKFSLKTVLMLAD 110
+ L+ N+ + V + +V++ ++++ ++F +
Sbjct: 61 RRLRH----KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFC 116
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
Q+I +EY+HS+G +H+DIKP N L L + I G+A P+ +
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLL--LTTGGT-LKISALGVA--------EALHPFAAD 165
Query: 171 KNLT---GTARYAS------CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAAT 220
G+ + +T G + D+ S G V LY G P++G
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKV----DIWSAG-VTLYNITTGLYPFEG---DN 217
Query: 221 KKQKYDKICEKKVSTP 236
+ ++ I + + P
Sbjct: 218 IYKLFENIGKGSYAIP 233
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-21
Identities = 40/166 (24%), Positives = 66/166 (39%), Gaps = 22/166 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVY-------KIL 59
Y+ +G G + H T + AVK I+ +G ++ IL
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 60 QGGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQM 112
+ SG PNI + + LV DL+ G +LF + + S K + +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTEKVTLSEKETRKIMRAL 133
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ I +H +HRD+KP+N L L N + + DFG + +
Sbjct: 134 LEVICALHKLNIVHRDLKPENIL--LDDDMN-IKLTDFGFSCQLDP 176
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 43/164 (26%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQGGS 63
+Y+L ++G G+F + V + A I N S H +L EA++ ++L+
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH-- 69
Query: 64 GIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARI 116
PNI + + E + L+ DL+ G +LF + R +S Q++ +
Sbjct: 70 --PNIVRLHDSISEEGHHYLIFDLVTGG----ELFEDIVAREYYSEADASHCIQQILEAV 123
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
+ H G +HR++KP+N L+ K V + DFGLA +
Sbjct: 124 LHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ 167
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-21
Identities = 41/200 (20%), Positives = 72/200 (36%), Gaps = 33/200 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSG 64
++ + +G G FG +F A + + A+K + N +++ E K L+
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH--- 62
Query: 65 IPNI-KWYGVDGEDNVLVLDLLGPSLEDLFV---YCRRK--------------FSLKTVL 106
P I +++ E N L++ CR++ L
Sbjct: 63 -PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-----YRDPTT 161
+ Q+ +E++HS+G +HRD+KP N + V + DFGL
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFT---MDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 162 NRHIPYRENKNLTGTARYAS 181
Y + GT Y S
Sbjct: 179 TPMPAYARHTGQVGTKLYMS 198
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-21
Identities = 49/165 (29%), Positives = 73/165 (44%), Gaps = 19/165 (11%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVYKILQ 60
Y + ++G G+F + H T A KI N S +L EA++ + LQ
Sbjct: 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 86
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMI 113
PNI + + E LV DL+ G +LF + R +S Q++
Sbjct: 87 H----PNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREFYSEADASHCIQQIL 138
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
I Y HS G +HR++KP+N L+ K V + DFGLA + D
Sbjct: 139 ESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 3e-21
Identities = 71/261 (27%), Positives = 101/261 (38%), Gaps = 60/261 (22%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----EAKVYK 57
+ + L + +G G++GE+ LA + T E VAVKI + + E + K
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINK 60
Query: 58 ILQGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVY-----------CRRKF 100
+L N+ K+YG E N+ L LE +LF +R F
Sbjct: 61 MLNH----ENVVKFYGHRREGNIQYL-----FLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 101 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
Q++A + Y+H G HRDIKP+N L L + N + I DFGLA +R
Sbjct: 112 H---------QLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNN 159
Query: 161 TNRHIPYRENKNLTGTARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
R + + GT Y D+ S G VL L G LPW
Sbjct: 160 RERLL-----NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ 210
Query: 216 LKAATKKQKYDKICEKKVSTP 236
+ Q+Y EKK
Sbjct: 211 --PSDSCQEYSDWKEKKTYLN 229
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 4e-21
Identities = 44/246 (17%), Positives = 82/246 (33%), Gaps = 76/246 (30%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKI-ENSGT-------------- 44
I+ +Y++ I G G I+LA +D N V +K +SG
Sbjct: 76 DIVAGQYEVKGCIAHGGLGWIYLA--LDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFL 133
Query: 45 ---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV-----LVLDLL-GPSLEDLFVY 95
HP I I + + + +V++ + G SL+
Sbjct: 134 AEVVHP----------------SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-- 175
Query: 96 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+K + + +++ + Y+HS G ++ D+KP+N ++ Q+ +ID G +
Sbjct: 176 -GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT----EEQLKLIDLGAVSR 230
Query: 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR-----RDDLESLGYVLLY-FLRG 209
L GT + + E R D+ ++G L
Sbjct: 231 INSFGY-----------LYGTPGFQA------PEIVRTGPTVATDIYTVG-RTLAALTLD 272
Query: 210 SLPWQG 215
G
Sbjct: 273 LPTRNG 278
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-21
Identities = 56/234 (23%), Positives = 95/234 (40%), Gaps = 47/234 (20%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----------E 52
+II +YK+ K+G G ++LA N VA+K E
Sbjct: 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKA-----IFIPPREKEETLKRFERE 61
Query: 53 AKVYKILQGGSGIPNI-KWY--GVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLML 108
L NI + + LV++ + GP+L + + S+ T +
Sbjct: 62 VHNSSQLSH----QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEY-IESHGPLSVDTAINF 116
Query: 109 ADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+Q++ I++ H +HRDIKP N L+ + I DFG+AK + +
Sbjct: 117 TNQILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDFGIAKALSETSLT------ 167
Query: 169 ENKNLTGTARYASCNTHLGIEQSR------RDDLESLGYVLLY-FLRGSLPWQG 215
+ ++ GT +Y S EQ++ D+ S+G ++LY L G P+ G
Sbjct: 168 QTNHVLGTVQYFS------PEQAKGEATDECTDIYSIG-IVLYEMLVGEPPFNG 214
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-21
Identities = 71/259 (27%), Positives = 114/259 (44%), Gaps = 57/259 (22%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN----SGTKHPQLLYEAKVY 56
+ IG Y+L + IG G+F ++ LA H+ T VA+KI + + T +L E ++
Sbjct: 10 EQPHIG-NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIM 68
Query: 57 KILQGGSGIPNI-KWYGV-DGEDNV-LVLDLLGPSLEDLFVY-----------CRRKFSL 102
KIL PNI K + V + E + L+++ S ++F Y R KF
Sbjct: 69 KILNH----PNIVKLFEVIETEKTLYLIMEYA--SGGEVFDYLVAHGRMKEKEARSKFR- 121
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
Q+++ ++Y H + +HRD+K +N L L N + I DFG + ++
Sbjct: 122 --------QIVSAVQYCHQKRIVHRDLKAENLL--LDADMN-IKIADFGFSNEFTV---- 166
Query: 163 RHIPYRENKNLT---GTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLR-GSLPWQGLK 217
L G YA+ G + D+ SLG V+LY L GSLP+ G
Sbjct: 167 -------GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG-VILYTLVSGSLPFDG-- 216
Query: 218 AATKKQKYDKICEKKVSTP 236
K+ +++ K P
Sbjct: 217 -QNLKELRERVLRGKYRIP 234
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-21
Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 42/231 (18%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-TKHPQLLY----EAKVYK 57
G Y+L R +G G G+++ A IVA+K+ + + P EA+
Sbjct: 31 TQFG-PYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAG 89
Query: 58 ILQGGSGIPNIKW---YGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMI 113
LQ P++ +G + + L+ G L + + + + + + Q+
Sbjct: 90 RLQE----PHVVPIHDFGEIDGQLYVDMRLINGVDLAAM-LRRQGPLAPPRAVAIVRQIG 144
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT---TNRHIPYREN 170
+ ++ H+ G HRD+KP+N L+ + Y++DFG+A D
Sbjct: 145 SALDAAHAAGATHRDVKPENILVS---ADDFAYLVDFGIASATTDEKLTQLG-------- 193
Query: 171 KNLTGTARYASCNTHLGIEQSR------RDDLESLGYVLLYFLRGSLPWQG 215
N GT Y + E+ R D+ +L VL L GS P+QG
Sbjct: 194 -NTVGTLYYMA------PERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-21
Identities = 39/173 (22%), Positives = 73/173 (42%), Gaps = 21/173 (12%)
Query: 12 GRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
+G G++G ++ + +A+K E L E ++K L+ NI
Sbjct: 27 RVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH----KNIV 82
Query: 69 KWYGVDGEDNVL--VLDLL-GPSLEDL--FVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
++ G E+ + ++ + G SL L + K + +T+ Q++ ++Y+H
Sbjct: 83 QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ 142
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
+HRDIK DN L + + + I DFG +K+ + TGT
Sbjct: 143 IVHRDIKGDNVL--INTYSGVLKISDFGTSKRLAGINPCT-------ETFTGT 186
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 8e-21
Identities = 63/255 (24%), Positives = 106/255 (41%), Gaps = 48/255 (18%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---------------ENSGTKHPQL 49
IG Y RK+GSG++GE+ L + + A+K+ +N H ++
Sbjct: 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 50 LYEAKVYKILQGGSGIPNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTV 105
E + K L PNI K + V + + LV + G L + + R KF
Sbjct: 94 YNEISLLKSLDH----PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDA 148
Query: 106 LMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165
+ Q+++ I Y+H +HRDIKP+N L+ + I+DFGL+ +
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-------- 200
Query: 166 PYRENKNLTGTARYASCNTHLGIEQSRRD-----DLESLGYVLLYF-LRGSLPWQGLKAA 219
+ ++ GTA Y + E ++ D+ S G V++Y L G P+ G
Sbjct: 201 KDYKLRDRLGTAYYIA------PEVLKKKYNEKCDVWSCG-VIMYILLCGYPPFGG---Q 250
Query: 220 TKKQKYDKICEKKVS 234
+ K+ + K
Sbjct: 251 NDQDIIKKVEKGKYY 265
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-20
Identities = 41/160 (25%), Positives = 80/160 (50%), Gaps = 17/160 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
+ +GSG+F E+FL T ++ A+K ++ + L E V K ++
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH---- 65
Query: 66 PNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEY 118
NI + + + LV+ L+ G +LF + R ++ K ++ Q+++ ++Y
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGG----ELFDRILERGVYTEKDASLVIQQVLSAVKY 121
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+H G +HRD+KP+N L + +++ I DFGL+K ++
Sbjct: 122 LHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-20
Identities = 43/188 (22%), Positives = 77/188 (40%), Gaps = 32/188 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y +G ++GSG F + T A K G ++ E + + +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRKFSL--KTVLMLADQM 112
N+ + V + D VL+L+L+ G +LF + +K SL + Q+
Sbjct: 73 LH----HNVITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATSFIKQI 124
Query: 113 IARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
+ + Y+H++ H D+KP+N ++ + +IDFGLA + E K
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--------DGVEFK 176
Query: 172 NLTGTARY 179
N+ GT +
Sbjct: 177 NIFGTPEF 184
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-20
Identities = 51/250 (20%), Positives = 90/250 (36%), Gaps = 47/250 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYKILQ 60
Y+L IG G F + + +T + AVKI + G L EA + +L+
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 61 GGSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF------VYCRRKFSLKTVLMLA 109
P+I + + + +V + + DL +S
Sbjct: 85 H----PHIVELLETYSSDGMLYMVFEFMDGA----DLCFEIVKRADAGFVYSEAVASHYM 136
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
Q++ + Y H +HRD+KP L+ + V + FG+A + +
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-------SGLV 189
Query: 170 NKNLTGTARYAS----CNTHLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQK 224
GT + + G D+ G V+L+ L G LP+ G TK++
Sbjct: 190 AGGRVGTPHFMAPEVVKREPYGKPV----DVWGCG-VILFILLSGCLPFYG----TKERL 240
Query: 225 YDKICEKKVS 234
++ I + K
Sbjct: 241 FEGIIKGKYK 250
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-20
Identities = 71/261 (27%), Positives = 101/261 (38%), Gaps = 60/261 (22%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----EAKVYK 57
+ + L + +G G++GE+ LA + T E VAVKI + + E + K
Sbjct: 3 VPFVE-DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDM-KRAVDCPENIKKEICINK 60
Query: 58 ILQGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVY-----------CRRKF 100
+L N+ K+YG E N+ L LE +LF +R F
Sbjct: 61 MLNH----ENVVKFYGHRREGNIQYL-----FLEYCSGGELFDRIEPDIGMPEPDAQRFF 111
Query: 101 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
Q++A + Y+H G HRDIKP+N L L + N + I DFGLA +R
Sbjct: 112 H---------QLMAGVVYLHGIGITHRDIKPENLL--LDERDN-LKISDFGLATVFRYNN 159
Query: 161 TNRHIPYRENKNLTGTARYA-----SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
R + + GT Y D+ S G VL L G LPW
Sbjct: 160 RERLL-----NKMCGTLPYVAPELLKRREFHAEPV----DVWSCGIVLTAMLAGELPWDQ 210
Query: 216 LKAATKKQKYDKICEKKVSTP 236
+ Q+Y EKK
Sbjct: 211 --PSDSCQEYSDWKEKKTYLN 229
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-20
Identities = 46/275 (16%), Positives = 94/275 (34%), Gaps = 40/275 (14%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLL----YEAKVYKILQGGSGI 65
++G IG G FG+++ VA+++ + + L E Y+ +
Sbjct: 36 EIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRH---- 88
Query: 66 PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVH 120
N+ + G ++ L G +L + + + +A + I + + Y+H
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE-IVKGMGYLH 147
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-KYRDPTTNRHIPYRENKNLTGTARY 179
++G LH+D+K N G+ V I DFGL R R G +
Sbjct: 148 AKGILHKDLKSKNVFYDNGK----VVITDFGLFSISGVLQAGRREDKLRIQ---NGWLCH 200
Query: 180 ---------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
+ + S+ D+ +LG + P++ A ++
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE---AIIWQMGT 257
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
++ E + +C + ++RP
Sbjct: 258 GMKPNLSQIGM---GKEISDILLFCWAFEQEERPT 289
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 3e-20
Identities = 66/278 (23%), Positives = 115/278 (41%), Gaps = 29/278 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY----EAKVYKILQGGSGI 65
+G++IGSGSFG ++ + VAVK+ N PQ L E V + +
Sbjct: 27 TVGQRIGSGSFGTVYKG---KWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH---- 79
Query: 66 PNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHS 121
NI + G + +V G SL KF +K ++ +A Q AR ++Y+H+
Sbjct: 80 VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQ-TARGMDYLHA 138
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+ +HRD+K +N + + N V I DFGLA +R + + L+G+ + +
Sbjct: 139 KSIIHRDLKSNNIFLH---EDNTVKIGDFGLAT-----EKSRWSGSHQFEQLSGSILWMA 190
Query: 182 ---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
S + D+ + G VL + G LP+ + Q + + +S +
Sbjct: 191 PEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEMVGRGSLSPDLS 248
Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276
+ + P C D+RP + + +L
Sbjct: 249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-20
Identities = 46/182 (25%), Positives = 76/182 (41%), Gaps = 16/182 (8%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHP-QLLYEAKVYKILQGGSGIPN 67
G +G G FG+ +H +T E++ +K + + L E KV + L+ PN
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH----PN 68
Query: 68 I-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYVHSR 122
+ K+ GV +D L + + + G +L + ++ + A IA + Y+HS
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD-IASGMAYLHSM 127
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
+HRD+ N L+ + V + DFGLA+ D T R K RY
Sbjct: 128 NIIHRDLNSHNCLVR---ENKNVVVADFGLARLMVDEKTQPEGL-RSLKKPDRKKRYTVV 183
Query: 183 NT 184
Sbjct: 184 GN 185
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 4e-20
Identities = 42/188 (22%), Positives = 79/188 (42%), Gaps = 32/188 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y++G ++GSG F + T + A K G ++ E + + +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYC--RRKFSLKTVLMLADQM 112
+ PNI + + + D VL+L+L+ G +LF + + + Q+
Sbjct: 66 RH----PNIITLHDIFENKTDVVLILELVSGG----ELFDFLAEKESLTEDEATQFLKQI 117
Query: 113 IARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
+ + Y+HS+ H D+KP+N ++ ++ +IDFG+A K E K
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE--------AGNEFK 169
Query: 172 NLTGTARY 179
N+ GT +
Sbjct: 170 NIFGTPEF 177
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 5e-20
Identities = 48/180 (26%), Positives = 73/180 (40%), Gaps = 19/180 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
Y + ++GSG+FG + T + K N + E + L
Sbjct: 52 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH---- 107
Query: 66 PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P + + D + VL+L+ L G L D K S V+ Q ++++H
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+H DIKP+N + +KA+ V IIDFGLA K P K T TA +A+
Sbjct: 168 HSIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLN--------PDEIVKVTTATAEFAA 218
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 6e-20
Identities = 52/223 (23%), Positives = 83/223 (37%), Gaps = 45/223 (20%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI 68
+K IGSG FG++F A H + +K + + E K L NI
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE--KAEREVKALAKLDH----VNI 66
Query: 69 -----KWYGVDGEDNVLVLDLLGPSLEDLFV---YC-------------RRKFSLKTVLM 107
W G D + + + LF+ +C K L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
L +Q+ ++Y+HS+ ++RD+KP N + QV I DFGL ++
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQVKIGDFGLVTSLKNDG------- 176
Query: 168 RENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL 207
+ GT RY S + + + DL +LG ++L L
Sbjct: 177 -KRTRSKGTLRYMSPEQIS---SQDYGKEVDLYALG-LILAEL 214
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 7e-20
Identities = 66/273 (24%), Positives = 111/273 (40%), Gaps = 36/273 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHP----QLLYEAKVYKILQGG 62
+++ +KIG G F E++ A+ + VA+K ++ + E + K L
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH- 91
Query: 63 SGIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIAR 115
PN+ K+Y EDN L VL+L L + + +++ +TV Q+ +
Sbjct: 92 ---PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
+E++HSR +HRDIKP N + V + D GL + + TT +L G
Sbjct: 149 LEHMHSRRVMHRDIKPANVFIT---ATGVVKLGDLGLGRFFSSKTTAA-------HSLVG 198
Query: 176 TARYAS---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
T Y S + + + D+ SLG +L P+ G KI +
Sbjct: 199 TPYYMSPERIH---ENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLYSLCKKIEQCD 254
Query: 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
P+ S E + C + ++RPD
Sbjct: 255 YP-PLPSDHYS--EELRQLVNMCINPDPEKRPD 284
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 8e-20
Identities = 37/186 (19%), Positives = 66/186 (35%), Gaps = 31/186 (16%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY---------EAKVYKILQ 60
+ ++IG G FG + V +VA+K G + E + L
Sbjct: 22 EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 61 GGSGIPNI-KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
PNI K YG+ +V++ + L + L L IA IE
Sbjct: 82 H----PNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD-IALGIE 136
Query: 118 YVHSRG--FLHRDIKPDNFLMGLGRKANQVY--IIDFGLAKKYRDPTTNRHIPYRENKNL 173
Y+ ++ +HRD++ N + + V + DFGL+++ +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL---------- 186
Query: 174 TGTARY 179
G ++
Sbjct: 187 LGNFQW 192
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 8e-20
Identities = 67/251 (26%), Positives = 97/251 (38%), Gaps = 56/251 (22%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
Y++ IG GS+ H TN AVKI + E +IL PN
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID--KSKRDPTEEI---EILLRYGQHPN 77
Query: 68 I-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEYVH 120
I V D V +V +L+ G +L + ++ FS + + + +EY+H
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGG----ELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 121 SRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT---GT 176
++G +HRD+KP N L + I DFG AK+ R EN L T
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA----------ENGLLMTPCYT 183
Query: 177 ARY------------ASCNTHLGIEQSRRDDLESLGYVLLYF-LRGSLPWQGLKAATKKQ 223
A + A+C D+ SLG VLLY L G P+ T ++
Sbjct: 184 ANFVAPEVLERQGYDAAC------------DIWSLG-VLLYTMLTGYTPFANGPDDTPEE 230
Query: 224 KYDKICEKKVS 234
+I K S
Sbjct: 231 ILARIGSGKFS 241
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 45/188 (23%), Positives = 78/188 (41%), Gaps = 32/188 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y +G ++GSG F + T A K G ++ E + + +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRKFSL--KTVLMLADQM 112
PNI + V + D VL+L+L+ G +LF + +K SL + Q+
Sbjct: 73 LH----PNIITLHDVYENRTDVVLILELVSGG----ELFDFLAQKESLSEEEATSFIKQI 124
Query: 113 IARIEYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
+ + Y+H++ H D+KP+N ++ + +IDFGLA + E K
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--------DGVEFK 176
Query: 172 NLTGTARY 179
N+ GT +
Sbjct: 177 NIFGTPEF 184
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 51/213 (23%), Positives = 92/213 (43%), Gaps = 19/213 (8%)
Query: 8 KYKLGRK-IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIP 66
Y+L +G G+ + ++ T++ AVKI H + +V ++L G
Sbjct: 13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREV-EMLYQCQGHR 71
Query: 67 NI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEYV 119
N+ + + ED LV + + G + ++ RR F+ ++ + + ++++
Sbjct: 72 NVLELIEFFEEEDRFYLVFEKMRGG----SILSHIHKRRHFNELEASVVVQDVASALDFL 127
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
H++G HRD+KP+N L + + V I DF L + I E G+A Y
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 180 AS-----CNTHLGIEQSRRDDLESLGYVLLYFL 207
+ + +R DL SLG V+LY L
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLG-VILYIL 219
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-19
Identities = 41/201 (20%), Positives = 67/201 (33%), Gaps = 41/201 (20%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQ-LLYEAKVYKILQGGS 63
++ KIGSG FG +F I A+K +G+ Q L E + +L
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL---G 68
Query: 64 GIPNI-KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIARI 116
++ +++ ED+ + + G SL D R F + L Q+ +
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 117 EYVHSRGFLHRDIKPDN-FLMGLGRKANQVYII---------------DFGLAKKYRDPT 160
Y+HS +H DIKP N F+ D G + P
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 161 TNRHIPYRENKNLTGTARYAS 181
G +R+ +
Sbjct: 189 V-----------EEGDSRFLA 198
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 4e-19
Identities = 54/165 (32%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVY 56
+R IG Y + +G GSFG++ LA+H T + VA+K + H ++ E
Sbjct: 5 KRHIG-PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYL 63
Query: 57 KILQGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
K+L+ P+I K Y V D V+V++ G L D V +++ + Q+I
Sbjct: 64 KLLRH----PHIIKLYDVITTPTDIVMVIEYAGGELFDYIVE-KKRMTEDEGRRFFQQII 118
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
IEY H +HRD+KP+N L L N V I DFGL+ D
Sbjct: 119 CAIEYCHRHKIVHRDLKPENLL--LDDNLN-VKIADFGLSNIMTD 160
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-19
Identities = 59/273 (21%), Positives = 99/273 (36%), Gaps = 70/273 (25%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGI 65
+Y L +IG GS+G + LA + + N A+K+ + + G
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 66 ----------------------PNI-KWYGV---DGEDNV-LVLDLL-----------GP 87
PN+ K V ED++ +V +L+ P
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 88 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 147
ED R F +I IEY+H + +HRDIKP N L+G + + I
Sbjct: 134 LSEDQ---ARFYFQ---------DLIKGIEYLHYQKIIHRDIKPSNLLVG---EDGHIKI 178
Query: 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLL 204
DFG++ +++ N GT + + + I + D+ ++G V L
Sbjct: 179 ADFGVSNEFKGSDALLS-------NTVGTPAFMAPESLSETRKIFSGKALDVWAMG-VTL 230
Query: 205 Y-FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
Y F+ G P+ + KI + + P
Sbjct: 231 YCFVFGQCPFMD---ERIMCLHSKIKSQALEFP 260
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-19
Identities = 45/188 (23%), Positives = 75/188 (39%), Gaps = 32/188 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y G ++GSG F + T A K G + E + K +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYC--RRKFSLKTVLMLADQM 112
Q PN+ + V + D +L+L+L+ G +LF + + + + Q+
Sbjct: 72 QH----PNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQI 123
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMG-LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
+ + Y+HS H D+KP+N ++ ++ IIDFGLA K E K
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--------FGNEFK 175
Query: 172 NLTGTARY 179
N+ GT +
Sbjct: 176 NIFGTPEF 183
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 5e-19
Identities = 61/281 (21%), Positives = 103/281 (36%), Gaps = 69/281 (24%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYK 57
+ KY L IG GS+G + +A T I A+KI + + ++ E ++ K
Sbjct: 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK 83
Query: 58 ILQGGSGIPNIKW-YGV-DGEDNV-LVLDLL----------------------------- 85
L PNI Y V + E + LV++L
Sbjct: 84 KLHH----PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQI 139
Query: 86 -----------GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF 134
S+ K + + Q+ + + Y+H++G HRDIKP+NF
Sbjct: 140 CPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENF 199
Query: 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS---CNTHLGIEQS 191
L K+ ++ ++DFGL+K++ + GT + + NT
Sbjct: 200 LF-STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT---KAGTPYFVAPEVLNT-TNESYG 254
Query: 192 RRDDLESLGYVLLYF-LRGSLP-W----QGLKAATKKQKYD 226
+ D S G VLL+ L G++P + +K
Sbjct: 255 PKCDAWSAG-VLLHLLLMGAVPFPGVNDADTISQVLNKKLC 294
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 7e-19
Identities = 39/186 (20%), Positives = 74/186 (39%), Gaps = 29/186 (15%)
Query: 8 KYKL-GRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGG 62
Y L +++G G F + T + A K ++L+E +L+
Sbjct: 29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA---VLELA 85
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRK----FSLKTVLMLADQMI 113
P + + V + + +L+L+ G ++F C + S V+ L Q++
Sbjct: 86 KSCPRVINLHEVYENTSEIILILEYAAGG----EIFSLCLPELAEMVSENDVIRLIKQIL 141
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
+ Y+H +H D+KP N L+ + I+DFG+++K E + +
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--------HACELREI 193
Query: 174 TGTARY 179
GT Y
Sbjct: 194 MGTPEY 199
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-19
Identities = 37/162 (22%), Positives = 65/162 (40%), Gaps = 15/162 (9%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
II + +G G G++ + T E A+K+ P+ E ++
Sbjct: 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREV---ELHWR 66
Query: 62 GSGIPNI-KWYGV-----DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQM 112
S P+I + V G + +V++ L G + + F+ + + +
Sbjct: 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 126
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
I+Y+HS HRD+KP+N L R + + DFG AK
Sbjct: 127 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 85.0 bits (210), Expect = 8e-19
Identities = 36/175 (20%), Positives = 71/175 (40%), Gaps = 21/175 (12%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTN-----EIVAVKIENSGTKHPQLLYEAKVYK 57
++ + +G G+F +++ A+ D N + +K++ + ++ +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW-EFYIGTQLME 119
Query: 58 ILQGGSGIPNIKWYGVDGEDN--VLVLDLL-GPSLEDLFVYCR----RKFSLKTVLMLAD 110
L+ +K+Y N VLV +L +L + + + V+ A
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ--------VYIIDFGLAKKYR 157
+M+ IE VH +H DIKPDNF++G G + +ID G + +
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 9e-19
Identities = 62/241 (25%), Positives = 97/241 (40%), Gaps = 55/241 (22%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT--NEIVAVKIENSGTKHPQLLY--------- 51
+ +Y+LG +G G E+ LA D + VAVK+ L
Sbjct: 8 SHLSDRYELGEILGFGGMSEVHLA--RDLRDHRDVAVKV-----LRADLARDPSFYLRFR 60
Query: 52 -EAKVYKILQGGSGIPNI-KWYGVDGEDNV-------LVLDLL-GPSLEDLFVYCRRKFS 101
EA+ L P I Y GE +V++ + G +L D+ V+ +
Sbjct: 61 REAQNAAALNH----PAIVAVYDT-GEAETPAGPLPYIVMEYVDGVTLRDI-VHTEGPMT 114
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
K + + + + H G +HRD+KP N ++ N V ++DFG+A+ D
Sbjct: 115 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGN 171
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSR------RDDLESLGYVLLY-FLRGSLPWQ 214
+ + GTA+Y S EQ+R R D+ SLG +LY L G P+
Sbjct: 172 ----SVTQTAAVIGTAQYLS------PEQARGDSVDARSDVYSLG-CVLYEVLTGEPPFT 220
Query: 215 G 215
G
Sbjct: 221 G 221
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 21/180 (11%)
Query: 8 KYKLGRK--IGSGSFGEIFLASHVDTNEIVAVK-IENSGTK-HPQLLYEAKVYKILQGGS 63
Y + + +G G FG++ T +A K I+ G K ++ E V L
Sbjct: 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH-- 145
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
N+ + Y D VLV++ + G L D + + ++ Q+ I ++
Sbjct: 146 --ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
H LH D+KP+N L + R A Q+ IIDFGLA++Y+ P + K GT +
Sbjct: 204 HQMYILHLDLKPENILC-VNRDAKQIKIIDFGLARRYK--------PREKLKVNFGTPEF 254
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 43/160 (26%), Positives = 69/160 (43%), Gaps = 19/160 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLY-EAKVYKILQGGSGIP 66
+Y + IGSG+FG L T E+VAVK G + + E ++ L+ P
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH----P 76
Query: 67 NI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVY--CRRKFSLKTVLMLADQMIARIEY 118
NI ++ V L + +E +L+ +FS Q+++ + Y
Sbjct: 77 NIVRFKEVILTPTHLAI-----IMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
HS HRD+K +N L+ G A ++ I DFG +K
Sbjct: 132 CHSMQICHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVL 170
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 42/178 (23%), Positives = 71/178 (39%), Gaps = 27/178 (15%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
++ +G G+FG + A + VA+K S ++ + E + + PNI
Sbjct: 11 EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNH----PNIV 64
Query: 69 KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIAR-IEYVHSR-- 122
K YG LV++ G SL ++ ++ + Q ++ + Y+HS
Sbjct: 65 KLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ-CSQGVAYLHSMQP 123
Query: 123 -GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
+HRD+KP N L L + I DFG A + TN G+A +
Sbjct: 124 KALIHRDLKPPNLL--LVAGGTVLKICDFGTACDIQTHMTNN----------KGSAAW 169
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 2e-18
Identities = 41/162 (25%), Positives = 64/162 (39%), Gaps = 26/162 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGS 63
KY +KIG GSFG+ L + +K N + E V ++
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH-- 82
Query: 64 GIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVYCRRK----FSLKTVLMLADQMI 113
PNI ++ E+ L + ++ DLF + F +L Q+
Sbjct: 83 --PNIVQYRESFEENGSLYI-----VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
+++VH R LHRDIK N + K V + DFG+A+
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDFGIARV 174
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-18
Identities = 58/221 (26%), Positives = 97/221 (43%), Gaps = 42/221 (19%)
Query: 5 IGVKYKLG---RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
Y L + +G GSF H +N+ AVKI + K + + ++ L+
Sbjct: 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEI-TALKL 61
Query: 62 GSGIPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIA 114
G PNI K + V + + LV++LL G +LF + ++ FS + ++++
Sbjct: 62 CEGHPNIVKLHEVFHDQLHTFLVMELLNGG----ELFERIKKKKHFSETEASYIMRKLVS 117
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
+ ++H G +HRD+KP+N L ++ IIDFG A+ +N+ L
Sbjct: 118 AVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP----------DNQPLK 167
Query: 175 ---GTARYAS-----CNTHLGIEQSRRDDLESLGYVLLYFL 207
T YA+ N + DL SLG V+LY +
Sbjct: 168 TPCFTLHYAAPELLNQNGY-----DESCDLWSLG-VILYTM 202
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 2e-18
Identities = 69/282 (24%), Positives = 107/282 (37%), Gaps = 53/282 (18%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
+R I L IG G FGE++ E VAVKI +S + EA++Y+ +
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVML 93
Query: 62 GSGIPNI-KWYGVDGEDNV------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMI 113
NI + D +DN LV D SL D R +++ ++ LA
Sbjct: 94 RH--ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALS-T 148
Query: 114 AR-IEYVHSR--------GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
A + ++H HRD+K N L+ +K I D GLA ++ T
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTID 205
Query: 165 IPYRENKNLTGTARY--------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGS------ 210
I + GT RY + H E +R D+ ++G V R
Sbjct: 206 IA---PNHRVGTKRYMAPEVLDDSINMKHF--ESFKRADIYAMGLVFWEIARRCSIGGIH 260
Query: 211 ----LPWQGLKA--ATKKQKYDKICEKKVSTPIEVLCKSHPA 246
LP+ L + ++ +CE+K+ I +S A
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA 302
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 3e-18
Identities = 37/161 (22%), Positives = 69/161 (42%), Gaps = 15/161 (9%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
+ +++ ++G G+ ++ T + A+K+ + E V L
Sbjct: 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH--- 107
Query: 65 IPNI-KWYGV-DGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIE 117
PNI K + + + LVL+L+ G +LF + + +S + Q++ +
Sbjct: 108 -PNIIKLKEIFETPTEISLVLELVTGG----ELFDRIVEKGYYSERDAADAVKQILEAVA 162
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
Y+H G +HRD+KP+N L + I DFGL+K
Sbjct: 163 YLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-18
Identities = 35/162 (21%), Positives = 67/162 (41%), Gaps = 16/162 (9%)
Query: 8 KYKLGRK-IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIP 66
Y+L ++ +G G G++ H T + A+K+ P+ E SG P
Sbjct: 29 DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY---DSPKARQEVD---HHWQASGGP 82
Query: 67 NI-KWYGV-----DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
+I V G+ + ++++ + G + + F+ + + + I+
Sbjct: 83 HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
++HS HRD+KP+N L K + + DFG AK+
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN 184
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 5e-18
Identities = 61/249 (24%), Positives = 100/249 (40%), Gaps = 43/249 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGS 63
Y++ IG+GS+G +I+ K + G+ L+ E + + L+
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH-- 64
Query: 64 GIPNI-KWYG--VDGEDNVL--VLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIA 114
PNI ++Y +D + L V++ G L + ++ + VL + Q+
Sbjct: 65 --PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 115 RIEYVHSRGF-----LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
++ H R LHRD+KP N + V + DFGLA+ T+
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLD---GKQNVKLGDFGLARILNHDTSFA------ 173
Query: 170 NKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKY 225
K GT Y S N + + + D+ SLG LLY L P+ A ++K+
Sbjct: 174 -KTFVGTPYYMSPEQMN---RMSYNEKSDIWSLG-CLLYELCALMPPFT---AFSQKELA 225
Query: 226 DKICEKKVS 234
KI E K
Sbjct: 226 GKIREGKFR 234
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-18
Identities = 49/160 (30%), Positives = 72/160 (45%), Gaps = 23/160 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y+L IGSG+ + A E VA+K E T +LL E +
Sbjct: 17 YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH---- 72
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----- 116
PNI +Y V ++ LV+ LL G S+ D+ + K K+ ++ IA I
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST-IATILREVL 131
Query: 117 ---EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
EY+H G +HRD+K N L+G + V I DFG++
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLG---EDGSVQIADFGVS 168
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 6e-18
Identities = 42/161 (26%), Positives = 71/161 (44%), Gaps = 16/161 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
KY+ KIG GS+G +F + DT +IVA+K ++ K L E ++ K L+
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK-KIALREIRMLKQLKH- 61
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PN+ V LV + ++ +R V + Q + + +
Sbjct: 62 ---PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
H +HRD+KP+N L+ K + + + DFG A+ P+
Sbjct: 119 HKHNCIHRDVKPENILIT---KHSVIKLCDFGFARLLTGPS 156
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 6e-18
Identities = 48/194 (24%), Positives = 80/194 (41%), Gaps = 29/194 (14%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
+R I + ++ ++IG G +GE+++ E VAVK+ + + E ++Y+ +
Sbjct: 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEA-SWFRETEIYQTVLM 88
Query: 62 GSGIPNI-KWYGVDGEDNV------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMI 113
NI + D + L+ D SL D K++L LA +
Sbjct: 89 RH--ENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSV 144
Query: 114 ARIEYVHSRGF--------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165
+ + ++H+ F HRD+K N L+ +K I D GLA K+ T I
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDI 201
Query: 166 PYRENKNLTGTARY 179
P GT RY
Sbjct: 202 P---PNTRVGTKRY 212
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 6e-18
Identities = 37/166 (22%), Positives = 66/166 (39%), Gaps = 15/166 (9%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
II + +G G G++ + T E A+K+ P+ E ++
Sbjct: 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREV---ELHWR 110
Query: 62 GSGIPNI-KWYGV-----DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQM 112
S P+I + V G + +V++ L G + + F+ + + +
Sbjct: 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 170
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
I+Y+HS HRD+KP+N L R + + DFG AK+
Sbjct: 171 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-17
Identities = 42/160 (26%), Positives = 69/160 (43%), Gaps = 16/160 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
KY+ +G GS+G + + DT IVA+K ++ K + E K+ K L+
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRH- 83
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
N+ V + LV + + ++ D + V Q+I I +
Sbjct: 84 ---ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
HS +HRDIKP+N L+ ++ V + DFG A+ P
Sbjct: 141 HSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAP 177
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-17
Identities = 51/182 (28%), Positives = 77/182 (42%), Gaps = 34/182 (18%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYK 57
+R V Y + IG+GSFG ++ A D+ E+VA+K K Q E ++ +
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQDKRFKNRELQIMR 102
Query: 58 ILQGGSGIPNI---KWY---GVDGEDNV---LVLDLLGPSLEDLFVYCRRKFSLKTVLML 108
L NI +++ + +D V LVLD + E ++ R K L +
Sbjct: 103 KLDH----CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP---ETVYRVARHYSRAKQTLPV 155
Query: 109 AD------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
Q+ + Y+HS G HRDIKP N L L + + DFG AK+ N
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL--LDPDTAVLKLCDFGSAKQLVRGEPN 213
Query: 163 RH 164
Sbjct: 214 VS 215
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 46/164 (28%), Positives = 70/164 (42%), Gaps = 25/164 (15%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKILQGG 62
Y LG +G G+FG++ + H T VAVKI N S ++ E + K+ +
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH- 70
Query: 63 SGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVYC--RRKFSLKTVLMLADQMIA 114
P+I K Y V + +E +LF Y + L Q+++
Sbjct: 71 ---PHIIKLYQVISTPTDFFM-----VMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
++Y H +HRD+KP+N L L N I DFGL+ D
Sbjct: 123 AVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 163
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 3e-17
Identities = 52/299 (17%), Positives = 101/299 (33%), Gaps = 58/299 (19%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-ENSGTKHPQLLYEAKVYKILQGGSGI- 65
Y++ R + G F +I L N+ A+K E S + + ++ KI
Sbjct: 32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 66 -------------PNI-KWYGV-DGEDNV-LVLDLL-GPSLEDLFVYCRR-------KFS 101
G+ D V ++ + + S+ Y
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 102 LKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
++ + + ++ Y+H+ + HRD+KP N LM K +V + DFG ++
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD---KNGRVKLSDFGESE------ 200
Query: 161 TNRHIPYRENKNLT---GTARYAS---CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPW 213
Y +K + GT + + + D+ SLG + LY +P+
Sbjct: 201 ------YMVDKKIKGSRGTYEFMPPEFFSNESSY-NGAKVDIWSLG-ICLYVMFYNVVPF 252
Query: 214 QGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272
+ + ++ I K + P++ +P L+ + FLK
Sbjct: 253 SL--KISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDI---DFLKLF 306
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 41/161 (25%), Positives = 75/161 (46%), Gaps = 28/161 (17%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
Y+L RK+G G + E+F A ++ NE V VKI K ++ E K+ + L+GG PN
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGG---PN 92
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVY------------CRRKFSLKTVLMLADQMIAR 115
I + + D++ + + + + +++
Sbjct: 93 I----------ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKA 142
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
++Y HS G +HRD+KP N + + + ++ +ID+GLA+ Y
Sbjct: 143 LDYCHSMGIMHRDVKPHNVM--IDHEHRKLRLIDWGLAEFY 181
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 7e-17
Identities = 47/161 (29%), Positives = 77/161 (47%), Gaps = 16/161 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
KY+ KIG G++G +F A + +T+EIVA+K ++ G L E + K L+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKELKH- 60
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
NI + + V D LV + L+ F C + V Q++ + +
Sbjct: 61 ---KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
HSR LHRD+KP N L+ + ++ + +FGLA+ + P
Sbjct: 118 HSRNVLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPV 155
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 7e-17
Identities = 48/181 (26%), Positives = 71/181 (39%), Gaps = 34/181 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGT--------------KHPQ 48
KY+ KIG G+FGE+F A H T + VA+K E G KH
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 77
Query: 49 L--LYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVL 106
+ L E K +I Y LV D L L KF+L +
Sbjct: 78 VVNLIEICRTKASPYNRCKGSI--Y--------LVFDFCEHDLAGLLSNVLVKFTLSEIK 127
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIP 166
+ ++ + Y+H LHRD+K N L+ + + + DFGLA+ + ++
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 167 Y 167
Y
Sbjct: 185 Y 185
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 9e-17
Identities = 48/172 (27%), Positives = 75/172 (43%), Gaps = 20/172 (11%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-ENSGTKHPQLLYEAKVYKIL- 59
E +Y L RK+G G F ++LA + N VA+KI E K+ + +
Sbjct: 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 73
Query: 60 ------QGGSGIPNI-------KWYGVDGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTV 105
+ G +I G +G V+V ++LG +L L R L V
Sbjct: 74 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 133
Query: 106 LMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRK---ANQVYIIDFGLA 153
++ Q++ ++Y+H R G +H DIKP+N LM + Q+ I D G A
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-16
Identities = 41/175 (23%), Positives = 81/175 (46%), Gaps = 32/175 (18%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
++L +G+G++G+++ HV T ++ A+K ++ +G + ++ E +L+ S N
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQE---INMLKKYSHHRN 82
Query: 68 I-KWYG------VDGEDNVL--VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI- 116
I +YG G D+ L V++ S+ DL + L ++ IA I
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYIC 135
Query: 117 -------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
++H +HRDIK N L+ + +V ++DFG++ + R+
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRRN 187
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 78.0 bits (192), Expect = 1e-16
Identities = 42/223 (18%), Positives = 75/223 (33%), Gaps = 40/223 (17%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI--PN 67
KL IG G +G ++ S VAVK+ + + + E +Y++ + N
Sbjct: 16 KLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ-NFINEKNIYRV----PLMEHDN 68
Query: 68 I-KWYGVDGEDNV-------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
I ++ D LV++ SL + LA + + Y
Sbjct: 69 IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGLAY 126
Query: 119 VHS---------RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY-RDPTTNRHIPYR 168
+H+ HRD+ N L+ + I DFGL+ + +
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 169 ENKNLTGTARY-------ASCNTHLGIEQSRRDDLESLGYVLL 204
+ GT RY + N ++ D+ +LG +
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 50/176 (28%), Positives = 75/176 (42%), Gaps = 44/176 (25%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN-----SGTKHPQLLYEAKVYKIL 59
IG Y LG +G G+FG++ + H T VAVKI N S ++ E + K+
Sbjct: 15 IG-HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF 73
Query: 60 QGGSGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVY-----------CRRKFSL 102
+ P+I K Y V + + + +E +LF Y RR F
Sbjct: 74 RH----PHIIKLYQVISTPSDIFM-----VMEYVSGGELFDYICKNGRLDEKESRRLFQ- 123
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
Q+++ ++Y H +HRD+KP+N L L N I DFGL+ D
Sbjct: 124 --------QILSGVDYCHRHMVVHRDLKPENVL--LDAHMN-AKIADFGLSNMMSD 168
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 2e-16
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 15/154 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+ R+IG GSFG ++ A V +E+VA+K + S K ++ E + + L+
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 113
Query: 63 SGIPNI-KWYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PN ++ G + LV++ S DL ++ + + + + Y+
Sbjct: 114 ---PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
HS +HRD+K N L+ + V + DFG A
Sbjct: 171 HSHNMIHRDVKAGNILLS---EPGLVKLGDFGSA 201
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 61/259 (23%), Positives = 100/259 (38%), Gaps = 74/259 (28%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI------------EN--------SGTKHP---QL 49
R IG GSFG++ + DT ++ A+K N G +HP L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 50 LY----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR--KFS 101
Y E ++ +V+DLL G DL + ++ F
Sbjct: 81 WYSFQDEEDMF-----------------------MVVDLLLGG----DLRYHLQQNVHFK 113
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
+TV + +++ ++Y+ ++ +HRD+KPDN L+ + V+I DF +A T
Sbjct: 114 EETVKLFICELVMALDYLQNQRIIHRDMKPDNILLD---EHGHVHITDFNIAAMLPRETQ 170
Query: 162 NRHIPYRENKNLTGTARYAS---CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
+ GT Y + ++ G S D SLG V Y LRG P+
Sbjct: 171 --------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG-VTAYELLRGRRPYHIRS 221
Query: 218 AATKKQKYDKICEKKVSTP 236
+ + K+ V+ P
Sbjct: 222 STSSKEIVHTFETTVVTYP 240
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-16
Identities = 42/163 (25%), Positives = 70/163 (42%), Gaps = 17/163 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQL----LYEAKVYKILQ 60
+Y+ +G G F ++ A +TN+IVA +K+ + + L E K+ + L
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 61 GGSGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
PNI G + LV D + LE + + + + +E
Sbjct: 71 H----PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
Y+H LHRD+KP+N L+ + + + DFGLAK + P
Sbjct: 127 YLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLAKSFGSPN 166
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-16
Identities = 46/195 (23%), Positives = 71/195 (36%), Gaps = 29/195 (14%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
M+R + L +G G +GE++ S E VAVKI +S + E ++Y +
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEK-SWFRETELYNTVM 58
Query: 61 GGSGIPNI-KWYGVDGEDNV------LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQM 112
NI + D L+ SL D + L + +
Sbjct: 59 LRH--ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSI 114
Query: 113 IARIEYVHSRGF--------LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+ + ++H F HRD+K N L+ +K Q I D GLA + T
Sbjct: 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLD 171
Query: 165 IPYRENKNLTGTARY 179
+ N GT RY
Sbjct: 172 VG---NNPRVGTKRY 183
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-16
Identities = 45/189 (23%), Positives = 71/189 (37%), Gaps = 37/189 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP------QLLYEAKVYKILQGGS 63
L IG G FG+++ A + VAVK + EAK++ +L+
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIGDE--VAVKAARHDPDEDISQTIENVRQEAKLFAMLKH-- 65
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEY 118
PNI GV + LV++ G L + ++ ++ A Q IAR + Y
Sbjct: 66 --PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQ-IARGMNY 120
Query: 119 VHSRG---FLHRDIKPDNFLMGLGRKANQVY-----IIDFGLAKKYRDPTTNRHIPYREN 170
+H +HRD+K N L+ + + I DFGLA R
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA---------REWHRTTK 171
Query: 171 KNLTGTARY 179
+ G +
Sbjct: 172 MSAAGAYAW 180
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-16
Identities = 60/258 (23%), Positives = 100/258 (38%), Gaps = 67/258 (25%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP- 47
+K G+ +G GSF + LA + T+ A+KI E S HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 48 --QLLY----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--K 99
+L + + K+Y L Y +GE L Y R+
Sbjct: 92 FVKLYFTFQDDEKLYFGLS----------YAKNGE---------------LLKYIRKIGS 126
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
F ++++ +EY+H +G +HRD+KP+N L+ + + I DFG AK
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPE 183
Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKA 218
+ + GTA+Y S + DL +LG ++Y + G P+ +A
Sbjct: 184 SKQ-----ARANSFVGTAQYVSPELLTEKSACKSSDLWALG-CIIYQLVAGLPPF---RA 234
Query: 219 ATKKQKYDKICEKKVSTP 236
+ + KI + + P
Sbjct: 235 GNEYLIFQKIIKLEYDFP 252
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 5e-16
Identities = 37/209 (17%), Positives = 83/209 (39%), Gaps = 14/209 (6%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQ-- 60
+ +Y + RK+G G F ++L+ + + VA+K+ S + + L E ++ K ++
Sbjct: 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNS 93
Query: 61 -----GGSGIPNI----KWYGVDGEDNVLVLDLLGPSLEDL-FVYCRRKFSLKTVLMLAD 110
+ + K GV+G +V ++LG L + L V +
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 111 QMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
Q++ ++Y+H++ +H DIKP+N L+ + + + + ++ P +
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLES 198
+ + + DL +
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGN 242
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 7e-16
Identities = 38/159 (23%), Positives = 70/159 (44%), Gaps = 13/159 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSG 64
Y K+G G++ ++ T+ +VA+K +E+ + E + K L+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH--- 59
Query: 65 IPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
NI + + + LV + L L+ C ++ V + Q++ + Y H
Sbjct: 60 -ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
+ LHRD+KP N L+ + ++ + DFGLA+ PT
Sbjct: 119 QKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPT 154
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-16
Identities = 66/278 (23%), Positives = 104/278 (37%), Gaps = 54/278 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLL----YEAKVYKILQGGSGI 65
+ KIG+GSFG + A VAVKI H + + E + K L+
Sbjct: 40 NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH---- 93
Query: 66 PNI-KWYGV--DGEDNVLVLDLL-GPSLEDLF--VYCRRKFSLKTVLMLADQMIAR-IEY 118
PNI + G + +V + L SL L R + + L +A +A+ + Y
Sbjct: 94 PNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYD-VAKGMNY 152
Query: 119 VHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK-KYRDPTTNRHIPYRENKNLTG 175
+H+R +HR++K N L+ K V + DFGL++ K + +K+ G
Sbjct: 153 LHNRNPPIVHRNLKSPNLLVD---KKYTVKVCDFGLSRLKASTFLS--------SKSAAG 201
Query: 176 TARY--------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227
T + N E+S D+ S G +L PW L A Q
Sbjct: 202 TPEWMAPEVLRDEPSN-----EKS---DVYSFGVILWELATLQQPWGNLNPA---QVVAA 250
Query: 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
+ K I + A+ C + +RP
Sbjct: 251 VGFKCKRLEIPRNL---NPQVAAIIEGCWTNEPWKRPS 285
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 60/245 (24%), Positives = 92/245 (37%), Gaps = 46/245 (18%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSGI 65
R IG G FGE++ DT ++ A+K G L E + ++ G
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETL--ALNERIMLSLVSTGDC- 251
Query: 66 PNIK--WYGVDGEDNV-LVLDLL--GPSLEDLF--VYCRRKFSLKTVLMLADQMIARIEY 118
P I Y D + +LDL+ G DL + FS + A ++I +E+
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGG----DLHYHLSQHGVFSEADMRFYAAEIILGLEH 307
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+H+R ++RD+KP N L+ + V I D GLA + + GT
Sbjct: 308 MHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPH---------ASVGTHG 355
Query: 179 Y------ASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEK 231
Y + D SLG +L+ LRG P++ K K +
Sbjct: 356 YMAPEVLQKGVAY-----DSSADWFSLG-CMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409
Query: 232 KVSTP 236
V P
Sbjct: 410 AVELP 414
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 56/234 (23%), Positives = 81/234 (34%), Gaps = 44/234 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI-- 65
+L G FG ++ A NE VAVKI K E +VY + G+
Sbjct: 25 PLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQ-SWQNEYEVYSL----PGMKH 77
Query: 66 PNI-KWYGVDGEDNVLVLDLL-------GPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
NI ++ G + + +DL SL D S + +A+ M +
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLA 135
Query: 118 YVHSRGF----------LHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRHIP 166
Y+H HRDIK N L+ K N I DFGLA K+ +
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLL----KNNLTACIADFGLALKFEAGKS----- 186
Query: 167 YRENKNLTGTARY-----ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
+ GT RY + + R D+ ++G VL G
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-15
Identities = 43/163 (26%), Positives = 74/163 (45%), Gaps = 16/163 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
+ KIG GSFGE+F T ++VA+KI E + + + E V
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS---- 79
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P + K+YG + ++++ L G S DL + + +++ ++Y+HS
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDL--LEPGPLDETQIATILREILKGLDYLHS 137
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+HRDIK N L+ + +V + DFG+A + D R+
Sbjct: 138 EKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN 177
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-15
Identities = 37/161 (22%), Positives = 73/161 (45%), Gaps = 11/161 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
+ + K+G GS+G ++ A H +T +IVA+K + +++ E + + P+
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS----PH 85
Query: 68 I-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
+ K+YG D +V++ S+ D+ + + + + + +EY+H
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+HRDIK N L+ + DFG+A + D R+
Sbjct: 146 KIHRDIKAGNILLN---TEGHAKLADFGVAGQLTDTMAKRN 183
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 37/159 (23%), Positives = 75/159 (47%), Gaps = 12/159 (7%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGG 62
+ +Y++ + IG GSFG++ A ++ VA+K + N H Q E ++ + L+
Sbjct: 94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQ 153
Query: 63 SGIPNIKWYGVDGEDN-------VLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIA 114
+ + +N + +LL +L +L + + FSL V A ++
Sbjct: 154 D--KDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQ 211
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
++ +H +H D+KP+N L+ + + + +IDFG +
Sbjct: 212 CLDALHKNRIIHCDLKPENILL-KQQGRSGIKVIDFGSS 249
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 5e-15
Identities = 38/189 (20%), Positives = 65/189 (34%), Gaps = 36/189 (19%)
Query: 8 KYKLGRKIGSG--SFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLY-EAKVYKILQG 61
Y+L IG G + LA + T E V V+ E + L E V K+
Sbjct: 26 CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH 85
Query: 62 GSGIPNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLM--LADQMIAR 115
PNI + + + +V + S +DL + T M + + IA
Sbjct: 86 ----PNIVPYRATFIADNELWVVTSFMAYGSAKDL---------ICTHFMDGMNELAIAY 132
Query: 116 I--------EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
I +Y+H G++HR +K + L+ +VY+ + + +
Sbjct: 133 ILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSGLRSNLSMISHGQRQRVVH 189
Query: 168 RENKNLTGT 176
K
Sbjct: 190 DFPKYSVKV 198
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-15
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQ-LLYEAKVYKILQG 61
+Y+ K+G G++GE++ A TNE VA+K E G P + E + K LQ
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV--PGTAIREVSLLKELQH 92
Query: 62 GSGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
NI + V ++ L+ + L+ S++ + Q+I + +
Sbjct: 93 ----RNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNF 147
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKAN--QVYIIDFGLAKKYRDPT 160
HSR LHRD+KP N L+ + + + I DFGLA+ + P
Sbjct: 148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 6e-15
Identities = 33/163 (20%), Positives = 74/163 (45%), Gaps = 13/163 (7%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
+++ ++G G+FG+++ A + +T + A K+ S + + E ++
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH---- 75
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P I K G ++++ G +++ + + R + + ++ QM+ + ++HS
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
+ +HRD+K N LM L + + DFG++ K R
Sbjct: 136 KRIIHRDLKAGNVLMTL---EGDIRLADFGVSAKNLKTLQKRD 175
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 72.9 bits (180), Expect = 6e-15
Identities = 50/162 (30%), Positives = 72/162 (44%), Gaps = 19/162 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHP-QLLYEAKVYKILQG 61
KY KIG G++G ++ A + + E A+K E+ G P + E + K L+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGI--PSTTIREISILKELKH 59
Query: 62 GSGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
NI K Y V VLV + L L+ L C T Q++ I Y
Sbjct: 60 ----SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
H R LHRD+KP N L+ + ++ I DFGLA+ + P
Sbjct: 116 CHDRRVLHRDLKPQNLLIN---REGELKIADFGLARAFGIPV 154
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 72.9 bits (180), Expect = 6e-15
Identities = 44/162 (27%), Positives = 69/162 (42%), Gaps = 17/162 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
++ KIG G++G ++ A + T E+VA+K E G + E + K L
Sbjct: 4 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP-STAIREISLLKELNH- 61
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEY 118
PNI K V +N LV + L L+ L + Q++ + +
Sbjct: 62 ---PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
HS LHRD+KP N L+ + + DFGLA+ + P
Sbjct: 119 CHSHRVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPV 157
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 6e-15
Identities = 39/161 (24%), Positives = 67/161 (41%), Gaps = 17/161 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-----IENSGTKHPQLLYEAKVYKILQGG 62
KY+ K+G G++G ++ A IVA+K E+ G + E + K L
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGI-PSTAIREISLLKELHH- 78
Query: 63 SGIPNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PNI V + LV + + L+ + + + + Q++ + +
Sbjct: 79 ---PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
H LHRD+KP N L+ + + DFGLA+ + P
Sbjct: 136 HQHRILHRDLKPQNLLIN---SDGALKLADFGLARAFGIPV 173
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 7e-15
Identities = 47/159 (29%), Positives = 75/159 (47%), Gaps = 24/159 (15%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
K R +G G FG++ L ++ T E+VAVK ++G +H E + + L
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH- 92
Query: 63 SGIPNI-KWYGV---DGEDNV-LVLDLLGPSLEDLFVYCRR-KFSLKTVLMLADQMIAR- 115
+I K+ G G ++ LV++ + L L Y R L +L+ A Q I
Sbjct: 93 ---EHIIKYKGCCEDAGAASLQLVMEYV--PLGSLRDYLPRHSIGLAQLLLFAQQ-ICEG 146
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ Y+H++ ++HRD+ N L+ V I DFGLAK
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAK 182
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 8e-15
Identities = 56/239 (23%), Positives = 91/239 (38%), Gaps = 37/239 (15%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY------KILQGGSG--IP 66
IG G+FGE+ L H T ++ A+K+ +++ + I+ + +
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKL----LSKFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 67 NIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG 123
+ + D +V++ + G DL K +++ ++ +HS G
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGG----DLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMG 188
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS-- 181
F+HRD+KPDN L+ K+ + + DFG K R GT Y S
Sbjct: 189 FIHRDVKPDNMLLD---KSGHLKLADFGTCMKMNKEGMVR------CDTAVGTPDYISPE 239
Query: 182 --CNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
+ R D S+G V LY L G P+ A + Y KI K S
Sbjct: 240 VLKSQGGDGYYGRECDWWSVG-VFLYEMLVGDTPF---YADSLVGTYSKIMNHKNSLTF 294
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 8e-15
Identities = 45/171 (26%), Positives = 74/171 (43%), Gaps = 31/171 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
KY KIG G+ G ++ A V T + VA++ N K ++ E V + +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN---- 76
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----- 116
PNI + + G++ +V++ L G SL D+ + + IA +
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECL 126
Query: 117 ---EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
E++HS +HRDIK DN L+G+ V + DFG + + R
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRS 174
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 1e-14
Identities = 40/170 (23%), Positives = 71/170 (41%), Gaps = 20/170 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVA---VKIENSGTKHPQL----LYEAKVYKILQ 60
+Y+ +IG G++G ++ A + VA V++ N G L + E + + L+
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 61 GGSGIPNI-------KWYGVDGEDNV-LVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQ 111
PN+ D E V LV + + L +T+ L Q
Sbjct: 70 AFEH-PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQ 128
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
+ ++++H+ +HRD+KP+N L+ V + DFGLA+ Y
Sbjct: 129 FLRGLDFLHANCIVHRDLKPENILVT---SGGTVKLADFGLARIYSYQMA 175
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-14
Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 19/171 (11%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL---LYEAKVYKILQGGSGIP 66
LG +IG G+FGE+F N +VAVK L EA++ K P
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH----P 172
Query: 67 NI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
NI + GV + +V++L+ G + +KT+L + A +EY+ S+
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH-----IPYR 168
+HRD+ N L+ + N + I DFG++++ D +P +
Sbjct: 233 CCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-14
Identities = 42/171 (24%), Positives = 73/171 (42%), Gaps = 31/171 (18%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGTKHPQLLYEAKVYKILQGGSGI 65
KIG GS G + LA + VAVK+ + + L E + + Q
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH---- 101
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----- 116
N+ + Y + GE+ ++++ L G +L D+ + + L ++ IA +
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIV----------SQVRLNEEQIATVCEAVL 151
Query: 117 ---EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
Y+H++G +HRDIK D+ L+ L +V + DFG + R
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTL---DGRVKLSDFGFCAQISKDVPKRK 199
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 72.5 bits (178), Expect = 2e-14
Identities = 34/196 (17%), Positives = 64/196 (32%), Gaps = 46/196 (23%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK----------------------------- 38
KY LG+ +G+GSFG + +++ + A+K
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVD 67
Query: 39 -----IENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV-LVLDLLGPSLEDL 92
+ K+ G + + ++++ + + L
Sbjct: 68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP---DTL 124
Query: 93 FVYCRRKFSLKTVLMLAD------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146
+ + + Q+ + ++HS G HRDIKP N L + K N +
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL--VNSKDNTLK 182
Query: 147 IIDFGLAKKYRDPTTN 162
+ DFG AKK +
Sbjct: 183 LCDFGSAKKLIPSEPS 198
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 22/175 (12%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVD--TNEIVAVK-IENSGTKHPQLLYEAKVYKI 58
ER+ + G K+G G++G ++ A D ++ A+K IE +G E + +
Sbjct: 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRE 74
Query: 59 LQGGSGIPNI-KWYGV---DGEDNV-LVLD--------LLGPSLEDLFVYCRRKFSLKTV 105
L+ PN+ V + V L+ D ++ + V
Sbjct: 75 LKH----PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 106 LMLADQMIARIEYVHSRGFLHRDIKPDNFL-MGLGRKANQVYIIDFGLAKKYRDP 159
L Q++ I Y+H+ LHRD+KP N L MG G + +V I D G A+ + P
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 185
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSG 64
++K K+G+G++ ++ + T VA+K +++ + E + K L+
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH--- 62
Query: 65 IPNI-KWYGVDGEDN--VLVLDLLGPSLEDL-----FVYCRRKFSLKTVLMLADQMIARI 116
NI + Y V +N LV + + L+ R L V Q++ +
Sbjct: 63 -ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160
+ H LHRD+KP N L+ K Q+ + DFGLA+ + P
Sbjct: 122 AFCHENKILHRDLKPQNLLIN---KRGQLKLGDFGLARAFGIPV 162
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-14
Identities = 42/170 (24%), Positives = 71/170 (41%), Gaps = 27/170 (15%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
K +IG GSF ++ +T VA + + ++ + EA++ K LQ
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH--- 84
Query: 65 IPNI-----KWYGVDGEDNVL--VLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIA 114
PNI W + V +L+ +L+ Y +R +K + Q++
Sbjct: 85 -PNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT---YLKRFKVMKIKVLRSWCRQILK 140
Query: 115 RIEYVHSRG--FLHRDIKPDN-FLMGLGRKANQVYIIDFGLAKKYRDPTT 161
++++H+R +HRD+K DN F+ G V I D GLA R
Sbjct: 141 GLQFLHTRTPPIIHRDLKCDNIFITG---PTGSVKIGDLGLATLKRASFA 187
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-14
Identities = 53/160 (33%), Positives = 80/160 (50%), Gaps = 24/160 (15%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
K R +G G FG++ L +T E VAVK SG H L E ++ + L
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH- 82
Query: 63 SGIPNI-KWYGV---DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
NI K+ G+ DG + + L+++ L G SL++ + K +LK L A Q I +
Sbjct: 83 ---ENIVKYKGICTEDGGNGIKLIMEFLPSG-SLKEYLPKNKNKINLKQQLKYAVQ-ICK 137
Query: 116 -IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
++Y+ SR ++HRD+ N L+ +QV I DFGL K
Sbjct: 138 GMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTK 174
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-14
Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 23/159 (14%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGS 63
K +++G G+FG + + +T E+VAVK ++ E ++ K LQ
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-- 70
Query: 64 GIPNI-KWYGV---DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR- 115
NI K+ GV G N+ L+++ L G SL D + + +L Q I +
Sbjct: 71 --DNIVKYKGVCYSAGRRNLKLIMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQ-ICKG 126
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+EY+ ++ ++HRD+ N L+ N+V I DFGL K
Sbjct: 127 MEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 162
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 4e-14
Identities = 52/177 (29%), Positives = 81/177 (45%), Gaps = 35/177 (19%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGG 62
+ Y + IG+GSFG +F A V+++E VA+K K Q E ++ +I++
Sbjct: 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIK------KVLQDKRFKNRELQIMRIVKH- 91
Query: 63 SGIPNI---KWY---GVDGEDNV---LVLDLLGPSLEDLFVYCRRKFSLKTVLMLAD--- 110
PN+ K + D +D V LVL+ + E ++ R LK + +
Sbjct: 92 ---PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP---ETVYRASRHYAKLKQTMPMLLIKL 145
Query: 111 ---QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164
Q++ + Y+HS G HRDIKP N L L + + +IDFG AK N
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLL--LDPPSGVLKLIDFGSAKILIAGEPNVS 200
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 4e-14
Identities = 28/220 (12%), Positives = 53/220 (24%), Gaps = 49/220 (22%)
Query: 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYK 57
RI +Y+L G + + A + VA+ + P L
Sbjct: 27 RIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS 86
Query: 58 ILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
+ G+ + ++V + + G SL+++ S + + A
Sbjct: 87 RIDK-PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA---DTSPSPVGAIRAMQSLAAAA 142
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
+ H G P + V +
Sbjct: 143 DAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPA----TMPDAN--------------- 180
Query: 177 ARYASCNTHLGIEQSRRDDLESLGYVLLYF-LRGSLPWQG 215
+DD+ +G LY L P
Sbjct: 181 ---------------PQDDIRGIG-ASLYALLVNRWPLPE 204
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-14
Identities = 47/159 (29%), Positives = 76/159 (47%), Gaps = 23/159 (14%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKIENSGTKHPQ--LLYEAKVYKILQGGS 63
K +++G G+FG + + +T E+VAVK T+ E ++ K LQ
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQH-- 101
Query: 64 GIPNI-KWYGV---DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR- 115
NI K+ GV G N+ L+++ L G SL D + + +L Q I +
Sbjct: 102 --DNIVKYKGVCYSAGRRNLKLIMEYLPYG-SLRDYLQKHKERIDHIKLLQYTSQ-ICKG 157
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+EY+ ++ ++HRD+ N L+ N+V I DFGL K
Sbjct: 158 MEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 193
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 7e-14
Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 23/159 (14%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVK-IENSGTKHPQ-LLYEAKVYKILQGGS 63
K ++G G+FG + L +T +VAVK +++SG + E ++ K L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-- 83
Query: 64 GIPNI-KWYGV---DGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIAR- 115
I K+ GV G ++ LV++ L G L D R + +L+ + Q I +
Sbjct: 84 --DFIVKYRGVSYGPGRQSLRLVMEYLPSG-CLRDFLQRHRARLDASRLLLYSSQ-ICKG 139
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+EY+ SR +HRD+ N L+ V I DFGLAK
Sbjct: 140 MEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAK 175
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 7e-14
Identities = 59/242 (24%), Positives = 94/242 (38%), Gaps = 40/242 (16%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY------KILQGGSG--IP 66
IG G+FGE+ + + +++ A+KI ++L A+ +L G I
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKI----LNKWEMLKRAETACFREERDVLVNGDSKWIT 137
Query: 67 NIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVHS 121
+ + D + LV+D G DL + + + +M+ I+ VH
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGG----DLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
++HRDIKPDN LM + + DFG K + T + + GT Y S
Sbjct: 194 LHYVHRDIKPDNILMD---MNGHIRLADFGSCLKLMEDGTVQ------SSVAVGTPDYIS 244
Query: 182 CNTHLGIEQSRRD-----DLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
+E + D SLG V +Y L G P+ A + + Y KI K
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLG-VCMYEMLYGETPFY---AESLVETYGKIMNHKERF 300
Query: 236 PI 237
Sbjct: 301 QF 302
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 9e-14
Identities = 30/149 (20%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI-K 69
++GSG+ G+++ T ++AVK + ++ ++L + ++ P I +
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMD---LDVVLKSHDCPYIVQ 88
Query: 70 WYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLH 126
+G + D + ++L+G E L + + + + ++ + Y+ G +H
Sbjct: 89 CFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIH 148
Query: 127 RDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
RD+KP N L+ + Q+ + DFG++ +
Sbjct: 149 RDVKPSNILLD---ERGQIKLCDFGISGR 174
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 2e-13
Identities = 54/245 (22%), Positives = 86/245 (35%), Gaps = 44/245 (17%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSG--I 65
IG G+F E+ + T ++ A+K ++ E +L G I
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC--FREERD---VLVNGDRRWI 123
Query: 66 PNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR---KFSLKTVLMLADQMIARIEYVH 120
+ + D LV++ G DL + + + +++ I+ VH
Sbjct: 124 TQLHFAFQDENYLYLVMEYYVGG----DLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY- 179
G++HRDIKPDN L+ + + + DFG K R T R + GT Y
Sbjct: 180 RLGYVHRDIKPDNILLD---RCGHIRLADFGSCLKLRADGTVR------SLVAVGTPDYL 230
Query: 180 ------ASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQKYDKICEKK 232
A D +LG V Y G P+ A + + Y KI K
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALG-VFAYEMFYGQTPFY---ADSTAETYGKIVHYK 286
Query: 233 VSTPI 237
+
Sbjct: 287 EHLSL 291
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-13
Identities = 40/168 (23%), Positives = 68/168 (40%), Gaps = 21/168 (12%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
KL + IG G FG++ L + VAVK + L EA V L+ N+
Sbjct: 24 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASVMTQLRH----SNLV 77
Query: 69 KWYGV--DGEDNV-LVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIAR-IEYVH 120
+ GV + + + +V + + + L Y R +L + + +EY+
Sbjct: 78 QLLGVIVEEKGGLYIVTEYM--AKGSLVDYLRSRGRSVLGGDCLLKFSLD-VCEAMEYLE 134
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
F+HRD+ N L+ + N + DFGL K+ +P +
Sbjct: 135 GNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 179
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 3e-13
Identities = 43/157 (27%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
+ K+G G +GE++ + VAVK T + L EA V K ++ PN
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNL 71
Query: 68 IKWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRRK-FSLKTVLMLADQMIAR-IEYVHS 121
++ GV ++ + + G +L D C R+ S +L +A Q I+ +EY+
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQ-ISSAMEYLEK 129
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ F+HRD+ N L+G + + V + DFGL++
Sbjct: 130 KNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTG 163
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 4e-13
Identities = 60/258 (23%), Positives = 99/258 (38%), Gaps = 72/258 (27%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP- 47
+ + +G+GSFG + L H ++ A+KI E P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 48 --QLLY----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--K 99
+L + + +Y +++ +G GE +F + RR +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAG----------GE---------------MFSHLRRIGR 137
Query: 100 FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159
FS A Q++ EY+HS ++RD+KP+N L+ + + + DFG AK+ +
Sbjct: 138 FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFGFAKRVKGR 194
Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKA 218
T L GT + L ++ D +LG VL+Y G P+ A
Sbjct: 195 T----------WTLCGTPEALAPEIILSKGYNKAVDWWALG-VLIYEMAAGYPPF---FA 240
Query: 219 ATKKQKYDKICEKKVSTP 236
Q Y+KI KV P
Sbjct: 241 DQPIQIYEKIVSGKVRFP 258
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 4e-13
Identities = 34/178 (19%), Positives = 71/178 (39%), Gaps = 38/178 (21%)
Query: 8 KYKLGRKIGSGSFGEIFLASHV-DTNEIVA---VKIEN-------------------SGT 44
+Y+ +IG G++G++F A + + VA V+++
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 45 KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKF-SLK 103
+HP ++ +++ + K LV + + L +
Sbjct: 72 EHPNVV---RLFDVCTVSRTDRETKLT--------LVFEHVDQDLTTYLDKVPEPGVPTE 120
Query: 104 TVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
T+ + Q++ ++++HS +HRD+KP N L+ + Q+ + DFGLA+ Y
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMA 175
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-13
Identities = 40/175 (22%), Positives = 68/175 (38%), Gaps = 40/175 (22%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK-----ILQG 61
++++ R G G+FG + L T VA+K K + + ++ I+Q
Sbjct: 23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK------K----VIQDPRFRNRELQIMQD 72
Query: 62 GSGI--PNI-------KWYGVDGEDNV---LVLDLLGPSLEDLFVYCRRKFSLKTVLMLA 109
+ + PNI G ++ +V++ + + L CR + +
Sbjct: 73 LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP---DTLHRCCRNYYRRQVAPPPI 129
Query: 110 D------QMIARIEYVH--SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
Q+I I +H S HRDIKP N L + + + DFG AKK
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVL--VNEADGTLKLCDFGSAKKL 182
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 6e-13
Identities = 43/166 (25%), Positives = 68/166 (40%), Gaps = 17/166 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNI- 68
KL + IG G FG++ L + VAVK + L EA V L+ N+
Sbjct: 196 KLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQAFLAEASVMTQLRH----SNLV 249
Query: 69 KWYGV---DGEDNVLVLDLL--GPSLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+ GV + +V + + G SL D L R +L + + +EY+
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKG-SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
F+HRD+ N L+ + N + DFGL K+ +P +
Sbjct: 309 NFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKLPVK 351
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 42/170 (24%), Positives = 77/170 (45%), Gaps = 19/170 (11%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
+ K+G G +GE++ + VAVK T + L EA V K ++ PN
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----PNL 278
Query: 68 IKWYGV--DGEDNVLVLDLL--GPSLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
++ GV ++ + + G +L D L R++ S +L +A Q+ + +EY+ +
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYG-NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 337
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYR 168
F+HR++ N L+G + + V + DFGL++ P +
Sbjct: 338 NFIHRNLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK 384
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 6e-13
Identities = 38/154 (24%), Positives = 69/154 (44%), Gaps = 13/154 (8%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
++IGSG FG + L ++ ++ VA+K G + + EA+V L P +
Sbjct: 11 TFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSH----PKL 65
Query: 69 -KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ YGV + LV + + L D R F+ +T+L + + + Y+
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+HRD+ N L+G + + + DFG+ + D
Sbjct: 126 IHRDLAARNCLVG---ENQVIKVSDFGMTRFVLD 156
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 7e-13
Identities = 42/161 (26%), Positives = 73/161 (45%), Gaps = 14/161 (8%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGG 62
+Y++ IG GSFG++ A E VA+K I+N Q E ++ +++
Sbjct: 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKH 110
Query: 63 SGIPNIKWYGVDGEDN-------VLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIA 114
+K+Y V + + LV ++L +L DL R SL A QM
Sbjct: 111 D--TEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 115 RIEYVHSR--GFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
+ ++ + +H D+KP+N L+ K + + I+DFG +
Sbjct: 169 ALLFLATPELSIIHCDLKPENILL-CNPKRSAIKIVDFGSS 208
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 8e-13
Identities = 38/168 (22%), Positives = 68/168 (40%), Gaps = 17/168 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+++G+G FG + + VA+K+ G+ + EAKV L +
Sbjct: 27 TFLKELGTGQFGVVKYGKWRGQYD-VAIKMIKEGSMSEDEFIEEAKVMMNLSH----EKL 81
Query: 69 -KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+ YGV ++ + + L + R +F + +L + + +EY+ S+ F
Sbjct: 82 VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH----IPYR 168
LHRD+ N L+ V + DFGL++ D P R
Sbjct: 142 LHRDLAARNCLVN---DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 1e-12
Identities = 55/271 (20%), Positives = 95/271 (35%), Gaps = 98/271 (36%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP- 47
+++ R +G+GSFG + L A+K+ E S HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 48 --QLLY----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR 98
++ +++ I+ +GG +LF R+
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGG----------------------------ELFSLLRK 99
Query: 99 --KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
+F A ++ +EY+HS+ ++RD+KP+N L+ K + I DFG AK
Sbjct: 100 SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFGFAKYV 156
Query: 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGY----------VLLY- 205
D T L GT Y + E + + Y +L+Y
Sbjct: 157 PDVT----------YTLCGTPDY------IAPEV-----VSTKPYNKSIDWWSFGILIYE 195
Query: 206 FLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
L G P+ + + Y+KI ++ P
Sbjct: 196 MLAGYTPFY---DSNTMKTYEKILNAELRFP 223
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-12
Identities = 42/157 (26%), Positives = 66/157 (42%), Gaps = 21/157 (13%)
Query: 10 KLGRKIGSGSFGEIF---LASHVDTNEI-VAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
K + +GSG+FG ++ + +I VA+K T +L EA V +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN- 76
Query: 63 SGIPNI-KWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
P++ + G+ V L+ L G L D + + +L Q IA+ +
Sbjct: 77 ---PHVCRLLGICLTSTVQLITQLMPFG-CLLDYVREHKDNIGSQYLLNWCVQ-IAKGMN 131
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ R +HRD+ N L+ V I DFGLAK
Sbjct: 132 YLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-12
Identities = 36/168 (21%), Positives = 65/168 (38%), Gaps = 17/168 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
L +++GSG FG + L + VAVK+ G+ EA+ L P +
Sbjct: 11 TLLKELGSGQFGVVKLGKWKGQYD-VAVKMIKEGSMSEDEFFQEAQTMMKLSH----PKL 65
Query: 69 -KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
K+YGV +V + + L + + +L + + + ++ S F
Sbjct: 66 VKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH----IPYR 168
+HRD+ N L+ + V + DFG+ + D P +
Sbjct: 126 IHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVK 170
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 2e-12
Identities = 44/203 (21%), Positives = 75/203 (36%), Gaps = 62/203 (30%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQL----LYEAKV 55
I ++L +G G++G + A+H T EIVA+K K P L E K+
Sbjct: 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK------KIEPFDKPLFALRTLREIKI 62
Query: 56 YKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD--- 110
K + NI + + ++ P + F VY + LM D
Sbjct: 63 LKHFKH----ENI----------ITIFNIQRPDSFENFNEVY------IIQELMQTDLHR 102
Query: 111 -----------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGL 152
Q + ++ +H +HRD+KP N L+ +N + + DFGL
Sbjct: 103 VISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI----NSNCDLKVCDFGL 158
Query: 153 AKKYRDPTTNRHIPYRENKNLTG 175
A+ + + P + +
Sbjct: 159 ARIIDESAADNSEPTGQQSGMVE 181
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-12
Identities = 39/157 (24%), Positives = 66/157 (42%), Gaps = 21/157 (13%)
Query: 10 KLGRKIGSGSFGEIF---LASHVDTNEI-VAVKI--ENSGTKHPQ-LLYEAKVYKILQGG 62
+ + +GSG FG + ++ +I V +K+ + SG + Q + L
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH- 74
Query: 63 SGIPNI-KWYGV-DGEDNVLVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
+I + G+ G LV LG SL D R + +L Q IA+ +
Sbjct: 75 ---AHIVRLLGLCPGSSLQLVTQYLPLG-SLLDHVRQHRGALGPQLLLNWGVQ-IAKGMY 129
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ G +HR++ N L+ +QV + DFG+A
Sbjct: 130 YLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVAD 163
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-12
Identities = 32/153 (20%), Positives = 67/153 (43%), Gaps = 25/153 (16%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI-K 69
+IG G++G + H + +I+AVK + QLL + ++ S P I +
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMD---LDVVMRSSDCPYIVQ 85
Query: 70 WYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI--------EYV 119
+YG D + ++L+ S + + + ++ ++++ +I ++
Sbjct: 86 FYGALFREGDCWICMELMSTSFDKFY----KYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 120 HS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151
+HRDIKP N L+ ++ + + DFG
Sbjct: 142 KENLKIIHRDIKPSNILLD---RSGNIKLCDFG 171
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 65.7 bits (160), Expect = 4e-12
Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 43/285 (15%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+L K+G G FGE+++ + T VA+K GT P+ L EA+V K L+ +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRH----EKL 324
Query: 69 -KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----EYVHS 121
+ Y V E+ + +V + + SL D K+ L+ M A+I YV
Sbjct: 325 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV---DMAAQIASGMAYVER 381
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYRENKNLTGTA 177
++HRD++ N L+G + + DFGLA+ D P + TA
Sbjct: 382 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 432
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
A+ + + D+ S G +LL +G +P+ G+ ++ D++ E+
Sbjct: 433 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRM 483
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
P C P C ++RP + +L+ D F+
Sbjct: 484 PCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-12
Identities = 19/184 (10%), Positives = 45/184 (24%), Gaps = 36/184 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLL----YEAKVYKILQGGSGI 65
K+ GE++ + VK+ + E +I
Sbjct: 13 NFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH---- 66
Query: 66 PNI-KWYGV----DGEDNVLVLDLL-GPSLED-LFVYCRRKFSLKTVLMLADQMIAR-IE 117
PN+ G L+ + SL + L + A +AR +
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD-MARGMA 125
Query: 118 YVHSRGF--LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
++H+ + + ++ + I + ++
Sbjct: 126 FLHTLEPLIPRHALNSRSVMID---EDMTARISMADVKF------------SFQSPGRMY 170
Query: 176 TARY 179
+
Sbjct: 171 APAW 174
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-12
Identities = 41/159 (25%), Positives = 69/159 (43%), Gaps = 18/159 (11%)
Query: 10 KLGRKIGSGSFGEIF---LASHVDTNEIVAVKIENSGTKHPQL---LYEAKVYKILQGGS 63
+LGR IG G FG++ S + VA+K + T L EA +
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-- 75
Query: 64 GIPNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IEYV 119
P+I K GV ++++L L + L ++++ A Q ++ + Y+
Sbjct: 76 --PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ-LSTALAYL 132
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
S+ F+HRDI N L+ + V + DFGL++ D
Sbjct: 133 ESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMED 168
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 5e-12
Identities = 36/157 (22%), Positives = 69/157 (43%), Gaps = 26/157 (16%)
Query: 14 KIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGIPNI-K 69
++G G++G + HV + +I+AVK + + +LL + I P
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMD---LDISMRTVDCPFTVT 70
Query: 70 WYG--VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI--------EYV 119
+YG D + ++L+ SL+ + K + + + ++ +I E++
Sbjct: 71 FYGALFREGDVWICMELMDTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 120 HS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
HS +HRD+KP N L+ QV + DFG++
Sbjct: 126 HSKLSVIHRDVKPSNVLIN---ALGQVKMCDFGISGY 159
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 6e-12
Identities = 45/185 (24%), Positives = 73/185 (39%), Gaps = 43/185 (23%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLY-EAKVYKILQGG 62
+G +Y + +G G G +F A D ++ VA+K I + + + E K+ + L
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH- 67
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTV-----LMLAD------- 110
NI V V ++LGPS L L +V M D
Sbjct: 68 ---DNI----------VKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ 114
Query: 111 -------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157
Q++ ++Y+HS LHRD+KP N + + + I DFGLA+
Sbjct: 115 GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLF--INTEDLVLKIGDFGLARIMD 172
Query: 158 DPTTN 162
++
Sbjct: 173 PHYSH 177
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 7e-12
Identities = 61/263 (23%), Positives = 98/263 (37%), Gaps = 84/263 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
+G GSFG++FLA TN+ A+K E +HP +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 51 Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFS 101
+ ++ +++ GG DL + KF
Sbjct: 85 CTFQTKENLFFVMEYLNGG----------------------------DLMYHIQSCHKFD 116
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
L A ++I ++++HS+G ++RD+K DN L+ K + I DFG+ K+ D
Sbjct: 117 LSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDA 173
Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
TN T GT Y + LG + + D S G VLLY L G P+ G
Sbjct: 174 KTN-----------TFCGTPDYIAPEILLGQKYNHSVDWWSFG-VLLYEMLIGQSPFHG- 220
Query: 217 KAATKKQKYDKICEKKVSTPIEV 239
+++ + I P +
Sbjct: 221 --QDEEELFHSIRMDNPFYPRWL 241
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 9e-12
Identities = 54/263 (20%), Positives = 94/263 (35%), Gaps = 84/263 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
+G GSFG++ LA +T ++ AVK+ E HP QL
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 51 Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFS 101
+++ +++ GG DL + R+F
Sbjct: 91 CCFQTPDRLFFVMEFVNGG----------------------------DLMFHIQKSRRFD 122
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
A ++I+ + ++H +G ++RD+K DN L+ + DFG+ K+
Sbjct: 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLD---HEGHCKLADFGMCKEGICNGV 179
Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
TT T GT Y + + D ++G VLLY L G P++
Sbjct: 180 TTA-----------TFCGTPDYIAPEILQEMLYGPAVDWWAMG-VLLYEMLCGHAPFEA- 226
Query: 217 KAATKKQKYDKICEKKVSTPIEV 239
+ ++ I +V P +
Sbjct: 227 --ENEDDLFEAILNDEVVYPTWL 247
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 9e-12
Identities = 56/259 (21%), Positives = 96/259 (37%), Gaps = 82/259 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
+G GSFG++ L+ T+E+ AVKI E K P QL
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 51 Y----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR--KFSL 102
++Y V++ + G DL + ++ +F
Sbjct: 88 SCFQTMDRLY-----------------------FVMEYVNGG----DLMYHIQQVGRFKE 120
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPT 160
+ A ++ + ++ S+G ++RD+K DN ++ + I DFG+ K+ + T
Sbjct: 121 PHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENIWDGVT 177
Query: 161 TNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
T T GT Y + + D + G VLLY L G P++G
Sbjct: 178 TK-----------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLAGQAPFEG-- 223
Query: 218 AATKKQKYDKICEKKVSTP 236
+ + + I E V+ P
Sbjct: 224 -EDEDELFQSIMEHNVAYP 241
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 60/263 (22%), Positives = 91/263 (34%), Gaps = 84/263 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
IG GSFG++ LA H AVK+ E + KHP L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105
Query: 51 Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFS 101
+ K+Y +L GG +LF + +R F
Sbjct: 106 FSFQTADKLYFVLDYINGG----------------------------ELFYHLQRERCFL 137
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
A ++ + + Y+HS ++RD+KP+N L+ + + DFGL K+ +
Sbjct: 138 EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD---SQGHIVLTDFGLCKENIEHNS 194
Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
TT+ T GT Y + R D LG +LY L G P+
Sbjct: 195 TTS-----------TFCGTPEYLAPEVLHKQPYDRTVDWWCLG-AVLYEMLYGLPPFYS- 241
Query: 217 KAATKKQKYDKICEKKVSTPIEV 239
+ YD I K + +
Sbjct: 242 --RNTAEMYDNILNKPLQLKPNI 262
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 41/170 (24%), Positives = 74/170 (43%), Gaps = 21/170 (12%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
KL ++G+G FGE+++ + + VAVK G+ P L EA + K LQ +
Sbjct: 16 KLVERLGAGQFGEVWMGYYNGHTK-VAVKSLKQGSMSPDAFLAEANLMKQLQH----QRL 70
Query: 69 -KWYGV-DGEDNVLVLDLLGPSLEDLFVYCR----RKFSLKTVLMLADQMIARIEYVHSR 122
+ Y V E ++ + + L + + K ++ +L +A Q+ + ++ R
Sbjct: 71 VRLYAVVTQEPIYIITEYM--ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH----IPYR 168
++HRD++ N L+ I DFGLA+ D P +
Sbjct: 129 NYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 34/181 (18%), Positives = 62/181 (34%), Gaps = 42/181 (23%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLAS-HVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQG 61
+ +Y++ +G G+FG++ H VA+K I N G E +L+
Sbjct: 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEIN---VLK- 71
Query: 62 GSGIPNIKWYGVDGEDNV--------------LVLDLLGPSLEDLFVYCRRK-FSLKTVL 106
IK + + + +LLG + + + + L V
Sbjct: 72 -----KIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVR 126
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLM----------------GLGRKANQVYIIDF 150
+A Q+ + ++H H D+KP+N L K + + DF
Sbjct: 127 HMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 151 G 151
G
Sbjct: 187 G 187
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-11
Identities = 51/239 (21%), Positives = 89/239 (37%), Gaps = 38/239 (15%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSG--I 65
+G G FGE+ T ++ A K + G L E + IL+ + +
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM--ALNEKQ---ILEKVNSRFV 246
Query: 66 PNIKWYGVDGEDNVLVLDLL--GPSLEDLFVY----CRRKFSLKTVLMLADQMIARIEYV 119
++ + + LVL L+ G DL + + F + A ++ +E +
Sbjct: 247 VSLAYAYETKDALCLVLTLMNGG----DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDL 302
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
H ++RD+KP+N L+ + I D GLA + T + GT Y
Sbjct: 303 HRERIVYRDLKPENILLD---DHGHIRISDLGLAVHVPEGQTIK--------GRVGTVGY 351
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQK-YDKICEKKVSTP 236
+ + D +LG LLY + G P+Q K K+++ + E
Sbjct: 352 MAPEVVKNERYTFSPDWWALG-CLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS 409
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 69/285 (24%), Positives = 118/285 (41%), Gaps = 43/285 (15%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPNI 68
+L K+G G FGE+++ + T VA+K GT P+ L EA+V K L+ +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRH----EKL 241
Query: 69 -KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARI----EYVHS 121
+ Y V E+ + +V + + SL D K+ L+ M A+I YV
Sbjct: 242 VQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV---DMAAQIASGMAYVER 298
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYRENKNLTGTA 177
++HRD++ N L+G + + DFGLA+ D P + TA
Sbjct: 299 MNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFPIK------WTA 349
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLY--FLRGSLPWQGLKAATKKQKYDKICEKKVST 235
A+ + + D+ S G +LL +G +P+ G+ ++ D++ E+
Sbjct: 350 PEAALYGRF----TIKSDVWSFG-ILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRM 400
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
P C P C ++RP + +L+ D F+
Sbjct: 401 PCPPEC---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 54/262 (20%), Positives = 97/262 (37%), Gaps = 83/262 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP---QLLY 51
+G G+FG++ L T A+KI E+ T+HP L Y
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 72
Query: 52 ----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSL 102
++ +++ GG +LF + R F+
Sbjct: 73 AFQTHDRLCFVMEYANGG----------------------------ELFFHLSRERVFTE 104
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPT 160
+ ++++ +EY+HSR ++RDIK +N ++ K + I DFGL K+ T
Sbjct: 105 ERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFGLCKEGISDGAT 161
Query: 161 TNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
T GT Y + + R D LG V++Y + G LP+
Sbjct: 162 MK-----------TFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRLPFYN-- 207
Query: 218 AATKKQKYDKICEKKVSTPIEV 239
++ ++ I +++ P +
Sbjct: 208 -QDHERLFELILMEEIRFPRTL 228
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 1e-11
Identities = 52/250 (20%), Positives = 95/250 (38%), Gaps = 57/250 (22%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVK-------IENSGTKHPQLLYEAKVYKILQGGSG--I 65
+G G FGE+F T ++ A K + G + + E K IL I
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQG--AMVEKK---ILAKVHSRFI 247
Query: 66 PNIKWYGVDGEDNV-LVLDLL--GPSLEDLF------VYCRRKFSLKTVLMLADQMIARI 116
++ Y + + ++ LV+ ++ G D+ F + Q+++ +
Sbjct: 248 VSLA-YAFETKTDLCLVMTIMNGG----DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
E++H R ++RD+KP+N L+ V I D GLA + + + T
Sbjct: 303 EHLHQRNIIYRDLKPENVLLD---DDGNVRISDLGLAVE-----------LKAGQTKTKG 348
Query: 177 ARYASCNTH--------LGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKAATKKQK-YD 226
T LG E D +LG V LY + P++ + ++
Sbjct: 349 ----YAGTPGFMAPELLLGEEYDFSVDYFALG-VTLYEMIAARGPFRARGEKVENKELKQ 403
Query: 227 KICEKKVSTP 236
++ E+ V+ P
Sbjct: 404 RVLEQAVTYP 413
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 48/201 (23%), Positives = 79/201 (39%), Gaps = 61/201 (30%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVY------- 56
+ KY+L +K+G G++G ++ + T E+VAVK I + ++
Sbjct: 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--------AFQNSTDAQRTFRE 58
Query: 57 -KILQGGSGIPNIKWYGVDGEDNVLVLDLLGP-SLEDLFVYCRRKFSLKTVLMLAD---- 110
IL SG NI V +L++L + D+++ M D
Sbjct: 59 IMILTELSGHENI----------VNLLNVLRADNDRDVYLV--------FDYMETDLHAV 100
Query: 111 ----------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLA 153
Q+I I+Y+HS G LHRD+KP N L+ A V + DFGL+
Sbjct: 101 IRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL----NAECHVKVADFGLS 156
Query: 154 KKYRDPTTNRHIPYRENKNLT 174
+ + + + T
Sbjct: 157 RSFVNIRRVTNNIPLSINENT 177
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 42/157 (26%), Positives = 65/157 (41%), Gaps = 21/157 (13%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
K + +GSG+FG ++ + E VA+K T +L EA V +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN- 76
Query: 63 SGIPNI-KWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIAR-IE 117
P++ + G+ V L+ L G L D + + +L Q IA+ +
Sbjct: 77 ---PHVCRLLGICLTSTVQLITQLMPFG-CLLDYVREHKDNIGSQYLLNWCVQ-IAKGMN 131
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ R +HRD+ N L+ V I DFGLAK
Sbjct: 132 YLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 34/160 (21%), Positives = 67/160 (41%), Gaps = 18/160 (11%)
Query: 10 KLGRKIGSGSFGEIFLA----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGG 62
+ IG+G FGE++ S VA+K +G Q L EA +
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH- 105
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
NI + GV + +++ + + +L+ +FS+ ++ + + A ++Y
Sbjct: 106 ---HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 162
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ + ++HRD+ N L+ + DFGL++ D
Sbjct: 163 LANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLED 199
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-11
Identities = 25/104 (24%), Positives = 39/104 (37%), Gaps = 12/104 (11%)
Query: 86 GPSLEDLFVYCRRKFSL--KTVLMLADQMIARIEYVHSRGFLHRDIKPDN-FLMGLGRKA 142
+L+D L + Q+ +E++HS+G +HRD+KP N F
Sbjct: 145 KENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFT----MD 200
Query: 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT-----GTARYAS 181
+ V + DFGL + + T GT Y S
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 2e-04
Identities = 15/67 (22%), Positives = 28/67 (41%), Gaps = 7/67 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK---IENSGTKHPQLLYEAKVYKILQGGSG 64
++ + +G G FG +F A + + A+K + N +++ E K L+
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE---- 62
Query: 65 IPNIKWY 71
P I Y
Sbjct: 63 HPGIVRY 69
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 48/260 (18%), Positives = 96/260 (36%), Gaps = 25/260 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSGI 65
++ ++G+G+ G +F SH + ++A K+ E Q++ E +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS---- 90
Query: 66 PNI-KWYG--VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
P I +YG + + ++ + G SL+ + R + + ++ +I + Y+
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGLTYLRE 149
Query: 122 RG-FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
+ +HRD+KP N L+ ++ + DFG++ + D N + GT Y
Sbjct: 150 KHKIMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSYM 197
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S G S + D+ S+G L+ G P A + + E +
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257
Query: 241 CKSHPAEFASYFHYCQSLTF 260
+
Sbjct: 258 RTPGRPLNKFGMDSRPPMAI 277
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 2e-11
Identities = 37/159 (23%), Positives = 66/159 (41%), Gaps = 17/159 (10%)
Query: 10 KLGRKIGSGSFGEIFLA---SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
+ + IGSG GE+ + VA+K +G Q L EA +
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH-- 109
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PNI + GV G ++V + + SL+ +F++ ++ + + A + Y+
Sbjct: 110 --PNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL 167
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
G++HRD+ N L+ + DFGL++ D
Sbjct: 168 SDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLED 203
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-11
Identities = 36/159 (22%), Positives = 67/159 (42%), Gaps = 17/159 (10%)
Query: 10 KLGRKIGSGSFGEIFLA--SHVDTNEI-VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
+ + +G+G FGE+ EI VA+K G Q L EA +
Sbjct: 48 SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH-- 105
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PNI + GV + ++V + + SL+ +F++ ++ + + + ++Y+
Sbjct: 106 --PNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL 163
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
G++HRD+ N L+ + DFGL + D
Sbjct: 164 SDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLED 199
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 51/221 (23%), Positives = 85/221 (38%), Gaps = 50/221 (22%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
I +Y++ IG+GS+G + A +VA+K I + + E + L
Sbjct: 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN 110
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKF---SLKTVLM----LAD- 110
++ V VLD++ P + F +Y + K + L +
Sbjct: 111 H----DHV----------VKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTEL 156
Query: 111 -------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTN 162
++ ++YVHS G LHRD+KP N L+ + V + DFGLA
Sbjct: 157 HIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV----NQDCSVKVCDFGLA--------- 203
Query: 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESL-GYV 202
R + Y EN N + +L ++ L G+V
Sbjct: 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHV 244
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 3e-11
Identities = 51/268 (19%), Positives = 99/268 (36%), Gaps = 85/268 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
IG GS+ ++ L T+ I A+++ E + HP L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 51 Y----EAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL--GPSLEDLFVYCRR--KFSL 102
E++++ V++ + G DL + +R K
Sbjct: 120 SCFQTESRLF-----------------------FVIEYVNGG----DLMFHMQRQRKLPE 152
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDPT 160
+ + ++ + Y+H RG ++RD+K DN L+ + + D+G+ K+ T
Sbjct: 153 EHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGDT 209
Query: 161 TNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLK 217
T+ T GT Y + G + D +LG VL++ + G P+ +
Sbjct: 210 TS-----------TFCGTPNYIAPEILRGEDYGFSVDWWALG-VLMFEMMAGRSPFDIVG 257
Query: 218 AA------TKKQKYDKICEKKVSTPIEV 239
++ T+ + I EK++ P +
Sbjct: 258 SSDNPDQNTEDYLFQVILEKQIRIPRSL 285
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 56/263 (21%), Positives = 97/263 (36%), Gaps = 84/263 (31%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
+G GSFG++ L+ T+E+ AVKI E K P QL
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 51 Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFS 101
++Y +++ GG DL + ++ +F
Sbjct: 409 SCFQTMDRLYFVMEYVNGG----------------------------DLMYHIQQVGRFK 440
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
+ A ++ + ++ S+G ++RD+K DN ++ + I DFG+ K+ +
Sbjct: 441 EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLD---SEGHIKIADFGMCKENIWDGV 497
Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
TT T GT Y + + D + G VLLY L G P++G
Sbjct: 498 TTK-----------TFCGTPDYIAPEIIAYQPYGKSVDWWAFG-VLLYEMLAGQAPFEG- 544
Query: 217 KAATKKQKYDKICEKKVSTPIEV 239
+ + + I E V+ P +
Sbjct: 545 --EDEDELFQSIMEHNVAYPKSM 565
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 3e-11
Identities = 52/269 (19%), Positives = 99/269 (36%), Gaps = 87/269 (32%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------ENS----GTKHP---QLL 50
IG GS+ ++ L T+ I A+K+ E + HP L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 51 Y----EAKVYKILQ---GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFS 101
E++++ +++ GG DL + +R K
Sbjct: 77 SCFQTESRLFFVIEYVNGG----------------------------DLMFHMQRQRKLP 108
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
+ + ++ + Y+H RG ++RD+K DN L+ + + D+G+ K+
Sbjct: 109 EEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD---SEGHIKLTDYGMCKEGLRPGD 165
Query: 160 TTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGL 216
TT+ T GT Y + G + D +LG VL++ + G P+ +
Sbjct: 166 TTS-----------TFCGTPNYIAPEILRGEDYGFSVDWWALG-VLMFEMMAGRSPFDIV 213
Query: 217 KAA------TKKQKYDKICEKKVSTPIEV 239
++ T+ + I EK++ P +
Sbjct: 214 GSSDNPDQNTEDYLFQVILEKQIRIPRSL 242
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 4e-11
Identities = 43/172 (25%), Positives = 72/172 (41%), Gaps = 25/172 (14%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
+ Y +GSG++G + A + E VA+K + + Y E + K +Q
Sbjct: 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81
Query: 61 GGSGIPNI---------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
N+ + D LV+ + DL KFS + + L Q
Sbjct: 82 H----ENVIGLLDVFTPASSLRNFYDFYLVMPFMQ---TDLQKIMGLKFSEEKIQYLVYQ 134
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTN 162
M+ ++Y+HS G +HRD+KP N + + ++ I+DFGLA+ T
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAV----NEDCELKILDFGLARHADAEMTG 182
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 61.4 bits (150), Expect = 4e-11
Identities = 37/154 (24%), Positives = 65/154 (42%), Gaps = 16/154 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQL---LYEAKVYKILQGGS 63
L R +G G FGE++ + + VAVK + EA + K L
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH-- 72
Query: 64 GIPNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P+I K G+ + E ++++L L + + T+++ + Q+ + Y+
Sbjct: 73 --PHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE 130
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
S +HRDI N L+ V + DFGL++
Sbjct: 131 SINCVHRDIAVRNILVA---SPECVKLGDFGLSR 161
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 6e-11
Identities = 41/166 (24%), Positives = 77/166 (46%), Gaps = 25/166 (15%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
+ +Y+ + IGSG+ G + A + VA+K + H + Y E + K +
Sbjct: 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 119
Query: 61 GGSGIPNI---------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
NI + + +D LV++L+ +L + + + + L Q
Sbjct: 120 H----KNIISLLNVFTPQKTLEEFQDVYLVMELMD---ANLCQVIQMELDHERMSYLLYQ 172
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKY 156
M+ I+++HS G +HRD+KP N ++ K++ + I+DFGLA+
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLARTA 214
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 8e-11
Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 20/172 (11%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
+LGR IG G FG++ ++ VA+K + T L EA +
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-- 450
Query: 64 GIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P+I K GV E+ V ++++L L + L ++++ A Q+ + Y+
Sbjct: 451 --PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYR 168
S+ F+HRDI N L+ + V + DFGL++ D + +P +
Sbjct: 509 SKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 8e-11
Identities = 36/177 (20%), Positives = 65/177 (36%), Gaps = 52/177 (29%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
+ Y + IG GS+G ++LA +T + VA+K + + + E + L+
Sbjct: 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK 83
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD-------- 110
I + + DL+ P F +Y + + +D
Sbjct: 84 S----DYI----------IRLYDLIIPDDLLKFDELY------IVLEIADSDLKKLFKTP 123
Query: 111 -------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLA 153
++ ++H G +HRD+KP N L+ + V + DFGLA
Sbjct: 124 IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL----NQDCSVKVCDFGLA 176
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 40/184 (21%), Positives = 65/184 (35%), Gaps = 50/184 (27%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN-SGTKHPQLLY-EAKVYKILQG 61
+G +Y IG G++G + A VA+K I + Q E K+ +
Sbjct: 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 84
Query: 62 GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLMLAD--------- 110
NI + + D++ + VY + LM D
Sbjct: 85 ----ENI----------IGINDIIRAPTIEQMKDVY------IVQDLMETDLYKLLKTQH 124
Query: 111 -----------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRD 158
Q++ ++Y+HS LHRD+KP N L+ + I DFGLA+
Sbjct: 125 LSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDFGLARVADP 180
Query: 159 PTTN 162
+
Sbjct: 181 DHDH 184
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 41/188 (21%), Positives = 74/188 (39%), Gaps = 56/188 (29%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQL----LYEAKVYKILQ 60
+ +Y+ +GSG++G + A T VAVK + + E ++ K ++
Sbjct: 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGP-----SLEDLFVYCRRKFSLKTVLMLAD----- 110
N+ + +LD+ P D+++ T LM AD
Sbjct: 87 H----ENV----------IGLLDVFTPARSLEEFNDVYLV--------THLMGADLNNIV 124
Query: 111 ---------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
Q++ ++Y+HS +HRD+KP N + + ++ I+DFGLA+
Sbjct: 125 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKILDFGLAR 180
Query: 155 KYRDPTTN 162
D T
Sbjct: 181 HTADEMTG 188
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 1e-10
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 19/154 (12%)
Query: 11 LGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSGTKHPQL----LYEAKVYKILQGGSG 64
+++GSG+FG + + + VAVKI + P L L EA V + L
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN--- 77
Query: 65 IPNI-KWYGV-DGEDNVLVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P I + G+ + E +LV+++ LG L ++ R K ++ L Q+ ++Y+
Sbjct: 78 -PYIVRMIGICEAESWMLVMEMAELG-PLNK-YLQQNRHVKDKNIIELVHQVSMGMKYLE 134
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
F+HRD+ N L+ + I DFGL+K
Sbjct: 135 ESNFVHRDLAARNVLLV---TQHYAKISDFGLSK 165
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-10
Identities = 44/158 (27%), Positives = 65/158 (41%), Gaps = 22/158 (13%)
Query: 10 KLGRKIGSGSFGEIF---LASHVDTNEIVAVKIENSGTKHPQ-----LLYEAKVYKILQG 61
+L K+G GSFG + + VAVK + E L
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80
Query: 62 GSGIPNI-KWYGVDGEDNV-LVLDL--LGPSLEDLFVYCRRKFSLKTVLMLADQMIAR-I 116
N+ + YGV + +V +L LG SL D + F L T+ A Q +A +
Sbjct: 81 ----RNLIRLYGVVLTPPMKMVTELAPLG-SLLDRLRKHQGHFLLGTLSRYAVQ-VAEGM 134
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
Y+ S+ F+HRD+ N L+ + V I DFGL +
Sbjct: 135 GYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMR 169
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 38/187 (20%), Positives = 71/187 (37%), Gaps = 50/187 (26%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGG 62
++ + + RK+G G+FG + L H+D + AVK+ + K EA + K +Q
Sbjct: 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQND 91
Query: 63 SGIPNIKWYGVDGEDN---------------VLVLDLLGPSLEDLFVYCRRK-FSLKTVL 106
D +N L+ + LGPSL ++ F ++ +
Sbjct: 92 -----------DINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIK 140
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLM----------------------GLGRKANQ 144
+ +++ + Y+ H D+KP+N L+ K+
Sbjct: 141 LYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTG 200
Query: 145 VYIIDFG 151
+ +IDFG
Sbjct: 201 IKLIDFG 207
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 17/168 (10%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIPN- 67
KL +K+G+G FGE+++A++ + VAVK G+ + L EA V K LQ
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHTK-VAVKTMKPGSMSVEAFLAEANVMKTLQH----DKL 245
Query: 68 IKWYGVDGEDNVLVLDLLGP--SLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
+K + V ++ + ++ SL D L K L ++ + Q+ + ++ R +
Sbjct: 246 VKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 305
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH----IPYR 168
+HRD++ N L+ + I DFGLA+ D P +
Sbjct: 306 IHRDLRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKFPIK 350
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 43/182 (23%), Positives = 70/182 (38%), Gaps = 27/182 (14%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQG 61
L R +G G+FGE++ + + VAVK E + L EA +
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 92
Query: 62 GSGIPNI-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQM----- 112
NI + GV ++++L+ G L+ R + S + L + D +
Sbjct: 93 ----QNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 148
Query: 113 IAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-----YRDPTTNRHIP 166
IA +Y+ F+HRDI N L+ I DFG+A+ Y +P
Sbjct: 149 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 208
Query: 167 YR 168
+
Sbjct: 209 VK 210
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 32/163 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE---IVAVKI--ENSGTKHPQ-LLYEAKVYKILQGGS 63
R IG G FG ++ ++D + A+K + + + L E + + L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNH-- 81
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLLGPSLE-----DLFVY---CRRKFSLKTVLMLADQM 112
PN+ G+ E VL L DL + +R ++K ++ Q
Sbjct: 82 --PNVLALIGIMLPPEGLPHVL------LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ- 132
Query: 113 IAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+AR +EY+ + F+HRD+ N ++ ++ V + DFGLA+
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLAR 172
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 38/176 (21%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKHPQ--LLYEAKVYKILQGG 62
L R++G G+FG++FLA + + +VAVK T + EA++ LQ
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH- 76
Query: 63 SGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKFSLK 103
+I K+YGV DG+ ++V DL ++ + + L
Sbjct: 77 ---EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 104 TVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+L +A Q IA + Y+ S+ F+HRD+ N L+G V I DFG++ RD
Sbjct: 134 QMLHIASQ-IASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMS---RD 182
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 51/261 (19%), Positives = 94/261 (36%), Gaps = 80/261 (30%)
Query: 15 IGSGSFGEIFLASHVDTNEIVAVKI-----------------EN---SGTKHP---QLLY 51
+G G+FG++ L T A+KI EN ++HP L Y
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 52 ----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR--KFSL 102
++ ++ GG +LF + R FS
Sbjct: 216 SFQTHDRLCFVMEYANGG----------------------------ELFFHLSRERVFSE 247
Query: 103 KTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRDP 159
++++ ++Y+HS + ++RD+K +N ++ K + I DFGL K+
Sbjct: 248 DRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLD---KDGHIKITDFGLCKEGIKDGA 304
Query: 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQGLKA 218
T GT Y + + R D LG V++Y + G LP+
Sbjct: 305 TMK---------TFCGTPEYLAPEVLEDNDYGRAVDWWGLG-VVMYEMMCGRLPFYN--- 351
Query: 219 ATKKQKYDKICEKKVSTPIEV 239
++ ++ I +++ P +
Sbjct: 352 QDHEKLFELILMEEIRFPRTL 372
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 3e-10
Identities = 35/181 (19%), Positives = 62/181 (34%), Gaps = 42/181 (23%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLA-SHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQG 61
++ +Y++ +G G+FG++ H VAVK ++N E +V + L
Sbjct: 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNT 70
Query: 62 GSGIPNIKWYGVDGEDNV--------------LVLDLLGPSLEDLF-VYCRRKFSLKTVL 106
+ +V +LLG S D F L +
Sbjct: 71 ---------TDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIR 121
Query: 107 MLADQMIARIEYVHSRGFLHRDIKPDNFLM----------------GLGRKANQVYIIDF 150
+A Q+ + ++HS H D+KP+N L + ++DF
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 151 G 151
G
Sbjct: 182 G 182
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 59.1 bits (144), Expect = 3e-10
Identities = 59/261 (22%), Positives = 102/261 (39%), Gaps = 85/261 (32%)
Query: 15 IGSGSFGEIFLASHV---DTNEIVAVKI----------------EN---SGTKHP---QL 49
+G GSFG++FL + D ++ A+K+ E HP +L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 50 LY----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKF 100
Y E K+Y IL +GG DLF + F
Sbjct: 92 HYAFQTEGKLYLILDFLRGG----------------------------DLFTRLSKEVMF 123
Query: 101 SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--YRD 158
+ + V ++ ++++HS G ++RD+KP+N L+ + + + DFGL+K+ +
Sbjct: 124 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD---EEGHIKLTDFGLSKESIDHE 180
Query: 159 PTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPWQG 215
+ GT Y + ++ D S G VL++ L G+LP+QG
Sbjct: 181 KKAY-----------SFCGTVEYMAPEVVNRRGHTQSADWWSFG-VLMFEMLTGTLPFQG 228
Query: 216 LKAATKKQKYDKICEKKVSTP 236
+K+ I + K+ P
Sbjct: 229 ---KDRKETMTMILKAKLGMP 246
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 4e-10
Identities = 43/184 (23%), Positives = 74/184 (40%), Gaps = 39/184 (21%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
IG G FG ++ + +D + AVK N T + L E + K
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 85
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLLGPSLE-----DLFVYCR---RKFSLKTVLMLADQM 112
PN+ G+ E + LV+ L DL + R ++K ++ Q
Sbjct: 86 --PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ- 136
Query: 113 IAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YR-DPTTNRH 164
+A+ ++Y+ S+ F+HRD+ N ++ + V + DFGLA+ Y T
Sbjct: 137 VAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 165 IPYR 168
+P +
Sbjct: 194 LPVK 197
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 5e-10
Identities = 47/191 (24%), Positives = 78/191 (40%), Gaps = 41/191 (21%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ--LLYEAKVYKILQGG 62
L ++G G+FG++FLA +VAVK ++ + EA++ +LQ
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH- 102
Query: 63 SGIPNI-KWYGV--DGEDNVLVL------DLL---------GPSLEDLFVYCRRKFSLKT 104
+I +++GV +G ++V DL L L
Sbjct: 103 ---QHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 105 VLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YR 157
+L +A Q +A + Y+ F+HRD+ N L+G G V I DFG+++ YR
Sbjct: 160 LLAVASQ-VAAGMVYLAGLHFVHRDLATRNCLVGQGL---VVKIGDFGMSRDIYSTDYYR 215
Query: 158 DPTTNRHIPYR 168
+P R
Sbjct: 216 -VGGRTMLPIR 225
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 5e-10
Identities = 27/169 (15%), Positives = 61/169 (36%), Gaps = 26/169 (15%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI-------VAVKIENSGTKHPQ--LLYEAKVYKILQ 60
+G G+F +IF + + V +K+ + ++ A + L
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70
Query: 61 GGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRR---KFSLKTVLMLADQMIA 114
++ YGV G++N+LV + + L Y ++ ++ L +A Q+ A
Sbjct: 71 H----KHLVLNYGVCVCGDENILVQEFV--KFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 115 RIEYVHSRGFLHRDIKPDNFL-----MGLGRKANQVYIIDFGLAKKYRD 158
+ ++ +H ++ N L + + D G++
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 5e-10
Identities = 40/177 (22%), Positives = 69/177 (38%), Gaps = 35/177 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ---LLYEAKVYKILQGGS 63
IG G FG ++ + +D + AVK N T + L E + K
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH-- 149
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLLGPSLE-----DLFVY---CRRKFSLKTVLMLADQM 112
PN+ G+ E + LV+ L DL + ++K ++ Q
Sbjct: 150 --PNVLSLLGICLRSEGSPLVV------LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ- 200
Query: 113 IAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+A+ ++++ S+ F+HRD+ N ++ + V + DFGLA RD
Sbjct: 201 VAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGLA---RDMYDKEFDSVH 251
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 44/187 (23%), Positives = 70/187 (37%), Gaps = 37/187 (19%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQG 61
L R +G G+FGE++ + + VAVK E + L EA +
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH 133
Query: 62 GSGIPNI-KWYGV--DGEDNVLVLDLL--GPSLEDLFVYCRR---------KFSLKTVLM 107
NI + GV ++L+L+ G DL + R ++ +L
Sbjct: 134 ----QNIVRCIGVSLQSLPRFILLELMAGG----DLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 108 LADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-----YRDPTT 161
+A IA +Y+ F+HRDI N L+ I DFG+A+ Y
Sbjct: 186 VARD-IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGG 244
Query: 162 NRHIPYR 168
+P +
Sbjct: 245 CAMLPVK 251
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 38/188 (20%), Positives = 71/188 (37%), Gaps = 56/188 (29%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
+ Y+ + +GSG++G + A T VA+K + + Y E ++ K ++
Sbjct: 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGP-----SLEDLFVYCRRKFSLKTVLMLAD----- 110
N+ + +LD+ P D ++ M D
Sbjct: 83 H----ENV----------IGLLDVFTPDETLDDFTDFYLV--------MPFMGTDLGKLM 120
Query: 111 ---------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAK 154
QM+ + Y+H+ G +HRD+KP N + + ++ I+DFGLA+
Sbjct: 121 KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELKILDFGLAR 176
Query: 155 KYRDPTTN 162
+ T
Sbjct: 177 QADSEMTG 184
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 6e-10
Identities = 42/195 (21%), Positives = 73/195 (37%), Gaps = 44/195 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI--ENSGTKHPQ-LLYEAKVYKILQG 61
G+ +G+G+FG++ A D VAVK+ ++ + L+ E KV L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL-- 83
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL------------GPSLEDLFVYCRRKF 100
NI G G +++ DLL + +
Sbjct: 84 -GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 101 SLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---- 155
L+ +L + Q +A+ + ++ S+ +HRD+ N L+ I DFGLA+
Sbjct: 143 DLEDLLSFSYQ-VAKGMAFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIKND 198
Query: 156 --YRDPTTNRHIPYR 168
Y N +P +
Sbjct: 199 SNYV-VKGNARLPVK 212
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 8e-10
Identities = 61/266 (22%), Positives = 102/266 (38%), Gaps = 87/266 (32%)
Query: 15 IGSGSFGEIFLASHV---DTNEIVAVKI------------------ENS---GTKHP--- 47
+G G +G++F V +T +I A+K+ E + KHP
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 48 QLLY----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRR-- 98
L+Y K+Y IL GG +LF+ R
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGG----------------------------ELFMQLEREG 116
Query: 99 KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK--Y 156
F T ++ + ++H +G ++RD+KP+N ++ V + DFGL K+ +
Sbjct: 117 IFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLN---HQGHVKLTDFGLCKESIH 173
Query: 157 RDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQSRRDDLESLGYVLLY-FLRGSLPW 213
T+ T GT Y + + +R D SLG L+Y L G+ P+
Sbjct: 174 DGTVTH-----------TFCGTIEYMAPEILMRSGHNRAVDWWSLG-ALMYDMLTGAPPF 221
Query: 214 QGLKAATKKQKYDKICEKKVSTPIEV 239
G +K+ DKI + K++ P +
Sbjct: 222 TG---ENRKKTIDKILKCKLNLPPYL 244
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 58.8 bits (142), Expect = 8e-10
Identities = 39/152 (25%), Positives = 70/152 (46%), Gaps = 15/152 (9%)
Query: 11 LGRKIGSGSFGEIFLAS-HVDTNEI-VAVKIENSGTKHPQ---LLYEAKVYKILQGGSGI 65
++G G+FG + + +I VA+K+ GT+ ++ EA++ L
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN---- 395
Query: 66 PNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
P I + GV E +LV+++ G L V R + + V L Q+ ++Y+ +
Sbjct: 396 PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
F+HR++ N L+ + I DFGL+K
Sbjct: 456 NFVHRNLAARNVLLV---NRHYAKISDFGLSK 484
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 1e-09
Identities = 40/163 (24%), Positives = 75/163 (46%), Gaps = 25/163 (15%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IEN--SGTKHPQLLY-EAKVYKILQ 60
+ +Y+ + IGSG+ G + A VA+K + H + Y E + K +
Sbjct: 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 82
Query: 61 GGSGIPNI---------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
NI + + +D +V++L+ +L + + + + L Q
Sbjct: 83 H----KNIIGLLNVFTPQKSLEEFQDVYIVMELMD---ANLCQVIQMELDHERMSYLLYQ 135
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLA 153
M+ I+++HS G +HRD+KP N ++ K++ + I+DFGLA
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA 174
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 10 KLGR-KIGSGSFGEIFLAS-HVDTNEI-VAVKI--ENSGTKHPQ-LLYEAKVYKILQGGS 63
+ ++G G+FG + + +I VA+K+ + + + ++ EA++ L
Sbjct: 12 LIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-- 69
Query: 64 GIPNI-KWYGV-DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P I + GV E +LV+++ G L V R + + V L Q+ ++Y+
Sbjct: 70 --PYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE 127
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ F+HRD+ N L+ + I DFGL+K
Sbjct: 128 EKNFVHRDLAARNVLLV---NRHYAKISDFGLSK 158
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 1e-09
Identities = 42/189 (22%), Positives = 76/189 (40%), Gaps = 41/189 (21%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ R++G GSFG ++ + VA+K N + L EA V K
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 87
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL------GPSLEDLFVYCRRKFSLKTVL 106
++ + GV G+ ++++ DL P++ + V SL ++
Sbjct: 88 ----HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV--LAPPSLSKMI 141
Query: 107 MLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YRDP 159
+A + IA + Y+++ F+HRD+ N ++ V I DFG+ + YR
Sbjct: 142 QMAGE-IADGMAYLNANKFVHRDLAARNCMVAEDFT---VKIGDFGMTRDIYETDYYR-K 196
Query: 160 TTNRHIPYR 168
+P R
Sbjct: 197 GGKGLLPVR 205
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 2e-09
Identities = 35/177 (19%), Positives = 61/177 (34%), Gaps = 39/177 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ ++G FG+++ + + + VA+K + P +EA + LQ
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH 71
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKFSL 102
PN+ GV + ++ DL D +
Sbjct: 72 ----PNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP 127
Query: 103 KTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158
+ L Q IA +EY+ S +H+D+ N L+ V I D GL R+
Sbjct: 128 PDFVHLVAQ-IAAGMEYLSSHHVVHKDLATRNVLVY---DKLNVKISDLGLF---RE 177
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 2e-09
Identities = 38/188 (20%), Positives = 61/188 (32%), Gaps = 63/188 (33%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQL------------L 50
+ Y + R I SGS+G + VA+K + N+ + + L
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 51 YEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCRRKFSLKTVLML 108
E ++ PNI + + D+ E +Y L T LM
Sbjct: 78 REIRLLNHFHH----PNI----------LGLRDIFVHFEEPAMHKLY------LVTELMR 117
Query: 109 AD----------------------QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QV 145
D ++ + +H G +HRD+ P N L+ N +
Sbjct: 118 TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL----ADNNDI 173
Query: 146 YIIDFGLA 153
I DF LA
Sbjct: 174 TICDFNLA 181
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 44/194 (22%), Positives = 78/194 (40%), Gaps = 43/194 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
KLG+ +G G+FG++ A T VAVK+ G H + L+ E K+ +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI-- 87
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL-------DLL----------GPSLEDLFVYCRRKFS 101
N+ G ++V+ +L P + +
Sbjct: 88 -GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 102 LKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK----- 155
L+ ++ + Q +A+ +E++ SR +HRD+ N L+ + N V I DFGLA+
Sbjct: 147 LEHLICYSFQ-VAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDP 202
Query: 156 -YRDPTTNRHIPYR 168
Y + +P +
Sbjct: 203 DYV-RKGDARLPLK 215
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 43/190 (22%), Positives = 76/190 (40%), Gaps = 38/190 (20%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ G+ +G+G+FG++ A+ + VAVK+ S + L+ E K+ L
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHL-- 106
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL--------GPSLEDLFVYCRRKFSLKT 104
NI G G +++ DLL + F S +
Sbjct: 107 -GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 105 VLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK-YRDP--- 159
+L + Q +A+ + ++ S+ +HRD+ N L+ G + I DFGLA+ D
Sbjct: 166 LLHFSSQ-VAQGMAFLASKNCIHRDVAARNVLLTNG---HVAKIGDFGLARDIMNDSNYI 221
Query: 160 -TTNRHIPYR 168
N +P +
Sbjct: 222 VKGNARLPVK 231
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 5e-09
Identities = 42/195 (21%), Positives = 75/195 (38%), Gaps = 44/195 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-------SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
LG+ +G G+FG++ +A VAVK+ L+ E ++ K++
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKF 100
NI G +++ +L D+ +
Sbjct: 98 ---GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 101 SLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---- 155
+ K ++ Q +AR +EY+ S+ +HRD+ N L+ + I DFGLA+
Sbjct: 155 TFKDLVSCTYQ-LARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLARDINNI 210
Query: 156 --YRDPTTNRHIPYR 168
Y+ TTN +P +
Sbjct: 211 DYYK-KTTNGRLPVK 224
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 6e-09
Identities = 41/187 (21%), Positives = 62/187 (33%), Gaps = 36/187 (19%)
Query: 10 KLGRKIGSGSFGEIFLA--SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQGGSG 64
K IG G+FG++ A A+K E +V L
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH-- 85
Query: 65 IPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKFSLKTV 105
PNI G L + +LL + S + +
Sbjct: 86 -PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 106 LMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---YRDPTT 161
L A +AR ++Y+ + F+HRD+ N L+G I DFGL++ Y T
Sbjct: 145 LHFAAD-VARGMDYLSQKQFIHRDLAARNILVGEN---YVAKIADFGLSRGQEVYV-KKT 199
Query: 162 NRHIPYR 168
+P R
Sbjct: 200 MGRLPVR 206
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 7e-09
Identities = 45/195 (23%), Positives = 77/195 (39%), Gaps = 44/195 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-------SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
LG+ +G G+FG++ LA + VAVK+ S L+ E ++ K++
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKF 100
NI G +++ +L + +
Sbjct: 132 ---GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 101 SLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---- 155
S K ++ A Q +AR +EY+ S+ +HRD+ N L+ + I DFGLA+
Sbjct: 189 SSKDLVSCAYQ-VARGMEYLASKKCIHRDLAARNVLVTEDNV---MKIADFGLARDIHHI 244
Query: 156 --YRDPTTNRHIPYR 168
Y+ TTN +P +
Sbjct: 245 DYYK-KTTNGRLPVK 258
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 9e-09
Identities = 45/192 (23%), Positives = 70/192 (36%), Gaps = 46/192 (23%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKHPQ----LLYEAKVYKILQGG 62
LGR +G G FG + A + VAVK+ + L EA K
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH- 84
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLL--------GPSLEDLFVYCR--------RKFSLK 103
P++ K GV + + G DL + L+
Sbjct: 85 ---PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHG----DLHAFLLASRIGENPFNLPLQ 137
Query: 104 TVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------Y 156
T++ IA +EY+ SR F+HRD+ N ++ + V + DFGL++K Y
Sbjct: 138 TLVRFMVD-IACGMEYLSSRNFIHRDLAARNCMLA---EDMTVCVADFGLSRKIYSGDYY 193
Query: 157 RDPTTNRHIPYR 168
R +P +
Sbjct: 194 R-QGCASKLPVK 204
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 42/195 (21%), Positives = 74/195 (37%), Gaps = 44/195 (22%)
Query: 10 KLGRKIGSGSFGEIFLA-------SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKIL 59
LG+ +G G FG++ +A VAVK+ L+ E ++ K++
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVL------DLL----------GPSLEDLFVYCRRKF 100
NI G +++ +L D+ +
Sbjct: 144 GKH---KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 101 SLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK---- 155
+ K ++ Q +AR +EY+ S+ +HRD+ N L+ + I DFGLA+
Sbjct: 201 TFKDLVSCTYQ-LARGMEYLASQKCIHRDLAARNVLVTENNV---MKIADFGLARDINNI 256
Query: 156 --YRDPTTNRHIPYR 168
Y+ TTN +P +
Sbjct: 257 DYYK-KTTNGRLPVK 270
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 47/187 (25%), Positives = 70/187 (37%), Gaps = 37/187 (19%)
Query: 10 KLGRKIGSGSFGEIFLASHVDTNEI---VAVKIENSGTKHPQ----LLYEAKVYKILQGG 62
LG+ +G G FG + + + VAVK + L EA K
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSH- 95
Query: 63 SGIPNI-KWYGVDGEDNVLVLDLLGPSLE-----DLFVYCR--------RKFSLKTVLML 108
PN+ + GV E + + L DL Y + L+T+L
Sbjct: 96 ---PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKF 152
Query: 109 ADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK------YRDPTT 161
IA +EY+ +R FLHRD+ N ++ V + DFGL+KK YR
Sbjct: 153 MVD-IALGMEYLSNRNFLHRDLAARNCMLR---DDMTVCVADFGLSKKIYSGDYYRQ-GR 207
Query: 162 NRHIPYR 168
+P +
Sbjct: 208 IAKMPVK 214
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 57/271 (21%), Positives = 105/271 (38%), Gaps = 89/271 (32%)
Query: 15 IGSGSFGEIFLASHV---DTNEIVAVKI------------------EN----SGTKHP-- 47
+G+G++G++FL + DT ++ A+K+ E + P
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 48 -QLLY----EAKVYKIL---QGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLF--VYCR 97
L Y E K++ IL GG +LF + R
Sbjct: 122 VTLHYAFQTETKLHLILDYINGG----------------------------ELFTHLSQR 153
Query: 98 RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFGLAK 154
+F+ V + +++ +E++H G ++RDIK +N L+ G V + DFGL+K
Sbjct: 154 ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG------HVVLTDFGLSK 207
Query: 155 KYRDPTTNRHIPYRENKNLT--GTARYASCNTHLGIEQ--SRRDDLESLGYVLLY-FLRG 209
+ + GT Y + + G + + D SLG VL+Y L G
Sbjct: 208 --------EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG-VLMYELLTG 258
Query: 210 SLPWQGL-KAATKKQKYDKICEKKVSTPIEV 239
+ P+ + ++ + +I + + P E+
Sbjct: 259 ASPFTVDGEKNSQAEISRRILKSEPPYPQEM 289
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 2e-08
Identities = 46/292 (15%), Positives = 91/292 (31%), Gaps = 94/292 (32%)
Query: 28 HVDT---NEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIP----NIKWYGVDGEDNVL 80
HV+ I+ + + +++ + + IP ++ W+ V D ++
Sbjct: 349 HVNCDKLTTIIESSLNVLEPAEYRKMFDRLS--VFPPSAHIPTILLSLIWFDVIKSDVMV 406
Query: 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI--KPDNFLMGL 138
V++ L K+SL + Q + S ++ ++ K +N L
Sbjct: 407 VVNKL------------HKYSL-----VEKQPKESTISIPS---IYLELKVKLEN-EYAL 445
Query: 139 GRKANQVYIID-FGLAKKY--RDPTTNR-------HIPYRENKNLTGTARYASCNTHL-G 187
R I+D + + K + D HI + HL
Sbjct: 446 HRS-----IVDHYNIPKTFDSDDLIPPYLDQYFYSHIGH-----------------HLKN 483
Query: 188 IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAE 247
IE R L + ++ FL +K ++D + + L +
Sbjct: 484 IEHPERMTLFRMVFLDFRFLE------------QKIRHDSTAWNASGSILNTL-----QQ 526
Query: 248 FASYFHYCQSLTFDQRPDY--------GFLKRLFHDLFSREGSLLLQFIMSY 291
Y Y D P Y FL ++ +L + + LL+ +
Sbjct: 527 LKFYKPY----ICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMA 574
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 3e-04
Identities = 57/334 (17%), Positives = 108/334 (32%), Gaps = 99/334 (29%)
Query: 48 QLLYEAKVYK--ILQG--GSGIPNIKWYGVDGEDNVLVLD-LLGPSLEDLF---VY---C 96
Q L E + K ++ G GSG K + LD L ++ ++
Sbjct: 142 QALLELRPAKNVLIDGVLGSG----KT--------WVALDVCLSYKVQCKMDFKIFWLNL 189
Query: 97 RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNF---------LMGLGRKANQVYI 147
+ S +TVL + +++ +I+ + H L+ N + +
Sbjct: 190 KNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLV 249
Query: 148 ID----------FGLAKKYRDPT--TNRHIPYRENKNLTGTARYASCNTHLGIEQSRR-- 193
+ F L+ K T R K +T A+ TH+ ++
Sbjct: 250 LLNVQNAKAWNAFNLSCK----ILLTTR------FKQVT-DFLSAATTTHISLDHHSMTL 298
Query: 194 DDLESLGYVLLYFLR---GSLPWQGLK---------AATKK------QKYDKICEKKVST 235
E +LL +L LP + L A + + + + K++T
Sbjct: 299 TPDEVKS-LLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTT 357
Query: 236 PIEV-LCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKRLFHDLFSREGSLLLQFIM 289
IE L PAE+ F S+ F P L ++ D+ + +++ +
Sbjct: 358 IIESSLNVLEPAEYRKMFDRL-SV-F---PPSAHIPTILLSLIWFDVIKSDVMVVVNKLH 412
Query: 290 SY-----------CSLHSITFQTNI-INIKKVFH 311
Y S+ SI + + + + H
Sbjct: 413 KYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 4e-08
Identities = 39/212 (18%), Positives = 61/212 (28%), Gaps = 59/212 (27%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---------------------------- 39
K + KIG G FGE+F + VA+KI
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 40 ------ENSGTKH----------------PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77
+ P LL +A + GS ++ D
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLM 136
VL + G LE + SL T + Q+ A + + F HRD+ N L+
Sbjct: 139 IVLEFEFGGIDLEQ---MRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 137 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYR 168
+K + + K P+ +
Sbjct: 196 ---KKTSLKKLHYTLNGKSSTIPSCGLQVSII 224
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 4e-08
Identities = 42/201 (20%), Positives = 73/201 (36%), Gaps = 51/201 (25%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
LG+ +G G FG++ A VAVK+ + LL E V K +
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH 85
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL------------------GPSLEDLFV 94
P++ K YG +L++ L + L
Sbjct: 86 ----PHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDH 141
Query: 95 YCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
R ++ ++ A Q I++ ++Y+ +HRD+ N L+ G ++ I DFGL+
Sbjct: 142 PDERALTMGDLISFAWQ-ISQGMQYLAEMKLVHRDLAARNILVAEG---RKMKISDFGLS 197
Query: 154 KK------YRDPTTNRHIPYR 168
+ Y + IP +
Sbjct: 198 RDVYEEDSYV-KRSQGRIPVK 217
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 5e-08
Identities = 49/201 (24%), Positives = 70/201 (34%), Gaps = 51/201 (25%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ R IG G+FG +F A + +VAVK+ EA +
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN 109
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL------------------GPSLEDLFV 94
PNI K GV G+ L+ DL + +
Sbjct: 110 ----PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 95 YCRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153
S L +A Q +A + Y+ R F+HRD+ N L+G V I DFGL+
Sbjct: 166 PGPPPLSCAEQLCIARQ-VAAGMAYLSERKFVHRDLATRNCLVGENMV---VKIADFGLS 221
Query: 154 KK------YRDPTTNRHIPYR 168
+ Y+ N IP R
Sbjct: 222 RNIYSADYYK-ADGNDAIPIR 241
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 1e-07
Identities = 43/200 (21%), Positives = 70/200 (35%), Gaps = 49/200 (24%)
Query: 10 KLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQ---LLYEAKVYKILQG 61
+ G+ +GSG+FG++ A S + VAVK+ + L+ E K+ L
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL-- 105
Query: 62 GSGIPNI-KWYGV--DGEDNVLVL------DLL-----------------GPSLEDLFVY 95
NI G L+ DLL
Sbjct: 106 -GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 96 CRRKFSLKTVLMLADQMIAR-IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+ + +L A Q +A+ +E++ + +HRD+ N L+ V I DFGLA+
Sbjct: 165 DLNVLTFEDLLCFAYQ-VAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLAR 220
Query: 155 K------YRDPTTNRHIPYR 168
Y N +P +
Sbjct: 221 DIMSDSNYV-VRGNARLPVK 239
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 1e-04
Identities = 22/87 (25%), Positives = 40/87 (45%), Gaps = 8/87 (9%)
Query: 87 PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146
E + +L+ ++ + Q+ +E++ SR +HRD+ N L+ V
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN---VVK 233
Query: 147 IIDFGLAKK-YRDP----TTNRHIPYR 168
I DFGLA+ Y+DP + +P +
Sbjct: 234 ICDFGLARDIYKDPDYVRKGDARLPLK 260
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 1e-04
Identities = 20/93 (21%), Positives = 39/93 (41%), Gaps = 15/93 (16%)
Query: 63 SGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
GIP + VD ++ +++ + G +D+ + +++ ++ H
Sbjct: 399 FGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIE------DNLDIAYKIGEIVGKL---HK 449
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154
+H D+ NF+ +YIIDFGL K
Sbjct: 450 NDVIHNDLTTSNFIFD-----KDLYIIDFGLGK 477
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 318 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.23 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.05 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.94 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.7 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.5 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.46 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.33 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.25 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.1 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.95 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.88 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.59 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.45 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.42 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.39 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.31 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.27 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.15 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.1 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.0 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.67 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.63 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.44 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.03 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.74 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.3 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 88.64 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 86.37 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 85.91 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=379.21 Aligned_cols=250 Identities=26% Similarity=0.340 Sum_probs=198.3
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||+|+||+||+|++..+++.||+|++.... ....+.+|+.++++++| +++..+..++.+....|+|
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRH-PHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECCEEEEE
Confidence 57999999999999999999999999999999876432 22367899999999976 6677777777788899999
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 92 mEy~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~ 167 (275)
T 3hyh_A 92 IEYAGNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNF 167 (275)
T ss_dssp EECCCEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTCCEEECCSSCC--------
T ss_pred EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE---CCCCCEEEeecCCCeecCCCCc
Confidence 99999999999887 4569999999999999999999999999999999999999 4889999999999976543322
Q ss_pred CccccccCCCCCcccccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
.....||+.|+|||++.+..+ +.++||||+||++|+|+||++||.+.+. ...+..+.......|
T Consensus 168 --------~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~---~~~~~~i~~~~~~~p---- 232 (275)
T 3hyh_A 168 --------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI---PVLFKNISNGVYTLP---- 232 (275)
T ss_dssp ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCCC----
T ss_pred --------cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHHcCCCCCC----
Confidence 234579999999999998886 6899999999999999999999987544 334444444433332
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
..+|+++.+++.+||..||++|||++++.+ +.++..
T Consensus 233 -~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hpw~k~ 268 (275)
T 3hyh_A 233 -KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ--DDWFKV 268 (275)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--CHHHHT
T ss_pred -CCCCHHHHHHHHHHccCChhHCcCHHHHHc--Cccccc
Confidence 457889999999999999999999999877 445543
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=389.69 Aligned_cols=247 Identities=19% Similarity=0.280 Sum_probs=208.6
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC--CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
..|++.++||+|+||+||+|+++.+|+.||||++... .....+.+|+.+++.++| ++++.+..++.+....|+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEeC
Confidence 5699999999999999999999999999999987533 334568899999999976 6677777777788899999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
| +|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 153 ~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~-- 225 (346)
T 4fih_A 153 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-- 225 (346)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSC--
T ss_pred CCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE---CCCCCEEEecCcCceecCCCCC--
Confidence 9 8899998875 459999999999999999999999999999999999999 4889999999999987654432
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhc
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (318)
......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+.. +.+..+.... .+....+..
T Consensus 226 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~~~--~~~~~~~~~ 295 (346)
T 4fih_A 226 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRDNL--PPRLKNLHK 295 (346)
T ss_dssp -----CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSS--CCCCSCGGG
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHcCC--CCCCCcccc
Confidence 123568999999999999999999999999999999999999999876553 3333333221 122223357
Q ss_pred CchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 244 HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 244 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+|+.+.+++.+||..||++|||+.++.+
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 8899999999999999999999998766
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-57 Score=386.99 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=209.9
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecC-----CCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
.++|++++.||+|+||+||+|++..+++.||||++.. ......+.+|+.++++++| +++..+..++.+....|+
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEEE
Confidence 3679999999999999999999999999999998753 2334578899999999976 667777777788889999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
||||| +|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 110 vmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECCTT
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE---cCCCCEEEEEcCCceecCCC
Confidence 99999 8899999987 4569999999999999999999999999999999999999 58899999999999876543
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.... ......||+.|+|||++.+..|+.++||||+||++|+|++|.+||.+.+. .+.+..+.......|
T Consensus 186 ~~~~-----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~---~~~~~~i~~~~~~~p--- 254 (311)
T 4aw0_A 186 SKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---GLIFAKIIKLEYDFP--- 254 (311)
T ss_dssp TTCC-----CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCCCCC---
T ss_pred CCcc-----cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCCCCCC---
Confidence 3211 22456899999999999999999999999999999999999999987654 344555555444433
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFL 269 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l 269 (318)
..+++++.+++.+||..||++|||++++
T Consensus 255 --~~~s~~~~dli~~lL~~dp~~R~t~~e~ 282 (311)
T 4aw0_A 255 --EKFFPKARDLVEKLLVLDATKRLGCEEM 282 (311)
T ss_dssp --TTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred --cccCHHHHHHHHHHccCCHhHCcChHHH
Confidence 4678899999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-56 Score=388.28 Aligned_cols=258 Identities=22% Similarity=0.217 Sum_probs=211.3
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~- 85 (318)
+.|++.++||+|+||.||+|+++.+++.||||+++.... ..+|+.++..++| ++++.+..++.+....|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~---~~~E~~il~~l~H-pnIV~l~~~~~~~~~~~ivmEy~~ 133 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF---RVEELVACAGLSS-PRIVPLYGAVREGPWVNIFMELLE 133 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CTHHHHTTTTCCC-TTBCCEEEEEEETTEEEEEECCCT
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh---HHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEeccC
Confidence 578999999999999999999999999999999875433 3579999999976 66777777777788899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCC-eEEEEeccceeeecCCCCCcc
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~-~~kL~dfg~~~~~~~~~~~~~ 164 (318)
+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++ .++ .+||+|||+|+..........
T Consensus 134 gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~---~~g~~vKl~DFGla~~~~~~~~~~~ 209 (336)
T 4g3f_A 134 GGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS---SDGSRAALCDFGHALCLQPDGLGKS 209 (336)
T ss_dssp TCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC---TTSCCEEECCCTTCEEC--------
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe---CCCCEEEEeeCCCCeEccCCCcccc
Confidence 89999999874 4699999999999999999999999999999999999994 665 699999999987654322111
Q ss_pred ccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcC
Q 021053 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (318)
........||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+.. ..+..+... ..+....+..+
T Consensus 210 --~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~~~--~~~~~~~~~~~ 282 (336)
T 4g3f_A 210 --LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG---PLCLKIASE--PPPIREIPPSC 282 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS---CCHHHHHHS--CCGGGGSCTTS
T ss_pred --eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH---HHHHHHHcC--CCCchhcCccC
Confidence 01123457999999999999999999999999999999999999999875443 333444332 23334455678
Q ss_pred chhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 245 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
|+.+.+++.+||..||++|||+.++.+.+...+.+
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 99999999999999999999999999998887654
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-57 Score=393.52 Aligned_cols=247 Identities=21% Similarity=0.215 Sum_probs=202.0
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
++|++++.||+|+||+||+|++..+++.||||++..... ...+.+|+.++++++| ++++.+..++.+....|+||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH-PNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCC-CCCCcEEEEEEECCEEEEEE
Confidence 589999999999999999999999999999999875432 2367899999999976 66777777777888999999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||| +|+|.+++...+ ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCc
Confidence 999 889999997643 347899999999999999999999999999999999999 488999999999998654321
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
. ......||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+.. +.+..+.....+. .
T Consensus 180 ~-------~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~~~~~~~----~ 245 (350)
T 4b9d_A 180 E-------LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NLVLKIISGSFPP----V 245 (350)
T ss_dssp H-------HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHTCCCC----C
T ss_pred c-------cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHcCCCCC----C
Confidence 1 112347999999999999999999999999999999999999999886543 3444554433322 2
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+|+++.+++.+||..||++|||+.++.+
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2467899999999999999999999998876
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=383.78 Aligned_cols=261 Identities=23% Similarity=0.328 Sum_probs=210.8
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
+.|-.++|.+.+.||+|+||+||+|++. .++..||||+++.... ...+.+|+.++.+++| ++++.+..+..+
T Consensus 8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-pnIV~l~g~~~~ 86 (299)
T 4asz_A 8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH-EHIVKFYGVCVE 86 (299)
T ss_dssp CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECS
T ss_pred cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCC-CCCccEEEEEee
Confidence 4556689999999999999999999875 3578899999875443 2468899999999976 666677666677
Q ss_pred CcceEEEEecc-CCCHHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCC
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCR------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~ 141 (318)
....++||||| +|+|.+++...+ ..+++..+..++.||+.||.|||+++|+||||||+|||+ +.
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl---~~ 163 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV---GE 163 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---CC
Confidence 78899999999 899999997532 358999999999999999999999999999999999999 58
Q ss_pred CCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhh
Q 021053 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (318)
Q Consensus 142 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~ 220 (318)
++.+||+|||+|+........ .......||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+...
T Consensus 164 ~~~~Ki~DFGla~~~~~~~~~-----~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~ 238 (299)
T 4asz_A 164 NLLVKIGDFGMSRDVYSTDYY-----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 238 (299)
T ss_dssp GGCEEECCCSCHHHHTGGGCE-----EETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred CCcEEECCcccceecCCCCce-----eecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 899999999999765432221 11234468999999999999999999999999999999999 999998866543
Q ss_pred hHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
.+..+...... + .+..+|+.+.+++.+||+.||++|||+.++.+.|+++..
T Consensus 239 ---~~~~i~~~~~~-~---~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 239 ---VIECITQGRVL-Q---RPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp ---HHHHHHHTCCC-C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHcCCCC-C---CCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 33333332221 1 124678999999999999999999999999999988643
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=391.71 Aligned_cols=247 Identities=19% Similarity=0.278 Sum_probs=208.5
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
+.|++.+.||+|+||.||+|+++.+|+.||||++.... ....+.+|+.+++.++| ++++.+..++.....+||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH-ENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCC-CCCCceEEEEEECCEEEEEEeC
Confidence 57999999999999999999999999999999876443 34568899999999976 6677777777778899999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
| +|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.......
T Consensus 230 ~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~-- 302 (423)
T 4fie_A 230 LEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVP-- 302 (423)
T ss_dssp CTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCC--
T ss_pred CCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEecCccceECCCCCc--
Confidence 9 8899998874 459999999999999999999999999999999999999 4889999999999987654432
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhc
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (318)
......||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+... .+..+.... .+....+..
T Consensus 303 -----~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~~~--~~~~~~~~~ 372 (423)
T 4fie_A 303 -----RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIRDNL--PPRLKNLHK 372 (423)
T ss_dssp -----CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSC--CCCCSCTTS
T ss_pred -----cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHcCC--CCCCccccc
Confidence 1245689999999999999999999999999999999999999998765533 333333221 122223356
Q ss_pred CchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 244 HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 244 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+++.+.+++..||..||++|||+.++.+
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 7899999999999999999999998776
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-55 Score=378.39 Aligned_cols=258 Identities=23% Similarity=0.291 Sum_probs=201.1
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
|-.++|++.+.||+|+||+||+|++.. .||||+++..... ..+.+|+.++.+++|++ ++.+..+.. ....+
T Consensus 33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpN-IV~l~g~~~-~~~~~ 107 (307)
T 3omv_A 33 IEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVN-ILLFMGYMT-KDNLA 107 (307)
T ss_dssp CCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTT-BCCEEEEEC-SSSCE
T ss_pred EcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCC-EeeEEEEEE-CCeEE
Confidence 445788999999999999999998643 5899988654332 35788999999998755 445544433 34689
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+||||| +|+|.+++......+++..+..++.||+.||.|||+++|+||||||+|||+ ++++.+||+|||+|+....
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC---
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE---CCCCcEEEeeccCceeccc
Confidence 999999 899999998766679999999999999999999999999999999999999 4889999999999986543
Q ss_pred CCCCccccccCCCCCcccccccccccccC---CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
..... ......||+.|+|||++.+ .+|+.++|||||||++|||+||+.||.+.++.... ...+......+
T Consensus 185 ~~~~~-----~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~--~~~~~~~~~~p 257 (307)
T 3omv_A 185 WSGSQ-----QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI--IFMVGRGYASP 257 (307)
T ss_dssp --------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHHTTCCCC
T ss_pred CCcce-----eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH--HHHHhcCCCCC
Confidence 22211 1234579999999999864 35899999999999999999999999876543222 12222222222
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
........+|+.+.+++.+||+.||++|||+.++.+.++.+
T Consensus 258 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 258 DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 23344567889999999999999999999999999988765
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-55 Score=379.55 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=204.1
Q ss_pred cccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
+-.++|.+.+.||+|+||+||+|++. .+++.||||+++.... ...+.+|+.++.+++| +|++.+..+..+..
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~H-pnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH-QHIVRFFGVCTEGR 116 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECC
Confidence 44578999999999999999999875 3678999999875432 2468899999999976 66666766667778
Q ss_pred ceEEEEecc-CCCHHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCC
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCR--------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~--------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~ 141 (318)
..++||||| +|+|.+++.... .++++..+..++.||+.||.|||+++|+||||||+|||+ +.
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~ 193 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV---GQ 193 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ET
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE---CC
Confidence 899999999 899999987532 358899999999999999999999999999999999999 58
Q ss_pred CCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhh
Q 021053 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (318)
Q Consensus 142 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~ 220 (318)
++.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+...
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~-----~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~ 268 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYR-----VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE 268 (329)
T ss_dssp TTEEEECCCC---------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred CCcEEEcccccceeccCCCcce-----ecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999998654332211 1234578999999999999999999999999999999999 999998866543
Q ss_pred hHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
.+..+.... ..+ .+..+|+.+.+++.+||+.||++|||+.++.+.|+.+..
T Consensus 269 ---~~~~i~~g~-~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 269 ---AIDCITQGR-ELE---RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp ---HHHHHHHTC-CCC---CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHcCC-CCC---CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 333333322 112 124678999999999999999999999999999988743
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-55 Score=377.89 Aligned_cols=258 Identities=18% Similarity=0.224 Sum_probs=208.4
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
++-..++++.+.||+|+||+||+|... .+++.||||+++.... ...+.+|+.++.+++| ++++.+..+...
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~H-pNIV~l~g~~~~ 100 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQH-PNVVCLLGVVTK 100 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCC-TTBCCEEEEECS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCC-CCCCCcceEEEE
Confidence 455578899999999999999999864 4668899999865432 2468899999999976 556666666666
Q ss_pred CcceEEEEecc-CCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecc
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 138 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~ 138 (318)
....++||||| +|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl-- 178 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV-- 178 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE--
Confidence 77899999999 89999999643 1348899999999999999999999999999999999999
Q ss_pred CCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchh
Q 021053 139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 217 (318)
Q Consensus 139 ~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~ 217 (318)
++++.+||+|||+++........ .......||+.|+|||++.+..|+.++|||||||++|||+| |..||.+.+
T Consensus 179 -~~~~~~Ki~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 179 -YDKLNVKISDLGLFREVYAADYY-----KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp -CGGGCEEECCSCCBCGGGGGGCB-----CSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred -CCCCCEEECCcccceeccCCCce-----eEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 58899999999999865432221 12235578999999999999999999999999999999999 899998876
Q ss_pred HhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
..+ .+..+.... ..|. +..+|..+.+++.+||+.||++||++.++.+.|+.+
T Consensus 253 ~~~---~~~~i~~~~-~~~~---p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 253 NQD---VVEMIRNRQ-VLPC---PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHH---HHHHHHTTC-CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHH---HHHHHHcCC-CCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 543 233333222 2222 246789999999999999999999999999988754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-55 Score=371.62 Aligned_cols=247 Identities=21% Similarity=0.258 Sum_probs=196.7
Q ss_pred ccee-eEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccc----cCc
Q 021053 6 GVKY-KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV----DGE 76 (318)
Q Consensus 6 ~~~y-~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~----~~~ 76 (318)
.+|| ++.+.||+|+||+||+|.+..++..||+|++..... ...+.+|+.++++++|+ +++.+..++. ...
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~Hp-nIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP-NIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCT-TBCCEEEEEEEEETTEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCC-CCCcEEEEEeeccCCCc
Confidence 3455 888999999999999999999999999998764332 23578999999999874 5555543332 235
Q ss_pred ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
..|+||||| +|+|.+++.. ...+++..+..++.||+.||.|||++| |+||||||+|||++ +.++.+||+|||+|
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla 179 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 179 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGG
T ss_pred EEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCC
Confidence 689999999 8999999987 456999999999999999999999999 99999999999994 24789999999999
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
+...... .....||+.|+|||++.+ .|+.++|||||||++|+|+||++||.+.+.. ...+..+...
T Consensus 180 ~~~~~~~---------~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~~i~~~-- 245 (290)
T 3fpq_A 180 TLKRASF---------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSG-- 245 (290)
T ss_dssp GGCCTTS---------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTT--
T ss_pred EeCCCCc---------cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHHHHHcC--
Confidence 7543221 134579999999999875 6999999999999999999999999764332 2222232221
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.++.......++++.+++.+||..||++|||+.++.+
T Consensus 246 -~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 246 -VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1222334567789999999999999999999998765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-55 Score=383.41 Aligned_cols=262 Identities=21% Similarity=0.306 Sum_probs=211.6
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCC-----cEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeec-ccc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN-----EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWY-GVD 74 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~-----~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~-~~~ 74 (318)
|-.++|++++.||+|+||+||+|.+...+ +.||||.+...... ..+.+|+.++.++.||++++.+..+ ...
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 44578999999999999999999986543 57999988765432 3578899999999998888777554 445
Q ss_pred CcceEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecc
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 138 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~ 138 (318)
....++||||| +|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl-- 218 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 218 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE--
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee--
Confidence 56789999999 899999997532 237899999999999999999999999999999999999
Q ss_pred CCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchh
Q 021053 139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 217 (318)
Q Consensus 139 ~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~ 217 (318)
++++.+||+|||+|+........ .......||+.|+|||++.+..|+.++|||||||++|||+| |..||.+.+
T Consensus 219 -~~~~~vKi~DFGlar~~~~~~~~-----~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 219 -SEKNVVKICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp -CGGGCEEECCCGGGSCTTTCTTS-----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred -CCCCCEEECcchhhhhcccCCCc-----eeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 48899999999999865433221 11234578999999999999999999999999999999998 999998754
Q ss_pred HhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
... .+..........+. +..+|+++.+++.+||+.||++|||+.++.++|.+++..
T Consensus 293 ~~~---~~~~~i~~g~~~~~---p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 293 IDE---EFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CSH---HHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH---HHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 321 12222222222221 235788999999999999999999999999999988654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-55 Score=377.28 Aligned_cols=242 Identities=23% Similarity=0.355 Sum_probs=196.4
Q ss_pred ccceeeEeeeeccCcccEEEEEEEc---CCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~---~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
-.++|++++.||+|+||+||+|++. .+++.||+|++.... ....+.+|+.++.+++| +++..+..++.+...
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH-PFIVKLHYAFQTEGK 100 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCC-TTEECEEEEEEETTE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCC-CCCCeEEEEEEECCE
Confidence 3478999999999999999999884 467899999876432 23357789999998876 667777777778889
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.|+||||| +|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+..
T Consensus 101 ~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTSCEEEESSEEEEC-
T ss_pred EEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE---cCCCCEEecccccceec
Confidence 99999999 8999999987 4469999999999999999999999999999999999999 58899999999999865
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
..... ......||+.|+|||++.+..|+.++||||+||++|+|+||++||.+.+.. +.+..+.......|
T Consensus 177 ~~~~~-------~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~~~~~~~p 246 (304)
T 3ubd_A 177 IDHEK-------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK---ETMTMILKAKLGMP 246 (304)
T ss_dssp ----C-------CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC
T ss_pred cCCCc-------cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH---HHHHHHHcCCCCCC
Confidence 43322 123567999999999999999999999999999999999999999886553 34445554444333
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCCh
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 266 (318)
..+|+++.+++.+||..||++||++
T Consensus 247 -----~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 247 -----QFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred -----CcCCHHHHHHHHHHcccCHHHCCCC
Confidence 4578899999999999999999985
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=377.77 Aligned_cols=256 Identities=21% Similarity=0.248 Sum_probs=202.2
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeecc------cc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYG------VD 74 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~------~~ 74 (318)
++++|++++.||+|+||+||+|++..+|+.||||++...... ..+.+|+.+++.++| ++++.+..++ .+
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKH-DNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCC-CCcceEeeeeeccccccc
Confidence 567999999999999999999999999999999998765433 256789999999987 4555554332 23
Q ss_pred CcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
....|+|||||+|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 131 ~~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 131 FKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMAR 206 (398)
T ss_dssp CCCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCB
T ss_pred CCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc---CCCCCEEEeecceee
Confidence 467899999999999999876 4569999999999999999999999999999999999999 588999999999998
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
.......... .......||+.|+|||++.+.. ++.++||||+||++|+|++|++||.+.+..+....+.. ...
T Consensus 207 ~~~~~~~~~~---~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~---~~g 280 (398)
T 4b99_A 207 GLCTSPAEHQ---YFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM---VLG 280 (398)
T ss_dssp CC-------C---CCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH---HHC
T ss_pred ecccCccccc---cccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHH---hcC
Confidence 6543221110 1224568999999999988765 69999999999999999999999998766544443333 222
Q ss_pred cCc--------------------------hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 234 STP--------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 234 ~~~--------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.++ ........++.+.+|+.+||..||++|||+.++.+
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 222 12223345777889999999999999999887665
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-52 Score=358.62 Aligned_cols=284 Identities=70% Similarity=1.211 Sum_probs=242.9
Q ss_pred CCccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 1 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
|+..++++|++.+.||+|+||.||+|.+..+++.||+|+.........+.+|+.++..+.|++++..+..++......++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred cccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 34567899999999999999999999999999999999887777777899999999999999999999888888888999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+||++...+..+.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 99999999999998766779999999999999999999999999999999999999444478899999999998876655
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
.....++.......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..+.......+.+..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh
Confidence 54444445556778999999999999999999999999999999999999999886655555666666677777887777
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCch
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLL 284 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~~ 284 (318)
...+|+.+.+++..||+.+|++||++.++.+.|++++.+.....
T Consensus 243 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~ 286 (296)
T 4hgt_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 286 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCT
T ss_pred hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCc
Confidence 78899999999999999999999999999999999987766544
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-52 Score=357.93 Aligned_cols=283 Identities=70% Similarity=1.215 Sum_probs=247.4
Q ss_pred CCccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 1 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
|+..++++|++.+.||.|+||.||+|++..+++.||+|++........+.+|+.++..+.|+++++.+..++......++
T Consensus 3 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 3 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp --CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 45568899999999999999999999999999999999988777777899999999999999999888888888888999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+++++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++..+..+.+||+|||++.......
T Consensus 83 v~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 83 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 99999999999998766779999999999999999999999999999999999999544478899999999998876655
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
.....++.......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..+.......+.+..
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 242 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH
Confidence 44444444556778999999999999999999999999999999999999999876555445556666666777777777
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCc
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSL 283 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 283 (318)
...+|+.+.+++..||+.+|++||++.++.+.|++++......
T Consensus 243 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~ 285 (296)
T 3uzp_A 243 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 285 (296)
T ss_dssp TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence 7889999999999999999999999999999999988775544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=369.56 Aligned_cols=206 Identities=23% Similarity=0.377 Sum_probs=172.7
Q ss_pred ccceeeEeeeeccCcccEEEEEEEc---CCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~---~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
+.++|++.+.||+|+||+||+|+++ .+++.||+|.+..........+|++++..+.+|+++..+..++....+.|+|
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lv 98 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIA 98 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEE
Confidence 5689999999999999999999875 4578999998877666667889999999998888998888888888899999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +++|.+++. .+++.+++.++.||+.||.|||++||+||||||+|||++ .+.+.+||+|||+|+......
T Consensus 99 mE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~~~ 172 (361)
T 4f9c_A 99 MPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHDTK 172 (361)
T ss_dssp EECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECTTCS
T ss_pred EeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe--CCCCeEEECcCCCCcccCCcc
Confidence 9999 789999884 389999999999999999999999999999999999995 344899999999998654322
Q ss_pred CCcc---------------------ccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccch
Q 021053 161 TNRH---------------------IPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGL 216 (318)
Q Consensus 161 ~~~~---------------------~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~ 216 (318)
.... ..........||+.|+|||++.+.+ |+.++||||+||++|+|++|++||...
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 1100 0001123457999999999998765 899999999999999999999999653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=354.33 Aligned_cols=277 Identities=58% Similarity=1.019 Sum_probs=242.1
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
+++++++|++.+.||+|+||.||+|.+..+++.||+|++........+.+|+.++..+.++++++.+..++......++|
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 46789999999999999999999999999999999999887777778999999999998888888888888888899999
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCe-----EEEEeccceeee
Q 021053 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ-----VYIIDFGLAKKY 156 (318)
Q Consensus 82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~-----~kL~dfg~~~~~ 156 (318)
||+++++|.+++...+..+++..+..++.||+.||.|||++||+||||||+||+++ ..+. +||+|||++...
T Consensus 85 ~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~~~~~~~~~~kl~Dfg~~~~~ 161 (298)
T 1csn_A 85 IDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG---RPNSKNANMIYVVDFGMVKFY 161 (298)
T ss_dssp EECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC---CSSSTTTTCEEECCCTTCEES
T ss_pred EEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEec---cCCCCCCCeEEEEECcccccc
Confidence 99999999999987666799999999999999999999999999999999999995 4444 999999999887
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
.........++.......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+..+.......+
T Consensus 162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (298)
T 1csn_A 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 241 (298)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence 66554444444445667899999999999999999999999999999999999999988654444555666666666677
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcC
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~ 281 (318)
.......+|+.+.+++..||+.+|++||++.++.+.|.+++.+..
T Consensus 242 ~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 242 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 777777899999999999999999999999999999999876643
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=360.58 Aligned_cols=288 Identities=55% Similarity=0.970 Sum_probs=245.8
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
-+++++|++.+.||.|+||.||+|.+..+++.||||++........+.+|+.+++.+.+|++++.+..++......++||
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 46789999999999999999999999999999999998877667789999999999977788888888888888899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCe-----EEEEeccceeeec
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ-----VYIIDFGLAKKYR 157 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~-----~kL~dfg~~~~~~ 157 (318)
|+++++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++ ..+. +||+|||++....
T Consensus 85 e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~---~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 85 ELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG---RPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC---CGGGTCTTSEEECCCTTCEESB
T ss_pred EeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec---cCCCCCCceEEEEEcccceeee
Confidence 9999999999987666799999999999999999999999999999999999994 5555 9999999998876
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
........++.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+..+.......+.
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 65554444444556778999999999999999999999999999999999999999886655555666666666777777
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCchhHHHhhhcCCc
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMSYCSLH 295 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~l~~~p~~ 295 (318)
+.....+| .+.+++..||+.+|.+||++.++.+.|.+++.+....... .+.|+...
T Consensus 242 ~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~-~~dw~~~~ 297 (330)
T 2izr_A 242 EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDY-EYDWIGKQ 297 (330)
T ss_dssp HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSC-CCTTTTSC
T ss_pred HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCC-CccCCCCC
Confidence 77666778 9999999999999999999999999999988765543322 24455433
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=375.95 Aligned_cols=283 Identities=77% Similarity=1.301 Sum_probs=254.5
Q ss_pred CCccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 1 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
|+..++++|++.+.||.|+||.||+|.+..+++.||||++........+.+|+.++..+.++++++.+..++......++
T Consensus 1 m~~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 1 MEPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp -CCEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 67889999999999999999999999999999999999988777777899999999999999999999888888889999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++..+..+.+||+|||++.......
T Consensus 81 vme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 81 VMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 99999999999998777779999999999999999999999999999999999999544578999999999999877665
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
.....++.......+|..|+|||++.+..++.++|||||||++|+|++|+.||.+.........+..+.......+.+.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEAL 240 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHH
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHH
Confidence 55555555666788999999999999999999999999999999999999999887666666677777777777888888
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCc
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSL 283 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 283 (318)
...+|..+.+++..||..+|++||++.++.+.|++++......
T Consensus 241 ~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~ 283 (483)
T 3sv0_A 241 CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQ 283 (483)
T ss_dssp HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCC
Confidence 8899999999999999999999999999999999998776544
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-53 Score=365.80 Aligned_cols=267 Identities=24% Similarity=0.247 Sum_probs=192.7
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHH--HHHHHcCCCCCCeee-eccccC---cce
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAK--VYKILQGGSGIPNIK-WYGVDG---EDN 78 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~--~l~~l~~~~~~~~i~-~~~~~~---~~~ 78 (318)
++++|.+.+.||+|+||+||+|++ +|+.||||++..... ..+.+|.+ .+.+++| +++..+. .+.... ...
T Consensus 1 Iar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~H-pNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRH-ENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECSSSEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch-hhHHHHHHHHHHhcCCC-CCCCcEEEEEEecCCCceEE
Confidence 467899999999999999999988 688999999865432 23344444 4445666 4555543 333322 357
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceeeccCCCCCeEEEEe
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--------GFLHRDIKPDNFLMGLGRKANQVYIID 149 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--------~i~H~dl~p~Nil~~~~~~~~~~kL~d 149 (318)
|+||||| +|+|.+++.. .++++..+..++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~D 151 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 151 (303)
T ss_dssp EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECC
T ss_pred EEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEe
Confidence 9999999 8999999985 4589999999999999999999987 99999999999999 5889999999
Q ss_pred ccceeeecCCCCCccccccCCCCCcccccccccccccCC------CCCCcchHHHHHHHHHHHHhCCCCccchhH-----
Q 021053 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI------EQSRRDDLESLGYVLLYFLRGSLPWQGLKA----- 218 (318)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~~l~tg~~pf~~~~~----- 218 (318)
||+++.......... .......||+.|+|||++.+. .++.++|||||||++|||+||.+||.....
T Consensus 152 FGla~~~~~~~~~~~---~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~ 228 (303)
T 3hmm_A 152 LGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp CTTCEEEETTTTEES---CC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred CCCCccccCCCCcee---eecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc
Confidence 999987654432211 112345799999999998765 357799999999999999999876643211
Q ss_pred -------hhhHHHHHHHHHhhccCchHHH--hhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCc
Q 021053 219 -------ATKKQKYDKICEKKVSTPIEVL--CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSL 283 (318)
Q Consensus 219 -------~~~~~~~~~i~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 283 (318)
.........+......++.+.. ....+..+.+++.+||+.||++|||+.++.+.|+++..++.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~ik 302 (303)
T 3hmm_A 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC----
T ss_pred hhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCCC
Confidence 0111222222222322222221 1123457899999999999999999999999999987665543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=355.57 Aligned_cols=252 Identities=20% Similarity=0.251 Sum_probs=182.8
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeecccc---------
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD--------- 74 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~--------- 74 (318)
++|++.+.||+|+||+||+|+++.+++.||||++...... ..+.+|+.++++++|+ +++.+..++..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~Hp-nIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHP-GIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCT-TBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCC-CCCeEEEEEEecCccccccc
Confidence 4599999999999999999999999999999987654332 3578899999999764 45555433321
Q ss_pred ---CcceEEEEecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEE
Q 021053 75 ---GEDNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148 (318)
Q Consensus 75 ---~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~ 148 (318)
....|+||||| +++|.+++..... ..+...+..++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vKl~ 160 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVG 160 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEEC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEEEc
Confidence 22479999999 8999999986322 24566788999999999999999999999999999999 488999999
Q ss_pred eccceeeecCCCCCccc-----cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHH
Q 021053 149 DFGLAKKYRDPTTNRHI-----PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223 (318)
Q Consensus 149 dfg~~~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~ 223 (318)
|||+|+........... .........||+.|+|||++.+..|+.++|||||||++|||++ ||....+. ..
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--~~ 235 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--VR 235 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--HH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--HH
Confidence 99999876543221110 1112234579999999999999999999999999999999996 88754322 22
Q ss_pred HHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+..+.. ...|. . ....++...+++.+||+.||++|||+.++.+
T Consensus 236 ~~~~~~~--~~~p~-~-~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 236 TLTDVRN--LKFPP-L-FTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHHHHHT--TCCCH-H-HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHhc--CCCCC-C-CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 2333222 22222 1 2233557789999999999999999998766
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-51 Score=377.56 Aligned_cols=248 Identities=24% Similarity=0.313 Sum_probs=203.9
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHc--CCCCCCeeeeccccCcce
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~--~~~~~~~i~~~~~~~~~~ 78 (318)
-++|++++.||.|+||.||+|+++.+|+.||+|++.+. .......+|..++..+. +|++++.+..++.+....
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 47899999999999999999999999999999987532 22234555655565554 457788888888888999
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+||||+ +|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+...
T Consensus 268 ylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl---d~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE---eCCCCEEecccceeeecC
Confidence 9999999 8999999987 4569999999999999999999999999999999999999 589999999999998765
Q ss_pred CCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
.... ....||+.|+|||++.. ..|+.++|||||||++|+|++|.+||.+.+..+.......+.......|
T Consensus 344 ~~~~---------~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p 414 (689)
T 3v5w_A 344 KKKP---------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414 (689)
T ss_dssp SCCC---------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC
T ss_pred CCCC---------CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC
Confidence 4322 34589999999999974 5799999999999999999999999987654443444444443333322
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCC-----hHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~-----~~~l~~ 271 (318)
..+|+.+.+++..||..||.+|++ ++++.+
T Consensus 415 -----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 415 -----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp -----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred -----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 467889999999999999999998 455544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=375.46 Aligned_cols=252 Identities=18% Similarity=0.254 Sum_probs=211.9
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
-++|++++.||+|+||.||+|.++.+|+.||+|++..... ...+.+|+.+++.++| +++..+..++.+....|+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCC-TTBCCEEEEEECSSEEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEEEe
Confidence 3689999999999999999999999999999998865432 3467889999999976 667777777788889999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
|| +|+|.+++......+++..++.++.||+.||.|||++||+||||||+|||++. +..+.+||+|||+++.......
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~- 312 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS- 312 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSE-
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCc-
Confidence 99 88999998765567999999999999999999999999999999999999941 2358999999999987654322
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
.....||+.|+|||++.+..|+.++||||+||++|+|++|.+||.+.+.. +.+..+.......+ ...+.
T Consensus 313 -------~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~---~~~~~i~~~~~~~~-~~~~~ 381 (573)
T 3uto_A 313 -------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKSCDWNMD-DSAFS 381 (573)
T ss_dssp -------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHTTCCCCC-SGGGT
T ss_pred -------eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHhCCCCCC-ccccc
Confidence 12447899999999999999999999999999999999999999886653 34444444333333 33345
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+++.+.+|+.+||..||.+||++.++.+
T Consensus 382 ~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 382 GISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 78899999999999999999999998876
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=338.32 Aligned_cols=274 Identities=29% Similarity=0.529 Sum_probs=210.8
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCC-----CcEEEEEeecCCCCChhHHHHHHHHHHHcC--------------CCC
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT-----NEIVAVKIENSGTKHPQLLYEAKVYKILQG--------------GSG 64 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~-----~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~--------------~~~ 64 (318)
+..++|++.+.||.|+||.||+|.+..+ ++.||+|++.... ....+|+.++..+.+ |++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~ 109 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN--GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLG 109 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC--HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc--hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCC
Confidence 4557999999999999999999998754 5789999887543 356667776666654 566
Q ss_pred CCeeeeccccC----cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCC
Q 021053 65 IPNIKWYGVDG----EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 140 (318)
Q Consensus 65 ~~~i~~~~~~~----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~ 140 (318)
++.+..++... ...++|||+++++|.+++......+++..+..++.||+.||.|||++||+||||||+|||++. +
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~-~ 188 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY-K 188 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES-S
T ss_pred CCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec-C
Confidence 76665554432 458999999999999999876667999999999999999999999999999999999999942 1
Q ss_pred CCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhh
Q 021053 141 KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 220 (318)
Q Consensus 141 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~ 220 (318)
..+.+||+|||+++....................||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 67899999999998765433222111122244569999999999999999999999999999999999999998643221
Q ss_pred hHHHHHHHHHhhccCchHHHh------hcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCc
Q 021053 221 KKQKYDKICEKKVSTPIEVLC------KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSL 283 (318)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~------~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 283 (318)
.... ............+. ..+|..+.+++..||..+|++||++.++.+.|.+++......
T Consensus 269 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 269 KYVR---DSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp HHHH---HHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred HHHH---HHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 1111 11111111222221 456889999999999999999999999999999998765543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=331.34 Aligned_cols=263 Identities=23% Similarity=0.339 Sum_probs=211.5
Q ss_pred CCccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-----hhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 1 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
++++++++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.++..++| +++..+..++...
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~ 83 (294)
T 4eqm_A 5 IGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH-QNIVSMIDVDEED 83 (294)
T ss_dssp CSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCB-TTBCCEEEEEECS
T ss_pred hhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCC-CCCceEEEeeeeC
Confidence 4678999999999999999999999999999999999987543322 256788999988876 5666666667777
Q ss_pred cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
...++|||++ +++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~ 159 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI---DSNKTLKIFDFGIAK 159 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCSSST
T ss_pred CeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCCEEEEeCCCcc
Confidence 8899999999 77999999874 469999999999999999999999999999999999999 488999999999987
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
........ ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ..........+
T Consensus 160 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~---~~~~~~~~~~~ 230 (294)
T 4eqm_A 160 ALSETSLT------QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS---IAIKHIQDSVP 230 (294)
T ss_dssp TC-------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH---HHHHHHSSCCC
T ss_pred cccccccc------ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHhhccCC
Confidence 65432221 1234568999999999999999999999999999999999999998765432 22233333333
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCC-ChHHHHHHHHHHH
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLF 277 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-~~~~l~~~l~~~~ 277 (318)
.........+|+.+.+++.+||+.+|.+|| +++++.+.|..++
T Consensus 231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 444455567899999999999999999998 8888888887654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=326.65 Aligned_cols=249 Identities=22% Similarity=0.306 Sum_probs=204.7
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.++..++| +++..+..++......++||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCC-CCCCeEeEEEEECCEEEEEE
Confidence 3578999999999999999999999999999999875432 33467889999999876 56666666666777899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC
T ss_pred ECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE---CCCCCEEEeeCCCceecCCccc
Confidence 999 8999999975 458999999999999999999999999999999999999 4889999999999887654332
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
. .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...+........ .... .+.....
T Consensus 172 ~-------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~~--~~~~~~~ 239 (297)
T 3fxz_A 172 K-------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNG--TPELQNP 239 (297)
T ss_dssp C-------BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHHC--SCCCSCG
T ss_pred c-------cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhCC--CCCCCCc
Confidence 1 23457899999999999999999999999999999999999999876554322222 2111 1111122
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..++..+.+++.+||..||++||++.++.+
T Consensus 240 ~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 467888999999999999999999998766
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=324.92 Aligned_cols=257 Identities=19% Similarity=0.247 Sum_probs=203.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+-+.++|++.+.||+|+||.||+|++. +++.||+|++...... ..+.+|+.+++.++| +++..+..+.......
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~ 94 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHH-PNIVSLIDVIHSERCL 94 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCC-TTBCCEEEEECCSSCE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCC-CCEeeeeeEEccCCEE
Confidence 457799999999999999999999985 4889999987644322 357889999999976 6666666666777889
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 79 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
++|||++.++|.+++......+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 95 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 95 TLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI---NSDGALKLADFGLARAFGI 171 (311)
T ss_dssp EEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEETTS
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE---CCCCCEEEccCcCceecCC
Confidence 9999999889999998766679999999999999999999999999999999999999 4889999999999987643
Q ss_pred CCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc---
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS--- 234 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~--- 234 (318)
+... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+....+..+.....+
T Consensus 172 ~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 172 PVRS-------YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp CCC----------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred Cccc-------ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 3221 234467999999999876 45899999999999999999999999876655444444333221111
Q ss_pred -------------------CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 235 -------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 235 -------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+.......+++.+.+++.+||..||++|||+.++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1112223345677889999999999999999887765
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=331.12 Aligned_cols=252 Identities=20% Similarity=0.287 Sum_probs=210.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--------ChhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
.-+.++|++++.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.++..+.| +++..+..++..
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~ 86 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLH-PNIITLHDVYEN 86 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCC-TTBCCEEEEEEC
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCC-cCCCcEEEEEEe
Confidence 4567899999999999999999999999999999998765432 2457899999999975 666667666677
Q ss_pred CcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCC----eEEEEe
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN----QVYIID 149 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~----~~kL~d 149 (318)
....++|||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++. ..+ .+||+|
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~---~~~~~~~~vkl~D 162 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLID 162 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECC
T ss_pred CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe---CCCCCccCEEEEe
Confidence 78899999999 8999999876 45699999999999999999999999999999999999995 444 799999
Q ss_pred ccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHH
Q 021053 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (318)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~ 229 (318)
||++........ .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.. ..+..+.
T Consensus 163 FG~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~---~~~~~i~ 231 (361)
T 2yab_A 163 FGLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANIT 231 (361)
T ss_dssp CSSCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHH
T ss_pred cCCceEcCCCCc--------cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH
Confidence 999987654321 13456899999999999999999999999999999999999999876543 3344444
Q ss_pred HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
......+ ...+..++..+.+++..||..||.+||++.++.+
T Consensus 232 ~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 232 AVSYDFD-EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp TTCCCCC-HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hcCCCCC-chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 4333333 3455688999999999999999999999998765
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=332.45 Aligned_cols=246 Identities=20% Similarity=0.299 Sum_probs=203.9
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
--++|++.+.||+|+||.||+|++..+++.||+|+++... ....+..|..++.++.+|++++.+..++......|
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 3478999999999999999999999999999999876432 23457889999999877788888888888888999
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 130 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCC
T ss_pred EEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---CCCCCEEEeecceeeeccc
Confidence 999999 7899988886 4569999999999999999999999999999999999999 5889999999999975332
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHh------hhHHHHHHHHHhh
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA------TKKQKYDKICEKK 232 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~------~~~~~~~~i~~~~ 232 (318)
... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ........+....
T Consensus 206 ~~~-------~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~ 278 (396)
T 4dc2_A 206 PGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ 278 (396)
T ss_dssp TTC-------CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC
T ss_pred CCC-------ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc
Confidence 222 123567899999999999999999999999999999999999999643211 1122333444433
Q ss_pred ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCCh
Q 021053 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 266 (318)
...| ..++..+.+++..||..||.+||++
T Consensus 279 ~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 IRIP-----RSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CCCC-----TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred cCCC-----CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 3333 3568899999999999999999996
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=333.92 Aligned_cols=244 Identities=18% Similarity=0.281 Sum_probs=202.1
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+--++|++.+.||.|+||.||+|++..+++.||+|++... .......+|..++..+.+|+++..+..++......
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 3457899999999999999999999999999999987642 23345778999999987788888888888888899
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 100 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~ 175 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGI 175 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE---CCCCCEEEccccceeecc
Confidence 9999999 78999998773 559999999999999999999999999999999999999 588999999999987533
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.. ..+..+.......|
T Consensus 176 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i~~~~~~~p- 244 (353)
T 3txo_A 176 CNGV-------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAILNDEVVYP- 244 (353)
T ss_dssp C----------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC-
T ss_pred cCCc-------cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCC-
Confidence 2221 123457899999999999888999999999999999999999999886553 34445554444333
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCCh
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 266 (318)
..++..+.+++..||..||.+||++
T Consensus 245 ----~~~~~~~~~li~~lL~~dP~~R~~~ 269 (353)
T 3txo_A 245 ----TWLHEDATGILKSFMTKNPTMRLGS 269 (353)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSTTS
T ss_pred ----CCCCHHHHHHHHHHhhhCHHHccCC
Confidence 3467899999999999999999998
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=326.04 Aligned_cols=248 Identities=21% Similarity=0.304 Sum_probs=205.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+--++|++.+.||.|+||.||+|++..+++.||+|++... .......+|..++..++| +++..+..++......
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCC-CcCcceEEEEEeCCEE
Confidence 3457999999999999999999999999999999987532 234467889999998865 6677777777777889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 81 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSC
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE---CCCCCEEEeeccchhhcc
Confidence 9999999 7899988876 4469999999999999999999999999999999999999 588999999999987543
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+.......|
T Consensus 157 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~p- 225 (337)
T 1o6l_A 157 SDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELILMEEIRFP- 225 (337)
T ss_dssp CTTC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC-
T ss_pred cCCC-------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCC-
Confidence 2222 123457899999999999999999999999999999999999999875543 33334443333333
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
..+++.+.+++..||..||.+|| ++.++.+
T Consensus 226 ----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 226 ----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp ----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred ----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 35688999999999999999999 7777765
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=323.32 Aligned_cols=259 Identities=17% Similarity=0.230 Sum_probs=199.4
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-------CChhHHHHHHHHHHHc--CCCCCCeeeecc
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-------KHPQLLYEAKVYKILQ--GGSGIPNIKWYG 72 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~e~~~l~~l~--~~~~~~~i~~~~ 72 (318)
+.++.++|++.+.||+|+||.||+|++..+++.||+|++.... ......+|+.+++.++ .|+++..+..++
T Consensus 4 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~ 83 (308)
T 3g33_A 4 GSMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVC 83 (308)
T ss_dssp ------CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred CcccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeee
Confidence 5678899999999999999999999999999999999875322 2346778998888887 246666654443
Q ss_pred ccCc-----ceEEEEeccCCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEE
Q 021053 73 VDGE-----DNVLVLDLLGPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146 (318)
Q Consensus 73 ~~~~-----~~~lv~e~~~~~L~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~k 146 (318)
.... ..+++||+++++|.+++..... .+++..+..++.||+.||.|||++||+||||||+||++ +.++.+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~---~~~~~~k 160 (308)
T 3g33_A 84 ATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVK 160 (308)
T ss_dssp EECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE---CTTSCEE
T ss_pred eccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---cCCCCEE
Confidence 3222 5899999999999999986433 38999999999999999999999999999999999999 4889999
Q ss_pred EEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHH
Q 021053 147 IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226 (318)
Q Consensus 147 L~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 226 (318)
|+|||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+.
T Consensus 161 l~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 232 (308)
T 3g33_A 161 LADFGLARIYSYQMA--------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232 (308)
T ss_dssp ECSCSCTTTSTTCCC--------SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH
T ss_pred EeeCccccccCCCcc--------cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999875543222 134577999999999999999999999999999999999999998866554443333
Q ss_pred HHHHh-------------------hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 227 KICEK-------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 227 ~i~~~-------------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..... ..+.+.......+++.+.+++.+||..||++|||+.++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 22210 0111122333456778899999999999999999887765
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=327.16 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=205.0
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
..-++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++| +++..+..+.......+
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-PNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCEEE
Confidence 3457899999999999999999999999999999988654322 356789999999976 66666666667778899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+|||++ +++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp EEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSS
T ss_pred EEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE---cCCCCEEEeeccCceecCC
Confidence 999999 88999998764 459999999999999999999999999999999999999 5889999999999875543
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCC-CcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQS-RRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
... .....||+.|+|||++.+..+. .++||||+||++|+|++|..||.+.+... ....+.......|
T Consensus 167 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~~~~p- 234 (328)
T 3fe3_A 167 GGK--------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRERVLRGKYRIP- 234 (328)
T ss_dssp SCG--------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCCCCC-
T ss_pred CCc--------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCCCC-
Confidence 221 1345789999999999988864 78999999999999999999998865533 3333433333333
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...++.+.+++.+||..||.+|||+.++.+
T Consensus 235 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 235 ----FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp ----TTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred ----CCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 246789999999999999999999998776
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=338.74 Aligned_cols=255 Identities=22% Similarity=0.262 Sum_probs=209.8
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
.+.++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++| +++..+..++......+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~~~~~~~ 86 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH-PNIVRLHDSISEEGHHY 86 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCB-TTBCCEEEEEECSSEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-cCCCeEEEEEEECCEEE
Confidence 456899999999999999999999999999999998876542 2357889999999976 66667766667788899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+|||++ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.....+.+||+|||++.....
T Consensus 87 lv~E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 87 LIFDLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEECCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999 8899999886 45699999999999999999999999999999999999996433568899999999976554
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
... ......||+.|+|||++.+..++.++||||+||++|+|++|.+||.+.+.. ..+..+.......+.+
T Consensus 166 ~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~~~~~~ 235 (444)
T 3soa_A 166 EQQ-------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQQIKAGAYDFPSP 235 (444)
T ss_dssp TCC-------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHTCCCCCTT
T ss_pred CCc-------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHHHHHhCCCCCCcc
Confidence 322 113457899999999999989999999999999999999999999876543 3334444444444433
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+..+++.+.+++..||..||++||++.++.+
T Consensus 236 -~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 236 -EWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp -TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 23577889999999999999999999998776
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=322.44 Aligned_cols=248 Identities=19% Similarity=0.203 Sum_probs=203.0
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCCh----hHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+++.++|++.+.||+|+||+||+|.+..+++.||||++....... ....|+..+..+.+|+++..+..++......
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred chhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 456689999999999999999999999999999999876544322 3456666676776778888887777888899
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 79 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
++|||+++++|.+++...+..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.....
T Consensus 133 ~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 133 YLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CGGGCEEECCCTTCEECC-
T ss_pred EEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE---CCCCCEEEccceeeeeccc
Confidence 9999999999999998877779999999999999999999999999999999999999 5889999999999876543
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||...... ..+.. .....
T Consensus 210 ~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~------~~~~~---~~~~~ 271 (311)
T 3p1a_A 210 AGA--------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW------QQLRQ---GYLPP 271 (311)
T ss_dssp -------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH------HHHTT---TCCCH
T ss_pred CCC--------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHhc---cCCCc
Confidence 322 124468999999999886 7899999999999999999997776654332 11111 12223
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+...+++.+.+++..||+.||++||++.++.+
T Consensus 272 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 445678899999999999999999999998765
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=330.15 Aligned_cols=256 Identities=19% Similarity=0.218 Sum_probs=208.2
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-------CCChhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
.++.++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+|+.++..++| +++..+..++...
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~ 98 (351)
T 3c0i_A 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH-PHIVELLETYSSD 98 (351)
T ss_dssp CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCC-TTBCCEEEEEEET
T ss_pred CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCC-CCCCcEEEEEEeC
Confidence 35678999999999999999999999999999999986421 123568899999999976 5666666666677
Q ss_pred cceEEEEecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecc
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg 151 (318)
...|+|||++ +++|.+.+.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++....+||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 8899999999 789988876432 248999999999999999999999999999999999999643344569999999
Q ss_pred ceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh
Q 021053 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (318)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~ 231 (318)
++........ ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.+... ..+..+...
T Consensus 179 ~a~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~~i~~~ 247 (351)
T 3c0i_A 179 VAIQLGESGL-------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFEGIIKG 247 (351)
T ss_dssp TCEECCTTSC-------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHHHHHHT
T ss_pred ceeEecCCCe-------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHHHHHcC
Confidence 9987654322 12345789999999999999999999999999999999999999987543 233344443
Q ss_pred hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
....+. ..+..++..+.+++.+||..||++||++.++.+
T Consensus 248 ~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 248 KYKMNP-RQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCCCCH-HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCc-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 433333 334578899999999999999999999998775
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=334.31 Aligned_cols=218 Identities=26% Similarity=0.356 Sum_probs=167.5
Q ss_pred CCccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccc--c
Q 021053 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV--D 74 (318)
Q Consensus 1 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~--~ 74 (318)
|++.+.++|++.+.||.|+||.||+|.+..+++.||+|++..... .....+|+.++..+.+|+++..+..++. +
T Consensus 3 v~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~ 82 (388)
T 3oz6_A 3 VDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADN 82 (388)
T ss_dssp -CHHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTT
T ss_pred ccCcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCC
Confidence 356677899999999999999999999999999999998764432 2356789999999986677777755543 3
Q ss_pred CcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
....|+|||++.++|.+++.. ..++...+..++.||+.||.|||+.||+||||||+||++ +.++.+||+|||+++
T Consensus 83 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 83 DRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADFGLSR 157 (388)
T ss_dssp SSCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CCEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE---cCCCCEEecCCcccc
Confidence 447899999999999999875 458999999999999999999999999999999999999 588999999999998
Q ss_pred eecCCCCCc-c-------------ccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHh
Q 021053 155 KYRDPTTNR-H-------------IPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA 219 (318)
Q Consensus 155 ~~~~~~~~~-~-------------~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~ 219 (318)
......... . ..........+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 654311100 0 00011234578999999999887 56899999999999999999999999987665
Q ss_pred hhHH
Q 021053 220 TKKQ 223 (318)
Q Consensus 220 ~~~~ 223 (318)
....
T Consensus 238 ~~~~ 241 (388)
T 3oz6_A 238 NQLE 241 (388)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 4433
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=330.92 Aligned_cols=260 Identities=20% Similarity=0.315 Sum_probs=210.3
Q ss_pred cccceeeEeeeeccCcccEEEEEEEc-------CCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHV-------DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~-------~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~ 73 (318)
+..++|++++.||+|+||.||+|++. .++..||+|++...... ..+.+|+.+++.+.+|+++..+..++.
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 157 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 157 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence 44689999999999999999999875 34567999998765332 357889999999966677878777777
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~ 137 (318)
.....|+||||+ +++|.+++.... ..++...+..++.||+.||.|||++||+||||||+||++
T Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll- 236 (370)
T 2psq_A 158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV- 236 (370)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE-
T ss_pred cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE-
Confidence 778899999999 789999998643 237889999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccch
Q 021053 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (318)
Q Consensus 138 ~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~ 216 (318)
+.++.+||+|||++.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 237 --~~~~~~kl~DFG~a~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 237 --TENNVMKIADFGLARDINNIDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp --CTTCCEEECCCSSCEETTCCCTTC-----TTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred --CCCCCEEEccccCCcccCccccee-----cccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 488999999999998654332211 1233456788999999999999999999999999999999 99999875
Q ss_pred hHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
.... ....+.. ....+ ....++..+.+++..||..+|++||++.++.+.|++++.
T Consensus 310 ~~~~---~~~~~~~-~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 310 PVEE---LFKLLKE-GHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp CGGG---HHHHHHT-TCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHH---HHHHHhc-CCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 5432 2222221 11111 123568899999999999999999999999999998764
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=331.21 Aligned_cols=256 Identities=23% Similarity=0.248 Sum_probs=210.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
+.++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+|+.++.++.+|+++..+..++.+....|+|||+
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~--~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~ 97 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR--DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC--CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC--ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence 56789999999999999999999999999999999876443 4567999999997778888888888888899999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCC-CCCeEEEEeccceeeecCCCCC
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~-~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
+ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||++...+ ..+.+||+|||++.........
T Consensus 98 ~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 176 (342)
T 2qr7_A 98 MKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176 (342)
T ss_dssp CCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCC
T ss_pred CCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCc
Confidence 9 7899999876 44599999999999999999999999999999999999985221 2246999999999876543321
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
.....+|+.|+|||++.+..++.++|||||||++|+|++|..||...........+..+.......+ ...+.
T Consensus 177 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~-~~~~~ 248 (342)
T 2qr7_A 177 -------LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLS-GGYWN 248 (342)
T ss_dssp -------BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCC-STTTT
T ss_pred -------eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccC-ccccc
Confidence 1244679999999999888889999999999999999999999986443333444555544433332 22345
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+++.+.+++..||..||++||++.++.+
T Consensus 249 ~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 67889999999999999999999998766
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=322.87 Aligned_cols=258 Identities=23% Similarity=0.295 Sum_probs=201.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
++..++|++.+.||+|+||.||+|++ +++.||+|++...... ..+.+|+.++.+++| +++..+..++......
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRH-PNIVLFMGAVTQPPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCC-TTBCCEEEEECSTTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCce
Confidence 45678999999999999999999987 5788999988765433 256789999999976 6666666666677789
Q ss_pred EEEEecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 79 VLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
++|||++ +++|.+++..... .+++..+..++.|++.||.|||++| |+||||||+||++ +.++.+||+|||++
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLS 186 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC--
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE---eCCCcEEECCCCCC
Confidence 9999999 7899999975322 3899999999999999999999999 9999999999999 48899999999998
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
........ ......+|+.|+|||++.+..++.++|||||||++|+|++|..||...+..... ..+.....
T Consensus 187 ~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~---~~~~~~~~ 256 (309)
T 3p86_A 187 RLKASTFL-------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV---AAVGFKCK 256 (309)
T ss_dssp ----------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH---HHHHHSCC
T ss_pred cccccccc-------ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhcCC
Confidence 75443221 123457899999999999999999999999999999999999999876553322 22211111
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
.. .....+++.+.+++..||..+|.+||++.++.+.|+.++..
T Consensus 257 ~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 257 RL---EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11 12246788999999999999999999999999999988643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=328.08 Aligned_cols=248 Identities=23% Similarity=0.342 Sum_probs=205.9
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+..++|++.+.||.|+||.||+|+++.+++.||+|+++.. ........|..++..+.+|+++..+..++......
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 3458999999999999999999999999999999987642 23446778999998886778888888888888899
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 169 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENM 169 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE---CCCCCEEEeEChhhhhcc
Confidence 9999999 88999998863 459999999999999999999999999999999999999 588999999999987543
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......|
T Consensus 170 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~p- 238 (345)
T 1xjd_A 170 LGDA-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRMDNPFYP- 238 (345)
T ss_dssp CTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC-
T ss_pred cCCC-------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHhCCCCCC-
Confidence 2211 123557899999999999999999999999999999999999999876543 33344433332222
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChH-HHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYG-FLK 270 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~-~l~ 270 (318)
..++..+.+++.+||..||++||++. ++.
T Consensus 239 ----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 239 ----RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ----cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 35688999999999999999999986 443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=323.05 Aligned_cols=252 Identities=20% Similarity=0.258 Sum_probs=208.3
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--------ChhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
+.+.++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.++..++| +++..+..++..
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH-PNVITLHEVYEN 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEEC
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEe
Confidence 4567899999999999999999999999999999998765432 2357899999999976 666666666677
Q ss_pred CcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCC----eEEEEe
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN----QVYIID 149 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~----~~kL~d 149 (318)
....++|||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++. ..+ .+||+|
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~---~~~~~~~~~kl~D 161 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL---DRNVPKPRIKIID 161 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES---CSSSSSCCEEECC
T ss_pred CCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEe---cCCCCCCCEEEEE
Confidence 78899999999 8899999875 45689999999999999999999999999999999999995 444 899999
Q ss_pred ccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHH
Q 021053 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (318)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~ 229 (318)
||++........ .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+..... .+..+.
T Consensus 162 fg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~~~ 230 (326)
T 2y0a_A 162 FGLAHKIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANVS 230 (326)
T ss_dssp CTTCEECCTTSC--------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH
T ss_pred CCCCeECCCCCc--------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHH
Confidence 999987643221 124568999999999999899999999999999999999999998765432 233333
Q ss_pred HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
......+ .......+..+.+++..||..||++||++.++.+
T Consensus 231 ~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 231 AVNYEFE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HTCCCCC-HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hcCCCcC-ccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 3333333 3445678889999999999999999999998876
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=326.59 Aligned_cols=253 Identities=17% Similarity=0.240 Sum_probs=210.2
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+.++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.++..++| +++..+..++......++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-RNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC-TTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCC-CCCCeEeEEEecCCEEEEEEE
Confidence 57899999999999999999999999999999998765432 2357789999999976 566666666677788999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++. +..+.+||+|||++........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~~- 159 (321)
T 1tki_A 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE-
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECCCCCc-
Confidence 99 78999999765556999999999999999999999999999999999999951 1278999999999987643322
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
.....+|+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.. ..+..+.......+ ...+.
T Consensus 160 -------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~-~~~~~ 228 (321)
T 1tki_A 160 -------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMNAEYTFD-EEAFK 228 (321)
T ss_dssp -------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCCC-HHHHT
T ss_pred -------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH---HHHHHHHcCCCCCC-hhhhc
Confidence 12346789999999999888999999999999999999999999876543 33444444444444 33446
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+|..+.+++.+||..||.+|||+.++.+
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 78999999999999999999999998877
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=319.52 Aligned_cols=251 Identities=23% Similarity=0.289 Sum_probs=200.0
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
++|++.+.||+|+||+||+|.+..+++.||+|++...... ..+.+|+.+++.++| +++..+..++......++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCC-CCEeeEEeEEEeCCEEEEEE
Confidence 5899999999999999999999999999999988654332 356789999999976 56666666667778899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
|++.+++.+.+......+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.....+..
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCS-
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEeecccceecCCccc-
Confidence 999989999888767779999999999999999999999999999999999999 4889999999999987653322
Q ss_pred ccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCc-cchhHhhhHHHHHHHHHhhccCchHH-
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPW-QGLKAATKKQKYDKICEKKVSTPIEV- 239 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf-~~~~~~~~~~~~~~i~~~~~~~~~~~- 239 (318)
......+|+.|+|||++.+.. ++.++|||||||++|+|++|..|| .+.+... .+..+.......+...
T Consensus 157 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~---~~~~i~~~~~~~~~~~~ 227 (292)
T 3o0g_A 157 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEEQW 227 (292)
T ss_dssp ------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH---HHHHHHHHHCCCCTTTC
T ss_pred ------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCChhhh
Confidence 223457799999999998776 899999999999999999877775 4433332 2333332222221111
Q ss_pred -----------------------HhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 240 -----------------------LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 240 -----------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
....++..+.+++.+||..||++|||+.++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 11235677889999999999999999887765
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=328.61 Aligned_cols=254 Identities=24% Similarity=0.295 Sum_probs=208.8
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
.+.++|++.+.||.|+||.||+|.+..+++.||+|++...... ..+.+|+.++..++| +++..+..++......+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~ 104 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFHY 104 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEE
Confidence 3567899999999999999999999999999999998765432 357789999999976 66667766667778899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+|||++ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||++...+..+.+||+|||++.....
T Consensus 105 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 105 LVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EEECCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999 7899998875 44589999999999999999999999999999999999996433456799999999976543
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.. .....+.......+..
T Consensus 184 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i~~~~~~~~~~ 252 (362)
T 2bdw_A 184 SEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQIKAGAYDYPSP 252 (362)
T ss_dssp CCS--------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCCCTT
T ss_pred Ccc--------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCCCCCCcc
Confidence 321 13457899999999999989999999999999999999999999876543 3333444344333333
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+..+++.+.+++.+||..||++||++.++.+
T Consensus 253 -~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 253 -EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp -GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -cccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 33577889999999999999999999997765
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=326.24 Aligned_cols=263 Identities=19% Similarity=0.270 Sum_probs=210.3
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCc---EEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~---~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
.++..++|++.+.||+|+||.||+|.+..+++ .||||++...... ..+.+|+.++..++| +++..+..++...
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~ 122 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDH-PNIIRLEGVVTRG 122 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeC
Confidence 35677899999999999999999999985554 5999998764332 357889999999975 6666666666777
Q ss_pred cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
...++|||++ +++|.+++......+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV---DSNLVCKVSDFGLSR 199 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCSSCE
T ss_pred CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---CCCCCEEECCCCccc
Confidence 7899999999 789999997666679999999999999999999999999999999999999 588999999999998
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
.......... ......+|..|+|||++.+..++.++|||||||++|+|++ |..||......... ..+.. ..
T Consensus 200 ~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~~~~~-~~ 271 (325)
T 3kul_A 200 VLEDDPDAAY----TTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI---SSVEE-GY 271 (325)
T ss_dssp ECC----CCE----ECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH---HHHHT-TC
T ss_pred ccccCcccee----eccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH---HHHHc-CC
Confidence 7654322111 1123345778999999998889999999999999999999 99999876554322 22222 22
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
..+. ...+|..+.+++..||..+|++||++.++.+.|+.+...
T Consensus 272 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 272 RLPA---PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCCC---CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 2221 236788999999999999999999999999999987543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=328.24 Aligned_cols=244 Identities=20% Similarity=0.290 Sum_probs=205.0
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+--++|++.+.||.|+||.||+|++..+++.||+|++... ........|..++..+.+|+++..+..++......
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 4457899999999999999999999999999999987642 23345778888888887888898888888888899
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCC
T ss_pred EEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE---cCCCcEEEEeCCcccccc
Confidence 9999999 78999998864 459999999999999999999999999999999999999 588999999999987543
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.. ..+..+.......|
T Consensus 173 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i~~~~~~~p- 241 (353)
T 2i0e_A 173 WDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIMEHNVAYP- 241 (353)
T ss_dssp CTTC-------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC-
T ss_pred cCCc-------ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHHHHHhCCCCCC-
Confidence 2221 123557899999999999999999999999999999999999999876543 34445554444333
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCCh
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 266 (318)
..++..+.+++..||..+|.+||+.
T Consensus 242 ----~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 242 ----KSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp ----TTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred ----CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 3578899999999999999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=323.96 Aligned_cols=249 Identities=20% Similarity=0.298 Sum_probs=204.1
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
+.+--++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|..++.++.+|+++..+..++....
T Consensus 4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 83 (345)
T 3a8x_A 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 83 (345)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence 45566899999999999999999999999999999998865432 1246788899988867788888888888888
Q ss_pred ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..|+|||++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 84 ~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~ 159 (345)
T 3a8x_A 84 RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL---DSEGHIKLTDYGMCKE 159 (345)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCGGGCBC
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEEecccccc
Confidence 999999999 7899999876 3469999999999999999999999999999999999999 5889999999999875
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhH------hhhHHHHHHHH
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA------ATKKQKYDKIC 229 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~------~~~~~~~~~i~ 229 (318)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .........+.
T Consensus 160 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~ 232 (345)
T 3a8x_A 160 GLRPGD-------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 232 (345)
T ss_dssp SCCTTC-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH
T ss_pred ccCCCC-------cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH
Confidence 332221 12345789999999999999999999999999999999999999965211 11122233333
Q ss_pred HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCCh
Q 021053 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 266 (318)
......| ..++..+.+++.+||..||.+||++
T Consensus 233 ~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 233 EKQIRIP-----RSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HCCCCCC-----TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred cCCCCCC-----CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 3333333 3568899999999999999999996
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=328.99 Aligned_cols=214 Identities=23% Similarity=0.374 Sum_probs=179.6
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHc----CCCCCCeeeeccccCc
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQ----GGSGIPNIKWYGVDGE 76 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~----~~~~~~~i~~~~~~~~ 76 (318)
..++.++|++.+.||+|+||.||+|++..+++.||+|++..... ......|..+++.+. .|+++..+..++....
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~ 109 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD 109 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence 45788999999999999999999999999999999999875332 235677999999987 3566777777777778
Q ss_pred ceEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccC----------------
Q 021053 77 DNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG---------------- 139 (318)
Q Consensus 77 ~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~---------------- 139 (318)
..++|||+++++|.+++.... ..++...+..++.||+.||.|||++||+||||||+||++...
T Consensus 110 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~ 189 (360)
T 3llt_A 110 HMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189 (360)
T ss_dssp EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCC
T ss_pred eeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccc
Confidence 899999999999999998643 348999999999999999999999999999999999999410
Q ss_pred ------CCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCc
Q 021053 140 ------RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213 (318)
Q Consensus 140 ------~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf 213 (318)
...+.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 190 ~~~~~~~~~~~~kl~DFG~a~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 259 (360)
T 3llt_A 190 KIQIYRTKSTGIKLIDFGCATFKSDYH----------GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLF 259 (360)
T ss_dssp EEEEEEESCCCEEECCCTTCEETTSCC----------CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSC
T ss_pred cccccccCCCCEEEEeccCceecCCCC----------cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCC
Confidence 127889999999998644322 2457899999999999999999999999999999999999999
Q ss_pred cchhHhhhHHHH
Q 021053 214 QGLKAATKKQKY 225 (318)
Q Consensus 214 ~~~~~~~~~~~~ 225 (318)
...+.......+
T Consensus 260 ~~~~~~~~~~~~ 271 (360)
T 3llt_A 260 RTHEHMEHLAMM 271 (360)
T ss_dssp CCSSHHHHHHHH
T ss_pred CCCcHHHHHHHH
Confidence 886654444333
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=320.30 Aligned_cols=253 Identities=24% Similarity=0.305 Sum_probs=198.8
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
++|++.+.||+|+||.||+|++ .+++.||+|++.... ....+.+|+.+++.++| +++..+..++......++||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC-TTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCC-CCEeeeeeEEccCCeEEEEE
Confidence 5899999999999999999998 678899999876433 23467889999999976 56666666666778899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
|++.++|.+++......+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.....+..
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~- 155 (288)
T 1ob3_A 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVR- 155 (288)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred EecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEeECccccccCcccc-
Confidence 999889999998766679999999999999999999999999999999999999 4889999999999876543221
Q ss_pred ccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc--------
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV-------- 233 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~-------- 233 (318)
......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+........
T Consensus 156 ------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (288)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhh
Confidence 11234678999999998764 589999999999999999999999988665443333332221100
Q ss_pred -------------cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 234 -------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 234 -------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+.+.......+++.+.+++.+||..||++||++.++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 01111223356788899999999999999999988765
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=321.76 Aligned_cols=263 Identities=19% Similarity=0.273 Sum_probs=208.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
-.++|++++.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.++..++| +++..+..++......++||
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH-PNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCC-cCcccEEEEEecCCeeEEEE
Confidence 35899999999999999999999999999999998754332 2357889999999975 66666766667778899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|++ +++|.+++......+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||.+........
T Consensus 87 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 87 EYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp ECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC----
T ss_pred EecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE---CCCCCEEEeecccceecccccc
Confidence 999 889999998766779999999999999999999999999999999999999 4889999999999987643322
Q ss_pred Cccc-------cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhH--HHHHHHHHhh
Q 021053 162 NRHI-------PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK--QKYDKICEKK 232 (318)
Q Consensus 162 ~~~~-------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~--~~~~~i~~~~ 232 (318)
.... .........||+.|+|||++.+..++.++|||||||++|+|++|..||......... .........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~- 242 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR- 242 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-
Confidence 1100 000112457899999999999999999999999999999999999999754322111 011111111
Q ss_pred ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
.....+|+.+.+++..||+.||++||++.++.+.|+.+..
T Consensus 243 ------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 243 ------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp ------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1124568899999999999999999999999999988743
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=327.87 Aligned_cols=256 Identities=20% Similarity=0.242 Sum_probs=195.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+.+.++|++.+.||+|+||.||+|.+..+++.||+|++........+.+|+.++..+.| +++..+..++......++||
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCC-TTBCCEEEEEECSSEEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCC-CCCcceeeeEecCCeEEEEE
Confidence 35678899999999999999999999999999999998876666678889999999976 55666666666777899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++..+..+.+||+|||++........
T Consensus 128 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 206 (349)
T 2w4o_A 128 ELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL 206 (349)
T ss_dssp CCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc
Confidence 999 7899999876 44589999999999999999999999999999999999996433589999999999876543221
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
.....+|+.|+|||++.+..++.++|||||||++|+|++|..||...... ...+..+....... ....+
T Consensus 207 --------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~i~~~~~~~-~~~~~ 275 (349)
T 2w4o_A 207 --------MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGD--QFMFRRILNCEYYF-ISPWW 275 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCH--HHHHHHHHTTCCCC-CTTTT
T ss_pred --------cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCccc--HHHHHHHHhCCCcc-CCchh
Confidence 12456899999999999999999999999999999999999999765432 22333333332222 22334
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..++..+.+++.+||..||++||++.++.+
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 567889999999999999999999998776
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=330.43 Aligned_cols=263 Identities=21% Similarity=0.307 Sum_probs=209.2
Q ss_pred ccccceeeEeeeeccCcccEEEEEE-----EcCCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccc-
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLAS-----HVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV- 73 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~-----~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~- 73 (318)
++..++|++.+.||.|+||.||+|+ +..+++.||||++...... ..+.+|+.++..+.+|+++..+..+..
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~ 97 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 97 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec
Confidence 3567899999999999999999999 4456689999998765433 357899999999977777777765544
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhcC------------------------------------------------------
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCRR------------------------------------------------------ 98 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~~------------------------------------------------------ 98 (318)
.....++||||+ +++|.+++.....
T Consensus 98 ~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (359)
T 3vhe_A 98 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVE 177 (359)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------
T ss_pred CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhh
Confidence 445689999999 7899999976432
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccccc
Q 021053 99 -----------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167 (318)
Q Consensus 99 -----------~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 167 (318)
.+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.........
T Consensus 178 ~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~----- 249 (359)
T 3vhe_A 178 EEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDY----- 249 (359)
T ss_dssp ------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTSCTTC-----
T ss_pred hcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---cCCCcEEEEeccceeeecccccc-----
Confidence 17889999999999999999999999999999999999 48899999999999765433221
Q ss_pred cCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCch
Q 021053 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246 (318)
Q Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 246 (318)
.......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+...... +..........+. ...+++
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~~~~~~~~~~---~~~~~~ 323 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---FCRRLKEGTRMRA---PDYTTP 323 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---HHHHHHHTCCCCC---CTTCCH
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH---HHHHHHcCCCCCC---CCCCCH
Confidence 12234567889999999998899999999999999999998 9999987543221 1122222212221 235688
Q ss_pred hHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 247 EFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 247 ~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
.+.+++..||+.+|++||++.++.+.|+.++..
T Consensus 324 ~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 324 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 999999999999999999999999999998754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=327.82 Aligned_cols=251 Identities=25% Similarity=0.340 Sum_probs=206.2
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
++..++|++.+.||.|+||.||+|++..+++.||+|++... .....+.+|+.++..++| ++++.+..++.....
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH-PFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCCE
Confidence 45668999999999999999999999999999999987532 233567889999999965 666677777777788
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.|+|||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +..+.+||+|||++...
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAML 165 (384)
T ss_dssp EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE---CCCCCEEEeccceeeec
Confidence 99999999 8899998876 4459999999999999999999999999999999999999 58899999999999876
Q ss_pred cCCCCCccccccCCCCCcccccccccccccC---CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.......+..+.....
T Consensus 166 ~~~~~--------~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~ 237 (384)
T 4fr4_A 166 PRETQ--------ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237 (384)
T ss_dssp CTTCC--------BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC
T ss_pred cCCCc--------eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc
Confidence 43322 235578999999999874 3589999999999999999999999986554444444444433333
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCC-hHHHHH
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-YGFLKR 271 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~-~~~l~~ 271 (318)
..| ..++..+.+++..||..||.+||+ +.++.+
T Consensus 238 ~~p-----~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 238 TYP-----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCC-----TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCC-----CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 333 356889999999999999999998 555543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=332.60 Aligned_cols=259 Identities=22% Similarity=0.310 Sum_probs=210.2
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
+-.++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++| +++..+..+.......++
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l 189 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH-PNIVRLIGVCTQKQPIYI 189 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCC-TTBCCEEEEECSSSSCEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEecCCCcEE
Confidence 3457899999999999999999999989999999988754322 357889999999976 556666666666778999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
|||++ +++|.+++...+..++...+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++......
T Consensus 190 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 190 VMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTS
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCC
Confidence 99999 789999998766679999999999999999999999999999999999999 48899999999998764332
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
.... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+.......+ ......+.
T Consensus 267 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~- 336 (377)
T 3cbl_A 267 VYAA-----SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV----EKGGRLPC- 336 (377)
T ss_dssp EEEC-----CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH----HTTCCCCC-
T ss_pred ceee-----cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCCC-
Confidence 1110 1122345678999999998889999999999999999998 99999886554322222 12222222
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
...+|+.+.+++.+||+.+|++||++.++.+.|+++..
T Consensus 337 --~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 337 --PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 23578899999999999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=320.55 Aligned_cols=266 Identities=21% Similarity=0.250 Sum_probs=204.0
Q ss_pred CccccceeeEeeeeccCcccEEEEEE----EcCCCcEEEEEeecCCCCC--hhHHHHHHHHHHHcCCCCCCeeeecc--c
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYG--V 73 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~----~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~i~~~~--~ 73 (318)
.++..++|++.+.||+|+||.||+|+ +..+++.||+|++...... ..+.+|+.++..++|+ ++..+..+. .
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~ 83 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHD-NIVKYKGVCYSA 83 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCT-TBCCEEEEECHH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCC-CEeeEEEEEecC
Confidence 46788999999999999999999998 5678899999988754432 3578899999999864 444443332 2
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
.....++|||++ +++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||+
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~---~~~~~kl~Dfg~ 160 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGL 160 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCS
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEc---CCCeEEEccCcc
Confidence 345689999999 8899999987666699999999999999999999999999999999999994 889999999999
Q ss_pred eeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhH----------
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK---------- 222 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~---------- 222 (318)
+.......... .......++..|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus 161 ~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 161 TKVLPQDKEFF----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236 (295)
T ss_dssp CC-----------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred cccccCCccee----eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence 98654332111 1123345677899999999889999999999999999999999998754321100
Q ss_pred --HHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 223 --QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 223 --~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
.............+ ....+|+.+.+++..||+.+|++||++.++.+.|+.+.+
T Consensus 237 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 237 IVFHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 01111111111112 124678899999999999999999999999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=322.02 Aligned_cols=255 Identities=20% Similarity=0.258 Sum_probs=188.4
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.++| +++..+..++......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH-ENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCB-TTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCC-CCcceEEEEEEECCeEEEEE
Confidence 478999999999999999999999999999999876433 23568899999999976 66666666667777899999
Q ss_pred eccCCCHHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 83 DLLGPSLEDLFVYCR-----RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 83 e~~~~~L~~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|++.++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 83 e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 83 EFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp ECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEETT
T ss_pred EecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE---cCCCCEEECcCccceecC
Confidence 999989999987643 348899999999999999999999999999999999999 488999999999998764
Q ss_pred CCCCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC-
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST- 235 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~- 235 (318)
.+.. ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+.......+..........
T Consensus 160 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 232 (317)
T 2pmi_A 160 IPVN-------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL 232 (317)
T ss_dssp SCCC-------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred CCcc-------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence 3322 12344679999999998864 58999999999999999999999998876654443333322110000
Q ss_pred --------------------ch-----HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 --------------------PI-----EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 --------------------~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.. ......++..+.+++.+||..||++|||+.++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 0011245678899999999999999999887655
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=328.34 Aligned_cols=267 Identities=31% Similarity=0.494 Sum_probs=195.8
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcC---CCcEEEEEeecCCCC-------------ChhHHHHHHHHHHHcCCCCCC
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTK-------------HPQLLYEAKVYKILQGGSGIP 66 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~---~~~~vaiK~~~~~~~-------------~~~~~~e~~~l~~l~~~~~~~ 66 (318)
++.+++|++.+.||+|+||.||+|.+.. ++..||+|+...... ...+.+|+..+..+.| +++.
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h-~ni~ 111 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDY-LGIP 111 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSC-CCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccc-cCcc
Confidence 4567899999999999999999999987 778999998775432 1224455555665655 5555
Q ss_pred eeeecccc----CcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCC
Q 021053 67 NIKWYGVD----GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (318)
Q Consensus 67 ~i~~~~~~----~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~ 142 (318)
.+..++.. ....++|||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~ 187 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLG---YK 187 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---SS
T ss_pred eeecccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEc---cC
Confidence 55444433 67899999999999999987644 699999999999999999999999999999999999995 44
Q ss_pred C--eEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhh
Q 021053 143 N--QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 220 (318)
Q Consensus 143 ~--~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~ 220 (318)
+ .+||+|||++.....................+|..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 5 99999999998764332211111111234578999999999999999999999999999999999999996532211
Q ss_pred h-HHHHHHHHHhhccCchH--HHhh--cCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 221 K-KQKYDKICEKKVSTPIE--VLCK--SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 221 ~-~~~~~~i~~~~~~~~~~--~~~~--~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
. ...... ......+.. .... .+|..+.+++..||..+|++||++.++.+.|+++
T Consensus 268 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 268 VAVQTAKT--NLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHHH--HHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHHHH--hhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 1 111111 111122211 1111 6788999999999999999999999999988764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=326.97 Aligned_cols=264 Identities=20% Similarity=0.303 Sum_probs=214.2
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCC-------CcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeecc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT-------NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYG 72 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~-------~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~ 72 (318)
++..++|++++.||+|+||.||+|.+..+ +..||+|++...... ..+.+|+.++..+.+|+++..+..++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 45678999999999999999999997533 357999998765433 35788999999996668888887777
Q ss_pred ccCcceEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee
Q 021053 73 VDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 136 (318)
Q Consensus 73 ~~~~~~~lv~e~~-~~~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~ 136 (318)
......++|||++ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 224 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEE
Confidence 7778899999999 779999998743 248999999999999999999999999999999999999
Q ss_pred ccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccc
Q 021053 137 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQG 215 (318)
Q Consensus 137 ~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~ 215 (318)
+.++.+||+|||++.......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 225 ---~~~~~~kL~DFG~a~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 225 ---TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp ---CTTCCEEECSCSCCCCSSCCCTTC-----CCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ---cCCCcEEEcccCcccccccccccc-----cccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 488999999999998654332211 2234466788999999999999999999999999999999 9999987
Q ss_pred hhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcC
Q 021053 216 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (318)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~ 281 (318)
.+.... ...+.. ..... ....+++.+.+++..||+.+|++||++.++.+.|+.+.....
T Consensus 297 ~~~~~~---~~~~~~-~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 297 VPVEEL---FKLLKE-GHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp CCHHHH---HHHHHT-TCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred CCHHHH---HHHHHc-CCCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 654322 222221 11111 124678899999999999999999999999999999865443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=319.91 Aligned_cols=245 Identities=22% Similarity=0.318 Sum_probs=204.6
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+--++|++.+.||.|+||.||+|++..+++.||+|++... .....+.+|..++..+.| +++..+..++.+....
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-PFIIRMWGTFQDAQQI 81 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB-TTBCCEEEEEECSSEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCC-CCCceEeEEEEeCCEE
Confidence 3457899999999999999999999999999999987642 233456788889988865 6666776677777889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+|||++ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 82 ~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp EEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECS
T ss_pred EEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE---cCCCCEEEeecCcceecC
Confidence 9999999 7899999986 4469999999999999999999999999999999999999 588999999999998654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
... ....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......|
T Consensus 158 ~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~i~~~~~~~p- 223 (318)
T 1fot_A 158 DVT----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYEKILNAELRFP- 223 (318)
T ss_dssp SCB----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHCCCCCC-
T ss_pred Ccc----------ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-
Confidence 321 2447899999999999999999999999999999999999999875543 33444444443333
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
..++..+.+++.+||..+|.+|| +++++.+
T Consensus 224 ----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 224 ----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 35688999999999999999999 7776664
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=320.34 Aligned_cols=267 Identities=20% Similarity=0.246 Sum_probs=203.9
Q ss_pred ccccceeeEe-eeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 3 RIIGVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 3 ~~~~~~y~~~-~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
..+.++|++. +.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.++.++.+|+++..+..++......+
T Consensus 8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 3467899995 789999999999999999999999998865432 3468899999999777788888877777788999
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+|||++ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++....+||+|||++.....
T Consensus 88 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 999999 78999999873 4589999999999999999999999999999999999996322234499999999876542
Q ss_pred CCCCccccccCCCCCcccccccccccccC-----CCCCCcchHHHHHHHHHHHHhCCCCccchhHhh------------h
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLG-----IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT------------K 221 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~------------~ 221 (318)
................+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+ .
T Consensus 167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 246 (316)
T 2ac3_A 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ 246 (316)
T ss_dssp ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence 22111000111223458999999999875 457899999999999999999999997643211 1
Q ss_pred HHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
......+.......|.. .+..++..+.+++.+||..||++||++.++.+
T Consensus 247 ~~~~~~i~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 247 NMLFESIQEGKYEFPDK-DWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp HHHHHHHHHCCCCCCHH-HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHhccCcccCch-hcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 22334444444444433 34567889999999999999999999998776
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=322.17 Aligned_cols=272 Identities=22% Similarity=0.380 Sum_probs=206.6
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcC--------CCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCC-----------
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVD--------TNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGI----------- 65 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~----------- 65 (318)
.+++|++.+.||.|+||.||+|.+.. .++.||+|++... ..+.+|+.++.+++|++.+
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT---STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc---chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 36899999999999999999999987 4789999998754 4688999999999763322
Q ss_pred ---Ceeeeccc-cCcceEEEEeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCC
Q 021053 66 ---PNIKWYGV-DGEDNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR 140 (318)
Q Consensus 66 ---~~i~~~~~-~~~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~ 140 (318)
+.+..++. .....++|||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~--- 193 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD--- 193 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE---
T ss_pred cCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc---
Confidence 22333333 36788999999999999999874 35699999999999999999999999999999999999994
Q ss_pred CCC--eEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhH
Q 021053 141 KAN--QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA 218 (318)
Q Consensus 141 ~~~--~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~ 218 (318)
.++ .+||+|||++.....................+|+.|+|||++.+..++.++|||||||++|+|++|..||.....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 666 899999999976543322111111122345789999999999999999999999999999999999999987542
Q ss_pred h-hhHHHHHHHHHhhccCchHH--HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCC
Q 021053 219 A-TKKQKYDKICEKKVSTPIEV--LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGS 282 (318)
Q Consensus 219 ~-~~~~~~~~i~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~ 282 (318)
. .................... .+..+|..+.+++..||..||++||++.++.+.|.+++.+...
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 274 NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV 340 (352)
T ss_dssp CHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence 1 11111111111111111000 1124678999999999999999999999999999998876543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=332.01 Aligned_cols=209 Identities=22% Similarity=0.312 Sum_probs=175.7
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCC-----CCCCeeeeccccCc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGG-----SGIPNIKWYGVDGE 76 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~-----~~~~~i~~~~~~~~ 76 (318)
+.+..+|++.+.||.|+||.||+|.+..+++.||||++..... ...+.+|+.+++.+++. +++..+..++....
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 4577899999999999999999999999999999999876432 24577899999998754 34555556666678
Q ss_pred ceEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCe--EEEEeccce
Q 021053 77 DNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ--VYIIDFGLA 153 (318)
Q Consensus 77 ~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~--~kL~dfg~~ 153 (318)
..++|||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++ ..+. +||+|||++
T Consensus 173 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~---~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 173 HICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK---QQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEES---STTSCCEEECCCTTC
T ss_pred eEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEc---cCCCcceEEeecccc
Confidence 899999999999999988744 3489999999999999999999999999999999999994 5555 999999999
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHH
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK 224 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~ 224 (318)
....... ....+|+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....
T Consensus 250 ~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~ 310 (429)
T 3kvw_A 250 CYEHQRV----------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310 (429)
T ss_dssp EETTCCC----------CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred eecCCcc----------cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 7643322 244779999999999999999999999999999999999999988766544433
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=328.72 Aligned_cols=264 Identities=18% Similarity=0.263 Sum_probs=208.0
Q ss_pred CccccceeeEeeeeccCcccEEEEEEE-----cCCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccc
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~-----~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~ 73 (318)
.++..++|++.+.||+|+||.||+|.+ ..+++.||+|++...... ..+.+|+.++..++| +++..+..++.
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~ 144 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH-QNIVRCIGVSL 144 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEC
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCC-CCCCeEEEEEe
Confidence 356678999999999999999999994 456778999988654322 257789999999976 56666666666
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEE
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCR------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~k 146 (318)
.....++|||++ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.+.....+|
T Consensus 145 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 145 QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 777889999999 889999998754 3488999999999999999999999999999999999995333455699
Q ss_pred EEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHH
Q 021053 147 IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKY 225 (318)
Q Consensus 147 L~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~ 225 (318)
|+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...+... ..
T Consensus 225 L~DFG~a~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~ 296 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYY-----RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VL 296 (367)
T ss_dssp ECCCHHHHHHHHHSSC-----TTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH
T ss_pred ECCCcccccccccccc-----ccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH
Confidence 9999999754322111 12234567889999999998899999999999999999998 999998765432 22
Q ss_pred HHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 226 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
..+.......+ ...+|..+.+++..||+.+|++||++.++.+.+..+..
T Consensus 297 ~~i~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 297 EFVTSGGRMDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCC----CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 22222221111 23568899999999999999999999999999987643
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=319.26 Aligned_cols=265 Identities=19% Similarity=0.237 Sum_probs=204.9
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccc--cCcc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGV--DGED 77 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~--~~~~ 77 (318)
.+++++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.+++.++| +++..+..++. ....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-KNIVKLFAIEEETTTRH 83 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECTTTCC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CCcceEEEEeecCCCce
Confidence 467899999999999999999999999999999999876432 23467799999999986 45555543333 3347
Q ss_pred eEEEEecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecc-CCCCCeEEEEeccce
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL-GRKANQVYIIDFGLA 153 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~-~~~~~~~kL~dfg~~ 153 (318)
.++|||++ +++|.+++..... .+++..+..++.||+.||.|||++||+||||||+||++.. .+..+.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 89999999 7899999986433 2899999999999999999999999999999999999722 236678999999999
Q ss_pred eeecCCCCCccccccCCCCCccccccccccccc--------CCCCCCcchHHHHHHHHHHHHhCCCCccchhH-hhhHHH
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHL--------GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKA-ATKKQK 224 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~-~~~~~~ 224 (318)
........ .....+|+.|+|||++. +..++.++|||||||++|+|++|..||..... ......
T Consensus 164 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 235 (319)
T 4euu_A 164 RELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (319)
T ss_dssp EECCTTCC--------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred eecCCCCc--------eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence 87654332 12446899999999886 56789999999999999999999999975432 222333
Q ss_pred HHHHHHhhccC-------------------c-hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 225 YDKICEKKVST-------------------P-IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 225 ~~~i~~~~~~~-------------------~-~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
+..+....... + .......++..+.+++..||..||++||++.++.+...+.
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 44443322110 0 0011223456788999999999999999999998877654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-46 Score=323.73 Aligned_cols=256 Identities=24% Similarity=0.285 Sum_probs=190.0
Q ss_pred cceeeEe---eeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 6 GVKYKLG---RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 6 ~~~y~~~---~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
.++|++. +.||+|+||.||+|.+..+++.||+|++... ......+|+.++..+.+|+++..+..++.+....++||
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~ 85 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM 85 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence 4678886 8899999999999999999999999988653 23567889999999987788888888888888999999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++....+||+|||++........
T Consensus 86 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 86 ELLNGGELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp CCCCSCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred EccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 999 7799999987 45699999999999999999999999999999999999996333344899999999986543322
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHh----hhHHHHHHHHHhhccCch
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA----TKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~----~~~~~~~~i~~~~~~~~~ 237 (318)
. .....+|+.|+|||++.+..++.++|||||||++|+|++|..||...+.. ...+.+..+.......+
T Consensus 165 ~-------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~- 236 (325)
T 3kn6_A 165 P-------LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE- 236 (325)
T ss_dssp --------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC-
T ss_pred c-------ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC-
Confidence 1 13446789999999999999999999999999999999999999865432 11233333333333333
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+..+++.+.+++..||..||.+||++.++.+
T Consensus 237 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 2334578899999999999999999999987654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=323.77 Aligned_cols=245 Identities=22% Similarity=0.341 Sum_probs=205.6
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
..-++|++.+.||.|+||.||+|++..+++.||+|++... .....+.+|+.++..+.| +++..+..++......
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEE
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEcCCEE
Confidence 3457999999999999999999999999999999987532 233467889999998865 6666777777778889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+|||++ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECS
T ss_pred EEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE---CCCCCEEEcccccceecc
Confidence 9999999 88999999874 459999999999999999999999999999999999999 588999999999998654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
... ....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.. ..+..+.......|
T Consensus 193 ~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~p- 258 (350)
T 1rdq_E 193 GRT----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYEKIVSGKVRFP- 258 (350)
T ss_dssp SCB----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC-
T ss_pred CCc----------ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH---HHHHHHHcCCCCCC-
Confidence 322 2447899999999999999999999999999999999999999876543 34444444443333
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCC-----hHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~-----~~~l~~ 271 (318)
..++..+.+++.+||..||.+||+ ++++.+
T Consensus 259 ----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 259 ----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 357889999999999999999998 666654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=334.07 Aligned_cols=255 Identities=22% Similarity=0.276 Sum_probs=207.6
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecC-----CCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+..++|++.+.||+|+||+||+|++..+++.||+|++.. ......+.+|..++..+.| +++..+..++.+....
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~h-p~Iv~l~~~~~~~~~~ 149 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS-KWITTLHYAFQDDNNL 149 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCT-TTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEeeCCEE
Confidence 456899999999999999999999999999999998753 2234457889999988855 6777777777788899
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+||||+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE---cCCCCEEEcchhhhhhcc
Confidence 9999999 899999998755679999999999999999999999999999999999999 588999999999997764
Q ss_pred CCCCCccccccCCCCCccccccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~ 232 (318)
..... ......||+.|+|||++. ...++.++|||||||++|||++|++||.+.+... .+..+....
T Consensus 227 ~~~~~------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~---~~~~i~~~~ 297 (437)
T 4aw2_A 227 EDGTV------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE---TYGKIMNHK 297 (437)
T ss_dssp TTSCE------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTHH
T ss_pred cCCCc------ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH---HHHhhhhcc
Confidence 43321 123457899999999987 4568999999999999999999999998765533 333443322
Q ss_pred ccCchHHHhhcCchhHHHHHHHHhhcCCCC--CCChHHHHH
Q 021053 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKR 271 (318)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~--Rp~~~~l~~ 271 (318)
...+.+.....+++.+.+++.+||..+|++ ||+++++.+
T Consensus 298 ~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 298 ERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 222222222457889999999999888887 999988776
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=318.84 Aligned_cols=265 Identities=21% Similarity=0.322 Sum_probs=214.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEE-----cCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~-----~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
++..++|++.+.||.|+||.||+|.+ ..+++.||+|++..... ...+.+|+.++.++.+|+++..+..++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 98 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence 35568999999999999999999985 35678999999876543 24578899999999666778787777777
Q ss_pred CcceEEEEecc-CCCHHHHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCRR-----------------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 136 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~~-----------------~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~ 136 (318)
....++|||++ +++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (313)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEE
Confidence 78899999999 7799999986432 38899999999999999999999999999999999999
Q ss_pred ccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccc
Q 021053 137 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQG 215 (318)
Q Consensus 137 ~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~ 215 (318)
+ .++.+||+|||++.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 179 ~---~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 179 T---HGRITKICDFGLARDIKNDSNYV-----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp E---TTTEEEECCCGGGSCTTSCTTSE-----ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred c---CCCCEEEccccccccccccccce-----eccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 4 88999999999987655433211 1234456788999999998899999999999999999999 9999987
Q ss_pred hhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcC
Q 021053 216 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (318)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~ 281 (318)
..... ............+. ...+|..+.+++..||+.||.+||++.++.+.|++++.+..
T Consensus 251 ~~~~~---~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 251 MPVDS---KFYKMIKEGFRMLS---PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp CCSSH---HHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred ccchh---HHHHHhccCCCCCC---cccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 54322 12222222222221 23568899999999999999999999999999999876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=324.69 Aligned_cols=254 Identities=19% Similarity=0.250 Sum_probs=199.0
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++| +++..+..++......++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKH-ANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCC-TTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCC-CCCCeeeeEEeeCCEEEEEec
Confidence 589999999999999999999999999999998764332 2245679999999876 566666666677788999999
Q ss_pred ccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 84 LLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
++.++|.+++...+..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~-- 155 (324)
T 3mtl_A 81 YLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTK-- 155 (324)
T ss_dssp CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE---CTTCCEEECSSSEEECC-------
T ss_pred ccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE---CCCCCEEEccCcccccccCCcc--
Confidence 99999999998876679999999999999999999999999999999999999 4889999999999976543322
Q ss_pred cccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC-------
Q 021053 164 HIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST------- 235 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~------- 235 (318)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+..........
T Consensus 156 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 156 -----TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred -----ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhc
Confidence 1234467999999999886 568999999999999999999999998876655444443332211100
Q ss_pred ---------------chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 ---------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 ---------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
........+++.+.+++.+||..||.+|||+.++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 001112345778899999999999999999998776
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=332.72 Aligned_cols=254 Identities=20% Similarity=0.278 Sum_probs=207.3
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+..++|++.+.||+|+||.||+|.+. ++.||||+++.......+.+|+.++.+++|++.+..+..+.......++|||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 44588999999999999999999884 6799999998877777899999999999875555444444445557999999
Q ss_pred cc-CCCHHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 84 LL-GPSLEDLFVYCRRK-FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~-~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
++ +++|.+++...+.. ++...+..++.||+.||.|||++|++||||||+||++ +.++.+||+|||+++......
T Consensus 268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~- 343 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ- 343 (450)
T ss_dssp CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTSCEEECCCTTCEECC----
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---CCCCCEEEeeCCCcccccccc-
Confidence 99 78999999875443 6899999999999999999999999999999999999 488999999999998543221
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
....++..|+|||++.+..++.++|||||||++|+|++ |..||.+........ .+.. ....+ .
T Consensus 344 ---------~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~---~i~~-~~~~~---~ 407 (450)
T 1k9a_A 344 ---------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP---RVEK-GYKMD---A 407 (450)
T ss_dssp ------------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH---HHHT-TCCCC---C
T ss_pred ---------cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHc-CCCCC---C
Confidence 12255788999999999999999999999999999998 999998765433222 2221 11112 1
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
...+|+.+.+++..||+.+|++||++.++.+.|+++...
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 246788999999999999999999999999999987643
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=324.75 Aligned_cols=264 Identities=19% Similarity=0.264 Sum_probs=209.1
Q ss_pred cccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
+-.++|++.+.||.|+||.||+|.+. .++..||+|++.... ....+.+|+.++.++..|+++..+..++...
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 45689999999999999999999973 456789999886432 3457889999999996667777777777777
Q ss_pred cceEEEEecc-CCCHHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRR----------------------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 132 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~----------------------~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~ 132 (318)
...++|||++ +++|.+++..... .+++..+..++.||+.||.|||++||+||||||+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 8899999999 7899999986432 2788999999999999999999999999999999
Q ss_pred ceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCC
Q 021053 133 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSL 211 (318)
Q Consensus 133 Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~ 211 (318)
||+++ .++.+||+|||++.......... ......+|+.|+|||++.+..++.++|||||||++|+|+| |..
T Consensus 202 NIll~---~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~ 273 (344)
T 1rjb_A 202 NVLVT---HGKVVKICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273 (344)
T ss_dssp GEEEE---TTTEEEECCCGGGSCGGGCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred hEEEc---CCCcEEeCCCccCcccccCccce-----eccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCC
Confidence 99994 88999999999997654432211 1234456788999999998889999999999999999998 999
Q ss_pred CccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcC
Q 021053 212 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (318)
Q Consensus 212 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~ 281 (318)
||.+..... .+..........+. ...+++.+.+++..||+.||.+||++.++.+.|..++....
T Consensus 274 p~~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 337 (344)
T 1rjb_A 274 PYPGIPVDA---NFYKLIQNGFKMDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE 337 (344)
T ss_dssp SSTTCCCSH---HHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred CcccCCcHH---HHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence 998754322 12222222222221 23568899999999999999999999999999998765433
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=323.51 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=197.9
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCC-CCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGG-SGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~-~~~~~i~~~~~~~~~~ 78 (318)
+.+++|++.+.||+|+||.||+|.+. +++.||+|++...... ..+.+|+.++..+.|+ +++..+..++......
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 56889999999999999999999884 5889999988754432 3567899999999864 7788887777788899
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 79 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
++|||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll----~~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 85 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEECCCSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----ETTEEEECCCSSSCCC--
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE----ECCcEEEeecccccccCc
Confidence 99999889999999987 4568999999999999999999999999999999999999 467899999999976543
Q ss_pred CCCCccccccCCCCCcccccccccccccC-----------CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHH
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLG-----------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (318)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ...+..
T Consensus 160 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~ 232 (343)
T 3dbq_A 160 DTTSV-----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHA 232 (343)
T ss_dssp ---------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHH
T ss_pred ccccc-----cCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--HHHHHH
Confidence 32211 1234578999999999864 56888999999999999999999999764322 122222
Q ss_pred HHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
+....... .+....+..+.+++..||..||.+||++.++.+.
T Consensus 233 ~~~~~~~~---~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 233 IIDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp HHCTTSCC---CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhcCCccc---CCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 22211111 1223456789999999999999999999988763
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=329.45 Aligned_cols=255 Identities=19% Similarity=0.171 Sum_probs=196.9
Q ss_pred cceeeEe-eeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccc----cCcceEE
Q 021053 6 GVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGEDNVL 80 (318)
Q Consensus 6 ~~~y~~~-~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~----~~~~~~l 80 (318)
-++|.+. +.||.|+||.||+|.+..+++.||||++.. .....+|+.++.++.+|+++..+..++. .....|+
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~---~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~l 136 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc---chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEE
Confidence 3556665 799999999999999999999999999863 3567889999877777788777755433 2567899
Q ss_pred EEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 81 VLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++..+.++.+||+|||++.....
T Consensus 137 v~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~ 216 (400)
T 1nxk_A 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216 (400)
T ss_dssp EEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred EEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCC
Confidence 99999 789999998643 3489999999999999999999999999999999999995322378999999999986543
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhH-HHHHHHHHhhccCch
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK-QKYDKICEKKVSTPI 237 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~-~~~~~i~~~~~~~~~ 237 (318)
... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..... .....+.......+.
T Consensus 217 ~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~ 288 (400)
T 1nxk_A 217 HNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN 288 (400)
T ss_dssp ------------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred CCc--------cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence 221 12456799999999999999999999999999999999999999765432211 122233333333332
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
. .+..++..+.+++..||..||++||++.++.++
T Consensus 289 ~-~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 289 P-EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp T-TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred c-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 2 234678899999999999999999999988773
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=319.39 Aligned_cols=262 Identities=22% Similarity=0.319 Sum_probs=198.6
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-----hhHHHHHHHHHHHcCCCCCCeeeeccccC-
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDG- 75 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~- 75 (318)
...+.++|++.+.||+|+||.||+|++..+++.||+|++...... ..+.+|+.++..++| +++..+..++...
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~ 85 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH-PAIVAVYDTGEAET 85 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCC-TTBCCEEEEEEEEE
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCC-CCcceEEEeeeccC
Confidence 356789999999999999999999999999999999998764332 246778888888866 4555554443322
Q ss_pred ---cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecc
Q 021053 76 ---EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (318)
Q Consensus 76 ---~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg 151 (318)
...|+|||++ +++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||
T Consensus 86 ~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~---~~~~~kl~Dfg 161 (311)
T 3ork_A 86 PAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFG 161 (311)
T ss_dssp TTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---TTSCEEECCCS
T ss_pred CCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEc---CCCCEEEeecc
Confidence 2359999999 78999999863 4599999999999999999999999999999999999994 88999999999
Q ss_pred ceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh
Q 021053 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (318)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~ 231 (318)
++.......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.... ......
T Consensus 162 ~a~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~---~~~~~~- 233 (311)
T 3ork_A 162 IARAIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV---AYQHVR- 233 (311)
T ss_dssp CC----------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHH-
T ss_pred Cccccccccccc----ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHhc-
Confidence 997654332211 112345689999999999999999999999999999999999999987655322 222222
Q ss_pred hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChH-HHHHHHHHH
Q 021053 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYG-FLKRLFHDL 276 (318)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~-~l~~~l~~~ 276 (318)
....+.......+|..+.+++.+||+.||++||+.. .+...+...
T Consensus 234 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 234 EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 233444455567899999999999999999999655 455555443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=330.93 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=204.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+..++|++.+.||+|+||.||+|+++.+++.||+|++... .....+.+|..++..+.| +++..+..++.+....
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~h-p~Iv~l~~~~~~~~~~ 136 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR-RWITQLHFAFQDENYL 136 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCT-TTBCCEEEEEECSSEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCC-CCeeeEEEEEeeCCEE
Confidence 4568999999999999999999999999999999987532 223457889999988765 6777777777888899
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+||||+ +++|.+++...+..+++..++.++.||+.||.|||++||+||||||+||++ +..+.+||+|||++....
T Consensus 137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL---DRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee---cCCCCEEEeechhheecc
Confidence 9999999 899999998766679999999999999999999999999999999999999 588999999999998765
Q ss_pred CCCCCccccccCCCCCccccccccccccc-------CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHH
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHL-------GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~ 230 (318)
..... ......||+.|+|||++. +..++.++|||||||++|||++|.+||.+.+.. +.+..+..
T Consensus 214 ~~~~~------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~ 284 (412)
T 2vd5_A 214 ADGTV------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA---ETYGKIVH 284 (412)
T ss_dssp TTSCE------ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHT
T ss_pred CCCcc------ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH---HHHHHHHh
Confidence 43321 112457899999999987 456899999999999999999999999876553 33334433
Q ss_pred hhccCchHHHhhcCchhHHHHHHHHhhcCCCCC---CChHHHHH
Q 021053 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR---PDYGFLKR 271 (318)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R---p~~~~l~~ 271 (318)
.......+.....+|..+.+++++||. +|.+| |+++++.+
T Consensus 285 ~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 285 YKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred cccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 221111122234678999999999999 99998 57777655
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=312.80 Aligned_cols=257 Identities=19% Similarity=0.279 Sum_probs=209.3
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+-.++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+|+.++.+++| +++..+..++......++||
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 84 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVF 84 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSEEEEE
T ss_pred eChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCceEEEE
Confidence 45689999999999999999999986 467799998876543 3568899999999986 66666666667777899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|++ +++|.+++......++...+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 85 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHH
T ss_pred EeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE---cCCCCEEecccccccccccccc
Confidence 999 789999998766668999999999999999999999999999999999999 4788999999999875432211
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
. ......++..|+|||++.+..++.++||||+|+++|+|++ |..||...+... ....+... .... .
T Consensus 162 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~~~~~~~-~~~~---~ 228 (269)
T 4hcu_A 162 T------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTG-FRLY---K 228 (269)
T ss_dssp H------STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTT-CCCC---C
T ss_pred c------cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhcC-ccCC---C
Confidence 1 1234456778999999998889999999999999999999 999998765432 22222222 1111 1
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
....++.+.+++..||+.+|++||++.++.+.|.++.+
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 23457889999999999999999999999999998754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=326.70 Aligned_cols=253 Identities=21% Similarity=0.295 Sum_probs=198.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcC-CCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQG-GSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~-~~~~~~i~~~~~~~~~~ 78 (318)
+.+++|++.+.||.|+||.||+|.+.. ++.||||++...... ..+.+|+.++..+.+ ++++..+..++......
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~ 131 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 131 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence 345779999999999999999999865 889999988654432 357889999999986 67888887777777889
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 79 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
++|||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ .++.+||+|||++.....
T Consensus 132 ~lv~E~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll----~~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 132 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEECCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE----SSSCEEECCCSSSCCC--
T ss_pred EEEEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE----ECCeEEEEecCccccccC
Confidence 99999779999999987 4468999999999999999999999999999999999999 458899999999986543
Q ss_pred CCCCccccccCCCCCcccccccccccccC-----------CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHH
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLG-----------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (318)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ...+..
T Consensus 207 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--~~~~~~ 279 (390)
T 2zmd_A 207 DTTSV-----VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHA 279 (390)
T ss_dssp ------------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH--HHHHHH
T ss_pred CCccc-----cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH--HHHHHH
Confidence 32211 1234578999999999875 35888999999999999999999999764322 222333
Q ss_pred HHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
+.......+ +....+..+.+++..||..||.+||++.++.+.
T Consensus 280 ~~~~~~~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 280 IIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp HHCTTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HhCccccCC---CCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 332222211 122346789999999999999999999988763
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=322.94 Aligned_cols=254 Identities=23% Similarity=0.275 Sum_probs=194.9
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
..++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.++| +++..+..++......++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCC-CCCCcEEEEEeeCCEEEEEEE
Confidence 35899999999999999999999999999999998875443 4578899999999976 666667666677788999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
|+ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++. +..+.+||+|||++........
T Consensus 97 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~-~~~~~~kl~Dfg~a~~~~~~~~- 173 (361)
T 3uc3_A 97 YASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQ- 173 (361)
T ss_dssp CCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS-SSSCCEEECCCCCC---------
T ss_pred eCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC-CCCceEEEeecCccccccccCC-
Confidence 99 8899999876 345999999999999999999999999999999999999941 1233599999999874332211
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCc-chHHHHHHHHHHHHhCCCCccchhHhh-hHHHHHHHHHhhccCchHHH
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRR-DDLESLGYVLLYFLRGSLPWQGLKAAT-KKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslG~il~~l~tg~~pf~~~~~~~-~~~~~~~i~~~~~~~~~~~~ 240 (318)
.....+|+.|+|||++.+..++.+ +|||||||++|+|++|..||.+..... ....+..+.......|..
T Consensus 174 -------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 244 (361)
T 3uc3_A 174 -------PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD-- 244 (361)
T ss_dssp --------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTT--
T ss_pred -------CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCc--
Confidence 134568999999999988887655 899999999999999999998754422 223333333333333322
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
..+++.+.+++.+||..+|.+|||+.++.++
T Consensus 245 -~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 245 -IRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -SCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -CCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 2568899999999999999999999988763
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=310.28 Aligned_cols=255 Identities=24% Similarity=0.292 Sum_probs=208.6
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
..+.++|++.+.||.|+||.||+|.+..+++.||+|++...... ..+.+|+.++..++| +++..+..+.......
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH-PNIVRLHDSIQEESFH 80 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCC-CCcCeEEEEEEcCCEE
Confidence 35789999999999999999999999999999999987654322 356789999999976 6666666666777789
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
++|||++ +++|.+.+.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++..+.+||+|||.+....
T Consensus 81 ~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999 7799888876 3558999999999999999999999999999999999999643344569999999997655
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
.... .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+... ....+.......+.
T Consensus 160 ~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 228 (284)
T 3kk8_A 160 DSEA--------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQIKAGAYDYPS 228 (284)
T ss_dssp SSCB--------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCCCCCT
T ss_pred cCcc--------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---HHHHHHhccccCCc
Confidence 3322 124568999999999999999999999999999999999999998765433 23333333333333
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+ ....+++.+.+++..||+.+|++||++.++.+
T Consensus 229 ~-~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 229 P-EWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp T-TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred h-hhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 2 23467889999999999999999999998876
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=320.21 Aligned_cols=249 Identities=22% Similarity=0.320 Sum_probs=193.8
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeecccc-----C
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVD-----G 75 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~-----~ 75 (318)
+.++|++.+.||.|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++.+..+..+... .
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 568999999999999999999999999999999988654332 3567899999999864444333333222 1
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..+|+|||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++.
T Consensus 103 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 103 TDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ 177 (367)
T ss_dssp CCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred ceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE---cCCCCEEEEeeecccc
Confidence 45799999999999999885 458999999999999999999999999999999999999 4889999999999987
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
..... ....+|+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+..+.. ..+......
T Consensus 178 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~ 244 (367)
T 1cm8_A 178 ADSEM----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL---KEIMKVTGT 244 (367)
T ss_dssp CCSSC----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCC
T ss_pred ccccc----------CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCC
Confidence 54322 24467999999999887 67999999999999999999999999886654433 333332222
Q ss_pred CchH--------------------------HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 235 TPIE--------------------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 235 ~~~~--------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
++.+ ......++.+.+++.+||..||++|||+.++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 2221 112345778999999999999999999998776
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=334.17 Aligned_cols=249 Identities=20% Similarity=0.252 Sum_probs=191.8
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccc-----cC
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV-----DG 75 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~-----~~ 75 (318)
+.++|++++.||.|+||.||+|.+..+++.||||++..... ...+.+|+.+++.++|++.+..+..+.. ..
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 45899999999999999999999999999999998865422 2357789999999977544433333322 22
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
...|+|||++.++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++.
T Consensus 140 ~~~~lv~E~~~~~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 140 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 213 (464)
T ss_dssp CEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC--
T ss_pred CeEEEEEeCCCCCHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeeee
Confidence 4679999999888888775 348999999999999999999999999999999999999 5889999999999986
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
...... .....+|+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+... .+......+
T Consensus 214 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~---~i~~~lg~p 282 (464)
T 3ttj_A 214 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN---KVIEQLGTP 282 (464)
T ss_dssp ---CCC--------C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCSC
T ss_pred cCCCcc--------cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCC
Confidence 543221 234578999999999999999999999999999999999999999876544333 333322222
Q ss_pred chHHHhhc--------------------------------------CchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 PIEVLCKS--------------------------------------HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 ~~~~~~~~--------------------------------------~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+.+ .... .++.+.+++.+||..||++|||+.++.+
T Consensus 283 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 283 CPE-FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CHH-HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHH-HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 211 1111 1456889999999999999999988765
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=311.59 Aligned_cols=257 Identities=16% Similarity=0.206 Sum_probs=210.0
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++..++|++.+.||+|+||.||+|.+. ++..||+|++..... ...+.+|+.++..++| +++..+..++......++|
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 81 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSH-PKLVKFYGVCSKEYPIYIV 81 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSEEEE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCceEEE
Confidence 466799999999999999999999876 466799998876543 3568899999999986 6666666666777789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||++ +++|.+++......+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||.+.......
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 82 TEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE---CTTCCEEECCTTCEEECCTTC
T ss_pred EEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE---CCCCCEEEccCccceecchhh
Confidence 9999 889999998766679999999999999999999999999999999999999 488999999999998665433
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+..... ..+..... ...
T Consensus 159 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~~~~~~~~-~~~-- 226 (268)
T 3sxs_A 159 YV------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV---LKVSQGHR-LYR-- 226 (268)
T ss_dssp EE------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HHHHTTCC-CCC--
T ss_pred hh------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH---HHHHcCCC-CCC--
Confidence 21 1123455778999999998889999999999999999999 99999876543222 22222111 111
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
....++.+.+++..||+.+|++||++.++.+.|+.+.
T Consensus 227 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 227 -PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp -CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred -CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1345788999999999999999999999999998763
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=313.99 Aligned_cols=259 Identities=21% Similarity=0.314 Sum_probs=197.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCC---CcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~---~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
++..++|++.+.||+|+||.||+|.+..+ +..||+|+...... ...+.+|+.++..++| +++..+..+. ...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~-~~~ 88 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVI-TEN 88 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEE-CSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CccceEEEEE-ccC
Confidence 46779999999999999999999998643 45799998765432 2357789999999976 4555554443 345
Q ss_pred ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..++|||++ +++|.+++......+++..+..++.|++.||.|||++|++||||||+||+++ .++.+||+|||++..
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 89 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRY 165 (281)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEEC---CCCCEEECccccccc
Confidence 689999999 6799999987655699999999999999999999999999999999999994 789999999999876
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+...... ...+.... .
T Consensus 166 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i~~~~-~ 235 (281)
T 1mp8_A 166 MEDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRIENGE-R 235 (281)
T ss_dssp -------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHHHTTC-C
T ss_pred cCccccc------ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHHHcCC-C
Confidence 5433221 1123456778999999998889999999999999999997 9999987654332 22222211 1
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
.+ ....+|+.+.+++..||+.+|++||++.++.+.|.+++.+
T Consensus 236 ~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 236 LP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11 2246788999999999999999999999999999998754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=314.84 Aligned_cols=260 Identities=18% Similarity=0.293 Sum_probs=209.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++..++|++.+.||.|+||.||+|.+. ++..||+|++..... ...+.+|+.++..+.| +++..+..++......++|
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 97 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKLVQLYGVCTKQRPIFII 97 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCC-CCEeeEEEEEecCCCeEEE
Confidence 355689999999999999999999876 567899998876543 3568899999999986 6666666666777789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||++ +++|.+++......+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||.+.......
T Consensus 98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHH
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE---cCCCCEEEccccccccccccc
Confidence 9999 889999998756679999999999999999999999999999999999999 488899999999987553221
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..... ..+.... ....
T Consensus 175 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~~~~-~~~~-- 242 (283)
T 3gen_A 175 YT------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---EHIAQGL-RLYR-- 242 (283)
T ss_dssp HH------STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---HHHHTTC-CCCC--
T ss_pred cc------cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH---HHHhccc-CCCC--
Confidence 11 1233456788999999998889999999999999999998 99999876553322 2222221 1111
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhc
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~ 280 (318)
....++.+.+++..||+.+|++||++.++.+.|.++++++
T Consensus 243 -~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~e 282 (283)
T 3gen_A 243 -PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEE 282 (283)
T ss_dssp -CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred -CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence 1345788999999999999999999999999999987654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=312.30 Aligned_cols=254 Identities=17% Similarity=0.287 Sum_probs=200.8
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC---------hhHHHHHHHHHHHcCCCCCCeeeecc
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---------PQLLYEAKVYKILQGGSGIPNIKWYG 72 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~---------~~~~~e~~~l~~l~~~~~~~~i~~~~ 72 (318)
..+..++|++.+.||.|+||.||+|++..+++.||+|++...... ..+.+|+.++..++| +++..+..+.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~ 92 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNH-PNIVKLYGLM 92 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCC-TTBCCEEEEE
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCC-CCchhhheee
Confidence 356789999999999999999999999999999999987643321 467889999999976 5555554443
Q ss_pred ccCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeeccCCCCCe-----
Q 021053 73 VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQ----- 144 (318)
Q Consensus 73 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~Nil~~~~~~~~~----- 144 (318)
.. ..++|||++ +++|.+.+......+++..+..++.|++.||.|||++| ++||||||+||+++ ..+.
T Consensus 93 ~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~---~~~~~~~~~ 167 (287)
T 4f0f_A 93 HN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQ---SLDENAPVC 167 (287)
T ss_dssp TT--TTEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEES---CCCTTCSCC
T ss_pred cC--CCeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEe---ccCCCCcee
Confidence 33 347999999 78999998776667999999999999999999999999 99999999999995 4444
Q ss_pred EEEEeccceeeecCCCCCccccccCCCCCccccccccccccc--CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhH
Q 021053 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL--GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK 222 (318)
Q Consensus 145 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~ 222 (318)
+||+|||.+...... .....+|+.|+|||++. ...++.++|||||||++|+|++|..||...+... .
T Consensus 168 ~kl~Dfg~~~~~~~~----------~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~ 236 (287)
T 4f0f_A 168 AKVADFGLSQQSVHS----------VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-I 236 (287)
T ss_dssp EEECCCTTCBCCSSC----------EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCH-H
T ss_pred EEeCCCCcccccccc----------ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccH-H
Confidence 999999998743322 12456899999999984 4457889999999999999999999997654322 1
Q ss_pred HHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
.....+....... .....+|+.+.+++..||+.||++||++.++.+.|++
T Consensus 237 ~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 237 KFINMIREEGLRP---TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHHHHHHSCCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HHHHHHhccCCCC---CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 1122222222222 2234678899999999999999999999999998864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=325.14 Aligned_cols=254 Identities=26% Similarity=0.289 Sum_probs=205.5
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecC-----CCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
...-++|++.+.||+|+||.||+|.+..+++.||+|++.. ......+.+|+.+++.++| +++..+..++.....
T Consensus 5 ~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 5 KRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-PHIIKLYDVITTPTD 83 (336)
T ss_dssp CSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCC-TTBCCEEEEEECSSE
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCE
Confidence 3455789999999999999999999999999999998653 2334578899999999876 566666666677778
Q ss_pred eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 78 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
.++||||++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 84 ~~lv~E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 84 IVMVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp EEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE---CTTCCEEECCSSCTBTTT
T ss_pred EEEEEECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE---cCCCCEEEEEeccceecc
Confidence 9999999999999998763 459999999999999999999999999999999999999 588999999999987543
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
.... .....||+.|+|||++.+..+ ++++|||||||++|+|++|..||.+....... ..+......
T Consensus 160 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---~~i~~~~~~-- 226 (336)
T 3h4j_B 160 DGNF--------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---KKVNSCVYV-- 226 (336)
T ss_dssp TSBT--------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---CCCCSSCCC--
T ss_pred CCcc--------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---HHHHcCCCC--
Confidence 3221 234568999999999998876 78999999999999999999999875432211 111111111
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
....+|+.+.+++.+||..||.+|||+.++.+ +.++..
T Consensus 227 ---~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~~ 264 (336)
T 3h4j_B 227 ---MPDFLSPGAQSLIRRMIVADPMQRITIQEIRR--DPWFNV 264 (336)
T ss_dssp ---CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT--CHHHHT
T ss_pred ---CcccCCHHHHHHHHHHcCCChhHCcCHHHHHh--Chhhcc
Confidence 22356889999999999999999999998876 344443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=315.54 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=207.9
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--------ChhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
+.+.++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.++..+.| +++..+..++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~ 86 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLH-HNVITLHDVYEN 86 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEEC
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCC-CCcceEEEEEec
Confidence 4567899999999999999999999999999999998765432 2357899999999986 556666666667
Q ss_pred CcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCC----eEEEEe
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN----QVYIID 149 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~----~~kL~d 149 (318)
....++|||++ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++. ..+ .+||+|
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~---~~~~~~~~~kl~D 162 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL---DKNIPIPHIKLID 162 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES---CTTSSSCCEEECC
T ss_pred CCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEe---cCCCCcCCEEEcc
Confidence 78899999999 8899999976 44589999999999999999999999999999999999995 444 799999
Q ss_pred ccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHH
Q 021053 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (318)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~ 229 (318)
||.+........ .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+... .+..+.
T Consensus 163 fg~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~ 231 (321)
T 2a2a_A 163 FGLAHEIEDGVE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLANIT 231 (321)
T ss_dssp CTTCEECCTTCC--------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH
T ss_pred CccceecCcccc--------ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH
Confidence 999987654322 134468999999999999999999999999999999999999998765432 333333
Q ss_pred HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..... .........+..+.+++..||..||++||++.++.+
T Consensus 232 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 232 SVSYD-FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp TTCCC-CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred hcccc-cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 33322 334445678889999999999999999999998876
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=320.72 Aligned_cols=255 Identities=26% Similarity=0.314 Sum_probs=203.1
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
..-+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++| +++..+..++......
T Consensus 2 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~ 80 (323)
T 3tki_A 2 AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNIQ 80 (323)
T ss_dssp CCTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred CCcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCC-CCCCeEEEEEecCCeE
Confidence 34466899999999999999999999999999999998764332 3568899999999976 5666666666777889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
++|||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +..+.+||+|||++....
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFR 156 (323)
T ss_dssp EEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECE
T ss_pred EEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE---eCCCCEEEEEeeccceec
Confidence 9999999 7799998875 3459999999999999999999999999999999999999 488999999999997654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...+.... .+..........+
T Consensus 157 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 229 (323)
T 3tki_A 157 YNNRER-----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTYLN 229 (323)
T ss_dssp ETTEEC-----CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH--HHHHHHTTCTTST
T ss_pred cCCccc-----ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHhcccccCC
Confidence 332211 1234578999999999988775 7789999999999999999999986543211 1112111111111
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+..++..+.+++.+||..||++||++.++.+
T Consensus 230 ---~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 230 ---PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 12467889999999999999999999998765
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=315.93 Aligned_cols=249 Identities=23% Similarity=0.334 Sum_probs=196.0
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEc---CCCcEEEEEeecCCC------CChhHHHHHHHHHHHcCCCCCCeeeeccc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGT------KHPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~---~~~~~vaiK~~~~~~------~~~~~~~e~~~l~~l~~~~~~~~i~~~~~ 73 (318)
.+..++|++.+.||.|+||.||+|++. .+++.||+|++.... ....+.+|+.+++.++| +++..+..++.
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~ 91 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKH-PFIVDLIYAFQ 91 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCC-TTBCCEEEEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCC-CCccceeEEEE
Confidence 466789999999999999999999985 678999999876542 23456789999999976 56666666667
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
.....|+|||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML---NHQGHVKLTDFGL 167 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE---CTTSCEEECCCSC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE---CCCCcEEEEeCCc
Confidence 778899999999 7899999876 3458999999999999999999999999999999999999 4889999999999
Q ss_pred eeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~ 232 (318)
+........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+....
T Consensus 168 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~~~ 237 (327)
T 3a62_A 168 CKESIHDGT-------VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK---KTIDKILKCK 237 (327)
T ss_dssp C-----------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHTC
T ss_pred ccccccCCc-------cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCC
Confidence 875432221 113456899999999999999999999999999999999999999876543 3334444443
Q ss_pred ccCchHHHhhcCchhHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
...| ..++..+.+++.+||..||.+|| ++.++.+
T Consensus 238 ~~~p-----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 238 LNLP-----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CCCC-----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CCCC-----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 3333 35688999999999999999999 5555544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=316.06 Aligned_cols=261 Identities=23% Similarity=0.347 Sum_probs=197.0
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
.++.+++|++.+.||+|+||.||+|.+.. .||+|+++..... ..+.+|+.+++.++|++ +..+..+. ....
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~-iv~~~~~~-~~~~ 93 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN-ILLFMGYS-TAPQ 93 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTT-BCCEEEEE-CSSS
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCc-EEEEEeec-cCCc
Confidence 47889999999999999999999998643 5999988755433 35778999999988754 44444443 4456
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++|||++ +++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++...
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~---~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 94 LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLH---EDNTVKIGDFGLATEK 170 (289)
T ss_dssp CEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---TTTEEEECCCC-----
T ss_pred cEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEEC---CCCCEEEccceecccc
Confidence 89999999 7899999976566799999999999999999999999999999999999994 8899999999998755
Q ss_pred cCCCCCccccccCCCCCccccccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
....... ......+|+.|+|||++. +..++.++|||||||++|+|++|+.||........ ....+.....
T Consensus 171 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~~~ 243 (289)
T 3og7_A 171 SRWSGSH-----QFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRGSL 243 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHHTSC
T ss_pred ccccccc-----cccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhccccc
Confidence 4322111 123456899999999987 55688899999999999999999999987544322 2222223333
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
..+.......+|+.+.+++..||+.+|++||++.++.+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 34444445577889999999999999999999999999998763
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=308.30 Aligned_cols=253 Identities=24% Similarity=0.265 Sum_probs=208.6
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC--CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
-+.++|++.+.||+|+||.||+|.+..++..||+|++... .....+.+|+.+++.++| +++..+..++......++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH-PNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCC-CCEeeEEEEEecCCeEEEE
Confidence 4678999999999999999999999999999999987653 234578899999999965 6666676666777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||++ +++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||++..++..+.++|+|||.+.......
T Consensus 85 ~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 85 MELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp EECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred EeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999 7899998876 4458999999999999999999999999999999999999544578899999999998655332
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
. .....+|+.|+|||++.+. ++.++||||||+++|+|++|..||...+.. .....+.......+. ..
T Consensus 164 ~--------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~-~~ 230 (277)
T 3f3z_A 164 M--------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS---EVMLKIREGTFTFPE-KD 230 (277)
T ss_dssp C--------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCCH-HH
T ss_pred c--------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCCCCCCc-hh
Confidence 2 1345689999999998764 899999999999999999999999876543 233334334444443 33
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+..+++.+.+++.+||+.+|++||++.++.+
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 231 WLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred hhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 4578899999999999999999999998765
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=318.40 Aligned_cols=256 Identities=24% Similarity=0.278 Sum_probs=200.1
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeecccc-------C
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVD-------G 75 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~-------~ 75 (318)
++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.++..++|++.+..+..+... .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 789999999999999999999999999999998754432 23678899999999875444443333221 4
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
...++|||++.++|.+.+......+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 97 ~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 97 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARA 173 (351)
T ss_dssp CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhccc
Confidence 5689999999989999988766679999999999999999999999999999999999999 4889999999999987
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
......... .......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+..... .
T Consensus 174 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---~ 247 (351)
T 3mi9_A 174 FSLAKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG---S 247 (351)
T ss_dssp CCCCSSSSC---CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC---C
T ss_pred ccccccccc---cccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC---C
Confidence 653322111 122345779999999998764 589999999999999999999999998766554444444332 2
Q ss_pred CchHHHh---------------------------hcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 235 TPIEVLC---------------------------KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 235 ~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+...+. ...++.+.+++.+||..||++||++.++.+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 2211110 012556889999999999999999988776
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=312.94 Aligned_cols=254 Identities=23% Similarity=0.312 Sum_probs=195.9
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
-++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.++..++| +++..+..++......++|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH-PNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCC-CCccchhheeecCCeEEEE
Confidence 47899999999999999999999999999999987655443 246789999999986 5566666666677889999
Q ss_pred EeccC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLLG-PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||++. ++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 81 FEYCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EECCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC---
T ss_pred EEeCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcc
Confidence 99995 455555543 5569999999999999999999999999999999999999 488999999999998765332
Q ss_pred CCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc-----
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS----- 234 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~----- 234 (318)
.. .....++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+........+
T Consensus 157 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (311)
T 4agu_A 157 DY-------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV 229 (311)
T ss_dssp ----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred cc-------cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence 21 134467899999999876 56899999999999999999999999887665444443332211000
Q ss_pred ------------------CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 235 ------------------TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 235 ------------------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+.......++..+.+++..||+.||++|||+.++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0111222456778999999999999999999998776
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=344.43 Aligned_cols=244 Identities=20% Similarity=0.291 Sum_probs=208.5
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecC-----CCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+--++|++.+.||+|+||.||+|++..+++.||||++.. .........|..++..+.+|+++..+..++......
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 345789999999999999999999999999999998763 234556788999998888889999998888888899
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 418 ~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML---DSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE---CSSSCEEECCCTTCEECC
T ss_pred EEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE---cCCCcEEEeecceeeccc
Confidence 9999999 88999999874 459999999999999999999999999999999999999 588999999999998643
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
.... ......||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+. .+.+..+.......|
T Consensus 494 ~~~~-------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~---~~~~~~i~~~~~~~p- 562 (674)
T 3pfq_A 494 WDGV-------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIMEHNVAYP- 562 (674)
T ss_dssp CTTC-------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHSSCCCCC-
T ss_pred cCCc-------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH---HHHHHHHHhCCCCCC-
Confidence 3222 12355789999999999999999999999999999999999999988654 344555554444443
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCCh
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 266 (318)
..++..+.+++..||..||++||++
T Consensus 563 ----~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 563 ----KSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ----TTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ----ccCCHHHHHHHHHHccCCHHHCCCC
Confidence 3578899999999999999999987
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=317.62 Aligned_cols=280 Identities=17% Similarity=0.247 Sum_probs=209.4
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCC----cEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~----~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
++...+|++.+.||+|+||.||+|.+..++ ..||+|++...... ..+.+|+.++..++| +++..+..+....
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH-HNIIRLEGVISKY 118 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEecC
Confidence 566789999999999999999999987543 45999998754432 257789999999976 5666666666677
Q ss_pred cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
...++|||++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+.
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~ 195 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLSR 195 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC--
T ss_pred CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE---CCCCcEEECCCCcch
Confidence 7899999999 679999998766679999999999999999999999999999999999999 488999999999997
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
.......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||...+... ....+... .
T Consensus 196 ~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~~~~~~-~ 267 (333)
T 1mqb_A 196 VLEDDPEATY----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKAINDG-F 267 (333)
T ss_dssp -------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTT-C
T ss_pred hhcccccccc----ccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHHCC-C
Confidence 6543321110 1123345778999999998899999999999999999999 999998755432 22222221 1
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCchhHHHhhhcCCccccc
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMSYCSLHSITF 299 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~l~~~p~~r~t~ 299 (318)
..+. ...+|..+.+++.+||+.+|++||++.++.+.|++++. ..+.++.+..++|..|+..
T Consensus 268 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~--~~~~~~~~~~~~p~~~~~~ 328 (333)
T 1mqb_A 268 RLPT---PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR--APDSLKTLADFDPRVSIRL 328 (333)
T ss_dssp CCCC---CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH--SGGGGGSBCCC--------
T ss_pred cCCC---cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh--cchhhhhhcCCCccchhhC
Confidence 2221 23578899999999999999999999999999999874 3455566677788766543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=325.10 Aligned_cols=260 Identities=18% Similarity=0.224 Sum_probs=200.9
Q ss_pred ccceeeEeeeeccC--cccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 5 IGVKYKLGRKIGSG--SFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 5 ~~~~y~~~~~lg~G--~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
.+++|++.+.||.| +||.||+|++..+++.||+|++...... ..+.+|+.+++.++| +++..+..++......
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNH-PNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCC-CCCCcEeEEEEECCEE
Confidence 35899999999999 9999999999999999999988654322 346779999999976 5666666666777889
Q ss_pred EEEEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 79 VLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
++|||++ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCGGGCEEC
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEcccccceee
Confidence 9999999 78999998764 2458999999999999999999999999999999999999 48899999999998765
Q ss_pred cCCCCCccccccCCCCCcccccccccccccC--CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc-
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV- 233 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~- 233 (318)
..................+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..... ..+.....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~~~ 255 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML---LEKLNGTVP 255 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH---HHC------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH---HHHhcCCCC
Confidence 4332221111122334578899999999987 57899999999999999999999999764432211 11111000
Q ss_pred ----------------------------------------cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 234 ----------------------------------------STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 234 ----------------------------------------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+.......+++.+.+++.+||..||++|||+.++.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00111233457788999999999999999999998875
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=328.04 Aligned_cols=250 Identities=23% Similarity=0.320 Sum_probs=206.0
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecC-----CCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+..++|++.+.||.|+||.||+|++..+++.||+|++.. ......+.+|..++..++| +++..+..++.+....
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~ 144 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQLFYAFQDDRYL 144 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEE
Confidence 445799999999999999999999999999999998753 2334567889999998865 6677777777788899
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||++ +..+.+||+|||++....
T Consensus 145 ~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl---~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 145 YMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp EEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECC
T ss_pred EEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE---CCCCCEEEeccceeEeec
Confidence 9999999 8899999875 458999999999999999999999999999999999999 588999999999998765
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCC----CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh-
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE----QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK- 232 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~- 232 (318)
..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.. ..+..+....
T Consensus 220 ~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~ 290 (410)
T 3v8s_A 220 KEGMV------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---GTYSKIMNHKN 290 (410)
T ss_dssp TTSEE------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTHHH
T ss_pred cCCcc------cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh---hHHHHHHhccc
Confidence 43221 123457899999999998765 789999999999999999999999876553 3333443322
Q ss_pred -ccCchHHHhhcCchhHHHHHHHHhhcCCCC--CCChHHHHH
Q 021053 233 -VSTPIEVLCKSHPAEFASYFHYCQSLTFDQ--RPDYGFLKR 271 (318)
Q Consensus 233 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~--Rp~~~~l~~ 271 (318)
...|. ...++..+.+++..||..+|.+ ||+++++.+
T Consensus 291 ~~~~p~---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 291 SLTFPD---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HCCCCT---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred cccCCC---cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 22222 1357889999999999999988 999998877
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=323.15 Aligned_cols=207 Identities=25% Similarity=0.323 Sum_probs=174.5
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCC-----CCeeeeccccCc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSG-----IPNIKWYGVDGE 76 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~-----~~~i~~~~~~~~ 76 (318)
+.+.++|++.+.||+|+||.||+|.+..+++.||||++..... ......|+.+++.+.++++ +..+..++....
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 4567899999999999999999999999999999999875432 2356778889999886664 555556666678
Q ss_pred ceEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 77 DNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVH--SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 77 ~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
..++|||+++++|.+++.... ..+++..+..++.|++.||.||| +.||+||||||+||+++. +..+.+||+|||++
T Consensus 130 ~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTTC
T ss_pred ceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccCc
Confidence 899999999889999998754 45899999999999999999999 579999999999999941 24778999999999
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhh
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT 220 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~ 220 (318)
....... ....+|+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+...
T Consensus 209 ~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 265 (382)
T 2vx3_A 209 CQLGQRI----------YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265 (382)
T ss_dssp EETTCCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred eeccccc----------ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 8764322 24577899999999999999999999999999999999999999866543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=314.21 Aligned_cols=249 Identities=20% Similarity=0.287 Sum_probs=194.9
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----------------------------ChhHHHHHHH
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------------------------HPQLLYEAKV 55 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----------------------------~~~~~~e~~~ 55 (318)
+.-++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 445899999999999999999999999999999998764321 2457889999
Q ss_pred HHHHcCCCCCCeeeeccc--cCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 021053 56 YKILQGGSGIPNIKWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 132 (318)
Q Consensus 56 l~~l~~~~~~~~i~~~~~--~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~ 132 (318)
++.++| +++..+..+.. .....++|||++ +++|.++.. ...+++..+..++.||+.||.|||++||+||||||+
T Consensus 90 l~~l~h-~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDH-PNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHTCCC-TTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhCCC-CCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 999976 44555544433 356789999999 778877654 346999999999999999999999999999999999
Q ss_pred ceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCC---CCCcchHHHHHHHHHHHHhC
Q 021053 133 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRG 209 (318)
Q Consensus 133 Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~~l~tg 209 (318)
||++ +.++.+||+|||++......... .....+|+.|+|||++.+.. ++.++|||||||++|+|++|
T Consensus 167 Nil~---~~~~~~kl~Dfg~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g 236 (298)
T 2zv2_A 167 NLLV---GEDGHIKIADFGVSNEFKGSDAL-------LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236 (298)
T ss_dssp GEEE---CTTSCEEECCCTTCEECSSSSCE-------ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred HEEE---CCCCCEEEecCCCcccccccccc-------ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence 9999 48899999999999876533221 12457899999999998765 37789999999999999999
Q ss_pred CCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 210 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 210 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..||...+... ....+.......+. ...+++.+.+++.+||+.||++||++.++.+
T Consensus 237 ~~pf~~~~~~~---~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 237 QCPFMDERIMC---LHSKIKSQALEFPD---QPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SCSSCCSSHHH---HHHHHHHCCCCCCS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCCCCCccHHH---HHHHHhcccCCCCC---ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 99998754422 22233222222221 2357889999999999999999999998765
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=328.74 Aligned_cols=206 Identities=21% Similarity=0.336 Sum_probs=170.4
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcC-------CCCCCeeeeccc
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQG-------GSGIPNIKWYGV 73 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~-------~~~~~~i~~~~~ 73 (318)
++++.++|++.+.||+|+||.||+|++..+++.||+|++..... ...+.+|+.+++.+++ |+++..+..++.
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 56788999999999999999999999999999999999875432 3467889999999974 333444443333
Q ss_pred ----cCcceEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeeccCC-------
Q 021053 74 ----DGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGR------- 140 (318)
Q Consensus 74 ----~~~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~Nil~~~~~------- 140 (318)
.....++|||++++++.+.+.... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.+.
T Consensus 112 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred ecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 456799999999999988887643 4599999999999999999999998 999999999999995211
Q ss_pred ---------------------------------------CCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccc
Q 021053 141 ---------------------------------------KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181 (318)
Q Consensus 141 ---------------------------------------~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~a 181 (318)
....+||+|||.+....... ....+|+.|+|
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~----------~~~~gt~~y~a 261 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF----------TEDIQTRQYRS 261 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS----------CSCCSCGGGCC
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC----------ccCCCCCcccC
Confidence 11379999999998754322 23467999999
Q ss_pred cccccCCCCCCcchHHHHHHHHHHHHhCCCCccchh
Q 021053 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (318)
Q Consensus 182 PE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~ 217 (318)
||++.+..++.++|||||||++|+|++|..||...+
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 999999999999999999999999999999997543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=316.86 Aligned_cols=264 Identities=22% Similarity=0.285 Sum_probs=199.6
Q ss_pred CCccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHH--HcCCCCCCeeeec----ccc
Q 021053 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKI--LQGGSGIPNIKWY----GVD 74 (318)
Q Consensus 1 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~--l~~~~~~~~i~~~----~~~ 74 (318)
|++++.++|++.+.||+|+||.||+|++ +++.||+|++.... ......|.+++.. ++| +++..+..+ ...
T Consensus 2 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~l~h-~niv~~~~~~~~~~~~ 77 (301)
T 3q4u_A 2 MQRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-EKSWFRETELYNTVMLRH-ENILGFIASDMTSRHS 77 (301)
T ss_dssp --CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHHHTCCCC-TTBCCEEEEEEEEETT
T ss_pred ccccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-chhhHHHHHHHHHhhccC-cCeeeEEEeeccccCC
Confidence 5788999999999999999999999988 68899999886532 3455677777777 445 555555333 223
Q ss_pred CcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCceeeccCCCCCeE
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH--------SRGFLHRDIKPDNFLMGLGRKANQV 145 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--------~~~i~H~dl~p~Nil~~~~~~~~~~ 145 (318)
....++|||++ +++|.+++.. ..+++..+..++.|++.||.||| ++||+||||||+||++ +.++.+
T Consensus 78 ~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~ 152 (301)
T 3q4u_A 78 STQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQC 152 (301)
T ss_dssp EEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCE
T ss_pred CceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCE
Confidence 45689999999 7899999963 46899999999999999999999 9999999999999999 488999
Q ss_pred EEEeccceeeecCCCCCccccccCCCCCcccccccccccccCC------CCCCcchHHHHHHHHHHHHhC----------
Q 021053 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI------EQSRRDDLESLGYVLLYFLRG---------- 209 (318)
Q Consensus 146 kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DvwslG~il~~l~tg---------- 209 (318)
||+|||++............ ......+|+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 153 kl~Dfg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 153 CIADLGLAVMHSQSTNQLDV---GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp EECCCTTCEEEETTTTEEEC---CCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred EEeeCCCeeecccccccccc---cccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 99999999876544332111 12344789999999999876 445789999999999999999
Q ss_pred CCCccchhHhh-hHHHHHHHH---HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 210 SLPWQGLKAAT-KKQKYDKIC---EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 210 ~~pf~~~~~~~-~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
..||....... ....+.... ......+........+..+.+++..||+.||++|||+.++.+.|+++
T Consensus 230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 88986532211 111122211 11222222222334567899999999999999999999999998864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=327.24 Aligned_cols=253 Identities=23% Similarity=0.228 Sum_probs=206.8
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+.++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.++..++| +++..+..++......++||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-PKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS-TTBCCEEEEEECSSEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCC-cCCCeEEEEEEeCCEEEEEE
Confidence 45789999999999999999999999999999998875432 2357889999999876 56666666667778899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++. +..+.+||+|||++........
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSC
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec-CCCCceEEEecccceecCCCcc
Confidence 999 88999998765556899999999999999999999999999999999999941 1457899999999987654322
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
. ....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+... .+..+.......+ ....
T Consensus 207 ~--------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~i~~~~~~~~-~~~~ 274 (387)
T 1kob_A 207 V--------KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVKRCDWEFD-EDAF 274 (387)
T ss_dssp E--------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHHCCCCCC-SSTT
T ss_pred e--------eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCCCC-cccc
Confidence 1 23468999999999999999999999999999999999999998765432 3333333222222 2233
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+++.+.+++..||..||++||++.++.+
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 467889999999999999999999998876
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=331.32 Aligned_cols=252 Identities=24% Similarity=0.331 Sum_probs=206.7
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecC----CCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
+.++|++.+.||+|+||.||+|.+..+++.||+|++.. ......+.+|+.+++.+.| +++..+..+.......++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCC-CCcCeEEEEEEcCCEEEE
Confidence 56899999999999999999999999999999998743 2334578899999999976 666666666677788999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
|||++ +++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+||++...+..+.+||+|||++......
T Consensus 99 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 177 (486)
T 3mwu_A 99 VGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177 (486)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred EEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence 99999 88999988763 46999999999999999999999999999999999999964445678999999998755432
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. .....||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+... .+..+.......+.+
T Consensus 178 ~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~- 244 (486)
T 3mwu_A 178 TK--------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRVETGKYAFDLP- 244 (486)
T ss_dssp ------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHTCCCSCSG-
T ss_pred Cc--------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHhCCCCCCCc-
Confidence 21 134568999999999876 58999999999999999999999998865533 334444333333333
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+..+|+.+.+++.+||..+|.+|||+.++.+
T Consensus 245 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 23578899999999999999999999998876
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=323.66 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=194.9
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+..++|++.+.||+|+||.||+|++..+++.||+|++.... .......|..++.+..+|+++..+..++......
T Consensus 35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~ 114 (373)
T 2r5t_A 35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKL 114 (373)
T ss_dssp CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEE
Confidence 44578999999999999999999999999999999876432 1223455555432223457777777777888899
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 115 ~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll---~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCBCGGGB
T ss_pred EEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---CCCCCEEEeeCccccccc
Confidence 9999999 7899999886 4458999999999999999999999999999999999999 588999999999987533
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.. ..+..+.......+
T Consensus 191 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i~~~~~~~~- 259 (373)
T 2r5t_A 191 EHNS-------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNILNKPLQLK- 259 (373)
T ss_dssp CCCC-------CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---HHHHHHHHSCCCCC-
T ss_pred cCCC-------ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHhcccCCC-
Confidence 2221 123557899999999999999999999999999999999999999876543 34444444433332
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYG 267 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 267 (318)
..++..+.+++..||..||.+||++.
T Consensus 260 ----~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 260 ----PNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp ----SSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred ----CCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 35688999999999999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=319.17 Aligned_cols=247 Identities=20% Similarity=0.298 Sum_probs=202.6
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-----hhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
..++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.++..++| +++..+..++......+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~ 130 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLREHTAW 130 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEECCeEE
Confidence 346799999999999999999999999999999988654332 357789999999976 55666666666777899
Q ss_pred EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 80 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
+|||++.++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++......
T Consensus 131 lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~---~~~~~kL~DfG~a~~~~~~ 207 (348)
T 1u5q_A 131 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA 207 (348)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBSSSSB
T ss_pred EEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC---CCCCEEEeeccCceecCCC
Confidence 9999999999999877667799999999999999999999999999999999999994 8899999999998754321
Q ss_pred CCCccccccCCCCCccccccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
....+|+.|+|||++. +..++.++|||||||++|+|++|..||...+.... +..+.....+..
T Consensus 208 -----------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~---~~~~~~~~~~~~ 273 (348)
T 1u5q_A 208 -----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---LYHIAQNESPAL 273 (348)
T ss_dssp -----------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHSCCCCC
T ss_pred -----------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHhcCCCCC
Confidence 2346899999999985 45689999999999999999999999987654322 223322222111
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
....++..+.+++..||..+|++||++.++.+.
T Consensus 274 ---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 274 ---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 123578899999999999999999999987763
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=316.14 Aligned_cols=261 Identities=17% Similarity=0.276 Sum_probs=209.6
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
++..++|++.+.||.|+||.||+|.+. .++..||+|++...... ..+.+|+.++..++| +++..+..++..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 97 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNH-PHVIKLYGACSQ 97 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCC-CceeeEEEEEec
Confidence 456789999999999999999999984 44588999998754432 356789999999965 666666666677
Q ss_pred CcceEEEEecc-CCCHHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCRR-----------------------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~~-----------------------~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~ 130 (318)
....++|||++ +++|.+++..... .+++..+..++.||+.||.|||++||+|||||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dik 177 (314)
T 2ivs_A 98 DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLA 177 (314)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccc
Confidence 77899999999 7899999986432 37889999999999999999999999999999
Q ss_pred CCceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-C
Q 021053 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-G 209 (318)
Q Consensus 131 p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g 209 (318)
|+||+++ .++.+||+|||++.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |
T Consensus 178 p~NIli~---~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 178 ARNILVA---EGRKMKISDFGLSRDVYEEDSYV-----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp GGGEEEE---TTTEEEECCCTTCEECTTTSCEE-----CSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred hheEEEc---CCCCEEEccccccccccccccce-----eccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 9999994 88999999999998664432211 1234456788999999998889999999999999999999 9
Q ss_pred CCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 210 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 210 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
..||.+....... ..+.. ....+ ....+++.+.+++.+||+.||++||++.++.+.|++++.+
T Consensus 250 ~~p~~~~~~~~~~---~~~~~-~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 250 GNPYPGIPPERLF---NLLKT-GHRME---RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CCSSTTCCGGGHH---HHHHT-TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCCCHHHHH---HHhhc-CCcCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 9999876543222 22221 11111 2246788999999999999999999999999999988653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=316.04 Aligned_cols=262 Identities=19% Similarity=0.302 Sum_probs=210.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEc-------CCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeecc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-------DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYG 72 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-------~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~ 72 (318)
++..++|++.+.||.|+||.||+|.+. .++..||+|++...... ..+.+|+.++..+.+|+++..+..++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 345789999999999999999999985 35678999998765432 35788999999996667787777777
Q ss_pred ccCcceEEEEecc-CCCHHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceee
Q 021053 73 VDGEDNVLVLDLL-GPSLEDLFVYCRR---------------KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLM 136 (318)
Q Consensus 73 ~~~~~~~lv~e~~-~~~L~~~~~~~~~---------------~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~ 136 (318)
......++|||++ +++|.+++..... .+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 190 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEE
Confidence 7778899999999 7799999986431 37899999999999999999999999999999999999
Q ss_pred ccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccc
Q 021053 137 GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQG 215 (318)
Q Consensus 137 ~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~ 215 (318)
+.++.+||+|||++.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 191 ---~~~~~~kL~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 262 (334)
T 2pvf_A 191 ---TENNVMKIADFGLARDINNIDYYK-----KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 262 (334)
T ss_dssp ---CTTCCEEECCCTTCEECTTTSSEE-----CCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ---cCCCCEEEcccccccccccccccc-----ccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence 488999999999998765432211 1233456788999999988889999999999999999999 9999987
Q ss_pred hhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 216 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 216 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
....... ..+.... ..+ ....++..+.+++..||..+|.+||++.++.+.|++++..
T Consensus 263 ~~~~~~~---~~~~~~~-~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 263 IPVEELF---KLLKEGH-RMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp CCHHHHH---HHHHHTC-CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHH---HHHhcCC-CCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 6543222 2222211 111 1235788999999999999999999999999999988653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=318.50 Aligned_cols=256 Identities=22% Similarity=0.220 Sum_probs=192.6
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
..-++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++| +++..+..+.......+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQH-RNIIELKSVIHHNHRLH 109 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCC-TTBCCEEEEEEETTEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCC-CCcceEEEEEecCCEEE
Confidence 345799999999999999999999999999999998864432 2356789999999965 66666766667778899
Q ss_pred EEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccC--CCCCeEEEEeccceeeec
Q 021053 80 LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 80 lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~--~~~~~~kL~dfg~~~~~~ 157 (318)
+|||++.++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.+ +..+.+||+|||++....
T Consensus 110 lv~e~~~~~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 110 LIFEYAENDLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EEEECCSEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EEEecCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 9999998899999987 4459999999999999999999999999999999999999522 145569999999997654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
.... ......+|+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......+ ......++
T Consensus 189 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~~~~~~ 258 (329)
T 3gbz_A 189 IPIR-------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKI---FEVLGLPD 258 (329)
T ss_dssp ------------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCCCC
T ss_pred Cccc-------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHH---HHHhCCCc
Confidence 3322 123446789999999998754 899999999999999999999999886654333332 22211111
Q ss_pred hH-------------------------HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 IE-------------------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ~~-------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.. .....+++.+.+++.+||..||++|||+.++.+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 11 111225667778888888888888888777654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=327.45 Aligned_cols=263 Identities=20% Similarity=0.254 Sum_probs=186.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeecc-----cc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYG-----VD 74 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~-----~~ 74 (318)
.+.++|++.+.||.|+||.||+|.+..+++.||||++...... ..+.+|+.++..++| +++..+..++ ..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNH-DHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCC-TTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCC-CCCCceEEEEecCCccc
Confidence 3568999999999999999999999999999999988654332 357789999999976 5555554433 23
Q ss_pred CcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
....|+|||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 129 ~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 129 FDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV---NQDCSVKVCDFGLAR 204 (458)
T ss_dssp CCCEEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCB
T ss_pred CceEEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE---CCCCCEeecccccch
Confidence 357899999999999999875 4459999999999999999999999999999999999999 588999999999998
Q ss_pred eecCCCCCcc-cc-------------------ccCCCCCcccccccccccc-cCCCCCCcchHHHHHHHHHHHHh-----
Q 021053 155 KYRDPTTNRH-IP-------------------YRENKNLTGTARYASCNTH-LGIEQSRRDDLESLGYVLLYFLR----- 208 (318)
Q Consensus 155 ~~~~~~~~~~-~~-------------------~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~t----- 208 (318)
.......... .+ ........+|+.|+|||++ .+..++.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~ 284 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence 7543321100 00 0122345779999999976 45669999999999999999999
Q ss_pred ------CCCCccchhH-----------------hhhHHHHHHHHHhhccCchHH--------------------------
Q 021053 209 ------GSLPWQGLKA-----------------ATKKQKYDKICEKKVSTPIEV-------------------------- 239 (318)
Q Consensus 209 ------g~~pf~~~~~-----------------~~~~~~~~~i~~~~~~~~~~~-------------------------- 239 (318)
|.++|.+.+. ......+..+......++.+.
T Consensus 285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 364 (458)
T 3rp9_A 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE 364 (458)
T ss_dssp CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence 7777766431 011223333332222222211
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.....++.+.+|+.+||..||++|||+.++.+
T Consensus 365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~ 396 (458)
T 3rp9_A 365 RFPASSADAIHLLKRMLVFNPNKRITINECLA 396 (458)
T ss_dssp GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HCCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 12244778999999999999999999998776
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=318.95 Aligned_cols=253 Identities=21% Similarity=0.247 Sum_probs=199.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-------ChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
..++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.++..++| +++..+..++.....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNIIGLLDAFGHKSN 86 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC-TTBCCEEEEECCTTC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCC-CCCCeEEEEEeeCCc
Confidence 35789999999999999999999999999999998764321 2367899999999976 566666666667778
Q ss_pred eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 78 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
.++|||++.++|.+++......+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 87 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~ 163 (346)
T 1ua2_A 87 ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFG 163 (346)
T ss_dssp CEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTT
T ss_pred eEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE---cCCCCEEEEecccceecc
Confidence 99999999889999988755568899999999999999999999999999999999999 488999999999987654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC-
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST- 235 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~- 235 (318)
.... ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..... ..+.......
T Consensus 164 ~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~---~~i~~~~~~~~ 233 (346)
T 1ua2_A 164 SPNR-------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPT 233 (346)
T ss_dssp SCCC-------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCC
T ss_pred CCcc-------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHcCCCC
Confidence 3322 12345679999999998765 4899999999999999999999999886654333 3333222111
Q ss_pred ----------------------chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 ----------------------PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 ----------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+........+..+.+++..||..||++|||+.++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 122233456788999999999999999999998776
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=326.15 Aligned_cols=263 Identities=18% Similarity=0.244 Sum_probs=195.9
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccC----
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG---- 75 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~---- 75 (318)
.+.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.++..++|+ ++..+..+....
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-nIv~l~~~~~~~~~~~ 101 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD-YIIRLYDLIIPDDLLK 101 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCT-TBCCEEEECCCSCTTT
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCC-CcceEEEEEecCCCCc
Confidence 3678999999999999999999999999999999998754332 3678999999999874 454554333322
Q ss_pred -cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 76 -EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 76 -~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
...|+|||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++
T Consensus 102 ~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl---~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 102 FDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL---NQDCSVKVCDFGLAR 177 (432)
T ss_dssp CCCEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred CCeEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCcc
Confidence 57899999999999999875 4459999999999999999999999999999999999999 488999999999998
Q ss_pred eecCCCCCccc---------------cccCCCCCcccccccccccc-cCCCCCCcchHHHHHHHHHHHHh----------
Q 021053 155 KYRDPTTNRHI---------------PYRENKNLTGTARYASCNTH-LGIEQSRRDDLESLGYVLLYFLR---------- 208 (318)
Q Consensus 155 ~~~~~~~~~~~---------------~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwslG~il~~l~t---------- 208 (318)
........... .........+|+.|+|||++ .+..++.++|||||||++|+|++
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~ 257 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGG
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccc
Confidence 76543221000 00112456789999999986 45669999999999999999998
Q ss_pred -CCCCccchhH--------------hhhHHHHHHHHHhhccCchH--------------------------HHhhcCchh
Q 021053 209 -GSLPWQGLKA--------------ATKKQKYDKICEKKVSTPIE--------------------------VLCKSHPAE 247 (318)
Q Consensus 209 -g~~pf~~~~~--------------~~~~~~~~~i~~~~~~~~~~--------------------------~~~~~~~~~ 247 (318)
|.++|.+.+. .....++..+......++.+ .....+++.
T Consensus 258 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~ 337 (432)
T 3n9x_A 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDD 337 (432)
T ss_dssp GCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHH
T ss_pred cccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHH
Confidence 4445544220 11123333333322222222 122356788
Q ss_pred HHHHHHHHhhcCCCCCCChHHHHH
Q 021053 248 FASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 248 ~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+.+++.+||..||++|||+.++.+
T Consensus 338 ~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 338 GINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHhcCCcccCCCHHHHhc
Confidence 999999999999999999988766
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=312.49 Aligned_cols=253 Identities=19% Similarity=0.290 Sum_probs=202.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+...++|++.+.||.|+||.||+|.+..+++.||+|++........+.+|+.++..+.| +++..+..+.......++||
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS-PHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCC-CCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999999999999999998877777889999999999976 55656655556677899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|++ +++|.+++......+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.+||+|||.+........
T Consensus 104 e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~ 180 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMA 180 (314)
T ss_dssp ECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBS
T ss_pred ecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE---CCCCCEEEeecccchhhhhhcc
Confidence 999 669999987656679999999999999999999999999999999999999 4788999999999977654322
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHh
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (318)
......++..|+|||++.+..++.++|||||||++|+|++|..||...+...... .+... ..+.....
T Consensus 181 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~--~~~~~~~~ 248 (314)
T 3com_A 181 -------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF---MIPTN--PPPTFRKP 248 (314)
T ss_dssp -------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHS--CCCCCSSG
T ss_pred -------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHhcC--CCcccCCc
Confidence 1234568899999999999899999999999999999999999998755432221 11111 11111123
Q ss_pred hcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 242 ~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..++..+.+++..||..||.+||++.++.+
T Consensus 249 ~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 249 ELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 456889999999999999999999998876
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=321.52 Aligned_cols=260 Identities=20% Similarity=0.307 Sum_probs=208.4
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
++..++|++.+.||+|+||.||+|++. .+++.||+|++..... ...+.+|+.++..++| +++..+..++..
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~ 121 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN-PNIVKLLGVCAV 121 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEcc
Confidence 345689999999999999999999987 3458899999876543 2357889999999965 666666666667
Q ss_pred CcceEEEEecc-CCCHHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCR-----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIK 130 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~-----------------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~ 130 (318)
....++|||++ +++|.+++.... ..+++..+..++.||+.||.|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 77899999999 789999998632 458899999999999999999999999999999
Q ss_pred CCceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-C
Q 021053 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-G 209 (318)
Q Consensus 131 p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g 209 (318)
|+||++ +.++.+||+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|++ |
T Consensus 202 p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 273 (343)
T 1luf_A 202 TRNCLV---GENMVVKIADFGLSRNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 273 (343)
T ss_dssp GGGEEE---CGGGCEEECCCSCHHHHTGGGCB-----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred cceEEE---CCCCeEEEeecCCCcccccCccc-----cccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcC
Confidence 999999 48899999999998765322111 12234567889999999998889999999999999999999 9
Q ss_pred CCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 210 SLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 210 ~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
..||.+.+... ....+....... ....+|..+.+++..||+.+|++||++.++.+.|.++..
T Consensus 274 ~~p~~~~~~~~---~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 274 LQPYYGMAHEE---VIYYVRDGNILA----CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp CCTTTTSCHHH---HHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCcCCCCChHH---HHHHHhCCCcCC----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 99998765432 222222222111 224678899999999999999999999999999988743
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=315.75 Aligned_cols=257 Identities=19% Similarity=0.253 Sum_probs=201.3
Q ss_pred CccccceeeEeeeeccCcccEEEEEEE-cCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCC-----CCCeeeecccc
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASH-VDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS-----GIPNIKWYGVD 74 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~-~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~-----~~~~i~~~~~~ 74 (318)
++++.++|++.+.||+|+||.||+|.+ ..+++.||+|++..... ...+.+|+.+++.+++++ ++..+..++..
T Consensus 9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 567889999999999999999999998 46789999999865432 246788999999987654 24455556667
Q ss_pred CcceEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCC------------
Q 021053 75 GEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK------------ 141 (318)
Q Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~------------ 141 (318)
....++|||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||++...+.
T Consensus 89 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~ 168 (339)
T 1z57_A 89 HGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDE 168 (339)
T ss_dssp TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEE
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccccc
Confidence 77899999999999999998643 25889999999999999999999999999999999999952111
Q ss_pred ----CCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchh
Q 021053 142 ----ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (318)
Q Consensus 142 ----~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~ 217 (318)
.+.+||+|||.+....... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||...+
T Consensus 169 ~~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 169 RTLINPDIKVVDFGSATYDDEHH----------STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp EEESCCCEEECCCSSCEETTSCC----------CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccCCCceEeeCcccccCcccc----------ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 6689999999987643322 24467999999999999999999999999999999999999998866
Q ss_pred HhhhHHHHHHHHHhhccCchHHHh---------------------------------------hcCchhHHHHHHHHhhc
Q 021053 218 AATKKQKYDKICEKKVSTPIEVLC---------------------------------------KSHPAEFASYFHYCQSL 258 (318)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~---------------------------------------~~~~~~~~~li~~cl~~ 258 (318)
.......+..+. .+.|..... ...++.+.+++.+||+.
T Consensus 239 ~~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 239 SKEHLAMMERIL---GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp HHHHHHHHHHHH---CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred hHHHHHHHHHHh---CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 554444443322 222221110 01135677888888888
Q ss_pred CCCCCCChHHHHH
Q 021053 259 TFDQRPDYGFLKR 271 (318)
Q Consensus 259 ~p~~Rp~~~~l~~ 271 (318)
||.+||++.++.+
T Consensus 316 dP~~Rpt~~ell~ 328 (339)
T 1z57_A 316 DPAKRITLREALK 328 (339)
T ss_dssp STTTSCCHHHHTT
T ss_pred CcccccCHHHHhc
Confidence 8888888887654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=308.97 Aligned_cols=252 Identities=25% Similarity=0.358 Sum_probs=198.4
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
+.++|++.+.||+|+||.||+|.+..++..||+|++.... ....+.+|+.+++.++| +++..+..++......++|
T Consensus 20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDH-PNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCC-chHHhHHHheecCCeEEEE
Confidence 5689999999999999999999999999999999876543 23567889999999976 5566666666677789999
Q ss_pred Eecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 82 LDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
||++ +++|.+.+... ...+++..+..++.|++.||.|||++||+||||||+||++...+..+.+||+|||++....
T Consensus 99 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 99 METCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp ECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred EEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999 77999988643 3569999999999999999999999999999999999999644456889999999997654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
.... .....+++.|+|||++. ..++.++|||||||++|+|++|..||.+.+..... ..+.......+.
T Consensus 179 ~~~~--------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~---~~~~~~~~~~~~ 246 (285)
T 3is5_A 179 SDEH--------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ---QKATYKEPNYAV 246 (285)
T ss_dssp ----------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHCCCCCCC
T ss_pred Cccc--------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH---hhhccCCccccc
Confidence 3322 13446899999999875 46889999999999999999999999876543222 222211212221
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
....+++.+.+++.+||+.||++||++.++.+
T Consensus 247 --~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 --ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred --ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12346788999999999999999999998765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=324.50 Aligned_cols=262 Identities=18% Similarity=0.286 Sum_probs=199.8
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEc---CCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~---~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
++..++|++.+.||+|+||.||+|++. .++..||||+++.... ...+.+|+.++.+++| +++..+..+.....
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH-PNIIRLEGVVTKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCC
Confidence 455679999999999999999999886 4677899999875432 2357889999999975 56666666667778
Q ss_pred ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..++|||++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 120 ~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~ 196 (373)
T 2qol_A 120 PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI---NSNLVCKVSDFGLGRV 196 (373)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC-----
T ss_pred ceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE---cCCCCEEECcCccccc
Confidence 899999999 889999998766679999999999999999999999999999999999999 5889999999999986
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
......... ......++..|+|||++.+..++.++|||||||++|++++ |..||...+.... ...+.. ...
T Consensus 197 ~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~---~~~i~~-~~~ 268 (373)
T 2qol_A 197 LEDDPEAAY----TTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV---IKAVDE-GYR 268 (373)
T ss_dssp ---------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH---HHHHHT-TEE
T ss_pred cccCCccce----eccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHc-CCC
Confidence 543322110 1122344678999999998899999999999999999998 9999987654332 222222 222
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
.+.. ..+|..+.+++..||+.+|++||++.++.+.|++++..
T Consensus 269 ~~~~---~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 269 LPPP---MDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp CCCC---TTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCC---ccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 2221 35688999999999999999999999999999998653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=317.73 Aligned_cols=254 Identities=20% Similarity=0.210 Sum_probs=200.5
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccc----cCcce
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV----DGEDN 78 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~----~~~~~ 78 (318)
+++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.++..++|++.+..+..+.. .....
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 48999999999999999999999999999999988754332 357789999999987544443333322 22468
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 79 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
++|+|+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||.+.....
T Consensus 106 ~iv~e~~~~~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~ 180 (364)
T 3qyz_A 106 YIVQDLMETDLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADP 180 (364)
T ss_dssp EEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCG
T ss_pred EEEEcccCcCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE---CCCCCEEEEeCcceEecCC
Confidence 99999999999999875 459999999999999999999999999999999999999 4888999999999987543
Q ss_pred CCCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc-
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP- 236 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~- 236 (318)
..... .......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.. ....++
T Consensus 181 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~---~~~~~~~ 253 (364)
T 3qyz_A 181 DHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG---ILGSPSQ 253 (364)
T ss_dssp GGCBC----CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHH---HHCSCCH
T ss_pred CCCcc----ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHH---HhCCCCH
Confidence 32211 112345789999999987654 489999999999999999999999987665443333322 222222
Q ss_pred -------------------------hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 -------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 -------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
........+..+.+++.+||..||++||++.++.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 22233456788999999999999999999998776
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=312.70 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=199.7
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
-++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.++..++| +++..+..++......++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-PHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCC-CCeeEEEEEEeeCCeEEE
Confidence 4789999999999999999999999999999998765432 1357789999998876 566666666667778999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
++|++ +++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||++ +.++.+||+|||++......
T Consensus 112 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV---SADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSCCC-------
T ss_pred EEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE---cCCCCEEEecCccCcccccc
Confidence 99999 67999999863 459999999999999999999999999999999999999 47889999999998765433
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
... ......++..|+|||++.+..++.++||||||+++|+|++|..||...+.. .+........ .....
T Consensus 188 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~-~~~~~ 256 (309)
T 2h34_A 188 KLT------QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS----VMGAHINQAI-PRPST 256 (309)
T ss_dssp ---------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH----HHHHHHHSCC-CCGGG
T ss_pred ccc------cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH----HHHHHhccCC-CCccc
Confidence 221 123446889999999999989999999999999999999999999876543 2222222222 22333
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCC-ChHHHHHHHHHHHHh
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDLFSR 279 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp-~~~~l~~~l~~~~~~ 279 (318)
....+|..+.+++.+||+.||++|| +++++.+.|+..+..
T Consensus 257 ~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 257 VRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp TSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred cCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 4557889999999999999999999 999999999876543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=317.96 Aligned_cols=259 Identities=21% Similarity=0.283 Sum_probs=199.5
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcE----EEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEI----VAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~----vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
.+..++|++.+.||+|+||.||+|.+..+++. ||+|.+.... ....+.+|+.++.+++| +++..+..++...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~ 89 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTS 89 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCB-TTBCCEEEEEESS
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEecC
Confidence 35568999999999999999999998877664 5777665332 23468889999999976 5555555444443
Q ss_pred cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
..+++++++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||+++
T Consensus 90 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~---~~~~~kl~Dfg~a~ 165 (327)
T 3poz_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165 (327)
T ss_dssp -SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTHHH
T ss_pred -CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEEC---CCCCEEEccCccee
Confidence 367788887 8999999987667799999999999999999999999999999999999994 88999999999998
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
......... ......+|..|+|||++.+..++.++|||||||++|+|++ |..||.+....... .......
T Consensus 166 ~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----~~~~~~~ 236 (327)
T 3poz_A 166 LLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS----SILEKGE 236 (327)
T ss_dssp HHTTTCC------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH----HHHHTTC
T ss_pred EccCCcccc-----cccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH----HHHHcCC
Confidence 765433221 1123456788999999999999999999999999999999 99999875543322 2222222
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
..+. ...++..+.+++..||..+|++||++.++.+.|..+..
T Consensus 237 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 237 RLPQ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCC---CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CCCC---CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 2221 13467889999999999999999999999999988753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=317.63 Aligned_cols=258 Identities=18% Similarity=0.236 Sum_probs=203.6
Q ss_pred CCccccceeeEeeeeccCcccEEEEEEEcCCC-cEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCC-----CCeeeeccc
Q 021053 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTN-EIVAVKIENSGTK-HPQLLYEAKVYKILQGGSG-----IPNIKWYGV 73 (318)
Q Consensus 1 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~-~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~-----~~~i~~~~~ 73 (318)
+++++.++|++.+.||+|+||.||+|.+..++ +.||+|++..... ...+.+|+.+++.+.|++. +..+..++.
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 35778999999999999999999999998776 6899999875432 3457789999999976543 334455556
Q ss_pred cCcceEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccC-------------
Q 021053 74 DGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG------------- 139 (318)
Q Consensus 74 ~~~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~------------- 139 (318)
.....++|||++++++.+.+.... ..+++..+..++.||+.||.|||++||+||||||+||++...
T Consensus 93 ~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 93 FHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp ETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred eCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 677899999999999988887643 358999999999999999999999999999999999999422
Q ss_pred ---CCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccch
Q 021053 140 ---RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 216 (318)
Q Consensus 140 ---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~ 216 (318)
+..+.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEHH----------TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH 242 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSCC----------CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccCCCcEEEeecCccccccccc----------cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 257889999999997643322 2447899999999999999999999999999999999999999886
Q ss_pred hHhhhHHHHHHHHHhhccCchHHHh---------------------------------------hcCchhHHHHHHHHhh
Q 021053 217 KAATKKQKYDKICEKKVSTPIEVLC---------------------------------------KSHPAEFASYFHYCQS 257 (318)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~---------------------------------------~~~~~~~~~li~~cl~ 257 (318)
+.......+..+. ...|..... ...+..+.+++.+||+
T Consensus 243 ~~~~~~~~~~~~~---~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 319 (355)
T 2eu9_A 243 ENREHLVMMEKIL---GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319 (355)
T ss_dssp SHHHHHHHHHHHH---CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTC
T ss_pred CHHHHHHHHHHHc---CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhc
Confidence 6554444443332 222221110 0013468899999999
Q ss_pred cCCCCCCChHHHHH
Q 021053 258 LTFDQRPDYGFLKR 271 (318)
Q Consensus 258 ~~p~~Rp~~~~l~~ 271 (318)
.||++|||+.++.+
T Consensus 320 ~dP~~Rpt~~e~l~ 333 (355)
T 2eu9_A 320 FDPAQRITLAEALL 333 (355)
T ss_dssp SSTTTSCCHHHHTT
T ss_pred CChhhCcCHHHHhc
Confidence 99999999987764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=312.13 Aligned_cols=260 Identities=20% Similarity=0.319 Sum_probs=213.3
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++..++|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+|+.+++.++| +++..+..++......++|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCCEEEE
Confidence 4677899999999999999999999999999999998876543 3467899999999986 5666666666777789999
Q ss_pred Eecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
||++ +++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||.+......
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 88 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp EECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSS
T ss_pred EEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE---cCCCCEEEccCccceeccCC
Confidence 9999 689999998643 348999999999999999999999999999999999999 48889999999998765433
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||...+....... .......+
T Consensus 165 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~----~~~~~~~~-- 232 (288)
T 3kfa_A 165 TYT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----LEKDYRME-- 232 (288)
T ss_dssp SSE------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH----HHTTCCCC--
T ss_pred ccc------cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HhccCCCC--
Confidence 221 1233456778999999998889999999999999999999 9999987554322222 22222222
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
....+|+.+.+++..||..+|.+||++.++.+.|++++.+
T Consensus 233 -~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 233 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 1246788999999999999999999999999999998765
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=330.39 Aligned_cols=248 Identities=21% Similarity=0.303 Sum_probs=196.4
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+..++|++.+.||.|+||.||+|.+..+++.||+|++... .....+.+|+.++..++| +++..+..++......
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~~ 223 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH-PFLTALKYSFQTHDRL 223 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSC-TTSCCEEEEEEETTEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCC-CeEeeEEEEEeeCCEE
Confidence 4557899999999999999999999999999999987632 233456778888888875 5666776666777889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
++||||+ +++|.+++.. ...+++..+..++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|||++...
T Consensus 224 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll---~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE---CSSSCEEECCCCCCCTT
T ss_pred EEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE---CCCCCEEEccCCCceec
Confidence 9999999 7899888876 4469999999999999999999998 999999999999999 48899999999998753
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. .....+.......|
T Consensus 300 ~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~~~~~~~p 369 (446)
T 4ejn_A 300 IKDGA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILMEEIRFP 369 (446)
T ss_dssp CC------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC
T ss_pred cCCCc-------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHHhCCCCCC
Confidence 32221 123457899999999999999999999999999999999999999876543 33333433333333
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
..+++.+.+++..||..||.+|| ++.++.+
T Consensus 370 -----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 370 -----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp -----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 35688999999999999999999 8887765
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=312.93 Aligned_cols=246 Identities=20% Similarity=0.289 Sum_probs=201.0
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
.|+..+.||+|+||.||+|++..+++.||||++..... ...+.+|+.++..++| +++..+..+.......++|||++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH-FNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEECCC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC-CCcceEEEEEEECCEEEEEEecC
Confidence 48889999999999999999998999999998765433 3457889999999976 55556655556667899999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 86 -~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.........
T Consensus 125 ~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~-- 197 (321)
T 2c30_A 125 QGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPK-- 197 (321)
T ss_dssp CSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCC--
T ss_pred CCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCccc--
Confidence 8899998874 459999999999999999999999999999999999999 47899999999998876543221
Q ss_pred ccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcC
Q 021053 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (318)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||...+... .+..+.... .+.......+
T Consensus 198 -----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~~~~~~~~--~~~~~~~~~~ 267 (321)
T 2c30_A 198 -----RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMKRLRDSP--PPKLKNSHKV 267 (321)
T ss_dssp -----BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSS--CCCCTTGGGS
T ss_pred -----cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhcCC--CCCcCccccC
Confidence 234578999999999999899999999999999999999999998755432 222222211 1111123467
Q ss_pred chhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 245 PAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 245 ~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
++.+.+++.+||..||++||++.++.+
T Consensus 268 ~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 268 SPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 888999999999999999999998876
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=318.50 Aligned_cols=257 Identities=19% Similarity=0.269 Sum_probs=207.8
Q ss_pred ccccceeeEe-eeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 3 RIIGVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 3 ~~~~~~y~~~-~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
+.+.++|.+. +.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.++..+.+++++..+..++.....
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3467889988 899999999999999999999999998765332 34678899999999988999888888788888
Q ss_pred eEEEEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 78 NVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
.++|||++ +++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++.....+.+||+|||++..
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~ 183 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK 183 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEE
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccc
Confidence 99999999 77998887542 34589999999999999999999999999999999999995322378999999999987
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.... ...+.......
T Consensus 184 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~~~~~~ 252 (327)
T 3lm5_A 184 IGHACE--------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET---YLNISQVNVDY 252 (327)
T ss_dssp C-----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHTCCCC
T ss_pred cCCccc--------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHHHhccccc
Confidence 643322 1245689999999999999999999999999999999999999987655332 23333333333
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+ ......++..+.+++..||..||++||++.++.+
T Consensus 253 ~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 253 S-EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp C-TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred C-chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 2 2333567889999999999999999999998765
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=315.60 Aligned_cols=264 Identities=21% Similarity=0.307 Sum_probs=209.0
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccc-
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV- 73 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~- 73 (318)
++..++|++.+.||.|+||.||+|.+. .+++.||+|++...... ..+.+|+.++..+.+|+++..+..+..
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 355789999999999999999999853 46689999998765432 257789999999977777777755543
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhcCC---------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCRRK---------------FSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~~~---------------~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~ 137 (318)
.....++|||++ +++|.+++...... +++..+..++.|++.||.|||++||+||||||+||++
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~- 181 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL- 181 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE-
Confidence 445699999999 77999999864322 7889999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccch
Q 021053 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (318)
Q Consensus 138 ~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~ 216 (318)
+..+.+||+|||.+.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 182 --~~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 182 --SEKNVVKICDFGLARDIYKDPDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp --CGGGCEEECCCGGGSCTTTCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred --CCCCCEEECCCccccccccCccce-----eccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 478999999999997654332211 1234456788999999998889999999999999999998 99999765
Q ss_pred hHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhc
Q 021053 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (318)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~ 280 (318)
.... .....+. .....+ ....+++.+.+++..||+.+|.+||++.++.+.|.+++...
T Consensus 255 ~~~~--~~~~~~~-~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 255 KIDE--EFCRRLK-EGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCSH--HHHHHHH-HTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred chhH--HHHHHhc-cCccCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 4321 1111211 111111 12346789999999999999999999999999999987543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=316.61 Aligned_cols=262 Identities=19% Similarity=0.295 Sum_probs=210.5
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCc-----EEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~-----~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
+..++|++.+.||.|+||.||+|.+..++. .||+|++..... ...+.+|+.++..+.+|+++..+..++...
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 456889999999999999999999876554 799998876543 235788999999996667787877777777
Q ss_pred cceEEEEecc-CCCHHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCC
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCR-------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRK 141 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~-------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~ 141 (318)
...++|||++ +++|.+++.... ..++...+..++.|++.||.|||++||+||||||+||+++ .
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~---~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---N 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEE---G
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEEC---C
Confidence 8899999999 779999987542 3478999999999999999999999999999999999994 8
Q ss_pred CCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhh
Q 021053 142 ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAAT 220 (318)
Q Consensus 142 ~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~ 220 (318)
++.+||+|||++.......... ......+++.|+|||++.+..++.++|||||||++|+|+| |..||.+.....
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~ 274 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYI-----VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS 274 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSE-----ECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH
T ss_pred CCeEEECcccccccccccccee-----ecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH
Confidence 8999999999998654332211 1234456788999999998889999999999999999999 999998754322
Q ss_pred hHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
. +..........+. ....|..+.+++..||+.+|.+||++.++.+.|+++..+
T Consensus 275 ~---~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 275 K---FYKLVKDGYQMAQ---PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp H---HHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred H---HHHHHhcCCCCCC---CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 1 2222222222221 134578899999999999999999999999999887543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=313.43 Aligned_cols=264 Identities=22% Similarity=0.241 Sum_probs=205.0
Q ss_pred ccccceeeEeeeeccCcccEEEEEE----EcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~----~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
.+..++|++.+.||+|+||.||+|+ +..+++.||+|++..... ...+.+|+.++..++| +++..+..++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH-ENIVKYKGICTED 95 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCC-TTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCC-CCeeeeeeEEecC
Confidence 4566889999999999999999999 567889999998775432 2467889999999976 4555554443333
Q ss_pred --cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 76 --EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 76 --~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
...++|||++ +++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||.
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGL 172 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTT
T ss_pred CCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEc---CCCCEEECcccc
Confidence 5689999999 7799999977667799999999999999999999999999999999999994 788999999999
Q ss_pred eeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHh-----------hh
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAA-----------TK 221 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~-----------~~ 221 (318)
+.......... .......+|..|+|||++.+..++.++|||||||++|+|++|..|+...... ..
T Consensus 173 ~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 173 TKAIETDKEYY----TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248 (302)
T ss_dssp CEECCTTCCEE----ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGH
T ss_pred cccccCCCcce----eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccC
Confidence 98765433211 1223456788899999999888999999999999999999999987543211 00
Q ss_pred HHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
...+..........+ ....+|+.+.+++..||+.||.+||++.++.+.|++++
T Consensus 249 ~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLP---CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCC---CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111111111111 22467889999999999999999999999999998874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=311.24 Aligned_cols=253 Identities=22% Similarity=0.296 Sum_probs=205.6
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
.+.++|++.+.||.|+||.||+|++..+++.||+|++.... ....+.+|+.++..++| +++..+..+.......++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-ENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCC-TTBCCEEEEEECSSEEEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCC-CCeeehhhhcccCCEEEEE
Confidence 46789999999999999999999999999999999887543 23467899999999976 5566666666777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||++ +++|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||++...+..+.+||+|||.+.......
T Consensus 85 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 163 (304)
T 2jam_A 85 MQLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI 163 (304)
T ss_dssp ECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT
T ss_pred EEcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc
Confidence 9999 7899999876 3458999999999999999999999999999999999999544478899999999986543221
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
.....+++.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.......+ ...
T Consensus 164 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~~~~~~~~-~~~ 230 (304)
T 2jam_A 164 ---------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKIKEGYYEFE-SPF 230 (304)
T ss_dssp ---------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHCCCCCC-TTT
T ss_pred ---------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHHcCCCCCC-ccc
Confidence 12345789999999999999999999999999999999999999875443 23333333332222 223
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+|..+.+++..||..||++||++.++.+
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3567889999999999999999999998876
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=329.66 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=205.6
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---------------CChhHHHHHHHHHHHcCCCCCCee
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---------------KHPQLLYEAKVYKILQGGSGIPNI 68 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---------------~~~~~~~e~~~l~~l~~~~~~~~i 68 (318)
-+.++|++++.||.|+||.||+|.+..+++.||+|++.... ....+.+|+.++..+.| ++++.+
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~ 111 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH-PNIIKL 111 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCC-TTBCCE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCC-CCCCeE
Confidence 46789999999999999999999999999999999876432 12457889999999976 666677
Q ss_pred eeccccCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEE
Q 021053 69 KWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 147 (318)
Q Consensus 69 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL 147 (318)
..++......++|||++ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||++........+||
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 66667788899999999 7899998876 355999999999999999999999999999999999999963323347999
Q ss_pred EeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHH
Q 021053 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (318)
Q Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (318)
+|||++........ .....||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+.. ..+..
T Consensus 191 ~Dfg~a~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~ 258 (504)
T 3q5i_A 191 VDFGLSSFFSKDYK--------LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ---DIIKK 258 (504)
T ss_dssp CCCTTCEECCTTSC--------BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH
T ss_pred EECCCCEEcCCCCc--------cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH
Confidence 99999987654322 134568999999999874 6899999999999999999999999886654 33344
Q ss_pred HHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+.......+.+ .+..+|+.+.+++..||..||.+|||+.++.+
T Consensus 259 i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 259 VEKGKYYFDFN-DWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHCCCCCCHH-HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHcCCCCCCcc-ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 44444433433 34678999999999999999999999998775
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=315.91 Aligned_cols=257 Identities=18% Similarity=0.219 Sum_probs=201.8
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcE----EEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEI----VAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~----vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
+..++|++.+.||+|+||.||+|.+..+++. |++|.+.... ....+.+|+.++..++| +++..+..+.. ..
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~-~~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH-AHIVRLLGLCP-GS 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCC-TTBCCEEEEEC-BS
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCC-CCcCeEEEEEc-CC
Confidence 4468999999999999999999999877765 7777664332 23467789999999876 55555544443 45
Q ss_pred ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..++|+|++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL---KSPSQVQVADFGVADL 164 (325)
T ss_dssp SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE---SSSSCEEECSCSGGGG
T ss_pred ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE---CCCCeEEECCCCcccc
Confidence 688999999 899999998655568999999999999999999999999999999999999 4889999999999987
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
........ ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+ . ....
T Consensus 165 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~-~~~~ 235 (325)
T 3kex_A 165 LPPDDKQL-----LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL---E-KGER 235 (325)
T ss_dssp SCCCTTCC-----C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH---H-TTCB
T ss_pred cCcccccc-----cccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH---H-cCCC
Confidence 54433211 1234467788999999998899999999999999999999 99999875543222222 1 1111
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
.+. ...++..+.+++..||..+|.+||++.++.+.|..+.
T Consensus 236 ~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 236 LAQ---PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CCC---CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCC---CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 111 1245778999999999999999999999999998864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=306.85 Aligned_cols=251 Identities=20% Similarity=0.287 Sum_probs=204.5
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--------ChhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
++.++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.++..++| +++..+..++...
T Consensus 2 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~ 80 (283)
T 3bhy_A 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH-PNIITLHDIFENK 80 (283)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECS
T ss_pred chhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCC-CCeeehhheecCC
Confidence 567899999999999999999999999999999998764321 2457889999999976 6666666666677
Q ss_pred cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCC----eEEEEec
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN----QVYIIDF 150 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~----~~kL~df 150 (318)
...++|||++ +++|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||++. ..+ .+||+||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~---~~~~~~~~~kl~df 156 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLL---DKNVPNPRIKLIDF 156 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES---CSSSSSCCEEECCC
T ss_pred CeEEEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEe---cCCCCCCceEEEec
Confidence 7899999999 7899999976 45699999999999999999999999999999999999995 444 8999999
Q ss_pred cceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHH
Q 021053 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (318)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~ 230 (318)
|.+........ .....+++.|+|||++.+..++.++||||||+++|+|++|..||.+.+... ....+..
T Consensus 157 g~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~ 225 (283)
T 3bhy_A 157 GIAHKIEAGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---TLTNISA 225 (283)
T ss_dssp TTCEECC----------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHT
T ss_pred ccceeccCCCc--------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---HHHHhHh
Confidence 99986543322 123467899999999998899999999999999999999999998765432 2333332
Q ss_pred hhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.... .........+..+.+++.+||..+|++||++.++.+
T Consensus 226 ~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 226 VNYD-FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp TCCC-CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred cccC-CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 2222 233444678889999999999999999999998876
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=330.12 Aligned_cols=252 Identities=24% Similarity=0.343 Sum_probs=203.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
+.++|++.+.||+|+||.||+|++..++..||+|++.... ....+.+|+.+++.+.| +++..+..++......++
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH-PNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCC-CCCCeEEEEEEeCCEEEE
Confidence 4568999999999999999999999999999999876432 34568899999999976 566666666677788999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
|||++ +++|.+.+... ..+++..+..++.||+.||.|||++||+||||||+||++...+..+.+||+|||++......
T Consensus 114 v~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 114 VMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 99999 78999988763 45999999999999999999999999999999999999964334667999999999876533
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. .....||+.|+|||++. ..++.++||||+||++|+|++|.+||.+.+.. ..+..+.......+.+
T Consensus 193 ~~--------~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~i~~~~~~~~~~- 259 (494)
T 3lij_A 193 KK--------MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ---EILRKVEKGKYTFDSP- 259 (494)
T ss_dssp BC--------BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCCCSG-
T ss_pred cc--------ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCCch-
Confidence 22 13456899999999876 46899999999999999999999999886654 3334444344333333
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+..+|+.+.+++..||..+|.+|||+.++.+
T Consensus 260 ~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 34578899999999999999999999998765
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=319.57 Aligned_cols=252 Identities=21% Similarity=0.288 Sum_probs=181.9
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccc-----cC
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGV-----DG 75 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~-----~~ 75 (318)
+.++|++.+.||.|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|++.+..+..+.. ..
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 568999999999999999999999999999999988654322 356789999999986444433333322 23
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
...++++++++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++.
T Consensus 107 ~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 107 NDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARH 181 (367)
T ss_dssp CCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECC------
T ss_pred CeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE---CCCCCEEEeecccccc
Confidence 56899999999999998875 459999999999999999999999999999999999999 4889999999999976
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh--
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK-- 232 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~-- 232 (318)
..... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+....+..
T Consensus 182 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 182 TADEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 251 (367)
T ss_dssp -------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred ccccC----------CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 54321 24477999999999887 678999999999999999999999998876544443333221100
Q ss_pred ---------------------ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 233 ---------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 233 ---------------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+........++.+.+++.+||..||++|||+.++.+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 001111222345677899999999999999999987765
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=335.23 Aligned_cols=258 Identities=19% Similarity=0.317 Sum_probs=211.1
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+-..+|++.+.||.|+||.||+|.+..++..||||+++.... ...+.+|+.++.+++| +++..+..+.......++||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCC-CCEeeEEEEEecCCcEEEEE
Confidence 345789999999999999999999998899999999876543 3578899999999976 55666666666677899999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|++ +++|.+++.... ..++...+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 296 E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCC
T ss_pred EccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---CCCCcEEEeecccceeccCCc
Confidence 999 789999998643 358899999999999999999999999999999999999 488999999999998754332
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+.+....... .......+
T Consensus 373 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~----~~~~~~~~--- 439 (495)
T 1opk_A 373 YT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----LEKDYRME--- 439 (495)
T ss_dssp EE------CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH----HHTTCCCC---
T ss_pred ee------ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHcCCCCC---
Confidence 21 1233455778999999998889999999999999999999 9999987654332222 22222222
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
....+|+.+.+++..||+.+|++||++.++.+.|++++.
T Consensus 440 ~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 123678899999999999999999999999999988753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=319.80 Aligned_cols=253 Identities=21% Similarity=0.265 Sum_probs=196.3
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeecc-----------
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG----------- 72 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~----------- 72 (318)
...++|++++.||+|+||.||+|.+..+++.||+|++..... ...+|+.+++.++|++.+..+..+.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~--~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~ 81 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR--YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQ 81 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT--SCCHHHHHHTTCCCTTBCCEEEEEEEC---------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc--hHHHHHHHHHHcCCCCccchhheeeecCcccccccc
Confidence 457899999999999999999999999999999998765433 3347999999997754444433331
Q ss_pred --------------------------ccCcceEEEEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 021053 73 --------------------------VDGEDNVLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRG 123 (318)
Q Consensus 73 --------------------------~~~~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~ 123 (318)
......++|||++.++|.+.+.. ....+++..++.++.||+.||.|||++|
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 161 (383)
T 3eb0_A 82 PPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG 161 (383)
T ss_dssp ----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred cccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCc
Confidence 22334889999998898887764 2456999999999999999999999999
Q ss_pred ccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHH
Q 021053 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYV 202 (318)
Q Consensus 124 i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~i 202 (318)
|+||||||+||++. ..++.+||+|||++........ .....+|+.|+|||++.+.. ++.++||||+||+
T Consensus 162 i~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 162 ICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEP--------SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp EECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSC--------CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred CccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCC--------CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999999999994 2578999999999987643322 13456789999999988754 8999999999999
Q ss_pred HHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH------------------------HhhcCchhHHHHHHHHhhc
Q 021053 203 LLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV------------------------LCKSHPAEFASYFHYCQSL 258 (318)
Q Consensus 203 l~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~~~~~~~li~~cl~~ 258 (318)
+|+|++|++||.+.+..+....+.. ....++.+. +....|..+.+++.+||..
T Consensus 232 l~ell~g~~pf~~~~~~~~~~~i~~---~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLVRIIQ---IMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHH---HHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHH---HhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 9999999999998766544333322 222222111 1234677899999999999
Q ss_pred CCCCCCChHHHHH
Q 021053 259 TFDQRPDYGFLKR 271 (318)
Q Consensus 259 ~p~~Rp~~~~l~~ 271 (318)
||.+|||+.++.+
T Consensus 309 dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 309 EPDLRINPYEAMA 321 (383)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999998765
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=333.43 Aligned_cols=254 Identities=26% Similarity=0.348 Sum_probs=209.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
.++.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.++.+++| ++++.+..++.....
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~ 100 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH-PNIMKLYEFFEDKGY 100 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCC-CCCCcEEEEEEeCCE
Confidence 467789999999999999999999999999999999875432 23467899999999965 666667666677788
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++|+|++ +++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||++...+..+.+||+|||++...
T Consensus 101 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 179 (484)
T 3nyv_A 101 FYLVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179 (484)
T ss_dssp EEEEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHB
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEc
Confidence 99999999 8899998876 456999999999999999999999999999999999999954446789999999998765
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
..... .....+|+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+... .+..+.......+
T Consensus 180 ~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 180 EASKK--------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILKKVEKGKYTFE 247 (484)
T ss_dssp CCCCS--------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCCCCC
T ss_pred ccccc--------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHcCCCCCC
Confidence 43322 123468999999999876 68999999999999999999999998866543 3334443333333
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+ .+..+|+.+.+++..||..+|.+|||+.++.+
T Consensus 248 ~~-~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 248 LP-QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp SG-GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred Cc-ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 33 23578899999999999999999999998765
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=309.79 Aligned_cols=254 Identities=20% Similarity=0.276 Sum_probs=198.5
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+..++|++.+.||+|+||.||+|.+ +++.||+|++........+.+|+.++..++|++.+..+..+.......++|||
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 4568999999999999999999987 47899999998777677889999999999875544444444455567999999
Q ss_pred cc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 84 LL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
++ +++|.+++..... .+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||.+........
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~ 172 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQD 172 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE---eCCCcEEEeecccccccccccc
Confidence 99 6699999976432 37899999999999999999999999999999999999 4889999999999875443221
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
...++..|+|||++.+..++.++||||||+++|+|++ |..||....... ....+... ...+ .
T Consensus 173 ----------~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~~-~~~~---~ 235 (278)
T 1byg_A 173 ----------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKG-YKMD---A 235 (278)
T ss_dssp -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTTT-CCCC---C
T ss_pred ----------CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhcC-CCCC---C
Confidence 2356788999999998889999999999999999998 999998754332 22222211 1111 2
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
...+|+.+.+++..||+.+|++||++.++.+.|+++...
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 236 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 246788999999999999999999999999999987543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-45 Score=317.51 Aligned_cols=260 Identities=20% Similarity=0.334 Sum_probs=189.5
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCc---EEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~---~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
+..++|++.+.||+|+||.||+|.+..++. .||+|++..... ...+.+|+.+++.++| +++..+..+.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH-PHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCC-TTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCC-Cceehhhceeeccc
Confidence 457899999999999999999999876664 899998865432 2467889999999965 55555544433333
Q ss_pred c------eEEEEecc-CCCHHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCe
Q 021053 77 D------NVLVLDLL-GPSLEDLFVYCRR-----KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (318)
Q Consensus 77 ~------~~lv~e~~-~~~L~~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~ 144 (318)
. .++|+|++ +++|.+++..... .+++..+..++.|++.||.|||++||+||||||+||++ +.++.
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli---~~~~~ 175 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML---AEDMT 175 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSC
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE---cCCCC
Confidence 2 39999999 7799999875431 48899999999999999999999999999999999999 48899
Q ss_pred EEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHH
Q 021053 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ 223 (318)
Q Consensus 145 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~ 223 (318)
+||+|||++.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--- 247 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYR-----QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE--- 247 (323)
T ss_dssp EEECCCCC----------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---
T ss_pred EEEeecccccccccccccc-----ccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---
Confidence 9999999997654332211 1233456778999999999899999999999999999999 999998765432
Q ss_pred HHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
....+..... .+ ....++..+.+++..||+.||++||++.++.+.+++++..
T Consensus 248 ~~~~~~~~~~-~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 248 IYNYLIGGNR-LK---QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HHHHHHTTCC-CC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHhcCCC-CC---CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 2222222211 11 1235688999999999999999999999999999998654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=314.39 Aligned_cols=251 Identities=20% Similarity=0.221 Sum_probs=206.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----------ChhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
+.++|++.+.||.|+||.||+|.+..+|+.||||++..... ...+.+|+.++..+..|+++..+..++..
T Consensus 92 ~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 171 (365)
T 2y7j_A 92 FYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES 171 (365)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB
T ss_pred hhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee
Confidence 34689999999999999999999998999999998865432 23467899999999666778787777777
Q ss_pred CcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
....++|||++ +++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||||+||++ +.++.+||+|||++
T Consensus 172 ~~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~---~~~~~ikl~DfG~~ 247 (365)
T 2y7j_A 172 SSFMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL---DDNMQIRLSDFGFS 247 (365)
T ss_dssp SSEEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTC
T ss_pred CCEEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---CCCCCEEEEecCcc
Confidence 88899999999 7799999876 3459999999999999999999999999999999999999 48899999999998
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccC------CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHH
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (318)
........ .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...+.. ..+..
T Consensus 248 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---~~~~~ 316 (365)
T 2y7j_A 248 CHLEPGEK--------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---LMLRM 316 (365)
T ss_dssp EECCTTCC--------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH
T ss_pred cccCCCcc--------cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---HHHHH
Confidence 87653322 134578999999998863 35788999999999999999999999875443 23333
Q ss_pred HHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+.......+.+ .+...+..+.+++.+||..||++||++.++.+
T Consensus 317 i~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 317 IMEGQYQFSSP-EWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HHHTCCCCCHH-HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhCCCCCCCc-ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 33333333333 33577889999999999999999999998765
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=314.03 Aligned_cols=265 Identities=18% Similarity=0.241 Sum_probs=191.1
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeecc--------c
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYG--------V 73 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~--------~ 73 (318)
+.+.+|++.+.||.|+||.||+|++..+++.||+|++..... ...+.+|+.++.++..|+++..+..+. .
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 446799999999999999999999999999999998754432 235788999999998667776664443 3
Q ss_pred cCcceEEEEeccCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeeccCCCCCeEEEEe
Q 021053 74 DGEDNVLVLDLLGPSLEDLFVYC--RRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIID 149 (318)
Q Consensus 74 ~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~kL~d 149 (318)
.....++++|++.++|.+++... ...+++..+..++.||+.||.|||++| |+||||||+||++ +.++.+||+|
T Consensus 105 ~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~D 181 (337)
T 3ll6_A 105 GQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCD 181 (337)
T ss_dssp SSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCC
T ss_pred CCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEec
Confidence 44568999999999999998753 345899999999999999999999999 9999999999999 4888999999
Q ss_pred ccceeeecCCCCCccc-----cccCCCCCcccccccccccc---cCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhh
Q 021053 150 FGLAKKYRDPTTNRHI-----PYRENKNLTGTARYASCNTH---LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221 (318)
Q Consensus 150 fg~~~~~~~~~~~~~~-----~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~ 221 (318)
||++............ .........+|+.|+|||++ .+..++.++|||||||++|+|++|+.||......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-- 259 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-- 259 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--
Confidence 9999865433221100 00011234588999999998 5666889999999999999999999999764332
Q ss_pred HHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcC
Q 021053 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (318)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~ 281 (318)
.+.......+.. ...+..+.+++..||+.+|.+||++.++.+.|..+.....
T Consensus 260 -----~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 260 -----RIVNGKYSIPPH---DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp -----------CCCCTT---CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred -----HhhcCcccCCcc---cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 111222222222 3556789999999999999999999999999998865543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=306.15 Aligned_cols=253 Identities=22% Similarity=0.362 Sum_probs=194.2
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC------ChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
++-.++|++.+.||+|+||.||+|.+ ++..||+|++..... ...+.+|+.+++.++| +++..+..++....
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH-PNIIALRGVCLKEP 79 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCC-TTBCCEEEEECCC-
T ss_pred ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCC-CCEeeEEEEEecCC
Confidence 45568999999999999999999998 478899998764322 2467889999999976 66666666666777
Q ss_pred ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCceeeccCC-----CCCeEEE
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG---FLHRDIKPDNFLMGLGR-----KANQVYI 147 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~Nil~~~~~-----~~~~~kL 147 (318)
..++|||++ +++|.+++. ...+++..+..++.|++.||.|||++| ++||||||+||+++... ..+.+||
T Consensus 80 ~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl 157 (271)
T 3dtc_A 80 NLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKI 157 (271)
T ss_dssp -CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEE
T ss_pred ceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEE
Confidence 899999999 788988886 456999999999999999999999999 89999999999995211 2778999
Q ss_pred EeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHH
Q 021053 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (318)
Q Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (318)
+|||.+........ ....+++.|+|||++.+..++.++||||||+++|+|++|+.||.+.+.... ...
T Consensus 158 ~Dfg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~ 225 (271)
T 3dtc_A 158 TDFGLAREWHRTTK---------MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV---AYG 225 (271)
T ss_dssp CCCCC----------------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH---HHH
T ss_pred ccCCcccccccccc---------cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHh
Confidence 99999876543322 234688999999999988899999999999999999999999987654322 222
Q ss_pred HHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
+.......+ ....+|+.+.+++.+||+.+|.+||++.++.+.|++
T Consensus 226 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 226 VAMNKLALP---IPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHTSCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred hhcCCCCCC---CCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 222222222 224678899999999999999999999999998864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=314.68 Aligned_cols=259 Identities=21% Similarity=0.287 Sum_probs=198.2
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEE----EEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIV----AVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~v----aiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
.+..++|++.+.||+|+||.||+|.+..+++.+ ++|.+.... ....+.+|+.++..++| +++..+..++...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~ 89 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTS 89 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCB-TTBCCCCEEEESS
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCC-CCeeEEEEEEecC
Confidence 355689999999999999999999998777655 666554332 23467889999999976 4555554444443
Q ss_pred cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
..+++++++ +++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++.
T Consensus 90 -~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~---~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAK 165 (327)
T ss_dssp -SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE---ETTEEEECCTTC--
T ss_pred -CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEc---CCCCEEEccCccee
Confidence 377788887 8999999987667799999999999999999999999999999999999994 88999999999998
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+........ ......
T Consensus 166 ~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~----~~~~~~ 236 (327)
T 3lzb_A 166 LLGAEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS----ILEKGE 236 (327)
T ss_dssp -------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH----HHHTTC
T ss_pred EccCccccc-----cccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----HHHcCC
Confidence 764332211 1223456778999999999999999999999999999999 999998765433222 222222
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
..+. ...++..+.+++..||..+|.+||++.++.+.|.++..
T Consensus 237 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 237 RLPQ---PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2222 23567889999999999999999999999999998753
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=315.56 Aligned_cols=263 Identities=23% Similarity=0.273 Sum_probs=207.0
Q ss_pred cceeeEeeeeccCcccEEEEEE----EcCCCcEEEEEeecCCCCC--hhHHHHHHHHHHHcCCCCCCeeeec--cccCcc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWY--GVDGED 77 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~----~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~i~~~--~~~~~~ 77 (318)
.++|++.+.||+|+||.||+|+ +..+++.||+|++...... ..+.+|+.++..++| +++..+..+ ......
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS-DFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCC-CceeEEEEEEecCCCce
Confidence 5899999999999999999999 4678899999988765432 357889999999966 455555333 235567
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++|||++ +++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||.+...
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~---~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCGGGCEEC
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEEC---CCCCEEEcccccceec
Confidence 89999999 8899999987666799999999999999999999999999999999999994 8899999999999876
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhH-----------HHH
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK-----------QKY 225 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~-----------~~~ 225 (318)
....... .......++..|+|||++.+..++.++|||||||++|+|++|..||......... ..+
T Consensus 178 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 178 PLDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CTTCSEE----ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ccCCccc----eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 5433211 1223456788899999999888999999999999999999999999765432110 111
Q ss_pred HHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 226 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
..........+ ....+|+.+.+++..||..||++||++.++.+.|+.++..
T Consensus 254 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 254 LELLEEGQRLP---APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HHHhhcccCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 11111111122 1246788999999999999999999999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=312.67 Aligned_cols=255 Identities=22% Similarity=0.272 Sum_probs=196.3
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCCh----hHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
-++|++.+.||.|+||.||+|++..+++.||+|++....... .+.+|+.++..++| +++..+..++......++|
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv 102 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH-ENLVNLLEVCKKKKRWYLV 102 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCC-CCEeeEEEEeecCCEEEEE
Confidence 478999999999999999999999999999999876554332 35689999999986 5666666666777889999
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
||++.+++.+.+......+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||.+........
T Consensus 103 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~ 179 (331)
T 4aaa_A 103 FEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGE 179 (331)
T ss_dssp EECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCTTC--------
T ss_pred EecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE---cCCCcEEEEeCCCceeecCCcc
Confidence 9999555555444435569999999999999999999999999999999999999 4888999999999976543322
Q ss_pred CccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh---------
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK--------- 231 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~--------- 231 (318)
......++..|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.......+......
T Consensus 180 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 180 -------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred -------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence 11344678999999998875 6899999999999999999999999876554333322221110
Q ss_pred --------------hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 232 --------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 232 --------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
....+.......+++.+.+++.+||..||++||++.++.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0011122223356888999999999999999999998776
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=310.81 Aligned_cols=252 Identities=20% Similarity=0.281 Sum_probs=194.0
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeecccc--CcceEEEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD--GEDNVLVL 82 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~--~~~~~lv~ 82 (318)
..++|++.+.||.|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+.+|+++..+..+... ....++||
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 468999999999999999999999999999999998753 346788999999999977888777655554 56789999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|++ +++|.+++.. ++...+..++.||+.||.|||++||+||||||+||+++ .+...+||+|||++........
T Consensus 113 e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~ 186 (330)
T 3nsz_A 113 EHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE 186 (330)
T ss_dssp ECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCC
T ss_pred eccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCCc
Confidence 999 7888887753 88999999999999999999999999999999999995 2334899999999986543322
Q ss_pred CccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchh-HhhhHHHHHHHHH---------
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLK-AATKKQKYDKICE--------- 230 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~-~~~~~~~~~~i~~--------- 230 (318)
.....++..|+|||++.+ ..++.++|||||||++|+|++|..||.... .......+.....
T Consensus 187 --------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 187 --------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp --------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHH
T ss_pred --------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHH
Confidence 134467889999999887 568999999999999999999999995422 2111111111110
Q ss_pred -hhccCch-------------------HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 231 -KKVSTPI-------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 231 -~~~~~~~-------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.....+. ......+++.+.+++..||..||.+|||+.++.+
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0001125777888888888888888888887765
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=324.22 Aligned_cols=254 Identities=25% Similarity=0.323 Sum_probs=194.9
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----------CChhHHHHHHHHHHHcCCCCCCeeeeccc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~e~~~l~~l~~~~~~~~i~~~~~ 73 (318)
.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.++.+++| +++..+..+..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~l~~~~~ 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH-PCIIKIKNFFD 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCC-TTBCCCCEEEE
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCC-CCEeeEEEEEe
Confidence 35689999999999999999999999999999999875421 12357899999999976 45555544433
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
....++|||++ +++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++..+....+||+|||+
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred -cCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 34589999999 8899888765 44599999999999999999999999999999999999996444556799999999
Q ss_pred eeeecCCCCCccccccCCCCCcccccccccccccC---CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHH
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~ 229 (318)
+........ .....||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....... .....+.
T Consensus 289 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~i~ 358 (419)
T 3i6u_A 289 SKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQIT 358 (419)
T ss_dssp TTSCC-------------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHHHHH
T ss_pred ceecCCCcc--------ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHHHHh
Confidence 976543221 134568999999999864 457889999999999999999999997643321 1222222
Q ss_pred HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.... ...+..+..+++.+.+++..||..||++||++.++.+
T Consensus 359 ~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 359 SGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp TTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCC-CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 2222 3334445678999999999999999999999998766
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=328.24 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=205.9
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
++..++|.+++.||.|+||.||+|.+..+++.||||++... .....+.+|+.+++.++| +++..+..+......
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH-PHIIKLYQVISTPSD 90 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCE
Confidence 45668999999999999999999999999999999987532 223467889999998876 566666666667778
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++|||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 91 ~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll---~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 91 IFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNMM 166 (476)
T ss_dssp EEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE---CTTCCEEECCCSSCEEC
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE---ecCCCeEEEeccchhhc
Confidence 99999999 8899999875 4469999999999999999999999999999999999999 58899999999999875
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
..... .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.. .....+.......
T Consensus 167 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~---~~~~~i~~~~~~~ 235 (476)
T 2y94_A 167 SDGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP---TLFKKICDGIFYT 235 (476)
T ss_dssp CTTCC--------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH---HHHHHHHTTCCCC
T ss_pred ccccc--------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH---HHHHHHhcCCcCC
Confidence 43322 134568999999999998775 78999999999999999999999875442 3334444333333
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
| ..+++.+.+++..||..||++||++.++.+
T Consensus 236 p-----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 236 P-----QYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp C-----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred C-----ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 3 346789999999999999999999999887
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=318.74 Aligned_cols=252 Identities=22% Similarity=0.242 Sum_probs=201.4
Q ss_pred cceeeE--eeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 6 GVKYKL--GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 6 ~~~y~~--~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
...|.+ .+.||.|+||.||+|.+..+++.||+|++.... ....+.+|+.++..++| +++..+..++......++|
T Consensus 86 ~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDH-ANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp GGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred ccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEE
Confidence 345555 678999999999999999999999999887643 23467889999999976 5666666666777789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+||++.. +..+.+||+|||++.......
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec-CCCCcEEEEeCCCceecCCcc
Confidence 9999 78999988765566999999999999999999999999999999999999842 256789999999998764332
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
. .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.. ..+..+.......+.. .
T Consensus 244 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---~~~~~i~~~~~~~~~~-~ 311 (373)
T 2x4f_A 244 K--------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA---ETLNNILACRWDLEDE-E 311 (373)
T ss_dssp B--------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCSCSG-G
T ss_pred c--------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhccCCCChh-h
Confidence 2 12346899999999999888999999999999999999999999886553 3334444444333322 3
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+++.+.+++..||..+|.+||++.++.+
T Consensus 312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 312 FQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 3567889999999999999999999998877
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=307.10 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=195.8
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
.+-.++|++.+.||+|+||.||+|++ .++.||+|++........+.+|+.++.+++| +++..+..+.. ...++||
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~--~~~~lv~ 78 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNH-PNIVKLYGACL--NPVCLVM 78 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCC-TTBCCEEEBCT--TTTEEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCC-CCcCeEEEEEc--CCcEEEE
Confidence 45568999999999999999999988 4688999998776656678899999999976 45555544433 4589999
Q ss_pred ecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCCCceeeccCCCCC-eEEEEeccceee
Q 021053 83 DLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHS---RGFLHRDIKPDNFLMGLGRKAN-QVYIIDFGLAKK 155 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~Nil~~~~~~~~-~~kL~dfg~~~~ 155 (318)
||+ +++|.+++..... .++...+..++.|++.||.|||+ +||+||||||+||++. ..+ .+||+|||.+..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~---~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTACD 155 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEE---TTTTEEEECCCCC---
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEe---CCCCEEEEcccccccc
Confidence 999 7899999985332 37888999999999999999999 8999999999999995 555 489999999875
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
..... ....+|+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......+.. ....
T Consensus 156 ~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~-~~~~ 223 (307)
T 2eva_A 156 IQTHM----------TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA-FRIMWAVHN-GTRP 223 (307)
T ss_dssp -------------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH-HHHHHHHHT-TCCC
T ss_pred ccccc----------ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH-HHHHHHHhc-CCCC
Confidence 43322 23357999999999999999999999999999999999999997543221 111112111 1111
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
.....+|..+.+++.+||..+|++||++.++.+.|+.+.
T Consensus 224 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 224 ---PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp ---CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred ---CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 123467889999999999999999999999999998874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=316.21 Aligned_cols=261 Identities=22% Similarity=0.247 Sum_probs=195.3
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-hhHHHHHHHHHHHcCCCCCCeeeecccc----CcceE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDNV 79 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~~~~~~~~i~~~~~~----~~~~~ 79 (318)
-.++|++.+.||+|+||.||+|++. ++.||||++...... ....+|+.++..++| +++..+..++.. ....+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKH-ENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCCC-CCchhhcceeccCCCCCceEE
Confidence 3579999999999999999999884 789999988653322 234557777888876 445555433333 33479
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CccccCCCCCceeeccCCCCCeEEEE
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR----------GFLHRDIKPDNFLMGLGRKANQVYII 148 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~----------~i~H~dl~p~Nil~~~~~~~~~~kL~ 148 (318)
+|||++ +++|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+||++ +..+.+||+
T Consensus 99 lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~ 173 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIA 173 (322)
T ss_dssp EEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEEC
T ss_pred EEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE---CCCCeEEEc
Confidence 999999 7799999975 4589999999999999999999999 99999999999999 488999999
Q ss_pred eccceeeecCCCCCccccccCCCCCcccccccccccccCC-----CCCCcchHHHHHHHHHHHHhCCCCccchhHhhh--
Q 021053 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK-- 221 (318)
Q Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~-- 221 (318)
|||++.......... ......+|+.|+|||++.+. .++.++|||||||++|+|+||..||.+..+...
T Consensus 174 DFg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 174 DFGLALKFEAGKSAG-----DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CCTTCEEECTTSCCC-----CCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred cCCcccccccccCcc-----ccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 999998765433211 12345789999999999874 456788999999999999999999976432111
Q ss_pred -----------HHHHHHHHHhhccCchHHHh--hcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 222 -----------KQKYDKICEKKVSTPIEVLC--KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 222 -----------~~~~~~i~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
......+......+.....+ ...+..+.+++.+||+.||++|||+.++.+.|+.+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp THHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11111111111111111111 1123459999999999999999999999999998754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=312.99 Aligned_cols=257 Identities=18% Similarity=0.264 Sum_probs=202.8
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCC-------cEEEEEeecCCC--CChhHHHHHHHHHHHcCCCCCCeeeecc
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTN-------EIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYG 72 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~-------~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~i~~~~ 72 (318)
.++..++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+|+.++..++| +++..+..++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~ 81 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH-KHLVLNYGVC 81 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCC-TTBCCEEEEE
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCC-CCEeEEEEEE
Confidence 5678899999999999999999999998766 469999875433 23467889999999976 6666666666
Q ss_pred ccCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCe-------
Q 021053 73 VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ------- 144 (318)
Q Consensus 73 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~------- 144 (318)
......++|||++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+||+++ ..+.
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~---~~~~~~~~~~~ 158 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLI---REEDRKTGNPP 158 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE---ECCBGGGTBCC
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEe---cCCcccccccc
Confidence 6677889999999 6899999987665699999999999999999999999999999999999995 4444
Q ss_pred -EEEEeccceeeecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhh
Q 021053 145 -VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATK 221 (318)
Q Consensus 145 -~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~ 221 (318)
+||+|||.+...... ....++..|+|||++.+ ..++.++|||||||++|+|++ |.+||...+....
T Consensus 159 ~~kl~Dfg~~~~~~~~-----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~ 227 (289)
T 4fvq_A 159 FIKLSDPGISITVLPK-----------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227 (289)
T ss_dssp EEEECCCCSCTTTSCH-----------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred eeeeccCcccccccCc-----------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH
Confidence 999999998543211 12356788999999987 668999999999999999999 5566655433221
Q ss_pred HHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCC
Q 021053 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGS 282 (318)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~ 282 (318)
. .........+ ...+..+.+++..||+.||++||++.++.+.|++++++.+.
T Consensus 228 ~----~~~~~~~~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 228 L----QFYEDRHQLP-----APKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp H----HHHHTTCCCC-----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred H----HHhhccCCCC-----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 1 1122222222 24577899999999999999999999999999988665443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=304.70 Aligned_cols=257 Identities=19% Similarity=0.269 Sum_probs=208.3
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+-.++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+|+.++..++| +++..+..++......++||
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 82 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVT 82 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCC-TTBCCEEEEECSSSSCEEEE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCC-CCEeeEEEEEccCCCeEEEE
Confidence 34589999999999999999999986 567899998876543 3568899999999975 66666666666677899999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|++ +++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.+||+|||.+........
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 83 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp CCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHHH
T ss_pred eCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE---CCCCCEEEcccccccccccccc
Confidence 999 789999998766668999999999999999999999999999999999999 4889999999999875432211
Q ss_pred CccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||...+... ....+.... ... .
T Consensus 160 ------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~i~~~~-~~~---~ 226 (267)
T 3t9t_A 160 ------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTGF-RLY---K 226 (267)
T ss_dssp ------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTTC-CCC---C
T ss_pred ------cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HHHHHhcCC-cCC---C
Confidence 11223456788999999998889999999999999999999 999998755432 222222221 111 1
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
....+..+.+++..||+.+|++||++.++.+.|.++..
T Consensus 227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 13457889999999999999999999999999998754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=306.76 Aligned_cols=261 Identities=22% Similarity=0.282 Sum_probs=196.1
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
..++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.++..++| +++..+..++......+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNVIKYYASFIEDNELN 108 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEcCCcEE
Confidence 45789999999999999999999999999999998875322 2357789999999976 55666666666677899
Q ss_pred EEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 80 LVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
+|||++ +++|.+++... ...++...+..++.|++.||.|||++|++|+||+|+||++ +.++.+||+|||++..
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~ 185 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRF 185 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCC-----
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE---cCCCCEEEEeccceee
Confidence 999999 67999998752 3458999999999999999999999999999999999999 4889999999999876
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
...... ......++..|+|||++.+..++.++||||||+++|+|++|..||.+.... .......+.....+.
T Consensus 186 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~ 257 (310)
T 2wqm_A 186 FSSKTT-------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCDYPP 257 (310)
T ss_dssp --------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHHHHHTTCSCC
T ss_pred ecCCCc-------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHHHhhcccCCC
Confidence 543322 112446789999999999989999999999999999999999999764321 112222222222111
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhc
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~ 280 (318)
. ....++..+.+++..||+.||++||++.++.+.+.++....
T Consensus 258 ~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 258 L---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp C---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 1 12357889999999999999999999999999999875543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=312.62 Aligned_cols=263 Identities=18% Similarity=0.270 Sum_probs=203.9
Q ss_pred CccccceeeEeeeeccCcccEEEEEE-----EcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccc
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLAS-----HVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~-----~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~ 73 (318)
.++..++|++.+.||.|+||.||+|. +..++..||+|++..... ...+.+|+.++..++| +++..+..++.
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~ 103 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNH-QNIVRCIGVSL 103 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEC
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCC-CCCCeEEEEEc
Confidence 46788999999999999999999999 456788999998864432 2357789999999965 66666666666
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEE
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCR------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~k 146 (318)
.....++|||++ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++.+.....+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 777889999999 889999998753 3488999999999999999999999999999999999995333556799
Q ss_pred EEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHH
Q 021053 147 IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKY 225 (318)
Q Consensus 147 L~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~ 225 (318)
|+|||.+.......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+... ..
T Consensus 184 l~Dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~ 255 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYR-----KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VL 255 (327)
T ss_dssp ECCCHHHHHHHC-----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HH
T ss_pred ECccccccccccccccc-----cCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HH
Confidence 99999987544332211 1234467889999999988889999999999999999998 999998754432 22
Q ss_pred HHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 226 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
..+.......+ ...++..+.+++..||..+|.+||++.++.+.+..+.
T Consensus 256 ~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 256 EFVTSGGRMDP----PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHTTCCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCCCCCC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 22222211111 2356889999999999999999999999999998764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=302.52 Aligned_cols=258 Identities=19% Similarity=0.226 Sum_probs=202.4
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcC---CCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~---~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
.+..++|++.+.||+|+||.||+|.+.. ++..||+|++..... ...+.+|+.++..++| +++..+..+... .
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~-~ 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDH-PHIVKLIGIIEE-E 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCC-TTBCCEEEEECS-S
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCC-CCcceEEEEEcC-C
Confidence 3567899999999999999999998753 334699998876532 2457889999999976 455555444333 4
Q ss_pred ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..++|||++ +++|.+++......++...+..++.|++.||.|||++|++||||||+||+++ .++.+||+|||.+..
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRY 162 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---ETTEEEECCCCGGGC
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEC---CCCcEEeCccCCCcc
Confidence 578999999 7899999987666799999999999999999999999999999999999994 788999999999876
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
....... ......++..|+|||++.+..++.++|||||||++|+|++ |+.||...........+ .. ...
T Consensus 163 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~---~~-~~~ 232 (281)
T 3cc6_A 163 IEDEDYY------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL---EK-GDR 232 (281)
T ss_dssp C---------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH---HH-TCC
T ss_pred ccccccc------ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH---hc-CCC
Confidence 5433221 1223456788999999988889999999999999999998 99999765443322222 11 111
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
.+. ...+|+.+.+++.+||+.+|++||++.++.+.|+++..
T Consensus 233 ~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 233 LPK---PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCC---CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 221 13568889999999999999999999999999998754
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=318.92 Aligned_cols=252 Identities=23% Similarity=0.242 Sum_probs=195.3
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccc-----cCcceE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV-----DGEDNV 79 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~-----~~~~~~ 79 (318)
...+|++.+.||.|+||.||+|++..+++.||||++..... ...+|+.+++.++|++.+..+..+.. +....+
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT--SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 34689999999999999999999999999999998765432 34579999999987554444333221 223467
Q ss_pred EEEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 80 LVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 80 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
+||||+.+++.+.+.. ....+++..+..++.||+.||.|||++||+||||||+|||++ .+.+.+||+|||+++..
T Consensus 130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~ 207 (420)
T 1j1b_A 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQL 207 (420)
T ss_dssp EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEEC
T ss_pred eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe--CCCCeEEeccchhhhhc
Confidence 9999998888877653 245689999999999999999999999999999999999994 24577899999999875
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
..... .....+|+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+... .+......+
T Consensus 208 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~---~i~~~lg~p 276 (420)
T 1j1b_A 208 VRGEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV---EIIKVLGTP 276 (420)
T ss_dssp CTTCC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCSC
T ss_pred ccCCC--------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCC
Confidence 43322 1245679999999998765 69999999999999999999999998866543333 333222211
Q ss_pred chHH------------------------HhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 PIEV------------------------LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 ~~~~------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+. +....+..+.+++.+||..||.+||++.++.+
T Consensus 277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 1111 12245778999999999999999999998765
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=306.34 Aligned_cols=248 Identities=21% Similarity=0.284 Sum_probs=203.4
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
..++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.++..+.| +++..+..++......++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCC-CCEeEEEEEEecCCeEEEE
Confidence 45789999999999999999999999999999998865432 3467889999999866 5566666566667789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||++ +++|.+++.. ..++...+..++.|++.||.|||++|++|+||+|+||++ +.++.+||+|||.+.......
T Consensus 99 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp EECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTB
T ss_pred EEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE---CCCCCEEEeecccceecCccc
Confidence 9999 6799998874 568999999999999999999999999999999999999 488999999999998765432
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
. ......+++.|+|||++.+..++.++|||||||++|+|++|..||...+..... ..+.... . ...
T Consensus 174 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~-~---~~~ 239 (303)
T 3a7i_A 174 I-------KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---FLIPKNN-P---PTL 239 (303)
T ss_dssp C-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHHSC-C---CCC
T ss_pred c-------ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH---HHhhcCC-C---CCC
Confidence 2 123456889999999999989999999999999999999999999875543222 2222111 1 112
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRL 272 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 272 (318)
...++..+.+++..||..+|++||++.++.+.
T Consensus 240 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 240 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 34678899999999999999999999998774
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=316.23 Aligned_cols=279 Identities=19% Similarity=0.270 Sum_probs=212.5
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
.++..++|++.+.||.|+||.||+|.+..+++.||+|++...... ..+.+|+.++..++| +++..+..++......
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCC-TTBCCEEEEEEETTEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCC-CCEEEEeEEEEECCEE
Confidence 567889999999999999999999999999999999988765332 357789999988865 6666666666677889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
++|||++ +++|.+++... ..+++..+..++.|++.||.|||+. ||+||||||+||++ +.++.+||+|||++...
T Consensus 107 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp EEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHH
T ss_pred EEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE---CCCCCEEEEECCCCccc
Confidence 9999999 77999999874 4589999999999999999999996 99999999999999 48899999999998654
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHH-----------
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKY----------- 225 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~----------- 225 (318)
..... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||...+.......+
T Consensus 183 ~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3eqc_A 183 IDSMA---------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253 (360)
T ss_dssp HHHC-------------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------
T ss_pred ccccc---------cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCC
Confidence 32211 2346799999999999999999999999999999999999999765443221111
Q ss_pred ----------------------------HHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHH-HHH
Q 021053 226 ----------------------------DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF-HDL 276 (318)
Q Consensus 226 ----------------------------~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l-~~~ 276 (318)
..+.... +.......++..+.+++..||..||++|||+.++.++- -+-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 330 (360)
T 3eqc_A 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP---PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330 (360)
T ss_dssp --------------------CCCHHHHHHHHHHSC---CCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCCcccCCCcccccccCCCCcccchhhhhHHhccC---CCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence 1111000 00011124677899999999999999999999877631 122
Q ss_pred HHhcCCchhHHHhhhcCCccc
Q 021053 277 FSREGSLLLQFIMSYCSLHSI 297 (318)
Q Consensus 277 ~~~~~~~~~~~~l~~~p~~r~ 297 (318)
...+..++..-+....+..++
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~p 351 (360)
T 3eqc_A 331 SDAEEVDFAGWLCSTIGLNQP 351 (360)
T ss_dssp HHHSCCCHHHHHHHHHTC---
T ss_pred chHhhhhHHHHHhhhhccCCC
Confidence 244666666555444444443
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=304.35 Aligned_cols=247 Identities=23% Similarity=0.328 Sum_probs=201.3
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
.+.-++|++.+.||.|+||.||+|.+..++..||+|++... .....+.+|+.++..++| +++..+..++.....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDATR 83 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCC-CCCcchhheEecCCE
Confidence 34568999999999999999999999999999999987532 223457789999998876 666666666677788
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++|||++ +++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||++ +.++.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili---~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHA 159 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE---CTTSCEEECSCCEESCC
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE---cCCCCEEEEeccccccC
Confidence 99999999 68999998764 459999999999999999999999999999999999999 48899999999988654
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
..... ....+++.|+|||++.+..++.++||||||+++|+|++|..||...+.... ...+.......|
T Consensus 160 ~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~ 227 (279)
T 3fdn_A 160 PSSRR---------TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKRISRVEFTFP 227 (279)
T ss_dssp -----------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHHTCCCCC
T ss_pred Ccccc---------cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---HHHHHhCCCCCC
Confidence 32221 344678999999999998999999999999999999999999987654332 223322222222
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..++..+.+++..||+.+|.+||++.++.+
T Consensus 228 -----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 228 -----DFVTEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp -----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -----CcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 346788999999999999999999998887
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=328.04 Aligned_cols=258 Identities=22% Similarity=0.368 Sum_probs=206.0
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++..++|++.+.||+|+||.||+|.+. ++..||||+++... ....+.+|+.+++.++|+ ++..+..+.. ....++|
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHD-KLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCT-TBCCEEEEEC-SSSCEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCC-CEeeEEEEEe-CCccEEE
Confidence 355688999999999999999999985 46789999887644 335788999999999764 4555544433 5578999
Q ss_pred Eecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
||++ +++|.+++.... ..++...+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 261 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV---SASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp ECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCH
T ss_pred EeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCC
Confidence 9999 889999997532 358899999999999999999999999999999999999 48899999999999765322
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
.. .......++..|+|||++....++.++|||||||++|+|+| |..||.+.+.......+ .. ....+.
T Consensus 338 ~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~~-~~~~~~- 406 (454)
T 1qcf_A 338 EY------TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---ER-GYRMPR- 406 (454)
T ss_dssp HH------HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---HH-TCCCCC-
T ss_pred ce------eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc-CCCCCC-
Confidence 11 11123355788999999998889999999999999999999 99999876554333222 22 222222
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
...+|+.+.+++.+||+.||++||++.++.+.|++++..
T Consensus 407 --~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 407 --PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred --CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 136788999999999999999999999999999887543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=314.94 Aligned_cols=249 Identities=20% Similarity=0.279 Sum_probs=187.3
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeecccc-----C
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVD-----G 75 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~-----~ 75 (318)
+.++|++.+.||.|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++|++.+..+..+... .
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 457999999999999999999999999999999988754322 3567899999999764444443333222 2
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
...++|||++.++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 103 ~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 103 QDVYIVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 176 (371)
T ss_dssp CEEEEEEECCSEEHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC---
T ss_pred cceEEEEEcCCCCHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE---cCCCCEEEEEeecccc
Confidence 3689999999889988885 348999999999999999999999999999999999999 4889999999999976
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
...... .....+|+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.... +..+..... .
T Consensus 177 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~-~ 244 (371)
T 2xrw_A 177 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLG-T 244 (371)
T ss_dssp ---------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHC-CC-C
T ss_pred cccccc--------cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhC-C
Confidence 543211 1345789999999999999999999999999999999999999988655332 233322211 1
Q ss_pred chHHHh--------------------------------------hcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 PIEVLC--------------------------------------KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 ~~~~~~--------------------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
|.+.+. ...+..+.+++.+||..||++|||+.++.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 111111 112456889999999999999999998776
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=307.91 Aligned_cols=261 Identities=18% Similarity=0.258 Sum_probs=203.2
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCC---CcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
..+|++.+.||+|+||.||+|.+..+ ...||+|.+...... ..+.+|+.++++++|++.+..+..+.......+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 46899999999999999999997543 346889987754432 357789999999987554444455566667889
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+|||++ +++|.+++......++...+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||.+.....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---CCCCCEEECcccccccccc
Confidence 999999 779999998656668999999999999999999999999999999999999 4889999999999976543
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
..... ........+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||...+..... ..+........
T Consensus 181 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~---~~~~~~~~~~~- 253 (298)
T 3f66_A 181 KEYYS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYLLQGRRLLQ- 253 (298)
T ss_dssp GGGCB---C-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH---HHHHTTCCCCC-
T ss_pred cchhc---cccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH---HHHhcCCCCCC-
Confidence 22111 112234567788999999998899999999999999999999 77777765443222 22222221111
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
...+|..+.+++..||+.+|++||++.++.+.|..++..
T Consensus 254 ---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 254 ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 235688899999999999999999999999999998764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=314.53 Aligned_cols=240 Identities=20% Similarity=0.237 Sum_probs=199.7
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----------CChhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
+.++|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+|+.++..++| +++..+..++..
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~Iv~~~~~~~~ 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEH-ANIIKVLDIFEN 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCC-TTBCCEEEEEEC
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCC-CCEeeEEEEEee
Confidence 4579999999999999999999999999999999877543 23467889999999965 666677666677
Q ss_pred CcceEEEEecc-CC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 75 GEDNVLVLDLL-GP-SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 75 ~~~~~lv~e~~-~~-~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
....++|||++ .+ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~ 176 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTIKLIDFGS 176 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTT
T ss_pred CCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE---cCCCcEEEeeccc
Confidence 78899999988 44 89888876 4459999999999999999999999999999999999999 4789999999999
Q ss_pred eeeecCCCCCccccccCCCCCcccccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~ 231 (318)
+........ .....+|+.|+|||++.+..+ +.++|||||||++|+|++|..||...... ...
T Consensus 177 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------~~~ 239 (335)
T 3dls_A 177 AAYLERGKL--------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------VEA 239 (335)
T ss_dssp CEECCTTCC--------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------TTT
T ss_pred ceECCCCCc--------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------Hhh
Confidence 987654322 123468999999999998876 78999999999999999999999764321 111
Q ss_pred hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
....| ..+++.+.+++..||..+|++||++.++.+
T Consensus 240 ~~~~~-----~~~~~~l~~li~~~L~~dP~~Rps~~ell~ 274 (335)
T 3dls_A 240 AIHPP-----YLVSKELMSLVSGLLQPVPERRTTLEKLVT 274 (335)
T ss_dssp CCCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCC-----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11222 246789999999999999999999998877
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=324.13 Aligned_cols=268 Identities=19% Similarity=0.236 Sum_probs=206.3
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeecccc--Ccc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVD--GED 77 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~--~~~ 77 (318)
.+++++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.++..++| +++..+..++.. ...
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-KNIVKLFAIEEETTTRH 83 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCC-TTBCCEEEEEECTTTCC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCC-CCCCeEEEeeccCCCCe
Confidence 467899999999999999999999999999999999876532 23457789999999986 455555443333 347
Q ss_pred eEEEEecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecc-CCCCCeEEEEeccce
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL-GRKANQVYIIDFGLA 153 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~-~~~~~~~kL~dfg~~ 153 (318)
.++||||+ +++|.+++..... .+++..+..++.||+.||.|||++||+||||||+||++.. .+..+.+||+|||.+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 89999999 7899999876433 2899999999999999999999999999999999999822 236677999999999
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccC--------CCCCCcchHHHHHHHHHHHHhCCCCccchhH-hhhHHH
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKA-ATKKQK 224 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l~tg~~pf~~~~~-~~~~~~ 224 (318)
........ .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ....+.
T Consensus 164 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 235 (396)
T 4eut_A 164 RELEDDEQ--------FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (396)
T ss_dssp EECCCGGG--------SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred eEccCCCc--------cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence 87543321 124568999999999865 4567899999999999999999999975432 222333
Q ss_pred HHHHHHhhccCc--------------------hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 225 YDKICEKKVSTP--------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 225 ~~~i~~~~~~~~--------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
+..+........ ...+...++..+.+++..||..||++||++.++.+.+.+++..
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 444433221100 0011123456789999999999999999999999999887653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=306.91 Aligned_cols=253 Identities=20% Similarity=0.276 Sum_probs=187.2
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCCh---hHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP---QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
++..++|++.+.||.|+||.||+|.+..+++.||+|++....... ....|...+.+..+|+++..+..+.......+
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 467899999999999999999999999999999999887654322 22333333333345577777777767778899
Q ss_pred EEEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 80 LVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 80 lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
+|||++.++|.+++.. ....+++..+..++.|++.||.|||++ |++||||||+||++ +..+.+||+|||.+..
T Consensus 83 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~ 159 (290)
T 3fme_A 83 ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISGY 159 (290)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE---CTTCCEEBCCC-----
T ss_pred EEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE---CCCCCEEEeecCCccc
Confidence 9999998899888764 245699999999999999999999998 99999999999999 4789999999999876
Q ss_pred ecCCCCCccccccCCCCCcccccccccccc----cCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTH----LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~ 231 (318)
...... .....+|+.|+|||++ .+..++.++|||||||++|+|++|..||...... ...+......
T Consensus 160 ~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~ 229 (290)
T 3fme_A 160 LVDDVA--------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP--FQQLKQVVEE 229 (290)
T ss_dssp ------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH--HHHHHHHHHS
T ss_pred cccccc--------ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch--HHHHHHHhcc
Confidence 543322 1234678999999996 4556899999999999999999999999753222 1222222222
Q ss_pred hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...... ...++..+.+++..||+.+|++||++.++.+
T Consensus 230 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 230 PSPQLP---ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCcc---cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 222111 2357889999999999999999999998877
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=312.04 Aligned_cols=263 Identities=20% Similarity=0.233 Sum_probs=201.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccc-----c
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV-----D 74 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~-----~ 74 (318)
..+.++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.++..++|+ ++..+..+.. .
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~ 85 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE-NIITIFNIQRPDSFEN 85 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCT-TBCCEEEECCCSCSTT
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCC-CcCCeeeeecccccCc
Confidence 34678999999999999999999999999999999988654322 2567899999999764 4444433322 2
Q ss_pred CcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 75 GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 75 ~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
....++|+|++.++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 86 ~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 86 FNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLAR 160 (353)
T ss_dssp CCCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCE
T ss_pred cceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE---cCCCcEEEEeccccc
Confidence 367899999999999999875 459999999999999999999999999999999999999 488999999999998
Q ss_pred eecCCCCCcccc---ccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHH
Q 021053 155 KYRDPTTNRHIP---YRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (318)
Q Consensus 155 ~~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~ 230 (318)
...........+ ........+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 765332211000 001223468999999998764 6789999999999999999999999988665433333322211
Q ss_pred hh------------------------ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 231 KK------------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 231 ~~------------------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.. ...+.......+++.+.+++.+||..||++||++.++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00 011223334567889999999999999999999998776
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=313.95 Aligned_cols=247 Identities=21% Similarity=0.293 Sum_probs=193.8
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCc----
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGE---- 76 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~---- 76 (318)
+.++|.+.+.||.|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++|++ +..+..++....
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN-VIGLLDVFTPASSLRN 118 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTT-BCCCSEEECSCSSSTT
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCC-chhhhhheeccCCccc
Confidence 568999999999999999999999999999999998765433 35678999999998754 444433333322
Q ss_pred --ceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 77 --DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 77 --~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
.+++|||++.++|.+.+. ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 119 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 119 FYDFYLVMPFMQTDLQKIMG---MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLAR 192 (371)
T ss_dssp CCCCEEEEECCCEEHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC-
T ss_pred ceeEEEEEccccccHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCccc
Confidence 249999999988887774 449999999999999999999999999999999999999 488999999999997
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
...... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+....+... ..
T Consensus 193 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~~ 259 (371)
T 4exu_A 193 HADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV---TG 259 (371)
T ss_dssp -----------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH---HC
T ss_pred ccccCc----------CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH---hC
Confidence 654322 23467899999999887 67899999999999999999999999886654333333221 11
Q ss_pred cCc--------------------------hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 234 STP--------------------------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 234 ~~~--------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+ .......+++.+.+++..||..||++||++.++.+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 111 11222356788999999999999999999998766
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=327.44 Aligned_cols=247 Identities=21% Similarity=0.298 Sum_probs=202.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+..++|++.+.||.|+||.||+|++..+++.||+|++... .....+.+|..++..++| +++..+..++......
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~l 260 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS-RFIVSLAYAFETKTDL 260 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCC-CCEeeEEEEEeeCCEE
Confidence 4558999999999999999999999999999999987532 233467889999999865 6666776666777889
Q ss_pred EEEEecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 79 VLVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
|+||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl---~~~g~vkL~DFGla~ 337 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLGLAV 337 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCE
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE---eCCCCEEEeecceee
Confidence 9999999 889999987542 358999999999999999999999999999999999999 588999999999998
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhh-hHHHHHHHHHhhc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-KKQKYDKICEKKV 233 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~-~~~~~~~i~~~~~ 233 (318)
........ .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+... .......+.....
T Consensus 338 ~~~~~~~~-------~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~ 410 (543)
T 3c4z_A 338 ELKAGQTK-------TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410 (543)
T ss_dssp ECCTTCCC-------BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCC
T ss_pred eccCCCcc-------cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhccc
Confidence 76543221 124478999999999999999999999999999999999999998753221 1223333333333
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCCh
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDY 266 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 266 (318)
..| ..+|..+.+++..||..||.+||++
T Consensus 411 ~~p-----~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 411 TYP-----DKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp CCC-----TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred CCC-----cccCHHHHHHHHHhccCCHhHCCCC
Confidence 322 4678899999999999999999975
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=330.54 Aligned_cols=251 Identities=20% Similarity=0.249 Sum_probs=203.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+..++|++.+.||.|+||.||+|++..+++.||+|++... .....+.+|+.++..++| +++..+..++......
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~h-p~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-RFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCC-CCEeeEEEEEeeCCEE
Confidence 5568899999999999999999999999999999987532 233467889999999976 5666666666777889
Q ss_pred EEEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 79 VLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
|+||||+ +++|.+++...+ ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl---d~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE---eCCCCeEEEecccceec
Confidence 9999999 889999887643 248999999999999999999999999999999999999 58899999999999876
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHH-HHHHhhccC
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD-KICEKKVST 235 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~-~i~~~~~~~ 235 (318)
..... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+. .+......
T Consensus 337 ~~~~~--------~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~- 407 (576)
T 2acx_A 337 PEGQT--------IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE- 407 (576)
T ss_dssp CTTCC--------EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCC-
T ss_pred ccCcc--------ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccccc-
Confidence 43322 123478999999999999899999999999999999999999998754322222222 22221111
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
+...++..+.+++..||..||.+|| ++.++.+
T Consensus 408 ----~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 408 ----YSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred ----CCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 2246788999999999999999999 5666654
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=314.42 Aligned_cols=255 Identities=18% Similarity=0.208 Sum_probs=176.3
Q ss_pred cccceeeEee-eeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeecccc----Ccce
Q 021053 4 IIGVKYKLGR-KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~-~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~----~~~~ 78 (318)
.+.++|++.+ .||.|+||.||+|.+..+++.||+|++... ....+|+..+.+...|+++..+..++.. ....
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 4678999965 699999999999999999999999998652 3455566655555566776666444332 4458
Q ss_pred EEEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 79 VLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
++|||++ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.++..+.+||+|||++...
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 9999999 779999998643 35899999999999999999999999999999999999964444677999999999765
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHH-HHHHhhccC
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD-KICEKKVST 235 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~-~i~~~~~~~ 235 (318)
..... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||............. .+.......
T Consensus 182 ~~~~~---------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (336)
T 3fhr_A 182 TQNAL---------QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252 (336)
T ss_dssp -------------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CC
T ss_pred ccccc---------ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcccccc
Confidence 43222 24467899999999988889999999999999999999999997654432211111 111112222
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+. ..+..++..+.+++..||..||++||++.++.+
T Consensus 253 ~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 253 PN-PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp CT-TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred Cc-hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 22 123467889999999999999999999998887
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=314.93 Aligned_cols=252 Identities=20% Similarity=0.303 Sum_probs=201.2
Q ss_pred cceeeEeeeeccCcccEEEEEEEc---CCCcEEEEEeecCC------CCChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~---~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
.++|++.+.||.|+||.||+|++. .+++.||||++... .....+.+|+.++..+.+|+++..+..++....
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 379999999999999999999984 57899999987532 233456789999999988888888877777788
Q ss_pred ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..++||||+ +++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++..
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE---CCCCcEEEeeCCCCee
Confidence 899999999 78999998863 459999999999999999999999999999999999999 5889999999999986
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCC--CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHH-HHHHHHHhh
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI--EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ-KYDKICEKK 232 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~-~~~~i~~~~ 232 (318)
....... ......+|+.|+|||++.+. .++.++|||||||++|+|++|..||.......... ....+....
T Consensus 209 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 282 (355)
T 1vzo_A 209 FVADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282 (355)
T ss_dssp CCGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC
T ss_pred cccCCCC------cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC
Confidence 5432221 11244689999999999863 47899999999999999999999997643322222 222222222
Q ss_pred ccCchHHHhhcCchhHHHHHHHHhhcCCCCCC-----ChHHHHHH
Q 021053 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKRL 272 (318)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~l~~~ 272 (318)
.. ....++..+.+++.+||..||.+|| ++.++.+.
T Consensus 283 ~~-----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 283 PP-----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp CC-----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred CC-----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 11 1235678899999999999999999 77776653
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=308.00 Aligned_cols=256 Identities=20% Similarity=0.252 Sum_probs=201.4
Q ss_pred ccceeeEeeeeccCcccEEEEEEEc-CCCcEEEEEeecCCC----CChhHHHHHHHHHHHc--CCCCCCeeeeccc----
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHV-DTNEIVAVKIENSGT----KHPQLLYEAKVYKILQ--GGSGIPNIKWYGV---- 73 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~-~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~--~~~~~~~i~~~~~---- 73 (318)
..++|++.+.||.|+||.||+|.+. .+++.||+|++.... ....+.+|+.+++.+. .|+++..+..+..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4589999999999999999999995 678899999865322 2346778999888885 4566666644433
Q ss_pred -cCcceEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecc
Q 021053 74 -DGEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (318)
Q Consensus 74 -~~~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg 151 (318)
.....++|+|++.++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||
T Consensus 89 ~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili---~~~~~~kl~Dfg 165 (326)
T 1blx_A 89 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFG 165 (326)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCC
T ss_pred CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE---cCCCCEEEecCc
Confidence 456789999999999999998643 348999999999999999999999999999999999999 488999999999
Q ss_pred ceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh
Q 021053 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (318)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~ 231 (318)
.+....... ......++..|+|||++.+..++.++|||||||++|+|++|.+||.+.+.......+......
T Consensus 166 ~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (326)
T 1blx_A 166 LARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237 (326)
T ss_dssp SCCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred ccccccCCC--------CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCC
Confidence 987543221 113456789999999999989999999999999999999999999876654333332221110
Q ss_pred h-------------------ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 232 K-------------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 232 ~-------------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
. ...+.......++..+.+++.+||..||++||++.++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0 011122233467888999999999999999999998775
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=306.85 Aligned_cols=259 Identities=20% Similarity=0.304 Sum_probs=202.7
Q ss_pred cccceeeEee-eeccCcccEEEEEEE--cCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 4 IIGVKYKLGR-KIGSGSFGEIFLASH--VDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 4 ~~~~~y~~~~-~lg~G~~~~v~~~~~--~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
+-.++|++.+ .||.|+||.||+|.+ ..+++.||+|++..... ...+.+|+.++..++| +++..+..+. ...
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~-~~~ 90 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGIC-EAE 90 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC-TTBCCEEEEE-ESS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEE-CCC
Confidence 3457899999 999999999999954 46678999998875432 2357889999999976 5555554444 456
Q ss_pred ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..++|||++ +++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++ .++.+||+|||++..
T Consensus 91 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~---~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 91 SWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKA 166 (291)
T ss_dssp SEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTEEEECCCTTCEE
T ss_pred CcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEe---CCCcEEEccCCccee
Confidence 789999999 7899999986 44599999999999999999999999999999999999994 788999999999987
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||...+...... .+.. ...
T Consensus 167 ~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~---~~~~-~~~ 238 (291)
T 1xbb_A 167 LRADENYY----KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA---MLEK-GER 238 (291)
T ss_dssp CCTTCSEE----EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHHT-TCC
T ss_pred eccCCCcc----cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHHc-CCC
Confidence 65433211 11123345788999999988888999999999999999999 999998765433222 2211 111
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
.+ ....+|+.+.+++..||+.||++||++.++.+.|++++..
T Consensus 239 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 239 MG---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp CC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11 2246788999999999999999999999999999998754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=315.14 Aligned_cols=274 Identities=16% Similarity=0.185 Sum_probs=208.0
Q ss_pred cccceeeEeeeeccCcccEEEEE-----EEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcC--CCCCCeeeeccccCc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG--GSGIPNIKWYGVDGE 76 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~-----~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~--~~~~~~i~~~~~~~~ 76 (318)
+..++|++.+.||+|+||.||+| .+..+++.||+|++... ....+..|..+++.+++ |+++..+..+.....
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~ 140 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSS
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCC
Confidence 34688999999999999999999 46678899999998764 34567888888888874 344555566666777
Q ss_pred ceEEEEecc-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecc--------CCCCC
Q 021053 77 DNVLVLDLL-GPSLEDLFVYC----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL--------GRKAN 143 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~--------~~~~~ 143 (318)
..++||||+ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++. .+..+
T Consensus 141 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~ 220 (365)
T 3e7e_A 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSA 220 (365)
T ss_dssp CEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CT
T ss_pred CcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccC
Confidence 899999999 89999999752 345999999999999999999999999999999999999951 11179
Q ss_pred eEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHH
Q 021053 144 QVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223 (318)
Q Consensus 144 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~ 223 (318)
.+||+|||++.......... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||....... .
T Consensus 221 ~~kl~DFG~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~ 293 (365)
T 3e7e_A 221 GLALIDLGQSIDMKLFPKGT-----IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--C 293 (365)
T ss_dssp TEEECCCTTCEEGGGSCTTE-----EECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE--E
T ss_pred CEEEeeCchhhhhhccCCCc-----eeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc--e
Confidence 99999999997654222211 1234578999999999999999999999999999999999999997543211 0
Q ss_pred HHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCC-CChHHHHHHHHHHHHhc---CCchhHHHhhhcCCc
Q 021053 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQR-PDYGFLKRLFHDLFSRE---GSLLLQFIMSYCSLH 295 (318)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~R-p~~~~l~~~l~~~~~~~---~~~~~~~~l~~~p~~ 295 (318)
... ...... ..++.+.+++..|+..+|.+| |++.++.+.|++++... ..+.+.++|.....+
T Consensus 294 ~~~----~~~~~~------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~~~~~~~l~~~l~~~~~e 359 (365)
T 3e7e_A 294 KPE----GLFRRL------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVLLLE 359 (365)
T ss_dssp EEC----SCCTTC------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHTTTTHHHHHHHHHHHHHH
T ss_pred eec----hhcccc------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhhhhchHHHHHHHHHHHHh
Confidence 000 000000 124568899999999999998 57888999998887653 345666665544333
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=325.02 Aligned_cols=257 Identities=22% Similarity=0.352 Sum_probs=201.1
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+..++|++.+.||+|+||.||+|.+.. +..||||+++.... ...+.+|+.++++++|++ +..+..+... ...++||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~-iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEK-LVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTT-BCCEEEEECS-SSCEEEE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCC-EeeEEEEEcC-CceEEEe
Confidence 456889999999999999999999865 45699999876543 357889999999998754 4444444333 5689999
Q ss_pred ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|++ +++|.+++... +..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||+++......
T Consensus 258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC------
T ss_pred hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE---CCCCCEEECCCccceecCCCc
Confidence 999 78999999753 3458999999999999999999999999999999999999 488999999999997654322
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+........ .+.. ....+.
T Consensus 335 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~---~i~~-~~~~~~-- 402 (452)
T 1fmk_A 335 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD---QVER-GYRMPC-- 402 (452)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH---HHHT-TCCCCC--
T ss_pred ee------cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHc-CCCCCC--
Confidence 11 1223456788999999998889999999999999999999 999998765543222 2221 112221
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
...+|+.+.+++.+||+.+|++||++.++.+.|++++..
T Consensus 403 -~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 403 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred -CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 135788999999999999999999999999999887543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=305.05 Aligned_cols=260 Identities=20% Similarity=0.296 Sum_probs=206.1
Q ss_pred cccceeeEee-eeccCcccEEEEEEEc--CCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 4 IIGVKYKLGR-KIGSGSFGEIFLASHV--DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 4 ~~~~~y~~~~-~lg~G~~~~v~~~~~~--~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
+..++|.+.+ .||+|+||.||+|.+. .++..||+|++..... ...+.+|+.++..++| +++..+..+. ....
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~-~~~~ 83 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVC-QAEA 83 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEE-ESSS
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCC-CCEeEEEEEe-cCCC
Confidence 3457888887 9999999999999864 4678899999876543 2357889999999976 5555554444 4456
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++|||++ +++|.+++......+++..+..++.|++.||.|||++|++||||+|+||+++ .++.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~---~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 84 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEEC
T ss_pred cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEc---CCCCEEECcccceeee
Confidence 89999999 6799999976556699999999999999999999999999999999999994 7899999999999876
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
....... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||...+... ....+.... ..
T Consensus 161 ~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i~~~~-~~ 232 (287)
T 1u59_A 161 GADDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQGK-RM 232 (287)
T ss_dssp TTCSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHTTC-CC
T ss_pred ccCccee----eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHhcCC-cC
Confidence 5432211 11233456889999999988889999999999999999998 999998755432 222222211 11
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
+ ....+|+.+.+++..||+.+|++||++.++.+.|.+++.+
T Consensus 233 ~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 233 E---CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp C---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C---CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1 2246788999999999999999999999999999988654
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=312.57 Aligned_cols=260 Identities=19% Similarity=0.229 Sum_probs=207.9
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEE--EEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIV--AVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~v--aiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+-.++|++.+.||.|+||.||+|++..++..+ ++|.+.... ....+.+|+.++.++.+|+++..+..++......
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 101 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 101 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCce
Confidence 34589999999999999999999998888755 889776432 3346888999999996678888887777777889
Q ss_pred EEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCC
Q 021053 79 VLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~ 142 (318)
++|||++ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||++ +.+
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~ 178 (327)
T 1fvr_A 102 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GEN 178 (327)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGG
T ss_pred EEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCC
Confidence 9999999 789999997543 358999999999999999999999999999999999999 488
Q ss_pred CeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhh
Q 021053 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATK 221 (318)
Q Consensus 143 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~ 221 (318)
+.+||+|||++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...
T Consensus 179 ~~~kL~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~- 249 (327)
T 1fvr_A 179 YVAKIADFGLSRGQEVYV--------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE- 249 (327)
T ss_dssp GCEEECCTTCEESSCEEC--------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-
T ss_pred CeEEEcccCcCccccccc--------cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-
Confidence 899999999987432211 1123355788999999988889999999999999999998 999998765432
Q ss_pred HHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcC
Q 021053 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (318)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~ 281 (318)
....+... ...+ ....+++.+.+++.+||..+|.+||++.++.+.|.+++.+..
T Consensus 250 --~~~~~~~~-~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 250 --LYEKLPQG-YRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp --HHHHGGGT-CCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred --HHHHhhcC-CCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 22222221 1111 123567899999999999999999999999999999876543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=303.67 Aligned_cols=258 Identities=21% Similarity=0.351 Sum_probs=206.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++..++|++.+.||+|+||.||+|.+. ++..||+|++..... ...+.+|+.++..++|+ ++..+..+.. ....++|
T Consensus 9 ~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~-~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQ-RLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCT-TBCCEEEEEC-SSSCEEE
T ss_pred ccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCc-CcceEEEEEc-CCCcEEE
Confidence 356789999999999999999999975 467899998875443 35688999999999764 4545544433 3468999
Q ss_pred Eecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 82 LDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
||++ +++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||.+......
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSS
T ss_pred EecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE---cCCCCEEECCCcccccccCc
Confidence 9999 889999987532 258999999999999999999999999999999999999 48899999999999876543
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.+...... ...+.. ....+
T Consensus 163 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~~~~-~~~~~-- 230 (279)
T 1qpc_A 163 EYT------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQNLER-GYRMV-- 230 (279)
T ss_dssp CEE------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHT-TCCCC--
T ss_pred ccc------cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---HHHHhc-ccCCC--
Confidence 221 1233456778999999988889999999999999999999 9999987554322 222221 11111
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
....+|..+.+++..||+.+|++||++.++.+.|++++..
T Consensus 231 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 231 -RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 1236788999999999999999999999999999998765
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=313.78 Aligned_cols=258 Identities=24% Similarity=0.311 Sum_probs=199.9
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-------CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
+.++|++.+.||.|+||.||+|.+..+++.||+|++... .....+.+|+.+++.++| +++..+..++.....
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pniv~~~~~~~~~~~ 102 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH-PNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCC-TTBCCEEEEEECSSE
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCC-CCcceeehhhccCCe
Confidence 468999999999999999999999999999999987532 223468889999999975 666677666677788
Q ss_pred eEEEEecc-CCCHHHHHHHh---------------------------------------cCCCCHHHHHHHHHHHHHHHH
Q 021053 78 NVLVLDLL-GPSLEDLFVYC---------------------------------------RRKFSLKTVLMLADQMIARIE 117 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~---------------------------------------~~~~~~~~~~~~~~qi~~~L~ 117 (318)
.++|||++ +++|.+++... ...+++..+..++.||+.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999 89999988421 011356778889999999999
Q ss_pred HHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccC--CCCCCcch
Q 021053 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDD 195 (318)
Q Consensus 118 ~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D 195 (318)
|||++||+||||||+||+++. +..+.+||+|||.+........... .......+|+.|+|||++.+ ..++.++|
T Consensus 183 ~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 183 YLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEY---YGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC-----------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCcccc---ccccccCCCccccCchhhccCCCCCCcHHH
Confidence 999999999999999999941 1233899999999986543222110 11234578999999999875 56899999
Q ss_pred HHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 196 LESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 196 vwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
||||||++|+|++|..||.+.+... ....+.......+.+ ....+++.+.+++..||..+|.+||++.++.+
T Consensus 259 iwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFPGVNDAD---TISQVLNKKLCFENP-NYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCCCTTSG-GGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCChHH---HHHHHHhcccccCCc-ccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 9999999999999999998765543 233333333333322 23457889999999999999999999998876
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=303.95 Aligned_cols=261 Identities=18% Similarity=0.261 Sum_probs=201.5
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCc---EEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~---~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
.+|++.+.||+|+||.||+|.+..++. .||+|++...... ..+.+|+.+++.++|++.+..+..+.......++
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 457778999999999999999765444 7999988754432 3567899999999764444444444444455699
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
+++++ +++|.+++......+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||.+......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML---DESFTVKVADFGLARDILDR 177 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEEeCcCCCcccccCC
Confidence 99998 899999998766678999999999999999999999999999999999999 48889999999998754322
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
... .........++..|+|||.+.+..++.++|||||||++|+|++ |.+||...+..... ..+. .....+.
T Consensus 178 ~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~---~~~~-~~~~~~~- 249 (298)
T 3pls_A 178 EYY---SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT---HFLA-QGRRLPQ- 249 (298)
T ss_dssp GGG---CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHH---HHHH-TTCCCCC-
T ss_pred ccc---ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHH---HHhh-cCCCCCC-
Confidence 111 1112234567889999999999999999999999999999999 55556554433222 2222 1222221
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhc
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~ 280 (318)
...+|+.+.+++..||+.+|.+||++.++.+.|++++...
T Consensus 250 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l 289 (298)
T 3pls_A 250 --PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289 (298)
T ss_dssp --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence 2356889999999999999999999999999999987653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=313.07 Aligned_cols=265 Identities=16% Similarity=0.215 Sum_probs=205.3
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC--hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
..++|++.+.||.|+||.||+|.+. +++.||+|++...... ..+.+|+.++..++| +++..+..++......++||
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~~lv~ 114 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRH-PHLVSLIGFCDERNEMILIY 114 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCC-TTBCCEEEECCCTTCCEEEE
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCC-CCEeeEEEEEcCCCeEEEEE
Confidence 4589999999999999999999964 6889999987655432 467889999988876 56666666666777899999
Q ss_pred ecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 83 DLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
|++ +++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++.....
T Consensus 115 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL---DENFVPKITDFGISKKGTE 191 (321)
T ss_dssp ECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSS
T ss_pred EcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE---CCCCCEEEeeccccccccc
Confidence 999 789999886432 248899999999999999999999999999999999999 5889999999999986543
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHH----Hhhc-
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC----EKKV- 233 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~----~~~~- 233 (318)
..... ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+..+........... ....
T Consensus 192 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (321)
T 2qkw_B 192 LDQTH-----LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266 (321)
T ss_dssp SSCCC-----CBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred ccccc-----cccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence 22111 1234468999999999988899999999999999999999999997644322111111000 0000
Q ss_pred ----cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 234 ----STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 234 ----~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
+..........+..+.+++.+||+.||++||++.++.+.|+.++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 0001111223456799999999999999999999999999988653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=315.88 Aligned_cols=253 Identities=22% Similarity=0.264 Sum_probs=194.5
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccc------cC
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV------DG 75 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~------~~ 75 (318)
.+....+|++.+.||.|+||.||+|++..++. ||+|.+..... ...+|+.+++.++|+ ++..+..++. ..
T Consensus 35 ~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~--~~~~E~~il~~l~h~-niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 35 GEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR--FKNRELQIMRIVKHP-NVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp CCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT--SCCHHHHHHHTCCCT-TBCCEEEEEEEESSSSSC
T ss_pred CCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc--hHHHHHHHHHhCCCC-CcceEEEEEEecCCCCCc
Confidence 34567899999999999999999999987766 77776654332 234799999999874 4545433332 22
Q ss_pred cceEEEEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 76 EDNVLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
...++||||+.+++.+.+.. ....+++..++.++.||+.||.|||++||+||||||+||+++ ...+.+||+|||+
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~ 188 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSGVLKLIDFGS 188 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTT
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEc--CCCCcEEEeeCCC
Confidence 34789999998887666543 245689999999999999999999999999999999999994 2689999999999
Q ss_pred eeeecCCCCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~ 231 (318)
+........ .....+|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+.... +...
T Consensus 189 a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~---i~~~ 257 (394)
T 4e7w_A 189 AKILIAGEP--------NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE---IIKV 257 (394)
T ss_dssp CEECCTTCC--------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHH
T ss_pred cccccCCCC--------CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHH
Confidence 987643322 1245679999999998765 489999999999999999999999998765443333 3222
Q ss_pred hccCchH------------------------HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 232 KVSTPIE------------------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 232 ~~~~~~~------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...++.+ .+....++.+.+++.+||..||.+||++.++.+
T Consensus 258 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred hCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 2121111 122346788999999999999999999998776
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=303.62 Aligned_cols=249 Identities=25% Similarity=0.299 Sum_probs=204.6
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
....++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.+.| +++..+..++.....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~ 89 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH-QHVVGFHGFFEDNDF 89 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSE
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCC-CCEeeeeeeeccCCE
Confidence 4567899999999999999999999999999999998764321 2356789999999865 566666666677778
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++|||++ +++|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||++ +.++.+||+|||.+...
T Consensus 90 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 90 VFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE---cCCCCEEEEeccCceec
Confidence 99999999 6899998876 3469999999999999999999999999999999999999 48899999999999876
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
...... .....+++.|+|||++.+..++.++||||||+++|+|++|..||....... ....+.......|
T Consensus 166 ~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~ 235 (294)
T 2rku_A 166 EYDGER-------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRIKKNEYSIP 235 (294)
T ss_dssp CSTTCC-------BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTTCCCCC
T ss_pred ccCccc-------cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhhccCCCc
Confidence 433221 234568899999999998889999999999999999999999998755432 2223322222222
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..++..+.+++.+||..+|++||++.++.+
T Consensus 236 -----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 236 -----KHINPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp -----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred -----cccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 356788999999999999999999998877
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=301.82 Aligned_cols=247 Identities=21% Similarity=0.295 Sum_probs=204.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
.+.-++|++.+.||.|+||.||+|.+..+++.||+|++... .....+.+|+.++..++| +++..+..++.....
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH-PNILRMYNYFHDRKR 88 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCC-CCEeeEEEEEEcCCE
Confidence 34568999999999999999999999999999999987532 223467889999999976 566666666667788
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++|||++ +++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||++ +.++.+||+|||.+...
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM---GYKGELKIADFGWSVHA 164 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE---CTTCCEEECCCTTCEEC
T ss_pred EEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE---cCCCCEEEecccccccC
Confidence 99999999 67999998874 458999999999999999999999999999999999999 48889999999998765
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
..... ....+++.|+|||++.+..++.++||||||+++|+|++|..||...+... ....+.......|
T Consensus 165 ~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 232 (284)
T 2vgo_A 165 PSLRR---------RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---THRRIVNVDLKFP 232 (284)
T ss_dssp SSSCB---------CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHTTCCCCC
T ss_pred ccccc---------ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---HHHHHhccccCCC
Confidence 43221 34568999999999999899999999999999999999999998755432 2223332222222
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..++..+.+++..||..+|.+||++.++.+
T Consensus 233 -----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 233 -----PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp -----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 356889999999999999999999998876
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=308.16 Aligned_cols=251 Identities=19% Similarity=0.318 Sum_probs=196.3
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-CChhHHHHHHHHHHHcCCCCCCeeeecccc------Ccc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVD------GED 77 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~------~~~ 77 (318)
..++|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+|+.++.++.+|+++..+..++.. ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~ 101 (326)
T 2x7f_A 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ 101 (326)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence 5689999999999999999999999999999999876543 345788999999999766777776555443 457
Q ss_pred eEEEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
.++|||++ +++|.+++.... ..+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.+||+|||++..
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~ 178 (326)
T 2x7f_A 102 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQ 178 (326)
T ss_dssp EEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC-
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCcee
Confidence 89999999 669999998643 458999999999999999999999999999999999999 4889999999999876
Q ss_pred ecCCCCCccccccCCCCCccccccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHH
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~ 230 (318)
...... ......+++.|+|||++. +..++.++|||||||++|+|++|..||...+.... ...+..
T Consensus 179 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~ 248 (326)
T 2x7f_A 179 LDRTVG-------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---LFLIPR 248 (326)
T ss_dssp -------------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHH
T ss_pred cCcCcc-------ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HHHhhc
Confidence 543221 113446899999999987 45688999999999999999999999987554322 222222
Q ss_pred hhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+ ......++..+.+++.+||..+|.+||++.++.+
T Consensus 249 ~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 249 NPAP---RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp SCCC---CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred Cccc---cCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 1111 1122467889999999999999999999998877
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=313.46 Aligned_cols=259 Identities=20% Similarity=0.291 Sum_probs=206.3
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
++..++|++.+.||.|+||.||+|.+. .+++.||+|++...... ..+.+|+.+++.++| +++..+..+...
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~ 99 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQ 99 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCC-TTBCCEEEEECS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCC-CCEeeeEEEEcc
Confidence 466789999999999999999999876 35678999988754432 246789999999876 456666666666
Q ss_pred CcceEEEEecc-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCe
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~---------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~ 144 (318)
....++|||++ +++|.+++.... ..++...+..++.||+.||.|||++||+||||||+||++ +.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE---cCCCe
Confidence 77899999999 789999987642 346899999999999999999999999999999999999 48889
Q ss_pred EEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHH
Q 021053 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQ 223 (318)
Q Consensus 145 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~ 223 (318)
+||+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 248 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYY-----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--- 248 (322)
T ss_dssp EEECCTTCCCGGGGGGCE-----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---
T ss_pred EEECcCcccccccccccc-----ccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---
Confidence 999999998754332211 11223456788999999998889999999999999999999 899998765432
Q ss_pred HHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 224 KYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
....+....... ....+|..+.+++..||+.+|.+||++.++.+.|.+.+
T Consensus 249 ~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 249 VLRFVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp HHHHHHTTCCCC----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 222222222111 12367889999999999999999999999999987753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=304.15 Aligned_cols=249 Identities=18% Similarity=0.193 Sum_probs=200.8
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
...+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+..+..+.+|+++..+..++.....
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~ 85 (289)
T 1x8b_A 6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85 (289)
T ss_dssp CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 44567899999999999999999999999999999998875432 23577888888888667888888777777889
Q ss_pred eEEEEecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCC-------------
Q 021053 78 NVLVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR------------- 140 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~------------- 140 (318)
.++|||++ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||+++.+.
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 99999999 779999997642 4589999999999999999999999999999999999995221
Q ss_pred ---CCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccch
Q 021053 141 ---KANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGL 216 (318)
Q Consensus 141 ---~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~ 216 (318)
....+||+|||.+....... ...+++.|+|||++.+. .++.++|||||||++|+|++|.+|+...
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred ccCCceEEEEcccccccccCCcc-----------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 44579999999988754322 23578999999998866 5678999999999999999999887654
Q ss_pred hHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.. ...+.....+ .....+++.+.+++..||+.||++||++.++.+
T Consensus 235 ~~------~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 235 DQ------WHEIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HH------HHHHHTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hH------HHHHHcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 32 1222222221 122467889999999999999999999998765
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=301.86 Aligned_cols=251 Identities=19% Similarity=0.176 Sum_probs=206.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----------ChhHHHHHHHHHHHcCCCCCCeeeeccc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----------HPQLLYEAKVYKILQGGSGIPNIKWYGV 73 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----------~~~~~~e~~~l~~l~~~~~~~~i~~~~~ 73 (318)
+.++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.++.++.+|+++..+..++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 56899999999999999999999999999999998865431 1346789999999986788888877777
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
.....++|||++ +++|.+++.. ...+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.+||+|||.
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~ 170 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 170 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred cCCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE---cCCCcEEEecccc
Confidence 788899999999 6899999986 4469999999999999999999999999999999999999 4888999999999
Q ss_pred eeeecCCCCCccccccCCCCCccccccccccccc------CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHH
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL------GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 226 (318)
+........ .....+++.|+|||++. ...++.++||||||+++|+|++|..||...+... ...
T Consensus 171 ~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~ 239 (298)
T 1phk_A 171 SCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLR 239 (298)
T ss_dssp CEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH
T ss_pred hhhcCCCcc--------cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---HHH
Confidence 887543322 13446789999999885 4457899999999999999999999998755432 233
Q ss_pred HHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 227 ~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+.......+.+ ....+|..+.+++.+||..||.+||++.++.+
T Consensus 240 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 240 MIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHhcCCcccCcc-cccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 333333333322 23467889999999999999999999998765
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=315.94 Aligned_cols=260 Identities=18% Similarity=0.259 Sum_probs=194.3
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCC---cEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~---~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
.+|++.+.||+|+||.||+|.+..++ ..||+|.+...... ..+.+|+.++.+++|++.+..+..+.......++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 46899999999999999999876432 46899987654332 3577899999999765444444445555667899
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
|||++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++.....
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC---------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE---CCCCCEEEeecccccccccc
Confidence 99999 789999998766668899999999999999999999999999999999999 48899999999999765432
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
.... ........+++.|+|||++.+..++.++|||||||++|+|++ |.+||...+..... ..+..... .+
T Consensus 246 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~---~~~~~~~~-~~-- 316 (373)
T 3c1x_A 246 EFDS---VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYLLQGRR-LL-- 316 (373)
T ss_dssp ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHH---HHHHTTCC-CC--
T ss_pred cccc---ccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHH---HHHHcCCC-CC--
Confidence 2111 011123456788999999998899999999999999999999 78888765443222 22222111 11
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
....+|..+.+++..||+.+|++||++.++.+.|.+++..
T Consensus 317 -~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 317 -QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1235688999999999999999999999999999988654
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=300.12 Aligned_cols=250 Identities=20% Similarity=0.265 Sum_probs=203.3
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeecc---------
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG--------- 72 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~--------- 72 (318)
+..++++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+|+.++..++|++.+..+..+.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN--EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS--GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc--HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 4567899999999999999999999999899999999887543 56789999999998754444333221
Q ss_pred ------ccCcceEEEEecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCe
Q 021053 73 ------VDGEDNVLVLDLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQ 144 (318)
Q Consensus 73 ------~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~ 144 (318)
......++|||++ +++|.+++... ...+++..+..++.|++.||.|||++||+|+||+|+||++. .++.
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~~ 160 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLV---DTKQ 160 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---ETTE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEc---CCCC
Confidence 1234589999999 67999999764 34689999999999999999999999999999999999994 8889
Q ss_pred EEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHH
Q 021053 145 VYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK 224 (318)
Q Consensus 145 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~ 224 (318)
+||+|||.+........ .....+++.|+|||++.+..++.++|||||||++|+|++|..||..... .
T Consensus 161 ~kl~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~ 227 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDGK--------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----F 227 (284)
T ss_dssp EEECCCTTCEESSCCSC--------CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-----H
T ss_pred EEECcchhheecccccc--------ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-----H
Confidence 99999999887654322 1234688999999999999999999999999999999999999864321 1
Q ss_pred HHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
...+.... ....++..+.+++..||+.||.+||++.++.+.+..+
T Consensus 228 ~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 228 FTDLRDGI-------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp HHHHHTTC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhhccc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11211111 1134678899999999999999999999999998875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=308.66 Aligned_cols=263 Identities=22% Similarity=0.283 Sum_probs=203.4
Q ss_pred cccccee-eEeeeeccCcccEEEEEEE----cCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 3 RIIGVKY-KLGRKIGSGSFGEIFLASH----VDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 3 ~~~~~~y-~~~~~lg~G~~~~v~~~~~----~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
.++.++| ++++.||+|+||.||+|.. ..+++.||+|++..... ...+.+|+.+++.++| +++..+..+...
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~ 104 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYH-EHIIKYKGCCED 104 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCC-cchhhEEEEEec
Confidence 5677777 9999999999999988754 35788999999876543 2357889999999986 555555444333
Q ss_pred --CcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecc
Q 021053 75 --GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (318)
Q Consensus 75 --~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg 151 (318)
....++|||++ +++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||
T Consensus 105 ~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg 179 (318)
T 3lxp_A 105 AGAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDFG 179 (318)
T ss_dssp TTTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCGG
T ss_pred CCCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE---cCCCCEEECCcc
Confidence 46789999999 7799999875 448999999999999999999999999999999999999 488999999999
Q ss_pred ceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhh-----------
Q 021053 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT----------- 220 (318)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~----------- 220 (318)
.+.......... .......++..|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 180 ~a~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 255 (318)
T 3lxp_A 180 LAKAVPEGHEYY----RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255 (318)
T ss_dssp GCEECCTTCSEE----EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHH
T ss_pred cccccccccccc----ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccch
Confidence 998765432211 12234467888999999998889999999999999999999999997643211
Q ss_pred hHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
....+..........+ ....+|..+.+++..||..+|++||++.++.+.|+.+.+
T Consensus 256 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 256 TVLRLTELLERGERLP---RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcccCCC---CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 0111112222222222 124678899999999999999999999999999988754
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=312.48 Aligned_cols=270 Identities=23% Similarity=0.309 Sum_probs=199.6
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHH-cCCCCCCeeeeccccC----cc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL-QGGSGIPNIKWYGVDG----ED 77 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~i~~~~~~~----~~ 77 (318)
+.+.++|++.+.||.|+||.||+|++. ++.||+|++.... ......|.+++... .+|+++..+..+.... ..
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 467789999999999999999999884 8899999886433 23445566655554 2456666665444433 67
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceeeccCCCCCeEEEE
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR--------GFLHRDIKPDNFLMGLGRKANQVYII 148 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~--------~i~H~dl~p~Nil~~~~~~~~~~kL~ 148 (318)
.++|||++ +++|.+++.. ..+++..+..++.|++.||.|||++ ||+||||||+||++ +.++.+||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~ 184 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIA 184 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEEC
T ss_pred eEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEE
Confidence 89999999 7799999975 4589999999999999999999999 99999999999999 488999999
Q ss_pred eccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCc------chHHHHHHHHHHHHhC----------CCC
Q 021053 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRR------DDLESLGYVLLYFLRG----------SLP 212 (318)
Q Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~------~DvwslG~il~~l~tg----------~~p 212 (318)
|||++............ ......+|+.|+|||++.+...+.. +|||||||++|+|++| +.|
T Consensus 185 Dfg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDI---PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp CCTTCEECC------------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred eCCCceeeccccccccC---CCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 99999765443322111 1234578999999999988776654 9999999999999999 777
Q ss_pred ccchhHhhh-HHHHHHHH-Hhh--ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCc
Q 021053 213 WQGLKAATK-KQKYDKIC-EKK--VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSL 283 (318)
Q Consensus 213 f~~~~~~~~-~~~~~~i~-~~~--~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 283 (318)
|........ ........ ... ...+.......+++.+.+++.+||+.||++||++.++.+.|+++.+...++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 336 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQDIK 336 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTTCC
T ss_pred HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcccC
Confidence 755322111 11111111 111 112211112345677999999999999999999999999999988766554
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=309.96 Aligned_cols=255 Identities=25% Similarity=0.317 Sum_probs=198.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----------CChhHHHHHHHHHHHcCCCCCCeeeecc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----------KHPQLLYEAKVYKILQGGSGIPNIKWYG 72 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----------~~~~~~~e~~~l~~l~~~~~~~~i~~~~ 72 (318)
..+.++|++.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.++..++| +++..+..+.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~ 84 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH-PCIIKIKNFF 84 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCC-TTBCCEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCC-CCCceEeeEE
Confidence 346789999999999999999999999999999999876432 12357889999999976 4555554444
Q ss_pred ccCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecc
Q 021053 73 VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (318)
Q Consensus 73 ~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg 151 (318)
... ..++|||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++..+.+||+|||
T Consensus 85 ~~~-~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 85 DAE-DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp ESS-SEEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred cCC-ceEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 333 489999999 7799998875 4468999999999999999999999999999999999999633334569999999
Q ss_pred ceeeecCCCCCccccccCCCCCccccccccccccc---CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHH
Q 021053 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHL---GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (318)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i 228 (318)
++........ .....+++.|+|||++. ...++.++|||||||++|+|++|..||........ ....+
T Consensus 163 ~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~ 232 (322)
T 2ycf_A 163 HSKILGETSL--------MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI 232 (322)
T ss_dssp TCEECCCCHH--------HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH
T ss_pred cceecccccc--------cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH
Confidence 9986543211 12345789999999874 45689999999999999999999999976543211 12222
Q ss_pred HHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..... ...+..+..++..+.+++.+||..||++||++.++.+
T Consensus 233 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 233 TSGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp HHTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HhCcc-ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 22222 2233445678899999999999999999999998764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=321.74 Aligned_cols=269 Identities=17% Similarity=0.198 Sum_probs=190.4
Q ss_pred ccccceeeE-eeeeccCcccEEEEEEEc--CCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeecc--ccCcc
Q 021053 3 RIIGVKYKL-GRKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG--VDGED 77 (318)
Q Consensus 3 ~~~~~~y~~-~~~lg~G~~~~v~~~~~~--~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~--~~~~~ 77 (318)
+.+.+.|++ +++||+|+||.||+|++. .+++.||+|++........+.+|+.+++.++|+ ++..+..++ .....
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hp-niv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHP-NVISLQKVFLSHADRK 94 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCT-TBCCCCEEEEETTTTE
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCC-CeeeEeeEEecCCCCe
Confidence 345678887 568999999999999966 568899999998777677889999999999864 455554333 34667
Q ss_pred eEEEEeccCCCHHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccC-CCCCeEEEE
Q 021053 78 NVLVLDLLGPSLEDLFVYCR--------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG-RKANQVYII 148 (318)
Q Consensus 78 ~~lv~e~~~~~L~~~~~~~~--------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~-~~~~~~kL~ 148 (318)
.++||||+.++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+
T Consensus 95 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 95 VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99999999999999886432 138899999999999999999999999999999999999432 367899999
Q ss_pred eccceeeecCCCCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHh------hh
Q 021053 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAA------TK 221 (318)
Q Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~------~~ 221 (318)
|||++......... ........+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.... ..
T Consensus 175 Dfg~a~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~ 250 (405)
T 3rgf_A 175 DMGFARLFNSPLKP----LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250 (405)
T ss_dssp CTTCCC--------------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred ECCCceecCCCCcc----cccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence 99999865432211 1122345789999999999875 4899999999999999999999999754321 11
Q ss_pred HHHHHHHHHhhccCchHHH---------------------------------hhcCchhHHHHHHHHhhcCCCCCCChHH
Q 021053 222 KQKYDKICEKKVSTPIEVL---------------------------------CKSHPAEFASYFHYCQSLTFDQRPDYGF 268 (318)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~---------------------------------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 268 (318)
...+..+......++...+ ....+..+.+++..||..||.+|||+.+
T Consensus 251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e 330 (405)
T 3rgf_A 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ 330 (405)
T ss_dssp HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 2233333322222111110 0011567889999999999999999988
Q ss_pred HHHHHHHHHH
Q 021053 269 LKRLFHDLFS 278 (318)
Q Consensus 269 l~~~l~~~~~ 278 (318)
+.+ +.++.
T Consensus 331 ~L~--hp~f~ 338 (405)
T 3rgf_A 331 AMQ--DPYFL 338 (405)
T ss_dssp HHT--SGGGT
T ss_pred Hhc--Chhhc
Confidence 776 34443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=310.26 Aligned_cols=248 Identities=25% Similarity=0.302 Sum_probs=204.1
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
...++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.+.| +++..+..++......
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH-QHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEecCCeE
Confidence 456899999999999999999999999999999998764321 2356789999999866 5666666666777889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
++|||++ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 117 ~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL---NEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred EEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE---cCCCCEEEeeccCceecc
Confidence 9999999 6899998876 3569999999999999999999999999999999999999 488999999999998764
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
..... .....++..|+|||++.+..++.++|||||||++|+|++|..||....... .+..+.......+
T Consensus 193 ~~~~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~- 261 (335)
T 2owb_A 193 YDGER-------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRIKKNEYSIP- 261 (335)
T ss_dssp STTCC-------BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHHTCCCCC-
T ss_pred cCccc-------ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH---HHHHHhcCCCCCC-
Confidence 33221 234568999999999999889999999999999999999999998755432 2223322222222
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..++..+.+++.+||..||++||++.++.+
T Consensus 262 ----~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 262 ----KHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ----ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 356788999999999999999999998876
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=312.07 Aligned_cols=252 Identities=17% Similarity=0.204 Sum_probs=192.2
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-------------hhHHHHHHHHHHHcCCCCCCeeee
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-------------PQLLYEAKVYKILQGGSGIPNIKW 70 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-------------~~~~~e~~~l~~l~~~~~~~~i~~ 70 (318)
.+.++|++.+.||.|+||.||+|.+.. ++.||||++...... ..+.+|+.++..++| +++..+..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~ 96 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH-PNILGLRD 96 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCC-TTBCCCSE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCC-cCccceee
Confidence 467899999999999999999999865 889999987543221 457899999999986 44444433
Q ss_pred cc-----ccCcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeE
Q 021053 71 YG-----VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (318)
Q Consensus 71 ~~-----~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~ 145 (318)
++ ......++|||++.++|.+.+......+++..+..++.||+.||.|||++||+||||||+||++ +.++.+
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~ 173 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDI 173 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCE
T ss_pred eEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE---cCCCCE
Confidence 32 2334689999999999999998766679999999999999999999999999999999999999 488999
Q ss_pred EEEeccceeeecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHH
Q 021053 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQK 224 (318)
Q Consensus 146 kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~ 224 (318)
||+|||.+........ .....+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......
T Consensus 174 kl~Dfg~~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 245 (362)
T 3pg1_A 174 TICDFNLAREDTADAN--------KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK 245 (362)
T ss_dssp EECCTTC-----------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred EEEecCcccccccccc--------cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9999999975433322 124467889999999887 6689999999999999999999999988655433333
Q ss_pred HHHHHHhhccCch---------------------------HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 225 YDKICEKKVSTPI---------------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 225 ~~~i~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+.. ....++. .......++.+.+++..||..||++|||+.++.+
T Consensus 246 i~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 246 IVE---VVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp HHH---HHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH---HcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 322 1111111 1222345778999999999999999999998776
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=305.18 Aligned_cols=252 Identities=21% Similarity=0.300 Sum_probs=195.8
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcC-CCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQG-GSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~-~~~~~~i~~~~~~~~~~ 78 (318)
+.+++|++.+.||+|+||.||+|.+. +++.||+|++...... ..+.+|+.++..+.+ ++++..+..+.......
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 56789999999999999999999985 4888999988654332 357889999999986 67777777777777889
Q ss_pred EEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 79 VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 79 ~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
++|||+.+++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||++ +++.+||+|||++.....
T Consensus 104 ~lv~e~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~----~~~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 104 YMVMECGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEEECCCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----ETTEEEECCCSSSCC---
T ss_pred EEEEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE----ECCeEEEeeccccccccC
Confidence 99999779999999986 4568999999999999999999999999999999999999 348999999999876543
Q ss_pred CCCCccccccCCCCCcccccccccccccC-----------CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHH
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLG-----------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK 227 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~ 227 (318)
..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||...... ...+..
T Consensus 179 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~~~~~~ 251 (313)
T 3cek_A 179 DTTSV-----VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--ISKLHA 251 (313)
T ss_dssp ----------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHH
T ss_pred ccccc-----cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH--HHHHHH
Confidence 32211 1124468999999999876 46788999999999999999999999764322 122222
Q ss_pred HHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 228 ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 228 i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+........ .....+..+.+++.+||+.+|.+||++.++.+
T Consensus 252 ~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 252 IIDPNHEIE---FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHCTTSCCC---CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhcccccC---CcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 222111111 12345678999999999999999999998876
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=306.12 Aligned_cols=255 Identities=19% Similarity=0.229 Sum_probs=191.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeecccc-------
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVD------- 74 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~------- 74 (318)
+-++|++.+.||+|+||.||+|++..+++.||||++..... ...+.+|+.++..++|++.+..+..+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 34789999999999999999999999999999998864432 24678899999999765444443332111
Q ss_pred -------------------------------------------------CcceEEEEecc-CCCHHHHHHHhcC--CCCH
Q 021053 75 -------------------------------------------------GEDNVLVLDLL-GPSLEDLFVYCRR--KFSL 102 (318)
Q Consensus 75 -------------------------------------------------~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~ 102 (318)
....++|||++ +++|.+++..... ..+.
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 12379999999 8899999986432 2556
Q ss_pred HHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccc-----cccCCCCCcccc
Q 021053 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI-----PYRENKNLTGTA 177 (318)
Q Consensus 103 ~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 177 (318)
..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++............ .........+|+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 6788999999999999999999999999999999 47899999999999876544221110 011224457899
Q ss_pred cccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhh
Q 021053 178 RYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQS 257 (318)
Q Consensus 178 ~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 257 (318)
.|+|||++.+..++.++|||||||++|+|++|..|+.... .....+. ....+ ......++.+.+++..||+
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~~~~~~~--~~~~~--~~~~~~~~~~~~li~~~l~ 311 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----RIITDVR--NLKFP--LLFTQKYPQEHMMVQDMLS 311 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----HHHHHHH--TTCCC--HHHHHHCHHHHHHHHHHHC
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----HHHHHhh--ccCCC--cccccCChhHHHHHHHHcc
Confidence 9999999999999999999999999999999988864321 1122221 11222 2223446688999999999
Q ss_pred cCCCCCCChHHHHH
Q 021053 258 LTFDQRPDYGFLKR 271 (318)
Q Consensus 258 ~~p~~Rp~~~~l~~ 271 (318)
.||++||++.++.+
T Consensus 312 ~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 312 PSPTERPEATDIIE 325 (332)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CCCCcCCCHHHHhh
Confidence 99999999998765
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=307.09 Aligned_cols=266 Identities=20% Similarity=0.233 Sum_probs=204.9
Q ss_pred ccccceeeEeeeeccCcccEEEEEE----EcCCCcEEEEEeecCCCCC--hhHHHHHHHHHHHcCCCCCCeeeeccc-cC
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLAS----HVDTNEIVAVKIENSGTKH--PQLLYEAKVYKILQGGSGIPNIKWYGV-DG 75 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~----~~~~~~~vaiK~~~~~~~~--~~~~~e~~~l~~l~~~~~~~~i~~~~~-~~ 75 (318)
.+..++|++.+.||+|+||.||+|+ +..+++.||+|++...... ..+.+|+.++..++|++.+..+..+.. ..
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC---
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCC
Confidence 4567889999999999999999998 4568899999998764432 357889999999976444433333322 33
Q ss_pred cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
...++|||++ +++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||.+.
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~---~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTK 193 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCE
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEc---CCCcEEEecCcchh
Confidence 4789999999 7899999987666699999999999999999999999999999999999994 78999999999998
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhh------------H
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK------------K 222 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~------------~ 222 (318)
......... .......++..|+|||++.+..++.++|||||||++|+|++|..||........ .
T Consensus 194 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (326)
T 2w1i_A 194 VLPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV 269 (326)
T ss_dssp ECCSSCSEE----ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHH
T ss_pred hcccccccc----ccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhH
Confidence 765432211 112334567789999999988899999999999999999999999875321110 0
Q ss_pred HHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
..+..........+ ....+|..+.+++..||+.+|++||++.++.+.|+++..
T Consensus 270 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 270 FHLIELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHhhcCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 01111111111122 124678899999999999999999999999999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=306.67 Aligned_cols=252 Identities=17% Similarity=0.309 Sum_probs=198.1
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
-..++|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+|+.++..++| +++..+..++......++|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH-PYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCC-TTBCCEEEEEECC-CEEEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCC-CCEeeeeeeeeeCCeEEEE
Confidence 35689999999999999999999999999999999876543 23567889999999976 5566665555666789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||++ +++|.+++......+++..+..++.|++.||.|||++|++||||+|+||++ +.++.+||+|||++.......
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHH
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE---CCCCCEEEEECCCCccccccc
Confidence 9999 778999888766779999999999999999999999999999999999999 478999999999875422111
Q ss_pred CCccccccCCCCCccccccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
. ......++..|+|||++. +..++.++|||||||++|+|++|..||...+.... ...+.... .
T Consensus 172 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~--~ 239 (302)
T 2j7t_A 172 Q-------KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV---LLKIAKSD--P 239 (302)
T ss_dssp H-------C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHSC--C
T ss_pred c-------ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HHHHhccC--C
Confidence 1 112346789999999983 56789999999999999999999999987654322 22222221 1
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+.......+|..+.+++..||+.+|++||++.++.+
T Consensus 240 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111123467889999999999999999999998765
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=307.27 Aligned_cols=261 Identities=19% Similarity=0.222 Sum_probs=194.6
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeecc--------
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYG-------- 72 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~-------- 72 (318)
..++++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.+++.++|++.+..+..+.
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 7 FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp EEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 4578999999999999999999999999999999998765432 245788999999997755444443332
Q ss_pred -----ccCcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEE
Q 021053 73 -----VDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYI 147 (318)
Q Consensus 73 -----~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL 147 (318)
......++|||++.++|.+++.. ..++...+..++.|++.||.|||++||+||||||+||+++ ..++.+||
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl 162 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKI 162 (320)
T ss_dssp ----CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEEE
T ss_pred ccccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEEE
Confidence 23467899999998899999874 5689999999999999999999999999999999999994 25679999
Q ss_pred EeccceeeecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHH
Q 021053 148 IDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226 (318)
Q Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 226 (318)
+|||.+.......... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.
T Consensus 163 ~Dfg~~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 163 GDFGLARIMDPHYSHK----GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp CCCTTCBCC------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccCccccccCCCcccc----cccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999998654321111 01233456888999998875 568999999999999999999999998765533222221
Q ss_pred HHHH----------------------hhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 227 KICE----------------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 227 ~i~~----------------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.... .....+.......++..+.+++.+||+.||++||++.++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 1100 00112223334567889999999999999999999998866
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=303.59 Aligned_cols=246 Identities=23% Similarity=0.320 Sum_probs=179.6
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+|+.++..++| +++..+..++......++|
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH-PSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCC-TTBCCEEEEEECSSEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCC-CCeEeEEEEEccCCeEEEE
Confidence 5799999999999999999999999999999987532 223567889999998876 5666666666777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
+|++ +++|.+++......+++..+..++.|++.||.|||++|++||||+|+||++ +.++.+||+|||.+.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE---CTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE---cCCCCEEEEeecceeeccCCC
Confidence 9999 789999998755679999999999999999999999999999999999999 488999999999998754332
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
.. .....+++.|+|||++.+..++.++|||||||++|+|++|+.||....... .+..+...... .
T Consensus 167 ~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~-----~ 231 (278)
T 3cok_A 167 EK-------HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---TLNKVVLADYE-----M 231 (278)
T ss_dssp --------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CCSSCCC-----C
T ss_pred Cc-------ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---HHHHHhhcccC-----C
Confidence 21 123467899999999998889999999999999999999999997644321 11221111111 1
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...++..+.+++.+||..||++||++.++.+
T Consensus 232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 2356788999999999999999999998765
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=297.88 Aligned_cols=249 Identities=24% Similarity=0.310 Sum_probs=196.2
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
+++..++|++.+.||.|+||.||+|.+..+++.||+|++... .....+.+|+.+++.++| +++..+..+.....
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH-PHIIKLYQVISTPT 84 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSS
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCC-CCEeEEEEEEecCC
Confidence 456779999999999999999999999989999999987532 223467889999999876 55666666666778
Q ss_pred ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..++|||++ +++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.+||+|||.+..
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~~l~dfg~~~~ 160 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHMNAKIADFGLSNM 160 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE---CTTSCEEECCCCGGGC
T ss_pred eEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE---CCCCCEEEeecccccc
Confidence 899999999 78999999764 458999999999999999999999999999999999999 4888999999999876
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
...... .....+++.|+|||++.+..+ +.++||||||+++|+|++|..||...+... ....+......
T Consensus 161 ~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~ 229 (276)
T 2h6d_A 161 MSDGEF--------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFKKIRGGVFY 229 (276)
T ss_dssp CCC---------------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCCC
T ss_pred cCCCcc--------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHhhcCccc
Confidence 543221 123467899999999988775 689999999999999999999998754432 22333222222
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.| ..++..+.+++..||+.||++||++.++.+
T Consensus 230 ~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 230 IP-----EYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CC-----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred Cc-----hhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 22 346788999999999999999999999887
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=300.13 Aligned_cols=250 Identities=10% Similarity=0.124 Sum_probs=199.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccC--c
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG--E 76 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~--~ 76 (318)
.+..++|++.+.||+|+||.||+|.+ +++.||+|++...... ..+.+|+.++.+++| +++..+..+.... .
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH-PNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSC-TTEECEEEEECTTTSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCC-CchhheEEEEccCCCC
Confidence 35568999999999999999999998 4788999988765432 256788888888865 5555554444433 6
Q ss_pred ceEEEEecc-CCCHHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRR-KFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
..++|||++ +++|.+++..... .+++..+..++.|++.||.|||++| ++||||||+||++ +.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~ 159 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADV 159 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGS
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE---cCCcceeEEeccc
Confidence 789999999 7899999986433 4899999999999999999999999 9999999999999 4888999999888
Q ss_pred eeeecCCCCCccccccCCCCCcccccccccccccCCCCCC---cchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHH
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSR---RDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~ 229 (318)
+..... ....+|+.|+|||++.+..++. ++|||||||++|+|++|..||...+..... ..+.
T Consensus 160 ~~~~~~------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~ 224 (271)
T 3kmu_A 160 KFSFQS------------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG---MKVA 224 (271)
T ss_dssp CCTTSC------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH---HHHH
T ss_pred eeeecc------------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH---HHHH
Confidence 654221 2346789999999998776544 799999999999999999999876543322 2222
Q ss_pred HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
......+ ....+|+.+.+++..||+.||++||++.++.+.|.++
T Consensus 225 ~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 225 LEGLRPT---IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp HSCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 2222222 2346788999999999999999999999999999876
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=305.65 Aligned_cols=261 Identities=21% Similarity=0.306 Sum_probs=194.1
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcC---CCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccC-
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVD---TNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG- 75 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~---~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~- 75 (318)
+..++|++.+.||.|+||.||+|.+.. ++..||+|++...... ..+.+|+.++..++|++.+..+..+....
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 446899999999999999999998764 4568999988755433 35778999999998644443333332222
Q ss_pred ---cceEEEEecc-CCCHHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEE
Q 021053 76 ---EDNVLVLDLL-GPSLEDLFVYC-----RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVY 146 (318)
Q Consensus 76 ---~~~~lv~e~~-~~~L~~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~k 146 (318)
...++|+|++ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli---~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML---RDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE---CTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE---cCCCcEE
Confidence 2469999999 78999998532 2458999999999999999999999999999999999999 4888999
Q ss_pred EEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHH
Q 021053 147 IIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKY 225 (318)
Q Consensus 147 L~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~ 225 (318)
|+|||++......... .......+++.|+|||++.+..++.++|||||||++|+|++ |.+||........ .
T Consensus 188 l~Dfg~~~~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~ 259 (313)
T 3brb_A 188 VADFGLSKKIYSGDYY-----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---Y 259 (313)
T ss_dssp ECSCSCC---------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---H
T ss_pred EeecCcceeccccccc-----CcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---H
Confidence 9999998765433221 11234456788999999999999999999999999999999 9999987554322 2
Q ss_pred HHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 226 DKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
..+..... .+ ....+++.+.+++..||..+|++||++.++.+.|.+++..
T Consensus 260 ~~~~~~~~-~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 260 DYLLHGHR-LK---QPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp HHHHTTCC-CC---CBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCC-CC---CCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 22222211 11 1246788999999999999999999999999999988653
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=320.74 Aligned_cols=250 Identities=16% Similarity=0.124 Sum_probs=185.2
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-----hhHHHHHHHHHHHcC-CCCCCe-eee------ccc
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQG-GSGIPN-IKW------YGV 73 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~-~~~~~~-i~~------~~~ 73 (318)
.+|++.+.||.|+||.||+|.+..+++.||+|++...... ..+.+|+.++..+++ |+++.. +.. ...
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4699999999999999999999999999999998875532 245677777777763 344333 211 111
Q ss_pred c-----------------CcceEEEEeccCCCHHHHHHHhcCCCCHHHH------HHHHHHHHHHHHHHHhCCccccCCC
Q 021053 74 D-----------------GEDNVLVLDLLGPSLEDLFVYCRRKFSLKTV------LMLADQMIARIEYVHSRGFLHRDIK 130 (318)
Q Consensus 74 ~-----------------~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~------~~~~~qi~~~L~~lH~~~i~H~dl~ 130 (318)
. ....|+||||+.++|.+++...+..++.... ..++.||+.||.|||++||+|||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 0 0348999999999999999875555555555 6777999999999999999999999
Q ss_pred CCceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccC--CCCCCcchHHHHHHHHHHHHh
Q 021053 131 PDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLR 208 (318)
Q Consensus 131 p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~t 208 (318)
|+|||+ +.++.+||+|||++........ ...+++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 222 p~NIll---~~~~~~kL~DFG~a~~~~~~~~----------~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 222 PDNLFI---MPDGRLMLGDVSALWKVGTRGP----------ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp GGGEEE---CTTSCEEECCGGGEEETTCEEE----------GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred HHHEEE---CCCCCEEEEecceeeecCCCcc----------CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999 4889999999999986542211 2355699999999987 679999999999999999999
Q ss_pred CCCCccchhHhhhHHHHHH---HHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 209 GSLPWQGLKAATKKQKYDK---ICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 209 g~~pf~~~~~~~~~~~~~~---i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
|..||.+..+.... .... ......... ......+|+.+.+++.+||..||++||++.++.+
T Consensus 289 g~~Pf~~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 289 LFLPFGLVTPGIKG-SWKRPSLRVPGTDSLA-FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SSCSTTBCCTTCTT-CCCBCCTTSCCCCSCC-CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCCcCccccc-chhhhhhhhccccccc-hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99999875432111 0000 000000111 1112467889999999999999999999998765
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=316.09 Aligned_cols=259 Identities=25% Similarity=0.333 Sum_probs=196.4
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcC----------CCCCCeeeec
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQG----------GSGIPNIKWY 71 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~----------~~~~~~i~~~ 71 (318)
.+..++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.+++++.+ |+++..+..+
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 3456899999999999999999999999999999999875332 3457789999998874 3455555433
Q ss_pred ccc----CcceEEEEeccCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeeccC---CCC
Q 021053 72 GVD----GEDNVLVLDLLGPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLG---RKA 142 (318)
Q Consensus 72 ~~~----~~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~Nil~~~~---~~~ 142 (318)
+.. ....+++||+++++|.+++.... ..+++..+..++.||+.||.|||++ ||+||||||+||+++.. +..
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 332 23789999999999999998643 4589999999999999999999998 99999999999999421 134
Q ss_pred CeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhh--
Q 021053 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAAT-- 220 (318)
Q Consensus 143 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~-- 220 (318)
+.+||+|||++....... ....+|+.|+|||++.+..++.++|||||||++|+|++|..||...+...
T Consensus 175 ~~~kl~Dfg~a~~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 244 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 244 (373)
T ss_dssp EEEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ceEEEcccccccccCCCC----------CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence 589999999998654322 23467999999999999999999999999999999999999998643211
Q ss_pred -hHHHHHHHHHhhccCchHHH-------------------------------------hhcCchhHHHHHHHHhhcCCCC
Q 021053 221 -KKQKYDKICEKKVSTPIEVL-------------------------------------CKSHPAEFASYFHYCQSLTFDQ 262 (318)
Q Consensus 221 -~~~~~~~i~~~~~~~~~~~~-------------------------------------~~~~~~~~~~li~~cl~~~p~~ 262 (318)
....+..+.......|.... ....+..+.+++..||..||++
T Consensus 245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 324 (373)
T 1q8y_A 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK 324 (373)
T ss_dssp CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence 11222233222222222110 1133567889999999999999
Q ss_pred CCChHHHHH
Q 021053 263 RPDYGFLKR 271 (318)
Q Consensus 263 Rp~~~~l~~ 271 (318)
||++.++.+
T Consensus 325 Rpt~~ell~ 333 (373)
T 1q8y_A 325 RADAGGLVN 333 (373)
T ss_dssp CBCHHHHHT
T ss_pred cCCHHHHhh
Confidence 999998776
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=308.96 Aligned_cols=244 Identities=23% Similarity=0.338 Sum_probs=201.8
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--------CChhHHHHHHHHHHHcC-CCCCCeeeecc
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQG-GSGIPNIKWYG 72 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~~-~~~~~~i~~~~ 72 (318)
.+.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.++..+.+ ++++..+..++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 3567899999999999999999999999999999999876432 22467789999999985 67777777777
Q ss_pred ccCcceEEEEeccC--CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEec
Q 021053 73 VDGEDNVLVLDLLG--PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 150 (318)
Q Consensus 73 ~~~~~~~lv~e~~~--~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~df 150 (318)
......++++|++. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++ .+.+.+||+||
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~--~~~~~~kL~Df 194 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDF 194 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe--CCCCCEEEeeC
Confidence 77788999999994 799999886 45689999999999999999999999999999999999994 26789999999
Q ss_pred cceeeecCCCCCccccccCCCCCcccccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHH
Q 021053 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229 (318)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~ 229 (318)
|++........ ....+|+.|+|||++.+..+ +.++|||||||++|+|++|..||..... +.
T Consensus 195 g~~~~~~~~~~---------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------~~ 256 (320)
T 3a99_A 195 GSGALLKDTVY---------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------II 256 (320)
T ss_dssp TTCEECCSSCB---------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HH
T ss_pred ccccccccccc---------cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---------hh
Confidence 99987653322 23468999999999887665 6889999999999999999999976432 11
Q ss_pred HhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..... ....+++.+.+++.+||..+|++||++.++.+
T Consensus 257 ~~~~~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 257 RGQVF-----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HCCCC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccccc-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111 12356889999999999999999999998866
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=300.72 Aligned_cols=252 Identities=26% Similarity=0.323 Sum_probs=200.3
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
+.++|++.+.||+|+||.||+|.+..+++.||+|++..... ...+.+|+.++..++| +++..+..+.......++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCC-CCceeeeeEEEcCCEEEEE
Confidence 45789999999999999999999999999999998764332 2467889999998876 5666666666677789999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
+|++ +++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.+||+|||.+.......
T Consensus 84 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 84 LEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECEETT
T ss_pred EEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE---ccCCCEEEeeCCCccccCCCc
Confidence 9999 6799988865 3458999999999999999999999999999999999999 478999999999987654322
Q ss_pred CCccccccCCCCCcccccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
... ......++..|+|||++.+..+ +.++|||||||++|+|++|..||...+.... .+..........+
T Consensus 160 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~~--- 229 (276)
T 2yex_A 160 RER-----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKKTYLN--- 229 (276)
T ss_dssp EEC-----CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--HHHHHHTTCTTST---
T ss_pred chh-----cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHhhhcccccC---
Confidence 111 1234568899999999987775 7789999999999999999999987543211 1222221111111
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
....++..+.+++..||+.||++||++.++.+
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 12467889999999999999999999987765
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=305.01 Aligned_cols=264 Identities=19% Similarity=0.251 Sum_probs=198.2
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--CChhHHHHHHHHHHHcCCCCCCeeeeccc----cCcc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGED 77 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~i~~~~~----~~~~ 77 (318)
+.+++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.++..++|+ ++..+..+.. ....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHP-NILRLVAYCLRERGAKHE 104 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCT-TBCCCCEEEEEEETTEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCC-CeeeEEEEEEeccCCCce
Confidence 45689999999999999999999999999999999875432 234678899999999764 4444433322 3457
Q ss_pred eEEEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 78 NVLVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
.++|+|++ +++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||.+
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSC
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcc
Confidence 89999999 77999998863 4558999999999999999999999999999999999999 48899999999987
Q ss_pred eeecCCCCCcc--ccccCCCCCcccccccccccccCCC---CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHH
Q 021053 154 KKYRDPTTNRH--IPYRENKNLTGTARYASCNTHLGIE---QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (318)
Q Consensus 154 ~~~~~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i 228 (318)
........... ..........+++.|+|||++.+.. ++.++|||||||++|+|++|..||......... ....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~ 259 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--VALA 259 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC--HHHH
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch--hhHH
Confidence 75432111000 0000001234588999999987654 688999999999999999999999754322111 1111
Q ss_pred HHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
.......+. ...++..+.+++..||..||.+||++.++.+.|+.+
T Consensus 260 ~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~ 304 (317)
T 2buj_A 260 VQNQLSIPQ---SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304 (317)
T ss_dssp HHCC--CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hhccCCCCc---cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhc
Confidence 112222221 135688999999999999999999999999999875
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=299.32 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=203.9
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
..+.++|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+|+.++++++| +++..+..+.......
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH-PNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccC-CCccEEEEEEeCCCeE
Confidence 346789999999999999999999999999999999875432 23467889999999966 5666666666677789
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
++|+|++ +++|.+.+... ..+++..+..++.||+.||.|||++|++|+||+|+||++...+..+.+||+|||.+....
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999 78998888763 459999999999999999999999999999999999999633345679999999987554
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
.... .....+++.|+|||++.+. ++.++||||||+++|+|++|..||.+.+... ....+.......+.
T Consensus 176 ~~~~--------~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~ 243 (287)
T 2wei_A 176 QNTK--------MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRVETGKYAFDL 243 (287)
T ss_dssp CCSS--------CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHCCCCCCS
T ss_pred CCCc--------cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHHcCCCCCCc
Confidence 3221 1234578899999998764 8999999999999999999999998765433 23333333333222
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+ ....+|..+.+++.+||..+|++||++.++.+
T Consensus 244 ~-~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 244 P-QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp G-GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred h-hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 2 22467889999999999999999999998876
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=298.24 Aligned_cols=249 Identities=21% Similarity=0.258 Sum_probs=195.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccc---cCcc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGV---DGED 77 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~---~~~~ 77 (318)
.++.|++.+.||+|+||.||+|.+..++..||+|++...... ..+.+|+.++..++|++.+..+..+.. ....
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 456799999999999999999999999999999987654322 357789999999976444443333222 3456
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
.++|||++ +++|.+++... ..++...+..++.|++.||.|||++| ++||||||+||+++ +..+.+||+|||++.
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGG
T ss_pred EEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCcc
Confidence 89999999 78999999863 55899999999999999999999999 99999999999994 367899999999986
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
....... ....+++.|+|||++.+ .++.++|||||||++|+|++|..||....... .....+.. .
T Consensus 181 ~~~~~~~---------~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~-~-- 245 (290)
T 1t4h_A 181 LKRASFA---------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTS-G-- 245 (290)
T ss_dssp GCCTTSB---------EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHTT-T--
T ss_pred ccccccc---------ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHHHHHhc-c--
Confidence 5433221 23468899999998874 58999999999999999999999997643321 22222211 1
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..........++.+.+++..||+.+|++||++.++.+
T Consensus 246 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 246 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1222334466788999999999999999999998765
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=322.94 Aligned_cols=239 Identities=14% Similarity=0.119 Sum_probs=182.2
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-----CChhHHHHHHHHHHHc--CCCCCCeee-------ec
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-----KHPQLLYEAKVYKILQ--GGSGIPNIK-------WY 71 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~--~~~~~~~i~-------~~ 71 (318)
.++|++.+.||.|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+. +|+++..+. .+
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 588999999999999999999998899999999876432 1245678886666665 234443332 11
Q ss_pred cccCc-----------------ceEEEEeccCCCHHHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHhCCcccc
Q 021053 72 GVDGE-----------------DNVLVLDLLGPSLEDLFVYCRRKFS-------LKTVLMLADQMIARIEYVHSRGFLHR 127 (318)
Q Consensus 72 ~~~~~-----------------~~~lv~e~~~~~L~~~~~~~~~~~~-------~~~~~~~~~qi~~~L~~lH~~~i~H~ 127 (318)
....+ ..|++||+++++|.+++..... ++ +..+..++.||+.||.|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS-HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHH-TTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccc-cccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 11111 3789999999999999986432 33 47788899999999999999999999
Q ss_pred CCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCC-----------CCCCcchH
Q 021053 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-----------EQSRRDDL 196 (318)
Q Consensus 128 dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~Dv 196 (318)
||||+|||+ +.++.+||+|||++....... ....| +.|+|||++.+. .++.++||
T Consensus 231 Dikp~NIll---~~~~~~kL~DFG~a~~~~~~~----------~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv 296 (377)
T 3byv_A 231 YLRPVDIVL---DQRGGVFLTGFEHLVRDGARV----------VSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA 296 (377)
T ss_dssp CCCGGGEEE---CTTCCEEECCGGGCEETTCEE----------ECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred CCCHHHEEE---cCCCCEEEEechhheecCCcc----------cCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence 999999999 478999999999998533211 23355 889999999887 79999999
Q ss_pred HHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 197 ESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 197 wslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
|||||++|+|++|+.||.+.+...... .+ ... ...+|+.+.+++.+||..||++||++.++.+
T Consensus 297 wSlG~il~elltg~~Pf~~~~~~~~~~---~~----~~~-----~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 297 WALGLVIYWIWCADLPITKDAALGGSE---WI----FRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHHHHHHSSCCC------CCSG---GG----GSS-----CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHHHHHHCCCCCcccccccchh---hh----hhh-----ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999999997754322111 11 111 1366889999999999999999999998876
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=303.19 Aligned_cols=260 Identities=21% Similarity=0.256 Sum_probs=195.7
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcC-CC--cEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeecccc
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVD-TN--EIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVD 74 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~-~~--~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~ 74 (318)
.+..++|++.+.||.|+||.||+|.+.. ++ ..||+|++..... ...+.+|+.++..++| +++..+..+...
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~ 92 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH-RNLIRLYGVVLT 92 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC-TTBCCEEEEECS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCC-CCcccEEEEEcc
Confidence 3557899999999999999999998653 33 3689998765421 2367789999999976 555555444443
Q ss_pred CcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
. ..++|+|++ +++|.+++......+++..+..++.|++.||.|||++|++|+||||+||+++ .++.+||+|||.+
T Consensus 93 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~---~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 93 P-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLM 168 (291)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTC
T ss_pred C-CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEc---CCCCEEEcccccc
Confidence 3 488999999 7899999987666799999999999999999999999999999999999994 7889999999998
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhh
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKK 232 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~ 232 (318)
.......... .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+... .+..+....
T Consensus 169 ~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~~~ 241 (291)
T 1u46_A 169 RALPQNDDHY----VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDKEG 241 (291)
T ss_dssp EECCC-CCEE----EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTSC
T ss_pred ccccccccch----hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---HHHHHHccC
Confidence 8764432211 11223456778999999988888999999999999999999 999998765432 223332222
Q ss_pred ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
...+ ....+|..+.+++..||+.+|++||++.++.+.|.++.
T Consensus 242 ~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 242 ERLP---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCC---CCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 2222 12467889999999999999999999999999998763
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=328.32 Aligned_cols=259 Identities=20% Similarity=0.298 Sum_probs=200.1
Q ss_pred cceeeEee-eeccCcccEEEEEEEc--CCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 6 GVKYKLGR-KIGSGSFGEIFLASHV--DTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 6 ~~~y~~~~-~lg~G~~~~v~~~~~~--~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
.++|.+.+ .||.|+||.||+|.+. .++..||||+++.... ...+.+|+.++..++| +++..+..+... ...+
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~h-pniv~l~~~~~~-~~~~ 411 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVCQA-EALM 411 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCC-TTBCCEEEEEES-SSEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCC-CCEeeEEEEecc-CCeE
Confidence 34566666 8999999999999876 3556799999876432 3468899999999976 455555444443 4689
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+|||++ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL---VNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECCCSTTTTCC-
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE---cCCCcEEEeeccCcccccC
Confidence 999999 889999997655669999999999999999999999999999999999999 4889999999999976543
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
.... +.......++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..... ..+.... ..+
T Consensus 489 ~~~~----~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~---~~i~~~~-~~~- 559 (613)
T 2ozo_A 489 DDSY----YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---AFIEQGK-RME- 559 (613)
T ss_dssp -----------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH---HHHHTTC-CCC-
T ss_pred CCce----eeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHcCC-CCC-
Confidence 2211 011123345678999999998899999999999999999998 99999876554322 2222211 111
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhc
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~ 280 (318)
....+|+.+.+++..||+.+|++||++.++.+.|++++...
T Consensus 560 --~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 560 --CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp --CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred --CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 12367889999999999999999999999999999887553
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=310.48 Aligned_cols=261 Identities=16% Similarity=0.219 Sum_probs=200.4
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
+..++|++.+.||+|+||.||+|.+. +++.||+|++..... ...+.+|+.++..+.| +++..+..++......++
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~~l 104 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVH-RNLLRLRGFCMTPTERLL 104 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCC-TTBCCCCEEECCSSCCEE
T ss_pred HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccC-CCccceEEEEecCCceEE
Confidence 45789999999999999999999854 588999998765432 2367889999998876 666666666667778899
Q ss_pred EEecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 81 VLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSR---GFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
|||++ +++|.+++.... ..+++..+..++.|++.||.|||++ ||+||||||+||++ +.++.+||+|||++
T Consensus 105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVGDFGLA 181 (326)
T ss_dssp EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE---CTTCCEEECCCSSC
T ss_pred EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE---CCCCCEEeccCccc
Confidence 99999 789999998633 2388999999999999999999999 99999999999999 48889999999999
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHH-HHHHHHHhh
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ-KYDKICEKK 232 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~-~~~~i~~~~ 232 (318)
......... ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.......... .........
T Consensus 182 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 182 KLMDYKDTH------VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp EECCSSSSC------EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cccCccccc------ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 876433221 1234458999999999988889999999999999999999999996432111100 011111000
Q ss_pred ccCc----------hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 233 VSTP----------IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 233 ~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
.... ........+..+.+++..||+.+|.+||++.++.+.|+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 0000 000111234679999999999999999999999999975
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=304.12 Aligned_cols=253 Identities=19% Similarity=0.169 Sum_probs=183.5
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-CChhHHHHHHHHHHHcCCCCCCeeeeccc------cCcce
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGV------DGEDN 78 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~i~~~~~------~~~~~ 78 (318)
-++|++.+.||.|+||.||+|.+..+++.||||++.... ......+++..+..++|++.+..+..+.. .....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 101 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL 101 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence 368999999999999999999999999999999875543 33456777778888876544444333322 12237
Q ss_pred EEEEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 79 VLVLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVH--SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 79 ~lv~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH--~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
++|||++.++|.+.+.. ....++...+..++.|++.||.||| ++||+||||||+||+++ ..++.+||+|||++
T Consensus 102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a 179 (360)
T 3e3p_A 102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSA 179 (360)
T ss_dssp EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTC
T ss_pred EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCc
Confidence 89999998888776653 2345889999999999999999999 99999999999999995 23789999999999
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~ 232 (318)
........ .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.+ ..
T Consensus 180 ~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~---~~ 248 (360)
T 3e3p_A 180 KKLSPSEP--------NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR---VL 248 (360)
T ss_dssp BCCCTTSC--------CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---HH
T ss_pred eecCCCCC--------cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH---Hc
Confidence 86543322 12446799999999987655 89999999999999999999999988665443333322 22
Q ss_pred ccCchHHHh---------------------------hcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 233 VSTPIEVLC---------------------------KSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 233 ~~~~~~~~~---------------------------~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+.+.+. ...+..+.+++.+||..||.+||++.++.+
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 222211110 014567999999999999999999998776
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=304.26 Aligned_cols=247 Identities=22% Similarity=0.281 Sum_probs=192.7
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccC-----
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDG----- 75 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~----- 75 (318)
+.++|.+.+.||.|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|+ ++..+..+....
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~-~iv~~~~~~~~~~~~~~ 100 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE-NVIGLLDVFTPASSLRN 100 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCT-TBCCCSEEECSCSSGGG
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCC-CcccHhheEeccccccc
Confidence 568999999999999999999999999999999998764432 3567899999999864 444443333322
Q ss_pred -cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 76 -EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 76 -~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
...++|||++.++|.+++. ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||++.
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 101 FYDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLAR 174 (353)
T ss_dssp CCCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTT
T ss_pred ceeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE---CCCCcEEEeeccccc
Confidence 2469999999988887764 348999999999999999999999999999999999999 488999999999987
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
...... ....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+.......+.. ...
T Consensus 175 ~~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~---~~~ 241 (353)
T 3coi_A 175 HADAEM----------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK---VTG 241 (353)
T ss_dssp C------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHH---HHC
T ss_pred CCCCCc----------cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH---HhC
Confidence 543221 23467899999999887 6789999999999999999999999988655433332222 111
Q ss_pred cCch--------------------------HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 234 STPI--------------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 234 ~~~~--------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.++. .......+..+.+++.+||..||++||++.++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 242 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp BCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111 1112355788999999999999999999998765
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=300.60 Aligned_cols=250 Identities=22% Similarity=0.249 Sum_probs=197.5
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeecc--ccCcceE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYG--VDGEDNV 79 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~--~~~~~~~ 79 (318)
.++|++.+.||.|+||.||+|.+..+++.||+|++...... ..+.+|+.+++.++| +++..+..+. ......+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH-PNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCC-CCCCeEEEEEecCCCceEE
Confidence 47999999999999999999999999999999988754422 357789999999976 4555554332 3456799
Q ss_pred EEEecc-CCCHHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCceeeccCCCCCeEEEEec
Q 021053 80 LVLDLL-GPSLEDLFVYCR---RKFSLKTVLMLADQMIARIEYVHSRG-----FLHRDIKPDNFLMGLGRKANQVYIIDF 150 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dl~p~Nil~~~~~~~~~~kL~df 150 (318)
+|||++ +++|.+++.... ..+++..+..++.|++.||.|||+.| ++||||+|+||++ +.++.+||+||
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~df 160 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF 160 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---CSSSCEEECCC
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEecC
Confidence 999999 679999987642 23899999999999999999999999 9999999999999 48899999999
Q ss_pred cceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHH
Q 021053 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (318)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~ 230 (318)
|.+......... .....++..|+|||++.+..++.++||||||+++|+|++|..||...+... ....+..
T Consensus 161 g~~~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~i~~ 230 (279)
T 2w5a_A 161 GLARILNHDTSF-------AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAGKIRE 230 (279)
T ss_dssp CHHHHC---CHH-------HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH
T ss_pred chheeecccccc-------ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH---HHHHHhh
Confidence 998765432211 123357889999999999899999999999999999999999998765432 2222222
Q ss_pred hhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHH
Q 021053 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLF 273 (318)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l 273 (318)
.... .....++..+.+++.+||+.+|++||++.++.+.+
T Consensus 231 ~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 231 GKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp TCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred cccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 2221 12235788999999999999999999999887744
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=326.95 Aligned_cols=257 Identities=22% Similarity=0.351 Sum_probs=205.0
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+..++|++.+.||+|+||.||+|.+.. +..||||+++.... ...+.+|+.+++.++|++ +..+..+... ...++||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpn-iv~~~~~~~~-~~~~lv~ 340 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEK-LVQLYAVVSE-EPIYIVT 340 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTT-BCCEEEEECS-SSCEEEE
T ss_pred cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCC-EeeEEEEEee-ccceEee
Confidence 556889999999999999999999865 46799999876543 357899999999998754 4444444333 5789999
Q ss_pred ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|++ +++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 341 e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~ 417 (535)
T 2h8h_A 341 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE 417 (535)
T ss_dssp CCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHH
T ss_pred ehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE---cCCCcEEEcccccceecCCCc
Confidence 999 78999999753 3458999999999999999999999999999999999999 478899999999987543211
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
. .......++..|+|||++.+..++.++|||||||++|+|++ |..||.+........ .+.. ....+.
T Consensus 418 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~---~i~~-~~~~~~-- 485 (535)
T 2h8h_A 418 Y------TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD---QVER-GYRMPC-- 485 (535)
T ss_dssp H------HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH---HHHT-TCCCCC--
T ss_pred e------ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHc-CCCCCC--
Confidence 1 11223456788999999998889999999999999999999 999998765543222 2221 112221
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
...+|..+.++|.+||+.+|++||++.++.+.|++++..
T Consensus 486 -~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 486 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred -CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 236788999999999999999999999999999887543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=299.35 Aligned_cols=250 Identities=18% Similarity=0.283 Sum_probs=196.7
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC------CCChhHHHHHHHHHHHcCCCCCCeeeecc--ccCc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSGIPNIKWYG--VDGE 76 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~i~~~~--~~~~ 76 (318)
+.++|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+|+.++..++| +++..+..+. ....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH-KNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCC-CCeeEEEEEEEcCCCC
Confidence 457999999999999999999999999999999987642 223467889999999976 4555554433 4456
Q ss_pred ceEEEEeccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 77 DNVLVLDLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 77 ~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..++|||++.++|.+++... ...+++..+..++.||+.||.|||++|++||||||+||++ +.++.+||+|||.+..
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL---TTGGTLKISALGVAEA 158 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEE
T ss_pred eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE---cCCCcEEeeccccccc
Confidence 78999999977788887763 3458999999999999999999999999999999999999 4889999999999987
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCC--CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhc
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
........ ......++..|+|||++.+.. ++.++|||||||++|+|++|..||.+.+... ....+.....
T Consensus 159 ~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~i~~~~~ 230 (305)
T 2wtk_C 159 LHPFAADD-----TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK---LFENIGKGSY 230 (305)
T ss_dssp CCTTCSSC-----EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHCCC
T ss_pred cCcccccc-----ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH---HHHHHhcCCC
Confidence 64322211 113446899999999988754 3779999999999999999999998755432 2333332222
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+ ..++..+.+++.+||+.||.+||++.++.+
T Consensus 231 ~~~-----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 231 AIP-----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CCC-----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCC-----CccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 222 356788999999999999999999999886
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=325.03 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=203.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCC---CcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
+..++|++.+.||+|+||.||+|.+..+ +..||+|........ ..+.+|+.++..++|+ ++..+..+.. ...
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~Hp-nIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP-HIVKLIGVIT-ENP 464 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCT-TBCCEEEEEC-SSS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCC-CCCeEEEEEe-cCc
Confidence 4568899999999999999999998643 457999987654332 4678899999999774 4555544433 356
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++|||++ +++|.+++......+++..+..++.|++.||.|||++||+||||||+||+++ .++.+||+|||++...
T Consensus 465 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~---~~~~vkL~DFG~a~~~ 541 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYM 541 (656)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCCCCCCSC
T ss_pred eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEe---CCCCEEEEecCCCeec
Confidence 89999999 7899999987555689999999999999999999999999999999999994 7899999999999765
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
...... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+.. ..+.... ..
T Consensus 542 ~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~---~~i~~~~-~~ 611 (656)
T 2j0j_A 542 EDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIENGE-RL 611 (656)
T ss_dssp CC----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHHHHTC-CC
T ss_pred CCCcce------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHcCC-CC
Confidence 433221 1123456788999999998889999999999999999997 99999876554322 2222211 11
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhc
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~ 280 (318)
+ ....+|+.+.+++.+||+.||++||++.++.+.|.+++.++
T Consensus 612 ~---~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~~ 653 (656)
T 2j0j_A 612 P---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 653 (656)
T ss_dssp C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred C---CCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 1 12367889999999999999999999999999999987653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=307.55 Aligned_cols=269 Identities=24% Similarity=0.291 Sum_probs=202.6
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHH-cCCCCCCeeeeccccCc----c
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKIL-QGGSGIPNIKWYGVDGE----D 77 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~i~~~~~~~~----~ 77 (318)
+.+.++|++.+.||+|+||.||+|.+ +++.||+|++.... ...+.+|.+++..+ .+|+++..+..+..... .
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh-HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 45678999999999999999999998 58899999986532 34567888888873 24455656544444333 7
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCceeeccCCCCCeEEEE
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH--------SRGFLHRDIKPDNFLMGLGRKANQVYII 148 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH--------~~~i~H~dl~p~Nil~~~~~~~~~~kL~ 148 (318)
.++|||++ +++|.+++.. ..+++..+..++.|++.||.||| ++||+||||||+||++ +.++.+||+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~ 189 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIA 189 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEEC
T ss_pred eEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEE
Confidence 89999999 6799999975 45899999999999999999999 8999999999999999 488899999
Q ss_pred eccceeeecCCCCCccccccCCCCCcccccccccccccCCC------CCCcchHHHHHHHHHHHHhC----------CCC
Q 021053 149 DFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE------QSRRDDLESLGYVLLYFLRG----------SLP 212 (318)
Q Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~il~~l~tg----------~~p 212 (318)
|||++........... .......+|+.|+|||++.+.. ++.++|||||||++|+|++| ..|
T Consensus 190 Dfg~~~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p 266 (342)
T 1b6c_B 190 DLGLAVRHDSATDTID---IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 266 (342)
T ss_dssp CCTTCEEEETTTTEEE---ECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred ECCCceeccccccccc---cccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccC
Confidence 9999987654432110 0123457899999999988663 33689999999999999999 789
Q ss_pred ccchhHh--hhHHHHHHHHHhhccCchHH--HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCC
Q 021053 213 WQGLKAA--TKKQKYDKICEKKVSTPIEV--LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGS 282 (318)
Q Consensus 213 f~~~~~~--~~~~~~~~i~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~ 282 (318)
|...... ........+.........+. .....+..+.+++.+||+.+|++||++.++.+.|+++..+...
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~~ 340 (342)
T 1b6c_B 267 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 340 (342)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC-
T ss_pred ccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhcC
Confidence 8764221 11112222222222221111 1123356799999999999999999999999999998766543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-42 Score=296.61 Aligned_cols=255 Identities=25% Similarity=0.311 Sum_probs=196.8
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC------ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
|..++.||+|+||.||+|.+ +++.||+|++..... ...+.+|+.++..++| +++..+..++......++||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH-ENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC-CCeEEEEEEEecCCceEEEE
Confidence 44568999999999999986 578899998764321 2357889999999976 56666666666777899999
Q ss_pred ecc-CCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 83 DLL-GPSLEDLFVYCR--RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
|++ +++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||.+......
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE---cCCCcEEEeecccccccccc
Confidence 999 889999987532 348999999999999999999999999999999999999 48899999999998865433
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.... ......+++.|+|||++.+ .++.++|||||||++|+|++|.+||...........+....... ......
T Consensus 187 ~~~~-----~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~ 259 (307)
T 2nru_A 187 AQTV-----MTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE-EKTIED 259 (307)
T ss_dssp SSCE-----ECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTT-SCCHHH
T ss_pred cccc-----cccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhh-hhhhhh
Confidence 2211 1234568999999998875 47889999999999999999999997654332222221111111 111111
Q ss_pred --------HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 240 --------LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 240 --------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
.....+..+.+++..||+.+|.+||++.++.+.|+++
T Consensus 260 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 260 YIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred hccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1122356799999999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=325.21 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=195.2
Q ss_pred eeeeccCcccEEEEEEE--cCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 12 GRKIGSGSFGEIFLASH--VDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~--~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
.+.||.|+||.||+|.+ ..+++.||||+++.... ...+.+|+.++..++| +++..+..+.. ....++|||++
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~l~~~~~-~~~~~lv~E~~ 451 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGICE-AESWMLVMEMA 451 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCC-TTBCCEEEEEE-SSSEEEEEECC
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEe-cCCEEEEEEcc
Confidence 34899999999999955 45678899998875432 2468899999999986 55555544443 34589999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 86 -~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.........
T Consensus 452 ~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~---~~~~~kL~DFGla~~~~~~~~~~- 526 (635)
T 4fl3_A 452 ELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYY- 526 (635)
T ss_dssp TTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE---ETTEEEECCTTHHHHTTC------
T ss_pred CCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEe---CCCCEEEEEcCCccccccCcccc-
Confidence 8899999976 45699999999999999999999999999999999999994 88899999999997654332210
Q ss_pred ccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhc
Q 021053 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (318)
.......++..|+|||++.+..++.++|||||||++|+|++ |+.||.+.+.......+. . ....+ ....
T Consensus 527 ---~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~---~-~~~~~---~p~~ 596 (635)
T 4fl3_A 527 ---KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---K-GERMG---CPAG 596 (635)
T ss_dssp -----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---T-TCCCC---CCTT
T ss_pred ---ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---c-CCCCC---CCCC
Confidence 11223456788999999998899999999999999999998 999998866543222222 1 11121 1236
Q ss_pred CchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 244 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
+|..+.+++..||+.||++||++.++.+.|++++.+
T Consensus 597 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 597 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 788999999999999999999999999999987643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=304.74 Aligned_cols=255 Identities=19% Similarity=0.291 Sum_probs=178.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCCh---hHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP---QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
+..++|++.+.||.|+||.||+|.+..+++.||+|++....... ....|+..+.+..+|+++..+..+.......++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l 98 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI 98 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence 45689999999999999999999999999999999887654322 344555534344456777777777677788999
Q ss_pred EEeccCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 81 VLDLLGPSLEDLFVYC----RRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 81 v~e~~~~~L~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
|||++.++|.+++... ...+++..+..++.|++.||.|||+. |++||||||+||+++ .++.+||+|||++..
T Consensus 99 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~---~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 99 CMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD---RSGNIKLCDFGISGQ 175 (327)
T ss_dssp EECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEE---TTTEEEECCCSSSCC
T ss_pred EEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEc---CCCCEEEccCCCcee
Confidence 9999988998888742 45589999999999999999999999 999999999999994 889999999999876
Q ss_pred ecCCCCCccccccCCCCCcccccccccccc----cCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTH----LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~ 231 (318)
...... .....+++.|+|||++ .+..++.++|||||||++|+|++|..||...+.. ...+..+...
T Consensus 176 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~ 245 (327)
T 3aln_A 176 LVDSIA--------KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSV--FDQLTQVVKG 245 (327)
T ss_dssp --------------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCCCCS
T ss_pred cccccc--------cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchH--HHHHHHHhcC
Confidence 543221 1233678999999998 4556899999999999999999999999864321 1111111111
Q ss_pred hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
............++..+.+++..||..||++||++.++.+
T Consensus 246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 1111111112357889999999999999999999998876
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=295.14 Aligned_cols=253 Identities=21% Similarity=0.271 Sum_probs=194.9
Q ss_pred cccceeeEee-----eeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 4 IIGVKYKLGR-----KIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 4 ~~~~~y~~~~-----~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
++..+|+..+ .||.|+||.||+|.+..+++.||+|.+..... ...+.+|+.++..++| +++..+..++....
T Consensus 14 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~ 92 (295)
T 2clq_A 14 LLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSFSENG 92 (295)
T ss_dssp CCCEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCC-TTBCCEEEEEEETT
T ss_pred cccccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCC-CCEeeEeeEEEeCC
Confidence 3444555554 99999999999999999999999998765432 3567889999999976 55656655666677
Q ss_pred ceEEEEecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
..++|||++ +++|.+++..... .+++..+..++.|++.||.|||++|++|+||+|+||+++ ...+.+||+|||.+
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~ 170 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN--TYSGVLKISDFGTS 170 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTCCEEECCTTTC
T ss_pred cEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEE--CCCCCEEEeecccc
Confidence 899999999 7899999986433 356888999999999999999999999999999999995 23789999999999
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCCC--CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~ 231 (318)
........ ......+++.|+|||++.+.. ++.++||||||+++|+|++|..||......... .. .....
T Consensus 171 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~-~~~~~ 241 (295)
T 2clq_A 171 KRLAGINP-------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MF-KVGMF 241 (295)
T ss_dssp EESCC------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HH-HHHHH
T ss_pred cccCCCCC-------cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HH-hhccc
Confidence 86543221 113446889999999987654 789999999999999999999999764332211 11 11111
Q ss_pred hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.... .....++..+.+++.+||..||++||++.++.+
T Consensus 242 ~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 242 KVHP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCC---CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccc---cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111 122467889999999999999999999988754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=298.03 Aligned_cols=243 Identities=23% Similarity=0.331 Sum_probs=191.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--------CChhHHHHHHHHHHHc---CCCCCCeeeec
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQ---GGSGIPNIKWY 71 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~---~~~~~~~i~~~ 71 (318)
+.+.++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.++.++. .|+++..+..+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 467889999999999999999999999999999999886543 2235677999999985 45777777666
Q ss_pred cccCcceEEEEec-c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEe
Q 021053 72 GVDGEDNVLVLDL-L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIID 149 (318)
Q Consensus 72 ~~~~~~~~lv~e~-~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~d 149 (318)
+......++|+|+ + +++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++ ..++.+||+|
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~d 183 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID--LRRGCAKLID 183 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE--TTTTEEEECC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe--CCCCeEEEEE
Confidence 6777789999998 4 7899999987 34599999999999999999999999999999999999994 2678999999
Q ss_pred ccceeeecCCCCCccccccCCCCCcccccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHH
Q 021053 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (318)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i 228 (318)
||.+........ ....++..|+|||++.+..+ +.++|||||||++|+|++|+.||..... +
T Consensus 184 fg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~---------~ 245 (312)
T 2iwi_A 184 FGSGALLHDEPY---------TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE---------I 245 (312)
T ss_dssp CSSCEECCSSCB---------CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------H
T ss_pred cchhhhcccCcc---------cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH---------H
Confidence 999887654322 24468899999999887665 4589999999999999999999976432 1
Q ss_pred HHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.......+ ..++..+.+++.+||+.+|++||++.++.+
T Consensus 246 ~~~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 LEAELHFP-----AHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp HHTCCCCC-----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhhccCCc-----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 12222222 356788999999999999999999998876
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=301.86 Aligned_cols=259 Identities=22% Similarity=0.255 Sum_probs=182.5
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
+..++|++.+.||+|+||.||+|.+..+++.||+|++.... ....+.+|+.++..++| +++..+..++......++
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHH-PNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCC-TTBCCEEEEEESSSCEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCC-CCEeeEEEEEeecCCcEE
Confidence 55789999999999999999999998889999999876432 23456788888888865 566666666666778999
Q ss_pred EEecc-CCCHHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 81 VLDLL-GPSLEDLFVYC-------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~-------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
|||++ +++|.+++... ...+++..+..++.||+.||.|||++|++||||+|+||++ +.++.+||+|||.
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE---cCCCCEEEEeccc
Confidence 99999 88999998752 3458999999999999999999999999999999999999 4889999999999
Q ss_pred eeeecCCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~ 231 (318)
+........... ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||........ .......
T Consensus 168 ~~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~ 242 (303)
T 2vwi_A 168 SAFLATGGDITR--NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV---LMLTLQN 242 (303)
T ss_dssp HHHCC-----------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHHTS
T ss_pred hheeccCCCccc--hhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH---HHHHhcc
Confidence 875433211100 011234568899999999875 4689999999999999999999999987544321 1111111
Q ss_pred hccCc-----hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 232 KVSTP-----IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 232 ~~~~~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..... .......++..+.+++.+||..||.+||++.++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11111 11123456788999999999999999999998876
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=297.13 Aligned_cols=251 Identities=20% Similarity=0.310 Sum_probs=181.3
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCCh---hHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP---QLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
-++|++.+.||.|+||.||+|.+..+++.||+|++....... ....|...+....+|+++..+..++......++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 368999999999999999999999999999999987654322 23334443333345577777777777778899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|++++.+..+.......+++..+..++.|++.||.|||++ |++|+||+|+||++ +.++.+||+|||.+........
T Consensus 104 e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~ 180 (318)
T 2dyl_A 104 ELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKA 180 (318)
T ss_dssp CCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE---CTTSCEEECCCTTC--------
T ss_pred eccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE---CCCCCEEEEECCCchhccCCcc
Confidence 9997777777766566799999999999999999999996 99999999999999 4889999999999876543221
Q ss_pred CccccccCCCCCccccccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
.....+++.|+|||++. ...++.++|||||||++|+|++|..||...... ...+..+........
T Consensus 181 --------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~ 250 (318)
T 2dyl_A 181 --------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD--FEVLTKVLQEEPPLL 250 (318)
T ss_dssp --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH--HHHHHHHHHSCCCCC
T ss_pred --------ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc--HHHHHHHhccCCCCC
Confidence 12346789999999985 456889999999999999999999999763221 222333332221111
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
. ....++..+.+++..||..||.+||++.++.+
T Consensus 251 ~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 251 P--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp C--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred C--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1 11356889999999999999999999998776
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=304.49 Aligned_cols=268 Identities=17% Similarity=0.229 Sum_probs=188.5
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHH--HHcCCCCCCeeee-----ccccC
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYK--ILQGGSGIPNIKW-----YGVDG 75 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~--~l~~~~~~~~i~~-----~~~~~ 75 (318)
.+--++|++.+.||+|+||.||+|++ +++.||+|++.... ......|.++.. .+.| +++..+.. .....
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~e~~~~~~~~~~h-~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-RQNFINEKNIYRVPLMEH-DNIARFIVGDERVTADGR 84 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-HHHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECTTSC
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-hhhHHHHHHHHHHHhccC-cchhhheecccccccCCC
Confidence 34568999999999999999999987 67899999886433 233444444433 3455 44444432 22334
Q ss_pred cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCceeeccCCCCCeE
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR---------GFLHRDIKPDNFLMGLGRKANQV 145 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---------~i~H~dl~p~Nil~~~~~~~~~~ 145 (318)
..+++||||+ +++|.+++.. ...++..+..++.||+.||.|||+. ||+||||||+||++ +.++.+
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~ 159 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSL--HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTC 159 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCE
T ss_pred ceEEEEEecCCCCcHHHHHhh--cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcE
Confidence 4679999999 8899999975 3468899999999999999999999 99999999999999 478999
Q ss_pred EEEeccceeeecCCCCCcc-ccccCCCCCcccccccccccccC-------CCCCCcchHHHHHHHHHHHHhCCCCccchh
Q 021053 146 YIIDFGLAKKYRDPTTNRH-IPYRENKNLTGTARYASCNTHLG-------IEQSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (318)
Q Consensus 146 kL~dfg~~~~~~~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~tg~~pf~~~~ 217 (318)
||+|||++........... ..........||+.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 9999999987653321110 00112234568999999999987 346678999999999999999977664322
Q ss_pred Hhhh-HH-------------HHHHHH-HhhccCchHHHh---hcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 218 AATK-KQ-------------KYDKIC-EKKVSTPIEVLC---KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 218 ~~~~-~~-------------~~~~i~-~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
.... .. .+.... ........+..+ ...++.+.+++.+||+.||++|||+.++.+.|.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~ 319 (336)
T 3g2f_A 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMI 319 (336)
T ss_dssp CCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred chhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHH
Confidence 1100 00 000100 011111111100 01234699999999999999999999999999998643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=301.70 Aligned_cols=260 Identities=17% Similarity=0.244 Sum_probs=197.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
++..++|++.+.||.|+||.||+|.+.. .+|+|++.... ....+.+|+.++..++| +++..+..+.......
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRH-ENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCC-TTBCCCCEEEECSSCE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCC-CCEeEEEEEEecCCce
Confidence 4566899999999999999999999854 48999876432 23457789999998876 5555665565666789
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
++++|++ +++|.+++......+++..+..++.|++.||.|||++|++||||||+||++ +++.+||+|||++....
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~----~~~~~~l~Dfg~~~~~~ 180 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISG 180 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE----C--CCEECCCSCCC---
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE----eCCCEEEeecCCccccc
Confidence 9999999 789999998655568999999999999999999999999999999999999 36799999999976543
Q ss_pred CCCCCccccccCCCCCcccccccccccccC---------CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHH
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLG---------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i 228 (318)
....... ........++..|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+
T Consensus 181 ~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~ 255 (319)
T 2y4i_B 181 VLQAGRR--EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI---IWQM 255 (319)
T ss_dssp ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH---HHHH
T ss_pred ccccccc--ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHh
Confidence 2111100 012234468899999999875 3478899999999999999999999987654322 2222
Q ss_pred HHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
.....+.. ....+|..+.+++..||+.+|++||++.++.+.|+++..
T Consensus 256 ~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 256 GTGMKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HTTCCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred ccCCCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 22211111 112578899999999999999999999999999987643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=294.82 Aligned_cols=258 Identities=19% Similarity=0.224 Sum_probs=189.4
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-CChhHHHHHHHHHHHcCCCCCCeeeecc-----------
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYG----------- 72 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~i~~~~----------- 72 (318)
+.++|++.+.||.|+||.||+|.+..+++.||+|++.... ....+.+|+.++..++|++.+..+..+.
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 4679999999999999999999999999999999875432 2245778999999997654444333221
Q ss_pred -ccCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEec
Q 021053 73 -VDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDF 150 (318)
Q Consensus 73 -~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~df 150 (318)
......++|||++ +++|.+++......++...+..++.|++.||.|||++|++||||+|+||++ +.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEeeC
Confidence 1245789999999 789999998755568889999999999999999999999999999999999 48899999999
Q ss_pred cceeeecCCCCCcc-------ccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhH
Q 021053 151 GLAKKYRDPTTNRH-------IPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK 222 (318)
Q Consensus 151 g~~~~~~~~~~~~~-------~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~ 222 (318)
|.+........... ..........+++.|+|||++.+. .++.++|||||||++|+|++ ||...... .
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~--~ 235 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER--V 235 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--H
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH--H
Confidence 99876542211000 000112345688999999998865 68999999999999999998 56532221 2
Q ss_pred HHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 223 QKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 223 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.....+.......| ..+....+..+.+++..||..||.+||++.++.+
T Consensus 236 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 236 NILKKLRSVSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp HHHHHHHSTTCCCC-TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccccccccC-ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 22223222222222 2233456677999999999999999999998776
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=303.97 Aligned_cols=252 Identities=16% Similarity=0.233 Sum_probs=199.7
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-------------------hhHHHHHHHHHHHcCCC
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-------------------PQLLYEAKVYKILQGGS 63 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-------------------~~~~~e~~~l~~l~~~~ 63 (318)
++..++|++.+.||.|+||.||+|.+ +++.||+|++...... ..+.+|+.++..++| +
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~ 103 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKN-E 103 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCC-T
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCC-C
Confidence 45668999999999999999999998 8999999986532111 678899999999975 5
Q ss_pred CCCeeeeccccCcceEEEEecc-CCCHHHH------HHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCce
Q 021053 64 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDL------FVYC-RRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNF 134 (318)
Q Consensus 64 ~~~~i~~~~~~~~~~~lv~e~~-~~~L~~~------~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~Ni 134 (318)
++..+..+.......++|||++ +++|.++ +... ...+++..+..++.|++.||.|||+ +|++||||+|+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 6666666666778899999999 6699888 5432 3458999999999999999999999 9999999999999
Q ss_pred eeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCC-CCCC-cchHHHHHHHHHHHHhCCCC
Q 021053 135 LMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSR-RDDLESLGYVLLYFLRGSLP 212 (318)
Q Consensus 135 l~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DvwslG~il~~l~tg~~p 212 (318)
++ +.++.+||+|||.+........ ....++..|+|||++.+. .++. ++|||||||++|+|++|..|
T Consensus 184 l~---~~~~~~kl~dfg~~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p 251 (348)
T 2pml_X 184 LM---DKNGRVKLSDFGESEYMVDKKI---------KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251 (348)
T ss_dssp EE---CTTSCEEECCCTTCEECBTTEE---------CSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCS
T ss_pred EE---cCCCcEEEeccccccccccccc---------cCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCC
Confidence 99 4889999999999987543311 345688999999999887 5665 99999999999999999999
Q ss_pred ccchhHhhhHHHHHHHHHhhccCchH--------------HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 213 WQGLKAATKKQKYDKICEKKVSTPIE--------------VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~--------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
|...... ......+.......|.. .....++..+.+++.+||..||.+||++.++.+
T Consensus 252 f~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 252 FSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp SCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 9875431 22233333222222210 111457889999999999999999999998876
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=309.21 Aligned_cols=255 Identities=18% Similarity=0.179 Sum_probs=188.4
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~ 85 (318)
..+|++.+.||.|+||+|+. ....+++.||||++.... .....+|+.+++.+.+|+++..+..++......|+|||++
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~ 100 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPEC-FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC 100 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTT-EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECC
Confidence 35799999999999999764 334578999999886533 3457889999999976778878877777788899999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCC--CCCeEEEEeccceeeecCCCCCc
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~--~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+++|.+++...........+..++.||+.||.|||++||+||||||+||+++..+ ....+||+|||++.........
T Consensus 101 ~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~- 179 (432)
T 3p23_A 101 AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS- 179 (432)
T ss_dssp SEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------
T ss_pred CCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcc-
Confidence 9999999986554455556778999999999999999999999999999995322 3346889999999865433211
Q ss_pred cccccCCCCCcccccccccccccC---CCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 164 HIPYRENKNLTGTARYASCNTHLG---IEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
........||+.|+|||++.+ ..++.++|||||||++|+|++ |.+||....... ...... ....+...
T Consensus 180 ---~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~~~~~-~~~~~~~~ 251 (432)
T 3p23_A 180 ---FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANILLG-ACSLDCLH 251 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HHHHTT-CCCCTTSC
T ss_pred ---eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HHHHhc-cCCccccC
Confidence 012234578999999999984 557889999999999999999 999997543221 111111 11111100
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.....+..+.+++.+||+.||.+||++.++.+
T Consensus 252 ~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 01122445889999999999999999998774
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=307.04 Aligned_cols=260 Identities=21% Similarity=0.188 Sum_probs=190.4
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++.+++.|.+.+.||+|+||+||.+. ..+++.||||++.... ...+.+|+.++..+.+|+++..+..++......++|
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~-~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF-CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG-HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH-HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 45678899999999999999998754 4578999999876532 345688999999886678888887777778889999
Q ss_pred EeccCCCHHHHHHHhcCCC------CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccC----------CCCCeE
Q 021053 82 LDLLGPSLEDLFVYCRRKF------SLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLG----------RKANQV 145 (318)
Q Consensus 82 ~e~~~~~L~~~~~~~~~~~------~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~----------~~~~~~ 145 (318)
||+++++|.+++....... ++..+..++.||+.||.|||++||+||||||+||+++.. +..+.+
T Consensus 88 ~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 88 LELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp ECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred EecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence 9999889999998532211 222346799999999999999999999999999999521 234689
Q ss_pred EEEeccceeeecCCCCCccccccCCCCCcccccccccccccC-------CCCCCcchHHHHHHHHHHHHh-CCCCccchh
Q 021053 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG-------IEQSRRDDLESLGYVLLYFLR-GSLPWQGLK 217 (318)
Q Consensus 146 kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwslG~il~~l~t-g~~pf~~~~ 217 (318)
||+|||++........... .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||....
T Consensus 168 kL~DFG~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFR---TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp EECCCTTCEECCC-----------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred EEcccccceecCCCCccce---eeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 9999999987654322110 01124578999999999876 568999999999999999999 999997643
Q ss_pred HhhhHHHHHHHHHhhccCchH--HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 218 AATKKQKYDKICEKKVSTPIE--VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
... ..+.......+.. .....++..+.+++.+||..||.+||++.++.+
T Consensus 245 ~~~-----~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 245 SRE-----SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp THH-----HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhH-----HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 321 1122222221111 011234578999999999999999999998765
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=311.90 Aligned_cols=239 Identities=15% Similarity=0.127 Sum_probs=183.9
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCee----------e--
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNI----------K-- 69 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i----------~-- 69 (318)
..|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.++..+.|..++..+ .
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 458899999999999999999999999999998773322 34677888888887763321111 0
Q ss_pred ---------eccc-----cCcceEEEEeccCCCHHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 021053 70 ---------WYGV-----DGEDNVLVLDLLGPSLEDLFVYC------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDI 129 (318)
Q Consensus 70 ---------~~~~-----~~~~~~lv~e~~~~~L~~~~~~~------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl 129 (318)
.+.. ....++++|+.++++|.+++... ...+++..+..++.||+.||.|||++||+||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 0011 12357889999999999998633 233667788899999999999999999999999
Q ss_pred CCCceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccc----------cCCCCCCcchHHHH
Q 021053 130 KPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH----------LGIEQSRRDDLESL 199 (318)
Q Consensus 130 ~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~Dvwsl 199 (318)
||+|||+ +.++.+||+|||+++...... ....| +.|+|||++ .+..++.++|||||
T Consensus 238 Kp~NILl---~~~~~~kL~DFG~a~~~~~~~----------~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl 303 (413)
T 3dzo_A 238 RPVDIVL---DQRGGVFLTGFEHLVRDGASA----------VSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL 303 (413)
T ss_dssp CGGGEEE---CTTCCEEECCGGGCEETTEEE----------CCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred ccceEEE---ecCCeEEEEeccceeecCCcc----------ccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence 9999999 488899999999987644321 23355 899999998 55568889999999
Q ss_pred HHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 200 GYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 200 G~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
||++|+|++|+.||...+...... .+. . ....+|+.+.+++..||..+|++||++.++.+
T Consensus 304 Gvil~elltg~~Pf~~~~~~~~~~---~~~----~-----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 304 GLAIYWIWCADLPNTDDAALGGSE---WIF----R-----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHHHSSCCCCTTGGGSCSG---GGG----S-----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHCCCCCCCcchhhhHH---HHH----h-----hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999999998755432111 111 1 11256789999999999999999999876654
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=287.44 Aligned_cols=233 Identities=21% Similarity=0.218 Sum_probs=180.3
Q ss_pred cceeeEe-eeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeecccc----CcceEE
Q 021053 6 GVKYKLG-RKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVD----GEDNVL 80 (318)
Q Consensus 6 ~~~y~~~-~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~----~~~~~l 80 (318)
-++|.+. +.||.|+||.||+|.+..+++.||+|++.. .....+|+.++.++.+|+++..+..++.. ....++
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l 92 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc---cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEE
Confidence 3556665 889999999999999999999999999864 45678899998777777777777555443 567899
Q ss_pred EEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 81 VLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
|||++ +++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||+++..+..+.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 171 (299)
T 3m2w_A 93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT- 171 (299)
T ss_dssp EECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-
Confidence 99999 779999998743 358999999999999999999999999999999999999633237899999999986432
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHH-HHHhhccCch
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK-ICEKKVSTPI 237 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~-i~~~~~~~~~ 237 (318)
+..++.++|||||||++|+|++|..||...+.......+.. +.......+
T Consensus 172 ----------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 222 (299)
T 3m2w_A 172 ----------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP- 222 (299)
T ss_dssp ----------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSC-
T ss_pred ----------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCC-
Confidence 12356789999999999999999999977543321111111 111112222
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+..+++.+.+++..||+.||++||++.++.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 2233578899999999999999999999998877
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=286.40 Aligned_cols=232 Identities=13% Similarity=0.076 Sum_probs=186.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-----hhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
+++++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+.+|+.++..+.| +++..+..++......
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-p~iv~~~~~~~~~~~~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK-PGVARVLDVVHTRAGG 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEEETTEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCC-CCcceeeEEEEECCcE
Confidence 7889999999999999999999999999999999998765433 467889999988866 5666776677777889
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
|+||||+ +++|.+++.. + .....+..++.|++.||.|||++||+||||||+||+++ .++.+||++++.
T Consensus 107 ~lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~---~~g~~kl~~~~~----- 175 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVS---IDGDVVLAYPAT----- 175 (286)
T ss_dssp EEEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEE---TTSCEEECSCCC-----
T ss_pred EEEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEc---CCCCEEEEeccc-----
Confidence 9999999 7899999853 2 46667888999999999999999999999999999994 788898874322
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
++ +++.++|||||||++|+|+||+.||.+.+............ .....+.
T Consensus 176 ----------------------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~-~~~~~~~ 225 (286)
T 3uqc_A 176 ----------------------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-AGQPIEP 225 (286)
T ss_dssp ----------------------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT-TSCBCCH
T ss_pred ----------------------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh-ccCCCCh
Confidence 22 25779999999999999999999998755432111111111 1122334
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
......+|+.+.+++.+||+.||++| |+.++.+.|.....
T Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 226 ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 45556789999999999999999999 99999999988753
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.16 Aligned_cols=255 Identities=18% Similarity=0.231 Sum_probs=188.2
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC---ChhHHHHHHHHHHHcCCCCCCeeeeccc------cC
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK---HPQLLYEAKVYKILQGGSGIPNIKWYGV------DG 75 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~~~~~~~~i~~~~~------~~ 75 (318)
..++|++.+.||.|+||.||+|.+..+++.||+|++..... ...+.+|+.++..++| +++..+..+.. ..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~H-pnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNH-PNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCB-TTBCCEEECCTTTCCCCTT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCC-CCCCceeeeecccccccCC
Confidence 34899999999999999999999999999999998875432 2357789999999976 55555543332 25
Q ss_pred cceEEEEecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRR--KFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
...++||||+ +++|.+++..... .+++..+..++.|++.||.|||++||+||||+|+||+++.++....+||+|||.
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 6789999999 8899999986432 488899999999999999999999999999999999996433445699999999
Q ss_pred eeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHH------HHH
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ------KYD 226 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~------~~~ 226 (318)
+........ .....+++.|+|||++.+..++.++|||||||++|+|++|..||.......... ...
T Consensus 171 a~~~~~~~~--------~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~ 242 (676)
T 3qa8_A 171 AKELDQGEL--------CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242 (676)
T ss_dssp CCBTTSCCC--------CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC-----
T ss_pred ccccccccc--------cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccch
Confidence 986543322 134578999999999999999999999999999999999999997532211100 000
Q ss_pred HH-----HHhh-----ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHH
Q 021053 227 KI-----CEKK-----VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGF 268 (318)
Q Consensus 227 ~i-----~~~~-----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ 268 (318)
.+ .... ..+.+......+++.+.+++..||..||++||++.+
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e 294 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ 294 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence 00 0000 001111122345778999999999999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=311.17 Aligned_cols=242 Identities=16% Similarity=0.203 Sum_probs=187.3
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcC-CCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVD-TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~-~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
++++.++|++.+.||.|+||.||+|.+.. +++.||||++...... ..+.+|+.++.+++| ++++.+..++.....
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-p~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVH-PSIVQIFNFVEHTDR 153 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCC-TTBCCEEEEEEEECT
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCC-CCcCeEeeeEeecCC
Confidence 35788999999999999999999999986 7899999987654322 246789999999876 555555444443333
Q ss_pred -----eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecc
Q 021053 78 -----NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (318)
Q Consensus 78 -----~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg 151 (318)
.|+||||+ +++|.+++.. .+++..+..++.||+.||.|||++||+||||||+||+++ . +.+||+|||
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~---~-~~~kl~DFG 226 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT---E-EQLKLIDLG 226 (681)
T ss_dssp TSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC---S-SCEEECCCT
T ss_pred CCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEe---C-CcEEEEecc
Confidence 69999999 7888877653 599999999999999999999999999999999999994 3 489999999
Q ss_pred ceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh
Q 021053 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (318)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~ 231 (318)
++...... ....||+.|+|||++.+.. +.++|||||||++|+|++|.+||.+.....
T Consensus 227 ~a~~~~~~-----------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------- 283 (681)
T 2pzi_A 227 AVSRINSF-----------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------- 283 (681)
T ss_dssp TCEETTCC-----------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------
T ss_pred cchhcccC-----------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------
Confidence 99865432 2346899999999987654 889999999999999999999987532110
Q ss_pred hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCC-hHHHHHHHHHHH
Q 021053 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-YGFLKRLFHDLF 277 (318)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~-~~~l~~~l~~~~ 277 (318)
.+.... ....++.+.+++.+||+.||++||+ ++.+...|..++
T Consensus 284 -~~~~~~--~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 -LPEDDP--VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp -CCTTCH--HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -cccccc--ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 000001 1123568999999999999999995 666777666554
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=287.42 Aligned_cols=240 Identities=21% Similarity=0.159 Sum_probs=180.2
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----------hhHHHHHHHHHHHc--------CCCCC
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------PQLLYEAKVYKILQ--------GGSGI 65 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~e~~~l~~l~--------~~~~~ 65 (318)
+..++|++.+.||+|+||.||+|++ +++.||||++...... ..+.+|+.+++.++ .|+++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3457899999999999999999998 6799999987654321 56889999999997 34444
Q ss_pred Ceeeec-----------------cc-------------cCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHH
Q 021053 66 PNIKWY-----------------GV-------------DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114 (318)
Q Consensus 66 ~~i~~~-----------------~~-------------~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~ 114 (318)
..+... +. .....|+||||+ ++++.+.+.. ..+++..++.++.||+.
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTA 172 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHH
Confidence 443221 11 257899999999 6766666643 55899999999999999
Q ss_pred HHHHHH-hCCccccCCCCCceeeccCCCCC--------------------eEEEEeccceeeecCCCCCccccccCCCCC
Q 021053 115 RIEYVH-SRGFLHRDIKPDNFLMGLGRKAN--------------------QVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173 (318)
Q Consensus 115 ~L~~lH-~~~i~H~dl~p~Nil~~~~~~~~--------------------~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~ 173 (318)
||.||| ++||+||||||+|||+. ..+ .+||+|||+++..... ..
T Consensus 173 aL~~lH~~~~ivHrDlKp~NILl~---~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------~~ 237 (336)
T 2vuw_A 173 SLAVAEASLRFEHRDLHWGNVLLK---KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------IV 237 (336)
T ss_dssp HHHHHHHHHCCBCSCCCGGGEEEE---ECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------------EE
T ss_pred HHHHHHHhCCEeECCCCHHHEEEe---ccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------------cE
Confidence 999999 99999999999999995 444 8999999999876532 23
Q ss_pred cccccccccccccCCCCCCcchHHHHHHH-HHHHHhCCCCccchhHhhhHHHHHHHHHh--hccCchHHHhhcCchhHHH
Q 021053 174 TGTARYASCNTHLGIEQSRRDDLESLGYV-LLYFLRGSLPWQGLKAATKKQKYDKICEK--KVSTPIEVLCKSHPAEFAS 250 (318)
Q Consensus 174 ~~~~~y~aPE~~~~~~~~~~~DvwslG~i-l~~l~tg~~pf~~~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~ 250 (318)
.||+.|+|||++.+.. +.++||||+|++ .+++++|..||...... ......+... ....+.......+++.+.+
T Consensus 238 ~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 238 VFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLTDKMLKQMTFKTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp ECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHHHHHHHTCCCSSCCCSHHHHHHHHHHHH
T ss_pred EEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hHHHHhhhhhhccCcccchhhhhhcCHHHHH
Confidence 6899999999998777 889999998777 77889999999653210 0111122211 1112222334567889999
Q ss_pred HHHHHhhcCCCCCCChHHHH
Q 021053 251 YFHYCQSLTFDQRPDYGFLK 270 (318)
Q Consensus 251 li~~cl~~~p~~Rp~~~~l~ 270 (318)
++.+||..+ |+.++.
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999976 676655
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-32 Score=251.15 Aligned_cols=184 Identities=16% Similarity=0.112 Sum_probs=128.6
Q ss_pred eeccCcccEEEEEEEcCCCcEEEEEeecCCCC------------ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 14 KIGSGSFGEIFLASHVDTNEIVAVKIENSGTK------------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 14 ~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~------------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
..+.|+.|.+..++....|+.+++|++..... ..++.+|+++|+++.+|++++.+..++.+....|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 34566677776666666788999998765421 135788999999999899999999999999999999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ |++|.+.+.. .++++.. .++.||+.||.|+|++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 321 MEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCC
Confidence 9999 8899999986 4456654 478999999999999999999999999999 488999999999998665443
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCC
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLP 212 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~p 212 (318)
. ......||+.|+|||++.+. +..++|+||+|++++.+.++..+
T Consensus 394 ~-------~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 394 S-------WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C-------CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred c-------cccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 2 22345799999999998764 56789999999998877655433
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.3e-27 Score=218.10 Aligned_cols=188 Identities=19% Similarity=0.173 Sum_probs=135.7
Q ss_pred eEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----------hhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----------PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 10 ~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
...+.||+|+||.||+|.. .+..+++|........ ..+.+|+.++++++| +++..+..++......|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKD-FGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGG-GTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCC-CCcCceEEEEEeCCccE
Confidence 3466899999999999944 5678899975443221 236899999999977 45553344444566789
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+||||+ +++|.+++.. ...++.|++.||.|||++||+||||||+||+++ . .+||+|||+++....
T Consensus 416 lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~---~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 416 IMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFD---K--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEES---S--SEEECCCTTCEECCC
T ss_pred EEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEEC---C--eEEEEECccCEECCC
Confidence 999999 7999998874 457899999999999999999999999999993 4 999999999987654
Q ss_pred CCCCccccccCCCCCcccccccccccccC--CCCCCcchHHHHHHHHHHHHhCCCCcc
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLG--IEQSRRDDLESLGYVLLYFLRGSLPWQ 214 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~tg~~pf~ 214 (318)
........+.......||+.|+|||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32111000001124578999999999986 457788999999988888887776663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=185.39 Aligned_cols=131 Identities=21% Similarity=0.322 Sum_probs=102.5
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--------------------ChhHHHHHHHHHHHcCCCCCC
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------------------HPQLLYEAKVYKILQGGSGIP 66 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--------------------~~~~~~e~~~l~~l~~~~~~~ 66 (318)
..|.+++.||.|+||.||+|.+ .+++.||+|++..... ...+.+|+.++..+.+ +.
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~ 165 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LA 165 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SS
T ss_pred eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CC
Confidence 3455669999999999999999 7899999998764321 1247799999999982 22
Q ss_pred eeeeccccCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeE
Q 021053 67 NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (318)
Q Consensus 67 ~i~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~ 145 (318)
....+ .....++|||++ +++|.+ +. . .....++.|++.||.|||++||+||||||+||++ + ++.+
T Consensus 166 v~~~~--~~~~~~lvmE~~~g~~L~~-l~-----~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl---~-~~~v 231 (282)
T 1zar_A 166 VPKVY--AWEGNAVLMELIDAKELYR-VR-----V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV---S-EEGI 231 (282)
T ss_dssp SCCEE--EEETTEEEEECCCCEEGGG-CC-----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE---E-TTEE
T ss_pred cCeEE--eccceEEEEEecCCCcHHH-cc-----h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE---E-CCcE
Confidence 22222 224679999999 679987 32 1 2244689999999999999999999999999999 4 8899
Q ss_pred EEEeccceee
Q 021053 146 YIIDFGLAKK 155 (318)
Q Consensus 146 kL~dfg~~~~ 155 (318)
||+|||++..
T Consensus 232 kl~DFG~a~~ 241 (282)
T 1zar_A 232 WIIDFPQSVE 241 (282)
T ss_dssp EECCCTTCEE
T ss_pred EEEECCCCeE
Confidence 9999999864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-21 Score=163.68 Aligned_cols=136 Identities=22% Similarity=0.272 Sum_probs=105.2
Q ss_pred eeeEeeeeccCcccEEEEEEEcCCCcE--EEEEeecCCCCC--------------------------hhHHHHHHHHHHH
Q 021053 8 KYKLGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSGTKH--------------------------PQLLYEAKVYKIL 59 (318)
Q Consensus 8 ~y~~~~~lg~G~~~~v~~~~~~~~~~~--vaiK~~~~~~~~--------------------------~~~~~e~~~l~~l 59 (318)
-|++.+.||.|+||.||+|.+..+|+. ||||++...... ..+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 478999999999999999998778888 999986543110 1578899999999
Q ss_pred cCCCC-CCeeeeccccCcceEEEEeccC--C----CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCC
Q 021053 60 QGGSG-IPNIKWYGVDGEDNVLVLDLLG--P----SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH-SRGFLHRDIKP 131 (318)
Q Consensus 60 ~~~~~-~~~i~~~~~~~~~~~lv~e~~~--~----~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH-~~~i~H~dl~p 131 (318)
.++.. ++.+... ...++||||++ + +|.+.... .++..+..++.|++.||.+|| ++||+||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 87532 3333322 35799999994 3 56655432 234456788999999999999 99999999999
Q ss_pred CceeeccCCCCCeEEEEeccceeee
Q 021053 132 DNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 132 ~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
+|||+. . .++|+|||++...
T Consensus 200 ~NILl~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYI---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEES---S--SEEECCCTTCEET
T ss_pred HHEEEc---C--cEEEEECcccccC
Confidence 999993 4 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=2.2e-17 Score=144.81 Aligned_cols=134 Identities=21% Similarity=0.301 Sum_probs=95.1
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----------------Ch--------hHHHHHHHHHHHcCCCC
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----------------HP--------QLLYEAKVYKILQGGSG 64 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----------------~~--------~~~~e~~~l~~l~~~~~ 64 (318)
|+++..||.|++|.||+|.+. +|+.||||+++.... .. ...+|...+.++.+. .
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~-g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE-G 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT-T
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc-C
Confidence 899999999999999999975 588999998653210 00 124567777777542 2
Q ss_pred CCeeeeccccCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCC
Q 021053 65 IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKAN 143 (318)
Q Consensus 65 ~~~i~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~ 143 (318)
++....+.. ...++||||+ +.+|..+.. ......++.|++.+|.+||++||+||||||.|||+. +++
T Consensus 175 v~vp~p~~~--~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~---~dg 242 (397)
T 4gyi_A 175 FPVPEPIAQ--SRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIR---EEK 242 (397)
T ss_dssp CSCCCEEEE--ETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE---EEE
T ss_pred CCCCeeeec--cCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEe---CCC
Confidence 222211111 2358999999 556644321 123456778999999999999999999999999995 333
Q ss_pred ----------eEEEEeccceeee
Q 021053 144 ----------QVYIIDFGLAKKY 156 (318)
Q Consensus 144 ----------~~kL~dfg~~~~~ 156 (318)
.+.++||+.+...
T Consensus 243 d~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 243 DAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSSCTTSEEEEEEECCCTTCEET
T ss_pred CcccccccccceEEEEeCCcccC
Confidence 4899999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=6.2e-12 Score=105.73 Aligned_cols=137 Identities=17% Similarity=0.194 Sum_probs=104.5
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC--CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG--TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
..|++...++.|+.+.||++.. .++.+++|+.... .....+.+|..+++.+..+..++.+..++...+..|+|||+
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 4589999999999999999975 3678999987642 23346889999999997655566676666667789999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS------------------------------------------ 121 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~------------------------------------------ 121 (318)
+ +.++.+.+. +......++.+++.+|..||+
T Consensus 92 i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 9 666665421 112234677899999999998
Q ss_pred -----------------CCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 122 -----------------RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 122 -----------------~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
.+++|+|++|.||++. +...+.|+||+.+.
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEchhcc
Confidence 4589999999999993 44445699998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.23 E-value=7e-11 Score=98.96 Aligned_cols=134 Identities=18% Similarity=0.127 Sum_probs=94.8
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCC-CCeeeeccccCcceEEEEecc
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGVDGEDNVLVLDLL 85 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~i~~~~~~~~~~~lv~e~~ 85 (318)
..|.+....+.|..+.||++.. .++..+++|+.... ....+.+|..+++.+.++.. ++.+..+....+..+++||++
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~-~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc-cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 3466655555677799999964 45677999987654 34568899999999987643 455555555666789999999
Q ss_pred -CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 021053 86 -GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG----------------------------------------- 123 (318)
Q Consensus 86 -~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~----------------------------------------- 123 (318)
+.++ + .. . .+. ..++.+++..|..||+..
T Consensus 98 ~G~~l-~-~~---~-~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 98 PGQDL-L-SS---H-LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp SSEET-T-TS---C-CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred CCccc-C-cC---c-CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 5555 3 11 1 222 245567777777777643
Q ss_pred -----------------ccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 124 -----------------FLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 124 -----------------i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
++|+|++|.||++. +...+.|+||+.+.
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcchhcc
Confidence 99999999999993 44555699999865
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.05 E-value=1.9e-09 Score=94.75 Aligned_cols=138 Identities=15% Similarity=0.196 Sum_probs=97.5
Q ss_pred eEeeeeccCcccEEEEEEEcCCCcEEEEEeec--CCC---CChhHHHHHHHHHHHcCCCC-CCeeeeccccC---cceEE
Q 021053 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIEN--SGT---KHPQLLYEAKVYKILQGGSG-IPNIKWYGVDG---EDNVL 80 (318)
Q Consensus 10 ~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~--~~~---~~~~~~~e~~~l~~l~~~~~-~~~i~~~~~~~---~~~~l 80 (318)
...+.|+.|.++.||++... +..+++|+.. ... ....+.+|..+++.+..... ++.+..+..+. +..|+
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 34678899999999999764 4678889765 322 23468889999999986322 44444443333 45899
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-------------------------------------- 121 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-------------------------------------- 121 (318)
|||++ +.++.+.. ...++......++.+++.+|..||+
T Consensus 119 vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 119 IMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999 44453311 2236778888899999999999997
Q ss_pred --------------------CCccccCCCCCceeeccCCCC--CeEEEEeccceee
Q 021053 122 --------------------RGFLHRDIKPDNFLMGLGRKA--NQVYIIDFGLAKK 155 (318)
Q Consensus 122 --------------------~~i~H~dl~p~Nil~~~~~~~--~~~kL~dfg~~~~ 155 (318)
.+++|+|++|.||++. .+ ..+.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~---~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFH---PTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEEC---SSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEe---CCCCcEEEEECcccccc
Confidence 3689999999999994 33 3368999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.94 E-value=5.5e-10 Score=95.92 Aligned_cols=185 Identities=15% Similarity=0.166 Sum_probs=116.5
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCC--CCeeeeccccC---cceEEEEecc-
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG--IPNIKWYGVDG---EDNVLVLDLL- 85 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~--~~~i~~~~~~~---~~~~lv~e~~- 85 (318)
.+.++.|..+.||++. ..+++|+.........+.+|..+++.+..+.. ++.+...+... ...|+||++.
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 4568999999999873 45888986543223467889999998854332 23333332222 2458899999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-------------------------------------------- 121 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-------------------------------------------- 121 (318)
+.++.+... ..++..+...++.+++..|..||+
T Consensus 100 G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 176 (304)
T 3sg8_A 100 GVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF 176 (304)
T ss_dssp CEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred CeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence 555544322 236777777888888888888885
Q ss_pred --------------CCccccCCCCCceeeccCCC--CCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccc
Q 021053 122 --------------RGFLHRDIKPDNFLMGLGRK--ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185 (318)
Q Consensus 122 --------------~~i~H~dl~p~Nil~~~~~~--~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 185 (318)
..++|+|++|.||++. . ...+.|+||+.+............ .... .-..|+..
T Consensus 177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~---~~~~~~~~~iD~~~~~~~~~~~Dl~~~-----~~~~---~~~~~~~~ 245 (304)
T 3sg8_A 177 YRDILENEIYFKYYPCLIHNDFSSDHILFD---TEKNTICGIIDFGDAAISDPDNDFISL-----MEDD---EEYGMEFV 245 (304)
T ss_dssp HHHHHTCGGGTCCCCEEECSCCCGGGEEEE---TTTTEEEEECCCTTCEEECTTHHHHTT-----CCTT---TSCCHHHH
T ss_pred HHHHHhccccccCCceeEeCCCCcccEEEe---CCCCCEEEEEeCCCCccCChHHHHHHH-----Hhhc---cccCHHHH
Confidence 1369999999999995 4 456789999988754321110000 0000 00112111
Q ss_pred c------CCC--------CCCcchHHHHHHHHHHHHhCCCCccc
Q 021053 186 L------GIE--------QSRRDDLESLGYVLLYFLRGSLPWQG 215 (318)
Q Consensus 186 ~------~~~--------~~~~~DvwslG~il~~l~tg~~pf~~ 215 (318)
. +.. .....+.|++|.++|.+.+|..+|..
T Consensus 246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 0 000 01125899999999999999988854
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=1.4e-06 Score=74.69 Aligned_cols=136 Identities=22% Similarity=0.258 Sum_probs=84.9
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCC--CCeeeecc-ccCcceEEEEecc-CC
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG--IPNIKWYG-VDGEDNVLVLDLL-GP 87 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~--~~~i~~~~-~~~~~~~lv~e~~-~~ 87 (318)
.+.++.|....||++ +..+++|+.........+.+|..++..+.++.. ++....++ ...+..+++|++. +.
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 456788998999998 456788985432223467899999999986422 33443333 2345678999999 54
Q ss_pred CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 021053 88 SLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS---------------------------------------------- 121 (318)
Q Consensus 88 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---------------------------------------------- 121 (318)
++.+... ..++......++.++...|..||+
T Consensus 99 ~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~ 175 (306)
T 3tdw_A 99 ILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLR 175 (306)
T ss_dssp ECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHH
T ss_pred ECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHH
Confidence 5544211 113344444444444444444443
Q ss_pred --------------CCccccCCCCCceeeccCCCCCe-EEEEeccceee
Q 021053 122 --------------RGFLHRDIKPDNFLMGLGRKANQ-VYIIDFGLAKK 155 (318)
Q Consensus 122 --------------~~i~H~dl~p~Nil~~~~~~~~~-~kL~dfg~~~~ 155 (318)
..++|+|+.|.||++..++..+. +.|+||+.+..
T Consensus 176 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 176 FQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 14699999999999951111345 47999988754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.46 E-value=1.4e-06 Score=73.12 Aligned_cols=131 Identities=17% Similarity=0.154 Sum_probs=89.7
Q ss_pred eccCccc-EEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CCCHHHH
Q 021053 15 IGSGSFG-EIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDL 92 (318)
Q Consensus 15 lg~G~~~-~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~~L~~~ 92 (318)
+..|..+ .||+......+..+++|+.... ....+..|...+..+...--++.+..++.+.+..++||++. +.++.+.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~ 110 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQV 110 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccccc
Confidence 4445444 6999887777788999975432 23457789999999876544566666666677899999999 5566655
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------------------------
Q 021053 93 FVYCRRKFSLKTVLMLADQMIARIEYVHSR-------------------------------------------------- 122 (318)
Q Consensus 93 ~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-------------------------------------------------- 122 (318)
.... ......+..++...|..||+.
T Consensus 111 ~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 185 (272)
T 4gkh_A 111 LEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHK 185 (272)
T ss_dssp HHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHT
T ss_pred ccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHh
Confidence 4421 122234555666666666641
Q ss_pred --------CccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 123 --------GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 123 --------~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
.++|+|+.|.||++. ..+.+-|+||+.+.
T Consensus 186 ~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 186 LLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVG 222 (272)
T ss_dssp TCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred cccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECcccc
Confidence 268999999999993 55555689998765
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=5.2e-06 Score=73.77 Aligned_cols=75 Identities=16% Similarity=0.177 Sum_probs=49.0
Q ss_pred EeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---------CChhHHHHHHHHHHHcCC--CCCCeeeeccccCcceE
Q 021053 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---------KHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 11 ~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---------~~~~~~~e~~~l~~l~~~--~~~~~i~~~~~~~~~~~ 79 (318)
-.+.||.|..+.||++.+..+++.+++|...... .......|..++..+... ...+.+..+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 3678999999999999766567789999654321 223567899999988653 233444433 334578
Q ss_pred EEEeccCC
Q 021053 80 LVLDLLGP 87 (318)
Q Consensus 80 lv~e~~~~ 87 (318)
+|||++.+
T Consensus 112 lvmE~l~g 119 (397)
T 2olc_A 112 TVMEDLSH 119 (397)
T ss_dssp EEECCCTT
T ss_pred EEEEeCCC
Confidence 99999954
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.25 E-value=5.1e-06 Score=72.61 Aligned_cols=79 Identities=10% Similarity=0.264 Sum_probs=51.9
Q ss_pred eeEeeee-ccCcccEEEEEEEc--C----CCcEEEEEeecCCC-----CChhHHHHHHHHHHHcCC--CCCCeeeecccc
Q 021053 9 YKLGRKI-GSGSFGEIFLASHV--D----TNEIVAVKIENSGT-----KHPQLLYEAKVYKILQGG--SGIPNIKWYGVD 74 (318)
Q Consensus 9 y~~~~~l-g~G~~~~v~~~~~~--~----~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~~~--~~~~~i~~~~~~ 74 (318)
....+.| +.|..+.+|++... . ++..+++|+..... ......+|..+++.+... ..++.+..+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3445778 88999999998753 1 15678899765432 235678899999988754 234444443333
Q ss_pred C---cceEEEEeccCC
Q 021053 75 G---EDNVLVLDLLGP 87 (318)
Q Consensus 75 ~---~~~~lv~e~~~~ 87 (318)
. +..+++||+..|
T Consensus 102 ~~~~g~~~~v~e~l~G 117 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEG 117 (357)
T ss_dssp STTTSSCEEEEECCCC
T ss_pred CCccCCceEEEEecCC
Confidence 2 357899999943
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.95 E-value=0.00012 Score=63.22 Aligned_cols=72 Identities=15% Similarity=0.143 Sum_probs=40.7
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCC-CCCeeee------ccccCcceEEEEec
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS-GIPNIKW------YGVDGEDNVLVLDL 84 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~-~~~~i~~------~~~~~~~~~lv~e~ 84 (318)
.+.|+.|..+.||++... +..+++|+.... ......|..+++.+.... .++.+.. +....+..++++++
T Consensus 37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~--~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRP--EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EEECC----CEEEEEEET--TEEEEEEEECSC--HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeeccccccCcEEEEEeC--CCCEEEEecCCC--HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 345666788999999763 345889987652 234455677777765322 2222221 11234567899999
Q ss_pred cCC
Q 021053 85 LGP 87 (318)
Q Consensus 85 ~~~ 87 (318)
+.|
T Consensus 113 i~G 115 (346)
T 2q83_A 113 IEG 115 (346)
T ss_dssp CCC
T ss_pred ecC
Confidence 944
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.88 E-value=0.00017 Score=61.28 Aligned_cols=68 Identities=18% Similarity=0.142 Sum_probs=46.5
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-CC
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GP 87 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~-~~ 87 (318)
.+.|+.|..+.+|++ ..+++|+...... ..+..+|..+++.+......+.+.... ...-++++++. ++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence 678989999999999 4578898765322 234577998888887655555554433 23356889998 55
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00034 Score=62.47 Aligned_cols=73 Identities=12% Similarity=0.298 Sum_probs=43.8
Q ss_pred EeeeeccCcccEEEEEEEcCCCcEEEEEeecC-------C--CCChhHHHHHHHHHHHc--CCCCCCeeeeccccCcceE
Q 021053 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-------G--TKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 11 ~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~-------~--~~~~~~~~e~~~l~~l~--~~~~~~~i~~~~~~~~~~~ 79 (318)
-.+.||.|..+.||++.. ++..+++|...+ . ........|.+++..+. .+..++.+..++ ....+
T Consensus 38 ~i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~ 113 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMAL 113 (420)
T ss_dssp EEEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTE
T ss_pred EEEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccE
Confidence 467889999999999964 467899993211 1 01123344555444432 223344444443 45689
Q ss_pred EEEecc-CC
Q 021053 80 LVLDLL-GP 87 (318)
Q Consensus 80 lv~e~~-~~ 87 (318)
+|||+. .+
T Consensus 114 lv~e~l~~g 122 (420)
T 2pyw_A 114 IGMRYLEPP 122 (420)
T ss_dssp EEECCCCTT
T ss_pred EEEeecCCc
Confidence 999999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00062 Score=58.30 Aligned_cols=138 Identities=17% Similarity=0.203 Sum_probs=75.5
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCC-CCeeeec------cccCcceEEEEec
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWY------GVDGEDNVLVLDL 84 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~i~~~------~~~~~~~~lv~e~ 84 (318)
.+.|+.|....+|++... +..+++|+.........+..|..++..+..... ++.+... ....+..++++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eeccCCCcccceEEEEeC--CccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 466778888999999763 236889987764344567788888888875432 2332211 1123457899999
Q ss_pred cCC-CHH-----------HH---HHHhcCCC--------CHHHHHH---------------HHHHHHHHHHHHHh-----
Q 021053 85 LGP-SLE-----------DL---FVYCRRKF--------SLKTVLM---------------LADQMIARIEYVHS----- 121 (318)
Q Consensus 85 ~~~-~L~-----------~~---~~~~~~~~--------~~~~~~~---------------~~~qi~~~L~~lH~----- 121 (318)
..| .+. .. ++.....+ ....... +...+...+..+..
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 844 211 11 11111111 1110000 00113344555542
Q ss_pred --CCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 122 --RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 122 --~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
.+++|+|+.|.||++. ....+.++||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFL---GDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEE---TTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEe---CCceEEEecchhcc
Confidence 3699999999999994 44445799998765
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.0021 Score=54.15 Aligned_cols=80 Identities=15% Similarity=0.104 Sum_probs=54.9
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
++.+.+..-.+.+|.|..+.||++.. .+|+.|++|+...... ...+..|...|+.+.....++.-..+.. ...++
T Consensus 11 ~l~G~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~~~l 87 (288)
T 3f7w_A 11 ELTGREVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DDRTL 87 (288)
T ss_dssp HHHCCCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ETTEE
T ss_pred HhcCCCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cCceE
Confidence 45567778889999999999999985 4578899997654332 2346789999999965432222222222 23578
Q ss_pred EEecc
Q 021053 81 VLDLL 85 (318)
Q Consensus 81 v~e~~ 85 (318)
+||+.
T Consensus 88 v~e~l 92 (288)
T 3f7w_A 88 AMEWV 92 (288)
T ss_dssp EEECC
T ss_pred EEEee
Confidence 89987
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0011 Score=56.54 Aligned_cols=75 Identities=25% Similarity=0.306 Sum_probs=54.3
Q ss_pred eEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCC--CCCCeeeeccccCcceEEEEeccCC
Q 021053 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNVLVLDLLGP 87 (318)
Q Consensus 10 ~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~--~~~~~i~~~~~~~~~~~lv~e~~~~ 87 (318)
.-.+.|+.|..+.+|++.. ++..+++|+.... ....+..|...++.+... ..++.+...+...+..++|||+..+
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS-YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG-GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc-cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 3457789999999999975 4667888976543 234578899999988653 3355555555556779999999943
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.31 E-value=0.0022 Score=55.22 Aligned_cols=77 Identities=9% Similarity=-0.009 Sum_probs=38.9
Q ss_pred eeeeccCcccE-EEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCC-CCeeeeccccCcceEEEEeccC-CC
Q 021053 12 GRKIGSGSFGE-IFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGVDGEDNVLVLDLLG-PS 88 (318)
Q Consensus 12 ~~~lg~G~~~~-v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~i~~~~~~~~~~~lv~e~~~-~~ 88 (318)
.+.|+.|.... +|+... .++..+++|...... ......|..++..+..... ++.+..+.... -+++||.++ .+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~-~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE-GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT-TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC-CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 34565565554 667753 225667777644322 1456778888888865432 34444432222 278999884 45
Q ss_pred HHHH
Q 021053 89 LEDL 92 (318)
Q Consensus 89 L~~~ 92 (318)
+.+.
T Consensus 99 l~~~ 102 (333)
T 3csv_A 99 FTEV 102 (333)
T ss_dssp HHHH
T ss_pred hHHH
Confidence 5433
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.27 E-value=0.012 Score=46.94 Aligned_cols=100 Identities=14% Similarity=0.120 Sum_probs=63.2
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCcc
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH 164 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~ 164 (318)
..||.+++...+.++++.+++.++.|.+.+|.-.-. +.-..+=+.|..|++. .+|.+...+ ..+.
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~---~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVW---RDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEE---TTSCEEECC-C-------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEe---cCCceeccc-cccc----------
Confidence 458999999989999999999999999999887622 1111222345677773 666665442 1100
Q ss_pred ccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhC
Q 021053 165 IPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG 209 (318)
Q Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg 209 (318)
.....+.+||... ...+.+.=|+|||+++|..+--
T Consensus 98 ---------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 ---------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp ------------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ---------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1123456777753 3345688999999999999863
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0031 Score=56.41 Aligned_cols=72 Identities=13% Similarity=0.116 Sum_probs=49.8
Q ss_pred EeeeeccCcccEEEEEEEcC-------CCcEEEEEeecCCCCC-hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 11 LGRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKH-PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 11 ~~~~lg~G~~~~v~~~~~~~-------~~~~vaiK~~~~~~~~-~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
-.+.|+.|....+|++.... .+..+++|+.... .. ..+..|..++..+......+.+...+.+ .+++
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 35678889999999998653 2568899987442 23 5667899999988765555555443322 3788
Q ss_pred eccCC
Q 021053 83 DLLGP 87 (318)
Q Consensus 83 e~~~~ 87 (318)
+|..|
T Consensus 152 e~l~G 156 (429)
T 1nw1_A 152 EYIPS 156 (429)
T ss_dssp CCCCE
T ss_pred EEeCC
Confidence 88843
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0017 Score=56.95 Aligned_cols=140 Identities=17% Similarity=0.167 Sum_probs=79.1
Q ss_pred eeeeccCcccEEEEEEEcC-------CCcEEEEEeecCCC-CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 12 GRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~-------~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
.+.+..|-...+|++.... ++..+++|+..... ......+|..+++.+......+.+...+.+ .+|++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 4567778899999998642 34689999864322 234567899999998876666666544433 28899
Q ss_pred ccCC-CHH--------------HHHHHh---c----CCCC--HHHHHHHHHHHHH-------------------HHHHH-
Q 021053 84 LLGP-SLE--------------DLFVYC---R----RKFS--LKTVLMLADQMIA-------------------RIEYV- 119 (318)
Q Consensus 84 ~~~~-~L~--------------~~~~~~---~----~~~~--~~~~~~~~~qi~~-------------------~L~~l- 119 (318)
+..| ++. ..+... . +... ...+..+..++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9843 221 111111 1 1122 2444555544322 12222
Q ss_pred ---Hh----CCccccCCCCCceeeccC-CCCCeEEEEeccceee
Q 021053 120 ---HS----RGFLHRDIKPDNFLMGLG-RKANQVYIIDFGLAKK 155 (318)
Q Consensus 120 ---H~----~~i~H~dl~p~Nil~~~~-~~~~~~kL~dfg~~~~ 155 (318)
.. ..++|+|+.+.||++..+ +..+.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 258999999999999521 0136889999987753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.00 E-value=0.0036 Score=54.67 Aligned_cols=72 Identities=17% Similarity=0.082 Sum_probs=43.7
Q ss_pred eeeeccCcccEEEEEEEcC--------CCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 12 GRKIGSGSFGEIFLASHVD--------TNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~--------~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
.+.|+.|....+|++.... .+..+++|+...... ..+...|..+++.+......+.+.... .-++++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 5677889899999998643 126788998654321 123468888998887654444443322 136889
Q ss_pred eccCC
Q 021053 83 DLLGP 87 (318)
Q Consensus 83 e~~~~ 87 (318)
++..|
T Consensus 114 e~i~G 118 (369)
T 3c5i_A 114 EWLYG 118 (369)
T ss_dssp ECCCS
T ss_pred EEecC
Confidence 99844
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.63 E-value=0.031 Score=50.28 Aligned_cols=73 Identities=11% Similarity=0.018 Sum_probs=48.0
Q ss_pred EeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEeccCC
Q 021053 11 LGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGP 87 (318)
Q Consensus 11 ~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~~~ 87 (318)
-.+.|+.|-...+|++.....+..+++|+...... ..+..+|..++..+......+.+...+.. ..+++|+.|
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G 185 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDG 185 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCS
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCC
Confidence 35678889999999998754457889998754321 22346899999999876655555544422 358998843
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.44 E-value=0.045 Score=46.66 Aligned_cols=73 Identities=12% Similarity=0.062 Sum_probs=45.2
Q ss_pred eeeccCcccEEEEEEEcCCCcEEEEEeecCCC-CChhHHHHHHHHHHHcCCCC-CCeeeec-c----ccCcceEEEEecc
Q 021053 13 RKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSG-IPNIKWY-G----VDGEDNVLVLDLL 85 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~-~~~i~~~-~----~~~~~~~lv~e~~ 85 (318)
..++ |....||++... +|+.+++|+..... .......|..++..+..... ++.+... + ...+..++++++.
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 788899988643 45578999886432 33466778888888865322 2222221 1 1234567899998
Q ss_pred CC
Q 021053 86 GP 87 (318)
Q Consensus 86 ~~ 87 (318)
.|
T Consensus 110 ~G 111 (328)
T 1zyl_A 110 GG 111 (328)
T ss_dssp CC
T ss_pred CC
Confidence 54
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.03 E-value=0.073 Score=45.79 Aligned_cols=31 Identities=32% Similarity=0.540 Sum_probs=26.0
Q ss_pred CCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 122 ~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
.+++|+|+.|.||++. .++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~---~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVG---NEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEEC---GGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEe---CCCeEEEEECCCCee
Confidence 3689999999999993 567899999987664
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.74 E-value=0.087 Score=46.82 Aligned_cols=73 Identities=19% Similarity=0.146 Sum_probs=49.9
Q ss_pred EeeeeccCcccEEEEEEEcCC-------CcEEEEEeecCCC-CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 11 LGRKIGSGSFGEIFLASHVDT-------NEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 11 ~~~~lg~G~~~~v~~~~~~~~-------~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
-.+.+..|-...+|++..... +..+++|+..... ...+..+|..+++.+......+.+...+ .-+.|+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 356677799999999987521 5778999865433 2235578999999987655555554322 237889
Q ss_pred eccCC
Q 021053 83 DLLGP 87 (318)
Q Consensus 83 e~~~~ 87 (318)
+|..|
T Consensus 150 efI~G 154 (424)
T 3mes_A 150 EFIDG 154 (424)
T ss_dssp ECCCS
T ss_pred EEeCC
Confidence 99844
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.30 E-value=0.13 Score=45.26 Aligned_cols=32 Identities=28% Similarity=0.508 Sum_probs=25.7
Q ss_pred ccccCCCCCceeeccC---CCCCeEEEEeccceee
Q 021053 124 FLHRDIKPDNFLMGLG---RKANQVYIIDFGLAKK 155 (318)
Q Consensus 124 i~H~dl~p~Nil~~~~---~~~~~~kL~dfg~~~~ 155 (318)
++|+|+.+.||++... ++...+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999421 3567899999988764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=88.64 E-value=0.053 Score=47.16 Aligned_cols=26 Identities=19% Similarity=0.229 Sum_probs=22.7
Q ss_pred hcCCchhHHHhhhcCCccccccccee
Q 021053 279 REGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 279 ~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
+++.+|+++||++||.+|+|++|++.
T Consensus 327 ~~a~DLl~~lL~~dP~~R~ta~eaL~ 352 (361)
T 4f9c_A 327 DEAYDLLDKLLDLNPASRITAEEALL 352 (361)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 45568999999999999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.37 E-value=0.12 Score=45.60 Aligned_cols=27 Identities=15% Similarity=0.189 Sum_probs=23.6
Q ss_pred HhcCCchhHHHhhhcCCccccccccee
Q 021053 278 SREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 278 ~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
.++..+|+++||.+||.+|+|+.+++.
T Consensus 318 s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 318 DRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 445678999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=85.91 E-value=0.25 Score=43.94 Aligned_cols=27 Identities=22% Similarity=0.334 Sum_probs=23.3
Q ss_pred HhcCCchhHHHhhhcCCccccccccee
Q 021053 278 SREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 278 ~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
.++..+|+++||.+||.+|+|+.+++.
T Consensus 335 s~~~~dLl~~mL~~dP~~R~ta~e~L~ 361 (432)
T 3n9x_A 335 SDDGINLLESMLKFNPNKRITIDQALD 361 (432)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 445568999999999999999999875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 318 | ||||
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-81 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-79 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-33 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-32 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-32 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-32 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-32 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-31 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-30 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-30 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-29 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-29 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-29 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-29 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-28 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-28 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-27 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-27 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-27 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-26 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-26 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-26 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-25 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-25 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-25 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-25 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-25 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-25 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 9e-25 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-24 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-24 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-24 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-24 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-24 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-23 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-23 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-23 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-23 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-23 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-23 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-22 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-22 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-22 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-21 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-21 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-21 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-21 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-20 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-20 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-19 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-19 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-19 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-17 |
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 247 bits (631), Expect = 1e-81
Identities = 161/280 (57%), Positives = 206/280 (73%), Gaps = 2/280 (0%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
++GV YK+GR+IG GSFG IF +++ N+ VA+K E + PQL E + YK+L G +
Sbjct: 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT 61
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
GIPN+ ++G +G NVLV+DLLGPSLEDL C RKFS+KTV M A QM+AR++ +H +
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 124 FLHRDIKPDNFLMGLG--RKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
++RDIKPDNFL+G + AN +Y++DFG+ K YRDP T +HIPYRE KNL+GTARY S
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
NTHLG EQSRRDDLE+LG+V +YFLRGSLPWQGLKAAT KQKY++I EKK STP+ LC
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC 241
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
P EF Y HY ++L FD PDY +L+ LF + R
Sbjct: 242 AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 242 bits (617), Expect = 2e-79
Identities = 198/281 (70%), Positives = 244/281 (86%)
Query: 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQ 60
ME +G +Y+LGRKIGSGSFG+I+L + + E VA+K+E TKHPQL E+K+YK++Q
Sbjct: 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ 60
Query: 61 GGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
GG GIP I+W G +G+ NV+V++LLGPSLEDLF +C RKFSLKTVL+LADQMI+RIEY+H
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ F+HRD+KPDNFLMGLG+K N VYIIDFGLAKKYRD T++HIPYRENKNLTGTARYA
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
S NTHLGIEQSRRDDLESLGYVL+YF GSLPWQGLKAATK+QKY++I EKK+STPIEVL
Sbjct: 181 SINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281
CK +P+EFA+Y ++C+SL FD +PDY +L++LF +LF R+G
Sbjct: 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 122 bits (308), Expect = 4e-33
Identities = 44/260 (16%), Positives = 94/260 (36%), Gaps = 17/260 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y + ++G+G+FG + + T A K + + E + +L+ +
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTL 85
Query: 66 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
N+ D + V++ + + G L + K S + Q+ + ++H +
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 145
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+H D+KP+N + +++N++ +IDFGL + + TGTA +A+
Sbjct: 146 VHLDLKPENIMF-TTKRSNELKLIDFGLTAHLDPKQSVKVT--------TGTAEFAAPEV 196
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244
G D+ S+G + L G P+ G + + +
Sbjct: 197 AEGKPVGYYTDMWSVGVLSYILLSGLSPFGG---ENDDETLRNVKSCDWNMDDSAF-SGI 252
Query: 245 PAEFASYFHYCQSLTFDQRP 264
+ + + R
Sbjct: 253 SEDGKDFIRKLLLADPNTRM 272
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 4e-33
Identities = 47/259 (18%), Positives = 98/259 (37%), Gaps = 16/259 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
KY + +G G FG + + + K ++ GT + E + I + I
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNIL 64
Query: 67 NIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFL 125
++ E+ V++ + + G + + + + + ++ Q+ ++++HS
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 126 HRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTH 185
H DI+P+N + R+++ + II+FG A++ + R + Y + H
Sbjct: 125 HFDIRPENIIYQ-TRRSSTIKIIEFGQARQLKPGDNFRLLF--------TAPEYYAPEVH 175
Query: 186 LGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHP 245
S D+ SLG ++ L G P+ T +Q + I + + E K
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINPFLA---ETNQQIIENIMNAEYTFDEEAF-KEIS 231
Query: 246 AEFASYFHYCQSLTFDQRP 264
E + R
Sbjct: 232 IEAMDFVDRLLVKERKSRM 250
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 121 bits (305), Expect = 1e-32
Identities = 54/260 (20%), Positives = 90/260 (34%), Gaps = 17/260 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
Y + ++GSG+FG + T + K + E + L +
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKL 88
Query: 66 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
N+ D + VL+L+ L G L D K S V+ Q ++++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSI 148
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+H DIKP+N + +KA+ V IIDFGLA K + T TA +A+
Sbjct: 149 VHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEIVKVT--------TATAEFAAPEI 199
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244
D+ ++G + L G P+ G + + + S
Sbjct: 200 VDREPVGFYTDMWAIGVLGYVLLSGLSPFAG---EDDLETLQNVKRCDWEFDEDAF-SSV 255
Query: 245 PAEFASYFHYCQSLTFDQRP 264
E + +R
Sbjct: 256 SPEAKDFIKNLLQKEPRKRL 275
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (298), Expect = 6e-32
Identities = 48/291 (16%), Positives = 101/291 (34%), Gaps = 20/291 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSG 64
++ ++G+G+ G +F SH + ++A K+ E Q++ E +V
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPY 65
Query: 65 IPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-G 123
I + + ++ + D + + + + ++ +I + Y+ +
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
+HRD+KP N L+ ++ + DFG++ + D N + GT Y S
Sbjct: 126 IMHRDVKPSNILVN---SRGEIKLCDFGVSGQLIDSMANSFV---------GTRSYMSPE 173
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
G S + D+ S+G L+ G P A + + E +
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 244 HPAEFASYFHYCQSLTFDQRPDY---GFLKRLFHDLFSREGSLLLQFIMSY 291
+ + + DY +L +FS E + +
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 7e-32
Identities = 65/280 (23%), Positives = 104/280 (37%), Gaps = 28/280 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+++GR +G G FG ++LA + I+A+K+ QL E ++ L+
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH- 65
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
I + Y D L+L+ + KF + ++ + Y HS+
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
+HRDIKP+N L+G A ++ I DFG + H P L GT Y
Sbjct: 126 RVIHRDIKPENLLLG---SAGELKIADFGWSV---------HAPSSRRTTLCGTLDYLPP 173
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
G + DL SLG + FL G P++ T ++ Y +I + + P V
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFPDFV--- 227
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGS 282
QRP + H + S
Sbjct: 228 --TEGARDLISRLLKHNPSQRPMLREVLE--HPWITANSS 263
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 8e-32
Identities = 51/289 (17%), Positives = 108/289 (37%), Gaps = 32/289 (11%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
+++ ++G G+FG+++ A + +T+ + A K+ S + + E + P
Sbjct: 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH----P 69
Query: 67 NI-KWYGVDGEDN--VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
NI K +N ++++ G +++ + + R + + ++ Q + + Y+H
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS- 181
+HRD+K N L + + DFG++ K R + GT + +
Sbjct: 130 KIIHRDLKAGNILFT---LDGDIKLADFGVSAKNTRTIQRRD-------SFIGTPYWMAP 179
Query: 182 ----CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
C T + D+ SLG L+ P L + KI + + P
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL---NPMRVLLKIAKSE--PPT 234
Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQ 286
+ F + C D R L + H + + + ++
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ--HPFVTVDSNKPIR 281
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-31
Identities = 59/268 (22%), Positives = 105/268 (39%), Gaps = 27/268 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ----LLYEAKVYKILQGGS 63
+ +G++IGSGSFG ++ VAVK+ N PQ E V + +
Sbjct: 9 QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH-- 63
Query: 64 GIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
NI + G + +V G SL KF + ++ +A Q ++Y+H
Sbjct: 64 --VNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
++ +HRD+K +N + + V I DFGLA + + + L+G+ +
Sbjct: 122 AKSIIHRDLKSNNIFLH---EDLTVKIGDFGLATVKSRWSGSHQF-----EQLSGSILWM 173
Query: 181 S---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
+ S + D+ + G VL + G LP+ + + Q + +S +
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVGRGYLSPDL 231
Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPD 265
+ + P C D+RP
Sbjct: 232 SKVRSNCPKAMKRLMAECLKKKRDERPL 259
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (290), Expect = 5e-31
Identities = 53/238 (22%), Positives = 93/238 (39%), Gaps = 19/238 (7%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+K G+ +G GSF + LA + T+ A+KI K P + E V L
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-H 67
Query: 63 SGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ + D E L L ++ F ++++ +EY+H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLK-YIRKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+G +HRD+KP+N L+ + + I DFG AK + + GTA+Y S
Sbjct: 127 KGIIHRDLKPENILLN---EDMHIQITDFGTAKVLSPESKQARA-----NSFVGTAQYVS 178
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
+ DL +LG ++ + G P++ + + KI + + P +
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA---GNEYLIFQKIIKLEYDFPEKF 233
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 112 bits (281), Expect = 7e-30
Identities = 56/269 (20%), Positives = 100/269 (37%), Gaps = 27/269 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+Y+LG +G G E+ LA + + VAVK+ + + + EA+ L
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH- 66
Query: 63 SGIPNI-KWYGVDGEDN------VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
P I Y + +V++ + V+ + K + +
Sbjct: 67 ---PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
+ + H G +HRD+KP N ++ N V ++DFG+A+ D + + + G
Sbjct: 124 LNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVT----QTAAVIG 176
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
TA+Y S G R D+ SLG VL L G P+ G + + +
Sbjct: 177 TAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG---DSPVSVAYQHVREDP-I 232
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
P + A+ + + + R
Sbjct: 233 PPSARHEGLSADLDAVVLKALAKNPENRY 261
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (283), Expect = 7e-30
Identities = 55/284 (19%), Positives = 97/284 (34%), Gaps = 37/284 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+ R+IG GSFG ++ A V +E+VA+K + S K ++ E + + L+
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH- 74
Query: 63 SGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYV 119
PN ++ G LV++ S DL ++ + + + + Y+
Sbjct: 75 ---PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
HS +HRD+K N L+ + V + DFG A + GT +
Sbjct: 132 HSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPANS-----------FVGTPYW 177
Query: 180 AS---CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
+ + + D+ SLG + P + I + +
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNESPAL 234
Query: 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
F ++ C RP L + H RE
Sbjct: 235 QSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLRE 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 1e-29
Identities = 67/248 (27%), Positives = 101/248 (40%), Gaps = 21/248 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSG 64
+ L + +G G++GE+ LA + T E VAVKI + + + E + K+L
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH--- 62
Query: 65 IPNI-KWYGVDGEDNV--LVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
N+ K+YG E N+ L L+ + Q++A + Y+H
Sbjct: 63 -ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
G HRDIKP+N L+ + + + I DFGLA +R R + + GT Y +
Sbjct: 122 IGITHRDIKPENLLLD---ERDNLKISDFGLATVFRYNNRERLL-----NKMCGTLPYVA 173
Query: 182 CNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
E + D+ S G VL L G LPW + Q+Y EKK
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQ--PSDSCQEYSDWKEKKTYLNPWKK 231
Query: 241 CKSHPAEF 248
S P
Sbjct: 232 IDSAPLAL 239
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (282), Expect = 2e-29
Identities = 47/237 (19%), Positives = 95/237 (40%), Gaps = 25/237 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
+ + +G G+FG++ L T A+KI + + + E++V + +
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH- 64
Query: 63 SGIPNI-KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK--FSLKTVLMLADQMIARIEYV 119
P + + L + + +LF + R+ F+ + ++++ +EY+
Sbjct: 65 ---PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 120 HSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
HSR ++RDIK +N ++ K + I DFGL K+ GT Y
Sbjct: 122 HSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMK-------TFCGTPEY 171
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
+ + R D LG V+ + G LP+ ++ ++ I +++ P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERLFELILMEEIRFP 225
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 3e-29
Identities = 54/277 (19%), Positives = 112/277 (40%), Gaps = 27/277 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
KL ++G+G FGE+++ + + + VAVK ++ L EA + K LQ
Sbjct: 14 TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH----Q 68
Query: 67 NI-KWYGVDGEDNV-LVLDLL--GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+ + Y V ++ + ++ + + G ++ L K ++ +L +A Q+ + ++ R
Sbjct: 69 RLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER 128
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
++HRD++ N L+ I DFGLA+ D + ++ +
Sbjct: 129 NYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAR------EGAKFPIKWTAP 179
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
+ + D+ S G +L + G +P+ G ++ + V
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG-------MTNPEVIQNLERGYRMVRP 232
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
+ P E C + RP + +L+ + D F+
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 6e-29
Identities = 49/227 (21%), Positives = 89/227 (39%), Gaps = 22/227 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
+Y++G +GSG FG ++ V N VA+K ++ E + K +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 60 QGG-SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRK-FSLKTVLMLADQMIARIE 117
G SG+ + + + VL+L+ P + R + Q++ +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
+ H+ G LHRDIK +N L + ++ +IDFG +D + GT
Sbjct: 125 HCHNCGVLHRDIKDENIL--IDLNRGELKLIDFGSGALLKDTVYT---------DFDGTR 173
Query: 178 RYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQ 223
Y+ R + SLG +L + G +P++ + + Q
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQ 220
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 110 bits (275), Expect = 6e-29
Identities = 47/269 (17%), Positives = 84/269 (31%), Gaps = 22/269 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----------ENSGTKHPQLLYEAKVY 56
Y+ +G G + H T + AVKI E L E +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 57 KILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIAR 115
+ + G I +K LV DL+ L D ++ + S K + ++
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD-YLTEKVTLSEKETRKIMRALLEV 122
Query: 116 IEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
I +H +HRD+KP+N L+ + + DFG + + R + +
Sbjct: 123 ICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE 179
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
+ + H G + D+ S G ++ L GS P+ + I
Sbjct: 180 IIECSMNDNHPGY--GKEVDMWSTGVIMYTLLAGSPPFWH---RKQMLMLRMIMSGNYQF 234
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
+ + +R
Sbjct: 235 GSPEW-DDYSDTVKDLVSRFLVVQPQKRY 262
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 8e-29
Identities = 51/245 (20%), Positives = 92/245 (37%), Gaps = 22/245 (8%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGI 65
KY KIG G+ G ++ A V T + VA++ K ++ E V + + I
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNI 79
Query: 66 PNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
N + G++ +V++ L G SL D+ + + + + +E++HS
Sbjct: 80 VNYLDSYLVGDELWVVMEYLAGGSLTDV--VTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRDIK DN L+ V + DFG + + R + GT + +
Sbjct: 138 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRS-------TMVGTPYWMAPEV 187
Query: 185 HLGIEQSRRDDLESLGYVLLYFLRGSLPWQG------LKAATKKQKYDKICEKKVSTPIE 238
+ D+ SLG + + + G P+ L + +K+S
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 247
Query: 239 VLCKS 243
Sbjct: 248 DFLNR 252
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 1e-28
Identities = 53/234 (22%), Positives = 93/234 (39%), Gaps = 20/234 (8%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--ENSGTKHPQLLYEAKVYKILQGGSGIP 66
+ L + +G GSFG++FLA TN+ A+K ++ + ++L P
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 67 NI-KWYGVDGEDNVLVLDL---LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+ + L + G L + KF L A ++I ++++HS+
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYH-IQSCHKFDLSRATFYAAEIILGLQFLHSK 122
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
G ++RD+K DN L+ K + I DFG+ K+ + GT Y +
Sbjct: 123 GIVYRDLKLDNILLD---KDGHIKIADFGMCKENMLGDAKTN-------TFCGTPDYIAP 172
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
LG + + D S G +L L G P+ G +++ + I P
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEELFHSIRMDNPFYP 223
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-28
Identities = 51/268 (19%), Positives = 89/268 (33%), Gaps = 19/268 (7%)
Query: 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63
II + +G G G++ + T E A+K+ P+ E +++
Sbjct: 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---DCPKARREVELHWRASQCP 65
Query: 64 GIPNIKWYGVDGEDN----VLVLDLL-GPSLEDLFV-YCRRKFSLKTVLMLADQMIARIE 117
I I + ++V++ L G L + F+ + + + I+
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 125
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
Y+HS HRD+KP+N L R + + DFG AK+ + Y T
Sbjct: 126 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--------TP 177
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL-KAATKKQKYDKICEKKVSTP 236
Y + + + D+ SLG ++ L G P+ A +I + P
Sbjct: 178 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237
Query: 237 IEVLCKSHPAEFASYFHYCQSLTFDQRP 264
E QR
Sbjct: 238 NP-EWSEVSEEVKMLIRNLLKTEPTQRM 264
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (272), Expect = 3e-28
Identities = 64/296 (21%), Positives = 102/296 (34%), Gaps = 27/296 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQG-- 61
KY+ KIG G+FGE+F A H T + VA+K L E K+ ++L+
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70
Query: 62 -----GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
Y LV D L L KF+L + + ++ +
Sbjct: 71 VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130
Query: 117 EYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGT 176
Y+H LHRD+K N L+ + + + DFGLA+ + ++ Y N T
Sbjct: 131 YYIHRNKILHRDMKAANVLIT---RDGVLKLADFGLARAFSLAKNSQPNRY---TNRVVT 184
Query: 177 ARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
Y LG DL G ++ S QG T++ + I + S
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG---NTEQHQLALISQLCGSI 241
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMSY 291
EV + + L + RL + L+ ++
Sbjct: 242 TPEVW------PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 291
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 107 bits (268), Expect = 9e-28
Identities = 51/261 (19%), Positives = 100/261 (38%), Gaps = 18/261 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQGGSG 64
Y +G+G+F E+ LA T ++VA+K + K + E V ++
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPN 68
Query: 65 IPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I + G L++ L+ G L D + + ++ + L Q++ ++Y+H G
Sbjct: 69 IVALDDIYESGGHLYLIMQLVSGGELFD-RIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
+HRD+KP+N L + +++ I DFGL+K + GT Y +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--------CGTPGYVAPE 179
Query: 184 THLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
S+ D S+G + L G P+ + +++I + +
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD---ENDAKLFEQILKAEYEFDSPYW-DD 235
Query: 244 HPAEFASYFHYCQSLTFDQRP 264
+ + ++R
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRF 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-27
Identities = 64/277 (23%), Positives = 119/277 (42%), Gaps = 27/277 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQ-LLYEAKVYKILQGGSGIP 66
+L K+G G FGE+++ + T VA+K GT P+ L EA+V K L+
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRH----E 72
Query: 67 NI-KWYGVDGEDNVLVL--DLLGPSLEDLFVYCRRKF-SLKTVLMLADQMIARIEYVHSR 122
+ + Y V E+ + ++ + SL D K+ L ++ +A Q+ + + YV
Sbjct: 73 KLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM 132
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
++HRD++ N L+G + + DFGLA+ D Y + ++ +
Sbjct: 133 NYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNE------YTARQGAKFPIKWTAP 183
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
L + + D+ S G +L +G +P+ G+ ++ D++ E+ P C
Sbjct: 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQV-ERGYRMPCPPEC 239
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
P C ++RP + +L+ D F+
Sbjct: 240 ---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 107 bits (268), Expect = 2e-27
Identities = 56/285 (19%), Positives = 107/285 (37%), Gaps = 16/285 (5%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
Y+L RK+G G + E+F A ++ NE V VKI K ++ E K+ + L+GG I
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-VKKKKIKREIKILENLRGGPNIIT 94
Query: 68 IKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHR 127
+ D L + D + + + +++ ++Y HS G +HR
Sbjct: 95 LADIVKDPVSRTPALVFEHVNNTDFKQLYQT-LTDYDIRFYMYEILKALDYCHSMGIMHR 153
Query: 128 DIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG 187
D+KP N + + + ++ +ID+GLA+ Y + + +
Sbjct: 154 DVKPHNVM--IDHEHRKLRLIDWGLAEFYHPGQEYNVR--------VASRYFKGPELLVD 203
Query: 188 IEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPA 246
+ D+ SLG +L + P+ + +I + + + +
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFH--GHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 247 EFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMSY 291
E F+ +R + H + S E L ++ Y
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLV-SPEALDFLDKLLRY 305
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 3e-27
Identities = 55/273 (20%), Positives = 95/273 (34%), Gaps = 33/273 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
Y++ IG+GS+G +I+ K + + L+ E + + L+
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HP 63
Query: 64 GIPNIKWYGVDGEDNV--LVLDLL-GPSLEDLFVYCRRK---FSLKTVLMLADQMIARIE 117
I +D + +V++ G L + ++ + VL + Q+ ++
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 118 YVHSRG-----FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
H R LHRD+KP N + V + DFGLA+ T+ K
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFA-------KA 173
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
GT Y S + + + D+ SLG +L P+ ++K+ KI E K
Sbjct: 174 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIREGK 230
Query: 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
E +L RP
Sbjct: 231 FRRIPYRY----SDELNEIITRMLNLKDYHRPS 259
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 106 bits (266), Expect = 4e-27
Identities = 54/239 (22%), Positives = 91/239 (38%), Gaps = 20/239 (8%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGS 63
+ + R IG G FGE++ DT ++ A+K L E + ++ G
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 64 --GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
I + + + +LDL+ + FS + A ++I +E++H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
R ++RD+KP N L+ + V I D GLA + + + GT Y +
Sbjct: 126 RFVVYRDLKPANILLD---EHGHVRISDLGLACDFSKKKPHASV---------GTHGYMA 173
Query: 182 CNTHL-GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
G+ D SLG +L LRG P++ K K + V P
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 2e-26
Identities = 49/266 (18%), Positives = 94/266 (35%), Gaps = 26/266 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGSG 64
K +IG GSF ++ +T VA + + ++ + EA++ K LQ +
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 65 IPNIKWYGVDGEDN---VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ + + VLV +L+ ++ + +K + Q++ ++++H+
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 122 RG--FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARY 179
R +HRD+K DN + V I D GLA R K + GT +
Sbjct: 131 RTPPIIHRDLKCDNIF--ITGPTGSVKIGDLGLATLKRASFA---------KAVIGTPEF 179
Query: 180 ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239
+ + + D+ + G +L P+ Q Y ++ +
Sbjct: 180 MAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSE--CQNAAQIYRRVTSGVKPASFD- 235
Query: 240 LCKSHPAEFASYFHYCQSLTFDQRPD 265
K E C D+R
Sbjct: 236 --KVAIPEVKEIIEGCIRQNKDERYS 259
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 3e-26
Identities = 64/290 (22%), Positives = 108/290 (37%), Gaps = 31/290 (10%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQG 61
+R V Y + IG+GSFG ++ A D+ E+VA+K + E ++ + L
Sbjct: 15 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDH 72
Query: 62 GSGIPNIKWYGVDGEDN-----VLVLDLLGPS-LEDLFVYCRRK--FSLKTVLMLADQMI 113
+ + ++ GE LVLD + + Y R K + V + Q+
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD----PTTNRHIPYRE 169
+ Y+HS G HRDIKP N L + + DFG AK+ + YR
Sbjct: 133 RSLAYIHSFGICHRDIKPQNL--LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRA 190
Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKIC 229
+ + G Y + D+ S G VL L G + G + + +I
Sbjct: 191 PELIFGATDY-----------TSSIDVWSAGCVLAELLLGQPIFPG---DSGVDQLVEII 236
Query: 230 EKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
+ + E + + +P F ++ + + L SR
Sbjct: 237 KVLGTPTREQIREMNPNYTEFKFPQIKAHPWT-KVFRPRTPPEAIALCSR 285
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (257), Expect = 4e-26
Identities = 51/236 (21%), Positives = 94/236 (39%), Gaps = 28/236 (11%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGS 63
+++ R +G+GSFG + L A+K+ + E + I+
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-- 63
Query: 64 GIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVH 120
P I + +G D + +++D + + ++F A ++ +EY+H
Sbjct: 64 --PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 121 SRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYA 180
S+ ++RD+KP+N L+ K + I DFG AK D T L GT Y
Sbjct: 122 SKDIIYRDLKPENILLD---KNGHIKITDFGFAKYVPDVTY----------TLCGTPDYI 168
Query: 181 SCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236
+ ++ D S G ++ L G P+ + + Y+KI ++ P
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKTYEKILNAELRFP 221
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 103 bits (257), Expect = 8e-26
Identities = 50/262 (19%), Positives = 99/262 (37%), Gaps = 27/262 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGG 62
++ + +G+GSFG + L H ++ A+KI + L E ++ + +
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-F 100
Query: 63 SGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
+ +++ D + +V++ + + +FS A Q++ EY+HS
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 160
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
++RD+KP+N L+ + + DFG AK+ + T GT +
Sbjct: 161 DLIYRDLKPENLLIDQQ---GYIQVTDFGFAKRVKGRTWTLC----------GTPEALAP 207
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
L ++ D +LG ++ G P+ Q Y+KI KV P
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA---DQPIQIYEKIVSGKVRFPSHF--- 261
Query: 243 SHPAEFASYFHYCQSLTFDQRP 264
++ + +R
Sbjct: 262 --SSDLKDLLRNLLQVDLTKRF 281
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 1e-25
Identities = 63/274 (22%), Positives = 98/274 (35%), Gaps = 30/274 (10%)
Query: 4 IIGVK-YKLGRKIGSGSFGEIFLASHVDTN---EIVAVKI-----ENSGTKHPQLLYEAK 54
+IG K +L K+G GSFG + + VAVK + + E
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 55 VYKILQGGSGIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQ 111
L N+ + YGV + +V +L SL D + F L T+ A Q
Sbjct: 64 AMHSLDH----RNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 119
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
+ + Y+ S+ F+HRD+ N L+ + V I DFGL + + Y +
Sbjct: 120 VAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDH----YVMQE 172
Query: 172 NLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICE 230
+ + + + S D G L G PW GL Q KI +
Sbjct: 173 HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDK 229
Query: 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
+ P C P + + C + + RP
Sbjct: 230 EGERLPRPEDC---PQDIYNVMVQCWAHKPEDRP 260
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (251), Expect = 2e-25
Identities = 57/274 (20%), Positives = 114/274 (41%), Gaps = 27/274 (9%)
Query: 13 RKIGSGSFGEIFLASHVD--TNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIP 66
+++GSG+FG + + + VAVKI + P +LL EA V + L P
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN----P 68
Query: 67 NI-KWYGV-DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I + G+ + E +LV+++ + ++ R K ++ L Q+ ++Y+ F
Sbjct: 69 YIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRD+ N L+ + I DFGL+K R Y+ + ++ +
Sbjct: 129 VHRDLAARNVLLV---TQHYAKISDFGLSKALRADENY----YKAQTHGKWPVKWYAPEC 181
Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
+ S + D+ S G ++ G P++G+K + +K +++ P
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK--GERMGCPAGC---- 235
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277
P E + C + + RP + ++ + +
Sbjct: 236 -PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 100 bits (249), Expect = 3e-25
Identities = 55/277 (19%), Positives = 108/277 (38%), Gaps = 25/277 (9%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIP 66
+ K+G G +GE++ + VAVK ++ + + L EA V K ++ P
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH----P 73
Query: 67 NI-KWYGVDGEDNVLVLDL----LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
N+ + GV + + G L+ L R++ S +L +A Q+ + +EY+
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
+ F+HRD+ N L+G + + V + DFGL++ T H + ++ +
Sbjct: 134 KNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAK------FPIKWTA 184
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
+ + S + D+ + G +L + + ++ EK C
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP---GIDLSQVYELLEKDYRMERPEGC 241
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278
P + C RP + + + F +F
Sbjct: 242 ---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.8 bits (248), Expect = 5e-25
Identities = 54/274 (19%), Positives = 106/274 (38%), Gaps = 27/274 (9%)
Query: 13 RKIGSGSFGEIFLASHVDTNE--IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPN 67
++G G+FG + + + VA+K+ GT+ +++ EA++ L P
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN----PY 70
Query: 68 I-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGF 124
I + GV + + LV+++ G L V R + + V L Q+ ++Y+ + F
Sbjct: 71 IVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 125 LHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNT 184
+HRD+ N L+ + I DFGL+K + ++ +
Sbjct: 131 VHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTA----RSAGKWPLKWYAPEC 183
Query: 185 HLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243
+ S R D+ S G + L G P++ + + I + K
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM---KGPEVMAFIEQGKRMECPPEC--- 237
Query: 244 HPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277
P E + C ++ RPD+ +++ +
Sbjct: 238 -PPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 6e-25
Identities = 53/289 (18%), Positives = 99/289 (34%), Gaps = 46/289 (15%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEI-----VAVKI---ENSGTKHPQLLYEAKVYKIL 59
+ G+ +GSG+FG++ A+ ++ VAVK+ + ++ L+ E K+ L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 60 QGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFS----------------- 101
I N+ L+ + L + R KFS
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 102 -----LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156
+ +L A Q+ +E++ + +HRD+ N L+ V I DFGLA+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT---HGKVVKICDFGLARDI 214
Query: 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQG 215
+ Y N ++ + + + + D+ S G +L G P+ G
Sbjct: 215 MSDSN-----YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269
Query: 216 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
+ + K+ + E C + +RP
Sbjct: 270 I---PVDANFYKLIQNGFKMDQPFYA---TEEIYIIMQSCWAFDSRKRP 312
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.5 bits (245), Expect = 8e-25
Identities = 57/280 (20%), Positives = 99/280 (35%), Gaps = 33/280 (11%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPN 67
+ KL + IG G FG++ L + VAVK + L EA V L+ N
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH----SN 61
Query: 68 I-KWYGVDGEDN---VLVLDLL-GPSLED-LFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ + GV E+ +V + + SL D L R +L + + +EY+
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
F+HRD+ N L+ + N + DFGL K+ ++ +
Sbjct: 122 NNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGK----------LPVKWTA 168
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
+ S + D+ S G +L G +P+ + K ++ + +
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGYKMDAPDGC 225
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
P C L RP + L+ + + E
Sbjct: 226 ----PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 9e-25
Identities = 60/283 (21%), Positives = 111/283 (39%), Gaps = 30/283 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
+ +LGR IG G FG++ ++ VA+K S + + L EA +
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 62 GSGIPNI-KWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
P+I K GV E+ V ++++L L + L ++++ A Q+ + Y
Sbjct: 68 ----PHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+ S+ F+HRDI N L+ + V + DFGL++ D T Y + +
Sbjct: 124 LESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDST------YYKASKGKLPIK 174
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
+ + + + D+ G + L G P+QG+ K + + + +
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV-------KNNDVIGRIENGER 227
Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280
+ + P S C + +RP + LK + E
Sbjct: 228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 1e-24
Identities = 53/269 (19%), Positives = 95/269 (35%), Gaps = 28/269 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI--------ENSGTKHPQLLYEAKVYKIL 59
Y G ++GSG F + T A K G + E + K +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 60 QGGSGIPNI-KWYGV--DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARI 116
Q PN+ + V + D +L+L+L+ F+ + + + Q++ +
Sbjct: 71 QH----PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 117 EYVHSRGFLHRDIKPDNFLM-GLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTG 175
Y+HS H D+KP+N ++ ++ IIDFGLA K ++I G
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI--------FG 178
Query: 176 TARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235
T + + D+ S+G + L G+ P+ G TK++ +
Sbjct: 179 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG---DTKQETLANVSAVNYEF 235
Query: 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRP 264
E + A + +R
Sbjct: 236 EDEYF-SNTSALAKDFIRRLLVKDPKKRM 263
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 98.7 bits (245), Expect = 1e-24
Identities = 48/290 (16%), Positives = 104/290 (35%), Gaps = 21/290 (7%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKI---ENSGTKHPQLLYEAKV 55
+ I K+ + IG+G FGE+ + VA+K + + L EA +
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 56 YKILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
+ +++ +++ + + SL+ +F++ ++ + + A
Sbjct: 81 MGQFDH-PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
++Y+ ++HRD+ N L+ + DFGL++ D T++ Y
Sbjct: 140 GMKYLADMNYVHRDLAARNILVN---SNLVCKVSDFGLSRFLEDDTSDPT--YTSALGGK 194
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKV 233
R+ + + + D+ S G V+ + G P+ + T + + I +
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIEQDYR 251
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSL 283
P P+ C + RP +G + + SL
Sbjct: 252 LPPPM----DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSL 297
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.0 bits (243), Expect = 3e-24
Identities = 53/285 (18%), Positives = 101/285 (35%), Gaps = 30/285 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHV-DTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGG 62
+Y+ +IG G++G++F A + + VA+K + E V + L+
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 63 SGIPNIKWYGVDGEDNVLVLDLL--------GPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
++ + V L L +T+ + Q++
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
++++HS +HRD+KP N L+ + Q+ + DFGLA+ Y +
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLARIYSFQMALTSV--------V 176
Query: 175 GTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234
T Y + L + DL S+G + R ++G ++ + KI +
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG---SSDVDQLGKIL-DVIG 232
Query: 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
P E A FH + ++ + L DL +
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD--IDELGKDLLLK 275
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.8 bits (245), Expect = 3e-24
Identities = 60/297 (20%), Positives = 97/297 (32%), Gaps = 36/297 (12%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
+G +Y IG G++G + A VA+K T + L E K+ +
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH 65
Query: 62 GSGIPNI-KWYGV-------DGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMI 113
NI + +D LV L+G L L + S + Q++
Sbjct: 66 ----ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL--KTQHLSNDHICYFLYQIL 119
Query: 114 ARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNL 173
++Y+HS LHRD+KP N L+ + I DFGLA+ +
Sbjct: 120 RGLKYIHSANVLHRDLKPSNLLLN---TTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176
Query: 174 TGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
A N ++ D+ S+G +L L + G + + I
Sbjct: 177 WYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLSNRPIFPG---KHYLDQLNHILGILG 230
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMS 290
S E L + +Y K ++ LF S L +
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHKN----------KVPWNRLFPNADSKALDLLDK 277
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.9 bits (243), Expect = 4e-24
Identities = 51/265 (19%), Positives = 95/265 (35%), Gaps = 24/265 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYKILQG 61
+K + +GSG+FG ++ + E V + + S + ++L EA V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 62 GSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS 121
+ + + ++ + L D + + +L Q+ + Y+
Sbjct: 71 -PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 122 RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYAS 181
R +HRD+ N L+ V I DFGLAK H + ++ +
Sbjct: 130 RRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMA 181
Query: 182 CNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240
+ L + + D+ S G + + GS P+ G+ A + I EK P +
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA----SEISSILEKGERLPQPPI 237
Query: 241 CKSHPAEFASYFHYCQSLTFDQRPD 265
C + C + D RP
Sbjct: 238 C---TIDVYMIMVKCWMIDADSRPK 259
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 96.1 bits (238), Expect = 1e-23
Identities = 62/281 (22%), Positives = 105/281 (37%), Gaps = 29/281 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
KY KIG G++G ++ A + + E A+K + + E + K L+ S
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH-S 60
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I + + VLV + L L+ L C T Q++ I Y H R
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRH-----IPYRENKNLTGTAR 178
LHRD+KP N L+ + ++ I DFGLA+ + P + YR L G+ +
Sbjct: 121 VLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
Y S D+ S+G + + G+ + G ++ + +I + + TP
Sbjct: 178 Y-----------STTIDIWSVGCIFAEMVNGTPLFPG---VSEADQLMRIF-RILGTPNS 222
Query: 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
+ ++ L DL S+
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSK 263
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.8 bits (240), Expect = 1e-23
Identities = 49/248 (19%), Positives = 106/248 (42%), Gaps = 23/248 (9%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKI------ENSGTKHPQLLYE 52
E++ ++L + +G+G++G++FL + DT ++ A+K+ E
Sbjct: 19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 78
Query: 53 AKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQM 112
+V + ++ + + + L+LD + + R +F+ V + ++
Sbjct: 79 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 138
Query: 113 IARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKN 172
+ +E++H G ++RDIK +N L+ V + DFGL+K++ T R +
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFC---- 191
Query: 173 LTGTARYASCNTHLGIEQ--SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230
GT Y + + G + + D SLG ++ L G+ P+ +K +I
Sbjct: 192 --GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV---DGEKNSQAEISR 246
Query: 231 KKVSTPIE 238
+ + +
Sbjct: 247 RILKSEPP 254
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 3e-23
Identities = 60/297 (20%), Positives = 107/297 (36%), Gaps = 46/297 (15%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
+Y+ +GSG++G + A T VAVK S + E ++ K ++
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH-- 76
Query: 64 GIPNI---------KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
N+ + D LV L+G L ++ +K + V L Q++
Sbjct: 77 --ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI--VKCQKLTDDHVQFLIYQILR 132
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLT 174
++Y+HS +HRD+KP N + + ++ I+DFGLA+ D T
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDEMTGYVA--------- 180
Query: 175 GTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKV 233
T Y + L ++ D+ S+G ++ L G + G + I
Sbjct: 181 -TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG---TDHIDQLKLILRLVG 236
Query: 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMS 290
+ E+L K +Y K F ++F L + +
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQ----------MPKMNFANVFIGANPLAVDLLEK 283
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.7 bits (237), Expect = 4e-23
Identities = 58/298 (19%), Positives = 112/298 (37%), Gaps = 48/298 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
Y+ + +GSG++G + A T VA+K S + E ++ K ++
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH-- 76
Query: 64 GIPNI-KWYGVDGEDN--------VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIA 114
N+ V D LV+ +G L L K + L QM+
Sbjct: 77 --ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM--KHEKLGEDRIQFLVYQMLK 132
Query: 115 RIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR--HIPYRENKN 172
+ Y+H+ G +HRD+KP N + + ++ I+DFGLA++ T YR +
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVN---EDCELKILDFGLARQADSEMTGYVVTRWYRAPEV 189
Query: 173 LTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232
+ RY ++ D+ S+G ++ + G ++G + + +I +
Sbjct: 190 ILNWMRY-----------TQTVDIWSVGCIMAEMITGKTLFKG---SDHLDQLKEIMKVT 235
Query: 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMS 290
+ P E + + E +Y + K+ F + + L + +
Sbjct: 236 GTPPAEFVQRLQSDEAKNYM----------KGLPELEKKDFASILTNASPLAVNLLEK 283
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.0 bits (233), Expect = 4e-23
Identities = 49/263 (18%), Positives = 99/263 (37%), Gaps = 27/263 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
+++G+G FG + VA+K I+ + + EAKV L
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH----EK 60
Query: 68 I-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
+ + YGV ++ + + L + R +F + +L + + +EY+ S+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
FLHRD+ N L+ V + DFGL++ D Y + R++
Sbjct: 121 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDE------YTSSVGSKFPVRWSPPE 171
Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
+ + S + D+ + G ++ G +P++ T + + I + +
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGLRLYRPHLA-- 226
Query: 243 SHPAEFASYFHYCQSLTFDQRPD 265
+ + + C D+RP
Sbjct: 227 --SEKVYTIMYSCWHEKADERPT 247
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 94.5 bits (234), Expect = 6e-23
Identities = 54/290 (18%), Positives = 93/290 (32%), Gaps = 47/290 (16%)
Query: 8 KYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKI---ENSGTKHPQLLYEAKVYKIL 59
+ R IG G+FG +F A + +VAVK+ E S EA +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 60 QGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDL-----------------------FVY 95
+ + + G+ L+ + + L +
Sbjct: 74 DNPNIVKLL-GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 96 CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155
S L +A Q+ A + Y+ R F+HRD+ N L+G + V I DFGL++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRN 189
Query: 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG 215
Y+ + N R+ + + D+ + G VL L
Sbjct: 190 IYSADY-----YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP-- 242
Query: 216 LKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
++ + + + E + P E + C S RP
Sbjct: 243 YYGMAHEEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPS 288
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.3 bits (233), Expect = 6e-23
Identities = 60/277 (21%), Positives = 99/277 (35%), Gaps = 19/277 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
KY+ KIG G++G +F A + +T+EIVA+K ++ L E + K L+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HK 61
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
I + + LV + L+ F C + V Q++ + + HSR
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
LHRD+KP N L+ + ++ + +FGLA+ + P T Y +
Sbjct: 122 VLHRDLKPQNLLIN---RNGELKLANFGLARAFGIPVRCYS-------AEVVTLWYRPPD 171
Query: 184 THLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
G + S D+ S G + P + +I + + TP E
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPL--FPGNDVDDQLKRIF-RLLGTPTEEQWP 228
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
S + T L DL
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQN 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.5 bits (234), Expect = 6e-23
Identities = 50/284 (17%), Positives = 92/284 (32%), Gaps = 39/284 (13%)
Query: 8 KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKI---ENSGTKHPQLLYEAKVYKIL 59
+ G+ +G+G+FG++ A D VAVK+ T+ L+ E KV L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 60 QGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDL-----------------FVYCRRKFS 101
I N+ G +++ + L +
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
L+ +L + Q+ + ++ S+ +HRD+ N L+ I DFGLA+ ++ +
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSN 200
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221
Y N ++ + + + D+ S G L
Sbjct: 201 -----YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY--PGMPV 253
Query: 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
K+ K+ ++ PAE C +RP
Sbjct: 254 DSKFYKMIKEGFRMLSPEHA---PAEMYDIMKTCWDADPLKRPT 294
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 93.9 bits (232), Expect = 2e-22
Identities = 64/317 (20%), Positives = 108/317 (34%), Gaps = 37/317 (11%)
Query: 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQ 60
E +Y L RK+G G F ++LA + N VA+K + E K+ + +
Sbjct: 8 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVN 67
Query: 61 ----------GGSGIPNIKWYGVDGEDNVLVLDLLG-----PSLEDLFVYCRRKFSLKTV 105
G + I + + N + + ++ L + Y R L V
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 106 LMLADQMIARIEYV-HSRGFLHRDIKPDNFLM---GLGRKANQVYIIDFGLAKKYRDPTT 161
++ Q++ ++Y+ G +H DIKP+N LM Q+ I D G A Y + T
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATK 221
N T Y S LG D+ S ++ + G ++ + +
Sbjct: 188 NSI----------QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237
Query: 222 KQKYD---KICEKKVSTPIEVLCKSHPAEF----ASYFHYCQSLTFDQRPDYGFLKRLFH 274
+ D +I E P +L L F D K F
Sbjct: 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 297
Query: 275 DLFSREGSLLLQFIMSY 291
++E S L ++
Sbjct: 298 KDEAKEISDFLSPMLQL 314
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.6 bits (229), Expect = 2e-22
Identities = 53/277 (19%), Positives = 95/277 (34%), Gaps = 19/277 (6%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
++ KIG G++G ++ A + T E+VA+K + + E + K L
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HP 61
Query: 64 GIPNIKWYGVDGEDNVLVLDLLGPSLEDLF-VYCRRKFSLKTVLMLADQMIARIEYVHSR 122
I + LV + L L+ L + Q++ + + HS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
LHRD+KP N L+ + + DFGLA+ + P + A
Sbjct: 122 RVLHRDLKPQNLLIN---TEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPE 172
Query: 183 NTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242
S D+ SLG + + + G ++ + +I + + TP EV+
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG---DSEIDQLFRIF-RTLGTPDEVVWP 228
Query: 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
+ + + D L L S+
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQ 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.9 bits (225), Expect = 6e-22
Identities = 45/213 (21%), Positives = 85/213 (39%), Gaps = 20/213 (9%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVK-IENSGTKHPQLLYEAKVYKILQGGSGIPN 67
++IGSG FG + L ++ ++ VA+K I + EA+V L P
Sbjct: 7 LTFVQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSH----PK 61
Query: 68 I-KWYGV--DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG 123
+ + YGV + LV + + L D R F+ +T+L + + + Y+
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 124 FLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCN 183
+HRD+ N L+ + + + DFG+ + D + ++AS
Sbjct: 122 VIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTK------FPVKWASPE 172
Query: 184 THLGIEQSRRDDLESLGYVLLYFL-RGSLPWQG 215
S + D+ S G ++ G +P++
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.7 bits (224), Expect = 1e-21
Identities = 56/278 (20%), Positives = 91/278 (32%), Gaps = 30/278 (10%)
Query: 13 RKIGSGSFGEIFLASHVDTNEIVAVKI-------ENSGTKHPQLLYEAKVYKILQGGSGI 65
+G G F ++ A +TN+IVA+K E + L E K+ + L
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH---- 59
Query: 66 PNI-KWYGVDGEDN--VLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR 122
PNI G + LV D + LE + + + + +EY+H
Sbjct: 60 PNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 123 GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASC 182
LHRD+KP+N L+ + + + DFGLAK + P + T Y +
Sbjct: 120 WILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYT-------HQVVTRWYRAP 169
Query: 183 NTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLC 241
G D+ ++G +L L G + + +I E + E
Sbjct: 170 ELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG---DSDLDQLTRIFETLGTPTEEQWP 226
Query: 242 KSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279
F + DL
Sbjct: 227 DMCSLPDYVTFKSFPGIPLHHIFSA--AGDDLLDLIQG 262
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 2e-21
Identities = 46/287 (16%), Positives = 100/287 (34%), Gaps = 30/287 (10%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNE----IVAVKI---ENSGTKHPQLLYEAKVYKILQG 61
+ IG+G FGE++ ++ VA+K + + L EA +
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 62 GSGIPNI-KWYGVDGEDNVLVLDL---LGPSLEDLFVYCRRKFSLKTVLMLADQMIARIE 117
NI + GV + +++ +L+ +FS+ ++ + + A ++
Sbjct: 69 ----HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 118 YVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTA 177
Y+ + ++HRD+ N L+ + DFGL++ D +
Sbjct: 125 YLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYT----TSGGKIPI 177
Query: 178 RYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK-KVSTP 236
R+ + + + D+ S G V+ + + + I + ++ TP
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAINDGFRLPTP 235
Query: 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSL 283
++ P+ C +RP + + + L SL
Sbjct: 236 MDC-----PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 91.2 bits (225), Expect = 2e-21
Identities = 51/247 (20%), Positives = 103/247 (41%), Gaps = 26/247 (10%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNEIVAVKI----ENSGTKHPQLLYEAKVYKILQGGS 63
+Y+ + IGSG+ G + A + VA+K + T + E + K + +
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 64 -----GIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
+ + + +D LV++L+ +L + + + + L QM+ I++
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQ---VIQMELDHERMSYLLYQMLCGIKH 134
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+HS G +HRD+KP N ++ + + I+DFGLA+ T
Sbjct: 135 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPY--------VVTRY 183
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238
Y + LG+ D+ S+G ++ +R + + G +++K+ E+ + E
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG---RDYIDQWNKVIEQLGTPCPE 240
Query: 239 VLCKSHP 245
+ K P
Sbjct: 241 FMKKLQP 247
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 89.1 bits (220), Expect = 6e-21
Identities = 49/279 (17%), Positives = 85/279 (30%), Gaps = 40/279 (14%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKI-----ENSGTKHPQLLYEAKVYKILQGGS 63
K IG G+FG++ A + I S H E +V L
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 64 GIPNIKWYGVDGEDNVLVLDLL-GPSLEDL---------------FVYCRRKFSLKTVLM 107
I N+ L ++ +L D S + +L
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 108 LADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPY 167
A + ++Y+ + F+HRD+ N L+G + I DFGL++
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSRGQEVYVKKTMG-- 186
Query: 168 RENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYD 226
R+ + + + D+ S G +L + G P+ G+ T + Y+
Sbjct: 187 ------RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYE 237
Query: 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
K+ + E C +RP
Sbjct: 238 KLPQGYRLEKPLNC----DDEVYDLMRQCWREKPYERPS 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (217), Expect = 1e-20
Identities = 52/310 (16%), Positives = 109/310 (35%), Gaps = 34/310 (10%)
Query: 7 VKYKLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTKHP---QLLYEAKVYKILQ 60
+ IG G FG ++ + +D + AVK N T Q L E + K
Sbjct: 27 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 86
Query: 61 GGSGIPNIKWYGVDGEDNV-LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEY 118
+ ++ + E + +VL + L + ++K ++ Q+ +++
Sbjct: 87 H-PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145
Query: 119 VHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTAR 178
+ S+ F+HRD+ N ++ + V + DFGLA+ D + +
Sbjct: 146 LASKKFVHRDLAARNCMLD---EKFTVKVADFGLARDMYDKEFDSV---HNKTGAKLPVK 199
Query: 179 YASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKICEKKVSTPI 237
+ + + + + + D+ S G +L + RG+ P+ + + + +
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---NTFDITVYLLQGRRLLQP 256
Query: 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSLLLQFIMSYCSLHSI 297
E P C + RP + L +FS ++ H +
Sbjct: 257 EYC----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS-----------TFIGEHYV 301
Query: 298 TFQTNIINIK 307
+N+K
Sbjct: 302 HVNATYVNVK 311
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.5 bits (213), Expect = 4e-20
Identities = 52/285 (18%), Positives = 103/285 (36%), Gaps = 42/285 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLASHVDTNE-------IVAVKI---ENSGTKHPQLLYEAKVYK 57
+ LG+ +G G+FG++ LA + ++ VAVK+ + + L+ E ++ K
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 58 ILQGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFS 101
++ I N+ ++++ +L + R + S
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 102 LKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161
K ++ A Q+ +EY+ S+ +HRD+ N L+ + N + I DFGLA+
Sbjct: 134 SKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARDIHHIDY 190
Query: 162 NRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAAT 220
+ N ++ + + + D+ S G +L G P+ G+
Sbjct: 191 YKK-----TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV---P 242
Query: 221 KKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
++ + + E E C QRP
Sbjct: 243 VEELFKLLKEGHRMDKPSNC----TNELYMMMRDCWHAVPSQRPT 283
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 2e-19
Identities = 53/277 (19%), Positives = 100/277 (36%), Gaps = 35/277 (12%)
Query: 8 KYKLGRKIGSGSFGEIFLASH-----VDTNEIVAVKI---ENSGTKHPQLLYEAKVYKIL 59
K + R++G GSFG ++ + VA+K S + + L EA V K
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 60 QGGSGIPNIKWYGVDGEDNVLVLDLL-GPSLEDLFVYCRR---------KFSLKTVLMLA 109
+ + G+ +++++L+ L+ R SL ++ +A
Sbjct: 81 N-CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 110 DQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRE 169
++ + Y+++ F+HRD+ N ++ + V I DFG+ + + YR+
Sbjct: 140 GEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY-----YRK 191
Query: 170 NKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFL-RGSLPWQGLKAATKKQKYDKI 228
R+ S + + D+ S G VL P+QGL + +Q +
Sbjct: 192 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQVLRFV 248
Query: 229 CEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPD 265
E + + P C RP
Sbjct: 249 MEGGLLDKPDNC----PDMLFELMRMCWQYNPKMRPS 281
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.1 bits (207), Expect = 3e-19
Identities = 72/311 (23%), Positives = 105/311 (33%), Gaps = 45/311 (14%)
Query: 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG 64
I L IG G FGE++ E VAVKI +S + EA++Y+ +
Sbjct: 1 IARTIVLQESIGKGRFGEVWRG--KWRGEEVAVKIFSS-REERSWFREAEIYQTVMLRH- 56
Query: 65 IPNI-KWYGVDGEDNV------LVLDLL-GPSLED------LFVYCRRKFSLKTVLMLAD 110
NI + D +DN LV D SL D + V K +L T LA
Sbjct: 57 -ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAH 115
Query: 111 QMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYREN 170
+ + HRD+K N L+ K I D GLA ++ T I
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVK---KNGTCCIADLGLAVRHDSATDTIDIAP--- 169
Query: 171 KNLTGTARY------ASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQG--------- 215
+ GT RY E +R D+ ++G V R
Sbjct: 170 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229
Query: 216 ---LKAATKKQKYDKICEKKVSTPIEVLCKSHPA--EFASYFHYCQSLTFDQRPDYGFLK 270
+ ++ +CE+K+ I +S A A C R +K
Sbjct: 230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289
Query: 271 RLFHDLFSREG 281
+ L +EG
Sbjct: 290 KTLSQLSQQEG 300
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.8 bits (206), Expect = 4e-19
Identities = 48/231 (20%), Positives = 83/231 (35%), Gaps = 33/231 (14%)
Query: 8 KYKLGRKIGSGSFGEIFLA-----SHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGG 62
+ KLG+ +G G+FG++ A T VAVK+ G H + KIL
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 63 SGIPNIK--WYGVDGEDNVLVLDLLGPSLEDLFVYCRRK------------------FSL 102
N+ L++ + +L Y R K +L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 103 KTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162
+ ++ + Q+ +E++ SR +HRD+ N L+ + N V I DFGLA+
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPD- 189
Query: 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW 213
Y + ++ + T + + D+ S G +L
Sbjct: 190 ----YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 236
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 75.6 bits (185), Expect = 5e-17
Identities = 28/183 (15%), Positives = 61/183 (33%), Gaps = 32/183 (17%)
Query: 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT------------KHPQLLYEAKV- 55
+G+ +G G +F + VK G A
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 56 ----YKILQGGSGIPNIKWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQ 111
++ LQ G+ K Y + N +++ E + + ++ + D
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWE--GNAVLM-------ELIDAKELYRVRVENPDEVLDM 111
Query: 112 MIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENK 171
++ + + RG +H D+ N L+ ++IIDF + + + + R+ +
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQSVEVGEEGWREIL-ERDVR 166
Query: 172 NLT 174
N+
Sbjct: 167 NII 169
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 318 | |||
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.5 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.17 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.82 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.33 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.33 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.99 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 88.75 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 87.56 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 87.3 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 85.68 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 84.94 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 84.64 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 83.62 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 83.24 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 83.11 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 82.79 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 82.52 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 82.47 |
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-57 Score=391.29 Aligned_cols=281 Identities=70% Similarity=1.229 Sum_probs=244.3
Q ss_pred CCccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 1 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
|+--++++|++++.||+|+||.||+|++..+++.||||++........+..|+++++.+.|++++..+..++......++
T Consensus 1 ~~~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~i 80 (299)
T d1ckia_ 1 MELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 80 (299)
T ss_dssp CCCEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEE
T ss_pred CCCeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEE
Confidence 67778999999999999999999999999999999999988777777899999999999999999999888888889999
Q ss_pred EEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 81 VLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 81 v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||++++++.+.+......+++..+..++.|++.||.|||++||+||||||+||++...+....+||+|||+++......
T Consensus 81 vme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 81 VMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 99999999999888777789999999999999999999999999999999999998655567789999999999877655
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
.....+........||+.|+|||++.+.+++.++|||||||++|||+||..||...........+..........+.+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 55444455556778999999999999999999999999999999999999999876665555555555566667777777
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcC
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREG 281 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~ 281 (318)
...+|+.+.+++..||+.+|++||++.++.+.|++++....
T Consensus 241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 78899999999999999999999999999999998876544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.2e-56 Score=382.82 Aligned_cols=280 Identities=58% Similarity=1.003 Sum_probs=247.1
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
++++++|++++.||+|+||+||+|++..+++.||||++........+.+|++++..+.++++++.+..++......++||
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 57899999999999999999999999999999999998777767788999999999999999999999999999999999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCC--CCCeEEEEeccceeeecCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR--KANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~--~~~~~kL~dfg~~~~~~~~~ 160 (318)
|+++++|.+++......++...+..++.|++.||.|||++||+||||||+||+++..+ ..+.+||+|||+++......
T Consensus 81 e~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 81 DLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred EecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 9999999999988777799999999999999999999999999999999999995321 35789999999999877665
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
.....+........||+.|+|||++.+..++.++|||||||++|+|+||..||.+............+.......+.+..
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l 240 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHh
Confidence 55545555566778999999999999999999999999999999999999999876655555556666666667777777
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCC
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGS 282 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~ 282 (318)
...+|+++.+++..||..+|++||+++.+.+.|.+++.+...
T Consensus 241 ~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 788999999999999999999999999999999998766543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-55 Score=369.77 Aligned_cols=244 Identities=24% Similarity=0.333 Sum_probs=206.9
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecC-----CCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
-++|++++.||+|+||+||+|+++.+++.||+|++.. ......+.+|+.+++.++| +++..+..++.+....|+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH-PNILRLYGYFHDATRVYL 83 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCC-TTBCCEEEEEECSSEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCC-CCCCeEEEEEEECCEEEE
Confidence 4689999999999999999999999999999998652 2334567899999999976 667777777778888999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++......
T Consensus 84 vmEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 84 ILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCC
T ss_pred EEeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee---cCCCCEeecccceeeecCCC
Confidence 99999 7899999886 4459999999999999999999999999999999999999 48899999999999765433
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. ....||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.. +.+..+.......|
T Consensus 160 ~~---------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~~~p--- 224 (263)
T d2j4za1 160 RR---------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKRISRVEFTFP--- 224 (263)
T ss_dssp CC---------EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHTTCCCCC---
T ss_pred cc---------cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH---HHHHHHHcCCCCCC---
Confidence 22 3457899999999999999999999999999999999999999876543 33444443333322
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+|+.+.+++.+||..||++|||+.++.+
T Consensus 225 --~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 225 --DFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 357889999999999999999999998876
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-55 Score=372.92 Aligned_cols=248 Identities=22% Similarity=0.316 Sum_probs=206.0
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
.++|++.+.||+|+||+||+|.+..+|+.||||++.... ..+.+.+|+.++++++| +++..+..++......|+|||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKN-PNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCC-CCEeeEeEEEEECCEEEEEEE
Confidence 358999999999999999999999999999999876432 33468899999999987 556667666677788999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
|+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTC-
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE---CCCCcEeeccchhheeeccccc-
Confidence 99 8899988764 459999999999999999999999999999999999999 4789999999999987654332
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
......||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+... .+..+..... +....+.
T Consensus 172 ------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~~~~~~~--~~~~~~~ 240 (293)
T d1yhwa1 172 ------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR---ALYLIATNGT--PELQNPE 240 (293)
T ss_dssp ------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHHCS--CCCSSGG
T ss_pred ------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH---HHHHHHhCCC--CCCCCcc
Confidence 1235579999999999999999999999999999999999999998765432 2223322221 1112235
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+|+.+.+++.+||+.||++|||+.++.+
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 67899999999999999999999998765
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=373.15 Aligned_cols=249 Identities=17% Similarity=0.302 Sum_probs=206.0
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
+.|++.+.||+|+||+||+|++..+++.||+|++..... ...+.+|+.++++++| +++..+..++.+....++||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH-PNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCC-TTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCC-CCCCeEEEEEeeCCeEEEEEec
Confidence 569999999999999999999999999999998865433 3578899999999976 6666776677777889999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+ +++|.+++......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|........
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~-- 165 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQ-- 165 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHH--
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE---CCCCCEEEEechhhhccCCCcc--
Confidence 9 889999887766779999999999999999999999999999999999999 4889999999999876543211
Q ss_pred cccccCCCCCccccccccccccc-----CCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 164 HIPYRENKNLTGTARYASCNTHL-----GIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
......||+.|+|||++. +..|+.++|||||||++|+|+||++||.+.+.. +.+..+..... +..
T Consensus 166 -----~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~---~~~~~i~~~~~--~~~ 235 (288)
T d2jfla1 166 -----RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM---RVLLKIAKSEP--PTL 235 (288)
T ss_dssp -----HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG---GHHHHHHHSCC--CCC
T ss_pred -----cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH---HHHHHHHcCCC--CCC
Confidence 112457899999999984 445889999999999999999999999876553 33344443222 222
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.....+|+.+.+++.+||..||++|||+.++.+
T Consensus 236 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 223467899999999999999999999998766
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-55 Score=370.61 Aligned_cols=251 Identities=26% Similarity=0.318 Sum_probs=202.8
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
-++|++.+.||+|+||+||+|+++.+++.||||++.... ....+.+|+.++++++| +++..+..++.+....|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-ENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCC-CCEeeEeeeeccCceeEEEE
Confidence 368999999999999999999999999999999876433 23468899999999976 66667777777788999999
Q ss_pred ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ ++++.+||+|||+|........
T Consensus 83 Ey~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 83 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECEETTE
T ss_pred eccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE---CCCCCEEEccchhheeeccCCc
Confidence 999 7899999865 4469999999999999999999999999999999999999 4788999999999987653322
Q ss_pred CccccccCCCCCcccccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
.. ......||+.|+|||++.+..+ +.++||||+||++|+|+||++||...+.... .+....... .....
T Consensus 159 ~~-----~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~~~~~~~~~---~~~~~ 228 (271)
T d1nvra_ 159 ER-----LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--EYSDWKEKK---TYLNP 228 (271)
T ss_dssp EC-----CBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--HHHHHHTTC---TTSTT
T ss_pred cc-----cccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--HHHHHhcCC---CCCCc
Confidence 11 1235579999999999998875 6789999999999999999999976543321 222222111 11112
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+..+|+.+.+++.+||+.||++|||++++.+
T Consensus 229 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 229 WKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 3467889999999999999999999998754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-54 Score=372.98 Aligned_cols=253 Identities=21% Similarity=0.280 Sum_probs=198.6
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
+.++|++.+.||+|+||+||+|+++.+++.||||++.... ....+.+|+.++..++| +++..+..++.+....|+|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKH-PNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEE
Confidence 5788999999999999999999999999999999876432 23456789999999976 6677777777788899999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||| +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++...+.++.+||+|||++.......
T Consensus 86 mE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~ 164 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS 164 (307)
T ss_dssp ECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred EeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC
Confidence 9999 7899999976 4569999999999999999999999999999999999999655568899999999997654332
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
. .....||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.. .....+.......+. ..
T Consensus 165 ~--------~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~~~~~~~~-~~ 232 (307)
T d1a06a_ 165 V--------LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA---KLFEQILKAEYEFDS-PY 232 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHTTCCCCCT-TT
T ss_pred e--------eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHhccCCCCCC-cc
Confidence 2 13457899999999999999999999999999999999999999876543 334444443333332 23
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+|+.+.+++.+||..||++|||+.++.+
T Consensus 233 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 233 WDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 4578899999999999999999999999877
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=369.11 Aligned_cols=249 Identities=22% Similarity=0.327 Sum_probs=206.0
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecC-----CCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
..++|++++.||+|+||+||+|++..+++.||||++.. ......+.+|+.++++++| +++..+..++.+....|
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH-PFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCS-TTBCCEEEEEECSSEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCC-CCeeEEEEEEEECCEEE
Confidence 44689999999999999999999999999999998753 2334568899999999976 66667777777788899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+||||+ +++|.+++.. .+.+++..++.++.|++.||.|||++||+||||||+||++ ++++.+||+|||+++....
T Consensus 85 ivmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL---NEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp EEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECC-
T ss_pred EEEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc---CCCceEEecccccceeccc
Confidence 999999 7899998876 4569999999999999999999999999999999999999 5889999999999987653
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
..... ......||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+.. ..+..+.......|
T Consensus 161 ~~~~~-----~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~~~~~~p-- 230 (288)
T d1uu3a_ 161 ESKQA-----RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY---LIFQKIIKLEYDFP-- 230 (288)
T ss_dssp --------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHTTCCCCC--
T ss_pred CCccc-----ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH---HHHHHHHcCCCCCC--
Confidence 32211 123457899999999999999999999999999999999999999876543 34445544433333
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..+++.+.+++++||..||++|||++++..
T Consensus 231 ---~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 231 ---EKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---TTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---ccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 467889999999999999999999998644
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-54 Score=365.77 Aligned_cols=259 Identities=22% Similarity=0.308 Sum_probs=202.8
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
+-.++|++++.||+|+||+||+|+.. ..||||+++.... ...+.+|+.++.+++| +++..+..+.. ....+
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~~~~~-~~~~~ 79 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRH-VNILLFMGYST-APQLA 79 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEC-SSSCE
T ss_pred cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCC-CCEeeeeEEEe-ccEEE
Confidence 45689999999999999999999753 3599998764332 2367789999999976 45555554433 35689
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+||||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+....
T Consensus 80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC---
T ss_pred EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE---cCCCCEEEccccceeeccc
Confidence 999999 789999998766679999999999999999999999999999999999999 4889999999999976543
Q ss_pred CCCCccccccCCCCCcccccccccccccCC---CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
..... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||.+.++.... ...+......+
T Consensus 157 ~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~~~~~~~~~~p 229 (276)
T d1uwha_ 157 WSGSH-----QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IFMVGRGYLSP 229 (276)
T ss_dssp --------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHHHTSCCC
T ss_pred cCCcc-----cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH--HHHHhcCCCCC
Confidence 22211 12345789999999998743 4789999999999999999999999876543222 22222333333
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
........+|+.+.+++.+||+.||++|||+.++.+.|+.+.
T Consensus 230 ~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 344555678899999999999999999999999999998764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-54 Score=373.75 Aligned_cols=255 Identities=19% Similarity=0.277 Sum_probs=200.6
Q ss_pred ccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 3 RIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 3 ~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
++..++|++.+.||+|+||+||+|++..+++.||+|+++..... ..+.+|+.+++.++| +++..+..++.+....|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCC-TTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEE
Confidence 56789999999999999999999999999999999988754332 367889999999976 56767777777778899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSR-GFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
+||||+ +++|.+++.+ .+.+++..++.++.|++.||.|||++ ||+||||||+|||+ ++++.+||+|||+|....
T Consensus 81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHH
T ss_pred EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE---CCCCCEEEeeCCCccccC
Confidence 999999 7899999876 34599999999999999999999974 99999999999999 488999999999998654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHH-HHh-----
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI-CEK----- 231 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i-~~~----- 231 (318)
.... ....||+.|+|||++.+.+|+.++||||+||++|||++|+.||.+.+........... ...
T Consensus 157 ~~~~---------~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 227 (322)
T d1s9ja_ 157 DSMA---------NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227 (322)
T ss_dssp HHTC------------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------
T ss_pred CCcc---------ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCC
Confidence 3221 2457999999999999999999999999999999999999999764432111110000 000
Q ss_pred ------------------------------hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 232 ------------------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 232 ------------------------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
....++......++.++.+++.+||..||.+|||++++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000000001124667889999999999999999998876
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.6e-54 Score=365.08 Aligned_cols=259 Identities=20% Similarity=0.308 Sum_probs=210.4
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+-.++|++.+.||+|+||+||+|.+..+++.||||+++.... .+.+.+|+.++++++| +++..+..++......++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKH-PNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCC-CCEecCCccEeeCCeeEEEe
Confidence 456799999999999999999999999999999998875543 3578999999999976 66667766667778899999
Q ss_pred ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||+ +|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE---CCCCcEEEccccceeecCCCC
Confidence 999 78999998763 3458999999999999999999999999999999999999 588999999999997654432
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCc-cchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPW-QGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf-~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. ......+++.|+|||++.+..++.++|||||||++|||++|..|| .+.+.. . +..........+
T Consensus 170 ~~------~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~---~-~~~~i~~~~~~~--- 236 (287)
T d1opja_ 170 YT------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---Q-VYELLEKDYRME--- 236 (287)
T ss_dssp SE------EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---H-HHHHHHTTCCCC---
T ss_pred ce------eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH---H-HHHHHhcCCCCC---
Confidence 21 123345788999999999999999999999999999999966555 443322 1 222222222222
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
.+..+|+.+.+++..||+.||++|||+.++.+.|+.++.+
T Consensus 237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 2246789999999999999999999999999999887543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-54 Score=363.28 Aligned_cols=248 Identities=22% Similarity=0.267 Sum_probs=191.4
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeecc--ccCcceE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYG--VDGEDNV 79 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~--~~~~~~~ 79 (318)
.++|++.+.||+|+||+||+|+++.+|+.||+|++...... +.+.+|+.++.+++|+ ++..+..+. ......|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~Hp-nIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP-NIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCT-TBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCC-CEeeEEEEEEeCCCCEEE
Confidence 36899999999999999999999999999999988765432 2477899999999874 455554333 2345689
Q ss_pred EEEecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCceeeccCCCCCeEEEEec
Q 021053 80 LVLDLL-GPSLEDLFVYC---RRKFSLKTVLMLADQMIARIEYVHSRG-----FLHRDIKPDNFLMGLGRKANQVYIIDF 150 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~-----i~H~dl~p~Nil~~~~~~~~~~kL~df 150 (318)
+||||+ +|+|.+++... ...+++..++.++.||+.||.|||++| |+||||||+|||+ +.++.+||+||
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DF 158 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDF 158 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE---CTTSCEEECCH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeec
Confidence 999999 88999998643 346999999999999999999999976 9999999999999 48899999999
Q ss_pred cceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHH
Q 021053 151 GLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE 230 (318)
Q Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~ 230 (318)
|+++....... ......||+.|+|||++.+..++.++|||||||++|+|+||++||.+.+.. +....+..
T Consensus 159 G~a~~~~~~~~-------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i~~ 228 (269)
T d2java1 159 GLARILNHDTS-------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKIRE 228 (269)
T ss_dssp HHHHHC------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH
T ss_pred cceeecccCCC-------ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHHHHc
Confidence 99987654322 123457899999999999999999999999999999999999999876553 23334433
Q ss_pred hhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 231 KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..... .+..+|+++.+++.+||..||++|||+.++.+
T Consensus 229 ~~~~~----~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 229 GKFRR----IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp TCCCC----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCC----CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 32221 23467889999999999999999999998764
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-53 Score=355.90 Aligned_cols=255 Identities=18% Similarity=0.281 Sum_probs=199.9
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
.++|++.+.||+|+||+||+|.+. +++.||||++..... ...+.+|+.++.+++| +++..+..+.......++||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCC-TTBCCEEEEECSSSSCEEEEEC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCC-CCcccccceeccCCceEEEEEe
Confidence 478999999999999999999986 467899998875443 3578999999999976 6666776666677789999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+ +++|.+++......+++..+..++.||+.||.|||+++|+||||||+||++ +.++.+||+|||+++........
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE---CGGGCEEECSCC------------
T ss_pred cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee---cCCCCeEecccchheeccCCCce-
Confidence 9 899999988766678999999999999999999999999999999999999 58899999999999765443321
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
......||+.|+|||++.+..++.++|||||||++|||+| |.+||...+... .+..+... ...+. +.
T Consensus 158 -----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~~i~~~-~~~~~---p~ 225 (263)
T d1sm2a_ 158 -----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTG-FRLYK---PR 225 (263)
T ss_dssp ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHHHHHHT-CCCCC---CT
T ss_pred -----eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHHHHHhc-CCCCC---cc
Confidence 1234568899999999999999999999999999999999 677776654432 22333222 11221 23
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
.+|+.+.+++.+||+.||++||+++++.+.|+++.+
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 568899999999999999999999999999998743
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-53 Score=364.34 Aligned_cols=262 Identities=18% Similarity=0.290 Sum_probs=199.9
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCc---EEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNE---IVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~---~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
+-.++|++.+.||+|+||+||+|++..+++ .||||.+...... ..+.+|+.++.+++| +++..+..+......
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH-PNVIHLEGVVTKSTP 101 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEECSSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC-CCCccEEEEEeeCCE
Confidence 445789999999999999999999876554 5888887654332 357899999999975 666677666677788
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++||||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV---NSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCC------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE---CCCCcEEECCcccceEc
Confidence 99999999 889999888766679999999999999999999999999999999999999 58899999999999876
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
........ ........+|+.|+|||++.+..++.++|||||||++|||+| |++||.+.+... .+..+.. ....
T Consensus 179 ~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~~i~~-~~~~ 252 (299)
T d1jpaa_ 179 EDDTSDPT--YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAIEQ-DYRL 252 (299)
T ss_dssp -------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHT-TCCC
T ss_pred cCCCCcce--eeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHHHHHc-CCCC
Confidence 54322111 111223457899999999999999999999999999999998 899998766543 2333332 2222
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
+. ...+|+.+.+++.+||+.||++||++.++.+.|+.++.
T Consensus 253 ~~---~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 253 PP---PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CC---CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CC---CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 22 23578899999999999999999999999999988754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.7e-53 Score=372.26 Aligned_cols=251 Identities=18% Similarity=0.260 Sum_probs=210.7
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
++|++++.||+|+||.||+|++..+|+.||||++..... ...+.+|+.++.+++| +++..+..++.+....|+||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCC-TTBCCEEEEEEETTEEEEEECC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEEc
Confidence 689999999999999999999999999999998865432 2357889999999976 6676777777778899999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
| +++|.+++....+.+++..+..++.||+.||.|||++||+||||||+|||++. +.++.+||+|||++........
T Consensus 105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~-- 181 (350)
T d1koaa2 105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQS-- 181 (350)
T ss_dssp CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTSC--
T ss_pred CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc-CCCCeEEEeecchheecccccc--
Confidence 9 88999999765667999999999999999999999999999999999999952 2467899999999987654332
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhhc
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKS 243 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (318)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.. +.+..+.......+ ......
T Consensus 182 ------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i~~~~~~~~-~~~~~~ 251 (350)
T d1koaa2 182 ------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNVKSCDWNMD-DSAFSG 251 (350)
T ss_dssp ------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHTCCCSC-CGGGGG
T ss_pred ------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-cccccC
Confidence 12457899999999999999999999999999999999999999876553 34444444443333 233457
Q ss_pred CchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 244 HPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 244 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+|+.+.+++.+||..||++|||+.++.+
T Consensus 252 ~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 252 ISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 8889999999999999999999998876
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-53 Score=357.88 Aligned_cols=249 Identities=21% Similarity=0.255 Sum_probs=197.8
Q ss_pred ccccee-eEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccc----c
Q 021053 4 IIGVKY-KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGV----D 74 (318)
Q Consensus 4 ~~~~~y-~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~----~ 74 (318)
..++|| ++.+.||+|+||+||+|.+..+++.||+|++..... ...+.+|++++++++| +++..+..++. .
T Consensus 5 ~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~ 83 (270)
T d1t4ha_ 5 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFYDSWESTVKG 83 (270)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEEESSS
T ss_pred CCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCC-CCeeeEEEEEeecccc
Confidence 345666 788899999999999999999999999998765432 2357889999999986 45555543322 2
Q ss_pred CcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceeeccCCCCCeEEEEecc
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRG--FLHRDIKPDNFLMGLGRKANQVYIIDFG 151 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~kL~dfg 151 (318)
....|+||||+ +++|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++ ++++.+||+|||
T Consensus 84 ~~~~~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFG 160 (270)
T d1t4ha_ 84 KKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLG 160 (270)
T ss_dssp CEEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES--STTSCEEECCTT
T ss_pred CCEEEEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee--CCCCCEEEeecC
Confidence 45689999999 8899999986 345999999999999999999999999 99999999999995 357899999999
Q ss_pred ceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh
Q 021053 152 LAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK 231 (318)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~ 231 (318)
++........ ....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+..+. ......+..
T Consensus 161 la~~~~~~~~---------~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~--~~~~~~i~~- 227 (270)
T d1t4ha_ 161 LATLKRASFA---------KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTS- 227 (270)
T ss_dssp GGGGCCTTSB---------EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTT-
T ss_pred cceeccCCcc---------CCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH--HHHHHHHHc-
Confidence 9975433221 34578999999999875 5999999999999999999999999764332 222333322
Q ss_pred hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
..++..+....++++.+++.+||+.||++|||+.++.+
T Consensus 228 --~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 228 --GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp --TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred --CCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 12223344567889999999999999999999998765
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-53 Score=360.79 Aligned_cols=253 Identities=19% Similarity=0.249 Sum_probs=209.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--------ChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
+.++|++++.||+|+||+||+|+++.+|+.||||++..... .+.+.+|+.++++++| +++..+..++.+..
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~ 86 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH-PNVITLHEVYENKT 86 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCC-TTBCCEEEEEECSS
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECC
Confidence 57889999999999999999999999999999998754321 2357899999999976 66667777777888
Q ss_pred ceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCC-CCCeEEEEecccee
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGR-KANQVYIIDFGLAK 154 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~-~~~~~kL~dfg~~~ 154 (318)
..|+||||| +++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||++..++ ....+||+|||++.
T Consensus 87 ~~~iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 87 DVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEEEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhh
Confidence 999999999 7899999876 34699999999999999999999999999999999999995221 12369999999998
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
....... .....+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.. +.+..+......
T Consensus 166 ~~~~~~~--------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~~~~~~ 234 (293)
T d1jksa_ 166 KIDFGNE--------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVSAVNYE 234 (293)
T ss_dssp ECTTSCB--------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHTTCCC
T ss_pred hcCCCcc--------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH---HHHHHHHhcCCC
Confidence 7653322 23457899999999999999999999999999999999999999876543 334444443333
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+ ......+|..+.+++.+||..||++|||+.++.+
T Consensus 235 ~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 FE-DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp CC-HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CC-chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 33 3445678899999999999999999999998765
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.9e-53 Score=364.10 Aligned_cols=244 Identities=20% Similarity=0.318 Sum_probs=199.4
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-----hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+|+.++.+++| +++..+..++.+....|+|
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH-PNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCC-CCEeeEEEEEEECCEEEEE
Confidence 3699999999999999999999999999999988754432 257889999999976 6666676666777889999
Q ss_pred EeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 82 LDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 82 ~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
||||.+++.+.+.....++++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++......
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~---~~~~~Kl~DFG~a~~~~~~-- 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPA-- 168 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTTEEEECCCTTCBSSSSB--
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEC---CCCCEEEeecccccccCCC--
Confidence 99994444444444456799999999999999999999999999999999999994 8899999999999754321
Q ss_pred CccccccCCCCCcccccccccccccCC---CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchH
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGI---EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIE 238 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (318)
....||+.|+|||++.+. .|+.++|||||||++|+|++|..||.+.+.. +.+..+.....+.+.
T Consensus 169 ---------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~---~~~~~i~~~~~~~~~- 235 (309)
T d1u5ra_ 169 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHIAQNESPALQ- 235 (309)
T ss_dssp ---------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHHHSCCCCCS-
T ss_pred ---------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH---HHHHHHHhCCCCCCC-
Confidence 245789999999998643 4889999999999999999999999876543 333444433333222
Q ss_pred HHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 239 VLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 239 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+|+.+.+++.+||..||++|||+.++.+
T Consensus 236 --~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 236 --SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp --CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 2367889999999999999999999998866
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=363.64 Aligned_cols=246 Identities=21% Similarity=0.296 Sum_probs=208.0
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecC-----CCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~l 80 (318)
-++|++++.||+|+||.||+|+++.+++.||+|++.. ......+.+|+.+++.++| +++..+..++.+....|+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCC-TTBCCEEEEEECSSEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCC-CCEEEEEeeecccccccc
Confidence 4689999999999999999999999999999998763 2334567899999999975 677777777788889999
Q ss_pred EEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCC
Q 021053 81 VLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDP 159 (318)
Q Consensus 81 v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~ 159 (318)
||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 83 v~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 83 VMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp EEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCT
T ss_pred ceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe---cCCCCEEEeecccccccccC
Confidence 99999 8899998887 4569999999999999999999999999999999999999 58899999999999865433
Q ss_pred CCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 160 TTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. ......||+.|+|||++.+..|+.++||||+||++|+|++|++||.+.+.. +.+..+.......|
T Consensus 159 ~~-------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~---~~~~~i~~~~~~~p--- 225 (337)
T d1o6la_ 159 GA-------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELILMEEIRFP--- 225 (337)
T ss_dssp TC-------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC---
T ss_pred Cc-------ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH---HHHHHHhcCCCCCC---
Confidence 22 123567999999999999999999999999999999999999999886653 33444444443333
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCC-----hHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~-----~~~l~~ 271 (318)
..+|+.+.+++.+||..||.+|++ ++++.+
T Consensus 226 --~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 226 --RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 467889999999999999999995 666655
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.3e-52 Score=356.85 Aligned_cols=263 Identities=21% Similarity=0.313 Sum_probs=204.4
Q ss_pred CccccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-----hhHHHHHHHHHHHcCCCCCCeeeecccc--
Q 021053 2 ERIIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----PQLLYEAKVYKILQGGSGIPNIKWYGVD-- 74 (318)
Q Consensus 2 ~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~e~~~l~~l~~~~~~~~i~~~~~~-- 74 (318)
...++++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.++|++.+..+..+...
T Consensus 2 p~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~ 81 (277)
T d1o6ya_ 2 PSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP 81 (277)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS
T ss_pred CcCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC
Confidence 456889999999999999999999999999999999998754332 2578899999998875554444433332
Q ss_pred -CcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 75 -GEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 75 -~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
....|+||||+ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++ ..+..+++|||.
T Consensus 82 ~~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~---~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 82 AGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGI 157 (277)
T ss_dssp SSEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTSCEEECCCTT
T ss_pred CCceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccC---ccccceeehhhh
Confidence 23589999999 7888888776 45699999999999999999999999999999999999994 889999999999
Q ss_pred eeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~ 232 (318)
+.......... .......||+.|+|||++.+..+++++||||+||++|+|+||++||.+.+.. +.+..+...
T Consensus 158 ~~~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~~~~~- 229 (277)
T d1o6ya_ 158 ARAIADSGNSV----TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV---SVAYQHVRE- 229 (277)
T ss_dssp CEECC--------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHHC-
T ss_pred hhhhccccccc----cccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH---HHHHHHHhc-
Confidence 87654332211 1234557899999999999999999999999999999999999999876543 233333332
Q ss_pred ccCchHHHhhcCchhHHHHHHHHhhcCCCCCC-ChHHHHHHHHHH
Q 021053 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRP-DYGFLKRLFHDL 276 (318)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp-~~~~l~~~l~~~ 276 (318)
...++......+|+.+.+++.+||..||++|| +++++...|..+
T Consensus 230 ~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 230 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 23344444567899999999999999999999 788888877664
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-53 Score=365.91 Aligned_cols=256 Identities=20% Similarity=0.279 Sum_probs=208.1
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCc-----EEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNE-----IVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~-----~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
-.++|++++.||+|+||+||+|++..+++ .||+|.+.... ....+.+|+.++.++.+|+++..+..++....
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34789999999999999999999875543 68999875432 33468899999999977788888887778888
Q ss_pred ceEEEEecc-CCCHHHHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCc
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCR----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDN 133 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~----------------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~N 133 (318)
..++||||| +|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 999999999 899999997542 237889999999999999999999999999999999
Q ss_pred eeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCC
Q 021053 134 FLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLP 212 (318)
Q Consensus 134 il~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~p 212 (318)
|++ +.++.+||+|||+|+......... ......+|+.|+|||++.+..++.++|||||||++|||+| |.+|
T Consensus 195 ill---~~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 195 VLV---THGKVVKICDFGLARDIMSDSNYV-----VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp EEE---ETTTEEEECCCGGGSCGGGCTTSE-----EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred ccc---ccCCeEEEeeccccccccCCCcee-----eeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCC
Confidence 999 488999999999998655443321 1234467999999999999999999999999999999998 8999
Q ss_pred ccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHH
Q 021053 213 WQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFH 274 (318)
Q Consensus 213 f~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 274 (318)
|.+.+.. ..+.++.......+. +..+|+.+.+++..||+.||++|||+.+|.+.|.
T Consensus 267 f~~~~~~---~~~~~~~~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 267 YPGIPVD---ANFYKLIQNGFKMDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp STTCCCS---HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCHH---HHHHHHHhcCCCCCC---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 9875443 223333333333322 2367889999999999999999999999999885
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.6e-52 Score=352.19 Aligned_cols=251 Identities=19% Similarity=0.172 Sum_probs=210.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC-----------hhHHHHHHHHHHHcCCCCCCeeeeccc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH-----------PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~-----------~~~~~e~~~l~~l~~~~~~~~i~~~~~ 73 (318)
+.++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+|+.+++++..|+++..+..++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 357999999999999999999999999999999987654321 247789999999997788888888888
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
+....|+||||+ +++|.+++.. ..++++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill---~~~~~~kl~DFG~ 156 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNIKLTDFGF 156 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTT
T ss_pred cCcceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE---cCCCCeEEccchh
Confidence 889999999999 7899999976 4569999999999999999999999999999999999999 5899999999999
Q ss_pred eeeecCCCCCccccccCCCCCcccccccccccccC------CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHH
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLG------IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYD 226 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~ 226 (318)
+........ .....||+.|+|||.+.+ ..++.++||||+||++|+|++|++||.+.++.. ...
T Consensus 157 a~~~~~~~~--------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~~~ 225 (277)
T d1phka_ 157 SCQLDPGEK--------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLR 225 (277)
T ss_dssp CEECCTTCC--------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH
T ss_pred eeEccCCCc--------eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH---HHH
Confidence 987654322 234578999999998863 346889999999999999999999999876543 334
Q ss_pred HHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 227 KICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 227 ~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+.......+.+ ....+|+.+.+++.+||+.+|.+||+++++.+
T Consensus 226 ~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMSGNYQFGSP-EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHTCCCCCTT-TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhCCCCCCCc-ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 444444333322 23478999999999999999999999988754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-53 Score=366.51 Aligned_cols=255 Identities=20% Similarity=0.178 Sum_probs=203.2
Q ss_pred ccceeeEee-eeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccc----cCcceE
Q 021053 5 IGVKYKLGR-KIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV----DGEDNV 79 (318)
Q Consensus 5 ~~~~y~~~~-~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~----~~~~~~ 79 (318)
+-++|++.. .||+|+||.||+|++..+++.||||+++. .....+|+.++.++.+|+++..+..++. .....|
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~---~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD---CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC---SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC---cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 346788875 69999999999999999999999999864 4567889999888776777777755543 246789
Q ss_pred EEEecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 80 LVLDLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
+||||| +|+|.+++...+ ..+++..++.++.||+.||.|||++||+||||||+||+++..+..+.+||+|||+++...
T Consensus 86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~ 165 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT 165 (335)
T ss_dssp EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence 999999 789999997643 358999999999999999999999999999999999999644457789999999998765
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHH-HHHhhccCc
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDK-ICEKKVSTP 236 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~-i~~~~~~~~ 236 (318)
.... .....||+.|+|||++.+..|+.++|||||||++|+|+||++||.+.+.......+.. +.......|
T Consensus 166 ~~~~--------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~ 237 (335)
T d2ozaa1 166 SHNS--------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFP 237 (335)
T ss_dssp CCCC--------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCC
T ss_pred CCCc--------cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCC
Confidence 4332 2345789999999999999999999999999999999999999987654332222211 111122222
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+ .+..+|+.+.+++.+||..||++|||+.++.+
T Consensus 238 ~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 238 NP-EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp TT-HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred Cc-ccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 22 23467889999999999999999999998876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=354.51 Aligned_cols=257 Identities=21% Similarity=0.345 Sum_probs=205.3
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
|-.++|++.+.||+|+||.||+|.++ +++.||||+++.... ...+.+|+.++.+++| +++..+..+.. ....++||
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~-~~~~~iv~ 86 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQH-QRLVRLYAVVT-QEPIYIIT 86 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCC-TTBCCEEEEEC-SSSCEEEE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCC-CCEeEEEeeec-cCCeEEEE
Confidence 55689999999999999999999975 567899998875443 3568999999999976 45555544433 34679999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||+ +|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+||++ +.++.+||+|||+++......
T Consensus 87 Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV---SDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSC
T ss_pred EeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee---ecccceeeccccceEEccCCc
Confidence 999 889988765432 358999999999999999999999999999999999999 588999999999998765432
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhC-CCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg-~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. ......+|+.|+|||++.+..++.++|||||||++|||+|| .+||...+.. +.+..+.. ....+.
T Consensus 164 ~~------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~---~~~~~i~~-~~~~~~-- 231 (272)
T d1qpca_ 164 YT------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP---EVIQNLER-GYRMVR-- 231 (272)
T ss_dssp EE------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHT-TCCCCC--
T ss_pred cc------cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH---HHHHHHHh-cCCCCC--
Confidence 21 22345788999999999988899999999999999999995 5566554432 22233322 222221
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
...+|+.+.+++.+||+.||++|||+.++.+.|++.+..
T Consensus 232 -p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 246788999999999999999999999999999998764
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.7e-53 Score=370.42 Aligned_cols=252 Identities=23% Similarity=0.227 Sum_probs=210.2
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
-++|++.+.||+|+||.||+|.+..+++.||||++..... ...+.+|+.++.+++| +++..+..++.+....|+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-PKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCS-TTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCC-CCCCcEEEEEEECCEEEEEEE
Confidence 4679999999999999999999999999999998876442 2356789999999976 666677777778889999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
|| +++|.+.+.....++++..++.++.||+.||.|||++||+||||||+|||+.. ...+.+||+|||++.........
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~~ 185 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIV 185 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSCE
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc-cCCCeEEEeecccceecCCCCce
Confidence 99 88998888765667999999999999999999999999999999999999942 25689999999999876543321
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
....+|+.|+|||++.+..++.++|||||||++|+|+||++||.+.+.. ..+..+.......+ .....
T Consensus 186 --------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---~~~~~i~~~~~~~~-~~~~~ 253 (352)
T d1koba_ 186 --------KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL---ETLQNVKRCDWEFD-EDAFS 253 (352)
T ss_dssp --------EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH---HHHHHHHHCCCCCC-SSTTT
T ss_pred --------eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-ccccc
Confidence 2457899999999999999999999999999999999999999886553 33344443333322 33345
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+|+.+.+++..||..||.+|||+.++.+
T Consensus 254 ~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 254 SVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 78899999999999999999999998876
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=355.03 Aligned_cols=257 Identities=21% Similarity=0.291 Sum_probs=205.2
Q ss_pred cceeeEeee-eccCcccEEEEEEEc--CCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcceE
Q 021053 6 GVKYKLGRK-IGSGSFGEIFLASHV--DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 6 ~~~y~~~~~-lg~G~~~~v~~~~~~--~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~ 79 (318)
.++|.+.+. ||+|+||.||+|.+. .++..||||+++..... ..+.+|+.++.+++| +++..+..+... ...+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~H-pnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN-PYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCC-TTBCCEEEEEES-SSEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCC-CCEeeEeeeecc-CeEE
Confidence 367888885 999999999999876 34557999998754432 357899999999976 555555444433 4689
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+||||+ +|+|.+++...+..+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||+++....
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~---~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---ETTEEEECCCTTCEECTT
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeec---cCCceeeccchhhhcccc
Confidence 999999 7899999876566799999999999999999999999999999999999994 889999999999987654
Q ss_pred CCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
..... .......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+ ....+.... ..+
T Consensus 162 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~i~~~~-~~~- 232 (285)
T d1u59a_ 162 DDSYY----TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIEQGK-RME- 232 (285)
T ss_dssp CSCEE----CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHHTTC-CCC-
T ss_pred ccccc----ccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC-CCC-
Confidence 33221 12234568899999999998899999999999999999998 999998765432 223332221 111
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
.+..+|+.+.+++.+||+.+|++||++.++.+.|+..+.
T Consensus 233 --~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 233 --CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp --CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 224678999999999999999999999999999887653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.5e-52 Score=358.74 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=204.6
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecC-----CCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++++.||+|+||+||+|+++.+|+.||||++.. ......+.+|+.+++.++| +++..+..++.+....|+|
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH-PFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCB-TTBCCEEEEEECSSEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccC-cChhheeeeEeeCCeeeeE
Confidence 579999999999999999999999999999998753 2334568899999999976 6667777777888899999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 83 mE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 83 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL---DKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE---CTTSCEEECCCSSCEECSSCB
T ss_pred eeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE---cCCCCEEEecCccceEecccc
Confidence 9999 7788777776 5568999999999999999999999999999999999999 588999999999998764332
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
....||+.|+|||++.+..++.++||||+||++|+|+||+.||.+.+.. +.+..+.......|
T Consensus 159 ----------~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~~~~~~~p---- 221 (316)
T d1fota_ 159 ----------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYEKILNAELRFP---- 221 (316)
T ss_dssp ----------CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHCCCCCC----
T ss_pred ----------ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH---HHHHHHHcCCCCCC----
Confidence 2457899999999999999999999999999999999999999876553 33444444433333
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
..+|+++.+++.+||..||.+|+ +++++.+
T Consensus 222 -~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 222 -PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp -TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 35688999999999999999996 7777765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=356.33 Aligned_cols=262 Identities=21% Similarity=0.290 Sum_probs=200.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcC-----CCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeec-ccc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWY-GVD 74 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~-~~~ 74 (318)
+-.++|++++.||+|+||.||+|.+.. +++.||||+++..... ..+.+|...+.++.||+++..+..+ ...
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 445789999999999999999999764 3468999988754432 3567788889899888877776544 445
Q ss_pred CcceEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeecc
Q 021053 75 GEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGL 138 (318)
Q Consensus 75 ~~~~~lv~e~~-~~~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~ 138 (318)
....++||||| +|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl-- 167 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL-- 167 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE--
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE--
Confidence 56789999999 899999997532 237899999999999999999999999999999999999
Q ss_pred CCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhC-CCCccchh
Q 021053 139 GRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPWQGLK 217 (318)
Q Consensus 139 ~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg-~~pf~~~~ 217 (318)
+.++.+||+|||+|+......... ......||+.|+|||++.+..++.++|||||||++|||+|| .+||.+.+
T Consensus 168 -~~~~~~Kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 168 -SEKNVVKICDFGLARDIYKDPDYV-----RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp -CGGGCEEECC------CCSCTTSC-----CTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred -CCCCcEEEccCcchhhcccccccc-----ccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 588999999999998654433211 22355789999999999999999999999999999999986 67887654
Q ss_pred HhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 218 AATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
... .+..........+ .+..+|+.+.+++.+||+.||++|||+.++.++|++++..
T Consensus 242 ~~~---~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 242 IDE---EFCRRLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CSH---HHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHH---HHHHHHhcCCCCC---CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 322 2222222222222 2245788999999999999999999999999999988643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-52 Score=362.76 Aligned_cols=242 Identities=22% Similarity=0.350 Sum_probs=205.5
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecC-----CCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++++.||+|+||.||+|+++.+|+.||||++.. ......+.+|+.+++.++| +++..+..++......++|
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF-PFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCC-CcEeecccccccccccccc
Confidence 689999999999999999999999999999998753 2334567899999999976 5666776677777889999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||++ +++|.+.+... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 120 ~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~~ 195 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGRT 195 (350)
T ss_dssp EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECSSCB
T ss_pred cccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc---CCCCCEEeeeceeeeeccccc
Confidence 9999 88998888764 469999999999999999999999999999999999999 488999999999998765332
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
....||+.|+|||++.+..++.++|||||||++|+|+||++||.+.+.. ..+..+.......|
T Consensus 196 ----------~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~~~~~~~p---- 258 (350)
T d1rdqe_ 196 ----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYEKIVSGKVRFP---- 258 (350)
T ss_dssp ----------CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC----
T ss_pred ----------ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HHHHHHhcCCCCCC----
Confidence 2457899999999999999999999999999999999999999876543 34445554443333
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCC-----ChHHHHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRP-----DYGFLKR 271 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp-----~~~~l~~ 271 (318)
..+|+++.+++++||..||.+|+ +++++.+
T Consensus 259 -~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 259 -SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 35788999999999999999994 7887765
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-52 Score=359.90 Aligned_cols=253 Identities=17% Similarity=0.240 Sum_probs=212.2
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
+-++|++++.||+|+||+||+|.+..+++.||+|++..... ...+.+|+++++.++| +++..+..++.+....|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~H-pnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARH-RNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCC-TTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCC-CCCCeEEEEEEECCEEEEEEe
Confidence 45789999999999999999999999999999998876443 2357799999999986 667677777777889999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
|| +++|.+++...+..+++.+++.++.||+.||.|||++||+||||||+|||++. +....+||+|||++........
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~- 159 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDN- 159 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCE-
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC-CCceEEEEcccchhhccccCCc-
Confidence 99 78999999865556999999999999999999999999999999999999942 2456899999999987643322
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
.....+++.|+|||.+.+..++.++||||+||++|+|++|.+||.+.+.. ..+..+.......+ ...+.
T Consensus 160 -------~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~~~~i~~~~~~~~-~~~~~ 228 (321)
T d1tkia_ 160 -------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENIMNAEYTFD-EEAFK 228 (321)
T ss_dssp -------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHHHHTCCCCC-HHHHT
T ss_pred -------ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH---HHHHHHHhCCCCCC-hhhcc
Confidence 12346789999999999999999999999999999999999999886553 34455554444444 34456
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+|+.+.+++..||..||++|||+.++.+
T Consensus 229 ~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 229 EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 78999999999999999999999999876
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=351.61 Aligned_cols=263 Identities=17% Similarity=0.243 Sum_probs=201.8
Q ss_pred CCccccceeeEeeeeccCcccEEEEEEEcCCC----cEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccc
Q 021053 1 MERIIGVKYKLGRKIGSGSFGEIFLASHVDTN----EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (318)
Q Consensus 1 ~~~~~~~~y~~~~~lg~G~~~~v~~~~~~~~~----~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~ 73 (318)
+.+|-...|++.+.||+|+||.||+|.+..++ ..||||++...... ..+.+|+.++.+++| +++..+..+..
T Consensus 1 ~~ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H-~nIv~~~g~~~ 79 (283)
T d1mqba_ 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH-HNIIRLEGVIS 79 (283)
T ss_dssp CCBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEC
T ss_pred CCcCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCC-CCEeeeeEEEe
Confidence 35677788999999999999999999987544 46999988654332 257889999999976 66667766667
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
.....++|||++ ++++.+++......+++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||+
T Consensus 80 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl---~~~~~~Kl~DFGl 156 (283)
T d1mqba_ 80 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGL 156 (283)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC
T ss_pred cCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE---CCCCeEEEcccch
Confidence 777899999999 778888877766679999999999999999999999999999999999999 5889999999999
Q ss_pred eeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhC-CCCccchhHhhhHHHHHHHHHh
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATKKQKYDKICEK 231 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg-~~pf~~~~~~~~~~~~~~i~~~ 231 (318)
++.......... ......||+.|+|||++.+..++.++|||||||++|||++| .+||...+.. +.+..+. .
T Consensus 157 a~~~~~~~~~~~----~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~---~~~~~i~-~ 228 (283)
T d1mqba_ 157 SRVLEDDPEATY----TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAIN-D 228 (283)
T ss_dssp ---------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH-T
T ss_pred hhcccCCCccce----EeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH---HHHHHHh-c
Confidence 987543322111 12344678999999999999999999999999999999995 5555544332 2233332 2
Q ss_pred hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 232 KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
....+.+ ..+|..+.+++.+||+.+|++||++.++.+.|+.+..
T Consensus 229 ~~~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 229 GFRLPTP---MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp TCCCCCC---TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred cCCCCCc---hhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 2222322 3578899999999999999999999999999987653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=349.52 Aligned_cols=252 Identities=18% Similarity=0.296 Sum_probs=208.7
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC-CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT-KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
.++|++++.||+|+||+||+|+++ +++.||||+++... ....+.+|+.++.+++| +++..+..+.......++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~H-pnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCC-TTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCC-CceeeEEEEEeeCCceEEEEEc
Confidence 478999999999999999999984 67889999887644 34578999999999976 5666666666667789999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCc
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNR 163 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~ 163 (318)
+ +|+|.+++......+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|||+++........
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCC-
T ss_pred cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE---cCCCcEEECcchhheeccCCCce-
Confidence 9 789999987766779999999999999999999999999999999999999 58899999999999765443322
Q ss_pred cccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 164 HIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
......+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+ ....+... ...+. +.
T Consensus 157 -----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~~i~~~-~~~~~---p~ 224 (258)
T d1k2pa_ 157 -----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIAQG-LRLYR---PH 224 (258)
T ss_dssp -----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHHTT-CCCCC---CT
T ss_pred -----eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHHHHHhC-CCCCC---cc
Confidence 2234578999999999999999999999999999999998 899998876543 23333322 22222 23
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHHHHHH
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHD 275 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 275 (318)
..|+.+.+++..||+.||++|||+.++.+.|.+
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 678899999999999999999999999988743
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-51 Score=355.70 Aligned_cols=245 Identities=23% Similarity=0.333 Sum_probs=204.4
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecC-----CCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENS-----GTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLV 81 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~-----~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv 81 (318)
++|++++.||+|+||+||+|+++.+++.||||++.. ......+..|..++....+|+++..+..++.+....|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 579999999999999999999999999999998753 233345677887776555567888888788888899999
Q ss_pred Eecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 82 LDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 82 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
|||+ +|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||.++......
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee---cCCCceeccccchhhhccccc
Confidence 9999 8899999876 4559999999999999999999999999999999999999 588999999999998654333
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVL 240 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 240 (318)
. ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+.. +.+..+.......|
T Consensus 158 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~~~~~~~p---- 223 (320)
T d1xjda_ 158 A-------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIRMDNPFYP---- 223 (320)
T ss_dssp C-------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHHCCCCCC----
T ss_pred c-------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH---HHHHHHHcCCCCCC----
Confidence 2 123457899999999999999999999999999999999999999886653 33334433332222
Q ss_pred hhcCchhHHHHHHHHhhcCCCCCCChH-HHH
Q 021053 241 CKSHPAEFASYFHYCQSLTFDQRPDYG-FLK 270 (318)
Q Consensus 241 ~~~~~~~~~~li~~cl~~~p~~Rp~~~-~l~ 270 (318)
..+|+.+.+++.+||..||++||++. ++.
T Consensus 224 -~~~s~~~~dli~~~L~~dP~~R~s~~~~l~ 253 (320)
T d1xjda_ 224 -RWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253 (320)
T ss_dssp -TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -ccCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence 45788999999999999999999985 554
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-52 Score=350.92 Aligned_cols=248 Identities=21% Similarity=0.317 Sum_probs=195.1
Q ss_pred eeeccCcccEEEEEEEc--CCCcEEEEEeecCCCC----ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEecc-
Q 021053 13 RKIGSGSFGEIFLASHV--DTNEIVAVKIENSGTK----HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDLL- 85 (318)
Q Consensus 13 ~~lg~G~~~~v~~~~~~--~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~~- 85 (318)
++||+|+||+||+|.+. ++++.||||+++.... ...+.+|+.++.+++| +++..+..+.. ....++||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~g~~~-~~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIVRMIGICE-AESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCC-TTBCCEEEEEE-SSSEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCC-CCCceEEEEec-cCCEEEEEEcCC
Confidence 47999999999999865 4557899998865432 2358899999999976 55555544443 34578999999
Q ss_pred CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCCccc
Q 021053 86 GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHI 165 (318)
Q Consensus 86 ~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~ 165 (318)
+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++..........
T Consensus 91 ~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~~- 165 (277)
T d1xbba_ 91 LGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYK- 165 (277)
T ss_dssp TEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEE-
T ss_pred CCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc---cccCcccccchhhhhhccccccccc-
Confidence 7899999876 4569999999999999999999999999999999999999 4889999999999987654433211
Q ss_pred cccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHHHhhcC
Q 021053 166 PYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCKSH 244 (318)
Q Consensus 166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 244 (318)
......+|+.|+|||++.+..++.++|||||||++|||+| |++||.+.+.... ...+.. ....+ .+..+
T Consensus 166 ---~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~---~~~i~~-~~~~~---~p~~~ 235 (277)
T d1xbba_ 166 ---AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TAMLEK-GERMG---CPAGC 235 (277)
T ss_dssp ---C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHT-TCCCC---CCTTC
T ss_pred ---cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH---HHHHHc-CCCCC---CCccc
Confidence 2234568899999999999899999999999999999998 8999988655332 222222 11122 22467
Q ss_pred chhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 245 PAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 245 ~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
|+.+.+++.+||+.||++|||+.++.+.|++.+
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 899999999999999999999999988887765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-51 Score=362.39 Aligned_cols=247 Identities=23% Similarity=0.310 Sum_probs=199.1
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCC-----CCChhHHHHHHHHHHHc--CCCCCCeeeeccccCcceE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSG-----TKHPQLLYEAKVYKILQ--GGSGIPNIKWYGVDGEDNV 79 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~--~~~~~~~i~~~~~~~~~~~ 79 (318)
++|++.+.||+|+||.||+|++..+|+.||||++... .....+.+|..+++.++ +|+++..+..++......|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999999999999999987532 22234566666666665 3567777777777888899
Q ss_pred EEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecC
Q 021053 80 LVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRD 158 (318)
Q Consensus 80 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~ 158 (318)
+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+|+....
T Consensus 84 ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl---~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL---DEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE---cCCCcEEEeeeceeeecCC
Confidence 999999 8999999876 4558999999999999999999999999999999999999 5889999999999987654
Q ss_pred CCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCch
Q 021053 159 PTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPI 237 (318)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (318)
... ....||+.|+|||++.. ..++.++|||||||++|+|+||+.||.+.+.......... .... .
T Consensus 160 ~~~---------~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~----~~~~-~ 225 (364)
T d1omwa3 160 KKP---------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM----TLTM-A 225 (364)
T ss_dssp SCC---------CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH----SSSC-C
T ss_pred Ccc---------cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----cccC-C
Confidence 322 34578999999999874 5689999999999999999999999987544332222222 1111 1
Q ss_pred HHHhhcCchhHHHHHHHHhhcCCCCCCC-----hHHHHH
Q 021053 238 EVLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (318)
Q Consensus 238 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~-----~~~l~~ 271 (318)
...+..+|+.+.+++.+||..||++||+ ++++.+
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 226 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 2233467889999999999999999999 466654
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=350.15 Aligned_cols=258 Identities=21% Similarity=0.313 Sum_probs=198.3
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCC---CcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDT---NEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~---~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
|..++|++++.||+|+||.||+|.+..+ +..||||.++..... ..+.+|+.++++++| +++..+..+.. ...
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~~~~~-~~~ 81 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH-PHIVKLIGVIT-ENP 81 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCC-TTBCCEEEEEC-SSS
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEe-cCe
Confidence 5568999999999999999999998644 346888887654332 357899999999976 55555554443 357
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++||||+ +++|.+++......+++..+..++.||+.||.|||++||+||||||+||++ +..+.+||+|||+++..
T Consensus 82 ~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 82 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---EETTEEEECC-------
T ss_pred EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee---cCCCcEEEccchhheec
Confidence 89999999 788988887766679999999999999999999999999999999999999 48899999999999865
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+... .+..+.... ..
T Consensus 159 ~~~~~~------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~~~~-~~ 228 (273)
T d1mp8a_ 159 EDSTYY------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIENGE-RL 228 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHTTC-CC
T ss_pred cCCcce------eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHHcCC-CC
Confidence 433221 1234467899999999999999999999999999999998 899998766543 233333221 12
Q ss_pred chHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 236 PIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 236 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
+ .+..+|+.+.+++.+||+.||++|||+.++.+.|.+++++
T Consensus 229 ~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 P---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred C---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 2 2346789999999999999999999999999999987654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=349.83 Aligned_cols=241 Identities=23% Similarity=0.338 Sum_probs=199.6
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--------CChhHHHHHHHHHHHcC-CCCCCeeeeccccC
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--------KHPQLLYEAKVYKILQG-GSGIPNIKWYGVDG 75 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~e~~~l~~l~~-~~~~~~i~~~~~~~ 75 (318)
++++|++++.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++++++ |+++..+..++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 5789999999999999999999999999999999875422 12346789999999974 67788887788888
Q ss_pred cceEEEEeccC--CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccce
Q 021053 76 EDNVLVLDLLG--PSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLA 153 (318)
Q Consensus 76 ~~~~lv~e~~~--~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~ 153 (318)
...++|||++. +++.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++. .+.+.+||+|||++
T Consensus 82 ~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~--~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 82 DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSG 158 (273)
T ss_dssp SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTC
T ss_pred CeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe--cCCCeEEECccccc
Confidence 89999999993 467777765 45699999999999999999999999999999999999994 35579999999999
Q ss_pred eeecCCCCCccccccCCCCCcccccccccccccCCCC-CCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh
Q 021053 154 KKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQ-SRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK 232 (318)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~ 232 (318)
........ ....||+.|+|||++.+..+ +.++||||+||++|+|+||+.||...+. +....
T Consensus 159 ~~~~~~~~---------~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------i~~~~ 220 (273)
T d1xwsa_ 159 ALLKDTVY---------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------IIRGQ 220 (273)
T ss_dssp EECCSSCB---------CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HHHCC
T ss_pred eecccccc---------cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---------Hhhcc
Confidence 86543322 34578999999999987764 6789999999999999999999986432 22222
Q ss_pred ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 233 VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
... ...+|+++.+++.+||..||++|||++++.+
T Consensus 221 ~~~-----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 221 VFF-----RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCC-----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCC-----CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 222 2467899999999999999999999998765
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-51 Score=350.88 Aligned_cols=251 Identities=20% Similarity=0.223 Sum_probs=197.4
Q ss_pred eEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-------ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 10 KLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-------HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 10 ~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+.++.||+|+||+||+|++..+++.||||++..... ...+.+|+.++++++| +++..+..++......|+||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH-PNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCC-TTBCCEEEEECCTTCCEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCC-CCEeEEEeeeccCCceeehh
Confidence 356899999999999999999999999998754321 2357899999999976 56666666667778899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
||+.+++...+......+++..+..++.||+.||.|||++||+||||||+|||+ +..+.+||+|||.+.....+..
T Consensus 80 E~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 80 DFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp ECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCC-
T ss_pred hhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe---cCCCccccccCccccccCCCcc-
Confidence 999776666666556679999999999999999999999999999999999999 5889999999999976544332
Q ss_pred ccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh---------
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--------- 232 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~--------- 232 (318)
......+|+.|+|||++.+. .++.++||||+||++|+|+||++||.+.++.+....+.+.....
T Consensus 156 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 156 ------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp ------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred ------cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchh
Confidence 12345789999999998755 58999999999999999999999998876654443333322100
Q ss_pred -----------ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 233 -----------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 233 -----------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+........++++.+++.+||..||++|||+.++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 011222333456778999999999999999999988765
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=343.12 Aligned_cols=252 Identities=20% Similarity=0.276 Sum_probs=199.2
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeecc-ccCcceEEEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG-VDGEDNVLVL 82 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~-~~~~~~~lv~ 82 (318)
+--++|++.+.||+|+||.||+|++ ++..||||+++.....+.+.+|++++++++| +++..+..+. ......++||
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~H-pnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRH-SNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCC-TTBCCEEEEECCC--CCEEEE
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEEecCCcEEEEE
Confidence 3447899999999999999999998 4678999999887777889999999999976 5565655443 4455689999
Q ss_pred ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYCR-RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||+ +|+|.+++...+ ..+++..+..++.||+.||.|||+++|+||||||+||++ +.++.+||+|||.++......
T Consensus 81 ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC--------
T ss_pred eccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee---cCCCCEeecccccceecCCCC
Confidence 999 899999987543 348999999999999999999999999999999999999 588999999999998654332
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
. ...++..|+|||++.+..+++++|||||||++|||+| |++||...+... ....+... ...+
T Consensus 158 ~----------~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~~~-~~~~--- 220 (262)
T d1byga_ 158 D----------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEKG-YKMD--- 220 (262)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTTT-CCCC---
T ss_pred c----------cccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHHcC-CCCC---
Confidence 2 3356888999999998899999999999999999998 799988754432 33333322 1222
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
....+|+.+.+++++||+.||.+|||+.++.+.|+.+-+
T Consensus 221 ~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 234678899999999999999999999999999987643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-50 Score=346.71 Aligned_cols=254 Identities=20% Similarity=0.229 Sum_probs=202.4
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
++|++++.||+|+||+||+|.+..+++.||||+++... ....+.+|+.++++++| +++..+..++.+....|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~H-p~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH-PNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCC-TTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC-CcEEEeccccccccceeEEE
Confidence 58999999999999999999999999999999876433 24578899999999876 66777777778888999999
Q ss_pred eccCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCC
Q 021053 83 DLLGPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTT 161 (318)
Q Consensus 83 e~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~ 161 (318)
|++++++.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||.+.....+..
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVR 157 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSB
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee---cccCcceeccCCcceeccCCcc
Confidence 99988877776543 4569999999999999999999999999999999999999 5888999999999976544332
Q ss_pred CccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh---------
Q 021053 162 NRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK--------- 231 (318)
Q Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~--------- 231 (318)
......+|+.|+|||++.... ++.++||||+||++|+|++|+.||.+.+..+...........
T Consensus 158 -------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 158 -------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp -------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred -------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence 224557899999999987766 588999999999999999999999876654333322221110
Q ss_pred ------------hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 232 ------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 232 ------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
....+.......++..+.+++.+||..||++|||++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 0011112223355678899999999999999999998766
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=345.66 Aligned_cols=258 Identities=21% Similarity=0.265 Sum_probs=197.6
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcC-CC--cEEEEEeecCCCC-----ChhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-TN--EIVAVKIENSGTK-----HPQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~-~~--~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
|-.++|++.+.||+|+||+||+|+... ++ ..||||+++.... ...+.+|+.++++++| +++..+..++.+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~~~g~~~~- 82 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH-RNLIRLYGVVLT- 82 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCC-TTBCCEEEEECS-
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCC-CCEEEEEEEEee-
Confidence 445779999999999999999998653 22 4689998764321 2367899999999965 666666555544
Q ss_pred cceEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
...++||||+ ++++.+.+......+++..+..++.||+.||.|||++||+||||||+||+++ .++.+||+|||+++
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~---~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMR 159 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEE---ETTEEEECCCTTCE
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccc---cccceeeccchhhh
Confidence 4678999999 8899988887667799999999999999999999999999999999999994 78899999999998
Q ss_pred eecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhc
Q 021053 155 KYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKV 233 (318)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~ 233 (318)
.......... ......++..|+|||++.+..++.++|||||||++|||+| |.+||.+.+... .+..+.....
T Consensus 160 ~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i~~~~~ 232 (273)
T d1u46a_ 160 ALPQNDDHYV----MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKIDKEGE 232 (273)
T ss_dssp ECCC-CCEEE----C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTSCC
T ss_pred hcccCCCcce----ecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHHHhCCC
Confidence 7654433211 2234456788999999999999999999999999999998 899998866543 3334433333
Q ss_pred cCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 234 STPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 234 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
..+. ...+|+.+.+++.+||+.||++|||+.++.+.|.++
T Consensus 233 ~~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 233 RLPR---PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCC---cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 3332 246788999999999999999999999999888753
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=350.70 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=198.4
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCc----EEEEEeecCCC---CChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNE----IVAVKIENSGT---KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~----~vaiK~~~~~~---~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
..+|++++.||+|+||+||+|.+..+++ .||+|.+.... ....+.+|+.++.+++| +++..+..+..+. ..
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-pnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN-PHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCC-TTBCCEEEEEESS-SE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCC-CCEeeEEEEEecC-Ce
Confidence 3579999999999999999999987765 58888765432 23468899999999976 5565665555544 45
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
+++++++ +++|.+.+......+++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++...
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---EETTEEEECCCSHHHHTT
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee---CCCCCeEeeccccceecc
Confidence 5666666 899999988777779999999999999999999999999999999999999 488999999999998754
Q ss_pred CCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
...... ......||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.+...... . .......+
T Consensus 163 ~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~---~-i~~~~~~~ 233 (317)
T d1xkka_ 163 AEEKEY-----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS---I-LEKGERLP 233 (317)
T ss_dssp TTCC-------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH---H-HHHTCCCC
T ss_pred cccccc-----cccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH---H-HHcCCCCC
Confidence 433211 1233467999999999999999999999999999999999 899998765433222 2 22222222
Q ss_pred hHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHH
Q 021053 237 IEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLF 277 (318)
Q Consensus 237 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 277 (318)
.+ ..+|+.+.+++.+||..||++|||+.++.+.|..+.
T Consensus 234 ~p---~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 234 QP---PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp CC---TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CC---cccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 22 356889999999999999999999999999988764
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=347.23 Aligned_cols=255 Identities=20% Similarity=0.250 Sum_probs=196.5
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCC-CcEEEEEeecCC----CCChhHHHHHHHHHHHc--CCCCCCeeeecc-----c
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDT-NEIVAVKIENSG----TKHPQLLYEAKVYKILQ--GGSGIPNIKWYG-----V 73 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~-~~~vaiK~~~~~----~~~~~~~~e~~~l~~l~--~~~~~~~i~~~~-----~ 73 (318)
.++|++++.||+|+||+||+|++..+ ++.||||++... .......+|+.+++.+. +|+++..+..++ .
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 57999999999999999999999765 677999986532 22346778999988885 456666654333 2
Q ss_pred cCcceEEEEeccCCCHHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccc
Q 021053 74 DGEDNVLVLDLLGPSLEDLFV-YCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGL 152 (318)
Q Consensus 74 ~~~~~~lv~e~~~~~L~~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~ 152 (318)
.....++++|++.+++..+.. .....+++..++.++.|++.||.|||++||+||||||+|||+ +..+.+||+|||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCCS
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE---cCCCCeeecchhh
Confidence 345789999999766655544 334568999999999999999999999999999999999999 4889999999999
Q ss_pred eeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHh-
Q 021053 153 AKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEK- 231 (318)
Q Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~- 231 (318)
+....... ......||+.|+|||++.+.+|+.++||||+||++|+|++|++||.+.++.+....+......
T Consensus 163 ~~~~~~~~--------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 163 ARIYSFQM--------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234 (305)
T ss_dssp CCCCCGGG--------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhhhcccc--------cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 87543222 123567899999999999999999999999999999999999999887665444333332210
Q ss_pred ------------------hccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 232 ------------------KVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 232 ------------------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
....+...+...+++.+.+++.+||..||++|||+.++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0111122233456777889999999999999999887765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=343.71 Aligned_cols=260 Identities=20% Similarity=0.312 Sum_probs=208.2
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCC-------cEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccc
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTN-------EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV 73 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~-------~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~ 73 (318)
|-.++|++++.||+|+||.||+|++..++ ..||||+++..... ..+.+|...+.++.+|+++..+..+..
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 34689999999999999999999976543 47999998765432 357778889999977788888877777
Q ss_pred cCcceEEEEecc-CCCHHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec
Q 021053 74 DGEDNVLVLDLL-GPSLEDLFVYCR---------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (318)
Q Consensus 74 ~~~~~~lv~e~~-~~~L~~~~~~~~---------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~ 137 (318)
+....++||||+ +|+|.+++.... ..+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl- 168 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV- 168 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee-
Confidence 788899999999 899999997532 348999999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccch
Q 021053 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (318)
Q Consensus 138 ~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~ 216 (318)
+.++.+||+|||.+.......... ......+++.|+|||++.+..++.++|||||||++|||++ |.+||.+.
T Consensus 169 --~~~~~~kl~dfg~~~~~~~~~~~~-----~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 169 --TEDNVMKIADFGLARDIHHIDYYK-----KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp --CTTCCEEECSTTCCCCGGGCCTTC-----CCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred --cCCCCeEeccchhhcccccccccc-----ccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 588999999999998765543322 2345678899999999999999999999999999999998 79999876
Q ss_pred hHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
+... ....+. .....+ ....+|+.+.+++.+||+.||++|||+.++.+.|++++.
T Consensus 242 ~~~~---~~~~i~-~~~~~~---~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 242 PVEE---LFKLLK-EGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp CHHH---HHHHHH-TTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHH---HHHHHH-cCCCCC---CCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 5432 222222 222222 224678899999999999999999999999999988754
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-50 Score=348.00 Aligned_cols=256 Identities=20% Similarity=0.297 Sum_probs=204.5
Q ss_pred ccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGE 76 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~ 76 (318)
-.++|++.+.||+|+||+||+|+++ .+++.||||+++..... ..+.+|+.++++++| +++..+..+.....
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDN-PNIVKLLGVCAVGK 89 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCC-TTBCCEEEEECSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCC-CCcccceeeeccCC
Confidence 3578999999999999999999975 34578999998754432 358899999999976 45555555556677
Q ss_pred ceEEEEecc-CCCHHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 021053 77 DNVLVLDLL-GPSLEDLFVYCR-----------------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPD 132 (318)
Q Consensus 77 ~~~lv~e~~-~~~L~~~~~~~~-----------------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~ 132 (318)
..++++|++ +++|.+++.... ..+++..+..++.|++.||.|||+++++||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 899999999 899999986532 23788899999999999999999999999999999
Q ss_pred ceeeccCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhC-CC
Q 021053 133 NFLMGLGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SL 211 (318)
Q Consensus 133 Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg-~~ 211 (318)
|||+ +.++.+||+|||+|+......... ......+++.|+|||++.+..++.++|||||||++|||++| .+
T Consensus 170 NILl---d~~~~~Kl~DFGls~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 170 NCLV---GENMVVKIADFGLSRNIYSADYYK-----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp GEEE---CGGGCEEECCCSCHHHHTGGGCBC---------CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ceEE---CCCCcEEEccchhheeccCCcccc-----ccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999 588999999999997654332211 22345678899999999999999999999999999999998 47
Q ss_pred CccchhHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 212 PWQGLKAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 212 pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
||.+.++.+ .+..+..... . ..+..+|+++.+++..||+.+|++|||+.++.+.|+++
T Consensus 242 p~~~~~~~e---~~~~v~~~~~-~---~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 242 PYYGMAHEE---VIYYVRDGNI-L---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp TTTTSCHHH---HHHHHHTTCC-C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCCCCCHHH---HHHHHHcCCC-C---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 888765543 2333332221 1 12346788999999999999999999999999998875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=343.78 Aligned_cols=262 Identities=21% Similarity=0.325 Sum_probs=214.3
Q ss_pred cccceeeEeeeeccCcccEEEEEEEc-----CCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHV-----DTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
+-.++|++++.||+|+||.||+|++. .+++.||||+++..... ..+.+|+.++..+.+|+++..+..+....
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 34589999999999999999999863 45678999998765432 25788999999998888898888887888
Q ss_pred cceEEEEecc-CCCHHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeec
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCR-----------------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMG 137 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~-----------------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~ 137 (318)
...+++|||| +++|.+++.... ..+++..+..++.||+.||.|||+++++||||||+||++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~- 178 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL- 178 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE-
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccc-
Confidence 8899999999 889999987532 248899999999999999999999999999999999999
Q ss_pred cCCCCCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHh-CCCCccch
Q 021053 138 LGRKANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLR-GSLPWQGL 216 (318)
Q Consensus 138 ~~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~t-g~~pf~~~ 216 (318)
+..+.+|++|||.++......... ......+|+.|+|||++.+..++.++|||||||++|||+| |.+||...
T Consensus 179 --~~~~~~ki~DfG~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 179 --THGRITKICDFGLARDIKNDSNYV-----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp --ETTTEEEECCCGGGSCTTSCTTSE-----ECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred --cccCcccccccchheeccCCCcce-----EeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 488999999999998765433221 2345678999999999999999999999999999999999 67777665
Q ss_pred hHhhhHHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 217 KAATKKQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
+... .+.++.......+.+ ..+|+.+.+++..||+.||++|||+.++.+.|++.+.+
T Consensus 252 ~~~~---~~~~~i~~~~~~~~~---~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 252 PVDS---KFYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp CSSH---HHHHHHHHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHH---HHHHHHhcCCCCCCc---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 4432 223333333333322 35688999999999999999999999999999887655
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=8.4e-50 Score=341.07 Aligned_cols=253 Identities=24% Similarity=0.299 Sum_probs=197.8
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+||++.+.||+|+||+||+|+++ +++.||||++.... ....+.+|+.++++++| +++..+..++......++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h-pnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH-SNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCC-TTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCC-CcEEeeeeecccCCceeEEE
Confidence 58999999999999999999985 67899999876543 24578899999999976 66667777777888899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
+++.+++...+....+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||.+.....+...
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC----
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE---cCCCCEEecccccceecccCccc
Confidence 999888878777666779999999999999999999999999999999999999 58899999999999876543321
Q ss_pred ccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhh---------
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKK--------- 232 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~--------- 232 (318)
.....+++.|+|||.+.+. .++.++||||+||++|+|++|++||.+.+..+....+.......
T Consensus 157 -------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 157 -------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred -------cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchh
Confidence 2344688999999998765 47999999999999999999999998766544333322221100
Q ss_pred ------------ccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 233 ------------VSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 233 ------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
...+.......+++.+.+++++||..||++|||+.++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 011112223345677888999999999999998887754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=339.73 Aligned_cols=256 Identities=22% Similarity=0.354 Sum_probs=198.3
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
|-.++|++.+.||+|+||+||+|.+..+ +.||||+++.... .+.+.+|+.++.+++|++ +..+..+..+ ...++||
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~n-Iv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEK-LVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTT-BCCEEEEECS-SSCEEEE
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCC-EeEEEEEEec-CCeEEEE
Confidence 4457899999999999999999998755 5699999875543 357899999999998754 5555444433 4588999
Q ss_pred ecc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCC
Q 021053 83 DLL-GPSLEDLFVYC-RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPT 160 (318)
Q Consensus 83 e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~ 160 (318)
||+ +|+|..++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCCTTC------
T ss_pred EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE---CCCCcEEEcccchhhhccCCC
Confidence 999 78888887653 3458999999999999999999999999999999999999 588999999999997654322
Q ss_pred CCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhC-CCCccchhHhhhHHHHHHHHHhhccCchHH
Q 021053 161 TNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATKKQKYDKICEKKVSTPIEV 239 (318)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg-~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (318)
.. ......+|+.|+|||++.+..++.++|||||||++|||++| .+||....... .+..+.. ....+.
T Consensus 168 ~~------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~---~~~~i~~-~~~~~~-- 235 (285)
T d1fmka3 168 YT------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVER-GYRMPC-- 235 (285)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT-TCCCCC--
T ss_pred ce------eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH---HHHHHHh-cCCCCC--
Confidence 21 12345689999999999999999999999999999999995 55555544432 2333322 222222
Q ss_pred HhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHH
Q 021053 240 LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFS 278 (318)
Q Consensus 240 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~ 278 (318)
...+|+.+.+++.+||+.||++||+++++.+.|++.+.
T Consensus 236 -~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 236 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 24678899999999999999999999999998887654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-49 Score=343.91 Aligned_cols=258 Identities=21% Similarity=0.239 Sum_probs=197.4
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccc----cCcc
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGV----DGED 77 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~----~~~~ 77 (318)
++.||++++.||+|+||+||+|.+..+++.||||++...... ..+.+|+.++++++|++.+.....+.. ....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 458999999999999999999999999999999998754432 357889999999987655444433322 2235
Q ss_pred eEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 78 NVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 78 ~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
+|+++++++++|.+++.. .++++..++.++.|++.||.|||++||+||||||+|||+ +..+.+||+|||++....
T Consensus 86 ~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECC
T ss_pred EEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeecc
Confidence 677777779999999975 459999999999999999999999999999999999999 588999999999998654
Q ss_pred CCCCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHH------
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICE------ 230 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~------ 230 (318)
...... .......+|+.|+|||++... .++.++||||+||++|+|++|+.||.+.+..+..........
T Consensus 161 ~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 161 PDHDHT----GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp GGGCBC----CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred CCCccc----eeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhh
Confidence 332211 122455789999999998654 578999999999999999999999987654433333222110
Q ss_pred -----------------hhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 231 -----------------KKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 231 -----------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.....+.......+++.+.+++.+||..||.+|||+.++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01112223334456778999999999999999999998876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-49 Score=343.83 Aligned_cols=249 Identities=21% Similarity=0.311 Sum_probs=193.7
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeecccc-----C
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVD-----G 75 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~-----~ 75 (318)
+.++|++++.||+|+||+||+|.+..+++.||||++...... ..+.+|+.+++.++|++.+..+..+... .
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 679999999999999999999999999999999998754432 2578899999999875444433333222 2
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
..+|+|||+++.+|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||.+..
T Consensus 96 ~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 96 TDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQ 170 (346)
T ss_dssp CCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEE
T ss_pred ceEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc---ccccccccccccceec
Confidence 35799999998888887764 459999999999999999999999999999999999999 5899999999999987
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
..... ....+|+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+........... ...
T Consensus 171 ~~~~~----------~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~---~~~ 237 (346)
T d1cm8a_ 171 ADSEM----------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV---TGT 237 (346)
T ss_dssp CCSSC----------CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH---HCC
T ss_pred cCCcc----------ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhc---cCC
Confidence 65433 245789999999998865 4789999999999999999999999876554433333222 222
Q ss_pred Cch--------------------------HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 235 TPI--------------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 235 ~~~--------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+. .......++.+.+|+.+||..||++|||+.++.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 211 1122345678899999999999999999998876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-50 Score=343.86 Aligned_cols=259 Identities=18% Similarity=0.209 Sum_probs=207.7
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcCCCcE--EEEEeecCC---CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcce
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVDTNEI--VAVKIENSG---TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDN 78 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~--vaiK~~~~~---~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~ 78 (318)
|--++|++.+.||+|+||+||+|.++.++.. ||||.+... .....+.+|+.++.++.+|+++..+..+.......
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 3347999999999999999999999887764 667765432 23456899999999997678888887777788899
Q ss_pred EEEEecc-CCCHHHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCC
Q 021053 79 VLVLDLL-GPSLEDLFVYC---------------RRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKA 142 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~---------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~ 142 (318)
++||||+ +|+|.+++... ...+++..+..++.||+.||.|+|+++|+||||||+|||+ +.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~ 163 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---GEN 163 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGG
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEE---cCC
Confidence 9999999 89999998643 2458999999999999999999999999999999999999 588
Q ss_pred CeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhC-CCCccchhHhhh
Q 021053 143 NQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATK 221 (318)
Q Consensus 143 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg-~~pf~~~~~~~~ 221 (318)
+.+||+|||+++....... .....+|..|+|||.+.+..++.++|||||||++|||++| .+||.+.+..
T Consensus 164 ~~~kl~DfG~a~~~~~~~~--------~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~-- 233 (309)
T d1fvra_ 164 YVAKIADFGLSRGQEVYVK--------KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-- 233 (309)
T ss_dssp GCEEECCTTCEESSCEECC--------C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--
T ss_pred CceEEcccccccccccccc--------ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH--
Confidence 9999999999975443222 1244678999999999999999999999999999999996 5678765543
Q ss_pred HHHHHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhc
Q 021053 222 KQKYDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSRE 280 (318)
Q Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~ 280 (318)
+.+..+... ...+ .+..+|+.+.+++.+||+.||++|||+.++.+.|++++.+.
T Consensus 234 -~~~~~i~~~-~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 234 -ELYEKLPQG-YRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp -HHHHHGGGT-CCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred -HHHHHHHhc-CCCC---CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 233333322 1121 22457889999999999999999999999999999986543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=339.09 Aligned_cols=216 Identities=25% Similarity=0.316 Sum_probs=171.7
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC----CChhHHHHHHHHHHHcCCCCCCeeeeccc-------cC
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT----KHPQLLYEAKVYKILQGGSGIPNIKWYGV-------DG 75 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~i~~~~~-------~~ 75 (318)
+||++++.||+|+||+||+|++..+++.||||++.... ....+.+|+.++++++|++.+..+..+.. ..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 79999999999999999999999999999999875432 23467899999999987655555443322 24
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
...+++||++.+.+..........+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARA 166 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEE
T ss_pred ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee---cCCCcEEeeecceeee
Confidence 5689999999877777776656679999999999999999999999999999999999999 4889999999999976
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCC-CCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHH
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGI-EQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKI 228 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i 228 (318)
......... .......+|+.|+|||++.+. .+++++||||+||++|+|++|++||.+.++......+...
T Consensus 167 ~~~~~~~~~---~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~ 237 (318)
T d3blha1 167 FSLAKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237 (318)
T ss_dssp CCC-----C---CCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccccc---ccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHh
Confidence 654332211 123345789999999998865 5899999999999999999999999887665555544443
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=334.58 Aligned_cols=258 Identities=17% Similarity=0.225 Sum_probs=199.3
Q ss_pred eEeeeeccCcccEEEEEEEcCCC---cEEEEEeecCCCCC---hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEe
Q 021053 10 KLGRKIGSGSFGEIFLASHVDTN---EIVAVKIENSGTKH---PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLD 83 (318)
Q Consensus 10 ~~~~~lg~G~~~~v~~~~~~~~~---~~vaiK~~~~~~~~---~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e 83 (318)
.+.+.||+|+||+||+|.+..++ ..||||.++..... ..+.+|++++.+++|++.+..+..+.......++|||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 44789999999999999986543 36899988643322 4689999999999874444444444445567999999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
|| +++|.+++.......+...+..++.|++.||.|+|+++|+||||||+|||+ ++++.+||+|||+++........
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTCC
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE---CCCCCEEEecccchhhccccccc
Confidence 99 889999888766668888999999999999999999999999999999999 58899999999999876543322
Q ss_pred ccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCchHHHhh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTPIEVLCK 242 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (318)
.. .......+|..|+|||.+.+..++.++|||||||++|||+||..||...... ......+.... ..+ ...
T Consensus 187 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~~g~-~~~---~p~ 257 (311)
T d1r0pa_ 187 SV---HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGR-RLL---QPE 257 (311)
T ss_dssp CT---TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTC-CCC---CCT
T ss_pred cc---eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCC-CCC---Ccc
Confidence 11 1223457899999999999999999999999999999999977777653322 12222222222 111 124
Q ss_pred cCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHh
Q 021053 243 SHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSR 279 (318)
Q Consensus 243 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~ 279 (318)
.+|+.+.+++.+||..||++||++.++.+.|+++...
T Consensus 258 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 5688999999999999999999999999999988654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=337.63 Aligned_cols=251 Identities=23% Similarity=0.243 Sum_probs=194.2
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeecc-----ccCcceEE
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYG-----VDGEDNVL 80 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~-----~~~~~~~l 80 (318)
..+|+..+.||+|+||+||+|++..+++.||||++..... ...+|+.++++++|++.+..+..+. .+..+.++
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR--FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch--HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 4579999999999999999999999999999999876443 3458999999998755444443331 23345789
Q ss_pred EEeccCCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeec
Q 021053 81 VLDLLGPSLEDLFVY---CRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYR 157 (318)
Q Consensus 81 v~e~~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~ 157 (318)
||||+++++.+.+.. ....+++..++.++.||+.||.|||++||+||||||+|||+. .+...+||+|||++....
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC--TTTCCEEECCCTTCEECC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEe--cCCCceeEecccchhhcc
Confidence 999998776666542 244599999999999999999999999999999999999994 234589999999998764
Q ss_pred CCCCCccccccCCCCCcccccccccccccC-CCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccCc
Q 021053 158 DPTTNRHIPYRENKNLTGTARYASCNTHLG-IEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVSTP 236 (318)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (318)
.... .....|+..|+|||++.+ ..++.++||||+||++|||++|++||...+..+.. ..+.......+
T Consensus 175 ~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l---~~i~~~~g~~~ 243 (350)
T d1q5ka_ 175 RGEP--------NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL---VEIIKVLGTPT 243 (350)
T ss_dssp TTSC--------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH---HHHHHHHCCCC
T ss_pred CCcc--------cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHH---HHHHHHhCCCh
Confidence 3322 234578999999998775 46899999999999999999999999876554333 33332222222
Q ss_pred hHH------------------------HhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 237 IEV------------------------LCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 237 ~~~------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
.+. .....++++.+++.+||..||++|||+.++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111 12245678999999999999999999998776
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=336.43 Aligned_cols=257 Identities=20% Similarity=0.284 Sum_probs=205.9
Q ss_pred cccceeeEeeeeccCcccEEEEEEEcC-----CCcEEEEEeecCCCCCh---hHHHHHHHHHHHcCCCCCCeeeeccccC
Q 021053 4 IIGVKYKLGRKIGSGSFGEIFLASHVD-----TNEIVAVKIENSGTKHP---QLLYEAKVYKILQGGSGIPNIKWYGVDG 75 (318)
Q Consensus 4 ~~~~~y~~~~~lg~G~~~~v~~~~~~~-----~~~~vaiK~~~~~~~~~---~~~~e~~~l~~l~~~~~~~~i~~~~~~~ 75 (318)
|-.++|++++.||+|+||+||+|.+.. +++.||||+++...... .+.+|+.++.+++| +++..+..+....
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h-~nIv~~~~~~~~~ 95 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC-HHVVRLLGVVSQG 95 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCC-TTBCCEEEEECSS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCC-CCEeeeeeEEecC
Confidence 456899999999999999999998752 35789999987544322 47899999999986 4555665555667
Q ss_pred cceEEEEecc-CCCHHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeE
Q 021053 76 EDNVLVLDLL-GPSLEDLFVYCR---------RKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQV 145 (318)
Q Consensus 76 ~~~~lv~e~~-~~~L~~~~~~~~---------~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~ 145 (318)
...++|||++ +|+|.+++.... ..++...+..++.|++.||.|||+++|+||||||+|||+ +.++.+
T Consensus 96 ~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~ 172 (308)
T d1p4oa_ 96 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---AEDFTV 172 (308)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE---CTTCCE
T ss_pred CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee---cCCceE
Confidence 7899999999 899999887532 236888999999999999999999999999999999999 589999
Q ss_pred EEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhC-CCCccchhHhhhHHH
Q 021053 146 YIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRG-SLPWQGLKAATKKQK 224 (318)
Q Consensus 146 kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg-~~pf~~~~~~~~~~~ 224 (318)
||+|||+++......... ......+++.|+|||.+.+..++.++|||||||++|||+|| .+||.+.+... .
T Consensus 173 Kl~DFGla~~~~~~~~~~-----~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~---~ 244 (308)
T d1p4oa_ 173 KIGDFGMTRDIYETDYYR-----KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---V 244 (308)
T ss_dssp EECCTTCCCGGGGGGCEE-----GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---H
T ss_pred EEeecccceeccCCccee-----eccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence 999999997654332211 22344688999999999999999999999999999999997 68887765543 2
Q ss_pred HHHHHHhhccCchHHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHH
Q 021053 225 YDKICEKKVSTPIEVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDL 276 (318)
Q Consensus 225 ~~~i~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 276 (318)
+..+..... .+ ....+|+.+.+++..||+.+|++|||+.++.+.|++.
T Consensus 245 ~~~i~~~~~-~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 245 LRFVMEGGL-LD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHTTCC-CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHhCCC-CC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 333332222 11 1246788999999999999999999999999988765
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=7.6e-48 Score=335.18 Aligned_cols=197 Identities=24% Similarity=0.392 Sum_probs=166.6
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccc--cCcceEEEEe
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGV--DGEDNVLVLD 83 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~--~~~~~~lv~e 83 (318)
.++|++++.||+|+||+||+|++..+++.||||+++.. ....+.+|+.++..+.+|+++..+..++. .....++|||
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 47899999999999999999999999999999998753 34578899999999987788877765543 4457899999
Q ss_pred cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 84 LL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 84 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
++ +++|..+. +.+++..++.++.||+.||.|||++||+||||||+|||++ .+...+||+|||.|........
T Consensus 113 ~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~~- 185 (328)
T d3bqca1 113 HVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQE- 185 (328)
T ss_dssp CCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTCC-
T ss_pred ecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCCc-
Confidence 99 66775543 3599999999999999999999999999999999999995 3455799999999987654322
Q ss_pred ccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchh
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLK 217 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~ 217 (318)
.....+|+.|+|||.+.+.. ++.++||||+||++|+|++|..||....
T Consensus 186 -------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 186 -------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp -------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred -------ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 23557899999999988765 7999999999999999999999997543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-48 Score=335.03 Aligned_cols=251 Identities=20% Similarity=0.319 Sum_probs=203.8
Q ss_pred ceeeEeeeeccCcccEEEEEEEc---CCCcEEEEEeecCC------CCChhHHHHHHHHHHHcCCCCCCeeeeccccCcc
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHV---DTNEIVAVKIENSG------TKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGED 77 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~---~~~~~vaiK~~~~~------~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~ 77 (318)
++|++++.||+|+||+||+|++. .+++.||||+++.. .....+.+|+.++++++|++++..+..+..+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 77999999999999999999874 46899999986532 2345678999999999999999998888888889
Q ss_pred eEEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 78 NVLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 78 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
.++++|++ +++|.+++... +.+++..+..++.||+.||.|+|++||+||||||+||++ +.++.+||+|||++...
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill---~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL---DSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee---cCCCCEEEeeccchhhh
Confidence 99999999 88999998874 457899999999999999999999999999999999999 57899999999999865
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCC--CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhcc
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIE--QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVS 234 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~ 234 (318)
...... ......+++.|+|||.+.+.. ++.++||||+||++|+|++|+.||.+.+.......+..... ...
T Consensus 180 ~~~~~~------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~-~~~ 252 (322)
T d1vzoa_ 180 VADETE------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSE 252 (322)
T ss_dssp CGGGGG------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-HCC
T ss_pred cccccc------cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcc-cCC
Confidence 433222 223457899999999987654 68899999999999999999999988665444444333221 111
Q ss_pred CchHHHhhcCchhHHHHHHHHhhcCCCCCCC-----hHHHHH
Q 021053 235 TPIEVLCKSHPAEFASYFHYCQSLTFDQRPD-----YGFLKR 271 (318)
Q Consensus 235 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~-----~~~l~~ 271 (318)
.+ ....+|+.+.+++.+||++||++||+ ++++.+
T Consensus 253 ~~---~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 PP---YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp CC---CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CC---CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11 22357889999999999999999995 566554
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-48 Score=334.27 Aligned_cols=267 Identities=24% Similarity=0.259 Sum_probs=195.0
Q ss_pred ccceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHH--HHHcCCCCCCeeeeccc-cC---cce
Q 021053 5 IGVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVY--KILQGGSGIPNIKWYGV-DG---EDN 78 (318)
Q Consensus 5 ~~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l--~~l~~~~~~~~i~~~~~-~~---~~~ 78 (318)
++.+|.+.+.||+|+||.||+|+. +|+.||||++.... .....+|.+++ ..++| +++..+..+.. .. ...
T Consensus 1 ~~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~H-pnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 1 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE-ERSWFREAEIYQTVMLRH-ENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCC-TTBCCEEEEEEEECSSSEEE
T ss_pred CCcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc-hhHHHHHHHHHHHhhCCC-CcCcceEEEEEeCCCcceEE
Confidence 467899999999999999999987 67899999886543 23344454444 34555 55555543332 22 368
Q ss_pred EEEEecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCCceeeccCCCCCeEEEEe
Q 021053 79 VLVLDLL-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS--------RGFLHRDIKPDNFLMGLGRKANQVYIID 149 (318)
Q Consensus 79 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~--------~~i~H~dl~p~Nil~~~~~~~~~~kL~d 149 (318)
++||||+ +++|.+++.+ ..+++.....++.|++.||.|+|+ +||+||||||+|||+ +.++.+||+|
T Consensus 77 ~lv~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~D 151 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIAD 151 (303)
T ss_dssp EEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECC
T ss_pred EEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEe
Confidence 9999999 8899999985 458999999999999999999996 599999999999999 5889999999
Q ss_pred ccceeeecCCCCCccccccCCCCCcccccccccccccCCC------CCCcchHHHHHHHHHHHHhCCCCccchhHh----
Q 021053 150 FGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIE------QSRRDDLESLGYVLLYFLRGSLPWQGLKAA---- 219 (318)
Q Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwslG~il~~l~tg~~pf~~~~~~---- 219 (318)
||++............ ......||+.|+|||++.+.. ++.++|||||||++|||+||.+||......
T Consensus 152 FGl~~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~ 228 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDI---APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 228 (303)
T ss_dssp CTTCEEEETTTTEECC-------CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT
T ss_pred cCccccccCCCcceec---cccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccch
Confidence 9999877554332211 223567899999999987653 567899999999999999998887432110
Q ss_pred --------hhHHHHHHHHHhhccCchHHH--hhcCchhHHHHHHHHhhcCCCCCCChHHHHHHHHHHHHhcCCc
Q 021053 220 --------TKKQKYDKICEKKVSTPIEVL--CKSHPAEFASYFHYCQSLTFDQRPDYGFLKRLFHDLFSREGSL 283 (318)
Q Consensus 220 --------~~~~~~~~i~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~~~~~~~~ 283 (318)
...............++.+.. ....+..+.+++.+||..||++|||+.++.+.|+++..++.++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~~~ 302 (303)
T d1vjya_ 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHCCC
T ss_pred hhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcCCC
Confidence 111111111222222221111 1223356899999999999999999999999999998777664
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=324.84 Aligned_cols=198 Identities=26% Similarity=0.379 Sum_probs=166.1
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEE
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVL 82 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~ 82 (318)
+||++++.||+|+||+||+|++..+++.||||+++..... ..+.+|+.+++.++| +++..+..+.......++++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH-KNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCC-TTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCc-CCEEeeccccccccceeEEe
Confidence 5899999999999999999999999999999998654332 367899999999877 55666666777778899999
Q ss_pred eccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeeecCCCCC
Q 021053 83 DLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKYRDPTTN 162 (318)
Q Consensus 83 e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~~~~~~~ 162 (318)
+++.+.....+....+.+++..++.++.|++.||.|||++||+||||||+|||+ +..+.+||+|||.+.....+...
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCSC
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc---ccCCceeeeecchhhcccCCCcc
Confidence 999555545554556679999999999999999999999999999999999999 47889999999999876544332
Q ss_pred ccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccc
Q 021053 163 RHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQG 215 (318)
Q Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~ 215 (318)
.....++..|+|||++.+.. ++.++||||+||++|+|++|..||..
T Consensus 158 -------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 158 -------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp -------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred -------ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 23446678899999988765 69999999999999999999988754
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=333.35 Aligned_cols=202 Identities=23% Similarity=0.294 Sum_probs=159.8
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCCh----hHHHHHHHHHHHcCCCCCCeeeeccc------cC
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHP----QLLYEAKVYKILQGGSGIPNIKWYGV------DG 75 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~----~~~~e~~~l~~l~~~~~~~~i~~~~~------~~ 75 (318)
-++|++++.||+|+||+||+|++..+|+.||||++....... .+.+|+.++++++| +++..+..++. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~h-pnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH-KNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCC-TTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCC-CCeeEEEEEEecccccccC
Confidence 378999999999999999999999999999999987654332 47789999999976 55555533332 34
Q ss_pred cceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceee
Q 021053 76 EDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKK 155 (318)
Q Consensus 76 ~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~ 155 (318)
.+.|+||||+.+++.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|++|||.++.
T Consensus 95 ~~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 95 QDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLART 168 (355)
T ss_dssp CEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---
T ss_pred ceeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc---ccccceeeechhhhhc
Confidence 6789999999888777664 458999999999999999999999999999999999999 4889999999999876
Q ss_pred ecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccchhHhhhH
Q 021053 156 YRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGLKAATKK 222 (318)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~ 222 (318)
...... .....+|+.|+|||++.+..+++++||||+||++|+|++|++||.+.+.....
T Consensus 169 ~~~~~~--------~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~ 227 (355)
T d2b1pa1 169 AGTSFM--------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred cccccc--------cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHH
Confidence 544322 23557899999999999999999999999999999999999999876654433
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=333.58 Aligned_cols=248 Identities=21% Similarity=0.270 Sum_probs=192.2
Q ss_pred cceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCC----hhHHHHHHHHHHHcCCCCCCeeeecc-----ccCc
Q 021053 6 GVKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKH----PQLLYEAKVYKILQGGSGIPNIKWYG-----VDGE 76 (318)
Q Consensus 6 ~~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~i~~~~-----~~~~ 76 (318)
.+||++.+.||+|+||+||+|++..+++.||||++...... ..+.+|+.++++++|++.+.....+. .+..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999999999999999998755432 25678999999998755444333332 2234
Q ss_pred ceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEEeccceeee
Q 021053 77 DNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAKKY 156 (318)
Q Consensus 77 ~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~~~ 156 (318)
..++++++++++|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|++|||.+...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc---cccccccccccchhccc
Confidence 4666666669999998864 569999999999999999999999999999999999999 58899999999998754
Q ss_pred cCCCCCccccccCCCCCcccccccccccccCCC-CCCcchHHHHHHHHHHHHhCCCCccchhHhhhHHHHHHHHHhhccC
Q 021053 157 RDPTTNRHIPYRENKNLTGTARYASCNTHLGIE-QSRRDDLESLGYVLLYFLRGSLPWQGLKAATKKQKYDKICEKKVST 235 (318)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~tg~~pf~~~~~~~~~~~~~~i~~~~~~~ 235 (318)
.... ....|++.|+|||+..+.. ++.++||||+||++|+|++|++||.+.+.......+.. .....
T Consensus 172 ~~~~----------~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~---~~~~~ 238 (348)
T d2gfsa1 172 DDEM----------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR---LVGTP 238 (348)
T ss_dssp TGGG----------SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---HHCCC
T ss_pred Cccc----------ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHH---hcCCC
Confidence 3322 3457899999999877665 68999999999999999999999987655433333322 22222
Q ss_pred ch--------------------------HHHhhcCchhHHHHHHHHhhcCCCCCCChHHHHH
Q 021053 236 PI--------------------------EVLCKSHPAEFASYFHYCQSLTFDQRPDYGFLKR 271 (318)
Q Consensus 236 ~~--------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 271 (318)
+. .......++.+.+++.+||..||.+|||+.++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 21 1122356778889999999999999999998776
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.5e-42 Score=302.14 Aligned_cols=205 Identities=25% Similarity=0.302 Sum_probs=156.0
Q ss_pred Ccccc-ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCC----------CCCeee
Q 021053 2 ERIIG-VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGS----------GIPNIK 69 (318)
Q Consensus 2 ~~~~~-~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~----------~~~~i~ 69 (318)
++++. +||++++.||+|+||+||+|++..+++.||||+++.... .....+|+.+++.+.|.+ ++..+.
T Consensus 7 g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~ 86 (362)
T d1q8ya_ 7 GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 86 (362)
T ss_dssp TCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred CCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence 45444 579999999999999999999999999999999876432 245678999999887643 344333
Q ss_pred eccc--cCcceEEEEecc--CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceeeccCCC--
Q 021053 70 WYGV--DGEDNVLVLDLL--GPSLEDLFVY-CRRKFSLKTVLMLADQMIARIEYVHS-RGFLHRDIKPDNFLMGLGRK-- 141 (318)
Q Consensus 70 ~~~~--~~~~~~lv~e~~--~~~L~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~-~~i~H~dl~p~Nil~~~~~~-- 141 (318)
.++. .....++++.++ .++....... ....+++..++.++.||+.||.|||+ .||+||||||+|||+...+.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence 3322 233455555555 4444444333 23458899999999999999999998 89999999999999952211
Q ss_pred -CCeEEEEeccceeeecCCCCCccccccCCCCCcccccccccccccCCCCCCcchHHHHHHHHHHHHhCCCCccch
Q 021053 142 -ANQVYIIDFGLAKKYRDPTTNRHIPYRENKNLTGTARYASCNTHLGIEQSRRDDLESLGYVLLYFLRGSLPWQGL 216 (318)
Q Consensus 142 -~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~tg~~pf~~~ 216 (318)
...++++|||.+....... ....+|+.|+|||++.+..++.++||||+||++++|++|+.||...
T Consensus 167 ~~~~~kl~dfg~s~~~~~~~----------~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEHY----------TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp TEEEEEECCCTTCEETTBCC----------CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred ccceeeEeeccccccccccc----------ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 1258999999987654332 2457899999999999999999999999999999999999999754
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=3.6e-24 Score=170.46 Aligned_cols=132 Identities=20% Similarity=0.311 Sum_probs=96.2
Q ss_pred eeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCCC--------------------ChhHHHHHHHHHHHcCCCCCCee
Q 021053 9 YKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTK--------------------HPQLLYEAKVYKILQGGSGIPNI 68 (318)
Q Consensus 9 y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~--------------------~~~~~~e~~~l~~l~~~~~~~~i 68 (318)
|-++++||+|+||.||+|.+. +|+.||||++..... .....+|...+.++.+.+. +..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v-~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAV-PKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSS-CCE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCc-ceE
Confidence 468999999999999999985 688999998653211 0123456677777766443 332
Q ss_pred eeccccCcceEEEEeccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceeeccCCCCCeEEEE
Q 021053 69 KWYGVDGEDNVLVLDLLGPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHSRGFLHRDIKPDNFLMGLGRKANQVYII 148 (318)
Q Consensus 69 ~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~Nil~~~~~~~~~~kL~ 148 (318)
..+ ...+++||++.+... ..++......++.|++.+|.|||++||+||||||+|||++ +..++|+
T Consensus 80 ~~~----~~~~lvme~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~----~~~~~li 144 (191)
T d1zara2 80 YAW----EGNAVLMELIDAKEL-------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWII 144 (191)
T ss_dssp EEE----ETTEEEEECCCCEEG-------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE----TTEEEEC
T ss_pred EEe----cCCEEEEEeeccccc-------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeee----CCCEEEE
Confidence 222 124799999965321 1244455677899999999999999999999999999994 4568999
Q ss_pred eccceeeec
Q 021053 149 DFGLAKKYR 157 (318)
Q Consensus 149 dfg~~~~~~ 157 (318)
|||.+....
T Consensus 145 DFG~a~~~~ 153 (191)
T d1zara2 145 DFPQSVEVG 153 (191)
T ss_dssp CCTTCEETT
T ss_pred ECCCcccCC
Confidence 999987643
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.50 E-value=4.5e-07 Score=73.74 Aligned_cols=137 Identities=18% Similarity=0.186 Sum_probs=89.6
Q ss_pred ceeeEeeeeccCcccEEEEEEEcCCCcEEEEEeecCCC--CChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 7 VKYKLGRKIGSGSFGEIFLASHVDTNEIVAVKIENSGT--KHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 7 ~~y~~~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
..|++.+..+.++.+.||++.. +++.+++|+..... ......+|...+..+..+-.++.+..++...+..++||++
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~ 91 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence 4677777766666789999863 56677888765432 2346788999998887654456666666666788999999
Q ss_pred c-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 021053 85 L-GPSLEDLFVYCRRKFSLKTVLMLADQMIARIEYVHS------------------------------------------ 121 (318)
Q Consensus 85 ~-~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~------------------------------------------ 121 (318)
. +.++.+.... ... ...++.++...+..||+
T Consensus 92 l~G~~~~~~~~~---~~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 92 ADGVLCSEEYED---EQS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHTTT---CSC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred cccccccccccc---ccc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 9 4455433221 011 12233444444555553
Q ss_pred -----------------CCccccCCCCCceeeccCCCCCeEEEEecccee
Q 021053 122 -----------------RGFLHRDIKPDNFLMGLGRKANQVYIIDFGLAK 154 (318)
Q Consensus 122 -----------------~~i~H~dl~p~Nil~~~~~~~~~~kL~dfg~~~ 154 (318)
..++|+|+.|.||++. ..+.+-|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDLGRSG 212 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeec---CCceEEEeechhcc
Confidence 1268999999999993 44445699998765
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.17 E-value=7.5e-06 Score=70.48 Aligned_cols=74 Identities=16% Similarity=0.191 Sum_probs=47.0
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecC------C---CCChhHHHHHHHHHHHcCC--CCCCeeeeccccCcceEE
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENS------G---TKHPQLLYEAKVYKILQGG--SGIPNIKWYGVDGEDNVL 80 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~------~---~~~~~~~~e~~~l~~l~~~--~~~~~i~~~~~~~~~~~l 80 (318)
.+.||.|....||++.+..+++.+++|.-.. . ....+...|...+..+... ...+.+..+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 5678999999999999877788899994221 1 1123456788888887643 223334333 4456789
Q ss_pred EEeccCC
Q 021053 81 VLDLLGP 87 (318)
Q Consensus 81 v~e~~~~ 87 (318)
+||++.+
T Consensus 109 vmE~L~~ 115 (392)
T d2pula1 109 VMEDLSH 115 (392)
T ss_dssp EECCCTT
T ss_pred EEeccCC
Confidence 9999843
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.82 E-value=5.5e-05 Score=60.55 Aligned_cols=72 Identities=18% Similarity=0.087 Sum_probs=48.6
Q ss_pred eeccCc-ccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCC-CCeeeeccccCcceEEEEeccCC
Q 021053 14 KIGSGS-FGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSG-IPNIKWYGVDGEDNVLVLDLLGP 87 (318)
Q Consensus 14 ~lg~G~-~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~-~~~i~~~~~~~~~~~lv~e~~~~ 87 (318)
.+..|. .+.||++... ++..+++|..... ....+..|...++.+..... ++.+..+..+.+..+++|+++.|
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~-~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G 90 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG-ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG 90 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSC-TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred EcCCcccCCeEEEEEeC-CCCEEEEEeCCcc-CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence 344444 4678999753 4556788976543 34567889999988876543 44455555666778999999943
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.33 E-value=0.00054 Score=58.55 Aligned_cols=72 Identities=13% Similarity=0.123 Sum_probs=52.4
Q ss_pred eeeeccCcccEEEEEEEcC-------CCcEEEEEeecCCCCChhHHHHHHHHHHHcCCCCCCeeeeccccCcceEEEEec
Q 021053 12 GRKIGSGSFGEIFLASHVD-------TNEIVAVKIENSGTKHPQLLYEAKVYKILQGGSGIPNIKWYGVDGEDNVLVLDL 84 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~~~~~i~~~~~~~~~~~lv~e~ 84 (318)
++.|+.|-...+|++.... ....|++++...........+|..+++.+......+.+..++.+ ++|++|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ef 122 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEY 122 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECC
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEE
Confidence 4678889999999998753 23568888876444445677899999998877767777666543 578888
Q ss_pred cCC
Q 021053 85 LGP 87 (318)
Q Consensus 85 ~~~ 87 (318)
..|
T Consensus 123 i~g 125 (395)
T d1nw1a_ 123 IPS 125 (395)
T ss_dssp CCE
T ss_pred ecc
Confidence 843
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.33 E-value=0.0014 Score=53.98 Aligned_cols=50 Identities=12% Similarity=0.148 Sum_probs=31.6
Q ss_pred eeeeccCcccEEEEEEEcCCCcEEEEEeecCCCCChhHHHHHHHHHHHcCCC
Q 021053 12 GRKIGSGSFGEIFLASHVDTNEIVAVKIENSGTKHPQLLYEAKVYKILQGGS 63 (318)
Q Consensus 12 ~~~lg~G~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~~~~ 63 (318)
.+.|..|.-.+.|++... +..+++|+............|..++..|.+..
T Consensus 23 ~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~~~~~l~~~~~~l~~L~~~g 72 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKG 72 (316)
T ss_dssp EEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTT
T ss_pred eecCCCCcccCeEEEEEC--CCcEEEEEcCCCCCHHHHHHHHHHHHhhhhcc
Confidence 344557777899999864 34589999876555566777888888886543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.99 E-value=0.0025 Score=52.62 Aligned_cols=69 Identities=12% Similarity=-0.022 Sum_probs=43.7
Q ss_pred CcccEEEEEEEcCCCcEEEEEeecCCCC-ChhHHHHHHHHHHHcCCCCCCe--ee----eccccCcceEEEEeccCC
Q 021053 18 GSFGEIFLASHVDTNEIVAVKIENSGTK-HPQLLYEAKVYKILQGGSGIPN--IK----WYGVDGEDNVLVLDLLGP 87 (318)
Q Consensus 18 G~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~e~~~l~~l~~~~~~~~--i~----~~~~~~~~~~lv~e~~~~ 87 (318)
+.-..||++.. .+|+.|++|+..+... ...+..|...+..|......+. +. .........+.++++..|
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence 44468999975 4678899999876543 3457788888888875432211 11 111234557888888743
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.75 E-value=0.033 Score=45.55 Aligned_cols=25 Identities=4% Similarity=-0.044 Sum_probs=21.9
Q ss_pred cCCchhHHHhhhcCCccccccccee
Q 021053 280 EGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 280 ~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
+..+|+.+||++||.+|||+.+.+.
T Consensus 273 ~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 273 EFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHhh
Confidence 4467999999999999999999875
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=87.56 E-value=0.04 Score=45.59 Aligned_cols=27 Identities=11% Similarity=-0.041 Sum_probs=20.9
Q ss_pred HhcCCchhHHHhhhcCCccccccccee
Q 021053 278 SREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 278 ~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
.++..+|+.+||.+||.+|||+.|++.
T Consensus 301 ~~~~~dll~~mL~~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 301 AKEISDFLSPMLQLDPRKRADAGGLVN 327 (362)
T ss_dssp HHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 445567888888888888888888764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.30 E-value=0.049 Score=45.08 Aligned_cols=23 Identities=13% Similarity=0.150 Sum_probs=11.6
Q ss_pred CCchhHHHhhhcCCcccccccce
Q 021053 281 GSLLLQFIMSYCSLHSITFQTNI 303 (318)
Q Consensus 281 ~~~~~~~~l~~~p~~r~t~~~~~ 303 (318)
..+|+++||.+||++|+||+|.+
T Consensus 287 ~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 287 ARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHHHCcCChhHCcCHHHHh
Confidence 34455555555555555555443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=85.68 E-value=0.04 Score=45.04 Aligned_cols=26 Identities=15% Similarity=0.161 Sum_probs=20.7
Q ss_pred hcCCchhHHHhhhcCCccccccccee
Q 021053 279 REGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 279 ~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
++..+|+++||.+||.+|+|++|.+.
T Consensus 293 ~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 293 PEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 34457888999999999999888764
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.94 E-value=0.085 Score=42.32 Aligned_cols=27 Identities=15% Similarity=0.060 Sum_probs=23.1
Q ss_pred HhcCCchhHHHhhhcCCccccccccee
Q 021053 278 SREGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 278 ~~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
.++..+|+++||++||++|+|+.|++.
T Consensus 253 s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 253 GDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 345568999999999999999999875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.64 E-value=0.077 Score=42.30 Aligned_cols=24 Identities=21% Similarity=0.307 Sum_probs=19.2
Q ss_pred CCchhHHHhhhcCCccccccccee
Q 021053 281 GSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 281 ~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
..+|+.+||++||.+||||+|.+.
T Consensus 259 ~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 259 GRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHccCChhHCcCHHHHhc
Confidence 346788889999999998888764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.62 E-value=0.056 Score=44.62 Aligned_cols=25 Identities=16% Similarity=0.127 Sum_probs=21.8
Q ss_pred cCCchhHHHhhhcCCccccccccee
Q 021053 280 EGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 280 ~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
+..+|+++||++||++|+|+.|.+.
T Consensus 278 ~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 278 EAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhc
Confidence 4457899999999999999999874
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.24 E-value=0.1 Score=42.20 Aligned_cols=26 Identities=8% Similarity=-0.015 Sum_probs=21.5
Q ss_pred hcCCchhHHHhhhcCCccccccccee
Q 021053 279 REGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 279 ~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
++..+|+.+||++||.+|+|++|.+.
T Consensus 279 ~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 279 PYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 34467899999999999999998763
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.11 E-value=0.067 Score=44.01 Aligned_cols=25 Identities=12% Similarity=0.061 Sum_probs=21.8
Q ss_pred cCCchhHHHhhhcCCccccccccee
Q 021053 280 EGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 280 ~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
+..+|+.+||.+||.+|||+++.+.
T Consensus 276 ~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 276 LAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHCcCChhHCcCHHHHhc
Confidence 3457999999999999999999874
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.79 E-value=0.11 Score=41.71 Aligned_cols=24 Identities=17% Similarity=0.218 Sum_probs=21.1
Q ss_pred CCchhHHHhhhcCCccccccccee
Q 021053 281 GSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 281 ~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
..+|+++||++||.+|+|+.|.+.
T Consensus 269 ~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 269 GKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHCcCChhHCcCHHHHhc
Confidence 356899999999999999999765
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.52 E-value=0.058 Score=44.39 Aligned_cols=26 Identities=19% Similarity=0.048 Sum_probs=22.7
Q ss_pred hcCCchhHHHhhhcCCccccccccee
Q 021053 279 REGSLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 279 ~~~~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
++..+|+++||.+||.+|+|+.|.+.
T Consensus 275 ~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 275 PLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 34568999999999999999999875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=82.47 E-value=0.12 Score=41.08 Aligned_cols=23 Identities=17% Similarity=0.077 Sum_probs=20.5
Q ss_pred CchhHHHhhhcCCccccccccee
Q 021053 282 SLLLQFIMSYCSLHSITFQTNII 304 (318)
Q Consensus 282 ~~~~~~~l~~~p~~r~t~~~~~~ 304 (318)
.+|+++||++||.+|+|+.|.+.
T Consensus 258 ~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 258 IDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHccCChhHCcCHHHHhc
Confidence 47899999999999999988763
|